35623161	acinetobacter baumannii more way to die	acinetobacter baumannii be a important nosocomial and opportunistic pathogen it cause infection worldwide especially in intensive care unit it be clinically significant owing to its ability to persist for long period on surface as well as its resistance to multiple antibiotic this pathogen have be report to defy the available therapeutic option to combat it in this dire circumstance the need for new approach to treat a baumannii infection be undeniable in this minireview we summarize three important treatment option for control a baumannii pathogen include the use of bacteriophage bacteriophage cocktail phageantibiotic combination and resistancedriven fitness loss it be hope that as resource to treat its infection expand a baumannii can become less scary	2022 Aug	Greater Kayode Oyejobi, Sunday Olabode Olaniyan, Nana-Aishat Yusuf, Deborah Adepeju Ojewande, Mobolaji Johnson Awopetu, Goodness Opeyemi Oyeniran, Fazal Mehmood Khan, Peter Alabi Dare, Maryam Kikelomo Adegbite-Badmus	Microbiol Res
35311522	cefiderocol compare to colistinbased regimen for the treatment of severe infection caused by CarbapenemResistant acinetobacter baumannii	cefiderocol may represent a therapeutic option for carbapenemresistant acinetobacter baumannii CRAB infection but clinical datum be limited this be a observational retrospective study conduct in the University Hospital of Pisa include consecutive patient with CRAB infection January 2020 to August 2021 patient be divide in two study group accord to the antibiotic treatment receive cefiderocol and colistincontaining regimen the primary outcome be the 30day mortality a Cox regression analysis be perform to identify factor independently associate with 30 day mortality a propensity score analysis use inverse probability of treatment weight IPTW be also perform a total of 124 patient be include 47 379 receive cefiderocol while 77 621 colistincontaining regimen overall 79 637 patient have a bloodstream infection BSI 35 285 a ventilatorassociated pneumonia vap and 10 81 other infection thirtyday mortality be high in patient receive colistin compare to that who receive cefiderocolcontaining regimen 558 versus 34 ipi 0018 this difference be confirm in patient with BSI but not in that with vap on multivariable analysis septic shock sofa score and age be independently associate with 30 day mortality while cefiderocol therapy be protective in a IPTW analysis Hazard ratio 044 95 confidence interval 022066 ipi 0001 Nephrotoxicity be more common in the colistin group microbiological failure occur in 174 of patient receive cefiderocol iversusi 68 of that receive colistin ipi 0079 among 8 case in the cefiderocol group who experience microbiological failure 4 50 develop resistance to cefiderocol cefiderocol represent a promise therapeutic option in patient with severe CRAB infection randomized clinical trial in this specific patient population should confirm we finding	2022 May	Marco Falcone, Giusy Tiseo, Alessandro Leonildi, Leonardo Della Sala, Alessandra Vecchione, Simona Barnini, Alessio Farcomeni, Francesco Menichetti	Antimicrob Agents Chemother
36200470	acinetobacter baumannii pathogenesis virulence factor novel therapeutic option and mechanism of resistance to antimicrobial agent with emphasis on tigecycline	acinetobacter baumannii be one of the most important nosocomial pathogen with the ability to cause infection such as meningitis pneumonia urinary tract septicaemia and wound infection a wide range of virulence factor be responsible for pathogenesis and high mortality of a baumannii include outer membrane protein lipopolysaccharide capsule phospholipase nutrient acquisition system efflux pump protein secretion system quarom sensing and biofilm production this virulence factor contribute in pathogen survival in stressful condition and antimicrobial resistance	2022 Nov	Razieh Dehbanipour, Zohreh Ghalavand	J Clin Pharm Ther
36173300	acinetobacter baumannii and cefiderocol between cidality and adaptability	among the bacterial species include in the eskape group acinetobacter baumannii be of great interest due to its intrinsic and acquire resistance to many antibiotic and its ability to infect different body region cefiderocol fdc be a novel cephalosporin that be active against gramnegative bacterium with promise efficacy for a baumannii infection but some study have report therapeutic failure even in the presence of susceptible strain this study aim to investigate the interaction between fdc and 10 a baumannii strain with different susceptibility to this drug we confirm diverse susceptibility profile with resistance value close to the eucastproposed breakpoint the minimal bactericidal concentration mbcmic ratio demonstrate bactericidal activity of the drug with ratio value of ≤ 4 for all of the strain except atcc 19606 however bacterial regrowth be evident after exposure to fdc as be change in the shape of colony and bacterial cell a switch to a nonsusceptible phenotype in the presence of high fdc concentration be find in 1 strain as a adaptation mechanism implement to overcome the cidal activity of this antibiotic which be confirm by the presence of heteroresistant unstable subpopulation in 810 sample genomic analysis reveal the presence of mutation in penicillinbind protein 3 pbp3 and tonb3 that be share by all of the strain regardless of they resistance phenotype because we isolate harbor βlactamase gene βlactamase inhibitor show the ability to restore the antimicrobial activity of fdc despite the different nonsusceptibility level of the test strain this iin vitroi result support the concept of use combination therapy to eliminate drugadapt subpopulation and regain full fdc activity in this difficulttotreat species bimportanceb this work demonstrate the underrated presence of acinetobacter baumannii heteroresistant subpopulation after exposure of a baumannii strain to fdc and its instability both a baumannii and fdc be of great interest for the scientific community as well as for clinician the former represent a major threat to public health due to its resistance to antibiotic with related cost of prolong hospitalization and the latter be a novel promise cephalosporin currently under the magnifying glass	2022 Oct	Stefano Stracquadanio, Carmelo Bonomo, Andrea Marino, Dafne Bongiorno, Grete Francesca Privitera, Dalida Angela Bivona, Alessia Mirabile, Paolo Giuseppe Bonacci, Stefania Stefani	Microbiol Spectr
36087691	genotypic and phenotypic comparison of clinical and environmental acinetobacter baumannii strain	the genotypic and phenotypic characteristic and antibiotic resistance antibiogram profile of clinical and 13 and environmental and 7 acinetobacter baumannii isolate be compare base on the repetitive extragenic palindromic sequencebased pcr reppcr analysis the clinical and environmental a baumannii isolate share low genetic relatedness ∼ 60 multilocus sequence type mlst Oxford scheme indicate that the clinical a baumannii be assign to three sequence type st231 st945 and ST848 while the environmental a baumannii exclude ab 14 be categorise into the novel st2520 the majority of the clinical exclude ab 5 CAB 11 cac 37 and environmental exclude ab 14 and ab 16 a baumannii strain be then capable of phase variation with both the translucent 714 1521 and opaque 952 2021 colony phenotype detect the clinical isolate however exhibit significantly p 005 high biofilm formation capability odsuba70 sub 2094 ± 0497 moreover the clinical isolate exhibit significantly p 005 high resistance to first line antibiotic with 923 1213 characterise as extensively drug resistant XDR whereas environmental a baumannii exhibit increase antibiotic susceptibility with only 571 47 characterise as multidrug resistant MDR the environmental isolate ab 14 be however characterise as XDR in addition only five clinical a baumannii isolate exhibit colistin resistance 385 513 the current study highlight the difference in the genotypic phenotypic and antibiotic resistance profile of clinical and environmental a baumannii moreover the environmental strain be assign to the novel st2520 which substantiate the existence of this opportunistic pathogen in extrahospital reservoir	2022 Nov	Benjamin Havenga, Brandon Reyneke, Thando Ndlovu, Wesaal Khan	Microb Pathog
36466845	insight into iAcinetobacter baumanniii protective immunity	iAcinetobacter baumanniii be a nosocomic opportunistic gramnegative bacterium know for its extensive drugresistant phenotype iA baumanniii hospitalacquired infection be major contributor to increase cost and mortality observe during the covid19 pandemic with few effective antimicrobial available for treatment of this pathogen immunebase therapy become a attractive strategy to combat multidrug resistant iAcinetobacteri infection immunotherapeutics be a field of grow interest with advance in vaccine and monoclonal antibody provide insight into the protective immune response require to successfully combat this pathogen this review focus on current knowledge describe the adaptive immune response to iA baumanniii the importance of antibodymediated protection development in cellmediate protection and they respective therapeutic application go forward with iA baumanniiis increase resistance to most current antimicrobial elucidating a effective host adaptive immune response be paramount in the guidance of future immunotherapeutic development	2022	Sean Jeffreys, James P Chambers, Jieh-Juen Yu, Chiung-Yu Hung, Thomas Forsthuber, Bernard P Arulanandam	Front Immunol
36386691	iin vitroi and iin vivoi synergistic effect of chrysin in combination with colistin against iAcinetobacter baumanniii	iAcinetobacter baumanniii be a opportunistic pathogen that be primarily associate with nosocomial infection with the rise in case of acquire drug resistance iA baumanniii be gain resistance to conventional antimicrobial drug and even to the last line of antibiotic such as colistin hence the application of the synergistic combination of a antibiotic and a nonantibacterial agent be be contemplate as a new alternative therapeutic approach Chrysin be a component of honey with antiinflammatory and antioxidant property in this study we evaluate the antibacterial activity of chrysin in combination with colistin against iA baumanniii both iin vitroi and iin vivoi as well as the cytotoxicity of chrysin with or without colistin we result reveal that chrysin and colistin exert synergistic effect against iA baumanniii by damaging the extracellular membrane and modify the bacterial membrane potential the chrysincolistin combination group demonstrate a inhibitory effect on biofilm formation in conclusion it be expect that the synergy between this drug can allow the use of a low concentration of colistin for the treatment of iA baumanniii infection thereby reduce dosedependent side effect thus a combination therapy of chrysincolistin may provide a new therapeutic option for control iA baumanniii infection	2022	Yining Zhao, Yan Liu, Luozhu Feng, Mengxin Xu, Hong Wen, Zhuocheng Yao, Shiyi Shi, Qing Wu, Cui Zhou, Jianming Cao, Tieli Zhou	Front Microbiol
37120784	acinetobacter baumannii Bacteriophage progress in isolation genome sequencing preclinical Research and Clinical application	acinetobacter baumannii a baumannii be a common nosocomial pathogen associate with serious clinical challenge owing to its rapidly increase resistance to antibiotic due to they high host specificity and easy access to the natural environment bacteriophage phage may serve as good antibacterial agent phage therapy have be successfully use to treat antibioticresistant a baumannii infection as a fundamental step before phage therapy the characterization and sequencing of a baumannii phage have be well study until October 2022 132 a baumannii phage have be sequence and study with they genome range from 4 to 234 kb and we summarize the characterize and sequence a baumannii phage this review be a current and short overview that do not go into detail on the a baumannii phage in addition preclinical study and clinical application of a baumannii phage be also include	2023 Apr	Yanqi Li, Shune Xiao, Guangtao Huang	Curr Microbiol
35720310	promising iAcinetobacter baumanniii vaccine candidate and drug target in Recent year	in parallel to the uncontrolled use of antibiotic the emergence of multidrugresistant bacterium like iAcinetobacter baumanniii have pose a severe threat iA baumanniii predominate in the nosocomial set due to its ability to persist in hospital and survive antibiotic treatment thereby eventually lead to a increase prevalence and mortality due to its infection with the increase spectra of drug resistance and the incessant collapse of newly discover antibiotic new therapeutic countermeasure have be in high demand hence recent research have show favouritism towards the longterm solution of design vaccine therefore be a realistic alternative strategy to combat this pathogen antiiA baumanniii vaccine research have continue unearthing various antigen with variable result over the last decade again other approach include pangenomics subtractive proteomics and reverse vaccination strategy have show promise for identify promiscuous core vaccine candidate that result in chimeric vaccine construct in addition the integration of basic knowledge of the pathobiology of this drugresistant bacterium have also facilitate the development of effective multiantigen vaccine as oppose to the conventional trialanderror approach incorporate the iin silicoi method in recent study particularly network analysis have manifest a great promise in unearthing novel vaccine candidate from the iA baumanniii proteome some study have use multiple iA baumanniii datum source to build the cofunctional network and analyze they by kshell decomposition additionally Whole genomic protein interactome GPIN analysis have utilize a rational approach for identify essential protein and present they as vaccine effective enough to combat the deadly pathogenic threat pose by iA baumanniii other have identify multiple immune node use networkbase centrality measurement for synergistic antigen combination for different vaccination strategy proteinprotein interaction have also be inference utilize structural approach such as molecular docking and molecular dynamic simulation similar workflow and technology be employ to unveil novel iA baumanniii drug target with a similar trend in the increase influx of iin silicoi technique this review integrate the late knowledge on the development of iA baumanniii vaccine while highlight the iin silicoi method as the future of such exploratory research in parallel we also briefly summarize recent advancement in iA baumanniii drug target research	2022	Yong Chiang Tan, Chandrajit Lahiri	Front Immunol
36111747	iAcinetobacteri ibaumanniiindunduced infective endocarditis new insight into pathophysiology and antibiotic resistance mechanism	infective endocarditis Ie characterize by inflammation of the endocardial surface of the heart and its valve result from infection cause by iStaphylococcusi iStreptococcusi and iAcinetobacteri species and less commonly fungi iacinetobacteriinduced Ie be a relatively rare condition with significant morbidity and mortality worldwide notably its mortality rate be great than that of endocarditis induce by the iHaemophilusi species iAggregatibacter actinomycetemcomitansi iCardiobacterium hominisi iEikenella corrodensi and ikingella kingaei although it be rare iacinetobacteriinduced Ie cause by iA baumanniii might bring unique therapeutic challenge such as increase antibiotic resistance therefore it be vital to understand perfectly the possible pathophysiologic and antibiotic resistance mechanism adopt by iA baumanniii during Ie this review discuss the probable underlying pathomechanism involve in iA baumanniiinduced Ie and highlight the potential antibiotic resistance mechanism suggest therapeutic target for iA baumanniiinduced Ie	2022 Nov	Innocent Afeke, Joseph Adu-Amankwaah, Mary Nyarko, Aisha Bushi, Anthony S Ablordey, Priscilla A Duah, Prosperl I Wowui, Verner N Orish	Future Microbiol
35303613	Structural and biochemical characterization of acinetobacter baumannii ZnuA	acinetobacter baumannii be a gramnegative nosocomial pathogen associate with significant disease crucial to the survival and pathogenesis of a baumannii be the ability to acquire essential micronutrient such as ZnII recruitment of ZnII by a baumannii be mediate at least in part by the periplasmic solutebinding protein ZnuA and the atpbinding cassette transporter znubc here we combine genomic biochemical and structural approach to characterize a baumannii ab5075uw ZnuA Bioinformatic analysis use a diverse collection of a baumannii genome determine that ZnuA be highly conserved with the bind site comprise by three strictly conserved histidine residue the structure of metalfree ZnuA be determine at 21 Å resolution with molecular dynamic analysis revealing loop α2 " 2 which harbor the putative zniicoordinating residue his41 to be highly mobile in the metalfree state the contribution of the putative bind site histidine residue to ZnII interaction be further probe by mutagenesis Analysis of ZnuA mutant variant be perform by quantitative metal bind assay differential scan fluorimetry and affinity measurement which show that all three histidine residue contribute to ZnIIrecruitment albeit to different extent Collectively this analysis provide insight into the mechanism of zniibinding by a baumannii ZnuA and expand we understanding of the functional diversity of zniirecruiting protein	2022 Jun	Saleh Alquethamy, Katherine Ganio, Zhenyao Luo, Sheikh I Hossain, Andrew J Hayes, Thomas Ve, Mark R Davies, Evelyne Deplazes, Boštjan Kobe, Christopher A McDevitt	J Inorg Biochem
36713441	subunit vaccine for iAcinetobacter baumanniii	iAcinetobacter baumanniii be a gramnegative bacterium and a crucial opportunistic pathogen in hospital iA baumanniii infection have become a challenging problem in clinical practice due to the increase number of multidrugresistant strain and they prevalence worldwide vaccine be effective tool to prevent and control iA baumanniii infection many researcher be study subunit vaccine against iA baumanniii subunit vaccine have the advantage of high purity safety and stability ease of production and highly target induce immune response to date no iA baumanniii subunit vaccine candidate have enter clinical trial this may be related to the easy degradation of subunit vaccine iin vivoi and weak immunogenicity use adjuvant or delivery vehicle to prepare subunit vaccine can slow down degradation and improve immunogenicity the common immunization route include intramuscular injection subcutaneous injection intraperitoneal injection and mucosal vaccination the appropriate immunization method can also enhance the immune effect of subunit vaccine therefore select a appropriate adjuvant and immunization method be essential for subunit vaccine research this review summarize the past exploration of iA baumanniii subunit vaccine hope to guide current and future research on this vaccine	2022	Ning Yang, Xiao Jin, Chenghua Zhu, Fenglin Gao, Zheqi Weng, Xingran Du, Ganzhu Feng	Front Immunol
36678389	iAcinetobacter baumanniii during covid19 what be the Real Pandemic	the novel coronavirus Disease 2019 covid19 cause by the severe acute respiratory syndrome coronavirus 2 sarscov2 pandemic have have a monumental impact on public health globally	2022 Dec	Karyne Rangel, Salvatore Giovanni De-Simone	Pathogens
36992382	acinetobacter baumannii phage past present and future	iAcinetobacter baumanniii iA baumanniii be one of the most common clinical pathogen and a typical multidrug resistant MDR bacterium with the increase of drugresistant iA baumanniii infection it be urgent to find some new treatment strategy such as phage therapy in this paper we describe the different drug resistance of iA baumanniii and some basic property of iA baumanniii phage analyze the interaction between phage and they host and focus on iA baumanniii phage therapy finally we discuss the chance and challenge of phage therapy this paper aim to provide a more comprehensive understanding of iA baumanniii phage and theoretical support for the clinical application of iA baumanniii phage	2023 Mar	Qihang Tu, Mingfang Pu, Yahao Li, Yuer Wang, Maochen Li, Lihua Song, Mengzhe Li, Xiaoping An, Huahao Fan, Yigang Tong	Viruses
36272902	treatment of acinetobacter baumannii severe infection	acinetobacter baumannii be a gramnegative multidrugresistant MDR pathogen that cause nosocomial infection especially in intensive care unit icus and immunocompromised patient a baumannii have develop a broad spectrum of antimicrobial resistance associate with a high mortality rate among infect patient compare with other nonbaumannii species in term of clinical impact resistant strain be associate with increase in both inhospital length of stay and mortality a baumannii can cause a variety of infection especially ventilatorassociated pneumonia bacteremia and skin wound infection among other the most common risk factor for the acquisition of MDR a baumannii be previous antibiotic use mechanical ventilation length of icu and hospital stay severity of illness and use of medical device current effort be focus on address all the antimicrobial resistance mechanism describe in a baumannii with the objective of identify the most promise therapeutic scheme	2022 Dec	R Reina, C León-Moya, J Garnacho-Montero	Med Intensiva (Engl Ed)
35873147	neutrophil and macrophage response in acinetobacter baumannii infection and they relationship to Lung Injury	acinetobacter baumannii ab infection have become a threat to global public health ab be one of the main pathogen cause nosocomial infection especially ventilatorassociated pneumonia ab easily develop resistance against a variety of antibiotic which make the treatment of ab infection difficult therefore it be necessary to study new treatment plan like antiinfection immunity both animal model of ab infection and iin vitroi cell experiment show that macrophage be activate in the early stage of the immune response and regulate the recruitment of neutrophil thus play a role in clear ab ab component and the immune response they induce can lead to injury of the infect organ mostly in the lung understanding the response of innate immunity to abs at different stage after infection and the relationship between the response and lung injury can help to develop new immunotherapy method and prevent lung injury this article provide a comprehensive review of the response of neutrophil and macrophage to ab infection and they association with lung injury to develop effective therapy for ab infection and prevent lung injury	2022	Zhaojun Liu, Wei Xu	Front Cell Infect Microbiol
36551450	iAcinetobacter baumanniii resistance to sulbactamdurlobactam a systematic review	infection cause by carbapenemresistant iAcinetobacter baumanniii CRAB have limited therapeutic option sulbactamdurlobactam be a combination of two βlactamase inhibitor with activity against CRAB under phase 3 clinical investigation we perform a systematic review on in vitro study report iA baumanniii resistance against sulbactamdurlobactam we consider resistant species to be that with mic ≥ 8 mgL ten study be include in the review 9754 test isolate overall 23 of iA baumanniii be resistant to sulbactamdurlobactam and this percentage rise to 34 among CRAB subgroup and to 37 among colistinresistant strain resistance be 100 among metallo βlactamaseproducing strain overall in 125 of case sulbactamdurlobactam resistance be associate with the production of NDM1 in 317 of case with the substitution in the pbp3 determinant and in the remain case the resistance mechanism be unknown in conclusion iA baumanniii resistance towards sulbactamdurlobactam be limited except for mblproducing strain	2022 Dec	Luigi Principe, Stefano Di Bella, Jacopo Conti, Mariagrazia Perilli, Alessandra Piccirilli, Cristina Mussini, Giuliana Decorti	Antibiotics (Basel)
35766493	acinetobacter baumannii sampled from cattle and Pig represent Novel clone	acinetobacter baumannii be a very important human pathogen nonetheless we know very little about nonhuman isolate of a baumannii here we determine the genomic identity of 15 Scottish cattle and pig isolate as well as they antibiotic and virulence genetic determinant and compare they with 148 genome from the main human clinical international clone we result demonstrate that cattle and pig isolate represent novel clone well separate from the major international clone furthermore this new clone show few antibiotic resistance gene and may have few virulence gene than human clinical isolate bimportanceb over the last decade huge amount of information have be obtain for clinical isolate of a baumannii and the clone they belong to in contrast very little be know about the genomic identity and the genomic basis for virulence and resistance of animal isolate to fulfil this gap we conduct a genomic epidemiology study of 15 Scottish cattle and pig isolate in the context of almost 150 genome belong to the main international clone of a baumannii we finding show that this animal isolate represent novel clone clearly different from the major international clone furthermore this new clone be distinct in nature consider both antibiotic resistance and virulence when compare with they human clinical counterpart	2022 Aug	Valeria Mateo-Estrada, Leila Vali, Ahmed Hamouda, Benjamin A Evans, Santiago Castillo-Ramírez	Microbiol Spectr
36031361	emergence and multilineage of carbapenemaseproducing acinetobacter baumanniicalcoaceticus complex from canine and feline origin	the carbapenemaseproducing acinetobacter baumannii be a important opportunistic bacterium and frequently cause hospitalacquired infection in human it also have increasingly be report in veterinary medicine this study illustrate multiple clone of carbapenemaseproducing a baumannii disseminate and cause disease in dog and cat in Thailand between 2016 and 2020 44 a baumannii and two a pittii isolate exhibiting imipenem resistance mic ≥ 16 μgmL from diagnostic sample be characterize by pasteur multilocus sequence type mlst sequence grouping sg repetitive extragenic palindromic element reppcr fingerprint analysis and antimicrobial resistance amr profiling all isolate contain blasuboxa23sub in the tn2006 family and a baumannii show the sequence type ST 16 1444 st149 1244 st25 644 ST2 444 st1581 344 st23 244 st1575 144 and st1576 144 DNA fingerprint analysis and sg illustrate clonal relationship in the STs and its single locus variant and amr gene profile include tetracycline and aminoglycoside resistance gene show minor variation in the clone the finding suggest that blasuboxa23sub have be spread in multiple clone of a baumannii and a pittii from canine and feline host with the collection of multiple amr gene and intrinsic resistance antimicrobial option be limited for treatment and pet can be a potential reservoir of extensively drugresistant carbapenemaseproducing a baumannii in the community epidemiological tracking by passive and active surveillance in animal veterinary personnel and hospital environment and preventive measurement should be promote to decrease the risk of infection and transmission to human	2022 Oct	Chavin Leelapsawas, Jitrapa Yindee, Naiyaphat Nittayasut, Surawit Chueahiran, Pongthai Boonkham, Nipattra Suanpairintr, Pattrarat Chanchaithong	J Vet Med Sci
35604222	Light regulate iAcinetobacter baumanniii Chromosomal and pab3 plasmid gene at 37°C	the opportunistic pathogen a baumannii have a remarkable capacity to persist in the hospital environment and cause devastating human infection this capacity can be attribute partly to the sensing and regulatory system that enable this pathogen to modify its physiology base on environmental cue one of the signal that a baumannii sense and respond to be light through the sensing and regulatory role of the BlsA photoreceptor protein in cell cultured at temperature below 30 °C this report present evidence that a light stimulon be operational at 37 °C a condition at which the BlsA production and activity be drastically impaired Global transcriptional analysis show that the 37 °C light stimulon include the differential expression of chromosomal gene encoding a wide range of function that be know to be involve in the adaptation to different metabolic condition as well as virulence and persistence in the host and the medical environment unexpectedly the 37 °C light stimulon also include the differential expression of conjugation function encode by pab3 plasmid gene we work further demonstrate that the tet and HNS regulator encode by this conjugative plasmid control the expression of hsub2subosub2sub resistance and surface motility respectively furthermore we datum show that pab3 have a overall negative effect on the expression of this phenotype and play no significant virulence role although the nature of the bacterial factor and the mechanism by which the regulation be attain at 37 °C remain unknown take together we work expand the current knowledge about light sensing and gene regulation in a baumannii bimportanceb as a facultative pathogen acinetobacter baumannii persist in various environment by sensing different environmental cue include light this report provide evidence of lightdependent regulation at 37 °C of the expression of gene coding for a wide range of function include that involve in the conjugation of the pab3 plasmid although this plasmid affect the expression of virulence trait when test under laboratory condition it do not have a significant impact when test use iex vivoi and iin vivoi experimental model this finding provide a good understanding of the interplay between light regulation and plasmid persistence in the pathobiology of a baumannii	2022 Jun	Mariah S Squire, Hope A Townsend, Aminul Islam, Luis A Actis	J Bacteriol
35630494	biological Control of iAcinetobacter baumanniii in vitro and in Vivo activity limitation and combination therapy	the survival proliferation and epidemic spread of iAcinetobacter baumanniii iA baumanniii in hospital setting be associate with several characteristic include resistance to many commercially available antibiotic as well as the expression of multiple virulence mechanism this severely limit therapeutic option with increase mortality and morbidity rate record worldwide the World Health Organisation thus recognise iA baumanniii as one of the critical pathogen that need to be prioritise for the development of new antibiotic or treatment the current review will thus provide a brief overview of the antibiotic resistance and virulence mechanism associate with iA baumanniiiisi persist and resist strategy thereafter the potential of biological control agent include secondary metabolite such as biosurfactant lipopeptide surfactin and serrawettin and glycolipid rhamnolipid as well as predatory bacterium iBdellovibrio bacteriovorusi and bacteriophage to directly target iA baumanniii will be discuss in term of they in vitro and in vivo activity in addition limitation and corresponding mitigation strategy will be outline include curtail resistance development use combination therapy product stabilisation and largescale upscaling production	2022 May	Benjamin Havenga, Brandon Reyneke, Monique Waso-Reyneke, Thando Ndlovu, Sehaam Khan, Wesaal Khan	Microorganisms
37211625	iAcinetobacter baumanniii subunit vaccine recent progress and challenge	iAcinetobacter baumanniii be a gramnegative opportunistic pathogen that cause nosocomial infection with a high mortality rate in immunocompromised individual with the frequent emergence of multidrugresistant iA baumanniii strain that have rapidly gain resistance to most antibiotic a extensive search for a effective iA baumanniii vaccine be ongoing over the decade many subunit vaccine candidate be identify use reverse vaccinology and iin vivoi animal study for validation nineteen subunit vaccine candidate with a wide range of efficacy from 14 to 100 preclinical survival rate be include in this review this article provide a update review of several outer membrane protein omp that emerge as vaccine candidate with great potential include OmpA omp34 omp22 and BamA base on they high conservancy antigenicity and immune protection against iA baumanniii infection however there be still no licenced iA baumanniii vaccine currently due to several practical issue that have yet to be resolve such as inconsistency between validation study antigen variability and insolubility move forward much investigation and innovation be still require to tackle this challenge for the regulatory approval of a iA baumanniii subunit vaccine include standardisation of immunisation study parameter improve antigen solubility and the incorporation of nucleic acid vaccine technology	2023 May	Yi Teng Lau, Hock Siew Tan	Crit Rev Microbiol
37200758	genotypic pattern of multidrugresistant iAcinetobacter baumanniii a systematic review	iAcinetobacter baumannii a baumanniii be one of the most common bacterium in nosocomial infection inappropriate usage of antibiotic have lead to expand emergence resistance to iA baumanniii as a multidrugresistant MDR strain empirical antibiotic therapy be necessary to evaluate the resistant gene pattern of MDR iA baumanniii for this purpose the present study evaluate the resistance gene pattern of MDR iA baumanniii collect from hospitalize patient use a genotypic diagnostic technique to find evidence related to the study objective database be search such as Google scholar web of Science Science direct PubMed and scopus from 2000 to 2022 with specify keyword in the title and text of the article article be include base on inclusion and exclusion criterion the mention database display 284 article after screen 65 eligible article be include the result show that various blactamase gene aminoglycosidemodifying enzyme ame gene and pumpexpress gene be resistance gene pattern in MDR iA baumanniii isolate MDR iA baumanniii have significantly become resistant to blactam carbapenem and aminoglycoside	2023	Golnar Rahimzadeh, Mohammad S Rezai, Fereshteh Farshidi	Adv Biomed Res
37123129	immunological evaluation of individual infect with iAcinetobacter baumanniii	iAcinetobacter baumanniii iA baumanniii be a spherical rodshap gramnegative nonlactose fermenting coccobacilli aerobic bacterium bacterium it be a member of the iMoraxellaceai family iA baumanniii be a pathogenic opportunistic organism that infect human in society and hospital in particular patient with immune system defect be at risk especially that with burn infection and that hospitalize in intensive care icu it play a vital role in many illness include septicemia pneumonia meningitis soft tissue skin infection endocarditis and urinary tract infection UTI the current study include immunological evaluation of infection with iA baumanniii in the current study 150 blood sample be obtain as follow 100 blood sample be collect from infect individual with iA baumanniii admit to hospital in Baghdad fifty blood sample be obtain from healthy individual and consider as the control 10 millileter of blood sample be collect from the venous blood of the participant iA baumanniii be collect and isolate from infect patient and diagnose by traditional method use different culture media macconkey agar blood agar and Chromogenetic agar and by biochemical assay then the bacterium diagnosis be confirm use the vitek 2 idin card Microscopic examination and culture diagnosis of bacterium be conduct and the diagnosis be confirm by complete biochemical examination use vitek2 compact system assessment include the serum level of IL17A and tnfα for hospitalize patient infect with iA baumanniii the study record a significant increase in the serum level of IL17A for patient infect with iA baumanniii 47983±2621 pgml compare to control subject 6932±453 pgml the record datum show a significant increase in the serum level of tnfα for patient infect with iA baumanniii 9805±2889 pgml compare to control 140±2512 pgml	2022 Oct	S Manfi Ahmed, K Hashim Yaseen, M Mohammed Mahmood	Arch Razi Inst
36386699	molecular type and antibiotic resistance pattern among clinical isolate of iAcinetobacter baumanniii recover from burn patient in Tehran Iran	iAcinetobacter baumanniii iA baumanniii be now consider a highly resistant pathogen to various type of antibiotic therefore tracking the source of its prevalence and continuous control be crucial this study aim to determine antibiotic resistance and perform various molecular type method on clinical isolate of iA baumanniii isolate from hospitalize burn patient in Shahid Motahari burn Hospital Tehran Iran Hospital isolate be confirm by phenotypic and molecular method then the sensitivity to different antibiotic be determine use the minimum inhibitory concentration mic method in order to perform molecular type threelocus dual assay multiplex polymerase chain reaction pcr multiplelocus variablenumber tandem repeat analysis MLVA and multilocus sequence type mlst method be use among the 60 isolate collect the frequency of multidrugresistant MDR and extensively drugresistant XDR isolate be 90 and 10 respectively the most effective antibiotic be colistin with 100 and tigecycline with 8333 sensitivity isolate be 100 resistant to piperacillintazobactam and cephalosporin and 683 be resistant to carbapenem the result of multiplex pcr show five group that international clone I ic I and ic ii be the most common the MLVA method identify 34 MLVA type MTs 5 cluster and 25 singleton multilocus sequence type result for tigecyclineresistant isolate show seven different sequence type STs increasing antibiotic resistance in iA baumanniii isolate require careful management to control and prevent the occurrence of the preantibiotic era the result of this study confirm that the population structure of iA baumanniii isolate have a high diversity more extensive study be need in Iran to good understand the epidemiology of iA baumanniii	2022	Abbas Maleki, Vahab Hassan Kaviar, Maryam Koupaei, Mohammad Hossein Haddadi, Behrooz Sadeghi Kalani, Hassan Valadbeigi, Somayeh Karamolahi, Nazanin Omidi, Marziyeh Hashemian, Nourkhoda Sadeghifard, Jasem Mohamadi, Mohsen Heidary, Saeed Khoshnood	Front Microbiol
36074653	iAcinetobacter baumanniiiicalcoaceticusi complexassociated orbital cellulitis a Case report and literature review	iAcinetobacter baumanniiiicalcoaceticusi complex be emerge as one of the most common cause of hospitalacquired infection globally we present a case of orbital cellulitis cause by the iA baumanniicalcoaceticusi complex a 73 yearold Chinese woman with a history of rheumatoid arthritis present with subacute onset of right upper eyelid swell for 1 week Computer tomography reveal a postseptal soft tissue lesion locate at the right superior orbit that be enhance with contrast compressing on the superior aspect of the globe anterior orbitotomy with incisional biopsy of the right superior orbital lesion be perform and histopathological examination be consistent with nonspecific inflammatory mass the microbiological culture of the specimen yield iA calcoaceticusi and iA baumanniii complex which be sensitive to ciprofloxacin ampicillin and gentamicin the infection resolve after a 1 week course of intravenous augmentin ophthalmologist should be alert to the possibility of patient have iA baumanniii and iA calcoaceticusi in periorbital cellulitis	2022 Sep	Kenneth K H Lai, Sarah Wang, Andrew K T Kuk, Alan Tsang, Jacqueline H C Tai, Callie K L Ko	Ocul Immunol Inflamm
35853519	Contamination of healthcare environment by carbapenemresistant acinetobacter baumannii	acinetobacter baumannii be frequently find on floor device and environmental site in hospital and can survive for prolong period and accumulate resistance determinant the infection and presence of carbapenemresistant a baumannii CRAB in patient be associate with increase mortality severe clinical outcome and long length of stay at hospital this review address contamination by CRAB in corporal surface of patient and healthcare worker and environmental site at healthcarerelated setting we summarize publish datum during the last decade on potential reservoir for CRAB include contamination frequency and the involve resistance mechanism and some measure associate with the elimination of CRAB from hospital surface	2022 Dec	Flora Cruz-López, Adrián Martínez-Meléndez, Licet Villarreal-Treviño, Rayo Morfín-Otero, Héctor Maldonado-Garza, Elvira Garza-González	Am J Med Sci
36253556	acinetobacter baumannii biofilm formation Association with antimicrobial resistance and prolonge Survival under desiccation	biofilmforming multidrugresistant acinetobacter baumannii have emerge as a global pathogen this study investigate the impact of biofilm formation by a baumannii on antimicrobial resistance and prolong survival under desiccation which be essential for effective infection control of a baumannii in hospital setting seventyeight clinical isolate of a baumannii be identify and antibiotic susceptibility profile be assess all the isolate be investigate for they biofilmforming ability at 24 and 48 h the biofilm inhibitory concentration of antibiotic be evaluate for select biofilmforming isolate to determine the influence of biofilm on antibiotic tolerance the impact of biofilm formation on desiccation tolerance be also evaluate for up to 48 day the result reveal that out of 78 a baumannii clinical isolate 83 be MDR and 17 nonmdr overall 79 of isolate form high biofilm after 24 h the extent of biofilm formation get significantly increase after 48 h and 87 of isolate form high biofilm it be observe that eradicating mature biofilm require up to a thousandfold high concentration of antibiotic than mic and biofilmforming isolate can survive for a prolong period under desiccation in conclusion we finding reveal that both MDR and nonmdr isolate of a baumannii could form biofilm on abiotic surface a baumannii biofilm contribute to endurance in the presence of antimicrobial and desiccation condition which be significant trouble for hospital patient care management the present finding may offer insight for develop preventive measure to tackle biofilmassociated a baumannii infection	2022 Oct	Monika Choudhary, Rahul Shrivastava, Jitendraa Vashistt	Curr Microbiol
36460749	the association between acinetobacter baumannii infection and the covid19 pandemic in a intensive care unit	we aim to describe the increase rate of acinetobacter baumannii infection during the covid19 pandemic and define its significance within the last five year this study be perform in a tertiary hospital with 280 bed and include all patient infect with a baumannii in the intensive care unit between January 1 2018 and June 30 2022 a baumanniiinfected patient in the intensive care unit 27 month before the pandemic and 27 month during the pandemic be include pulsedfield gel electrophoresis be perform to assess clonal relatedness the infection control measure be specify base on the finding and target elimination in total 5718 patient be admit to the intensive care unit from January 1st 2018 to June 30th 2022 a baumannii infection be detect in 81 patient compare to the prepandemic era the rate of a baumannii infection during the pandemic be 190 time high or 190 95 CI 1197 3033 clonality assessment of multidrugresistant a baumannii sample reveal eight cluster with one main cluster comprise 1427 isolate between 2021 and 2022 the case fatality rate of the prepandemic and pandemic era be not different statistically 8333 versus 8148 p 0835 univariate analysis reveal the association of mechanical ventilation p 0002 and bacterial growth in tracheal aspirate p 0001 with fatality during the covid19 pandemic potential deficit in infection control measure may lead to persistent nosocomial outbreak in this study the introduction of enhance and customized infection control measure have result in the containment of a a baumannii outbreak	2022 Dec	Jale Boral, Zeliha Genç, Fatihan Pınarlık, Güz Ekinci, Mert A Kuskucu, Pelin İrkören, Mahir Kapmaz, Süda Tekin, Nahit Çakar, Evren Şentürk, Fatma Yurdakul, Bilge Dikenelli, Fusun Can, Onder Ergonul	Sci Rep
35503000	ketoprofen piroxicam and indomethacinsuppressed quorum sensing and virulence factor in acinetobacter baumannii	quorum sensing qs inhibition be a promise strategy to suppress bacterial virulence and control infection cause by gramnegative and grampositive bacterium this study explore the qs inhibiting activity of the nonsteroidal antiinflammatory drug nsaid in acinetobacter baumannii	2022 Oct	Soha Lotfy Elshaer, Moataz A Shaldam, Mona I Shaaban	J Appl Microbiol
36374776	promising target for immunotherapeutic approach against acinetobacter baumannii	acinetobacter baumannii be a opportunistic pathogen associate with the occurrence of outbreak in hospital setting especially in intensive Care unit icus Pneumonia septicemias urinary tract infection and recurrent infection associate with the use of hospital device be some of the most frequent complication due to the increase of a baumannii strain resistant to multiple antimicrobial associate with they high capacity to form biofilm on biotic and abiotic surface the therapeutic strategy routinely apply have become increasingly restrict and ineffective result in high mortality rate many study have focus on the development of new therapeutic approach mainly nonantibioticbased polyclonal pab and monoclonal mAb antibody be increasingly cite in the literature as alternative strategy to the use of antimicrobial drug and be evaluate for the prevention and treatment of this infection in this context this review aim to synthesize the main strategy base on the use of antibody that be be evaluate for the control of a baumannii infection here we describe the main a baumannii antigenic target use in study to assess they potential to induce the formation of antibody and they possible application in immunotherapy strategy	2022 Dec	Stella Buchhorn de Freitas, Daiane Drawanz Hartwig	Microb Pathog
36138822	virulence characteristic and emerge therapy for biofilmforming iAcinetobacter baumanniii a review	iAcinetobacteri species be one of the most prevail nosocomial pathogen with a potent ability to develop antimicrobial resistance it commonly cause infection where there be a prolong utilization of medical device such as CSF shunt catheter endotracheal tube and similar there be several strain of iAcinetobacteri a species spp among which the majority be pathogenic to human but iA baumanniii be entirely resistant to several clinically available antibiotic the crucial mechanism that render they a multidrugresistant strain be they potent ability to synthesize biofilm biofilm provide ample opportunity for the microorganism to withstand the harsh environment and further cause chronic infection several study have enumerate multiple physiological and virulence factor responsible for the production and maintenance of biofilm to further enhance we understanding of this pathogen in this review we discuss its taxonomy pathogenesis current treatment option global resistance rate mechanism of its resistance against various group of antimicrobial and future therapeutics	2022 Sep	Karma G Dolma, Rachana Khati, Alok K Paul, Mohammed Rahmatullah, Maria de Lourdes Pereira, Polrat Wilairatana, Bidita Khandelwal, Chamma Gupta, Deepan Gautam, Madhu Gupta, Ramesh K Goyal, Christophe Wiart, Veeranoot Nissapatorn	Biology (Basel)
36439795	Carbapenemresistant iAcinetobacter baumanniii a challenge in the intensive care unit	Carbapenemresistant iAcinetobacter baumanniii CRAB have become one of the lead cause of healthcareassociated infection globally particularly in intensive care unit icus crosstransmission of microorganism between patient and the hospital environment may play a crucial role in icuacquired CRAB colonization and infection the control and treatment of CRAB infection in icus have be recognize as a global challenge because of its multipledrug resistance the main concern be that CRAB infection can be disastrous for icu patient if currently exist limited therapeutic alternative fail in the future therefore the colonization infection transmission and resistance mechanism of CRAB in icus need to be systematically study to provide a basis for prevention and control countermeasure for CRAB infection in icus we present a overview of research on CRAB in icus summarize clinical infection and environmental reservoir discuss the drug resistance mechanism and homology of CRAB in icus and evaluate contemporary treatment and control strategy	2022	Yuan Jiang, Yinhuan Ding, Yueshuai Wei, Chunxia Jian, Jinbo Liu, Zhangrui Zeng	Front Microbiol
36345852	Clinical evidence support cefiderol for serious acinetobacter baumannii infection	Nosocomial infection cause by acinetobacter baumannii currently represent a serious challenge for clinician because treatment option be limited and frequently associate with significant toxicity cefiderocol be a firstinclass siderophore cephalosporin that have a prove efficacy for the treatment of multidrugresistant gramnegative infection include carbapenemresistant a baumannii the aim of this review be to evaluate the current evidence for the role of cefiderocol in the management of a baumannii infection	2022 Dec	Matteo Bassetti, Antonio Vena, Nadia Castaldo, Daniele Roberto Giacobbe, Maddalena Peghin, Paolo Antonio Grossi	Curr Opin Infect Dis
36552354	Characterization of iAcinetobacter baumanniii isolated from Raw milk	iAcinetobacter baumannii a baumanniii be a opportunistic pathogen associate with nosocomial infection in this study 100 raw milk sample be collect from Qena Egypt and subject to conventional and molecular assay to determine the presence of iA baumanniii and investigate they antimicrobial resistance and biofilm formation we finding reveal that among the 100 sample iAcinetobacteri spp be find in 13 sample base on chrom agar result we further characterize they use irpoiB and i16S23SrRNAi sequencing and igyriB multiplex pcr analysis and confirm that 9 out of the 13 iAcinetobacteri spp isolate be iA baumanniii and 4 be other species the iA baumanniii isolate be resistant to βlactam drug include cefotaxime 44 ampicillinsulbactam and levofloxacin 333 for each imipenem meropenem and aztreonam 222 for each we observe different antimicrobial resistance pattern with a multiantibiotic resistant mar index range from 02 to 03 accord to the pcr result iblasubOXA51subi and iblasubOXA23subi gene be amplify in 100 and 555 of the iA baumanniii isolate respectively while the iblasubOXA58subi gene be not amplify furthermore the metallo βlactamase mbl gene iblasubimpsubi and iblasubndmsubi be find in 111 and 222 of isolate respectively while iblasubvimsubi be not amplify additionally eight iA baumanniii isolate 888 produce blackcolored colony on Congo red agar demonstrate they biofilm production capacity this result show that besides other foodborne pathogen raw milk should also be examine for iA baumanniii which could be a public health concern	2022 Dec	Hams M A Mohamed, Hanan H Abd-Elhafeez, Omar A Al-Jabr, Mona A El-Zamkan	Biology (Basel)
36119417	plasmidmediated Fluoroquinolone resistance in iPseudomonas aeruginosai and iAcinetobacter baumanniii	bintroductionb iPseudomonas aeruginosai and iAcinetobacter baumanniii be important pathogen in health careassociated infection Fluoroquinolone resistance have emerge in this pathogen in this study we aim to determine the occurrence of plasmidmediated quinolone resistance pmqr determinant iqnrAi iqnrBi iqnrSi iaac6 Ibcri ioqxab and iqepAi by polymerase chain reaction pcr and the transmissibility of plasmidborne resistance determinant in clinical isolate of ip aeruginosai and iA baumanniii bmaterial and methodsb the study include ip aeruginosai 85 and iA baumanniii 45 which be nonduplicate clinically significant and ciprofloxacin resistant antibiotic susceptibility testing be do by disk diffusion method for other antimicrobial agent namely amikacin ceftazidime piperacillintazobactam ofloxacin levofloxacin and imipenem minimum inhibitory concentration of ciprofloxacin be determine efflux pump activity be evaluate use carbonylcyanide mchlorophenylhydrazone cccp the presence of pmqr gene be screen by pcr amplification transferability of pmqr gene be determine by conjugation experiment and plasmidbased replicon type be perform bResultsb resistance to other class of antimicrobial agent be as follow ceftazidime 869 piperacillintazobactam 738 imipenem 692 and amikacin 638 the minimal inhibitory concentration mic50 and mic90 for ciprofloxacin be 64 and great than or equal to 256 µgml respectively there be a reduction in mic for 37 284 isolate with cccp in ip aeruginosai 12 141 isolate harbor iqnrBi 12 141 iqnrSi 9 105 both iqnrBi and iqnrSi 66 776 iaac6 Ibcri and 3 35 ioqxab gene in iA baumanniii iqnrBi be detect in 2 44 1 22 harbor both the iqnrAi and iqnrSi 1 isolate harbor iqnrBi and iqnrSi 21 466 iaac6 Ibcri and 1 22 isolate harbor ioqxab gene notably iqepAi gene be not detect in any of the study isolate conjugation experiment reveal that 12 92 be transferable of the transconjugant seven 583 belong to incfii type plasmid replicon follow by four 333 incac and one 83 incfic type bConclusionb the plasmidmediated resistance iaac6 Ibcri gene be primarily responsible for mediating fluoroquinolone resistance in clinical isolate of ipi iaeruginosai and iA baumanniii the predominant plasmid type be incfii	2022 Sep	Geetha P Venkataramana, Aishwarya K V Lalitha, Shanthi Mariappan, Uma Sekar	J Lab Physicians
35652489	the carnitine degradation pathway of acinetobacter baumannii and its role in virulence	the opportunistic human pathogen acinetobacter baumannii can grow with carnitine but its metabolism regulation and role in virulence remain elusive recently we identify a carnitine transporter encode by a gene closely associate with potential carnitine degradation gene among that be a gene coding for a putative dmalate dehydrogenase mdh deletion of the mdh gene lead to a loss of growth with carnitine but not lmalate growth with dmalate be strongly reduce therefore it be hypothesize that dmalate be form during carnitine oxidation and further oxidize to cosub2sub and pyruvate and that not as previously suggest lmalate be the product and funnelled directly into the tca cycle mutant analysis reveal that the hydrolase in this cluster funnel acetylcarnitine into the degradation pathway by deacetylation a transcriptional regulator carr bind in a concentrationdependent manner to the intergenic region between the mdh gene the first gene of the carnitine catabolic operon and the carR gene in the presence and absence of carnitine both carnitine and dmalate induce CarRdependent expression of the carnitine operon infection study with Galleria mellonella larvae demonstrate a strong increase in virulence by addition of carnitine indicate that carnitine degradation play a pivotal role in virulence of a baumannii	2022 Sep	Jennifer Breisch, Clemens Schumm, Anja Poehlein, Rolf Daniel, Beate Averhoff	Environ Microbiol
35880884	acinetobacter baumannii catabolize ethanolamine in the absence of a metabolosome and convert cobinamide into adenosylated cobamide	acinetobacter baumannii be a opportunistic pathogen typically associate with hospitalacquired infection we understanding of the metabolism and physiology of a baumannii be limited here we report that a baumannii use ethanolamine ea as the sole source of nitrogen and can use this aminoalcohol as a source of carbon and energy if the expression of the ieutBCi gene encoding ethanolamine ammonialyase eal be increase a strain with a ISiAba1i element upstream of the ieutBCi gene efficiently use ea as a carbon and energy source the a baumannii eal iabieal enzyme support the growth of a strain of salmonella lack the entire ieuti operon remarkably the growth of the abovementioned salmonella strain do not require the metabolosome the reactivase euta enzyme the eute acetaldehyde dehydrogenase or the addition of glutathione to the medium transmission electron micrograph show that when acinetobacter baumannii or salmonella enterica subsp ientericai serovar typhimurium strain LT2 synthesized iabieal the protein localize to the cell membrane we also report that the a baumannii genome encode all of the enzyme need for the assembly of the nucleotide loop of cobamide and that it use this enzyme to synthesize different cobamide from the precursor cobinamide and several nucleobase in the absence of exogenous nucleobase the most abundant cobamide produce by a baumannii be cobalamin bimportanceb acinetobacter baumannii be a gramnegative bacterium commonly find in soil and water a baumannii be a opportunistic human pathogen consider by the CDC to be a serious threat to human health due to the multidrug resistance commonly associate with this bacterium knowledge of the metabolic capability of a baumannii be limited the importance of the work report here lie in the identification of ethanolamine catabolism occur in the absence of a metabolosome structure in other bacterium this structure protect the cell against damage by acetaldehyde generate by the deamination of ethanolamine in addition the ethanolamine ammonialyase eal enzyme of this bacterium be unique in that it do not require a reactivase enzyme to remain active importantly we also demonstrate that the a baumannii genome encode the function need to assemble adenosylcobamide the coenzyme of eal from the precursor cobinamide	2022 Aug	Elizabeth A Villa, Jorge C Escalante-Semerena	mBio
35899254	Coevolutionary adaptation of iAcinetobacter baumanniii and a clinical carbapenemaseencoding plasmid during carbapenem exposure	oxa23 be the predominant carbapenemase in carbapenemresistant iAcinetobacter baumanniii the coevolutionary dynamic of iA baumanniii and oxa23encoding plasmid be poorly understand here we transform iA baumanniii atcc 17978 with pagl221 a iblai suboxa23subcontaining plasmid from clinical iA baumanniii isolate a221 and subject the transformant to experimental evolution in the presence of a subinhibitory concentration of imipenem for nearly 400 generation we use population sequencing to track genetic change at six time point and evaluate phenotypic change increase fitness of evolve population temporary duplication of iblai suboxa23sub in pagl221 interfere allele dynamic and chromosomal locuslevel parallelism be observe to characterize genotypetophenotype association we focus on six mutation in parallel target predict to affect small RNAs and a cyclic dimeric 3 → 5 GMPmetabolizing protein six isogenic mutant with or without pagl221 be engineer to test for the effect of this mutation on fitness cost and plasmid kinetic and the evolve plasmid contain two copy of iblai suboxa23sub be transfer to ancestral atcc 17978 five of the six mutation contribute to improve fitness in the presence of pagl221 under imipenem pressure and all but one of they impaired plasmid conjugation ability the duplication of iblai suboxa23 sub increase host fitness under carbapenem pressure but impose a burden on the host in antibioticfree media relative to the ancestral pagl221 overall we study provide a framework for the coevolution of iA baumanniii and a clinical iblai suboxa23subcontaining plasmid in the presence of imipenem involve early iblai suboxa23sub duplication follow by chromosomal adaptation that improve the fitness of plasmidcarry cell	2022 Jul	Linyue Zhang, Ying Fu, Linghong Zhang, Qingye Xu, Yunxing Yang, Jintao He, Sebastian Leptihn, Belinda Loh, Robert A Moran, Willem van Schaik, Mark Alexander Toleman, Qiong Chen, Lilin Liu, Yunsong Yu, Xiaoting Hua	Evol Appl
37204271	introduction and spread of ndMproducing enterobacterale and iAcinetobacter baumanniii into Middle Eastern country a molecularbased hypothesis	the goal of this review be to provide a plausible explanation for the dissemination of ndMproducing enterobacterale ndme and iAcinetobacter baumanniii ndmab across the I	2023 May	Shelley Reich, Amos Adler	Expert Rev Anti Infect Ther
36618317	detection of the iaadA1i and aac 31V resistance gene in iAcinetobacter baumanniii	iAcinetobacter baumanniii be a gramnegative aerobic bacterium that can be find in different environment such as food contain vegetable meat and fish moreover it can be present in soil and freshwater iA baumanniii have globally consider a opportunistic nosocomial bacterium in the healthcare set contribute to increase morbidity and mortality the current study aim to detect the aminoglycoside gene in iA baumanniii isolate from different clinical cause in total 20 isolate of iA baumanniii be obtain from different clinical case bacterial isolate DNA be extract use a DNA extraction kit quantus fluorometer be use to detect the concentration of the extract DNA in order to detect the goodness of sample 1 μl of DNA and 199 μl of dilute quantiflour Dye be mix after 5 minute incubation at room temperature DNA concentration value be evaluate and follow the initial amplification of the iA baumanniii iaadA1i gene 20 μl of pcr product with F and R primer be send to sanger sequencing the result of the antimicrobial susceptibility reveal that iA baumanniii isolate be resistant to gentamicin 95 amikacin 90 and tobramycin 60 molecular investigation of the iaadA1i and iaac 3ivi gene exhibit that the iaadA1i gene be detect in 15 of the isolate however the iaac 3ivi gene be not detect in any of the isolate the gel electrophoresis reveal that the molecular weight of the iaadA1i gene be 490 bp the DNA sequence of the iaadA1i gene be conduct in this study and the result exhibit no mutation in all isolate	2022 Jun	E A Hussain, H Qasim Hameed, A Mujahid Al-Shuwaikh, R Mujahid Abdullah	Arch Razi Inst
36119640	Differentiation between iAcinetobacter baumanniii Colonization and infection and the Clinical outcome prediction by infection in Lower respiratory tract	iAcinetobacter baumanniii be the most common microorganism in sputum culture from longterm hospitalize patient and be often the cause of hospitalacquired pneumonia hap which be usually associate with poor prognosis and high mortality it be sometimes difficult to distinguish between iA baumanniii infection and colonization this study aim to evaluate factor that differentiate infection from colonization and predict mortality in patient with nosocomial pneumonia cause by iA baumanniii	2022	Ding-Yun Feng, Jian-Xia Zhou, Xia Li, Wen-Bin Wu, Yu-Qi Zhou, Tian-Tuo Zhang	Infect Drug Resist
33719791	loss of thermotolerance in antibioticresistant iAcinetobacter baumanniii	Bacterium iAcinetobacter baumanniii be a lead cause of nosocomial infection the occurrence of antibioticresistant iA baumanniii isolate outside hospital suggest that monitoring of this pathogen in environmental sample be need Survival of pandrugresistant iA baumanniii be follow on selective plate with and without carbapenem in water and soil after a few day of starvation iA baumanniii lose the ability to be cultivate at 44°c on plate supplement with carbapenem once cultivate on plate without carbapenem andor at 36 °C iA baumanniii could grow again at 44°c in the presence of carbapenem comparative proteomic analysis reveal that impaired membrane integrity and reduce function of efflux pump due to elevate temperature combine with antibiotic exposure be the main reason for this phenomenon loss of thermotolerance in the presence of antibiotic point to the need for temperature adjustment in longterm monitoring of iA baumanniii in environmental sample to avoid the underestimation of viable bacterium	2022 Jul	Svjetlana Dekić Rozman, Ana Butorac, Rea Bertoša, Jasna Hrenović, Marina Markeš	Int J Environ Health Res
35972564	acinetobacter baumannii Klebsiella pneumoniae and Elizabethkingia miricola isolate from wastewater have biodegradable activity against fluoroquinolone	ciprofloxacin CIP and levofloxacin LEV widely use fluoroquinolone antibiotic be often find in sewage from the sewage treatment plant and marine environment in this study CIP and LEV biodegrading bacterial consortia be obtain from industrial wastewater microorganism in this consortia be identify as acinetobacter baumannii a baumannii Klebsiella pneumoniae k pneumoniae and Elizabethkingia miricola E miricola the impact of the critical operate parameter on the elimination of CIP and LEV by bacterial consortia have be investigate and optimize to achieve the maximum level of CIP and LEV biodegradation use liquid chromatography with tandem mass spectrometry lcmsm possible degradation pathway for CIP and LEV be suggest by analyze the intermediate degradation product the role of the enzyme fluoroquinoloneacetylating aminoglycoside 6 nacetyltransferase and cytochrome p450 cyp450 in the breakdown of fluoroquinolone fas be investigate as well accord to we finding various biodegradation mechanism have be suggest include cleavage of piperazine ring substitution of F atom hydroxylation decarboxylation and acetylation as the main biotransformation reaction this study discover the ability of nonreport bacterial strain to biodegrade both CIP and LEV as a sole carbon source provide new insight into the biodegradation of CIP and LEV	2022 Aug	Reham Alaa Eldin Shaker, Yosra Ibrahim Nagy, Mina E Adly, Rania Abdelmonem Khattab, Yasser M Ragab	World J Microbiol Biotechnol
37162304	generation of synthetic iAcinetobacter baumanniiiSpecific nanobody	the bacterial pathogen iAcinetobacter baumanniii be a lead cause of drugresistant infection here we investigate the potential of develop nanobody that can recognize iA baumanniii over other gramnegative bacterium through generation and pann of a synthetic nanobody library we identify several potential lead candidate we demonstrate how incorporation of nextgeneration sequencing analysis can aid in the selection of lead candidate nanobody use monoclonal phage display we validate the bind of lead nanobody to iA baumanniii subsequent purification and biochemical characterization reveal one particularly robust nanobody that specifically bind select iA baumanniii strain compare to other common drugresistant pathogen this finding support the potential for nanobody to selectively target iA baumanniii and the identification of lead candidate for future investigation	2023 May	Gregory A Knauf, Kyra E Groover, Angela C O'Donnell, Bryan W Davies	ACS Infect Dis
36978383	colistin resistance in iAcinetobacter baumanniii molecular mechanism and epidemiology	iAcinetobacter baumanniii be recognize as a clinically significant pathogen cause a wide spectrum of nosocomial infection colistin be consider a lastresort antibiotic for the treatment of infection cause by multidrugresistant iA baumanniii since the reintroduction of colistin a number of mechanism of colistin resistance in iA baumanniii have be report include complete loss of LPS by inactivation of the biosynthetic pathway modification of target LPS drive by the addition of phosphoethanolamine petn moiety to lipid a mediate by the chromosomal ipmrcabi operon and ieptAi geneencod enzyme or plasmidencoded imcri gene and efflux of colistin from the cell in addition to resistance to colistin widespread heteroresistance be another feature of iA baumanniii that lead to colistin treatment failure this review aim to present a critical assessment of relevant publish 50 experimental paper uptodate knowledge on the molecular mechanism of colistin resistance in iA baumanniii with a detailed review of implicate mutation and the global distribution of colistinresistant strain	2023 Mar	Katarina Novović, Branko Jovčić	Antibiotics (Basel)
35812377	strain specific variation in iAcinetobacter baumanniii complement sensitivity	the complement system be require for innate immunity against iAcinetobacter baumanniii a important cause of antibiotic resistant systemic infection iA baumanniii strain differ in they susceptibility to the membrane attack complex mac form from terminal complement pathway protein but the reason for this variation remain poorly understand we have characterize in detail the complement sensitivity phenotype of nine iA baumanniii clinical strain and some of the factor that might influence difference between strain use iA baumanniii laboratory strain and flow cytometry assay we first reconfirm that both opsonization with the complement protein c3bic3 b and mac formation be inhibit by the capsule there be mark difference in c3bic3 b and mac bind between the nine clinical iA baumanniii strain but this variation be partially independent of capsule composition or size Opsonization with c3bic3b improve neutrophil phagocytosis of most strain importantly although c3bic3b bind and mac formation on the bacterial surface correlate closely mac formation do not correlate with variation between iA baumanniii strain in they level of serum resistance genomic analysis identify only limited difference between strain in the distribution of gene require for serum resistance but rnaseq datum identify three complementresistance gene that be differentially regulate between a mac resistant and two mac intermediate resistant strain when cultured in serum this datum demonstrate that clinical iA baumanniii strain vary in they sensitivity to different aspect of the complement system and that the serum resistance phenotype be influence by factor in addition to the amount of mac form on the bacterial surface	2022	Gathoni Kamuyu, Giuseppe Ercoli, Elisa Ramos-Sevillano, Sam Willcocks, Chidchamai Kewcharoenwong, Pattarachai Kiratisin, Peter W Taylor, Brendan W Wren, Ganjana Lertmemongkolchai, Richard A Stabler, Jeremy S Brown	Front Immunol
36474906	Clinical characteristic and prognosis Analysis of iAcinetobacter baumanniii bloodstream infection base on propensity match	in view of the fact that iAcinetobacter baumanniii bloodstream infectionBSI be a great threat to human survival early identification of the risk factor affect prognosis will be of great benefit to the clinic	2022	Jinghui Wang, Jun Zhang, Zhuang-Hao Wu, Lei Liu, Zijun Ma, Cheng-Cheng Lai, Yong-Gang Luo	Infect Drug Resist
36246061	antiiacinetobacter baumanniii singlechain variable fragment show direct bactericidal activity	the high resistance rate of iAcinetobacter baumanniii and the limited number of available antibiotic have prompt a worldwide effort to develop effective antimicrobial agent accordingly identify singlechain variable fragment antibody sclv capable of exert direct antibacterial activity in a immune systemindependent manner may be make immunocompromised patient more susceptible to iA baumanniii infection	2022 Sep	Eilnaz Basardeh, Somayeh Piri-Gavgani, Behnoush Soltanmohammadi, Mostafa Ghanei, Mir Davood Omrani, Mahdieh Soezi, Mohammad Ali Shokrgozar, Masoumeh Azizi, Abolfazl Fateh, Farzam Vaziri, Seyed Davar Siadat, Zahra Sharifzadeh, Fatemeh Rahimi-Jamnani	Iran J Basic Med Sci
36186828	mucoid iAcinetobacter baumanniii enhance antiphagocytosis through reduce c3b deposition	Multidrug resistant MDR iAcinetobacter baumanniii cause serious infection in intensive care unit and be hard to be eradicated by antibiotic many iA baumanniii isolate be identify as the mucoid type recently but the biological characteristic of mucoid iA baumanniii and they interaction with host cell remain unclear	2022	Xiaoxia Gong, Qian Zhao, Yifan Wu, Hongwei Zhou, Shuangyang Ding, Kui Zhu	Front Med (Lausanne)
36659926	comparative genomics and molecular epidemiology of colistinresistant iAcinetobacter baumanniii	this study aim to investigate the prevalence and resistance mechanism of colistinresistant iAcinetobacter baumanniii colrab isolate in Serbia assess they genetic relatedness to other circulate iA baumanniii isolate in the neighbour European country and analyse the global genomic epidemiology of colrab isolate a total of 784 isolate of iA baumanniii be recover from hospitalise patient in Serbia between 2018 and 2021 the antimicrobial susceptibility testing be perform use disk diffusion and broth microdilution all colrab isolate be subject to DNA isolation and wholegenome sequencing wgs overall 394 and 30 isolate be confirm as colrab result of mutational and transcriptional analysis of gene associate with colistin resistance indicate the central role of the twocomponent regulate system pmrab and increase expression of the ipmrCi gene in colrab most of the isolate and 29 966 belong to international clone ii with the most common sequence type be stsuppassup2 and 23 766 base on the wgs analysis colrab isolate belong to the same ST isolate in various country be group into the same cluster indicate the global dissemination of several highrisk clonal lineage phylogenomic analysis of colrab isolate together with all previously publish iA baumanniii genome from SouthEastern European country show that colistin resistance arise independently in several clonal lineage comparative genomic analysis reveal multiple gene with various role transcriptional regulation transmembrane transport outer membrane assembly etc which might be associate with colistin resistance in iA baumanniii the obtain finding serve as the basis for further study contribute to a good understanding of colistin resistance mechanism in iA baumanniii	2023	Jovana Kabic, Katarina Novovic, Dusan Kekic, Anika Trudic, Natasa Opavski, Ivica Dimkic, Branko Jovcic, Ina Gajic	Comput Struct Biotechnol J
36066263	Iron Acquisition mechanism and they role in the virulence of acinetobacter baumannii	Iron be a essential element for survival of most organism one mechanism of host defense be to tightly chelate iron to several protein to limit its extracellular availability this have force pathogen such as acinetobacter baumannii to adapt mechanism for the acquisition and utilization of iron even in ironlimiting condition a baumannii use a variety of iron acquisition strategy to meet its iron requirement it can lyse erythrocyte to harvest the heme molecule use ironchelate siderophore and use outer membrane vesicle to acquire iron Iron acquisition pathway in general have be see to affect many other virulence factor such as cell adherence cell motility and biofilm formation the knowledge gain from research on iron acquisition lead to the synthesis of the antibiotic cefiderocol which use iron uptake pathway for entry into the cell with some success as a novel cephalosporin understanding the mechanism of iron acquisition of a baumannii allow for insight into clinical infection and offer potential target for novel antibiotic or potentiator of current drug	2022 Oct	Shoshana Cook-Libin, Ellen M E Sykes, Vanessa Kornelsen, Ayush Kumar	Infect Immun
36356792	combination of BauA and OmpA elicit immunoprotection against acinetobacter baumannii in a murine sepsis model	acinetobacter baumannii cause severe nosocomial infection and be a difficulttotreat pathogen due to the development of multidrugresistant MDR strain vaccine and antibody therapy represent alternative promise strategy for the control of infection cause by a baumannii or its MDR strain OmpA and BauA have be assign as protective antigen however the efficacy of the combination of this antigen be yet to be investigate in this study we target two critical antigen of a baumannii BauA and OmpA to enhance immunoprotect against a baumannii	2022 Dec	Motahare Tamehri, Iraj Rasooli, Mahdi Pishgahi, Abolfazl Jahangiri, Fatemeh Ramezanalizadeh, Seyedeh Reyhaneh Banisaeed Langroodi	Microb Pathog
36759602	crossprotection and crossfeeding between Klebsiella pneumoniae and acinetobacter baumannii promote they coexistence	acinetobacter baumannii and Klebsiella pneumoniae be opportunistic pathogen frequently coisolated from polymicrobial infection the infection where this pathogen coexist can be more severe and recalcitrant to therapy than infection cause by either species alone however there be a lack of knowledge on they potential synergistic interaction in this study we characterise the genome of a baumannii and k pneumoniae strain coisolated from a single human lung infection we examine various aspect of they interaction through transcriptomic phenomic and phenotypic assay that form a basis for understanding they effect on antimicrobial resistance and virulence during coinfection use coculturing and analysis of secreted metabolite we discover the ability of k pneumoniae to crossfeed a baumannii byproduct of sugar fermentation minimum inhibitory concentration testing of mono and coculture reveal the ability for a baumannii to crossprotect k pneumoniae against the cephalosporin cefotaxime we study demonstrate distinct syntrophic interaction occur between a baumannii and k pneumoniae help to elucidate the basis for they coexistence in polymicrobial infection	2023 Feb	Lucie Semenec, Amy K Cain, Catherine J Dawson, Qi Liu, Hue Dinh, Hannah Lott, Anahit Penesyan, Ram Maharjan, Francesca L Short, Karl A Hassan, Ian T Paulsen	Nat Commun
36358226	bactericidal and antibiofilm activity of the ftsr inhibitor c109 against iAcinetobacter baumanniii	in the last few year iAcinetobacter baumanniii have rank as a number one priority due to its multi drug resistant phenotype the different metabolic state such as the one adopt when grow as biofilm help the bacterium to resist a wide variety of compound place the discovery of new molecule able to counteract this pathogen as a topic of utmost importance in this context bacterial cell division machinery and the conserved protein ftsr be consider very interesting cellular target the benzothiadiazole compound c109 be able to inhibit bacterial growth and to block ftsr GTPase and polymerization activity in iBurkholderia cenocepaciai iPseudomonas aeruginosai and iStaphylococcus aureusi in this work the activity of c109 be test against a panel of antibiotic sensitive and resistant iA baumanniii strain its ability to inhibit biofilm formation be explore together with its activity against the iA baumanniii ftsr purify protein we result indicate that c109 have good mic value against iA baumanniii clinical isolate moreover its antibiofilm activity make it a interesting alternative treatment effective against diverse metabolic state finally its activity be confirm against iA baumanniii ftsr	2022 Nov	Viola Camilla Scoffone, Samuele Irudal, Aseel AbuAlshaar, Aurora Piazza, Gabriele Trespidi, Giulia Barbieri, Vadim Makarov, Roberta Migliavacca, Edda De Rossi, Silvia Buroni	Antibiotics (Basel)
35441249	biological characterization and genomic analysis of acinetobacter baumannii phage buct628	acinetobacter baumannii be a opportunistic pathogen that be resistant to the most commonly use antibiotic in this study the acinetobacter phage buct628 be isolate from hospital wastewater blast analysis show that the genome sequence of buct628 share 8976 identity with 66 query coverage with that of acinetobacter phage bphir2919 genome sequencing show that the buct628 genome be a 44935 bp linear dsDNA molecule with 375 gc content and 86 open read frame orf and no trnas be identify	2022 Jun	Yinuo Zhu, Ke Han, Long Chen, Shizhong Luo, Huahao Fan, Yigang Tong	Arch Virol
35867473	polyphosphate kinase be required for the process of virulence and persistence in acinetobacter baumannii	acinetobacter baumannii one of the most successful bacterium cause severe nosocomial infection be identify as a toppriority pathogen by the who thus genetic manipulation to clarify the potential target for fight a baumannii resistance and virulence be vital polyphosphate polyP kinase ppk be conserved in nearly all bacterium and be responsible for polyP formation which be associate with bacterial pathogenicity and antibiotic resistance in this study ippk1ideficient Δippk1iApr ippk1icomplemented δippk1iaprpjl02ippk1i and wildtype strain of a baumannii atcc 17978 be use to determine the influence of ppk1 on a baumannii virulence and persistence mainly by polyP quantification surface motility biofilm formation and bacterial persistence assay we work find that ppk1 be indispensable for polyP formation iin vivoi and that the motility of the ppk1 deficient strain be significantly impaired due to the lack of a piluslike structure typically present compare with the complemented and wildtype strain the deficiency of ppk1 also inhibit the biofilm formation of a baumannii and decrease bacterial persistence under stimulus of highconcentration ampicillin amp treatment hsub2subosub2sub stress heat shock and starvation stress furthermore ippk1 ideficient bacteriuminfected mouse show a significantly reduce bacterial load and a decrease inflammatory response however complementation with ppk1 effectively rescue the impaired virulence and persistence of ippk1ideficient a baumannii in addition metabonomic analysis reveal that ppk1 be associate with glycerophospholipid metabolism and fatty acid biosynthesis taken together we result suggest that target ppk1 to control a baumannii pathogenicity and persistence be a feasible strategy to fight this pathogen bimportanceb a baumannii be identify as a toppriority pathogen by the who due to its antibiotic resistance meanwhile the pathogenicity of a baumannii mediate by several vital virulence factor also cannot be ignore here the role of ppk1 in a baumannii be also explore we find that the motility ability and biofilm formation of a ppk1 deficient strain be significantly impaired furthermore ppk1 be essential for its persistence maintenance to resist stimulus of highconcentration amp treatment hsub2subosub2sub stress heat shock and starvation stress metabonomic analysis reveal that ppk1 be associate with glycerophospholipid metabolism and fatty acid biosynthesis in addition ippk1 ideficient bacteriuminfected mouse show significantly reduce bacterial load and a decrease inflammatory response iin vivoi together we result suggest that ppk1 be vital for a baumannii pathogenicity and persistence	2022 Aug	Hongfa Lv, Yonglin Zhou, Baichen Liu, Jian Guan, Peng Zhang, Xuming Deng, Dan Li, Jianfeng Wang	Microbiol Spectr
35787944	recombinant acnb nrdr and ribd of acinetobacter baumannii and they potential interaction with DNA adenine methyltransferase Aama	in the last decade acinetobacter baumannii develop into a increasingly challenging nosocomial pathogen a baumannii atcc 17978 harbor a dnaadenine n6 methyltransferase term Aama previous study reveal a low specific activity of Aama in vitro despite prove fold which lead we to speculate about possible interaction partner assist Aama in target methylation site here apply a pulldown assay with subsequent mass spectrometry we identify aconitate hydratase 2 acnb as possible interaction partner in addition we consider the putative transcriptional regulator gene nrdR a1s0220 and the pyrimidine deaminasereductase gene ribD a1s0221 of a baumannii strain atcc 17978 to encode additional potential interaction partner due to they vicinity to the aamA gene a1s0222 protein be recombinantly produce in the milligram scale purify to near homogeneity and interaction with Aama be study apply blue native gel electrophore electrophoretic mobility shift assay chemical crosslinking and coimmunoprecipitation this analysis do not provide evidence of interaction between Aama and purify protein solution structure of ribd nrdr and acnb be study by smallangle Xray scattering saxs alone and in combination with Aama while in the case of ribd and acnb no evidence of a interaction with Aama be produce addition of Aama to nrdr result in dissociation of long and rodshap polymeric nrdr structure imply a specific but transient interaction moreover we identify a molecular crowding effect possibly impeding the DNA methyltransferase activity in vivo and a sequenceindependent DNA bind activity of Aama call for continue effort to identify the interaction network of Aama	2022 Nov	Kristin Weber, Joerg Doellinger, Cy M Jeffries, Gottfried Wilharm	Protein Expr Purif
36261919	target virulence regulation to disarm iAcinetobacter baumanniii pathogenesis	the development of antivirulence drug therapy against iAcinetobacter baumanniii infection would provide a alternative to traditional antibacterial therapy that be increasingly fail here we demonstrate that the ompr transcriptional regulator play a pivotal role in the pathogenesis of diverse iA baumanniii clinical strain in multiple murine and iG mellonellai invertebrate infection model we identify omprregulated gene use RNA sequencing and further validate two gene whose expression can be use as robust biomarker to quantify ompr inhibition in iA baumanniii moreover the determination of the structure of the ompr DNA bind domain of iA baumanniii and the development of iin vitroi proteinDNA bind assay enable the identification of a ompr small molecule inhibitor we conclude that ompr be a valid and unexplored target to fight iA baumanniii infection and we believe that the describe platform combine iin silicoi method iin vitroi ompr inhibitory assay and iin vivo G mellonellai surrogate infection model will facilitate future drug discovery program	2022 Dec	Vincent Trebosc, Valentina Lucchini, Mohit Narwal, Basil Wicki, Sarah Gartenmann, Birgit Schellhorn, Julian Schill, Marilyne Bourotte, Daniel Frey, Jürgen Grünberg, Andrej Trauner, Livia Ferrari, Antonio Felici, Olivia L Champion, Marc Gitzinger, Sergio Lociuro, Richard A Kammerer, Christian Kemmer, Michel Pieren	Virulence
35569319	insight into mucoid acinetobacter baumannii a review of microbiological characteristic virulence and pathogenic mechanism in a threaten nosocomial pathogen	acinetobacter baumannii a baumannii be a opportunistic pathogen and lead cause of health careassociated infection several know pathogenic factor include lipopolysaccharide capsular polysaccharide phospholipase protein secretion system two component efflux pump and biofilm formation be associate with the bacterium however owing to the new biological characteristic rapidly develop under the external stress the pathogenesis become complicated the formation of mucoid phenotype be a major adaptive defense response for a baumannii the mucus be mainly comprise of capsular polysaccharide which form a barrier around the bacterial cell wall and provide protection from environmental pressure and host immune response importantly mucoid formation have be show to confer change in the pathogenicity and pathogenesis of a baumannii thus this review aim to highlight the biological characteristic virulence and underlying pathogenic mechanism of mucoid a baumannii we primarily provide profound insight into the structure function and detect method of the mucus in mucoid a baumannii then we mainly illustrate the current study on mucoid a baumannii finally the unsolved area associate with mucoid a baumannii be summarize in summary this review will critically offer a comprehensive understanding of mucoid a baumannii and provide novel insight into the diagnosis and intervention strategy for the increasingly deadly human pathogen	2022 Aug	Wulin Shan, Jinsong Kan, Xueqin Cai, Meiling Yin	Microbiol Res
36760499	nonantibiotic prevention and treatment against iAcinetobacter baumanniii infection be vaccine and adjuvant effective strategy	iAcinetobacter baumanniii iA baumanniii be a gramnegative opportunistic pathogen widely attach to the surface of medical instrument make it one of the most common pathogen of nosocomial infection and often lead to crossinfection and coinfection due to the extensive antibiotic and panresistance iA baumanniii infection be face few treatment option in the clinic therefore the prevention and treatment of iA baumanniii infection have become a tricky global problem the requirement for research and development of the new strategy be urgent now nonantibiotic treatment strategy be urgently need this review describe the research on iA baumanniii vaccine and antibacterial adjuvant discuss the advantage and disadvantage of different candidate vaccine test iin vitroi and iin vivoi especially subunit protein vaccine and show the antibacterial efficacy of adjuvant drug in monotherapy	2023	Yue Hu, Xianqin Zhang, Shanshan Deng, Changwu Yue, Xu Jia, Yuhong Lyu	Front Microbiol
35647655	activity of omadacycline Alone and in combination against carbapenemnonsusceptible acinetobacter baumannii with vary minocycline susceptibility	tetracyclinebased combination be increasingly use for serious carbapenemnonsusceptible acinetobacter baumannii cnsab infection give they potent iin vitroi activity synergism with other agent and acceptable toxicity profile omadacycline be a novel aminomethylcycline with activity against minocyclineresistant pathogen once daily oral dose and favorable pharmacokinetic property give this potential advantage the iin vitroi potency and antibacterial activity of omadacycline be evaluate alone and in combination against cnsab with vary minocycline susceptibility broth microdilution testing of 41 cnsab reveal that omadacycline micsub5090 sub 48 mgL inhibit 683 2841 of isolate at ≤ 4 mgL and its activity be unaffected by minocycline nonsusceptibility micsub5090 sub 48 mgL 742 2331 inhibit at ≤ 4 mgL ten 5 minocycline susceptible and 5 nonsusceptible of the 41 cnsab isolate be then evaluate in timekill analysis against omadacycline and comparator agent alone and in dual and tripledrug combination at the free maximum concentration of drug in serum ifCisubmaxsub amikacin meropenem and polymyxin B alone be each bactericidal against 4 of 10 40 isolate while omadacycline and sulbactam be bactericidal against 0 0 and 1 10 respectively in dualdrug combination with omadacycline synergy be observe against 80 of isolate with sulbactam follow by 30 with amikacin or polymyxin B and 0 with meropenem or rifampin the tripledrug combination of omadacycline sulbactam and polymyxin B achieve synergy against just one additional strain over the omadacyclinesulbactam dual combination but significantly reduce the time to 999 kill by more than 6 h 46 ± 28 h versus 113 ± 59 h ip i001 this result support the continue investigation into tetracyclinebased combination against cnsab particularly that include sulbactam and suggest that omadacycline may have iin vitroi advantage over exist tetracyclinederivative bimportanceb treatment of infection due to acinetobacter baumannii often involve the use of multiple antibiotic simultaneously as combination therapy but it be unknown which antibiotic be good use together tetracycline agent such as minocycline and tigecycline maintain good activity against a baumannii and be often use with one or more other agent to achieve good kill of the bacterium omadacycline be a new tetracycline that may have a role in the treatment of a baumannii but no datum be available evaluate its interaction with other commonly use drug such as polymyxin B and sulbactam therefore the purpose of this study be to investigate the antibacterial activity of omadacycline when combine with one or more other agent against carbapenemresistant strain of a baumannii this finding may then be use to design confirmatory study that could help decide what drug work good together and what combination of agent should be use for patient	2022 Jun	Taylor Abbey, Alesia Vialichka, Michele Jurkovic, Mark Biagi, Eric Wenzler	Microbiol Spectr
35867872	3indoleacetonitrile attenuate biofilm formation and enhance sensitivity to imipenem in acinetobacter baumannii	acinetobacter baumannii pose a global danger due to its ability to resist most of the currently available antimicrobial agent furthermore the rise of carbapenemresistant a baumannii isolate have limited the treatment option available in the present study plant auxin 3indoleacetonitrile 3IAN be find to inhibit biofilm formation and motility of a baumannii at sublethal concentration mechanistically 3IAN inhibit the synthesis of the quorum sensing signal 3ohc12hsl by downregulate the expression of the abaI autoinducer synthase gene 3IAN be find to reduce the minimum inhibitory concentration of a baumannii atcc 17978 against imipenem ofloxacin ciprofloxacin tobramycin and levofloxacin and significantly decrease persistence against imipenem inhibition of efflux pump by downregulate gene expression may be responsible for enhance sensitivity and low persistence 3IAN reduce the resistance to imipenem in carbapenemresistant a baumannii isolate by downregulate the expression of oxa βlactamase blaoxa51 and blaoxa23 outer membrane protein carO and transporter protein ade B this finding demonstrate the therapeutic potential of 3IAN which could be explore as a adjuvant with antibiotic for control a baumannii infection	2022 Aug	Shruti Kashyap, Harsimran Sidhu, Prince Sharma, Neena Capalash	Pathog Dis
35938813	CRISPRCas in acinetobacter baumannii contribute to antibiotic susceptibility by target endogenous iAbaIi	acinetobacter baumannii be a wellknown human opportunistic pathogen in nosocomial infection and the emergence of multidrugresistant acinetobacter baumannii have become a complex problem for clinical antiinfective treatment the way this organism obtain multidrug resistance phenotype include horizontal gene transfer and other mechanism such as alter target decrease permeability increase enzyme production overexpression of efflux pump metabolic change and biofilm formation a CRISPRCas system generally consist of a crispr array and one or more operon of icasi gene which can restrict horizontal gene transfer in bacterium nevertheless it be unclear how CRISPRCas system regulate antibiotic resistance in acinetobacter baumannii thus we seek to assess how CRISPRCas affect biofilm formation membrane permeability efflux pump reactive oxygen species and quorum sensing to clarify further the mechanism of CRISPRCas regulation of acinetobacter baumannii antibiotic resistance in the clinical isolate ab43 which have a complete IFb CRISPRCas system we discover that the cas3 nuclease of this type if CRISPRCas system regulate acinetobacter baumannii quorum sensing and have a unique function in change drug resistance as a result of quorum sensing synthase iabaIi be reduce allow efflux pump to decrease biofilm formation to become weak reactive oxygen species to generate and drug resistance to decrease in response to CRISPRCas activity this observation suggest that the CRISPRCas system target endogenous iabaIi may boost bacterial antibiotic sensitivity bimportanceb CRISPRCas system be vital for genome editing bacterial virulence and antibiotic resistance how CRISPRCas system regulate antibiotic resistance in acinetobacter baumannii be almost wholly unknown in this study we reveal that the quorum sensing regulator iabaIi mRNA be a primary target of the IFb CRISPRCas system and the cleavage activity of cas3 be the most critical factor in regulate iabaIi mRNA degradation this result advance we understanding of how CRISPRCas system inhibit drug resistance however the mechanism of endogenous target of iabaIi by CRISPRCas need to be further explore	2022 Aug	Yuhang Wang, Jie Yang, Xiaoli Sun, Mengying Li, Pengyu Zhang, Zhongtian Zhu, Hongmei Jiao, Tingting Guo, Guocai Li	Microbiol Spectr
36318583	differential activation of nlrp3 inflammasome by acinetobacter baumannii strain	acinetobacter baumannii be a emerge nosocomial opportunistic pathogen with grow clinical significance globally a baumannii have a exceptional ability to rapidly develop drug resistance it be frequently responsible for ventilatorassociated pneumonia in clinical setting and inflammation result in severe sepsis the inflammatory response be mediate by host patternrecognition receptor and the inflammasomes inflammasome activation trigger inflammatory response include the secretion of the proinflammatory cytokine il1 " and IL18 the recruitment of innate immune effector against a baumannii infection and the induction program cell death by pyroptosis a important knowledge gap be how variation among clinical isolate affect the host innate response and activation of the inflammasome during a baumannii infection in this study we compare nine a baumannii strain include clinical locallyacquired isolate in they ability to induce activation of the inflammasome and program cell death in primary macrophage epithelial lung cell line and mouse we find a variation in survival outcome of mouse and bacterial dissemination in organ among three commercially available a baumannii strain likely due to the difference in virulence between strain interestingly we find variability among a baumannii strain in activation of the nlrp3 inflammasome noncanonical caspase11 pathway plasmatic secretion of the proinflammatory cytokine il1 " and program cell death we study highlight the importance of utilise multiple bacterial strain and clinical isolate with different virulence to investigate the innate immune response to a baumannii infection	2022	Fei-Ju Li, Lora Starrs, Anukriti Mathur, Hikari Ishii, Si Ming Man, Gaetan Burgio	PLoS One
35610334	acinetobacter baumannii response to cefiderocol challenge in human urine	cefiderocol CFDC be a novel chlorocatecholsubstituted siderophore antibiotic approve to treat complicated urinary tract infection cuti and hospitalacquired and ventilatoracquired pneumonia hapvap previous work determine that albuminrich human fluid increase the minimum inhibitory concentration mic of acinetobacter baumannii against CFDC and reduce the expression of gene related to iron uptake system this latter effect may contribute to the need for high concentration of CFDC to inhibit growth the presence of human urine HU which contain low albumin concentration do not modify mic value of two carbapenemresistant a baumannii level of resistance to CFDC be not modify by HU in strain ama40 but be reduce in strain ab5075 expand the study to other carbapenemresistant a baumannii isolate show that the presence of HU result in unmodify or reduce mic of CDFC value the expression of piuA pirA bauA and bfnH determine by qrtpcr be enhance in a baumannii ama40 and ab5075 by the presence of HU in the culture medium all four test gene code for function related to recognition and transport of ferricsiderophore complex the effect of HU on expression of pbp1 pbp3 blasuboxa51 likesub blasubadcsub and blasubndm1 sub gene associate with resistance to βlactam as well as gene coding for efflux pump and porin be variable show dependence with the strain analyze we conclude that the lack of significant concentration of albumin and free iron in HU make this fluid behave differently from other we test unlike other albumin rich fluid the presence of HU do not impact the antibacterial activity of CFDC when test against a baumannii	2022 May	Brent Nishimura, Jenny Escalante, Marisel R Tuttobene, Tomás Subils, Vyanka Mezcord, Camila Pimentel, Nardin Georgeos, Fernando Pasteran, Cecilia Rodriguez, Rodrigo Sieira, Luis A Actis, Marcelo E Tolmasky, Robert A Bonomo, María Soledad Ramirez	Sci Rep
36671607	Recent advance in phagebased therapeutics for MultiDrug resistant iAcinetobacter baumanniii	iAcinetobacter baumanniii be a important opportunistic pathogen common in clinical infection phage therapy become a hot research field worldwide again after the postantibiotic era this review summarize the important progress of phage treatment for iA baumanniii in the last five year and focus on the new interesting advance include the combination of phage and other substance like photosensitizer and the phage encapsulation by microparticle hydrogel in delivery we also discuss the remain challenge and promise direction for phagebase therapy of iA baumanniii infection in the future and the innovative combination of material in this area may be one promise direction	2022 Dec	Yujing Tan, Jianhui Su, Minghui Fu, Hongmei Zhang, Haiyan Zeng	Bioengineering (Basel)
35944804	tn7382 a novel composite transposon harbor blasubndm1sub and aphA6 in acinetobacter baumannii	cotransfer of carbapenem and amikacin resistance might contribute to the evolution of extensively drug resistant XDR acinetobacter baumannii the current study use bioinformatic tool and a in silico approach to investigate the potential mobility of a novel composite transposon coharboring blasubndm1sub and aphA6	2022 Sep	Samira M Hamed, Amira F A Hussein, Mohamed H Al-Agamy, Hesham H Radwan, Mai M Zafer	J Glob Antimicrob Resist
36290064	Recent progress in phage therapy to modulate multidrugresistant iAcinetobacter baumanniii include in human and poultry	iAcinetobacter baumanniii be a multidrugresistant and invasive pathogen associate with the etiopathology of both a increase number of nosocomial infection and be of relevance to poultry production system multidrugresistant iAcinetobacter baumanniii have be report in connection to severe challenge to clinical treatment mostly due to a increase rate of resistance to carbapenem amid the possible strategy aim to reduce the insurgence of antimicrobial resistance phage therapy have gain particular importance for the treatment of bacterial infection this review summarize the different phagetherapy approach currently in use for multipledrug resistant iAcinetobacter baumanniii include single phage therapy phage cocktail phageantibiotic combination therapy phagederive enzyme active on iAcinetobacter baumanniii and some novel technology base on phage intervention although phage therapy represent a potential treatment solution for multidrugresistant iAcinetobacter baumanniii further research be need to unravel some unanswered question especially in regard to its in vivo application before possible routine clinical use	2022 Oct	Yan Zhang, Yuanqing Lin, Salvatore Galgano, Jos Houdijk, Weiquan Xie, Yajie Jin, Jiameng Lin, Wuqiang Song, Yijuan Fu, Xiuying Li, Wenting Chui, Wei Kan, Cai Jia, Guangwei Hu, Tao Li	Antibiotics (Basel)
36335338	Insight into carbapenem resistance and virulence of acinetobacter baumannii from a child medical centre in eastern China	Carbapenemresistant acinetobacter baumannii CRAB appear more frequently in child and cause a great threat to global public health it be urgent to investigate the carbapenem resistance and virulence of CRAB for clinician to choose appropriate antibiotic a retrospective study of 77 nonduplicated CRAB isolate be conduct the carbapenem resistance and virulence gene be characterize by polymerase chain reaction pcr and gel electrophoresis in the present study a baumannii mainly come from the intensive care unit and be mostly isolate from sputum sample the carbapenem resistant rate of a baumannii in 20182020 increase significantly compare with that in 20162017 all isolate have carbapenem resistant gene they be highly resistant to a variety of antibiotic but be relatively sensitive to fluoroquinolone and tetracycline blavim and blaoxa23 be detect in all isolate whereas blangak1 blaimp and blandm be present in 9870 6753 and 3117 of isolate respectively notably 1 isolate a baumannii be identify as multidrugresistant a baumannii mdrab and 76 other extensively drugresistance XDR isolate be also detect virulence gene be present in 100 of all isolate include gene in the iron acquisition system basJ secretion system ounce pA plcD quorum sensing system abaI and biofilm formation csuA adeH pgaA and ptk be present in 9870 9870 and 9480 of isolate respectively CRAB which be prevalent in east China carry a large number of drug resistance and virulence gene fluoroquinolone and tetracycline may be effective antibiotic for the treatment of CRAB infection in child a indepth understanding of the resistance and virulence of CRAB be conducive to timely guide empirical drug use and control infection	2022 Nov	Yunfen Zhu, Xin Zhang, Yunzhong Wang, Yunzhen Tao, Xuejun Shao, Yang Li, Wei Li	Ann Clin Microbiol Antimicrob
35950629	SemiSynthetic glycoconjugate vaccine lead against acinetobacter baumannii 17978	acinetobacter baumannii be a opportunistic bacterial pathogen responsible for serious nosocomial infection that be become increasingly resistant against antibiotic capsular polysaccharide CPS that cover a baumannii be a major virulence factor that play a important role in pathogenesis be use to assign serotype and provide the basis for vaccine development synthetic oligosaccharide resembling the CPS of a baumannii 17978 be print onto microarray slide and use to screen sera from patient infect with a baumannii as well as a monoclonal mouse antibody mAb c8 a synthetic oligosaccharide emerge from glycan array screen as lead for the development of a vaccine against a baumannii 17978 tetrasaccharide 20 be a key epitope for recognition by a antibody and be a vaccine lead	2022 Oct	Julinton Sianturi, Patricia Priegue, Jing Hu, Jian Yin, Peter H Seeberger	Angew Chem Int Ed Engl
35760825	a unique antigen against sarscov2 acinetobacter baumannii and pseudomonas aeruginosa	the recent outbreak of covid19 have increase hospital admission which could elevate the risk of nosocomial infection such as a baumannii and p aeruginosa infection although effective vaccine have be develop against sarscov2 no approve treatment option be still available against antimicrobialresistant strain of a baumannii and p aeruginosa in the current study a allinone antigen be design base on a innovative stateoftheart strategy in this regard experimentally validate linear epitope of spike protein sarscov2 OmpA a baumannii and oprf p aeruginosa be select to be harbor by mature OmpA as a scaffold the select epitope be use to replace the loop and turn of the barrel domain in OmpA OprFsub311341 sub replace the most similar sequence within the OmpA and three validate epitope of OmpA be retain intact the obtain antigen encompass five antigenic peptide of spike protein which be involve in sarscov2 pathogenicity one of this epitope viz QTQTNSPRRARSV could trigger antibody prevent superantigenic characteristic of spike and alleviating probable autoimmune response the design antigen could raise antibody neutralizing emerge variant of sarscov2 since at least two epitope be consensus in conclusion the design antigen be expect to raise protective antibody against sarscov2 a baumannii and p aeruginosa	2022 Jun	Mohammad Reza Rahbar, Shaden M H Mubarak, Anahita Hessami, Bahman Khalesi, Navid Pourzardosht, Saeed Khalili, Kobra Ahmadi Zanoos, Abolfazl Jahangiri	Sci Rep
37090073	Drug‑resistant iAcinetobacter baumanniii from molecular mechanism to potential therapeutics review	bacterial drug resistance be increasingly become a important problem that need to be solve urgently in modern clinical practice infection cause by iAcinetobacter baumanniii be a serious threat to the life and health of patient the drug resistance rate of iAcinetobacter baumanniii strain be increase thus research on the drug resistance of iAcinetobacter baumanniii have also see a increase when patient be infect with drugresistant iAcinetobacter baumanniii the availability of suitable antibiotic commonly use in clinical practice be become increasingly limited and the prognosis of patient be worsen study the molecular mechanism of the drug resistance of iAcinetobacter baumanniii be fundamental to solving the problem of drugresistant iAcinetobacter baumanniii and potentially other super bacterium drug resistance mechanism primarily include enzyme membrane protein efflux pump and beneficial mutation Research on the underlying mechanism provide a theoretical basis for the use and development of antibiotic and the development of novel treatment method	2023 May	Hao-Jia Wu, Zhi-Gang Xiao, Xiao-Juan Lv, Hai-Tang Huang, Chu Liao, Chen-Yang Hui, Yue Xu, Heng-Fei Li	Exp Ther Med
36098410	multidrugresistant iAcinetobacter baumanniii a emerge aspect of New drug Discovery	acinetobacter baumannii be a opportunistic multidrugresistant aerobic glucose nonfermentative and oxidativenegative coccobacilli bacterium this lifethreatening nosocomial infection be associate with immunocompromised patient	2023	Khushi R Mittal, Nandini Jain, Poornima Srivastava, Chakresh Kumar Jain	Recent Adv Antiinfect Drug Discov
36191190	elongation factor p modulate iAcinetobacter baumanniii physiology and virulence as a cyclic dimeric guanosine monophosphate effector	cyclic diguanosine monophosphate cdigmp be widely use by bacterium to control biological function in response to diverse signal or cue a previous study show that potential cdigmp metabolic enzyme play a role in the regulation of biofilm formation and motility in iAcinetobacter baumanniii however it be unclear whether and how iA baumanniii cell use cdigmp signal to modulate biological function here we report that cdigmp be a important intracellular signal in the modulation of biofilm formation motility and virulence in iA baumanniii the intracellular level of cdigmp be principally control by the diguanylate cyclase dgcs a1s1695 a1s2506 and a1s3296 and the phosphodiesterase PDE a1s1254 intriguingly we reveal that a1s2419 a elongation factor p efp be a novel cdigmp effector in iA baumanniii response to a cdigmp signal boost a1s2419 activity to rescue ribosome from stalling during synthesis of protein contain consecutive proline and thus regulate iA baumanniii physiology and pathogenesis we study present a unique and widely conserved effector that control bacterial physiology and virulence by sensing the second messenger cdigmp	2022 Oct	Quan Guo, Binbin Cui, Mingfang Wang, Xia Li, Huihui Tan, Shihao Song, Jianuan Zhou, Lian-Hui Zhang, Yinyue Deng	Proc Natl Acad Sci U S A
35743328	Durlobactam in the treatment of multidrugresistant iAcinetobacter baumanniii infection a systematic review	iA baumanniii be a frequent cause of difficulttotreat healthcareassociated infection the use of a novel betalactamase inhibitor durlobactam have be propose against multidrugresistant iA baumanniii a systematic review of study assess the efficacy and safety of durlobactam in the treatment of multidrugresistant iA baumanniii infection be carry out the study protocol be preregister on prospero crd42022311723 published article on durlobactam be identify through computerized literature search with the search term durlobactam and etx2514 use PubMed PubMed be search until 15 February 2022 article provide datum on the main characteristic of durlobactam and on the efficacy and safety of durlobactam in the treatment of iA baumanniii infection be include in this systematic review attempt be make to obtain information about unpublish study English language restriction be apply the risk of bias in the include study be not assess both quantitative and qualitative information be summarize by mean of textual description thirty study on durlobactam be identify publish from June 2017 to November 2020 sixteen study meet the inclusion criterion Durlobactam be effective against iA baumanniii when use in combination with sulbactam future clinical trial be need to confirm the possibility to treat infection cause by multidrugresistant iA baumanniii with this combination	2022 Jun	Guido Granata, Fabrizio Taglietti, Francesco Schiavone, Nicola Petrosillo	J Clin Med
35978016	socioeconomic burden of pneumonia due to multidrugresistant acinetobacter baumannii and pseudomonas aeruginosa in Korea	we aim to estimate the socioeconomic burden of pneumonia due to multidrugresistant acinetobacter baumannii mrab and pseudomonas aeruginosa MRPA we prospectively search for mrab and MRPA pneumonia case and match they with susceptibleorganism pneumonia and noninfected patient from 10 hospital the match criterion be same principal diagnosis same surgery or intervention during hospitalisation age sex and admission date within 60 day we calculate the economic burden by use the difference in hospital cost the difference in caregiver cost and the sum of productivity loss from a unexpected death we identify 108 mrab pneumonia mrabp and 28 MRPA pneumonia mrpap case the estimate number of annual mrabp and mrpap case in South Korea be 13092483 and 339644 with 485920 and 133253 death respectively the annual socioeconomic burden of mrabp and mrpap in South Korea be 64549723122533585 and 1524188328994008 respectively the result reveal that mrabp and mrpap occur in 16483127 patient result in 6181173 death and cause a nationwide socioeconomic burden of 79791606151527593 multidrugresistant organism mdro impose a great clinical and economic burden at a national level therefore control the spread of mdro will be a effective measure to reduce this burden	2022 Aug	Chung-Jong Kim, Kyoung-Ho Song, Nam-Kyong Choi, Jeonghoon Ahn, Ji Yun Bae, Hee Jung Choi, Younghee Jung, Seung Soon Lee, Ji-Hwan Bang, Eu Suk Kim, Song Mi Moon, Je Eun Song, Yee Gyung Kwak, Shin Hye Chun, Yeon-Sook Kim, Kyung-Hwa Park, Yu Min Kang, Pyoeng Gyun Choe, Shinwon Lee, Hong Bin Kim, Korea INfectious Diseases (KIND) Study Group	Sci Rep
36423170	isolation and Characterization of a iPhapecoctavirusi infecting multidrugresistant iAcinetobacter baumanniii in a549 alveolar epithelial cell	multidrugresistant iAcinetobacter baumanniii MDR iA baumanniii be a emerge pathogen in the eskape group the global burden of antimicrobial resistance have lead to renew interest in alternative antimicrobial treatment strategy include phage therapy this study isolate and characterize a phage vbabam abpw7 vabpw7 specific to MDR iA baumanniii morphological analysis show that phage vabpw7 belong to the iMyoviridaei family genome analysis show that the phage DNA genome consist of 148647 bp and that the phage be a member of the iPhapecoctavirusi genus of the order iCaudoviralesi a short latent period and a large burst size indicate that phage vabpw7 be a lytic phage that could potentially be use in phage therapy phage vabpw7 be a highstability phage that have high lytic activity phage vabpw7 could effectively reduce biofilm formation and remove preform biofilm the utility of phage vabpw7 be investigate in a human a549 alveolar epithelial cell culture model phage vabpw7 be not cytotoxic to a549 cell and the phage could significantly reduce planktonic MDR iA baumanniii and MDR iA baumanniii adhesion on a549 cell without cytotoxicity this study suggest that phage vabpw7 have the potential to be develop further as a new antimicrobial agent against MDR iA baumanniii	2022 Nov	Phitchayapak Wintachai, Komwit Surachat, Ganyalak Chaimaha, Abdi Wira Septama, Duncan R Smith	Viruses
36683680	detection and homology analysis of carbapenem resistant acinetobacter baumannii resistance gene	to explore the carry status and homology of carbapenem resistant acinetobacter baumannii CRAB in we hospital	2022	Hong-Bo Guo, Hua-Liang Huang, Yue-Yu Li	Front Cell Infect Microbiol
36293461	role of emasr in ethanol metabolism by iAcinetobacter baumanniii	iAcinetobacter baumanniii be a wellknown nosocomial pathogen that can survive in different environment through the use of intricate network to regulate gene expression twocomponent system TCS form a important part of such regulatory network and in this study we describe the identification and characterization of a novel emasr TCS in iA baumanniii we construct a tni5itagge mutagenesis library from which a iemaSi sensor kinase gene and iemari response regulator gene be identify we find that iemaSiiemari singlemutant and doublemutant be unable to replicate in m9 medium with 1 ethanol as the single carbon source motility and biofilm formation be negatively affect in doublemutant and transcriptomic analysis show that mutation of iemasri dysregulate gene require for carbon metabolism in addition iemaSiiemari singlemutant and doublemutant be unable to survive in acetic acid and sodium acetatecontaining medium indicate that the emasr TCS be also important for acetate metabolism furthermore virulence against iGalleria mellonellai be diminish in iemaSiiemari single and doublemutant taken together this result show that this novel emasr TCS be involve in the regulation of iA baumanniii ethanol metabolism and acetate metabolism with important implication on motility biofilm formation and virulence if mutate further research on the underlying mechanism be warrant	2022 Oct	Hung-Yu Shu, Yu-Wen Huang, Ping-Yi Tsai, Kun-Sheng Hsieh, Guang-Huey Lin	Int J Mol Sci
35883478	identification and Characterization of a rrmcontaining RNA binding protein in iAcinetobacter baumanniii	iAcinetobacter baumanniii be a gramnegative pathogen know to acquire resistance to antibiotic use in the clinic the rnabinding proteome of this bacterium be poorly characterize in particular for what concern the protein contain RNA Recognition motif RRM here we browsed the iA baumanniii proteome for homologous protein to the human hurelavl1 a RNA bind protein contain three rrm we identify a unique locus that we call iabiielavli coding for a protein with a single RRM with a average of 34 identity to the first hur RRM we also wide the research to the genome of all the bacterium find 227 entry in 12 bacterial phyla notably we observe a partial evolutionary divergence between the rnp1 and rnp2 conserved region present in the prokaryote in comparison to the metazoan consensus sequence we check the expression at the transcript and protein level clone the gene and express the recombinant protein the Xray and nmr structural characterization of the recombinant abelavl reveal that the protein maintain the typical " sub1subαsub1subβsub2subβsub3subαsub2subβsub4sub and threedimensional organization of eukaryotic rrm the biochemical analysis show that although the rnp1 and rnp2 show difference it can bind to aurich region like the human hur but with less specificity and low affinity therefore we identify a rrmcontaining rnabinding protein actually express in iA baumanniii	2022 Jun	Caterina Ciani, Anna Pérez-Ràfols, Isabelle Bonomo, Mariachiara Micaelli, Alfonso Esposito, Chiara Zucal, Romina Belli, Vito Giuseppe D'Agostino, Irene Bianconi, Vito Calderone, Linda Cerofolini, Orietta Massidda, Michael Bernard Whalen, Marco Fragai, Alessandro Provenzani	Biomolecules
36475894	phenotypic Characterization and heterogeneity among modern Clinical isolate of acinetobacter baumannii	acinetobacter baumannii be a opportunistic pathogenic bacterium prioritize by who and CDC because of its increase antibiotic resistance heterogeneity among strain represent the hallmark of a baumannii bacterium we wonder to what extent extensively use strain socalled reference strain reflect the dynamic nature and intrinsic heterogeneity of this bacterium we analyze multiple phenotypic trait of 43 nonredundant modern and multidrugresistant extensively drugresistant and pandrugresistant clinical isolate and broadly use strain of a baumannii Comparison of this isolate at the genetic and phenotypic level confirm a high degree of heterogeneity importantly we observe that a significant portion of modern clinical isolate strongly differ from several historically establish strain in the light of colony morphology cellular density capsule production natural transformability and iin vivoi virulence the significant difference between modern clinical isolate of a baumannii and establish strain could hamper the study of a baumannii especially concern its virulence and resistance mechanism hence we propose a variable collection of modern clinical isolate that be characterize at the genetic and phenotypic level cover a wide range of the phenotypic spectrum with six different macrocolony type group from avirulent to hypervirulent phenotype and with naturally noncapsulated to hypermucoid strain with intermediate phenotype as well strainspecific mechanistic observation remain interesting iper sei and establish reference strain have undoubtedly be show to be very useful to study basic mechanism of a baumannii biology however any study base on a specific strain of a baumannii should be compare to modern and clinically relevant isolate bimportanceb acinetobacter baumannii be a bacterium prioritize by the CDC and who because of its increase antibiotic resistance lead to treatment failure the hallmark of this pathogen be the high heterogeneity observe among isolate due to a very dynamic genome in this context we test if a subset of broadly use isolate consider reference strain be reflect the genetic and phenotypic diversity find among currently circulate clinical isolate we observe that the socalled reference strain do not cover the whole diversity of the modern clinical isolate while formerly establish strain successfully generate a strong base of knowledge in the a baumannii field and beyond we study show that a rational choice of strain related to a specific biological question should be take into consideration any datum obtain with historically establish strain should also be compare to modern and clinically relevant isolate especially concern drug screen resistance and virulence context	2023 Feb	Adam Valcek, Chantal Philippe, Clémence Whiteway, Etienne Robino, Kristina Nesporova, Mona Bové, Tom Coenye, Tim De Pooter, Wouter De Coster, Mojca Strazisar, Charles Van der Henst	Microbiol Spectr
35652720	Characterization of carbapenemresistant acinetobacter baumannii st540 and Klebsiella pneumoniae st2237 isolate in a pneumonia case from China	this study aim to characterize the chromosome and plasmid sequence and determine the transferability of plasmid in carbapenemresistance acinetobacter baumannii dd520 and Klebsiella pneumoniae dd521 isolate from the same patient who be coinfected in a hospital in China	2022 Sep	Dao-Feng Zhang, Zeng-Feng Zhang, Pan-Dong Li, Ping-Hua Qu	J Appl Microbiol
36015076	Novel antimicrobial peptide Octoprohibitin against Multidrug resistant iAcinetobacter baumanniii	Octoprohibitin be a synthetic antimicrobial peptide AMP derive from the prohibitin2 gene of ioctopus minori it show substantial activity against multidrug resistant MDR iAcinetobacter baumanniii with a minimum inhibitory concentration mic and minimum bactericidal concentration mbc of 200 and 400 µgml respectively timekill kinetic and bacterial viability assay confirm the concentrationdependent antibacterial activity of octoprohibitin against iA baumanniii the morphology and ultrastructure of iA baumanniii be alter by treatment with octoprohibitin at the mic and mbc level furthermore propidium iodidefluorescein diacetate pifda staining and 27dichlorodihydrofluorescein diacetate hsub2subdfda staining of octoprohibitintreated iA baumanniii reveal membrane permeability alteration and reactive oxygen species ROS generation respectively agarose gel retardation result confirm the dnabinding ability of octoprohibitin to the genomic DNA of iA baumanniii furthermore octoprohibitin show concentrationdependent inhibition of biofilm formation and eradication the minimum biofilm inhibition concentration mbic and minimum biofilm eradication concentration mboc of octoprohibitin be 1000 and 1460 µgml respectively Octoprohibitin produce no significant cytotoxicity up to 800 µgml and no hemolysis be observe up to 400 µgml furthermore in vivo analysis in a iA baumanniiiinfected zebrafish model confirm the effective bactericidal activity of octoprohibitin with high cumulative survival percent 466 and few pathological sign histological analysis show reduce alteration in the gut kidney and gill tissue in the octoprohibitintreated group compare with that in the phosphatebuffered saline pbstreated group in conclusion we result suggest that octoprohibitin be a potential antibacterial and antibiofilm agent against MDR iA baumanniii	2022 Jul	E H T Thulshan Jayathilaka, Dinusha C Rajapaksha, Chamilani Nikapitiya, Joeun Lee, Mahanama De Zoysa, Ilson Whang	Pharmaceuticals (Basel)
35638738	Peptidoglycan recycling promote Outer membrane integrity and carbapenem tolerance in acinetobacter baumannii	" lactam antibiotic exploit the essentiality of the bacterial cell envelope by perturbing the peptidoglycan layer typically result in rapid lysis and death many gramnegative bacterium do not lyse but instead exhibit tolerance the ability to sustain viability in the presence of bactericidal antibiotic for extend period antibiotic tolerance have be implicate in treatment failure and be a steppingstone in the acquisition of true resistance and the molecular factor that promote intrinsic tolerance be not well understand acinetobacter baumannii be a criticalthreat nosocomial pathogen notorious for its ability to rapidly develop multidrug resistance carbapenem βlactam antibiotic ie meropenem be firstline prescription to treat a baumannii infection but treatment failure be increasingly prevalent meropenem tolerance in gramnegative pathogen be characterize by morphologically distinct population of spheroplast but the impact of spheroplast formation be not fully understand here we show that susceptible a baumannii clinical isolate demonstrate tolerance to highlevel meropenem treatment form spheroplast upon exposure to the antibiotic and revert to normal growth after antibiotic removal use transcriptomics and genetic screen we show that several gene associate with outer membrane integrity maintenance and efflux promote tolerance likely by limiting entry into the periplasm gene associate with peptidoglycan homeostasis in the periplasm and cytoplasm also answer we screen and they disruption compromise cell envelope barrier function finally we define the enzymatic activity of the tolerance determinant penicillinbind protein 7 pbp7 and elsl a cytoplasmic ldcarboxypeptidase this datum show that outer membrane integrity and peptidoglycan recycle be tightly link in they contribution to a baumannii meropenem tolerance bimportanceb carbapenem treatment failure associate with superbug infection have rapidly increase in prevalence highlight the urgent need to develop new therapeutic strategy antibiotic tolerance can directly lead to treatment failure but have also be show to promote the acquisition of true resistance within a population while some study have address mechanism that promote tolerance factor that underlie gramnegative bacterial survival during carbapenem treatment be not well understand here we characterize the role of peptidoglycan recycle in outer membrane integrity maintenance and meropenem tolerance in a baumannii this study suggest that the pathogen limit antibiotic concentration in the periplasm and highlight physiological process that could be target to improve antimicrobial treatment	2022 Jun	Nowrosh Islam, Misha I Kazi, Katie N Kang, Jacob Biboy, Joe Gray, Feroz Ahmed, Richard D Schargel, Cara C Boutte, Tobias Dörr, Waldemar Vollmer, Joseph M Boll	mBio
36482960	prognostic evaluation of iAcinetobacter baumanniii ventilatorassociated pneumonia in covid19	since the emergence of the pandemic of sarscov2 a high report incidence of vap in covid19 sustained by carbapenem resistant iAcinetobacter baumanniii CRAB have be observe but datum be scarce to date	2022	Ilaria De Benedetto, Tommaso Lupia, Nour Shbaklo, Alessandro Bianchi, Erika Concialdi, Maurizio Penna, Silvia Corcione, Francesco Giuseppe De Rosa	Infez Med
35890253	Safety and Prophylactic efficacy of liposomebase vaccine against the DrugResistant iAcinetobacter baumanniii in mice	in recent year the emergence of multidrugresistant iacientobacter baumanniii have greatly threaten public health and deplet we currently available antibacterial armory due to limited therapeutic option the development of a effective vaccine formulation become critical in order to fight this drugresistant pathogen the objective of the present study be to develop a safe vaccine formulation that can be effective against iA baumanniii infection and its associate complication here we prepare liposomesencapsulated whole cell antigen Lipwcag as a vaccine formulation and investigate its prophylactic efficacy against the systemic infection of iA baumanniii the immunization with Lipwcag induce the high production of antigenspecific antibody titer great lymphocyte proliferation and increase secretion of th1 cytokine particularly IFN γ and IL12 antisera from lipwcagsimmunized mouse show the utmost bactericidal activity and potently inhibit the biofilm formation by iA baumanniii interestingly lipWCAgsinduced immune response be translate in in vivo protection study as the immunize mouse exhibit the high resistance to iA baumanniii infection mice in the group immunize with Lipwcag have a 80 survival rate and a bacterial burden of 5464 ± 1193 CFU per gram of the lung tissue whereas the mouse immunize with ifawcag have a 50 survival rate and 51521 ± 8066 CFU in addition Lipwcag vaccinate mouse have low level of the inflammatory marker include CRP IL6 il1 " and tnf α the finding of this study suggest that Lipwcag may be consider a potential vaccine formulation to protect individual against iA baumanniii infection	2022 Jun	Masood Alam Khan, Khaled S Allemailem, Hamzah Maswadeh, Hina Younus	Pharmaceutics
35403751	acinetobacter baumannii insight towards a comprehensive approach for the prevention of outbreak in healthcare facility	acinetobacter baumannii be know to be a opportunistic pathogen frequently responsible for outbreak in healthcare facility particularly in intensive Care unit icu it can easily survive in the hospital set for long period and can be transmit throughout the hospital in a variety of way explore in this review it can also easily acquire antibiotic resistance determinant rendering several antibiotic drug useless in 2019 the US Centre for Disease Control CDC consider the organism as a urgent threat the aim of this review be to raise the awareness of the medical community about the relevance of this pathogen and discuss how it may impact seriously the healthcare institution particularly in the aftermath of the recent covid19 pandemic PubMed be search and article that meet inclusion criterion be review we conclude by the need to raise awareness to this pathogen relevance and to encourage the implementation of preventive measure in order to mitigate its consequence namely the triage of specific highrisk patient	2022 Jun	Diogo Filipe Borges Duarte, Acácio Gonçalves Rodrigues	APMIS
36417919	acinetobacter baumannii among patient receiving Glucocorticoid aerosol therapy during invasive mechanical ventilation China	acinetobacter baumannii be a nosocomial pathogen associate with severe illness and death Glucocorticoid aerosol be a common inhalation therapy in patient receive invasive mechanical ventilation we conduct a prospective cohort study to analyze the association between glucocorticoid aerosol therapy and a baumannii isolation from ventilator patient in China of 497 enrol patient 262 527 receive glucocorticoid aerosol and a baumannii be isolate from 159 320 Glucocorticoid aerosol therapy be a independent risk factor for a baumannii isolation hazard ratio 15 95 CI 102228 p 0038 patient receive glucocorticoid aerosol have a high cumulative hazard for a baumannii isolation and analysis show that glucocorticoid aerosol therapy increase a baumannii isolation in most subpopulation Glucocorticoid aerosol be not a direct risk factor for 30 day mortality but a baumannii isolation be independently associate with 30 day mortality in ventilator patient physician should consider potential a baumannii infection when prescribing glucocorticoid aerosol therapy	2022 Dec	Wenchao Zhang, Mei Yin, Wei Li, Nana Xu, Haining Lu, Weidong Qin, Hui Han, Chen Li, Dawei Wu, Hao Wang	Emerg Infect Dis
36992448	Characterization of Virulent t4 like iAcinetobacter baumanniii bacteriophage DLP1 and DLP2	the world be currently face a global health crisis due to the rapid increase in antimicrobialresistant bacterial infection one of the most concern pathogen be iAcinetobacter baumanniii which be list as a priority 1 pathogen by the World Health Organization this gramnegative bacterium have many intrinsic antibiotic resistance mechanism and the ability to quickly acquire new resistance determinant from its environment a limited number of effective antibiotic against this pathogen complicate the treatment of iA baumanniii infection a potential treatment option that be rapidly gain interest be phage therapy or the clinical application of bacteriophage to selectively kill bacterium the myoviruse DLP1 and DLP2 vbabamdly and vbabamdlp2 respectively be isolate from sewage sample use a capsule minus variant of iA baumanniii strain ab5075 host range analysis of this phage against 107 iA baumanniii strain show a limited host range infecting 15 and 21 for phage DLP1 and DLP2 respectively phage DLP1 have a large burst size of 239 pfucell a latency period of 20 minute and virulence index of 093 in contrast DLP2 have a small burst size of 24 pfucell a latency period of 20 minute and virulence index of 086 both phage show potential for use as therapeutics to combat iA baumanniii infection	2023 Mar	Danielle L Peters, Carly M Davis, Greg Harris, Hongyan Zhou, Philip N Rather, Sabahudin Hrapovic, Edmond Lam, Jonathan J Dennis, Wangxue Chen	Viruses
36891157	phenotypic and genomic comparison of dominant and nondominant sequencetype of iAcinetobacter baumanniii isolate in China	iA baumanniii be a common clinical pathogen that often cause pneumonia and bloodstream infection in icu patient sequence type ST be use to investigate the distribution and spread of iA baumanniii biological characteristic such as virulence and resistance may play a role in iA baumanniii become a specific dominant stdstst191 st195 and ST208 strain to characterize the biological genetic and transcriptomic difference between the dst and nondominant stnstst462 and st547etc strain in iA baumanniii we perform several biological experiment and genetic and transcriptomic analysis the dst group display more resistance ability to desiccation oxidation multiple antibiotic and complement kill than the nst group however the latter have high biofilm formation ability than the former the genomic analysis show the dst group exhibit more capsulerelated and aminoglycosideresistant gene besides go analysis indicate that function involve in lipid biosynthetic transport and the metabolic process be upregulate in the dst group while kegh analysis manifest that the twocomponent system related to potassium ion transport and pile be downregulated in short resistance to desiccation oxidation multiple antibiotic and serum complement kill be important reason for the formation of dst gene related to capsule synthesis and lipid biosynthesis and metabolism play a important role at the molecular level in the formation of dst	2023	Xiaoyang Kong, Tao Chen, Lihua Guo, Yanzi Zhou, Ping Lu, Yonghong Xiao	Front Cell Infect Microbiol
35884213	combatting planktonic and biofilm population of CarbapenemResistant iAcinetobacter baumanniii with polymyxinbased combination	Carbapenemresistant iAcinetobacter baumanniii CRAB can cause serious infection that be associate with high mortality rate during the course of a infection many CRAB isolate be able to form biofilm which be recalcitrant to several antibiotic and can be difficult to treat polymyxinbased regimen be a firstline treatment option for CRAB infection but they have not be optimize against both planktonic and biofilm phase of growth the objective of this study be to identify polymyxinbased combination that be active against planktonic and biofilm population of CRAB four CRAB isolate meropenem mic 8256 mgL capable of form biofilm be use in each experiment the activity of polymyxin B alone and in combination with ampicillinsulbactam meropenem minocycline and rifampin be assess use timekill assay with the CRAB isolate grow in planktonic and biofilm phase Viable colony count be use to detect the bactericidal activity and synergy of the antibiotic combination against the planktonic population polymyxin B combine with meropenem minocycline ampicillinsulbactam and rifampin cause 378 015 438 and 323 mean logsub10 sub CFUmL reduction against all isolate at 24 h respectively polymyxin B combine with meropenem ampicillinsulbactam or rifampin be synergistic against 75100 34 or 44 of CRAB isolate against biofilm polymyxin B combine with meropenem minocycline ampicillinsulbactam and rifampin cause 186 101 066 and 355 mean logsub10 sub CFUmL reduction against all isolate at 24 h respectively only the combination of polymyxin B and rifampin retain bactericidal activity or synergy against any of the isolate when grow as biofilm 50 of isolate the combination of polymyxin B and rifampin may be promise for CRAB infection that have planktonic and biofilm population present	2022 Jul	Marisol Wences, Elliot R Wolf, Cindy Li, Nidhi Singh, Nene Bah, Xing Tan, Yanqin Huang, Zackery P Bulman	Antibiotics (Basel)
36451560	biological and physical characterization of bacteriophage jha against multidrugresistant acinetobacter baumannii	due to the emergence of antibiotic resistance bacteriophage therapy appear to be a ideal weapon to utilize against pathogenic bacterium this study aim to isolate identify and characterize the lytic bacteriophage effective against the multidrugresistant acinetobacter baumannii clinical isolate the isolate bacteriophage cause lysis by apply the doublelayer agar technique on a baumannii up to 99 in 18 hour of incubation at 37supºsupc the bacterial growth reduction assay exhibit that jha phage have high adsorption rate and could rapidly inhibit bacterial growth the pH and thermal stability testing show that jha phage be stable in vast range of pH from 5 to 9 but its activity be high at ph7 1860000±1000 pfumL it be stable in broad range of temperature from 25 supºsupC to 60 supºsupC but the high activity be find at 37 supºsupC 1300000±30000 pfumL onestep growth test result show that it have a short latent period strong lytic ability high burst size and adsorption rate and be host specific scanning electron microscopy SEM of jha phage demonstrate icosahedral head and tailless particle transmission electron microscopy tem reveal jha phage belong to tectiviridae family all the characteristic of jha phage possess lytic activity against a baumannii strain and exhibit novel candidate to use as a alternative competitor to antibiotic in control such infection	2022 Sep	Heba Ajmal, Zubaida Sharif, Basit Zeshan, Nureen Zahra, Madiha Khan	Pak J Pharm Sci
37125466	Global epidemiology and mechanism of resistance of acinetobacter baumanniicalcoaceticus complex	acinetobacter baumanniicalcoaceticus complex be the most commonly identify species in the genus acinetobacter and it account for a large percentage of nosocomial infection include bacteremia pneumonia and infection of the skin and urinary tract a few key clone of a baumanniicalcoaceticus be currently responsible for the dissemination of this organism worldwide unfortunately multidrug resistance be a common trait among this clone due to they unrival adaptive nature a baumanniicalcoaceticus isolate can accumulate resistance trait by a plethora of mechanism include horizontal gene transfer natural transformation acquisition of mutation and mobilization of genetic element that modulate expression of intrinsic and acquire gene	2023 May	Mariana Castanheira, Rodrigo E Mendes, Ana C Gales	Clin Infect Dis
37219426	prevalence and Clinical consequence of colistin heteroresistance and Evolution into full resistance in CarbapenemResistant acinetobacter baumannii	colistin heteroresistance hr refer to a bacterial population comprise of several subpopulation with different level of resistance to colistin in this study we discuss the classic form of hr in which a resistant subpopulation exist within a predominantly susceptible population we investigate the prevalence of colistin hr and its evolution into full resistance among 173 clinical carbapenemresistant acinetobacter baumannii isolate and examine the effect of hr on clinical outcome to determine hr we perform population analysis profiling we result show a high prevalence of hr 671 to examine evolution of hr strain into full resistance the hr strain be grow in colistincontaining broth transfer onto colistincontaining plate and colony on this plate be transfer into colistinfree broth many of the hr strain 802 evolve into full resistance 172 revert to hr and 26 be borderline we use logistic regression to compare 14day clinical failure and 14day mortality between patient infect by hr versus susceptible nonHR carbapenemresistant a baumannii in the subgroup of patient with bacteremia hr be significantly associate with 14day mortality bimportanceb to we knowledge this be the first largescale study to report on hr in gramnegative bacterium we describe the prevalence of colistin hr in a large sample of carbapenemresistant a baumannii isolate the evolution of many colistin hr isolate to a resistant phenotype follow colistin exposure and withdrawal and the clinical consequence of colistin hr we find a high prevalence of hr among clinical carbapenemresistant a baumannii isolate most evolve into a resistant phenotype follow colistin exposure and withdrawal in patient treat with colistin evolution of hr a baumannii into full resistance could lead to high rate of treatment failure and contribute to the reservoir of colistinresistant pathogen in health care setting	2023 May	Hadas Kon, Amichay Hameir, Amir Nutman, Elizabeth Temkin, Alona Keren Paz, Jonathan Lellouche, David Schwartz, David S Weiss, Keith S Kaye, George L Daikos, Anna Skiada, Emanuele Durante-Mangoni, Yael Dishon Benattar, Dafna Yahav, Vered Daitch, Mariano Bernardo, Domenico Iossa, Lena E Friberg, Ursula Theuretzbacher, Leonard Leibovici, Yaakov Dickstein, Dina Pollak, Sigal Mendelsohn, Mical Paul, Yehuda Carmeli	Microbiol Spectr
35151875	Fighting acinetobacter baumannii infection with the acylase PvdQ	acinetobacter baumannii be a opportunistic gramnegative bacterial pathogen that pose a threat for frail patient worldwide the high ability to withstand environmental stress as well as its resistance towards a broad range of antibiotic make a baumannii a effective hardtoeradicate pathogen one of the key mechanism mediating tolerance against antibiotic treatment be the formation of biofilm a process that be control by a multitude of different regulatory mechanism a key factor with major impact on biofilm formation be celltocell communication by quorumsensing which in a baumannii be mediate by acyl homoserine lactone signal molecule here we show that the NtnHydrolase PvdQ from pseudomonas aeruginosa can reduce biofilm formation by the a baumannii atcc 17978 type strain and several clinical isolate on abiotic surface further we study show that a combination treatment of pvdfmediated quorumquench with the antibiotic gentamicin have a synergistic effect on the clearance of a baumannii biofilm and possible biofilm dispersal moreover we demonstrate in a Galleria mellonella larval infection model that PvdQ administration significantly prolong survival of the larvae altogether we conclude that the acylasemediated irreversible cleavage of quorumsensing signal molecule as exemplify with PvdQ can set a profound limit to the progression of a baumannii infection	2022 Jun	Jan Vogel, Lisa Jansen, Rita Setroikromo, Francis M Cavallo, Jan Maarten van Dijl, Wim J Quax	Microbes Infect
35603008	molecular and genetic characterization of emerge carbapenemaseproducing iAcinetobacter baumanniii strain from patient and hospital environment in Bangladesh	carbapenemaseproducing multidrugresistant MDR iAcinetobacter baumanniii be a global health care problem MDR iA baumanniii have emerge as a important nosocomial pathogen costing many life worldwide include Bangladesh	2022 Jun	Refath Farzana, Göte Swedberg, Christian G Giske, Badrul Hasan	Infect Prev Pract
36009885	be it possible to eradicate CarbapenemResistant iAcinetobacter baumanniii CRAB from endemic hospital	despite the global effort to antagonize carbapenemresistant iAcinetobacter baumanniii CRAB spread it remain a emerge threat with a related mortality exceeding 40 among critically ill patient the purpose of this review be to provide evidence concern the good infection prevention and control ipc strategy to fight CRAB spread in endemic hospital	2022 Jul	Filippo Medioli, Erica Bacca, Matteo Faltoni, Giulia Jole Burastero, Sara Volpi, Marianna Menozzi, Gabriella Orlando, Andrea Bedini, Erica Franceschini, Cristina Mussini, Marianna Meschiari	Antibiotics (Basel)
35862954	the cellcell Communication signal indole controls the physiology and interspecy Communication of acinetobacter baumannii	many bacterium utilize quorum sensing qs to control group behavior in a cell densitydependent manner previous study have demonstrate that acinetobacter baumannii employ a nacyllhomoserine lactone ahlbased qs system to control biological function and virulence here we report that indole control biological function virulence and ahl signal production in a baumannii the biosynthesis of indole be perform by a1s3160 abis uAucinetobacter ubuaumannii uiundole usuynthase which be a novel indole synthase annotate as a ialphaiibetai hydrolase in a baumannii heterologous expression of abis in a Escherichia coli indoledeficient mutant also rescue the production of indole by use a distinct biosynthetic pathway from the tryptophanase TnaA which produce indole directly from tryptophan in E coli moreover we reveal that indole from a baumannii reduce the competitive fitness of pseudomonas aeruginosa by inhibiting its qs system and type iii secretion system t3ss as a baumannii and p aeruginosa usually coexist in human lung we result suggest the crucial role of indole in both the bacterial physiology and interspecy communication bimportanceb acinetobacter baumannii be a important human opportunistic pathogen that usually cause high morbidity and mortality it employ the nacyllhomoserine lactone ahltype quorum sensing qs system abaiabar to regulate biological function and virulence in this study we find that a baumannii utilize another qs signal indole to modulate biological function and virulence it be further reveal that indole positively control the production of ahl signal by regulate iabaIi expression at the transcriptional level furthermore indole repress the qs system and type iii secretion system t3ss of p aeruginosa and enhance the competitive ability of a baumannii together we work describe a qs signal network where a pathogen use to control the bacterial physiology and pathogenesis and the competitive ability in microbial community	2022 Aug	Binbin Cui, Xiayu Chen, Quan Guo, Shihao Song, Mingfang Wang, Jingyun Liu, Yinyue Deng	Microbiol Spectr
36531260	growth kinetic of multiple iAcinetobacter baumanniii resistotype after meropenembase antibiotic combination exposure	bBackgroundb carbapenem be the treatment of choice for multidrugresistant MDR and extensively drugresistant XDR iAcinetobacter baumanniii infection but the emergence of carbapenemresistant iA baumanniii CRAB have render it ineffective in the vast majority of case combination therapy have grow in popularity over the last decade this study aim to analyze iAbaumanniii growth kinetic after exposure to meropenem and ampicillinsulbactam compare with meropenem and amikacin antibiotic combination in clinically relevant concentration bMethodsb this experimental laboratory study be conduct on the iA baumanniii atcc 19606 isolate and three clinical isolate that be intermediate or resistant to test antibiotic meropenem and ampicillinsulbactam as well as meropenem and amikacin be test at four different concentration against isolate turbidity measurement be take at predetermine time point of 0 1 2 4 6 8 and 24 hour follow exposure bacterial concentration be enumerate use the agar plate method with the result plot in a timekill curve bResultsb a bactericidal effect be achieve in isolate that be intermediate to ampicillinsulbactam and resistant to meropenem after the administration of meropenem and ampicillinsulbactam combination with a concentration of 4 µgml and 168 µgml respectively the combination of meropenem and ampicillinsulbactam demonstrate bacteriostatic activity against isolate that be resistant to both antibiotic isolate treat with resistant antibiotic show a increase growth rate compare to the growth control bConclusionb the combination of meropenem and ampicillinsulbactam could be a promise combination therapy in treat CRAB infection the mechanism and degree of antibiotic resistance in the isolate affect the efficacy of antibiotic combination further research be need to corroborate the finding of this study	2022	Erizka Rivani, Pepy Dwi Endraswari, Agung Dwi Wahyu Widodo	F1000Res
36971967	different efflux Pump system in acinetobacter baumannii and they role in Multidrug resistance	several infection such as pneumonia urinary tract infection utis as well as bloodstream skin and soft tissue infection be cause by acinetobacter baumannii a nosocomial pathogen and gramnegative coccobacillus due to its resistance to a variety of medication multidrug therapy and occasionally pan therapy this bacterium be a huge public health concern drug resistance be a big worry not only in a baumannii but it be also a major challenge in many other disease antibiotic resistance biofilm development and genetic alteration be all link to variable like the efflux pump efflux pump be transport protein involve in the extrusion of hazardous substrate from within cell into the external environment include nearly all type of therapeutically relevant antibiotic both grampositive and gramnegative bacterium as well as eukaryotic organism contain this protein efflux pump may be specialized for a single substrate or can transport a variety of structurally dissimilar molecule include antibiotic of many class this pump have be link to multiple drug resistance MDR there be five primary family of efflux transporter in the prokaryotic kingdom mf major facilitator mate multidrug and toxic efflux RND resistancenodulationdivision SMR small multidrug resistance and ABC atpbinding cassette the efflux pump and they type as well as the mechanism of a efflux pump involve in multidrug resistance in bacterium have be discuss here the main focus be on the variety of efflux pump commonly find in a baumannii along with they mechanism by which they make this bacterium drug resistant the effluxpumpinhibitorbased strategy that be significant in target efflux pump in a baumannii have also be discuss the connection of biofilm and bacteriophage with the efflux pump can prove as a efficient strategy for target effluxpumpbased resistance in a baumannii	2023 Mar	Saroj Sharma, Vaishali Kaushik, Mukta Kulshrestha, Vishvanath Tiwari	Adv Exp Med Biol
35367743	BauA and omp34 surface loop trigger protective antibody against acinetobacter baumannii in a murine sepsis model	the complexity of treat acinetobacter baumannii infection with the newly develop resistant strain have lead researcher to confront this pathogen by develop vaccine in this study we use two important virulence factor of a baumannii to elicit immunity against the a baumannii the immunogenic loop be from baumannii acinetobactin utilization a BauA and 34kD outer membrane protein omp34 clobe derivative of the TbpB surface lipoprotein be use to display the superficial epitope of the TbpA receptor protein of Neisseria meningitidis the result loopless clobe LCL with implant nucleotide sequence of the immunogenic loop from BauA and omp34 be use as a hybrid antigen the hybrid antigen be express in the E coli and be use to immunize mouse the mouse be challenge with a clinical isolate of a baumannii abi022 Immunization with the hybrid antigen of the BauA loop 7 bauslapl omp34 loop 3 omp34l3p1 and the combination of both loop baual7p3omp34l3p1 bring about 4286 4286 and 7143 protection against a baumannii infection histopathological finding in the immunize mouse show bronchiole clear from inflammatory cell and normal texture of the spleen and liver the finding support the use of a multivalent vaccine to induce broadly reactive antibody response against heterologous a baumannii strain	2022 Jul	Zahra Akbari, Iraj Rasooli, Mohammad Hossein Ghaini, Somshukla Chaudhuri, Vahid Farshchi Andisi, Abolfazl Jahangiri, Fatemeh Ramezanalizadeh, Anthony B Schryvers	Int Immunopharmacol
35922185	Risk factor and resistance pattern of invasive iAcinetobacter baumanniii infection in Children	bObjectiveb to understand the risk factor and antibioticsresistant pattern of invasive iAcinetobacter baumanniii infection in Children bMethodsb this retrospective study be conduct in 6 tertiary hospital from January 2016 to December 2018 the basic information clinical datum and the result of antimicrobial susceptibility testing be collect from the 98 pediatric inpatient with iAcinetobacter baumanniii isolate from blood or cerebrospinal fluid and analyze accord to the susceptibility of the infect strain to carbapenem they be divide into carbapenemsensitive iAcinetobacter baumanniii csab group and carbapenemresistant iAcinetobacter baumanniii CRAB group accord to the possible source of infection they be divide into nosocomial infection group and community infection group chisquare test or Fisher exact test be use to analyze categorical variable and rank sum test be use to analyze continuous variable the risk factor of invasive CRAB infection in child be analyze by logistic regression bresultb there be 56 male and 42 female in 98 case the onset age of patient be 8 2 24 month there be 62 case 63 from rural area a total of 87 case 89 be confirm with bloodstream infection and 12 case 12 confirm with meningitis 1 case be accompany with bloodstream infection in this patient 66 case 67 receive invasive medical procedure or surgery 54 case 55 receive carbapenemscontaining therapy twentyfour case be infect with CRAB and 74 case with csab the onset age of case in CRAB group be low than that in csab group 4 1 9 ivsi 10 4 24 month izi216 ipi0031 the proportion of hospitalization in intensive care unit carbapenem antibiotic use pneumonia and adverse prognosis in CRAB group be high than that in csab group 6 case 25 ivsi 4 case 5 18 case 75 ivsi 36 case 49 17 case 71 ivsi 17 case 23 6 case 25 ivsi 4 case 5 χsup2sup561 509 1832 561 all ipi005 seventyseven case be nosocomial infection and 21 case be hospitalacquired infection the proportion of child hospitalize in highrisk ward for nosocomial infection length of hospitalization number of antimicrobial therapy receive and duration of antimicrobial therapy be high in the hospital associate infection group than that in the community acquire infection group all ipi005 logistic regression analysis show that child from rural area iori842 95icii 1454888 prior mechanical ventilation iORi1262 95icii 13112176 and prior antibiotic therapy iori490 95icii 1351772 be independent risk factor for CRAB infection the resistance percentage of csab isolate to many class of antibiotic be 6 except to gentamicin which be as high as 20 1365 all CRAB isolate of resistant to ampicillinsulbactam 2020 cefepime 2323 piperacillin 1717 meropenem 2323 and imipenem 2424 be 100 the resistance percentage to other antibiotic be up to 4296 bConclusionsb most of invasive iAcinetobacter baumanniii infection in child in China be hospitalacquired the outcome of invasive CRAB infection be poorer than that of csab infection the drug resistance rate of CRAB strain isolate be high live in rural area prior invasive mechanical ventilation and prior antibiotic therapy be independent risk factor for invasive CRAB infection the prevention and control of nosocomial infection and appropriate use of antibiotic to reduce iAcinetobacter baumanniii infection	2022 Aug	Y L Ge, Q W Shan, Y Qiu, S P Zhou, Y B Cheng, F Wang, J W Yang, C M Wan, Y Zhu, Y Xu, M X Chen, D J Lin, C H Zhu, Mei Zeng	Zhonghua Er Ke Za Zhi
35783362	multidrugresistant iAcinetobacter baumanniii May cause patient to develop polymicrobial bloodstream infection	the incidence of polymicrobial bloodstream infection be increase the clinical characteristic of polymicrobial iAcinetobacter baumanniii bloodstream infection abbsi be unclear and there be no report of polymicrobial abbsi in mainland China therefore we objective be to identify the clinical characteristic risk factor and outcome of polymicrobial abbsi versus monomicrobial abbsi	2022	Qingqing Chen, Zhencang Zheng, Qingxin Shi, Huijuan Wu, Yuping Li, Cheng Zheng	Can J Infect Dis Med Microbiol
36227120	acinetobacter nosocomialis cause as severe Disease as acinetobacter baumannii in Northeast Thailand underestimated role of a nosocomialis in infection	infection by acinetobacter species be recognize as a serious global threat due to cause severe disease and they high level of antibiotic resistance acinetobacter baumannii be the most prevalent pathogen in the genus but infection by acinetobacter nosocomialis have be report widely diagnosis of patient with a baumannii infection be often misdiagnosed with other acinetobacter species especially a nosocomialis this study investigate whether there be significant difference in clinical outcome between patient infect with a baumannii versus a nosocomialis in Northeast Thailand and to characterize serological response to infection with this pathogen the result show that a baumannii have high level of multidrug resistance despite this clinical outcome for infection with a baumannii or a nosocomialis be similar with mortality of 33 and 36 respectively both pathogen cause communityacquired infection a baumannii 35 and a nosocomialis 29 of case Plasma from uninfect healthy control contain IgG antibody that recognize both organism and infect patient do not show a significantly enhance antibody response from the first week versus 2 week late finally the pattern of antigen recognition for plasma IgG be similar for patient infect with a baumannii or a nosocomialis infection and distinct to the pattern for patient infect with nonAcinetobacter in conclusion we datum reveal that infection with a nosocomialis be associate with a similarly high level of mortality as infection with a baumannii the high rate of communityacquired infection and antibody in uninfect individual suggest that there be significant community exposure to both pathogen bimportanceb bacterial infection by acinetobacter species be global threat due to they severity and high level of antibiotic resistance a baumannii be the most common pathogen in the genus however infection by a nosocomialis have also be widely report but be think to be less severe in this study we have prospectively investigate 48 report case of a baumannii infection in Northeast Thailand and characterize the serological response to infection we find that 14 29 of this infection be actually cause by a nosocomialis furthermore the incidence of antibiotic resistance among a nosocomialis strain apache ii score and mortality for patient infect with a nosocomialis be much high than publish datum both a baumannii and a nosocomialis have unexpectedly mortality rate of over 30 and both pathogen cause a high rate of communityacquired infection importantly background antibody in uninfect individual suggest significant community exposure to both pathogen in the environment	2022 Dec	Arnone Nithichanon, Chidchamai Kewcharoenwong, Hudadini Da-Oh, Sirithorn Surajinda, Aranya Khongmee, Surathinee Koosakunwat, Brendan W Wren, Richard A Stabler, Jeremy S Brown, Ganjana Lertmemongkolchai	Microbiol Spectr
36353984	antimicrobial and antibiofilm activity of desloratadine against multidrugresistant iAcinetobacter baumanniii	bAimb the antimicrobial and antibiofilm activity of the antihistamine desloratadine against multidrugresistant MDR iAcinetobacter baumanniii be evaluate bResultsb desloratadine inhibit 90 bacterial growth at a concentration of 64 μgml the combination of desloratadine with meropenem reduce the mic by twofold in the planktonic state and increase the antibiofilm activity by eightfold Survival curve show that combination of this drug be successful in eradicating all bacterial cell within 16 h scanning electron microscopy also confirm a synergistic effect in imparting a harmful effect on the cellular structure of MDR iA baumanniii a iin vivoi model show significant protection of up to 83 of iCaenorhabditis elegansi infect with MDR iA baumanniii bConclusionb we result indicate that reposition of desloratadine may be a safe and lowcost alternative as a antimicrobial and antibiofilm agent for the treatment of MDR iA baumanniii infection	2023 Jan	Junio Eduvirgem, Luana Rossato, Andressa Lf Melo, Anna Cm Valiente, Luiz F Plaça, Heberton Wender, Marcia Sm Vaz, Suzana M Ribeiro, Simone Simionatto	Future Microbiol
35741297	performance evaluation of the vitek2 and sensititre system to determine colistin resistance and mic for iAcinetobacter baumanniii	performance of the colistin antimicrobial susceptibility testing ast system of iAcinetobacter baumanniii vary depend on the manufacturer and datum on colistinresistant iA baumanniii be limited we evaluate the vitek2 and sensititre system to determine colistin resistance and minimum inhibitory concentration mic for iA baumanniii isolate from a clinical microbiology laboratory a total of 213 clinical iA baumanniii isolate be test include 81 colistinresistant iA baumanniii _st be perform use the vitek2 and sensititre system accord to the manufacturer instruction reference mic for colistin be determine use the manual broth microdilution method bmd the result of the two ast method be compare with the bmd result vitek2 and sensititre system show category agreement of 953 and 991 respectively vitek2 have a relatively high very major error VME rate 99 sensititre report high mic than the reference method for the susceptible isolate and show low essential agreement in conclusion the automated system investigate in this study show good category agreement for colistin ast of iA baumanniii however vitek2 have a high VME rate and sensititre have difference in mic result colistin ast remain a challenging task in the clinical laboratory	2022 Jun	Hae-Sun Chung, Soo-Kyung Kim, Chorong Hahm, Miae Lee	Diagnostics (Basel)
36145776	antibacterial activity of Monsonia Angustifolia and momordica Balsamina Linn Extract against CarbapenemResistant acinetobacter baumannii	carbapenemaseproducing iAcinetobacter baumanniii iA baumanniii be resistant to most of the available antibiotic and pose serious therapeutic challenge the study investigate iMonsonia angustifoliai iM angustifoliai and iMomordica balsamina Linni iM balsamina Linni extract for antibacterial activity against a clinical isolate of carbapenemaseproducing iA baumanniii use the kirby bauer disc diffusion and tlc couple with bioautography mic determination experiment be conduct on a molecularly characterize iA baumanniii isolate identify use vitek2 positive pcr detection of iblasubOXA51subi and iblasubOXA23subi confirm isolate identity and the presence of a carbapenemaseencoding gene antibacterial activity be observe with the methanolic extract of iM balsamina Linni with a mic of 05 mgmL compound with Rf value of 005 017 039 obtain from iM angustifoliai hexane extract compound with Rf value of 058 078 036 048 05 056 067 09 obtain from iM angustifoliai dichloromethane extract compound with Rf value of 011 056 024 037 obtain from iM angustifoliai acetone extract and compound with Rf value of 011 027 obtain from iM angustifoliai methanol extract demonstrate a level of antibacterial activity iM angustifoliai and iM balsamina Linni plant extract have a clinically significant antibacterial activity against a carbapenemaseproducing iA baumanniii strain	2022 Sep	Noel-David Nogbou, Dimpho Raesibe Mabela, Buang Matseke, Ntwanano Sipho Mapfumari, Mmammosheledi Elsie Mothibe, Lawrence Chikwelu Obi, Andrew Munyalo Musyoki	Plants (Basel)
36976008	Heterocyclic diaryliodoniumbased inhibitor of CarbapenemResistant acinetobacter baumannii	find new therapeutic strategy against gramnegative pathogen such as acinetobacter baumannii be challenging starting from diphenyleneiodonium dPI salt which be moderate grampositive antibacterial we synthesized a focus heterocyclic library and find a potent inhibitor of patientderived multidrugresistant acinetobacter baumannii strain that significantly reduce bacterial burden in a animal model of infection cause by carbapenemresistant acinetobacter baumannii CRAB list as a priority 1 critical pathogen by the World Health Organization next use advanced chemoproteomic platform and activitybase protein profiling abpp we identify and biochemically validate betaine aldehyde dehydrogenase BetB a enzyme that be involve in the metabolism and maintenance of osmolarity as a potential target for this compound together use a new class of heterocyclic iodonium salt a potent CRAB inhibitor be identify and we study lay the foundation for the identification of new druggable target against this critical pathogen bimportanceb Discovery of novel antibiotic target multidrugresistant MDR pathogen such as a baumannii be a urgent unmet medical need we work have highlight the potential of this unique scaffold to annihilate MDR a baumannii alone and in combination with amikacin both iin vitroi and in animal that too without inducing resistance further in depth analysis identify central metabolism to be a putative target taken together this experiment lay down the foundation for effective management of infection cause due to highly MDR pathogen	2023 Mar	Pooja Kumari, Grace Kaul, T Anand Kumar, Abdul Akhir, Manjulika Shukla, Suraj Sharma, Siddhesh S Kamat, Sidharth Chopra, Harinath Chakrapani	Microbiol Spectr
35749906	a electrochemical assay for sensitive detection of acinetobacter baumannii gene	a new genosensor which allow sensitive and selective detection of acinetobacter baumannii gene sequence be develop herein in this assay capture probe of acinetobacter baumannii be immobilize on the surface of chitosan modify singleuse pencil graphite electrode cPGE to obtain acinetobacter baumannii genosensor then acinetobacter baumannii target DNA sequence be recognize after solidstate hybridization on cpge genosensor by measure guanine signal via differential pulse voltammetry DPV in order to improve hybridization efficiency experimental parameter affect all assay step be study and the analytical performance of the genosensor be test the low limit of detection LOD for acinetobacter baumannii target DNA sequence be obtain as 186 nm with develop genosensor the selectivity of the propose assay be then test in the presence of 1 base mismatch or two different type of noncomplementary sequence and no interference effect be observe the propose electrochemical assay protocol be easy convenient and rapid which can be a decent alternative to exist method	2022 Nov	Ece Eksin	Talanta
35543248	Chemical synthesis and antigenic evaluation of Inner core oligosaccharide from acinetobacter baumannii lipopolysaccharide	acinetobacter baumannii be currently pose a serious threat to global health lipopolysaccharide LPS be a potent virulence factor of pathogenic gramnegative bacterium to explore the antigenic property of a baumannii LPS four kdocontaining inner core glycans from a baumannii strain atcc 17904 be synthesized a flexible and divergent method base on the use of the orthogonally substitute αkdo2 →5 kdo disaccharide be develop selective removal of different protect group in this key precursor and elongation of sugar chain via αstereocontrolled coupling with 57 oditertbutylsilylene or 5 obenzoyl protect kdo thioglycoside and 2 azido2deoxyglucosyl thioglycoside allow efficient assembly of the target molecule glycan microarray analysis of sera from infect patient reveal that the 45 branch kdo trimer be a potential antigenic epitope which be attractive for further immunological research to develop carbohydrate vaccine against a baumannii	2022 Jul	Xian-Yang Zhou, Ling-Xin Li, Zhen Zhang, Shi-Chao Duan, Ying-Wen Huang, Yi-Yang Luo, Xiao-Dong Mu, Zhi-Wei Chen, Yong Qin, Jing Hu, Jian Yin, Jin-Song Yang	Angew Chem Int Ed Engl
35660472	synergism of eravacycline combine with other antimicrobial agent against carbapenemresistant enterobacteriaceae and acinetobacter baumannii	this study aim to investigate the synergistic activity of eravacycline combine with other antimicrobial agent against carbapenemresistant enterobacteriaceae and acinetobacter baumannii collect from China	2022 Sep	Yun Li, Lanqing Cui, Feng Xue, Qing Wang, Bo Zheng	J Glob Antimicrob Resist
36442439	synthesis and antibiofilm evaluation of nacyl2 aminopyrimidine derivative against acinetobacter baumannii	the overuse of antibiotic will lead to the increase of drug resistance especially the multidrugresistant a baumannii become the lead cause of nosocomial infection with high rate of morbimortality the drug resistance of a baumannii be greatly attribute to its biofilm to alleviate the burden of drug resistance the antivirulence signal strategy be develop by specifically interfere with the ability of the bacterium to recognize host signal that be need to establish infection the bacterium be less able to colonize the host in this paper 39 nacyl2 aminopyrimidine derivative be synthesized and test for they biofilm inhibition efficacy the screen result reveal that some of the analogue 3 ac 8d efficiently inhibit the biofilm formation of a baumannii icsub50 sub as low as 38 μM and the biofilm inhibition ability be further demonstrate with laser confocal result and extracellular polysaccharide inhibition test further motility test reveal we compound be quorum sensing inhibitor besides the synergistic effect of compound 3ac and 8d with different antibiotic suggest its potential clinical significance which be further enhance by the long time biofilm inhibition test after coating with plga finally we also look into the safety of the compound with cytotoxicity assay	2022 Dec	Xue-Min Jia, Cheng Cheng, Ting Liu, Yong-Long Zhao, Bing Guo, Lei Tang, Yuan-Yong Yang	Bioorg Med Chem
36002793	prevalence genetic diversity antibiotic resistance and biofilm formation of acinetobacter baumannii isolate from urban environment	acinetobacter baumannii be a wellknown nosocomial pathogen that have be isolate from different clinical source this pathogen also cause communityacquired infection with mortality rate as high as 64 the exact natural habitat of this bacterium be still unknown in this study we investigate the prevalence of a baumannii in diverse soil and hightouch surface sample collect from a university campus mall park hypermarket and produce market roundabout playground slide and bank atm	2022 Dec	Qutaiba Ababneh, Sally Abu Laila, Ziad Jaradat	J Appl Microbiol
36830106	uncovering the secretion system of iAcinetobacter baumanniii structure and function in Pathogenicity and antibiotic resistance	infection lead by iAcinetobacter baumanniii strain be of great concern in healthcare environment due to the strong ability of the bacterium to spread through different apparatuse and develop drug resistance severe disease can be cause by iA baumanniii in critically ill patient but its biological process and mechanism be not well understand secretion system have recently be demonstrate to be involve in the pathogenic process and five type of secretion system out of the currently know six from gramnegative bacterium have be find in iA baumanniii they can promote the fitness and pathogenesis of the bacterium by release a variety of effector additionally antibiotic resistance be find to be related to some type of secretion system in this review we describe the genetic and structural composition of the five secretion system that exist in iAcinetobacteri in addition the function and molecular mechanism of each secretion system be summarize to explain how they enable this critical pathogen to overcome eukaryotic host and prokaryotic competitor to cause disease	2023 Jan	Pu Li, Sirui Zhang, Jingdan Wang, Mona Mohamed Al-Shamiri, Bei Han, Yanjiong Chen, Shaoshan Han, Lei Han	Antibiotics (Basel)
36498165	transcriptome Analysis of iAcinetobacter baumanniii in rapidforsey@ect response to subinhibitory Concentration of minocycline	the increase emergence of multidrugresistant acinetobacter baumannii bring great threat to public health minocycline be a kind of semisynthetic derivative of the antibacterial drug tetracycline and be often use to treat infection cause by multidrugresistant a baumannii with other antibiotic however minocyclineresistant a baumannii appear constantly to rapidly explore the response of a baumannii to minocycline stress rnaseq be carry out to compare the difference in the transcriptome of a baumannii atcc19606 in the presence or absence of minocycline the result show that 25 gene be differentially express include 10 downregulated gene and 15 upregulate gene and 24 sRNA be upregulate and 24 be downregulated base on the filter criterion log2fc 1 or − 1 and FDR 005 rtcb family protein and ABC transporter atpbinding protein be upregulate by 26 and 113 fold and molecular chaperone groe chaperonin grol class C betalactamase adc158 amino acid ABC transporter permease and apc family permease be downregulated by at least twofold in the presence of halfMIC minocycline the differentially express gene be mainly involve in the stress response the groesgroel chaperonin system and transport metabolic pathway sRNA 1248 be significantly upregulate and sRNA 1767 5182 and 6984 be downregulated in a rapid response to minocycline this result provide insight into the adaptive mechanism of a baumannii to minocycline	2022 Dec	Lili Gao, Xiaochun Ma	Int J Environ Res Public Health
35594766	a comprehensive review on potential therapeutic inhibitor of nosocomial acinetobacter baumannii superbug	acinetobacter baumannii a gramnegative glucose nonfermentative coccobacilli be responsible for cause a wide range of opportunistic nosocomial infection thus list as a who critical priority pathogen for which identification and development of new antibacterial agent be a urgent unmet medical need the current review attempt to present a overview of various mechanism enzymatic and nonenzymatic virulence factor responsible for a baumannii resistance furthermore inhibitor of a baumannii be categorized into different class highlight they MDR inhibition property in addition novel adjuvant that potentiate exist antibiotic as well as natural and synthetic compound that limit biofilm formation in a baumannii infection be discuss	2022 Jul	Danaboina Srikanth, Swanand Vinayak Joshi, Mahammad Ghouse Shaik, Gaurav Pawar, Sushmitha Bujji, Vinaykumar Kanchupalli, Sidharth Chopra, Srinivas Nanduri	Bioorg Chem
36920192	probiotic iLactobacillusi species and they biosurfactant eliminate acinetobacter baumannii biofilm in various manners	acinetobacter baumannii be a critical biofilmforming pathogen that have present great challenge in the clinic due to multidrug resistance thus new method of intervention be need to control biofilmassociated infection in this study among three test iLactobacillusi species Lactobacillus rhamnosus show significant antimaturation and antiadherence effect against a baumannii biofilm lactic acid LA and acetic acid aa be the most effective antibiofilm biosurfactant bss produce by L rhamnosus this antibiofilm phenomenon produce by LA and aa be due to the strong bactericidal effect which work from very early time point as determine by colony enumeration and confocal laser scan microscope the cell destruction of a baumannii appear in both the cell envelope and cytoplasm a discontinuous cell envelope the leakage of cell content and the increase extracellular activity of atpase demonstrate the disruption of the cell membrane by LA and aa this effect also demonstrate the occurrence of protein lysis in addition bacterial DNA interact with and be damage by LA and aa result in significantly reduce expression of biofilm and DNA repair gene the result highlight the possibility and importance of use probiotics in clinical prevention probiotics can be utilize as novel biocide to block and decrease biofilm formation and microbial contamination in medical equipment and during the treatment of infection bimportanceb a baumannii biofilm be a significant virulence factor that cause the biofilm colonization of invasive illness rising bacterial resistance to synthetic antimicrobial have prompt researcher to look at natural alternative such as probiotics and they derivative in this study L rhamnosus and its bss LA and aa demonstrate remarkable antibiofilm and antimicrobial characteristic with a significant inhibitory effect on a baumannii this effect be achieve by several mechanism include the disruption of the cell envelope membrane protein lysis reduce expression of biofilmrelated gene and destruction of bacterial DNA the result provide support for the possibility of use probiotics and they derivative in the clinical prevention and therapy of a baumannii infection	2023 Mar	Mona Mohamed Al-Shamiri, Jingdan Wang, Sirui Zhang, Pu Li, Woodvine Otieno Odhiambo, Yanjiong Chen, Bei Han, E Yang, Meng Xun, Lei Han, Shaoshan Han	Microbiol Spectr
36017154	the investigation on Nosocomial infection of acinetobacter baumannii and the Clinical Analysis of sequential therapy of cefoperazonesulbactam sodium for intracranial infection	intracranial infection be a serious complication after neurosurgery accord to a survey the incidence of intracranial infection be about 2226 and patient with severe symptom may even pose a threat to they life safety	2022	Zezhong Xiong, Defu Zeng, Shilong Shen, Zhibang Han	Comput Math Methods Med
35743027	evasion of antimicrobial activity in iAcinetobacter baumanniii by target Site modification a effective resistance mechanism	iAcinetobacter baumanniii be a gramnegative bacillus that cause multiple infection that can become severe mainly in hospitalize patient its high ability to persist on abiotic surface and to resist stressor together with its high genomic plasticity make it a remarkable pathogen currently the isolation of strain with high antimicrobial resistance profile have gain relevance which complicate patient treatment and prognosis this resistance capacity be generate by various mechanism include the modification of the target site where antimicrobial action be direct this mechanism be mainly generate by genetic mutation and contribute to resistance against a wide variety of antimicrobial such as βlactam macrolide fluoroquinolone aminoglycoside among other include polymyxin resistance which include colistin a rescue antimicrobial use in the treatment of multidrugresistant strain of iA baumanniii and other gramnegative bacterium therefore the aim of this review be to provide a detailed and uptodate description of antimicrobial resistance mediate by the target site modification in iA baumanniii as well as to detail the therapeutic option available to fight infection cause by this bacterium	2022 Jun	Arturo Martínez-Trejo, Juan Manuel Ruiz-Ruiz, Luis Uriel Gonzalez-Avila, Andrés Saldaña-Padilla, Cecilia Hernández-Cortez, Miguel Angel Loyola-Cruz, Juan Manuel Bello-López, Graciela Castro-Escarpulli	Int J Mol Sci
35763257	phenotypic genomic and transcriptomic change in a acinetobacter baumannii strain after spaceflight in chinas tiangong2 space laboratory	acinetobacter baumannii be a opportunistic pathogen often find in patient with low immunity it cause nosocomial infection which be difficult to treat this bacterium can rapidly mutate develop resistance to antimicrobial and adapt to environmental stress thereby increase its survival understanding such adaptive mechanism will be beneficial for control the spread of a baumannii astrobiology study have demonstrate that microbiome from astronaut and manned spaceflight environment show resistance to stress and antibiotic astronaut also encounter low immunity during spaceflight mission the extreme condition of spaceflight provide a unique research platform for study how opportunistic pathogen such as a baumannii adapt to condition such as microgravity and mutate during spaceflight in this study we compare phenotypic variation and analyze genomic and transcriptomic variation in a baumannii strain expose to three different condition ST1 64 day on tiangon g2 space laboratory gt1 ground control and Aba original strain biofilm formation ability of the ST1 strain increase after 64 day of spaceflight in addition highthroughput sequencing reveal that some differentially express gene be upregulate in the ST1 strain compare to the gt1 strain this result provide insight into the environmental adaptation of this widespread pathogen	2022 Sep	Xian Zhao, Yi Yu, Xuelin Zhang, Bing Huang, Chou Xu, Bin Zhang, Po Bai, Changting Liu	Braz J Microbiol
36212889	Metabolomic profiling of polymyxinB in combination with meropenem and sulbactam against multidrug resistant iAcinetobacter baumanniii	empirical therapy use polymyxin combine with other antibiotic be recommend in the treatment of iAcinetobacter baumanniii infection in the present study the synergistic activity of polymyxinB meropenem and sulbactam as combination therapy be investigate use metabolomic analysis the metabolome of iA baumanniii be investigate after treatment with polymyxinB alone 2 mgl meropenem 2 mgl alone combination of polymyxinBmeropenem at they clinical breakpoint and tripleantibiotic combination of polymyxinBmeropenem and 4 mgl sulbactam the tripleantibiotic combination significantly change the metabolite level involve in cell outer membrane and cell wall biosynthesis include fatty acid glycerophospholipid lipopolysaccharide peptidoglycan and nucleotide within 15 minute of administration in contrast significant change in metabolome be observe after 1 h in sample treat with either meropenem or polymyxinB alone after 1 h of administration the double and triple combination therapy significantly disrupt nucleotide and amino acid biosynthesis pathway as well as the central carbon metabolism include pentose phosphate and glycolysisgluconeogenesis pathway and tricarboxylic acid cycle the addition of sulbactam to polymyxinB and meropenem combination appear to be a early disruptor of iA baumanniii metabolome which pave the way for further antibiotic penetration into bacterium cell combination antibiotic consisting of sulbactammeropenempolymyxinB can effectively confer susceptibility to iA baumanniii harbor oxa23 and other drug resistant gene Metabolomic profiling reveal underlying mechanism of synergistic effect of polymyxinB combine with meropenem and sulbactam against multidrug resistant iA baumanniii	2022	Shixing Zhu, Jiayuan Zhang, Chu Song, Yuwei Liu, Charles Oo, M Tobias Heinrichs, Zhihua Lv, Yuanqi Zhu, Sherwin K B Sy, Pan Deng, Mingming Yu	Front Microbiol
36314559	kinetic and Structural Characterization of a flavindependent putrescine iNiHydroxylase from iAcinetobacter baumanniii	iAcinetobacter baumanniii be a gramnegative opportunistic pathogen that cause nosocomial infection especially among immunocompromised individual the rise of multidrug resistant strain of iA baumanniii have limited the use of standard antibiotic highlight a need for new drug that exploit novel mechanism of pathogenicity disrupting iron acquisition by inhibiting the biosynthesis of ironchelate molecule siderophore secreted by the pathogen be a potential strategy for develop new antibiotic here we investigate FbsI a inihydroxylating monooxygenase involve in the biosynthesis of fimsbactin a the major siderophore produce by iA baumanniii FbsI be characterize use steadystate and transientstate kinetic spectroscopy Xray crystallography and smallangle Xray scattering FbsI be find to catalyze the iNihydroxylation of the aliphatic diamine putrescine and cadaverine Maximum coupling of the reductive and oxidative halfreaction occur with putrescine suggest it be the prefer iin vivoi substrate FbsI use both nadph and nadh as the reduce cofactor with a slight preference for nadph the crystal structure of FbsI complex with nadpsupsup be determine at 22 Å resolution the structure exhibit the protein fold characteristic of Class B flavindependent monooxygenase FbsI be most similar in 3D structure to the cadaverine iNihydroxylase desb and DfoA smallangle Xray scattering show that FbsI form a tetramer in solution like the inihydroxylating monooxygenase of the SidAIucDPvdA family a model of putrescine dock into the active site provide insight into substrate recognition a mechanism for the catalytic cycle be propose where dehydration of the C4ahydroxyflavin intermediate be partially ratelimiting and the hydroxylated putrescine product be release before nadpsupsup	2022 Nov	Noah S Lyons, Alexandra N Bogner, John J Tanner, Pablo Sobrado	Biochemistry
36265736	comparative assessment of the mouse immune response to colistinresistant and colistinsensitive isolate of acinetobacter baumannii	acinetobacter baumannii be know as the most frequent species in clinical sample that be responsible for a large number of nosocomial infection outbreak the colistinresistance of this bacterium have be find to be increase this study aim to evaluate the immune response to colistinsusceptible and colistinresistant a baumannii isolate in a mouse model sample be prepare from the wound of patient suspect of a baumannii admit to the intensive care unit of namazi Hospital in shiraz antibiotic susceptibility be study by disk diffusion and broth microdilution accord to clsi and eucast criterion among the isolate one colistinsensitive isolate and one colistinresistant isolate be injected intraperitoneally to balbc mouse Blood sample be collect after 4 h and cytokine il1 " IL12 IFN γ and IL10 and surface marker CD4 CD8 CD3 and CD45 be determine by elisa and flow cytometry then hematologic and histopathological factor be analyze and colony count in lung liver kidney and spleen tissue be also perform the result show that level of cytokine il1 " IL12 IFN γ and IL10 and marker CD4 CD8 CD3 and CD45 be high in mouse receive colistinresistant a baumannii isolate than in mouse receive colistinsensitive a baumannii isolate indicate that colistinresistant isolate 4 h follow the intraperitoneal injection stimulate host innate immune system good and produce a strong immune response on the other hand histopathological finding show inflammatory cell infiltration hyperemia and tissue damage in addition the bacterial load and tissue damage in the lung be high than other tissue the result of this study can have promise potential for the development of a prevention and treatment strategy base on cellular immune response for infection cause by colistinsensitive and colistinresistant a baumannii	2022 Dec	Shahriar Sepahvand, Mahboobeh Madani, Hassan Sepahvand, Mohammad Ali Davarpanah	Microb Pathog
36084216	Animal model testing for efficacy and adverse effect of bacteriophage against acinetobacter baumannii	this study aim to conduct a detailed study on murine model testing of bacteriophage against acinetobacter baumannii this bacteriophage be test not only for they efficacy in heal wound of murine model infect with multidrug resistant a baumannii but be also study for any derangement in hematological parameter as well as liver and kidney function the study also include any histological change observe in hepatic and renal tissue of the bacteriophage treat murine animal this experimental study be conduct at Institute of basic Medical Science khyber Medical University peshawar and Institute of pure and apply biology Department of microbiology and molecular genetics bahauddin zakariya University multan a baumannii isolate be obtain from the microbiology Department armed force Institute of pathology Rawalpindi antimicrobial susceptibility be do by use standard procedure and as per Clinical Laboratory Standard Institute guideline bacteriophage be isolate from sewage water sample collect from different hospital in multan this bacteriophage be characterize and finally use for treat the murine model and efficacy of phage as a therapeutic option be determine by use superficial rat wound model in this study the isolate lytic bacteriophage be effective in relatively fast wound heal of the infect animal moreover there be no significant hematological or renal and hepatic profile change in treat animal histology of renal and hepatic tissue be also normal as compare to control animal we study conclude that the isolate phage could serve as a attractive therapeutic candidate to combat the deadly multidrug resistant a baumannii	2022 Dec	Aamir Hussain, Ihsan Ullah, Muhammad Q Saeed	J Basic Microbiol
36579124	molecular Characterization of CarbapenemResistant iAcinetobacter baumanniii with special reference to carbapenemase a systematic review	carbapenemase be βlactamase enzyme that hydrolyze a variety of βlactam include carbapenem and belong to different ambler class a B D this enzyme can be encode by plasmid or chromosomalmediated gene the major issue associate with carbapenemasesproducing organism be compromise the activity and increase the resistance to carbapenem which be the last resort antibiotic use in treat serious infection the global increase of pathogen carbapenemresistant iA baumanniii have significantly threaten public health thus there be a press need for a good understanding of this pathogen to know the various carbapenem resistance encoding gene and dissemination of resistance gene from iA baumanniii which help in develop strategy to overcome this problem the horizontal transfer of resistant determinant through mobile genetic element increase the incidence of multidrug extensive drug and pandrug resistant iA baumanniii therefore the current review aim to know the various mechanism of carbapenem resistance categorize and discuss carbapenemase encoding gene and various mobile genetic element and the prevalence of carbapenemase gene in recent year in iA baumanniii from various geographical region	2022	Neetu Gupta, Kalpana Angadi, Savita Jadhav	Infect Drug Resist
35277885	structure and function of a nacetyltransferase from the human pathogen acinetobacter baumannii isolate bal212	acinetobacter baumannii be a gramnegative bacterium commonly find in soil and water that can cause human infection of the blood lung and urinary tract of particular concern be its prevalence in healthcare setting where it can survive on surface and share equipment for extend period of time the capsular polysaccharide surround the organism be know to be the major contributor to virulence the structure of the k57 capsular polysaccharide produce by a baumannii isolate bal212 from Vietnam be recently show to contain the rare sugar 4acetamido46dideoxydglucose three enzyme be require for its biosynthesis one of which be encode by the gene H6W49RS17300 and refer to as viob a putative nacetyltransferase here we describe a combine structural and functional analysis of viob kinetic analysis show that the enzyme do indeed function on dtdp4 amino46 dideoxydglucose with a catalytic efficiency of 39 x 10 sup4 sup msup1 sup ssup1 sup ±6000 albeit at a reduce value compare to similar enzyme three highresolution Xray structure of various enzymeligand complex be determine to resolution of 165 Å or good one of this model represent a intermediate analogue of the tetrahedral transition state difference between the viob structure and that determine for the nacetyltransferase from campylobacter jejuni pgld caulobacter crescentus perb and psychrobacter cryohalolentis pcryo0637 be highlight taken together this investigation shed new insight into the type I sugar nacetyltransferase	2022 Aug	Noah R Herkert, James B Thoden, Hazel M Holden	Proteins
36216579	a highefficiency scarfree genomeediting toolkit for acinetobacter baumannii	the current mutagenesis tool for acinetobacter baumannii leave selection marker or residual sequence behind or involve tedious counterselection and screen step furthermore they be usually adapt for model strain rather than for MDR clinical isolate	2022 Nov	Rubén de Dios, Kavita Gadar, Ronan R McCarthy	J Antimicrob Chemother
35995289	Bioremediation of petroleumcontaminated saline soil by acinetobacter baumannii and talaromyce sp and functional potential analysis use metagenomic sequencing	microbial remediation be a potential remediation method for petroleumcontaminated soil in order to explore the petroleum degradation mechanism by microorganism the oilfield soil be remedy by acinetobacter baumannii combine with talaromyce sp the degradation mechanism be study by analyze soil microbial community and functional gene through metagenomics during the degradation process the result show the degradation rate of petroleum be 656 after 28 day the concentration of petroleum decrease from 1220 mgkg to 420 mgkg in the coculture group acinetobacter baumannii become the dominant species the annotate gene of it at the species level account for 734 while that of talaromyce sp account for only 034 meanwhile the annotate gene of bacillus halomona and nitriliruptor at the genus level be upregulate by 183 090 and 071 respectively in addition large functional gene be significantly upregulate include the peroxisome p450 enzyme cyp53 cyp116 cyp102 cyp645 and biofilm formulation promote the oxidation and hydroxylation and catalyzing the epoxidation of aromatic and aliphatic hydrocarbons meanwhile the degrade gene of alkane and aromatic hydrocarbons be express promotionally and degradation pathway be deduce in conclusion the inoculation of acinetobacter baumannii combine with talaromyce sp accelerate the degradation of petroleum in oilfield soil and improve the growth of indigenous petroleumdegradeuradeuradeuradeuradeuradeuradeurad bacterium many functional gene related to petroleum degradation be promote significantly this result prove the coculture of bacteriafungi consortium contribute to the bioremediation of petroleumcontaminated soil	2022 Oct	Xiaoyan Liu, Lihong He, Xinying Zhang, Dewen Kong, Zongze Chen, Jia Lin, Chuanhua Wang	Environ Pollut
36227610	interaction between host epithelial cell and iAcinetobacter baumanniii promote the emergence of highly antibiotic resistant and highly mucoid strain	iAcinetobacter baumanniii be a important nosocomial pathogen upon colonizing a host iA baumanniii be subject to selective pressure by immune defens as they adapt to the host environment however the mechanism of this pathoadaptation be unknown here we establish a iin vitroi system to evolve iA baumanniii drive by the continuous selective pressure exert by epithelial cell and we use a combination of experimental evolution phenotypic characterization and multiomic analysis to address the underlying mechanism when continuously expose to selective pressure by pulmonary epithelial cell iA baumanniii show iptki mutationmediated mucoid conversion reduce adhesion and increase antiphagocytic ability by enhancement of capsular exopolysaccharide chain length irsmGi mutationmediated deficiency of 7 methylguanosine modification in the 524th nucleotide of 16S rRNA which increase ribosome translation efficiency and irnase ii mutationmediated change in outer membrane permeability and efflux pump expression together this mutation alter susceptibility to a variety of antimicrobial agent include the novel antibiotic cefiderocol by regulate siderophore and siderophorereceptor biosynthesis in conclusion pulmonary epithelial cell modulate iA baumanniii pathoadaptation implicating the hostmicrobe interaction in the survival and persistence of iA baumanniii	2022 Dec	Wang Zhang, Yue Yao, Hua Zhou, Jintao He, Jingfen Wang, Li Li, Minsong Gao, Xiaochen Liu, Ya Shi, Jinzhong Lin, Jianzhao Liu, Huan Chen, Yu Feng, Zhihui Zhou, Yunsong Yu, Xiaoting Hua	Emerg Microbes Infect
33855919	emergence of carbapenem resistant iAcinetobacter baumanniii clonal complex CC2 and CC10 among fecal carriage in a educational hospital	Carbapenemresistant iAcinetobacter baumanniii strain be increase worldwide in this study sample be collect from hospital environment extra hospital environment and fecal carriage 76 89117 of bacterial isolate be detect as iA baumanniii strain the imipenem resistance in the hospital environment fecal carriage extra hospital environment and clinical isolate be 377 1745 100 99 0 045 and 929 9299 respectively the iblaiVIM and iblaiOXA23 be detect in 66 345 and 22 145 of strain isolate from hospital environment interestingly strain isolate from fecal carriage have iblaiVIM iblaiOXA23 and iblaiimp gene which resemble carbapenem resistance gene in clinical strain the structure of clonal relatedness among all nonclinical isolate be as follow CC2 37 3389 CC1 224 2089 CC3 123 1189 cc25 78 789 CC10 44 489 and cc15 22 289 Comparison of clonal relatedness among clinical and nonclinical isolate indicate that widespread clone include CC2 CC3 and CC10 be common clonal complex between two category	2022 Jul	Mohsen Nazari, Omid Azizi, Hamid Solgi, Sepideh Fereshteh, Shervin Shokouhi, Farzad Badmasti	Int J Environ Health Res
35276227	dynamics of the acinetobacter baumannii inner membrane under exogenous polyunsaturated fatty acid stress	exogenous polyunsaturated fatty acid pufa be readily incorporate into the synthesis pathway of a baumannii membrane phospholipid where they contribute to reduce bacterial fitness and increase antimicrobial susceptibility here we examine the impact of pufa membrane modification on membrane organisation and biophysical property use coarse grain martinion simulation of chemically representative membrane model develop from massspectrometry dataset of a untreated arachidonic acid aa treat and docosahexaenoic acid DHA treat a baumannii membrane enzymatic integration of aa or DHA into phospholipid of the a baumannii membrane result in modulation of membrane biophysical property membrane thickness decrease slightly follow pufa treatment concomitant with change in the lateral area per lipid of each lipid headgroup class pufa treatment result in a decrease in membrane order and a increase in lipid lateral diffusion change in lateral membrane organisation be observe in the pufa treat membrane with a concurrent increase in order cardiolipin domain and disorder pufacontaining domain notably separation between order and disorder domain be enhance and be more pronounce for DHA relative to aa provide a possible mechanism for great antimicrobial action of DHA relative to aa observe experimentally furthermore the membrane active antimicrobial pentamidine preferentially adsorb to cardiolipin domain of the a baumannii model membrane this interaction and membrane penetration of pentamidine be enhance follow pufa treatment Cumulatively this work explore the wideranging effect of pufa incorporation on the a baumannii membrane and provide a molecular basis for bacterial inner membrane disruption by pufa	2022 Jul	Hugo I MacDermott-Opeskin, Alessandra Panizza, Bart A Eijkelkamp, Megan L O'Mara	Biochim Biophys Acta Biomembr
36695425	evaluation of chromagar acinetobacter and macconkey media for the recovery of acinetobacter baumannii from soil sample	the opportunistic pathogen acinetobacter baumannii occupy niche in human and veterinary clinic and other environment this comparative study be design to assess the recovery rate of ac baumannii from 20 soil sample collect in Germany from which ac baumannii have be previously isolate on selective chromagar acinetobacter CMA and macconkey agar MCA suspected ac baumannii be confirm by detection and sequencing of blangak1 like gene overall the recovery rate of ac baumannii from both media be similar out of the 20 soil sample enrich in mineral salt medium mm plus 02 acetate for 5 h ac baumannii be recover from 12 60 on CMA and 11 55 on MCA and from 14 70 with both selective media after enrichment for 24 h Typical and distinct colony of ac baumannii be more often observe on CMA with soil enrich in mm for 5 h while on MCA distinct colony be more obvious after 24 h in five soil sample 25 strain harbour different oxa51 like variant be recover on MCA late lactose fermentation 48 h be observe on MCA the study suggest that no single growth medium would efficiently recover ac baumannii from all soil sample	2023 Feb	I Yusuf, E Skiebe, G Wilharm	Lett Appl Microbiol
37020803	antimicrobial peptide cec4 eradicate multidrugresistant iAcinetobacter baumanniii in vitro and in vivo	iAcinetobacter baumanniii have become a major difficulty in the treatment of bacteriaassociated infection the previously report antimicrobial peptide cec4 exhibit good and stable activity against iA baumanniii in vitro but the mechanism and effect in vivo be elusive	2023	Jian Peng, Yue Wang, Zhaoyin Wu, Chengju Mao, Lu Li, Huijun Cao, Zhilang Qiu, Guo Guo, Guiyou Liang, Feng Shen	Drug Des Devel Ther
35833804	evaluation of genetic diversity of colistinresistant iAcinetobacter baumanniii by boxpcr and ericpcr the first report	bAimb to control the spread of iAcinetobacter baumanniii in hospital it be necessary to identify the reservoir of organism and the way they be transmit this study analyze sample by boxpcr and enterobacterial repetitive intergenic consensus pcr technique bMethodsb isolated strain be identify use the microgen kit and iblaOXA51i gene the genetic diversity of strain that be sensitive or resistant to colistin be evaluate by boxpcr and enterobacterial repetitive intergenic consensus pcr method bResultsb a total of 13 of the isolate be resistant to colistin whereas 87 of the strain be sensitive to this medication iA baumanniii strain that be resistant or sensitive to colistin be divide into five group use the boxpcr method and six group use the enterobacterial repetitive intergenic consensus pcr method bConclusionb rapidforsey@ect identification and the use of appropriate tool to control colistinresistant clone be essential to prevent the further spread of iA baumanniii	2022 Aug	Shahriar Sepahvand, Mohammad Darvishi, Maral Mokhtari, Mohammad Ali Davarpanah	Future Microbiol
36071964	molecular epidemiology and carbapenem resistance characteristic of iAcinetobacter baumanniii cause bloodstream infection from 2009 to 2018 in northwest China	bloodstream infection BSI cause by iAcinetobacter baumanniii pose a serious threat to health and be correlate with high mortality in patient with hospitalacquired infection so the molecular epidemiology and antimicrobial resistance characteristic of this pathogen urgently need to be explore iA baumanniii isolate from BSI patient be collect in three tertiary hospital in northwest China from 2009 to 2018 antimicrobial susceptibility testing be use to determine the mic of the iA baumanniii isolate wholegenome sequencing base on the illumina platform be perform for molecular epidemiological analysis and acquire resistance gene screen the efflux pump phenotype be detect by examine the influence of a efflux pump inhibitor the expression of efflux pump gene be evaluate by rtpcr in total 47 iA baumanniii isolate cause BSI be collect and they present multidrug resistance include resistance to carbapenem clone complex CC 92 be the most prevalent with 30 isolate among which a cluster be observe in the phylogenetic tree base on the core genome multilocus sequence type indicate the dissemination of a dominant clone bsirelated iA baumanniii isolate normally harbour multiple resistance determinant of which oxacillinase gene be most common except for the intrinsic iblai suboxa51 sub family there be some carbapenemresistant determinant in this iA baumanniii isolate include iblai suboxa23sub which be encode within the tni2006i tni2008 I or tni2009i transposon structure and iblai suboxa72sub the transfer of iblai suboxa72sub be suggest by xercd sitespecific recombination the adeabc efflux pump system contribute to carbapenem resistance in iA baumanniii isolate as evidence by the high expression of some of its encoding gene both the clone dissemination and carbapenem resistance mediate by oxacillinase or efflux pump suggest a effective strategy for hospital infection control	2022	Yihai Gu, Wei Zhang, Jine Lei, Lixia Zhang, Xuan Hou, Junqi Tao, Hui Wang, Minghui Deng, Mengrong Zhou, Rui Weng, Jiru Xu	Front Microbiol
36626755	Triple combination of spr741 clarithromycin and erythromycin against acinetobacter baumannii and its tolerant phenotype	extensively drugresistant XDR acinetobacter baumannii pose a severe threat to public health due to its ability to form biofilm and persister cell which contribute to critical drug resistance and refractory deviceassociated infection a novel strategy to alleviate such a emergency be to identify promise compound that restore the antimicrobial susceptibility of exist antibiotic against refractory infection	2023 Jan	Zehao Li, Pengfei She, Yaqian Liu, Lanlan Xu, Yimin Li, Shasha Liu, Zubair Hussain, Linhui Li, Yifan Yang, Yong Wu	J Appl Microbiol
36082242	myrtenol inhibit biofilm formation and virulence in the DrugResistant iAcinetobacter baumanniii insight into the molecular mechanism	iblaNDM1 iproducing iAcinetobacter baumanniii bpab remain a critical problem in nosocomial infection because of its resistance mediate by the biofilm formation and virulence factor no study have confirm myrtenol efficacy in inhibiting the biofilm formation and virulence associate with biofilm of bpab	2022	Lei Liu, Bin Liu, Liang Li, Ming-Xin He, Xiang-Dong Zhou, Qi Li	Infect Drug Resist
35970267	therapeutic evaluation of the acinetobacter baumannii phage phab24 for clinical use	phage have show to be effective in treat bacterial infection however when evaluate the therapeutic potential of novel phage isolate which have the ability to infect and kill a pathogen it be important to include parameter such as stability crucial for storage and delivery infection dynamic in vitro and in vivo for efficacy and dose and a indepth genome analysis to exclude the presence of virulence or lysogeny gene among other in this study we characterize bacteriophage phab24 which infect a colistinresistant strain of the notorious nosocomial pathogen acinetobacter baumannii we study be crucial for the use of phab24 in therapy while also advance we understanding of phage predation	2022 Oct	Liwei Zhang, Xiaoqing Wang, Xiaoting Hua, Yunsong Yu, Sebastian Leptihn, Belinda Loh	Virus Res
36640263	detection of multidrugresistant acinetobacter baumannii from burn patient and healthcare worker in Iran	multidrugresistant MDR acinetobacter baumannii be a serious global health threat burn patient be at high risk to acquire a baumannii infection from endogenous source this study evaluate carbapenem resistance and clonal relatedness of a baumannii isolate from burn patient and healthcare worker hcw the study be perform in 100 nonduplicated a baumannii isolate from nasal and hand sample of hospitalize burn patient and hcw in two hospital of Iran from June 2020 to August 2021 antimicrobial susceptibility testing be perform and carbapenemase gene be detect by pcr clonal relatedness of a baumannii isolate be determine by two singlelocus sequencebased type of blangak1 like and ampC and by multilocus sequence type mlstall a baumannii isolate be find to be MDR while susceptible to colistin the intI1 conserved segment of class 1 integron intI1 cs blaimp blavim blangak1 like and blaoxa23 like gene be detect in 325 291 36 953 100 100 and 143 143 214 929 100 and 857 of isolate from patient and from healthcare worker respectively the blay and blaoxa143 be not detect among the isolate use duallocus blangak1 like and ampC sequencebased type sbt the isolate obtain from nasal sample of burn patient be group into 3 cluster include blaoxa317 blaadc88 721 blaoxa64 ampc25 186 and blaOXA69 ampc1 93 while only allele type blaoxa317 blaadc88 be determine among isolate from hcw mlst result show a baumannii st136 st25 and ST1 from burn patient however a baumannii strain from hcw belong to st136 we finding indicate high prevalence of globally spread of MDR a baumannii st136 carry blaoxa23 like from nasal and hand sample of burn patient and hcw	2023 Mar	Farzaneh Firoozeh, Fatemeh Bakhshi, Masoud Dadashi, Farzad Badmasti, Mohammad Zibaei, Narges Omidinia	Acta Microbiol Immunol Hung
35732264	Comparing coregenome mlst with pfge and mlst for cluster analysis of carbapenemresistant acinetobacter baumannii	Carbapenemresistant acinetobacter baumannii CRAB be a prevalent pathogen contribute to hospital infection pulsedfield gel electrophoresis pfge multilocus sequence type mlst and coregenome mlst cgmlst be frequently use method to illuminate the nosocomial transmission of CRAB in this study we compare the discriminatory power of the three type method	2022 Sep	Tingting Li, Yunxing Yang, Rushuang Yan, Peng Lan, Haiyang Liu, Ying Fu, Xiaoting Hua, Yan Jiang, Zhihui Zhou, Yunsong Yu	J Glob Antimicrob Resist
34196126	Bacteriophage therapeutics to confront multidrugresistant acinetobacter baumannii a global health menace	we have already enter the postantibiotic era as the outbreak of numerous multidrugresistant strain in the community as well as hospitalacquired infection be ringing alarm bell in the health sector acinetobacter baumannii be one such pathogen that have be consider a worldwide threat as it acquire multidrug resistance it be one of the most challenging hospitalacquired pathogen as World Health Organization have list carbapenemresistant a baumannii as a critical priority pathogen with limited therapeutic option there be a urgent need to develop novel strategy against such pathogen to tackle the global crisis bacteriophage phage especially the lytic one have reemerge as a potential therapeutic approach this review encompass vast majority of phage against a baumannii strain with special reference related to single phage or monophage therapy use of phage cocktail combination therapy with antibiotic use of phagederive enzyme like endolysin and depolymerase to combat the pathogen and explore they therapeutic aspect the concurrent ecological as well as evolutionary interplay between the phage and host bacterium demand in depthresearch and knowledge so as to utilize the maximum potential of the bacteriophage therapy	2022 Jun	Sandhya Rai, Amod Kumar	Environ Microbiol Rep
36289955	gastrointestinal Colonization of CarbapenemResistant iAcinetobacter baumanniii what be the implication for infection Control	the epidemiology of patient with gastrointestinal colonization of carbapenemresistant acinetobacter baumannii CRAB have not be systematically analyze we aim to analyze the incidence risk factor and clinical outcome of patient with newly identify gastrointestinal colonization of CRAB in a healthcare region in Hong Kong where a multipronge screen strategy for gastrointestinal colonization of CRAB together with other multidrugresistant organism MDROs be conduct by collect fecal specimen rectal swab or stool upon admission and during hospitalization from 1 October 2015 to 31 December 2019 a total of 161339 fecal specimen from 63588 patient 61856 973 of whom be hospitalize patient and 54525 881 be screen upon admission with 1309 positive for CRAB 24 prevalence among patient positive for CRAB in fecal specimen 698 533 have newly detect gastrointestinal colonization of CRAB give a incidence of 1003 per 10000 patient admission and constituting 2646 CRAB colonization day in the general ward exclude the 164 patient with cocolonization of other MDROs 534 patient have gastrointestinal colonization with only CRAB and 125 67534 develop symptomatic CRAB infection at a median of 61 day range 2 to 671 day during prospective followup for 2 year compare with age and sexmatch control patient be refer from residential care home for the elderly the presence of indwelling device use of betalactambetalactamase inhibitor carbapenem and proton pump inhibitor in the precede 6 month and history of hospitalization in the past 6 month be significantly associate with gastrointestinal colonization with CRAB as show by multivariable analysis logrank test show that case have significantly short survival duration than control p 0001 the adjust hazard ratio of gastrointestinal colonization of CRAB be 18 95 CI 15 − 22 p 0001 as show by Cox regression analysis wholegenome sequencing of eight patient with CRAB isolate in they blood culture and rectal swab during the same episode of hospitalization reveal st195 as the predominant type as show by multilocus sequencing type gastrointestinal colonization of CRAB pose a considerable challenge for infection prevention and control	2022 Sep	Shuk-Ching Wong, Jonathan Hon-Kwan Chen, Pui-Hing Chau, Simon Yung-Chun So, Christine Ho-Yan AuYeung, Lithia Lai-Ha Yuen, Veronica Wing-Man Chan, Germaine Kit-Ming Lam, Kelvin Hei-Yeung Chiu, Pak-Leung Ho, Janice Yee-Chi Lo, Kwok-Yung Yuen, Vincent Chi-Chung Cheng	Antibiotics (Basel)
35884146	Clinical feature and outcome of monobacterial and Polybacterial episode of ventilator Associated Pneumonia due to multidrugresistant iAcinetobacter baumanniii	multidrugresistant a baumannii mdrab vap have high morbidity and mortality and the rate be constantly increase globally mono and polybacterial mdrab vap might differ include outcome we conduct a singlecenter retrospective January 2014 −December 2016 study in the four icus 12−18−24 bed each of a reference Lithuanian university hospital aim to compare the clinical feature and the 30day mortality of monobacterial and polybacterial mdrab vap episode a total of 156 mdrab vap episode be analyze 105 675 be monomicrobial the 30 day mortality be high p 005 in monobacterial episode overall 571 versus 373 subgroup with appropriate antibiotic therapy 507 versus 235 and subgroup of XDR a baumannii 573 versus 364 monobacterial mdrab vap be associate p 005 with charlson comorbidity index ≥ 3 676 versus 471 respiratory comorbidity 190 versus 59 obesity 276 versus 98 prior hospitalization 581 versus 314 prior antibiotic therapy 990 versus 922 sepsis 886 versus 765 septic shock 519 versus 346 severe hypoxemia 238 versus 78 high leukocyte count on vap onset median IQR 116 84−166 versus 109 73−134 and RRT need during icu stay 371 versus 176 patient with polybacterial vap have a high frequency of decrease level of consciousness p 005 on icu admission 294 versus 143 and on vap onset 294 versus 114 we conclude that monobacterial mdrab vap have different demographicclinical characteristic compare to polybacterial and carry bad outcome this important finding need to be validate in a large prospective study and the management implication to be further investigate	2022 Jul	Dalia Adukauskiene, Ausra Ciginskiene, Agne Adukauskaite, Despoina Koulenti, Jordi Rello	Antibiotics (Basel)
35859248	enhance thermal stability and lytic activity of phage lysin plyab1 from acinetobacter baumannii	with the increasingly serious drug resistance of acinetobacter baumannii there be a increasingly urgent need for new antibacterial drug phage lysin plyab1 have a bactericidal effect on drugresistant a baumannii which have the potential to replace antibiotic to fight infection cause by a baumannii however its application be limited by its thermal stability and lytic activity to solve this problem molecular dynamic md simulation combine with hotspot wizard 30 be use to identify key residue site affect thermal stability and evolutionary analysis combine with multiple sequence alignment be use to identify key residue site affect lytic activity four singlepoint variant with significantly increase thermal stability and four singlepoint variant with significantly lytic activity be obtain respectively furthermore by superimposing mutation we obtain three doublepoint variant g100qk69r g100rk69r and g100kk69r with significantly improve thermal stability and improve lytic activity at 45 °C the lytic activity and halflife of the optimal variant g100qk69r be 151 and 24 fold high than that of the wild plyab1 respectively this result deepen we understanding of the structure and function of phage lysin and contribute to the application of phage lysin in antibiotic substitution	2022 Oct	Yingbo Yuan, Qingbin Li, Shuhang Zhang, Jinhong Gu, Guangtao Huang, Qingsheng Qi, Xuemei Lu	Biotechnol Bioeng
35948242	Global update on the in vitro activity of tigecycline and comparator against isolate of acinetobacter baumannii and rate of resistant phenotype 20162018	this study present 20162018 in vitro antimicrobial activity datum and rate of resistant phenotype for clinical isolate of acinetobacter baumannii from africamiddle East asiasouth Pacific Europe Latin America and North America	2022 Dec	Harald Seifert, Joseph Blondeau, Kai Lucaßen, Eric A Utt	J Glob Antimicrob Resist
36136497	Biodegradation of Dibutyl phthalate by the New strain iAcinetobacter baumanniii dp2	optimizing the culture condition of dbp degradation by bacterium and investigate its biodegradation pathway have a great importance to develop effective pay pollution control strategy in this study we investigate the cultivation condition optimization degradation kinetic and degradation pathway of a newly isolate dibutyl phthalate dbp degradation strain which be isolate from activate sludge and identify as iAcinetobacter baumanniii dp2 via morphological observation biochemical identification and 16S rDNA sequence analysis the degradation condition be optimize base on the result of singlefactor experiment and response surface optimization experiment the dbp degradation rate of iAcinetobacter baumanniii dp2 reach up to 8586 when the inoculation amount be 1714 the dbp concentration be 981 mg·lsup1sup and the NaCl concentration be 5 g·lsup1sup the gcms analysis result indicate that the intermediate metabolite of iAcinetobacter baumanniii dp2 mainly consist of DMP mbp PA and benzoic acid derivative which confirm the degradation pathway from dbp to PA under aerobic pathway and then to BA under anaerobic pathway in summary iAcinetobacter baumanniii dp2 show great potential for the degradation of dbp in contaminate soil	2022 Sep	Cheng Li, Chunjing Liu, Rongzhen Li, Yue Liu, Jianzhi Xie, Bowen Li	Toxics
36721500	investigation the effect of silver nanoparticle and gold nanoparticle on expression of ibapi and icsui gene in biofilm formation of iAcinetobacter baumanniii	iAcinetobacter baumanniii be one of the main pathogen of the hospital and cause various infection icsu ababcdei involve in the initial surface attachment during biofilm formation and ibapi gene produce specific protein at the cell surface that play a direct role in formation of biofilm and the infectivity of this bacterium the aim of this study be to investigate the effect of silver nanoparticle and gold nanoparticle on the expression of ibapi and icsui gene in the iAcinetobacter baumanniii biofilm formation	2022 Aug	Niloofar Rezania, Parisa Rahmati, Fatemeh Noorbakhsh, Nazanin Farhadyar, Ensieh Lotfali	Iran J Microbiol
36299724	cinnamon essential oil and its emulsion as efficient antibiofilm agent to combat iAcinetobacter baumanniii	iAcinetobacter baumanniii be a emerge nosocomial pathogen resistant to a wide spectrum of antibiotic with great potential to form a biofilm which further aggravate treatment of infection cause by it therefore search for new potent agent that be efficient against iA baumanniii seem to be a necessity one of they which have already be prove to possess a wide spectrum of biological activity include antimicrobial effect be cinnamon essential oil still further increase of antibacterial efficacy and improvement of bioavailability of cinnamon oil be possible by emulsification process the aim of this study be comparative analysis of cinnamon essential oil and its emulsion against biofilm form iA baumanniii clinical isolate furthermore the investigation of toxicological aspect of possible application of essential oil and emulsion be do as well Gas chromatographymass spectrometry of essential oil indicate itransicinnamaldehyde as the most abundant component the cinnamon emulsion be synthesized from cinnamon essential oil by combine modify low and high energy method synthesized emulsion be characterize with Fouriertransform infrared spectroscopy and photon correlation spectroscopy both substance exhibit significant antibacterial minimal inhibitory concentration in the range 012505 mgml and antibiofilm effect inhibition of formation and reduction of preform biofilm be 4781 and 3062 respectively compare to essential oil the efficacy of emulsion be even strong consider the small share of pure oil 20 in the emulsion the result of biofilm eradication assay be confirm by scan electron microscopy even though the cytotoxicity be high especially for the emulsion genotoxicity be not determine in conclusion strong antibacterialantibiofilm effect against iA baumanniii of the cinnamon essential oil and the fact that emulsification even potentiat the activity seem to be of great significance observe cytotoxicity implicate that further analysis be need in order to clearly determine active principle be responsible for obtain antibacterialantibiofilm and cytotoxic property	2022	Tea Ganić, Stefana Vuletić, Biljana Nikolić, Magdalena Stevanović, Maja Kuzmanović, Dušan Kekić, Saša Đurović, Stefana Cvetković, Dragana Mitić-Ćulafić	Front Microbiol
35618210	in vitro activity of sulbactamdurlobactam against carbapenemresistant acinetobacter baumannii and mechanism of resistance	multidrugresistant acinetobacter baumannii mdrab particularly strain produce oxacillinase oxatype carbapenemase have rapidly emerge in health care setting as a frequent cause of serious infection with limited treatment option this study evaluate the in vitro activity of sulbactam sul combine with durlobactam DUR against a collection of carbapenemaseproducing a baumannii and investigate the mechanism of resistance	2022 Sep	Jacqueline Findlay, Laurent Poirel, Maxime Bouvier, Patrice Nordmann	J Glob Antimicrob Resist
36191015	ecofriendly phytosynthesized zirconium oxide nanoparticle as antibiofilm and quorum quenching agent against iAcinetobacter baumanniii	the worldwide increase of multidrug resistance have direct the researcher to focus on ecofriendly way of nanoparticle synthesis with effective antivirulence property here we report the antibiofilm and quorum quenching qq potential of zirconium oxide nanoparticle zrosub2sub nps synthesized from aqueous ginger extract against multidrug resistant MDR iAcinetobacter baumanniii the result indicate that zrosub2sub nps be of tetragonal shape with average diameter of 16 nm minimum inhibitory concentration mic and minimum bactericidal concentration mbc value for iA baumanniii be 156 and 625 µgml respectively as reveal by broth microdilution assay exposure of bacterial cell to zrosub2sub nps result in reactive oxygen species ROS generation which in turn lead to cellular membrane disruption as observe by a increase in leakage of cellular content such as protein sugars and DNA the antibiofilm activity be evaluate by microtiter plate assay and the result reveal that the percentage inhibition of biofilm be find to be 143806 zrosub2sub nps also obstruct the chemical composition of biofilm matrix by reduce the protein and carbohydrate content molecular docking study of zrosub2sub nps with four protein 2naz 4hkg 5D6H and 5HM6 involve in biofilm formation of iA baumanniii reveal the interaction of zirconium with target protein this finding suggest the iin vitroi efficacy of phytosynthesized zrosub2sub nps as antibiofilm and qq agent that can be exploit in the development of alternative therapeutic option against MDR iA baumanniii	2022 Sep	Muhammad Hussnain Siddique, Sumreen Hayat, Saima Muzammil, Asma Ashraf, Arif Muhammad Khan, Muhammad Umar Ijaz, Mohsin Khurshid, Muhammad Afzal	Drug Dev Ind Pharm
36060914	in silico analysis of Extracellular protein of iAcinetobacter baumanniii as immunogenic candidate	iAcinetobacter baumanniii be a important nosocomial pathogen cause high morbidity and mortality in immunocompromised patient with prolong hospitalization multidrugresistant iA baumanniii infection be on the rise worldwide therefore the discovery of a effective vaccine against this bacterium seem necessary as a costeffective and preventive strategy	2022 Dec	Sepideh Fereshteh, Narjes Noori Goodarzi, Amin Sepehr, Morvarid Shafiei, Soheila Ajdary, Farzad Badmasti	Iran J Pharm Res
36968113	deciphering the virulence factor regulation and immune response to iAcinetobacter baumanniii infection	deciphering the virulence factor regulation and immune response to iAcinetobacter baumanniii infectioniAcinetobacter baumanniii be a gramnegative multidrugresistant nosocomial pathogen and a major cause of hospital acquire infetion carbapenem resistant iA baumanniii have be categorise as a priority 1 critial pathogen by the World Health Organisation iA baumanniii be responsible for infection in hospital setting clinical sector ventilatorassociated pneumonia and bloodstream infection with a mortality rate up to 35 with the development of advanced genome sequencing molecular mechanism of manipulate bacterial genome and animal infection study it have become more convenient to identify the factor that play a major role in iA baumanniii infection and its persistence in the present review we have explore the mechanism of infection virulence factor and various other factor associate with the pathogenesis of this organism additionally the role of the innate and adaptive immune response and the current progress in the development of innovative strategy to combat this multidrugresistant pathogen be also discuss	2023	Afreen Shadan, Avik Pathak, Ying Ma, Ranjana Pathania, Rajnish Prakash Singh	Front Cell Infect Microbiol
35818769	enhancement of acinetobacter baumannii biofilm growth by cephem antibiotic via enrichment of protein and extracellular DNA in the biofilm matrice	the aim be to determine the effect of subinhibitory concentration of eight cephem and carbapenem antibiotic on the biofilm formation of acinetobacter baumannii cell and examine they effect on preestablished biofilm	2022 Sep	Kaoru Yamabe, Yukio Arakawa, Masaki Shoji, Katsushiro Miyamoto, Takahiro Tsuchiya, Katsuhiko Minoura, Yukihiro Akeda, Kazunori Tomono, Mitsuko Onda	J Appl Microbiol
35644510	the role of acinetobacter baumannii CarO outer membrane protein in carbapenem influx	the gramnegative strain acinetobacter baumannii be a cocobacillus nonmotile and aerobic organism that be often find in nosocomial infection many institution worldwide such as who be grapple with antibiotic resistance a baumannii therefore in recent year there have be many study in the literature about antibiotic resistance mechanism we study the specificity of carbapenem for CarO a outer membrane protein associate with imipenemresistance that be strongly related to a decrease in CarO expression level or change in protein structure the specificity of five different carbapenem imipenem biapenem ertapenem faropenem and meropenem against the a baumannii atcc1797as CarO protein as well as the specificity of imipenem for five different type Type1 type2 Type3 Type4 and atcc1797as CarO protein be investigate use computational method in this study homology modeling molecular docking membraneprotein complex building and 800 n long md simulation method be follow the interaction of imipenem with the extracellular region of five different form of CarO protein be investigate in this study as well as five different antibiotic bind profile to the model organism atcc1797as CarO protein the mechanism of CarO influx have be reveal with this study at the molecular level and this datum be intend to be use in future research mutagenesis and clinical trial	2022	Emrah Sariyer	Res Microbiol
36721516	first report of SPM metallo βlactamase produce iAcinetobacter baumanniii isolate in Morocco	Carbapenemresistant iAcinetobacter baumanniii have recently be identify by the World Health Organization as a critical pathogen we propose to characterize the molecular characteristic of clinical isolate of iA baumanniii resistant to carbapenem collect in a moroccan hospital	2022 Aug	Abdelhamid Massik, Lahbib Hibaoui, Benboubker Moussa, Ghita Yahyaoui, Bouchra Oumokhtar, Mustapha Mahmoud	Iran J Microbiol
36625573	acinetobacter baumannii kill fungi via a type VI dnase effector	many gramnegative bacterium deploy a type VI secretion system t6ss to inject toxin into target cell to promote they survival and replication in complex environment here we report that acinetobacter baumannii use its t6ss to kill fungi and that the effector tafe iacx6015365i be responsible for such kill although ectopically express tafe be toxic to both Escherichia coli and saccharomyce cerevisiae deletion of itafEi only affect the antifungal activity of a baumannii we demonstrate that tafe be a dnase capable of target the nuclei of yeast cell and that a ntox15 domain be essential for its ability to degrade DNA furthermore we finding show that a baumannii be protect from the toxicity of tafe by elaborating the immunity protein taei iacx6015360 I which antagonize the activity of the effector by direct bind the discovery of a baumannii t6ss effector capable of kill multiple taxonomically distinct microbe have shed light on a mechanism of the highlevel fitness of this pathogen in environment characterize by scarce nutrient and the potential presence of diverse microorganism bimportanceb acinetobacter baumannii be a increase important nosocomial pathogen that be difficult to combat due to its ability to survive in harsh environment and the emergence of isolate that be resistant to multiple antibiotic a good understanding of the mechanism underlying the toughness of a baumannii may identify its Achilles heel which will facilitate the development of novel preventive and treatment measure in this study we finding show that a baumannii kill fungi with the dnase effector tafe injected into competitor cell by its type VI secretion system a baumannii be protect from the activity of tafe by the immunity protein taei which inactivate the effector by direct bind we result suggest that inactivation of its t6ss or effector may reduce the fitness of a baumannii and increase the effectiveness of treatment by mean such as antibiotic furthermore we find suggest that target degradation of taei may be a effective strategy to kill a baumannii	2023 Feb	Jingjing Luo, Xiao Chu, Jing Jie, Yu Sun, Qingtian Guan, Dan Li, Zhao-Qing Luo, Lei Song	mBio
36009914	genomic Analysis of iAcinetobacter baumanniii isolate carrying oxa23 and oxa58 gene from animal reveal ST1 and st25 as Major clonal lineage	iAcinetobacter baumanniii be increasingly be recognize as a relevant pathogen for animal with a putative zoonotic impact this study aim at identify and characterize carbapenemaseproducing iA baumanniii from animal among 503 iA baumanniii mainly isolate from dogscat 757 between 2013 and 2018 42 isolate from 22 veterinary clinic VC harbour iblaisubOXA58 sub ini 29 or iblaisuboxa23sub ini 13 the iblaisubOXA58 sub gene be locate on plasmid 114211 kb within different genetic surroundings pattern ad iblaisuboxa23sub be embed in tni2006 I on the chromosome ini 4 pattern a or tni2008 I on plasmid ini 9 412713 kb pattern be the predominant ic1st1suppsupox8 667 964 cgmlst complex type CT1808 be disseminate among 11 VC in Germany resistance island iAbaiR3 like ini 15 and iAbaiR10 ini 1 have emerge among st1isolate since 2016 ic7st25suppsupoxa23 isolate 214 occur in seven VC in Germany France and Italy and differ in they resistance gene pattern from that of oxa58 isolate they be separate into six CTs basically accord to they regional origin other STs observe be ST10 st578 and st602 in conclusion oxa23 and oxa58 be link with ST1 and st25 two globally distribute lineage in human the suggest transmission of certain lineage within and among VC together with the acquisition of iAbaiR island hint at a successful dissemination of multidrugresistant strain in the VC environment	2022 Aug	Lisa Jacobmeyer, Torsten Semmler, Ivonne Stamm, Christa Ewers	Antibiotics (Basel)
36360551	molecular Characterization and antibiogram of iAcinetobacter baumanniii Clinical isolate recovered from the patient with ventilator Associated Pneumonia	a 2 year prospective study carry out on ventilatorassociated pneumonia vap patient in the intensive care unit at a tertiary care hospital hail Kingdom of Saudi Arabia KSA reveal a high prevalence of extremely drugresistant XDR iAcinetobacter baumanniii about a 9 increase in the incidence rate of iA baumanniii occur in the vap patient between 2019 and 2020 214 to 307 in 2019 the isolate be positive for imp1 and vim2 311 and 257 respectively as detect by pcr in comparison a high proportion of isolate produce NDM1 in 2020 here we observe a high proportion of resistant icu isolate towards the most common antibiotic in use colistin sensitivity drop to 914 in the year 2020 as compare to 2019 100 thus the find of this study have a highly significant clinical implementation in the clinical management strategy for vap patient furthermore strict implementation of antibiotic stewardship policy regular surveillance program for antimicrobial resistance monitoring and screen for gene encoding drug resistance phenotype have become imperative	2022 Nov	Mohd Saleem, Azharuddin Sajid Syed Khaja, Ashfaque Hossain, Fahaad Alenazi, Kamaleldin B Said, Soha Abdallah Moursi, Homoud Abdulmohsin Almalaq, Hamza Mohamed, Ehab Rakha	Healthcare (Basel)
35846753	selection and identification of a DNA aptamer for multidrugresistant iAcinetobacter baumanniii use a inhouse cellselex methodology	infection cause by multidrugresistant iA baumanniii be a worldwide health concern with high mortality rate rapidforsey@ect identification of this infectious agent be critical as it can easily spread with difficult or no option for treatment in this context the development of reliable and economically viable detection and therapeutic methodology be still challenging one of the promise solution be the development of nucleic acid aptamer capable of interact with bacterium this aptamer can be use for specific recognition of infectious agent as well as for blocking they function cellselex technology currently allow the selection and identification of aptamer and be flexible enough to target molecule present in a entire bacterial cell without they prior knowledge however the aptamer technology be still face many challenge such as the complexity of the screen process here we describe the selection and identification of a new aptamer a01 use a inhouse wholecell selexbase methodology against multiresistant iAcinetobacter baumanniii with rapid execution and low cost in addition this protocol allow the identification of the aptamer a01 with the whole iA baumanniii cell as a target the aptamer a01 demonstrate a bind preference to iA baumanniii when compare to iK pneumoniae ic albicansi and be aureusi in fluorescence assay although the timekill assay do not show a effect on bacterial growth the potential bactericidal or bacteriostatic cannot be totally discard the new categorized aptamer a01 display a significant bind affinity to MDR iA baumanniii	2022	Marina Farrel Côrtes, Taniela Marli Bes, Beatriz Ribeiro Deo, Beatriz Barbosa Dos Anjos, Andrés Jimenez Galisteo, Ester Cerdeira Sabino, Carlos Santos, Silvia Figueiredo Costa	Front Cell Infect Microbiol
35138649	Comparison of the outer membrane proteome between clinical carbapenemresistant and susceptible acinetobacter baumannii	carbapenem resistance have become a major obstacle in combating acinetobacter baumannii infection although enzymatic degradation by βlactamase be the pivotal mechanism of carbapenem resistance porin deficiency have also be implicate in the mechanism in this study outer membrane protein omp pattern of a clinical multidrugresistant a baumannii isolate be analyse in order to attain a deep understanding of carbapenemresistance strategy	2022 Jun	T Zhu, Z Lei, S Qu, F Zhao, L Yan, M Chen, X W Zhou, D Qu, Y Zhao	Lett Appl Microbiol
36731874	growth of acinetobacter baumannii impact by iron chelation	acinetobacter baumannii ab have become multidrugresistant MDR in recent year and currently there be limited effective treatment option nutrient metal eg iron be essential to the metabolic function of ab this study examine the impact of iron chelation on the growth of ab in vitro and in vivo susceptible and mdrab bloodstream isolate and 9 be recover from different patient between 2011 and 2018 clonal diversity be ascertained by Fouriertransform infrared spectroscopy in vitro bacterial density be measure over 20 h to determine growth profile variable amount of a chelate agent deferiprone DFP be add to create a concentration gradient Galleria mellonella larvae be inoculate with a isolate with and without DFP quantitative culture be use to ascertain the bacterial burden of aggregate larvae immediately and 4 h postinfection increasing concentration of DFP cause a transient and concentrationdependent hindrance to in vitro growth compare to the notreatment group in vivo bacterial burden immediately postinfection in both group be comparable after 4 h the burden be much high in the control group comparatively 87 and 67 log CFU g1 this result support that micronutrient limitation have the potential of be a novel approach for treat highrisk infection due to mdrab	2023 Feb	Brianna M Eales, Bing Bai, Paul R Merlau, Vincent H Tam	Lett Appl Microbiol
35467374	Synergistic antimicrobial effect of colistin in combination with econazole against multidrugresistant acinetobacter baumannii and its persister	colistin be a lastline antibiotic which act by cause membrane permeabilization in gramnegative bacterium however its clinical value have be limited by its toxicity and the emergence of resistant organism in this study we show that econazole and colistin can act synergistically to produce a strong antimicrobial effect sufficient for eradication of starvationinduced tolerant and multidrugresistant population of acinetobacter baumannii a notorious pathogen cause recalcitrant infection both iin vitroi and in mouse infection model investigation of the underlying mechanism show that while colistin disrupt the membrane structure econazole cause the dissipation of proton motive force eliciting a vicious cycle of membrane structural damage and disruption of membrane protein function and eventually cell death this drug combination therefore achieve we goal of use a much small dosage of colistin to produce a much strong antimicrobial effect to tackle the problem of toxicity and resistance associate with colistin usage bimportanceb finding describe in this study constitute concrete evidence that it be possible to significantly enhance the antimicrobial activity of colistin by use a antifungal drug econazole as a colistin adjuvant we show that this drug combination can kill not only multidrugresistant a baumannii but also the tolerant subpopulation of such strain know as persister which may cause chronic and recurrent infection in clinical setting the synergistic kill effect of the econazole and colistin combination be also observable in mouse infection model at a very low concentration suggest that such a drug combination have high potential to be use clinically finding in this study therefore have important implication for enhancing its clinical application potential as well as develop new approach to enhance treatment effectiveness and reduce suffer in patient	2022 Jun	Miaomiao Xie, Kaichao Chen, Edward Wai-Chi Chan, Sheng Chen	Microbiol Spectr
35961093	onestep saltingout extraction of bacteriophage from its infection broth of acinetobacter baumannii	phage as a potential alternative antibiotic for multidrugresistant bacterial infection be receive great attention worldwide however the traditional separation and purification of phage be cumbersome timeconsumeng costly and inefficient in this study phage phibb9 for multidrugresistant acinetobacter baumannii be separate and purify by a simple and costsaving onestep saltingout extraction soe several kind of salt and organic solvent without effect on phage survival be choose to form the soe system and the composition of soe system be optimize accord to the phage recovery rate and impurity removal rate after onestep soe by a optimal system compose of 18 ww ammonium citrate and 40 ww ethyl acetate the recovery rate of phage in the middle phase could reach to 9082 and most protein 9957 cell 9798 and endotoxin 8408 be well remove with a concentration factor of 210 and the purification factor of phage to protein cell and endotoxin be 30364 13355 and 536 respectively Comparing with twostep soe and traditional aqueous twophase extraction onestep soe may be a available method for the separation and purification of phage	2022 Aug	Suyang Duan, Yuesheng Dong, Yongping Xu, Jiajun Yin, Lili Geng, Zhilong Xiu	J Chromatogr A
36128545	Oxa376 and Oxa530 variant of βlactamase computational study uncover potential therapeutic target of iAcinetobacter baumanniii	antimicrobial resistance be a major global health crisis result in thousand of death each year antibiotic effectiveness against microorganism deteriorate over time as multidrug resistance MDR develop which be exacerbate by irregular antibiotic use poor disease management and the evasive nature of bacterium the World Health Organization have recognize multidrug resistance as a critical public health concern and iAcinetobacter baumanniii have be at the center of attention due to its ability to develop multidrug resistance MDR it generally produce carbapenemhydrolyzing oxacillinase which have be identify as the primary source of betalactam resistance in MDR bacterium recently point mutation in iA baumanniii have be identify as a key factor of multidrug resistance make they a prime concern for researcher the goal of the current work be to establish a unique way of find multidrugresistant variant and identify the most damaging mutation in the exist database we characterize the deleterious variant of oxacillinase use several computational tool follow a thorough analysis Oxa376 and Oxa530 be find to be more damaging when compare with the wildtype Oxa51 the mutant 3D structure be then prepare and refine with raptorx galaxyrefine and saves server we research incorporate seven antimicrobial agent to illustrate the resistance capability of the variant of oxacillinase by evaluate bind affinity in Autodockvina and schrodinger software rmsd rmsf radius of gyration analysis the solventaccessible surface area sasa hydrogen bond analysis and mmgbsa from molecular dynamics simulation reveal the dynamic nature and stability of wildtype and Oxa376 and Oxa530 variant we finding will benefit researcher look for the deleterious mutation of iAcinetobacter baumanniii and new therapeutics to combat that variant however further study be necessary to evaluate the mechanism of hydrolyze activity and antibiotic resistance of this variant	2022 Aug	Sajal Kumar Halder, Maria Mulla Mim, Md Meharab Hassan Alif, Jannatul Fardous Shathi, Nuhu Alam, Aparna Shil, Mahbubul Kabir Himel	RSC Adv
36649779	Characterization of the enzymatic and multifunctional property of acinetobacter baumannii erythrose phosphate dehydrogenase e4pdh	infection due to acinetobacter baumannii a baumannii be rapidly increase worldwide and consequently therapeutic option for treatment be limited the emergence of multi drug resistant MDR strain have render available antibiotic ineffective necessitating the urgent discovery of new drug and drug target the vitamin b6 biosynthetic pathway have be consider as a potential antibacterial drug target but it be as yet uncharacterize for a baumannii in the current work we have carry out in silico and biochemical characterization of erythrose phosphate dehydrogenase e4pdh ec 12172 this enzyme catalyze the first step in the deoxyxylulose5 phosphate dxp dependent Vitamin b6 biosynthetic pathway ie the conversion of derythrose phosphate e4p to 4Phosphoerythronate e4pdh also possess a additional activity whereby it can catalyze the conversion of glyceraldehyde3 phosphate g3p to 13 bisphosphoglycerate 13bpg we study have reveal that this enzyme exhibit a alternate moonlighting function as a cell surface receptor for the human iron transport protein transferrin tf and lactoferrin Lf the present work report the internalization of tf and consequent iron acquisition as a alternate strategy for iron acquisition give its essential role in two crucial pathway ie metabolism and iron acquisition a baumannii e4pdh may play a vital role in bacterial pathogenesis	2023 Feb	Ramesh Nimma, Ajay Kumar, Zahid Gani, Anuj Gahlawat, Rahul Dilawari, Rajesh Kumar Rohilla, Hemangi Kumbhar, Prabha Garg, Sidharth Chopra, Manoj Raje, Chaaya Iyengar Raje	Microb Pathog
35946816	description of a rare pyomelaninproducing CarbapenemResistant acinetobacter baumannii strain coharboring Chromosomal oxa23 and NDM1	Carbapenemresistant acinetobacter baumannii CRAB which belong to global clone 1 gc1 or 2 gc2 have be widely report and become a global threat however nonGC1 and nonGC2 CRAB strain be not wellstudy especially for that with rare phenotype here one pyomelaninproducing CRAB strain a baumannii detabr21 be isolate from oral swab in the icu antimicrobial susceptibility testing show it be resistant to carbapenem ceftazidime levofloxacin and ciprofloxacin detabr21 be st164subpassub and st1418suboxfsub with kl47 and ocl5 respectively wholegenome sequencing wgs analysis reveal chromosome contain three copy of iblaisuboxa23sub on three 4805 bp tni2006 I composite transposon with various novel 9bp target site duplication tsd a tni125 ilike structure include iblaisubndm1 sub a novel 4343 bp composite transposon encoding iblaisubcarb16sub and three prophage region be also identify importantly ihmgai be interrupt by a tni2006 I and contribute to pyomelanin production and further confirm by ihmgai overexpression furthermore a baumannii irradiate with ultra-violet light detabr21 show a high relatively survival rate compare to a control strain that do not produce pyomelanin no effect of pyomelanin be observe on disinfectant susceptibility growth or virulence in conclusion pyomelaninproducing CRAB carry the iblaisubndm1sub and iblaisuboxa23 sub gene embed in the bacterial chromosome be of grave concern for health care setting highlight the need for effective measure to prevent further dissemination bimportanceb pyomelanin production be a quite rare phenotype in a baumannii moreover the mechanism lead to the pyomelanin production be still unclear here we for the first time confirm the mechanism of pyomelanin production and further investigate the impact of pyomelanin on disinfectant susceptibility growth virulence and ultra-violet irradiation more importantly many mobile genetic element mge include three copy of tni2006 I composite transposon one copy of iblaisubndm1sub on the tni125 ilike structure and three prophage region be identify in the chromosome demonstrate strong plasticity of a baumannii genome we study provide important insight into the new rare st164subpassub a baumannii strain with high level carbapenem resistance which be of great threat for patient this finding will provide important insight into the resistance gene transfer via transposition event and further spread in the clinic	2022 Aug	Feng Zhao, Haiyang Liu, Yue Yao, Linghong Zhang, Zhihui Zhou, Sebastian Leptihn, Yunsong Yu, Xiaoting Hua, Ying Fu	Microbiol Spectr
34967505	mechanism of transcription regulation by acinetobacter baumannii hpar in the catabolism of phydroxyphenylacetate	hpar be a transcription regulator in the marr family that control the expression of the gene cluster responsible for conversion of phydroxyphenylacetate to pyruvate and succinate for cellular metabolism here we report the biochemical and structural characterization of acinetobacter baumannii hpar abhpar and its complex with cognate DNA we study reveal that abhpar bind upstream of the divergently transcribed hpaA gene and the metacleavage operon as well as the hpaR gene thereby repressing they transcription by blocking access of RNA polymerase Structural analysis of abhpardna complex reveal that the DNA bind specificity can be achieve via a combination of both direct and indirect DNA sequence readout DNA bind of abhpar be weaken by 34dihydroxyphenylacetate DHPA which be the substrate of the metacleavage reaction this likely lead to expression of the target gene base on we finding we propose a model for how a baumannii control transcription of heametabolizing gene which highlight the independence of global catabolite repression and could be beneficial for metabolic engineering toward bioremediation application database the structural datum that support this finding be openly available in the wwpdb at httpsdoiorg102210pdb7el2pdb and httpsdoiorg102210 pdb7el3pdb for abhpar and abhpardna complex respectively	2022 Jun	Permkun Permsirivisarn, Anan Yuenyao, Nuttawan Pramanpol, Ratana Charoenwattanasatien, Wipa Suginta, Pimchai Chaiyen, Danaya Pakotiprapha	FEBS J
35884124	in silico docking resistance modulation and biofilm gene expression in multidrugresistant iAcinetobacter baumanniii via Cinnamic and gallic acid	despite the mount global burden of antimicrobial resistance amr the generation of new class of effective antimicrobial still lag far behind the interplay between multidrug resistance and biofilm formation in acinetobacter baumannii have drastically narrow the available therapeutic choice the use of natural compound hold promise as a alternate option for restoring the activity of exist antibiotic and attenuating virulence trait through reduce biofilm formation this study aim to evaluate the modulatory effect of combine cinnamic and gallic acid at ½MIC with various antibiotic against multidrugresistant MDR a baumannii clinical isolate as well as study the effect on the expression of the biofilmassociated gene bap csuE ompA via quantitative realtime pcr combining cinnamic or gallic acid with imipenem amikacin or doxycycline result in significant reduction of resistance p 005 on the contrary no effect be record when both acid be combine with levofloxacin and only cinnamic acid have a synergistic effect with colistin the transcriptomic change of biofilmrelated gene in the presence of gallic acid at ½MIC be compare with untreated control sample the fold expression value prove that gallic acid substantially downregulated the respective gene in all five strong biofilm former molecular docking study of gallic and cinnamic acid on target gene reveal good bind affinity and verify the propose mechanism of action to the good of we knowledge this be the first report on the effect of gallic acid on the expression of bap csuE and ompA gene in a baumannii which may permit its use as a adjunct antivirulence therapeutic strategy	2022 Jun	Neveen A Abdelaziz, Walid F Elkhatib, Mahmoud M Sherif, Mohammed A S Abourehab, Sara T Al-Rashood, Wagdy M Eldehna, Nada M Mostafa, Nooran S Elleboudy	Antibiotics (Basel)
35378360	highresolution crystal structure of acinetobacter baumannii thioredoxin 1	thioredoxin trx be a central component of the redox control system that maintain the redox homeostasis critical for organism survival owe to its central role in survival trx be a prospective target for novel antimicrobial agent herein we report a 145 Å highresolution structure of Trx1 of acinetobacter baumannii abtrx1 a antibioticresistant pathogenic superbug although abtrx1 exhibit the canonical trx fold which consist of a fourstrand " sheet surround by four αhelice structural difference be detect in the loop form the CXXC redox center and the cterminal the unique capc sequence of the CXXC motif in the abtrx1 redox center be characterize by mutagenesis this study contribute to the field of drug design against superbug	2022 Jun	Ye Ji Chang, Hyun Ho Park	Biochem Biophys Res Commun
35884089	molecular Characterization of CarbapenemResistant iAcinetobacter baumanniii isolated from intensive Care unit patient in jordanian hospital	iAcinetobacter baumanniii be a common cause of healthcareassociated infection hai worldwide mostly occur in intensive care unit icus extendedspectrum beta lactamase esblpositive iA baumanniii strain have emerge as highly resistant to most currently use antimicrobial agent include carbapenem the most common mechanism for carbapenem resistance in this species be βlactamasemediated resistance carbapenemhydrolyzing class D oxacillinase be widespread among multidrugresistant MDR iA baumanniii strain the present study be conduct to determine the presence and distribution of iblasubofasubi gene among multidrugresistant iA baumanniii isolate from icu patient and gene encoding insertion sequence IS1 in this isolate additionally the plasmid DNA profile of this isolate be determine a total of 120 clinical isolate of iA baumanniii from various icu clinical specimen of four main jordanian hospital be collect bacterial isolate identification be confirm by biochemical testing and antibiotic sensitivity be then assess pcr amplification and automated sequencing be carry out to detect the presence of iblaisuboxa51 sub iblaisuboxa23sub iblaisuboxa24sub and iblaisubOXA58 sub gene and ISiAba1i insertion sequence out of the 120 iA baumanniii isolate 95 of the isolate be resistant to three or more class of the antibiotic test and be identify as MDR the most frequent resistance of the isolate be against piperacillin 967 cephalosporin 975 and βlactam βlactamase inhibitor combination antibiotic 958 there be 24 20 esblproducing isolate a coexistence of iblaisuboxa51 sub gene and ISiAba1i in all the 24 esblproducing isolate be determine in addition in the 24 esblproducing isolate 21 875 carry iblaisuboxa51sub and iblaisuboxa23sub gene 1 42 carry iblaisuboxa51sub and iblaisuboxa24sub but all be negative for the iblaisubOXA58 sub gene plasmid DNA profile a and profile B be the most common 29 in esblpositive MDR iA baumanniii isolate while plasmid DNA profile a be the most common in the esblnegative isolate in conclusion there be a increase in prevalence of mdria baumanniii in icu ward in jordanian hospital especially that have a esbl phenotype thus identification of esbl gene be necessary for the surveillance of they transmission in hospital	2022 Jun	Suhaila A Al-Sheboul, Salam Z Al-Moghrabi, Yasemin Shboul, Farah Atawneh, Ahmed H Sharie, Laila F Nimri	Antibiotics (Basel)
36290038	Fitness cost of tigecycline resistance in iAcinetobacter baumanniii and the resistance mechanism revealed by a transposon mutation Library	iAcinetobacter baumanniii be one of the main pathogen cause nosocomial and communityacquired infection tigecycline be a important antibiotic for the treatment of multidrugresistant iA baumanniii infection but strain resistant to tigecycline have also emerge there be still many unclear question concern the mechanism of tigecycline resistance in iA baumanniii in this study tigecyclinesusceptible and tigecyclineintermediate strain be gradually cultured with subminimum inhibitory concentration of tigecycline to select for tigecyclineresistant mutant and a tigecyclineresistant strain be cultured under 42 °C to select for tigecyclinesusceptible mutant we find that the acquisition of tigecycline resistance affect the susceptibility of the strain to other antibiotic resistance to ampicillinsulbactam be negatively correlate with tigecycline resistance the strain will experience fitness cost along with the acquisition of tigecycline resistance tigecycline resistance in the strain be not related to 16S rRNA target variation or outer membrane integrity alteration by construct a transposon mutation library we find that transposon insertion of the iadeLi gene reduce the sensitivity of iA baumanniii to tigecycline this study provide important clue for understanding the mechanism of tigecycline resistance in iA baumanniii	2022 Oct	Ping Wang, Hongou Wang, Cunwei Liu, Chengjie Feng, Qinghui Lu, Qinghua Zou	Antibiotics (Basel)
35638783	origin phylogeny and transmission of the epidemic clone ST208 of CarbapenemResistant acinetobacter baumannii on a Global scale	Carbapenemresistant acinetobacter baumannii CRAB be a opportunistic pathogen that have become a global threat the dissemination of global clone 2 gc2 CRAB have be well document Oxford sequence type ST 208 be one of the most prevalent lineage of a baumannii gc2 however its evolution and phylogeny be unclear we collect 45 representative ST208 isolate from 14 city in China between 1999 and 2018 moreover 411 ST208 genome sequence be download from the genbank database for comparison the global ST208 phylogeny show that ST208 might have originate from North America and subsequently evolve into two clade notably the widespread oxa23 produce ST208 a baumannii be correlate with the transposon structure and dynamic of replicative transposition and the tni2009i tandem structure of five copy of iblaisuboxa23sub and potential circular intermediate of tni2009i be first detect furthermore 15 Chinese ST208 isolate carry gr25 pabtj1 like plasmid which contain iblaisuboxa23sub and have only be find in China in the last decade in conclusion we work suggest that replicative transposition contribute to the evolution and transmission of oxa23 produce ST208 a baumannii and highlight the new challenge pose by the epidemiological surveillance of globally distribute clonal group via whole genome sequencing bimportanceb ST208 as one of the most prevalent lineage of CRAB have cause several difficulttotreat infection and outbreak around the world however few study have focus on evaluate the genetic background difference of ST208 a baumannii isolate from very distant geographic region a comprehensive genomic analysis of 456 clinical strain of ST208 a baumannii from a wide temporal and geographic range be perform in this study moreover the mechanism lead to the horizontal transfer of iblaisuboxa23sub in ST208 a baumannii be poorly understand we first describe experimental evidence of the potential circular intermediate of tni2009i and the tni2009i tandem structure of five copy of iblaisuboxa23sub be first detect the interbacterial transfer of genetic element carry resistance to lastline antibiotic carbapenem highlight the essential need to enhance epidemiologic surveillance	2022 Jun	Yue Gao, Henan Li, Hongbin Chen, Jiangang Zhang, Ruobing Wang, Zhiren Wang, Hui Wang	Microbiol Spectr
35535800	nasupsup homeostasis in acinetobacter baumannii be facilitate via the activity of the mrp antiporter	the human opportunistic pathogen acinetobacter baumannii be a global threat to healthcare institution worldwide since it develop very efficient strategy to evade host defence and to adapt to the different environmental condition of the host this work focus on the importance of nasupsup homeostasis in a baumannii with regards to pathobiological aspect in silico study reveal a homologue of a multicomponent nasupsup hsupsup antiporter system Inactivation of the mrp antiporter through deletion of the first gene mrpA result in a mutant that be sensitive to increase pH value furthermore the strain be highly sensitive to increase nasupsup and lisupsup concentration increasing nasupsup sensitivity be think to be responsible for growth impairment in human fluid furthermore deletion of mrpA be associate with energetic defect inhibition of motility and survival under anoxic and dry condition	2022 Sep	Josephine Joy Hubloher, Lisa van der Sande, Volker Müller	Environ Microbiol
35561952	bactericidal activity and action mechanism of the novel antimicrobial peptide hylin a1 and its analog peptide against acinetobacter baumannii infection	we develop a antimicrobial peptide AMP as a candidate substance for replace antibiotic previously a novel 18 amino acid antimicrobial peptide hylin a1 be isolate from a electrostimulated arboreal South American frog hypsiboa albopunctatus and be find to demonstrate antimicrobial activity and cytotoxicity in a recent study the analog peptide be design base on the parent peptide hylin a1 to decrease toxicity and to maintain antimicrobial efficacy the analog peptide be substitute with alanine and lysine result in the formation of amphipathic αhelical structure in membranemiming environment and in the induction of hydrophobic moment and net charge moreover the analog peptide show low hemolytic effect and mammalian cell selectivity than hylin a1 in particularly hylin a 111 k and hylin a 115 k exhibit broadspectrum antimicrobial activity and antibiofilm activity against carbapenemresistant acinetobacter baumannii permeability assay indicate that analog peptide eliminate bacterium by bind to lipopolysaccharide and by disrupt the bacterial membrane hylin a 111 k and hylin a 115 k reduce inflammation by suppressing proinflammatory cytokine expression by a baumannii infection and effectively ameliorated carbapenemresistant a baumannii infection in mouse therefore we result suggest that the analog peptide substitute with several residue base on hylin a1 have antibacterial and antiinflammatory activity and may be effective in the treatment of carbapenemresistant a baumannii infection	2022 Aug	Hee Joo Park, Hee Kyoung Kang, Eunji Park, Min Kyung Kim, Yoonkyung Park	Eur J Pharm Sci
37178001	DNA modification impact natural transformation of acinetobacter baumannii	acinetobacter baumannii be a dangerous nosocomial pathogen especially due to its ability to rapidly acquire new genetic trait include antibiotic resistance gene arg in a baumannii natural competence for transformation one of the primary mode of horizontal gene transfer hgt be think to contribute to arg acquisition and have therefore be intensively study however knowledge regard the potential role of epigenetic DNA modification on this process remain lack here we demonstrate that the methylome pattern of diverse a baumannii strain differ substantially and that this epigenetic mark influence the fate of transform DNA specifically we describe a methylomedependent phenomenon that impact intra and interspecy DNA exchange by the competent a baumannii strain A118 we go on to identify and characterize a A118 specific restrictionmodification rm system that impair transformation when the incoming DNA lack a specific methylation signature Collectively we work contribute towards a more holistic understanding of hgt in this organism and may also aid future endeavor towards tackle the spread of novel ARGs in particular we result suggest that DNA exchange between bacterium that share similar epigenome be favored and could therefore guide future research into identify the reservoir of dangerous genetic trait for this multidrug resistant pathogen	2023 May	Nina Vesel, Christian Iseli, Nicolas Guex, Alexandre Lemopoulos, Melanie Blokesch	Nucleic Acids Res
35707776	molecular detection of iblaoxa subtypesubi Carbapenemase gene and antimicrobial resistance pattern among Clinical isolate of iAcinetobacter baumanniii	iAcinetobacter baumanniii be a bacterium find in most place especially in clinic and hospital and a important agent of nosocomial infection the presence of class D enzyme such as oxatype carbapenemase in iA baumanniii be prove to have a key function in resistance to carbapenem the aim of the current study be to determine the iblaoxa subtypesubi carbapenemase gene and antimicrobial resistance among clinically isolate sample of iA baumanniii we assess 100 clinically isolate specimen of iA baumanniii from patient in intensive care unit of educational hospital of hamadan West of Iran the iA baumanniii isolate susceptibility to antibiotic be perform employing disk diffusion method multiplex polymerase chain reaction be use to identify the ibla suboxa24 likesubi ibla suboxa23 likesubi ibla subogaka likesubi and ibla suboxa51 likesubi gene I the bla suboxa23 likesubi ibla suboxa24 likesubi subsub and ibla subogaka likesubi gene prevalence be find to be 84 58 and 3 respectively the high coexistence of the gene be for ibla suboXA5123subi 84 follow by ibla suboxa5124 likesubi 58 the ibla suboXA5123subi sublikesub pattern of gene be a sort of dominant gene in resistance in iA baumanniii from hamadan hospital the high resistance to piperacillin 83 and ciprofloxacin 81 have be observe in positive isolate of ibla suboxa23 likesubi the iA baumanniii isolate with ibla subogaka likesubi gene do not show much resistance to antibiotic base on the result of the phylogenetic tree analysis all isolate have show a high degree of similarity this study show the high frequency of ioxai type carbapenemase gene among iA baumanniii isolate from hamadan hospital Iran thus apply a appropriate strategy to limit the spread of this strain and also perform new treatment regimen be necessary	2022 Jun	Maghsoud Kafshnouchi, Marzieh Safari, Amir Khodavirdipour, Abbas Bahador, Seyed Hamid Hashemi, Mohammad Sina Alikhani, Massoud Saidijam, Mohammad Yousef Alikhani	Glob Med Genet
36985332	iAcinetobacter baumanniii from sample of Commercially reared turkey genomic relationship antimicrobial and biocide susceptibility	iAcinetobacter baumanniii be especially know as a cause of nosocomial infection worldwide it show intrinsic and acquire resistance to numerous antimicrobial agent which can render the treatment difficult in contrast to the situation in human medicine there be only few study focus on iA baumanniii among livestock in this study we have examine 643 sample from turkey reared for meat production include 250 environmental and 393 diagnostic sample for the presence of iA baumanniii in total 99 isolate be identify confirm to species level via malditofm and characterise with pulsedfield gel electrophoresis antimicrobial and biocide susceptibility be test by broth microdilution method base on the result 26 representative isolate be select and subject to wholegenome sequencing wgs in general iA baumanniii be detect at a very low prevalence except for a high prevalence of 79e in chickboxpaper and 118 of onedayold turkey chick the distribution of the minimal inhibitory concentration value be unimodal for the four biocide and for most of the antimicrobial agent test wgs reveal 16 pasteur and 18 Oxford sequence type include new one core genome mlst highlight the diversity of most isolate in conclusion the isolate detect be highly diverse and still susceptible to many antimicrobial agent	2023 Mar	Anna Schmitz, Dennis Hanke, Dörte Lüschow, Stefan Schwarz, Paul G Higgins, Andrea T Feßler	Microorganisms
35614377	Eradication of drugresistant acinetobacter baumannii by cellpenetrate peptide fuse endolysin	antimicrobial agent target peptidoglycan have show successful result in eliminate bacterium with high selective toxicity Bacteriophage encode endolysin as a alternative antibiotic be a peptidoglycan degrade enzyme with a low rate of resistance here the engineer endolysin be develop to defeat multiple drugresistant MDR acinetobacter baumannii first putative endolysin pa90 be predict by genome analysis of isolate pseudomonas phage pbpa the histagged pa90 be purify from bl21de3 plyss and test for the enzymatic activity use gramnegative pathogen know for have a high antibiotic resistance rate include a baumannii since the measure activity of pa90 be low probably due to the outer membrane cellpenetrate peptide cpp ds43 be introduce at the nterminus of pa90 to aid access to its substrate this engineer endolysin dspa90 completely kill a baumannii at 025 µm at which concentration pa90 could only eliminate less than one log in CFUml additionally dspa90 have tolerance to NaCl where the ∼50 of activity could be maintain in the presence of 150 mM NaCl and stable activity be also observe with change in pH or temperature even MDR a baumannii strain be highly susceptible to dspa90 treatment five out of nine strain be entirely kill and four strain be reduce by 34 log in CFUml consequently dspa90 could protect waxworm from a baumanniiinduced death by ∼ 70 for atcc 17978 or ∼ 44 for MDR strain 16562 infection Collectively we datum suggest that cePfused endolysin can be a effective antibacterial agent against gramnegative pathogen regardless of antibiotic resistance mechanism	2022 Aug	Jeonghyun Lim, Jaeyeon Jang, Heejoon Myung, Miryoung Song	J Microbiol
36009945	Control of healthcare Associated CarbapenemResistant iAcinetobacter baumanniii by enhancement of infection Control measure	antimicrobial stewardship and infection control measure be equally important in the control of antimicrobialresistant organism we conduct a retrospective analysis of the incidence rate of hospitalonset carbapenemresistant acinetobacter baumannii CRAB infection per 1000 patient day in the Queen Mary Hospital a 1700b universityaffiliated teaching hospital from period 1 1 January 2007 to 31 December 2013 to period 2 1 January 2014 to 31 December 2019 where enhance infection control measure include directly observe hand hygiene before meal and medication round to conscious patient and the priority use of single room isolation be implement during period 2 this study aim to investigate the association between enhance infection control measure and change in the trend in the incidence rate of hospitalonset CRAB infection antimicrobial consumption define daily dose per 1000 patient day be monitor interrupted time series in particular segment Poisson regression be use the hospitalonset CRAB infection increase by 213 per year relative risk rr 1213 95 confidence interval CI 1162 −1266 p 0001 whereas the consumption of the extend spectrum betalactambetalactamase inhibitor blbi combination and cephalosporin increase by 112 per year rr 1112 95 CI 1102 − 1122 p 0001 and 42 per year rr 1042 95 CI 1028 −1056 p 0001 respectively in period 1 with enhance infection control measure the hospitalonset CRAB infection decrease by 98 per year rr 0902 95 CI 0854−0953 p 0001 whereas the consumption of the extend spectrum blbi combination and cephalosporin increase by 38 per year rr 1038 95 CI 1033 −1044 p 0001 and 76 per year rr 1076 95 CI 1056−1097 p 0001 respectively in period 2 the consumption of carbapenem increase by 84 per year rr 184 95 CI 1073 −1094 p 0001 in both period 1 and period 2 the control of healthcareassociated CRAB could be achieve by infection control measure with a emphasis on directly observe hand hygiene despite a increase trend of antimicrobial consumption	2022 Aug	Shuk-Ching Wong, Pui-Hing Chau, Simon Yung-Chun So, Germaine Kit-Ming Lam, Veronica Wing-Man Chan, Lithia Lai-Ha Yuen, Christine Ho-Yan Au Yeung, Jonathan Hon-Kwan Chen, Pak-Leung Ho, Kwok-Yung Yuen, Vincent Chi-Chung Cheng	Antibiotics (Basel)
35750869	a rare occurrence of multidrugresistant environmental acinetobacter baumannii strain from the soil of Mangaluru India	over the last decade acinetobacter baumannii have emerge as one of the main cause of infection acquire in the hospital set Outbreak associate with this pathogen be cause mainly due to contamination and transmission in hospital territory however the natural habitat of a baumannii of clinical significance still remain unclear in this study we highlight the isolation and identification of multidrugresistant environmental strain of a baumannii from the soil of Mangaluru city all the recover isolate be biofilm former and two isolate be multidrugresistant and show resistance to fluoroquinolone aminoglycoside sulfonamide tetracycline and carbapenem in addition they exhibit protease activity and produce phospholipase C and siderophore to the good of we knowledge this be the first study to isolate and identify drugresistant strain of a baumannii from the soil	2022 Jun	Sarika Suresh, Vankadari Aditya, Vijaya Kumar Deekshit, Radhakrishna Manipura, Ramya Premanath	Arch Microbiol
35992699	molecular characterisation of iAcinetobacter baumanniii isolate from bloodstream infection in a tertiarylevel hospital in South Africa	iAcinetobacter baumanniii be a opportunistic pathogen and cause various infection in patient this study aim to describe the clinical epidemiological and molecular characteristic of iA baumanniii isolate from bcs in patient at a tertiarylevel hospital in South Africa ninetysix isolate from bloodstream infection be collect Clinical characteristic of patient be record from patient file Organism identification and ast be perform use automated system pcr screen for the imcr1i to imcri5 gene be do to infer genetic relatedness a dendrogram be construct use malditof ms all colistinresistant isolate ini 9 be select for wgs the patient be divide into three group infant 1 year ini 54 paediatrics 118 year ini 6 and adult ≥ 19 year ini 36 with a median age of 13 day 1 and 41 year respectively of the 96 iA baumanniii bacteraemia case 969 9396 be healthcareassociated the crude mortality rate at 30 day be 522 4892 the majority of the isolate be multidrugresistant MDR all isolate be pcrnegative for the imcri1 to imcri5 gene the majority of the isolate belong to cluster 1 6296 accord to the malditof ms dendrogram colistin resistance be confirm in nine iA baumanniii isolate 94 the colistinresistant isolate belong to sequence type ST 1 56 and ST2 16 the majority of ST1 isolate show low snp diversity ≤ 4 snp all the colistinresistant isolate be resistant to carbapenem exhibit a XDR phenotype and harbour the iblai subiOXAi23 sub gene the iblai subindmisub gene be only detect in ST1 colistinresistant isolate ini 5 the ilpsiB gene be detect in all colistinresistant isolate as well as various efflux pump gene belong to the RND the MFS and the SMR family the lipooligosaccharide ocl1 be detect in all colistinresistant ST1 and ST2 isolate and the capsular polysaccharide KL3 and kl17 be detect in ST2 and ST1 respectively this study demonstrate a 94 prevalence of colistinresistant ST1 and ST2 iA baumanniii in bc isolate the detection of the ilpsiB gene indicate a potential threat and require close prospective monitoring	2022	Michelle Lowe, Ashika Singh-Moodley, Husna Ismail, Teena Thomas, Vindana Chibabhai, Trusha Nana, Warren Lowman, Arshad Ismail, Wai Yin Chan, Olga Perovic	Front Microbiol
35935207	genetic configuration of genomic resistance Island in iAcinetobacter baumanniii Clinical isolate from Egypt	in iAcinetobacter baumanniii iA baumanniii a wide repertoire of resistance gene be often carry within genomic resistance island RIs particularly in highrisk global clone gcs as the first in Egypt the current study aim at explore the diversity and genetic configuration of RIs in the clinical isolate of iA baumanniii for this purpose draft genome of 18 isolate be generate by illumina sequencing disk diffusion susceptibility profiling reveal multidrug resistance MDR and extensive drug resistance XDR phenotype in 277 and 722 respectively the high susceptibility be note for tigecycline 1000 follow by colistin 944 for which a micsub50 sub of 025 μgml be record by the broth microdilution assay sequence type ST show that the majority of the isolate belong to highrisk global clone gc1 gc2 and gc9 a novel Oxford sequence type st2329 that also form a novel clonal complex be submit to the pubmlst database a novel iblai subADCsub variant iblai subADC258 sub be also identify in strain M18 st85suppassup1089supoxfsup in addition to a wide array of resistance determinant wholegenome sequencing wgs disclose at least nine configuration of genomic RIs distribute over 1618 isolate gc2 isolate accumulate the large number of RIs three risisolate follow by that that belong to gc1 two risisolate in addition to tni6022i 444 the icomMi gene be interrupt by abar4 55 and three variant of a biaumanniii genomic resistance island 1abgritype RIs 444 include abar4 b 166 and two novel configuration of abgri1 like RIs 222 three of which abar4 abar4 b and abgri1 like2 carry iblai suboxa23sub within tni2006 I with less abundance 388 isi26 ibound RIs be detect exclusively in gc2 isolate this include a short version of abgri2 abgri215 carry the gene iblai subtem1sub and iaphA1i and two variant of abgri3 RIs carry up to seven resistance gene imphemsrearmasul1aada1catb8aaca4i confined to gc1 222 sulfonamide resistance be acquire by a ISiAba1i bracket gisul2 RI a additional RI riper7 be also identify on a plasmid carry by strain m03 among other riper7 carry the resistance gene iarmAi and iblai subper7sub here we provide a close view of the diversity and genetic organization of RIs carry by a previously unexplored population of iA baumanniii	2022	Samira M Hamed, Amira F A Hussein, Mohamed H Al-Agamy, Hesham H Radwan, Mai M Zafer	Front Microbiol
36003364	coisolate of iAcinetobacter baumanniii complex in polymicrobial infection a metaanalysis	bBackgroundb iAcinetobacter baumanniii complex ABC infection be commonly polymicrobial examine which pathogen be most commonly coisolated with ABC be a important first step for assess disease potential due to pathogenpathogen interaction bMethodsb base on a systematic search of PubMed scopus and central we estimate percent proportion of coisolate in polymicrobial pulmonary and bloodstream ABC infection use randomeffect metaanalysis	2022 Aug	Stamatis Karakonstantis, Petros Ioannou, Evangelos I Kritsotakis	Access Microbiol
37074067	virulence characteristic and drug resistance of the prevalent capsule type in iAcinetobacter baumanniii	iAcinetobacter baumanniii be a highly antibioticresistant pathogen cause nosocomial severe lifethreatening infection especially in critically ill patient capsular polysaccharide be a major virulence factor of iA baumanniii both iin vitroi and iin vivoi in this study 220 isolate be collect in the hospital the prevalent capsular type of iA baumanniii be determine use polymerase chain reaction and the clinical characteristic of infection be analyze the virulence of this strain be determine by serumkilling resistance biofilm formation and iGalleria mellonellai survival assay twentyeight isolate 127 carry KL2 and 22 isolate 10 carry the type KL10 KL14 KL22 and kl52 compare with nonKL2 KL10 KL14 KL22 and kl52 isolate KL2 isolate have significantly high resistance to all antimicrobial except tigecycline cefoperazonesulbactam or colistin seventyfive percent of KL2 iA baumanniii and 727 of nonKL2 be highly virulent use a iG mellonellai model biofilm formation be significantly different between the KL2 and nonKL2 group the biofilm production of nonKL2 iA baumanniii be significantly strong than that of KL2 iA baumanniii this finding highlight the role of KL2 as a powerful factor for drug resistance and virulence of iA baumanniii	2023 Apr	Jiao Chen, Guanghui Li, Fen Wan, Peng Liu, Fangling Du, Yanting Shao, Qi Zhang, Zhibin Cheng, Yang Liu	Microb Drug Resist
36551489	optimization of pyrazole compound as antibiotic adjuvant Active against colistin and CarbapenemResistant iAcinetobacter baumanniii	the diffusion of antibioticresistant gramnegative opportunistic pathogen a increasingly important global public health issue cause a significant socioeconomic burden iAcinetobacter baumanniii isolate despite cause a low number of infection than enterobacterale often show multidrugresistant phenotype carbapenem resistance be also rather common prompt the who to include carbapenemresistant iA baumanniii as a critical priority for the discovery and development of new antibacterial agent in a previous work we identify several series of compound show either directacting or synergistic activity against relevant gramnegative species include iA baumanniii among this two pyrazole compound despite be devoid of any directacting activity show remarkable synergistic activity in the presence of a subinhibitory concentration of colistin on iK pneumoniae and iA baumanniii and serve as a start point for the synthesis of new analogue in this work a new series of 47 pyrazole compound be synthesized some compound show significant directacting antibacterial activity on grampositive organism furthermore a evaluation of they activity as potential antibiotic adjuvant allow for the identification of two highly active compound on MDR iAcinetobacter baumanniii include colistinresistant isolate this work confirm the interest in pyrazole amide as a start point for the optimization of synergistic antibacterial compound active on antibioticresistant gramnegative pathogen	2022 Dec	Filomena Sannio, Antonella Brizzi, Rosita Del Prete, Marialuce Avigliano, Tiziana Simone, Carlotta Pagli, Teresa Ferraro, Filomena De Luca, Marco Paolino, Federico Corelli, Claudia Mugnaini, Jean-Denis Docquier	Antibiotics (Basel)
35811021	the type VI secretion system in acinetobacter baumannii clinical isolate and its role in antimicrobial resistance acquisition	acinetobacter baumannii be a successful pathogen that can acquire various antibiotic resistance in a short time however little be know about how it can evolve from a antibiotic sensitive to a resistant phenotype in this study we investigate the role of the type VI secretion system t6ss in the acquisition of antibiotic resistance of a baumannii t6ss gene cluster be find to be present in 51 of 77 a baumannii clinical isolate of which it be find in 62 813 of the multiple drug resistant MDR isolate 90 3640 of the extensively drugresistant XDR isolate and 26 623 of the antibiotic sensitive isolate there be a close relationship between the antimicrobial resistance and the presence of t6ss besides t6ss isolate show low biofilm formation activity and high survival ability in the presence of normal human serum than t6ss isolate a baumannii a152 with complete t6ss can outcompete ecoli effectively and can acquire the antibiotic resistance plasmid release by ecoli in contrast the t6ss core gene mutant a152 Δhcp show significantly decrease ability to acquire antimicrobial resistance plasmid from the prey bacterium this result suggest that t6ss mediate bacterial competition play important role in the antimicrobial resistance of a baumannii which point out a new direction for we to study the antimicrobial resistance of a baumannii	2022 Aug	Jun-Fang Dong, Cun-Wei Liu, Ping Wang, Lei Li, Qing-Hua Zou	Microb Pathog
35347673	mimusop elengei flowermediated Green Silver nanoparticle Control Staphylococcus aureus and acinetobacter baumannii	the use of antibiotic against infectioncause bacterium be inactivate due to the presence of antibioticdegrading enzyme this enzyme resist the action of antibiotic and make difficult for the already exist antibiotic to break the drug resistance hence there be a need to formulate alternate therapy against the enzyme provide multidrug resistance to bacterium include Staphylococcus aureus and acinetobacter baumannii a silver nanoparticle coat with the natural compound be a way of find a alternative to the traditional antibiotic objective of the study be to identify and assess mimusop elengis floral silver nanoparticle menp for its effective antibacterial activity the method involve be in silico analysis involve screen by adme drug likeness and docking of ligand to the protein crtm and ctxm15 in vitro analysis which include silver nanoparticle preparation characterization by uvvis spectrum SEM ftir DLS and antimicrobial assay which include agar well diffusion minimum inhibitory concentration minimum bactericidal concentration and antibiofilm assay the compound present in the flower extract be identify and they usability against the enzyme under study be assure by silico screen the in vitro analysis furthermore support through show potent antibacterial activity of menp against select organism hence both in silico and in vitro study reveal that menp can be use as a alternative to break multidrug resistance	2022 Jul	Charlz Nithin J, Ranjani S, Hemalatha S	Appl Biochem Biotechnol
35656953	the susceptibility pattern and distribution of blaoxa23 gene of clinical isolate acinetobacter baumannii in a tertiary hospital Indonesia	acinetobacter baumannii a pathogen of concern in hospital worldwide have diverse antimicrobial resistance mechanism lead to limiting the antibiotic option and carbapenemase enzyme production be one of the common mechanism in carbapenem resistance the epidemiology and resistance pattern of clinical isolate be critical in develop a prevention and treatment strategy the aim of this be to determine the prevalence and resistance pattern of carbapenem nonsusceptible strain CNS a baumannii at arifin achmad General Hospital Pekanbaru Indonesia	2022 May	Dewi Anggraini, Rahmat Azhari Kemal, Usman Hadi, Kuntaman Kuntaman	J Infect Dev Ctries
36470921	the role of pmrcab gene in colistinresistant acinetobacter baumannii	the progressively increase antimicrobialresistant acinetobacter baumannii infection have enforced the use of colistin as the last option for therapy result in the colistin resistance evolution this work aim to study the pmrcab expression in a baumannii isolate as well as the presence of the mcr1 gene colistin mic of 100 a baumannii isolate be measure use the broth microdilution assay in four colistinsusceptible and four colistinresistant isolate the relative expression of the pmrA pmrB and pmrC gene be determine use reverse transcription pcr and then select isolate be sequence use the sanger technique finally the mcr1 gene be detect use conventional pcr the colistin resistance rate among the study isolate be 49 the expression level of pmrA and pmrB be statistically significantly high in colistinresistant isolate than in colistinsusceptible one while the pmrC expression have no statistically significant change there be a weak positive correlation between colistin mic and the expression level of each of the pmrA and pmrB gene by sequencing two colistinresistant strain with low pmrcab expression show insertion mutation 32771883277189T in pmrB and 11851491185150T in pmrC only one isolate 1 be positive for the presence of mcr1 we conclude that pmrcab increase expression andor mutation may cause colistin resistance in a baumannii however increase pmrC expression may not necessarily result in colistin resistance in Egypt this be the first study to reveal the existence of mcr1 in a baumanni this should attract attention in clinical setting due to the ultimate tendency of spread colistin resistance	2022 Dec	Shaimaa Mohamed Seleim, Marwa Salah Mostafa, Nadia Hafez Ouda, Rania Yahia Shash	Sci Rep
36638876	clonal evolution and antimicrobial resistance of acinetobacter baumannii isolate from Korean hospital over the last decade	the widespread of drugresistant acinetobacter baumannii be a global health problem this study investigate the clonal distribution and antimicrobial resistance of 167 a baumannii isolate from two Korean university hospital from 2009 to 2019 by analyze the sequence type STs antimicrobial resistance and resistance determinant of carbapenem and aminoglycoside twenty STs include 16 preexisting STs and four unassign STs be identify in a baumannii isolate use the Oxford multilocus sequence type scheme two STs st191 and 77 and st451 and 40 be prevalent and majority and 153 of the isolate belong to clonal complex 208 the st191 isolate be detect during the study period whereas st451 isolate be detect after 2016 one hundred fortyseven 87 of 167 a baumannii isolate be nonsusceptible to carbapenem the st191 and st451 isolate exhibit high resistance to antimicrobial agent than that of the sporadic ST isolate interestingly st451 isolate exhibit low susceptibility to minocycline and tigecycline than the other ST isolate all carbapenemnonsusceptible a baumannii isolate except four carry the isabaiblasuboxa23sub structure armA be detect in all amikacinnonsusceptible isolate and 128 except for one isolate five aminoglycosidemodifying enzyme AME gene be detect but they carriage varied between STs ant3 " ia and aac6 ib be more common in st191 than in st451 while aph3 ia be more common in st451 than in st191 this study demonstrate the clonal evolution related to antimicrobial resistance in a baumannii	2023 Mar	So Hyun Jun, Da Eun Lee, Hye Ryeong Hwang, Nayeong Kim, Ki Tae Kwon, Yu Kyung Kim, Je Chul Lee	Infect Genet Evol
35746711	isolation and Characterization of a Novel iSiphoviridaei phage vBAbaSTCUP2199 infecting multidrugresistant iAcinetobacter baumanniii	multidrugresistant iAcinetobacter baumanniii mdrab be a pathogen recognize as antimicrobialresistant bacterium involve in healthcareassociated infection resistance to antibiotic have make alternative therapy necessary Bacteriophage therapy be consider a potential solution to treat mdrab in this study we isolate and characterize the phage vBAbaSTCUP2199 tcup2199 which can infect mdrab morphological analysis reveal that tcup2199 belong to the iSiphoviridaei family tcup2199 have a wide host range can adsorb rapidly 6828 in 2 minute and have a burst size of 196 pfucell at least 16 distinct structural protein be visualized by SDS polyacrylamide gel electrophoresis a stability test show that tcup2199 be stable at 37 °C and pH 7 genome analysis of tcup2199 show that it consist of a doublestranded DNA genome of 79572 bp with a gc content of 4039 which contain 98 putative open read frame none of which be closely related to the bacteriophage genome sequence that be find in the public database tcup2199 show similarity in genomic organization and putative packaging mechanism with iAchromobacteri phage jwf and ipseudoalteromonasi phage kb1238 base on protein blast and phylogenetic analysis because of that unique characteristic we consider tcup2199 to be a novel phage that be suitable for inclusion in a phage cocktail to treat iA baumanniii infection	2022 Jun	Meity Mardiana, Soon-Hian Teh, Ling-Chun Lin, Nien-Tsung Lin	Viruses
36719216	phenotypic and genomic Characterization of nine stringpositive CarbapenemResistant acinetobacter baumannii isolate from Israel	a positive string test indicate the ability of bacterial colony grow on agar plate to form viscous string of 5 mm when stretch this phenotype be strongly associate with hypervirulence in Klebsiella pneumoniae but have never be describe in carbapenemresistant acinetobacter baumannii CRAB a emerge human pathogen of high clinical significance in this work we screen 1000 CRAB isolate among which we identify and characterize 9 stringpositive CRAB stcrab isolate phenotypic and genotypic analysis reveal that the isolate be not phylogenetically related and possess different antibiotic resistance and virulence profile transmission electron microscopy tem show the presence of capsule in stringpositive isolate stringpositive isolate be more motile but do not form more biofilm than nonstringpositive isolate they be less virulent in a murine thigh fitness model and a Galleria mellonella survival assay in conclusion here we describe stringpositive a baumannii isolate and they phenotypic and molecular characteristic we find that unlike k pneumoniae stcrab isolate be not associate with increase virulence bimportanceb acinetobacter baumannii have be consider a major health care threat in recent year despite many effort the pathogenesis and molecular mechanism of a baumannii virulence remain poorly understand moreover the plasticity of its genome frequently give rise to new and more virulent isolate we current study be of significant importance as it concern a previously undescribed a baumannii phenotype the stringpositive phenotype be strongly associate with increase fitness and virulence in other gramnegative bacterium such as k pneumoniae although no clear correlation with virulence or fitness be find in we 9 stcrab isolate this could have be due to the limited statistical power of we research we suggest that this phenotype should be take into consideration as due to its genome plasticity the next change can give rise to stringpositive and hypervirulent strain as be know for k pneumoniae additional future research be need regard its possible consequence	2023 Jan	Nadya Rakovitsky, Mor N Lurie-Weinberger, Amichay Hameir, Liat Wulffhart, Alona Keren Paz, David Schwartz, Yehuda Carmeli	Microbiol Spectr
36462662	combination of isothiocy and antibiotic increase susceptibility against acinetobacter baumannii Escherichia coli Klebsiella pneumoniae proteus mirabilis and Serratia marcescen	the development and spread of multidrugresistant organism mdro be evolve rapidly worldwide although effective antibiotic be still available some infection be difficult to treat among MDROs S marcescen and a baumannii be among the difficulttotreat pathogen cause for instance sepsis and urinary tract infection UTI isothiocyanate itc be natural plant product the antimicrobial property of itc appear to be more effective in combination with some antibiotic	2022 Nov	Bidii Stephen Ngalah, Katharina Börner, Moritz Kropidlowsky, Johanna Finkbeiner, Alexander Harter, Klaus Biehler, Uwe Frank	Fitoterapia
36122366	iin Vitroi reconstitution of fimsbactin biosynthesis from iAcinetobacter baumanniii	siderophore produce via nonribosomal peptide synthetase nrps pathway serve as critical virulence factor for many pathogenic bacterium improved knowledge of siderophore biosynthesis guide the development of inhibitor vaccine and other therapeutic strategy fimsbactin a be a mix ligand siderophore derive from human pathogenic iAcinetobacter baumanniii that contain phenolateoxazoline catechol and hydroxamate metal chelate group branch from a central lSer tetrahedral unit via amide and ester linkage fimsbactin a be derive from two molecule of lSer two molecule of 23 dihydroxybenzoic acid dhb and one molecule of lOrn and be a product of the ifbsi biosynthetic operon here we report the complete iin vitroi reconstitution of fimsbactin a biosynthesis in a cellfree system use purify enzyme we demonstrate the conversion of lOrn to inisub1subacetylinisub1subhydroxyputrescine ahPutr via order action of fbsj decarboxylase FbsI flavin iNimonooxygenase and fbsk iNiacetyltransferase we achieve conversion of lSer dhb and lOrn to fimsbactin a use FbsIJK in combination with the nrps module fbsefgh we also demonstrate chemoenzymatic conversion of synthetic ahPutr to fimsbactin a use fbsefgh and establish the substrate selectivity for the nrps adenylation domain in fbsh dhb and fbsf lSer we assign a role for the type ii thioesterase fbsm in produce the shunt metabolite 223 dihydroxypheny l45dihydrooxazole4carboxylic acid dhboxa via cleavage of the corresponding thioester intermediate that be tether to nrps peptidyl carrier domain during biosynthetic assembly we propose a mechanism for branch nrpsderived peptide via amide and ester linkage via the dynamic equilibration of inidhbser and ioidhbser thioester intermediate via hydrolysis of dhboxa thioester intermediate we also propose a genetic signature for nrps branch in the presence of a terminating ctc motif FbsG	2022 Oct	Jinping Yang, Timothy A Wencewicz	ACS Chem Biol
36876192	total synthesis of a pentasaccharide ioiglycan from iAcinetobacter baumanniii	iAcinetobacter baumanniii be a gramnegative bacterium associate with drug resistance and infection in healthcare setting a understanding of both the biological role and antigenicity of surface molecule of this organism may provide a important step in the prevention and treatment of infection through vaccination or the development of monoclonal antibody with this in mind we have perform the multistep synthesis of a conjugationready pentasaccharide ioiglycan from iA baumanniii with a long linear synthetic sequence of 19 step this target be particularly relevant due to its role in both fitness and virulence across a apparently broad range of clinically relevant strain synthetic challenge include formulating a effective protect group scheme as well as the installation of a particularly difficult glycosidic linkage between the anomeric position of a 23 diacetamido23dideoxydglucuronic acid and the 4position of Dgalactose	2022 Dec	Dancan K Njeri, Justin R Ragains	European J Org Chem
36680270	biological property of 12 newly isolated iAcinetobacter baumanniiiSpecific bacteriophage	infection with the opportunistic gramnegative bacterium iAcinetobacter baumanniii pose a serious threat today which be aggravate by the grow problem of multidrug resistance among bacterium cause by the overuse of antibiotic treatment of infection cause by antibioticresistant iA baumanniii strain with the use of phage therapy be not only a promise alternative but sometimes the only option therefore phage specific for clinical multidrug resistant iA baumanniii be search for in environmental municipal and hospital wastewater sample collect from different location in Poland the conduct research allow we to determine the biological property and morphology of the test phage as a result of we research 12 phage specific for iA baumanniii 11 of which turn out to be temperate and only one lytic be isolate they lytic spectra rang from 11 to 75 the plaque form by most phage be small and transparent while one of they form relatively large plaque with a clearly mark halo effect base on transmission electron microscopy tem most of we phage have be classify as siphoviruse only one phage be classify as a podovirus all phage have icosahedral capsid symmetry and 11 of they have a long tail optimal multiplicity of infection moi and the adsorption rate be also determine moi value varied depend on the phagefrom 0001 to 10 base on similarity to know bacteriophage we iA baumanniiispecific phage have be propose to belong to the ibeijerinckvirinaei and bjunivirinae subfamily this study provide a additional tool in the fight against this important pathogen and may boost the interest in phage therapy as a alternative and supplement to the current antibiotic	2023 Jan	Natalia Bagińska, Marek Adam Harhala, Martyna Cieślik, Filip Orwat, Beata Weber-Dąbrowska, Krystyna Dąbrowska, Andrzej Górski, Ewa Jończyk-Matysiak	Viruses
36718445	extensively drugresistant iAcinetobacter baumanniii role of conjugative plasmid in transfer resistance	iAcinetobacter baumanniii be one of the most successful pathogen that can cause difficulttotreat nosocomial infection Outbreak and infection cause by multidrug resistant iA baumanniii be prevalent worldwide with only a few antibiotic be currently available for treatment plasmid represent a ideal vehicle for acquire and transfer resistance gene in iA baumanniii five extensively drugresistant iA baumanniii clinical isolate from three major jordanian hospital be fully sequence wholegenome sequence wgs be use to study the antimicrobial resistance and virulence gene sequence type and phylogenetic relationship of the isolate plasmid be characterize iinsilicoi follow by conjugation and plasmid curing experiment eight plasmid be recover resistance plasmid carry either aminoglycoside or sulfonamide gene be detect Chromosomal resistance gene include iblasuboxa66 sub blasuboxa91sub and blasuboXA23subi and the detect virulence factor be involve in biofilm formation adhesion and many other mechanism conjugation and plasmid curing experiment result in the transfer or loss of several resistance phenotype plasmid profiling along with phylogenetic analysis reveal high similarity between two iA baumanniii isolate recover from two different intensive care unit icu the high similarity between the isolate of the study especially the two icu isolate suggest that there be a common iA baumanniii strain prevail in different icu ward in jordanian hospital three resistance gene be plasmidborne and the transfer of the resistance phenotype emphasize the role and importance of conjugative plasmid in spread resistance among iA baumanniii clinical strain	2023	Qutaiba Ababneh, Sara Al Sbei, Ziad Jaradat, Sebawe Syaj, Neda'a Aldaken, Hamza Ababneh, Zeina Inaya	PeerJ
36089583	Metformin reverse minocycline to inhibit minocyclineresistant acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro	acinetobacter baumannii a baumannii be a opportunistic pathogen and have emerge as one of the most troublesome pathogen drug resistance in a baumannii have be report on a global scale minocycline be find to be active against multidrug resistant a baumannii and be approve by the FDA for the infection cause by sensitive strain of a baumannii however the emergence of minocycline resistance and its toxic effect still need to be address therefore this study aim to evaluate the synergistic effect of metformin combine with minocycline on minocyclineresistant a baumannii	2022 Sep	Tingting Guo, Xiaoli Sun, Jie Yang, Liying Yang, Mengying Li, Yuhang Wang, Hongmei Jiao, Guocai Li	BMC Microbiol
35639112	molecular epidemiology of CarbapenemResistant iAcinetobacter baumanniii in the United State 20132017	healthcareassociated carbapenemresistant iAcinetobacter baumanniii CRAB infection be a serious threat associate with global epidemic clone and a variety of carbapenemase gene class in this study we describe the molecular epidemiology include wholegenome sequencing analysis and antimicrobial susceptibility profile of 92 select nonredundant CRAB collect through public health effort in the United State from 2013 to 2017 among the 92 isolate the Oxford OX multilocus sequence type scheme identify 30 sequence type STs the majority of isolate ini 59 64 represent STs belong to the international clonal complex 92 cc92suboxsub among this st208suboxsub ini 21 and st281suboxsub ini 20 be the most common all isolate carry a oxatype carbapenemase gene comprise 20 allele ninety isolate 98 encode a intrinsic oxa51 like enzyme 67 73 harbor a additional acquire iblaisubOXAsub gene most commonly iblaisuboxa23 sub ini 45 49 compare with isolate harbor only intrinsic oxacillinase gene acquire iblaisubOXAsub gene presence be associate with high prevalence of resistance and a high median minimum inhibitory concentration to the carbapenem imipenem 64 μgmL versus 8 μgmL and antibiotic from other drug class include penicillin aminoglycoside cephalosporin and polymyxin this datum illustrate the wide distribution of cc92suboxsub and high prevalence of acquire iblaisubOXAsub carbapenemase gene among CRAB in the United State	2022 Jun	Susannah L McKay, Nicholas Vlachos, Jonathan B Daniels, Valerie S Albrecht, Valerie A Stevens, J Kamile Rasheed, J Kristie Johnson, Joseph D Lutgring, Maria Sjölund-Karlsson, Alison Laufer Halpin	Microb Drug Resist
36472426	detection and type of plasmid in acinetobacter baumannii use irep gene encoding replication initiation protein	plasmid find in acinetobacter species contribute to the spread of antibiotic resistance gene they appear to be largely confine to this genus and cannot be type with available tool and database here a method for distinguishing and type this plasmid be develop use a curate nonredundant set of 621 complete sequence of plasmid from acinetobacter baumannii plasmid be separate into 3 group base on the Pfam domain of the encode replication initiation rep protein and a fourth group that lack a identifiable rep protein the irep gene of each repencoding group ini 13 rep1 ini 107 repprict ini 351 rep3 be then cluster use a threshold of 95 nucleotide identity to define 80 distinct type five rep1 subgroup designate r1t1 to r1t5 be identify and a sixth report recently be add each r1 type corresponded to a conserved small plasmid sequence the repprict plasmid fall into 5 subgroup designate RPT1 to rpt5 and the rep3 plasmid comprise 69 distinct type r3t1 to r3t69 three r1 2 rp and 32 R3 type be represent by only a single plasmid over half of the plasmid belong to the 4 most abundant type the RPT1 plasmid ini 97 which include conjugation gene and be often associate with various acquire antibiotic resistance gene and r3t1 r3t2 and r3t3 ini 95 30 and 45 respectively to facilitate type and the identification of plasmid in draft genome use this framework we establish the acinetobacter type database contain representative nucleotide and protein sequence of the type marker httpsgithubcommehradhamidianacinetobacterplasmidtyping bimportanceb though they contribute to the dissemination of gene that confer resistance to clinically important carbapenem and aminoglycoside antibiotic use to treat lifethreatening acinetobacter baumannii infection plasmid find in acinetobacter species have not be well study as this plasmid do not resemble that find in other gramnegative pathogen available type system be unsuitable the plasmid type system develop for a baumannii plasmid with a identifiable irep gene will facilitate the classification and tracking of sequence plasmid it will also enable the detection of plasmidderive contigs present in draft genome that be widely ignore currently hence it will assist in the tracking of resistance gene and other gene that affect survival in the environment as they spread through the population as identical or similar plasmid have be find in other acinetobacter species the type system will also be broadly applicable in identify plasmid in other member of the genus	2023 Feb	Margaret M C Lam, Jonathan Koong, Kathryn E Holt, Ruth M Hall, Mehrad Hamidian	Microbiol Spectr
36106080	Cinnamaldehyde derivative act as antimicrobial agent against iAcinetobacter baumanniii through the inhibition of cell division	iAcinetobacter baumanniii be a pathogen with high intrinsic antimicrobial resistance while multidrug resistant MDR and extensively drug resistant XDR strain of this pathogen be emerge treatment option for infection by this strain be very limited hence new therapy be urgently need the bacterial cell division protein ftsr be a promise drug target for the development of novel antimicrobial agent we have previously report limited activity of cinnamaldehyde analog against iEscherichia colii in this study we have determine the antimicrobial activity of six cinnamaldehyde analog for antimicrobial activity against iA baumanniii Microscopic analysis be perform to determine if the compound inhibit cell division the ontarget effect of the compound be assess by analyze they effect on polymerization and on the GTPase activity of purify ftsr from iA baumanniii iin silicoi docking be use to assess the bind of cinnamaldehyde analog finally iin vivoi and iin vitroi safety assay be perform all six compound display antibacterial activity against the critical priority pathogen iA baumanniii with 4 bromophenylsubstituted b4b display the most potent antimicrobial activity mic 32 μgmL bioactivity be significantly increase in the presence of a efflux pump inhibitor for iA baumanniii atcc 19606 up to 32 fold and significantly for extensively drug resistant UW 5075 great than 4fold suggest that efflux contribute to the intrinsic resistance of iA baumanniii against this agent the compound inhibit cell division in iA baumanniii as observe by the elongate phenotype and target the ftsr protein as see from the inhibition of polymerization and GTPase activity iin silicoi docking predict that the compound bind in the interdomain cleft adjacent to the h7 core helix dichlorinated b6 b be devoid of hemolytic activity and cytotoxicity against mammalian cell iin vitroi as well as adverse activity in a iCaenorhabditis elegansi nematode model iin vivoi together this finding present halogenate analog b4 b and b6 b as promise candidate for further development as antimicrobial agent aim at combating iA baumanniii this be also the first report of ftsZtargeting compound with activity against a XDR iA baumanniii strain	2022	Wern Chern Chai, Jonathan J Whittall, Steven W Polyak, Klyie Foo, Xin Li, Cameron J Dutschke, Abiodun D Ogunniyi, Shutao Ma, Matthew J Sykes, Susan J Semple, Henrietta Venter	Front Microbiol
35633297	Auranofin promote antibacterial effect of doripenem against carbapenemresistant acinetobacter baumannii	this study be perform to identify the potential for repurposing auranofin as a antibiotic adjuvant against carbapenemaseproducing acinetobacter baumannii	2022 Sep	Hye-Rim Kim, Yong-Bin Eom	J Appl Microbiol
36614160	application of antimicrobial Photodynamic therapy for Inactivation of iAcinetobacter baumanniii biofilm	iAcinetobacter baumanniii be a dangerous hospital pathogen primarily due to its ability to form biofilm on different abiotic and biotic surface the present study investigate the effect of riboflavin and chlorophyllinbased antimicrobial photodynamic therapy perform with nearultraviolet or blue light on the viability of bacterial cell in biofilm and they structural stability also determine the extent of photoinduce generation of intracellular reactive oxygen species as well as the ability of iA baumanniii to form biofilm after the treatment the efficacy of antimicrobial photodynamic therapy be compare with that of light alone and the role of the photosensitizer type on the photosensitization mechanism be demonstrate we find that the antibacterial effect of riboflavinbased antimicrobial photodynamic therapy depend on the ability of photoactivated riboflavin to generate intracellular reactive oxygen species but do not depend on the concentration of riboflavin and preincubation time before irradiation moreover we result suggest a clear interconnection between the inactivation efficiency of chlorophyllinbased antimicrobial photodynamic therapy and the sensitivity of iA baumanniii biofilm to use light in summary all the analyze result suggest that riboflavinbased antimicrobial photodynamic therapy and chlorophyllinbased antimicrobial photodynamic therapy have the potential to be apply as a antibacterial treatment against iA baumanniii biofilm or as a preventive measure against biofilm formation	2022 Dec	Irina Buchovec, Enrika Vyčaitė, Kazimieras Badokas, Edita Sužiedelienė, Saulius Bagdonas	Int J Mol Sci
36106853	a unprecedented tolerance to deletion of the periplasmic chaperone SurA skp and degp in the Nosocomial pathogen acinetobacter baumannii	the outer membrane om of gramnegative bacterium efficiently protect from harmful environmental stress such as antibiotic disinfectant or dryness the main constituent of the om be integral om βbarrel protein omp in gramnegative bacterium such as Escherichia coli yersinia enterocolitica and pseudomonas aeruginosa the insertion of omp depend on a sophisticated biogenesis pathway this comprise the secyeg translocon which enable inner membrane IM passage the chaperone SurA skp and degp which facilitate the passage of βbarrel omp through the periplasm and the βbarrel assembly machinery bam which facilitate insertion into the om in E coli Y enterocolitica and p aeruginosa the deletion of SurA be particularly detrimental and lead to a loss of om integrity sensitization to antibiotic treatment and reduce virulence in search of target that could be exploit to develop compound that interfere with om integrity in acinetobacter baumannii we employ the multidrugresistant strain ab5075 to generate single gene knockout strain lack individual periplasmic chaperone in contrast to E coli Y enterocolitica and p aeruginosa ab5075 tolerate the lack of SurA skp or degp with only weak mutant phenotype while the double knockout strain ΔisurAiΔiskpi and ΔisurAiΔidegPi be conditionally lethal in E coli all double deletion be well tolerate by ab5075 strikingly even a tripleknockout strain of ab5075 lack isurai iskpi and idegPi be viable bimportanceb acinetobacter baumannii be a major threat to human health due to its ability to persist in the hospital environment resistance to antibiotic treatment and ability to deploy multiple and redundant virulence factor in a rise number of case infection with multidrugresistant a baumannii end up fatally because all antibiotic treatment option fail thus novel target have to be identify and alternative therapeutics have to be develop the knockout of periplasmic chaperone have previously prove to significantly reduce virulence and even break antibiotic resistance in other gramnegative pathogen we study in a baumannii demonstrate how variable the importance of the periplasmic chaperone SurA skp and degp can be and suggest the existence of mechanism allow a baumannii to cope with the lack of the three periplasmic chaperone	2022 Oct	Karolin Birkle, Fabian Renschler, Angel Angelov, Gottfried Wilharm, Mirita Franz-Wachtel, Boris Maček, Erwin Bohn, Elena Weber, Jennifer Müller, Lea Friedrich, Monika Schütz	J Bacteriol
36179976	bovine skin fibroblast mediate immune response to defend against bovine acinetobacter baumannii infection	acinetobacter baumannii a baumannii be a opportunistic pathogen which can cause pneumonia sepsis and infection of skin and soft tissue the host mostly rely on innate immune response to defend against the infection of a baumannii currently it have be confirm that fibroblast involve in innate immune response therefore to explore how bovine skin fibroblast mediate immune response to defend against a baumannii infection we analyze the differential transcript datum of bovine skin fibroblast infect with bovine a baumannii by rNAsequencing rnaseq we find that there be 3014 differentially express gene deg at 14h with bovine a baumannii infection include 1940 upregulate gene and 1074 downregulated gene gene ontology go enrichment show that ubiquitin protein ligase bind IL6 receptor complex erk1 and erk2 cascade term be mainly enrich Kyoto Encyclopedia of gene and genome kegh enrichment show that innate immune pathway be significantly enrich such as tnf il17 nlr mapk nfκb endocytosis apoptosis and hif1 signal pathway furthermore gene set enrichment Analysis GSEA reveal that go term such as chemokine receptor bind and th17 cell differentiation and kegh pathway such as tlr and cytokinecytokine receptor interaction pathway be upregulate in addition casp3 and JUN be the core functional gene of apoptosis while IL6 erbb2 egfr CHUK and mapk8 be the core functional gene of immunity by ProteinProtein interaction ppi analysis we study provide a indepth understanding of the molecular mechanism of fibroblast against a baumannii infection it also lay the foundation for the development of new therapeutic target for the disease cause by a baumannii infection and formulate effective therapeutic strategy for the prevention and control of the disease cause by a baumannii	2022 Dec	Simeng Hou, Haotian Wu, Si Chen, Xubo Li, Zhenxing Zhang, Yiwen Cheng, Yuanyuan Chen, Meirong He, Qi An, Churiga Man, Li Du, Qiaoling Chen, Fengyang Wang	Microb Pathog
35947200	Characterization of sequence type and mechanism of resistance to tigecycline among acinetobacter baumannii isolated from Children	the present study aim to investigate the mechanism of resistance to tigecycline and to determine sequence type of acinetobacter baumannii isolate recover from child use the multilocus sequence type mlst a total of 74 a baumannii isolate be recover from patient at one of the child hospital in Tehran Iran antimicrobial susceptibility testing of the isolate be perform for different class of antibiotic and minimum inhibitory concentration of colistin and tigecycline be determine use broth microdilution method and etest strip respectively the presence of isaba1 abar tet39 and tetX and the expression of adeB adeg and adeJ efflux pump gene be measure use polymerase Chain reaction pcr and quantitative realtime pcr rtpcr respectively the diversity of mutation across the regulatory gene of RND efflux pump aders adeL and aden and trm gene be determine use they pcr amplification and DNA sequencing in tigecyclineresistant isolate in addition STs of tigecyclineresistant isolate be determine use mlst method three a baumannii isolate be resistant to tigecycline several amino acid substitution be identify in ader aden and Trm but no alteration be find in adel nevertheless adeB adeg and adeJ overexpression be observe in 1 2 and 1 isolate respectively the tigecyclineresistant isolate belong to st1720 and st2285 this be the first study report on st2285 in a baumannii population among 74 isolate two tigecycline susceptible isolate carry tet39 gene but no tetX gene be detect we conclude that mutation in regulatory gene of RND efflux pump and the trm gene may play some important role in a baumannii resistance to tigecycline	2022 Aug	Zohreh Ghalavand, Gita Eslami, Ali Hashemi, Mehrzad Sadredinamin, Neda Yousefi, Razieh Dehbanipour	Curr Microbiol
37151210	Outer membrane vesiclecoated nanoparticle vaccine protect against iAcinetobacter baumanniii Pneumonia and sepsis	the highly multidrugresistant MDR gramnegative bacterial pathogen iAcinetobacter baumanniii be a top global health priority where a effective vaccine could protect susceptible population and limit resistance acquisition Outer membrane vesicle omv shed from gramnegative bacterium be enrich with virulence factor and membrane lipid but heterogeneous in size and cargo we report a vaccine platform combine precise and replicable nanoparticle technology with immunogenic iA baumanniii omv abomv Gold nanoparticle core coat with abomv abnp induce robust IgG titer in rabbit that enhance human neutrophil opsonophagocytic kill and passively protect against lethal iA baumanniii sepsis in mouse Active abnp immunization in mouse protect against sepsis and pneumonia accompany by B cell recruitment to drain lymph node activation of dendritic cell marker improve splenic neutrophil response and mitigation of proinflammatory cytokine storm nanoparticle be a efficient and efficacious platform for OMV vaccine delivery against iA baumanniii and perhaps other highpriority MDR pathogen	2023 Feb	Elisabet Bjanes, Jiarong Zhou, Tariq Qayum, Nishta Krishnan, Raymond H Zurich, Nitasha D Menon, Alexandria Hoffman, Ronnie H Fang, Liangfang Zhang, Victor Nizet	Adv Nanobiomed Res
36605106	intensification in genetic information and Acquisition of resistant gene in genome of iAcinetobacter baumanniii a pangenomic Analysis	iAcinetobacter baumanniii iA baumanniii attribute 26 of the mortality rate in hospitalize patient and the percentage can rise to 46 in patient admit to icu as it be a major cause of ventilatorassociated pneumonia it have be nominate as the critical priority organism by who for which new therapeutic drug be urgently require to understand the genomic identification of different strain antimicrobial resistance pattern and epidemiological type of organism wholegenome sequencing wgs analysis provide insight to explore new epitope to develop new drug against the organism therefore the study be aim at investigate the whole genome sequence of iA baumanniii strain to report the new intensification in its genomic profile the genome sequence be retrieve from the ncbi database system pangenome bpga bacterial pangenome Analysis tool be use to analyze the core pan and speciesspecific genome analysis the pan and core genome curve be extrapolate use the empirical power law equation ifiixi iaiixbi and the exponential equation ifi1ixi iciiei idiixi to identify the resistant gene with resistant mutation against antibiotic resfinder and galaxy Community hub bioinformatic tool be use accord to pangenome analysis there be 2227 core gene present in each species of the iA baumanniii genome furthermore the number of accessory gene rang from 1182 to 1460 and the unique gene in the genome be 931 there be 325 exclusively absent gene in the genome of iAcinetobacter baumanniii the pangenome analysis show that there be a 5 fold increase in the genome of iA baumanniii in 5 year and the genome be still open there be the addition of multiple unique gene among they gene participate in the function of information and processing be increase	2022	Akhtar Ali, Ambrina Khatoon, Talat Mirza, Farah Ahmad	Biomed Res Int
36619166	the iAcinetobacter baumanniii model can explain the role of small noncoding RNAs as potential mediator of hostpathogen interaction	bacterial small RNAs srna research have accelerate over the past decade boost by advance in rnaseq technology and methodology for capture both proteinRNA and rnarna interaction the emerge picture be that this regulatory srna play important role in control complex physiological process and be require to survive the antimicrobial challenge in recent year the RNA content of ommses have also gain increase attention particularly in the context of infection secreted RNAs from several bacterial pathogen have be characterize but the exact mechanism promote pathogenicity remain elusive in this review we briefly discuss how secreted srna interact with target in infect cell thus represent a novel perspective of host cell manipulation during bacterial infection during the last decade iAcinetobacter baumanniii become clinically relevant emerge pathogen responsible for nosocomial and communityacquired infection therefore we also summarize recent finding of regulation by srna in iA baumanniii and discuss how this emerge bacterium utilize many of this srna to adapt to its niche and become successful human pathogen	2022	Meysam Sarshar, Daniela Scribano, Anna Teresa Palamara, Cecilia Ambrosi, Andrea Masotti	Front Mol Biosci
36581226	antibacterial activity of silver nanoparticle functionalize with amikacin apply against multidrugresistant acinetobacter baumannii	multidrugresistant bacterium be one of the world big health problem therefore improve the spectrum of action of antibiotic could be necessary to reverse this situation amikacin and silver salt have wellknown antimicrobial property however both drug lose they effectiveness against some bacterium such as acinetobacter baumannii this work aim to develop a nanodrug from silver nanoparticle agsp functionalize with amikacin against multidrugresistant acinetobacter baumannii	2022 Dec	Larissa de O Camargo, Inglid Fontoura, Thaís S Veriato, Leandro Raniero, Maiara L Castilho	Am J Infect Control
36710969	role of peptidoglycan recycle enzyme ampd and AnmK in iAcinetobacter baumanniii virulence feature	iAcinetobacter baumanniii be a important causative agent of hospital acquire infection in addition to acquire resistance to many currentlyavailable antibiotic it be intrinsically resistant to fosfomycin it have previously be show that ampd and AnmK contribute to intrinsic fosfomycin resistance in iA baumanniii due to they involvement in the peptidoglycan recycle pathway however the role that this two enzyme play in the fitness and virulence of iA baumanniii have not be study the aim of this study be to characterize several virulencerelated phenotypic trait in iA baumanniii mutant lack ampd and AnmK specifically cell morphology peptidoglycan thickness membrane permeability growth under ironlimiting condition fitness resistance to disinfectant and antimicrobial agent twitching motility and biofilm formation of the mutant strain iA baumanniii atcc 17978 ΔiampDiKan and ΔianmKiKan be compare to the wild type strain we result demonstrate that bacterial growth and fitness of both mutant be compromise especially in the ΔiampDiKan mutant in addition biofilm formation be decrease by up to 69 whereas twitching movement be reduce by about 80 in both mutant this result demonstrate that in addition to increase susceptibility to fosfomycin alteration of the peptidoglycan recycle pathway affect multiple aspect related to virulence inhibition of this enzyme could be explore as a strategy to develop novel treatment for iA baumanniii in the future furthermore this study establish a link between intrinsic fosfomycin resistance mechanism and bacterial fitness and virulence trait	2022	Ana Tajuelo, María C Terrón, Mireia López-Siles, Michael J McConnell	Front Cell Infect Microbiol
34265885	antibiofilm action of ipersea americanas glycolic extract over iAcinetobacter baumanniii and absence of toxicity in iGalleria mellonellai	this study aim to evaluate the antibiofilm activity and toxicity of the glycolic extract of ipersea americanas ip americanas over multidrugresistant strain of iAcinetobacter baumannii a baumanniii as alternative therapy to be investigate	2022 Dec	Sabrina Ferreira Dos Santos Liberato, Mariana Raquel da Cruz Vegian, Amjad Abu Hasna, Janaína Araújo de Alvarenga, Juliana Guimarães Dos Santos, Ítalo Rigotti Pereira Tini, Isabela Amêndola, Juliana Campos Junqueira, Luciane Dias de Oliveira	J Complement Integr Med
37110301	phenotypic and molecular characteristic of CarbapenemResistant iAcinetobacter baumanniii isolate from bulgarian intensive Care unit patient	Carbapenemresistant iAcinetobacter baumanniii CRAB be designate as a urgent public health threat both due to its remarkable multidrug resistance and propensity for clonal spread this study aim to explore the phenotypic and molecular characteristic of antimicrobial resistance in CRAB isolate ini 73 from intensive care unit icu patient in two university hospital in Bulgaria 20182019 the methodology include antimicrobial susceptibility testing pcr wholegenome sequencing wgs and phylogenomic analysis the resistance rate be as follow imipenem 100 meropenem 100 amikacin 986 gentamicin 89 tobramycin 863 levofloxacin 100 trimethoprimsulfamethoxazole 753 tigecycline 863 colistin 0 and ampicillinsulbactam 137 all isolate harbor iblaisuboxa51 likesub gene the frequency of distribution of other antimicrobial resistance gene ARGs be iblaisuboxa23 likesub 986 iblaisubOXA2440 likesub 27 iarmAi 863 and isul1i 753 the wgs of select extensively drugresistant iA baumanniii xdrab isolate ini 3 reveal the presence of oxa23 and oxa66 carbapenemhydrolyzing class D βlactamase in all isolate and oxa72 carbapenemase in one of they various insertion sequency such as isiaba24i isiaba31i isiaba125i iSiVsa3i ISi17 I and isi6100i be also detect provide increase ability for horizontal transfer of ARGs the isolate belong to the widespread highrisk sequence type ST2 ini 2 and st636 ini 1 pasteur scheme we result show the presence of xdrab isolate carry a variety of ARGs in bulgarian icu setting which highlight the crucial need for nationwide surveillance especially in the condition of extensive antibiotic usage during covid19	2023 Mar	Tanya V Strateva, Ivo Sirakov, Temenuga J Stoeva, Alexander Stratev, Slavil Peykov	Microorganisms
35982877	a microbiological Study of iAcinetobacter calcoaceticus baumanniii with special reference to Multidrug resistance	bintroductionb the outbreak of iAcinetobacter calcoaceticus baumanniii iacbi be mainly report to be a notorious pathogen at healthcare setting it be the major problem on the healthcare system with high morbidity and mortality rate because of the broad range of antibiotic resistance and lack of understanding the mechanism of develop new antibiotic resistance rapidly it emphasize the importance of local surveillance in describe or understanding and predict microbial resistance pattern so that there will be limited use of antibiotic by develop strategy to control the extensive use of antimicrobial chemotherapy in clinical environment which be still consider as one of the factor in the emergence of multidrug resistance microorganism bObjectivesb the study aim to detect the occurrence rate of iacbi infection from various clinical sample identify the resistance level to different group of antimicrobial agent and the occurrence rate of multidrug resistant MDR iacbi clinical isolate from a tertiary hospital in durgapur West Bengal India bmaterial and methodsb the study be perform in the Department of microbiology of the IQ City Medical College and Hospital durgapur West Bengal India for the 24 month duration that be from January 1 2018 to December 31 2019 altogether 15800 clinical sample consisting of endotracheal tube aspirate sputum pus blood catheter tip urine tissue and other body fluid be study iacbi from clinical sample be identify by its characteristic colony nonlactose fermenting glisten small mucoid colony gramstaining pattern gramnegative coccobacillus and standard biochemical reaction it be further confirm in the Department of microbiology of the healthworld Hospital durgapur West Bengal India by vitek2 compact system biomerieux Inc Durham North Carolina United State antibiotic susceptibility testing be perform use automated broth microdilution by vitek2 compact system biomerieux Inc and kirbybauer disk diffusion test on muellerhinton agar HiMedia bResultsb Nonrepetitive 289 iacbi be isolate from various clinical sample a total of 277 96 isolate of iacbi be MDR strain bConclusionb iacbi be mostly isolate from the intensive care unit department and be find to be the most MDR type in the tertiary care hospital by this study	2022 Jun	Langamba Angom Longjam, Dechen Chomu Tsering, Dipmala Das	J Lab Physicians
36079137	the burden of CarbapenemResistant iAcinetobacter baumanniii in icu covid19 patient a Regional experience	since the beginning of the covid19 pandemic the impact of superinfection in intensive care unit icus have progressively increase especially carbapenemresistant acinetobacter baumannii CRAb this observational multicenter retrospective study be design to investigate the characteristic of covid19 icu patient develop CRAb colonizationinfection during a icu stay and evaluate mortality risk factor in a regional icu network a total of 913 covid19 patient be admit to the participate icus 19 become positive for CRAb either colonization or infection and 176 the icu mortality rate in CRAb patient be 647 on average patient develop colonization or infection within 10 ± 84 day from icu admission score of sap ii and sofa be significantly high in the decease patient 438 ± 135 p 0006 and 95 ± 36 p 0001 respectively the mortality rate be significantly high in patient with extracorporeal membrane oxygenation 12 7 p 003 septic shock 61 35 p 0001 and in elder 66 ± 10 p 0001 among the 176 patient 129 73 have invasive infection with CRAb 105 607 ventilator Associated Pneumonia vap and 46 266 bloodstream infection BSIs in 22 case 65 vap be associate with concomitant BSI Colonization be report in 165 patient 937 mortality be significantly high in patient with vap p 0009 colonize patient who do not develop invasive infection have a high survival rate p 0001 be colonize by CRAb be associate with a high risk of develop invasive infection p 0001 in a multivariate analysis risk factor significantly associate with mortality be age or 1070 95 CI 1028 −1115 p 0001 and CRAb colonization or 5463 ic95 1572−18988 p 0008 constant infectioncontrol measure be necessary to stop the spread of a baumannii in the hospital environment especially at this time of the sarscov2 pandemic with active surveillance culture and the efficient performance of a multidisciplinary team	2022 Sep	Giorgia Montrucchio, Silvia Corcione, Tommaso Lupia, Nour Shbaklo, Carlo Olivieri, Miriam Poggioli, Aline Pagni, Davide Colombo, Agostino Roasio, Stefano Bosso, Fabrizio Racca, Valeria Bonato, Francesco Della Corte, Stefania Guido, Andrea Della Selva, Enrico Ravera, Nicoletta Barzaghi, Martina Cerrano, Pietro Caironi, Giacomo Berta, Cecilia Casalini, Bruno Scapino, Michele Grio, Massimiliano Parlanti Garbero, Gabriella Buono, Federico Finessi, Simona Erbetta, Paola Federica Sciacca, Gilberto Fiore, Alessandro Cerutti, Sergio Livigni, Daniela Silengo, Fulvio Agostini, Maurizio Berardino, Mauro Navarra, Silvia Vendramin, Enzo Castenetto, Marco Maria Liccardi, Emilpaolo Manno, Luca Brazzi, Francesco Giuseppe De Rosa	J Clin Med
35685727	polymyxin B cefoperazone sodiumsulbactam sodium and tigecycline against multidrugresistant iAcinetobacter baumanniii Pneumonia	the purpose of this study be to investigate the significance of polymyxin B in combination with cefoperazone sodiumsulbactam sodium CSSS and tigecycline for the treatment of multidrugresistant iAcinetobacter baumanniii mdrab induce pneumonia on the level of white blood cell wbc count serum Creactive protein CRP and procalcitonin pct	2022	Guangxue Hu, Wanzong Liu, Mali Wang	Evid Based Complement Alternat Med
36108779	biophysical mechanism of dehydrate membrane of acinetobacter baumannii link to droughtresistance	acinetobacter baumanni be a opportunistic nosocomial multidrug resistant bacterium which represent a threat for human health this pathogen be able to persist in intensive care unit thanks to its extraordinary resistance towards dehydration whose mechanism be unknown and enable it to easily spread through surface contaminating also medical device in this article we reveal with a multimodal approach base on μR spectroscopy Gas Chromatography couple to mass spectroscopy Atomic Force microscopy and fluorescence recovery after photobleach the biophysical mechanism that the membrane of two a baumannii strain undergo during dehydration showing a substantial decoupling of the phase transition from liquid crystalline to gel phase from evidence of cell lysis such decoupling may be the core of the resistance of a baumannii against dehydration and highlight the different ability to resist to drought between strain	2022 Dec	Elisa Fardelli, Massimiliano Lucidi, Michael Di Gioacchino, Shadi Bashiri, Luca Persichetti, Giulia Capecchi, Tecla Gasperi, Armida Sodo, Paolo Visca, Giovanni Capellini	Biochim Biophys Acta Biomembr
36049792	epidemiology of carbapenem resistant acinetobacter baumannii in New Zealand	carbapenem resistant acinetobacter baumannii have limited treatment option and a propensity to cause hospital outbreak in recent year a increase in they detection have be observe in New Zealand this study aim to describe the molecular epidemiology of this isolate	2022 Sep	Matthew R Blakiston, Mark B Schultz, Indira Basu, Susan A Ballard, Deborah Williamson, Sally Roberts	N Z Med J
35748948	phagescorebased analysis of acinetobacter baumannii infecting phage antibiotic interaction in liquid medium	the grow interest in bacteriophage and antibiotic combine use pose new challenge regard this phenomenon accurate description this study aim to apply the phagescore methodology to assess the phageantibiotic combination activity in liquid bacterial culture for this purpose previously describe acinetobacter infecting phage vbabapagc01 Aba1 and Aba4 and antibiotic gentamicin ciprofloxacin meropenem norfloxacin and fosfomycin be use to obtain a lysis curve of bacteriophage under antibiotic pressure the experimental datum be analyze use the fractional Inhibitory Concentration index FICI and phagescore methodology the result obtain by this method clearly show difference between phage lytic activity after antibiotic addition thus we present the potential use of the phagescore method as a tool for characterize the phage antibiotic synergy in liquid culture further the optimization of the phagescore for this purpose can help compare antibiotic and they outcome on bacteriophage lytic activity	2022 Jun	Bartłomiej Grygorcewicz, Marta Roszak, Rafał Rakoczy, Adrian Augustyniak, Maciej Konopacki, Joanna Jabłońska, Natalia Serwin, Elżbieta Cecerska-Heryć, Marian Kordas, Katarzyna Galant, Barbara Dołęgowska	Arch Microbiol
36289956	evaluating the efficacy of Eravacycline and omadacycline against extensively DrugResistant iAcinetobacter baumanniii patient isolate	for decade the spread of multidrugresistant MDR iAcinetobacter baumanniii have be rampant in critically ill hospitalize patient traditional antibiotic therapy against this pathogen have be fail lead to rise concern over management option for patient two new antibiotic eravacycline and omadacycline be introduce to the market and have show promise result in the treatment of gramnegative infection since this drug be newly available there be limited in vitro datum about they effectiveness against MDR iA baumanniii or even susceptible strain here we examine the effectiveness of 22 standardofcare antibiotic eravacycline and omadacycline against susceptible and extensively drugresistant XDR iA baumanniii patient isolate from Cooper University Hospital furthermore we examine select combination of eravacycline or omadacycline with other antibiotic against a XDR strain we demonstrate that this collection of strain be largely resistant to monotherapy of carbapenem fluoroquinolone folate pathway antagonist cephalosporin and most tetracycline while clinical breakpoint datum be not available for eravacycline or omadacycline base on minimum inhibitory concentration eravacycline be highly effective against this strain the aminoglycoside amikacin alone and in combination with eravacycline or omadacycline yield the most promise result we comprehensive characterization offer direction in the treatment of this deadly infection in hospitalize patient	2022 Sep	Manas S Deolankar, Rachel A Carr, Rebecca Fliorent, Sean Roh, Henry Fraimow, Valerie J Carabetta	Antibiotics (Basel)
36985130	genomic diversity antimicrobial susceptibility and biofilm formation of Clinical iAcinetobacter baumanniii isolate from horse	iAcinetobacter a baumanniii be a opportunistic pathogen that cause severe infection in human and animal include horse the occurrence of dominant international clone ics frequent multidrug resistance and the capability to form biofilm be consider major factor in the successful spread of iA baumanniii in human and veterinary clinical environment since little be know about iA baumanniii isolate from horse we study 78 equine iA baumanniii isolate obtain from clinical sample between 2008 and 2020 for they antimicrobial resistance amr clonal distribution biofilmassociated gene bag and biofilmforming capability base on wholegenome sequence analysis ics multilocus ml and coregenome ml sequence type STs and amr gene be determine antimicrobial susceptibility testing be perform by microbroth dilution a crystal violet assay be use for biofilm quantification almost 372 of the isolate be assign to ic1 103 ic2 205 and ic3 64 overall the isolate reveal high genomic diversity we identify 51 different STs include 22 novel STs st1723st1744 and 34 variant of the intrinsic oxacillinase oxa include 8 novel variant oxa970 to oxa977 all isolate be resistant to ampicillin amoxicillinclavulanic acid cephalexin cefpodoxime and nitrofurantoin ic1ic3 isolate be also resistant to gentamicin enrofloxacin marbofloxacin tetracycline and trimethoprimsulfamethoxazole all isolate be susceptible to imipenem thirtyone multidrugresistant MDR isolate mainly accumulate in the ic1ic3 group in general this isolate show less biofilm formation ic1 250 ic2 184 ic3 150 than the group of nonic1ic3 isolate 584 isolate belong to the same iCsSt reveal identical bag pattern bag iblp1i be absent in all isolate whereas ibfmRi and ipgaai be present in all isolate at the level of the ic group the amr status be negatively correlate with the isolate ability to form a biofilm a considerable portion of equine iA baumanniii isolate reveal iCsSt that be globally present in human both a MDR phenotype and the capability to form biofilm might lead to therapeutic failure in equine medicine particularly due to the limited availability of license drug	2023 Feb	Johanna Rühl-Teichner, Lisa Jacobmeyer, Ursula Leidner, Torsten Semmler, Christa Ewers	Microorganisms
37018035	molecular characterization and comparative genomic analysis of iAcinetobacter baumanniii isolate from the community and the hospital a epidemiological study in segamat Malaysia	iAcinetobacter baumanniii be a common cause of multidrugresistant MDR nosocomial infection around the world however little be know about the persistence and dynamic of iA baumanniii in a healthy community this study investigate the role of the community as a prospective reservoir for iA baumanniii and explore possible link between hospital and community isolate a total of 12 independent iA baumanniii strain be isolate from human faecal sample from the community in segamat Malaysia in 2018 and 2019 another 15 be obtain in 2020 from patient at the colocated tertiary public hospital the antimicrobial resistance profile and biofilm formation ability be analyse and the relatedness of community and hospital isolate be determine use wholegenome sequencing wgs antibiotic profile analysis reveal that 12 out of 15 hospital isolate be MDR but none of the community isolate be MDR however phylogenetic analysis base on singlenucleotide polymorphism snp and a pangenome analysis of core gene show clustering between four community and two hospital strain such clustering of strain from two different setting base on they genome suggest that this strain could persist in both wgs reveal 41 potential resistance gene on average in the hospital strain but few ini32 be detect in the community strain in contrast 68 virulence gene be commonly see in strain from both source this study highlight the possible transmission threat to public health pose by virulent iA baumanniii present in the gut of asymptomatic individual in the community	2023 Apr	Nazmul Hasan Muzahid, Md Hamed Hussain, Marie Andrea Laetitia Huët, Jacky Dwiyanto, Tin Tin Su, Daniel Reidpath, Faizah Mustapha, Qasim Ayub, Hock Siew Tan, Sadequr Rahman	Microb Genom
36671295	in vitro Synergistic activity of antimicrobial combination against carbapenem and ColistinResistant iAcinetobacter baumanniii and iKlebsiella pneumoniae	Polymyxin be commonly use as the last resort for the treatment of MDR iAcinetobacter baumanniii and iKlebsiella pneumoniae nosocomial infection however apart from the already know toxicity issue resistance to this agent be emerge in the present study we assess the in vitro synergistic activity of antimicrobial combination against carbapenemresistant and colistinresistant iA baumanniii and iK pneumoniae in a effort to provide more option for they treatment two hundred iA baumanniii and one hundred and six iK pneumoniae single clinical isolate with resistance to carbapenem and colistin recover between 1 January 2021 and 31 July 2022 be include iA baumanniii be test by the mic test strip fixedratio method for combination of colistin with either meropenem or rifampicin or daptomycin iK pneumoniae be test for the combination of colistin with meropenem and ceftazidimeavibactam with aztreonam synergy be observe at 9899 for colistin and meropenem against iA baumanniii 9152 for colistin and rifampicin and 100 for colistin and daptomycin synergy be also observe at 7356 for colistin and meropenem against iK pneumoniae and and 93 for ceftazidimeavibactam with aztreonam the test antimicrobial combination present high synergy rate rendering they valuable option against iA baumanniii and iK pneumoniae infection	2023 Jan	Paraskevi Mantzana, Efthymia Protonotariou, Angeliki Kassomenaki, Georgios Meletis, Areti Tychala, Eirini Keskilidou, Maria Arhonti, Charikleia Katsanou, Aikaterini Daviti, Olga Vasilaki, Georgia Kagkalou, Lemonia Skoura	Antibiotics (Basel)
35625321	the specific capsule depolymerase of phage pmk34 sensitize iAcinetobacter baumanniii to serum killing	the rise antimicrobial resistance be particularly alarming for iAcinetobacter baumanniii call for the discovery and evaluation of alternative to treat iA baumanniii infection some bacteriophage produce a structural protein that depolymerize capsular exopolysaccharide such purify depolymerase be consider as novel antivirulence compound we identify and characterize a depolymerase dpomk34 from acinetobacter phage vbabappmk34 active against the clinical isolate iA baumanniii MK34 in silico analysis reveal a modular protein display a conserved nterminal domain for anchor to the phage tail and variable central and cterminal domain for enzymatic activity and specificity alphafoldmultilty predict a trimeric protein adopt a elongate structure due to a long αhelix a enzymatic βhelix domain and a hypervariable 4 amino acid hotspot in the most ultimate loop of the cterminal domain in contrast to the tail fiber of phage t3 this hypervariable hotspot appear unrelated with the primary receptor the functional characterization of dpomk34 reveal a mesophilic enzyme active up to 50 °C across a wide pH range 4 to 11 and specific for the capsule of iA baumanniii MK34 enzymatic degradation of the iA baumanniii MK34 capsule cause a significant drop in phage adsorption from 95 to 9 after 5 minute although lack intrinsic antibacterial activity dpomk34 render iA baumanniii MK34 fully susceptible to serum kill in a serum concentration dependent manner unlike phage pmk34 dpomk34 do not easily select for resistant mutant either against pmk34 or itself in sum dpomk34 be a potential antivirulence compound that can be include in a depolymerase cocktail to control difficult to treat iA baumanniii infection	2022 May	Karim Abdelkader, Diana Gutiérrez, Agnieszka Latka, Dimitri Boeckaerts, Zuzanna Drulis-Kawa, Bjorn Criel, Hans Gerstmans, Amal Safaan, Ahmed S Khairalla, Yasser Gaber, Tarek Dishisha, Yves Briers	Antibiotics (Basel)
36858180	intranasal immunization with outer membrane vesicle OMV protect against airway colonization and systemic infection with acinetobacter baumannii	the multidrugresistant bacterium acinetobacter baumannii be a major cause of hospitalassociated infection a vaccine could significantly reduce this burden the aim be to develop a clinically relevant model of a baumannii respiratory tract infection and to test the impact of different immunization route on protective immunity provide by a outer membrane vesicle OMV vaccine	2023 Jun	Sophie L Higham, Stephen Baker, Katie E Flight, Aishwarya Krishna, Paul Kellam, Stephen T Reece, John S Tregoning	J Infect
36606321	interaction of lytic phage t1245 with antibiotic for enhancement of antibacterial and antibiofilm efficacy against multidrugresistant iAcinetobacter baumanniii	biofilm associate with multidrugresistant MDR iAcinetobacter baumanniii on medical device remain a big clinical problem antibiotic susceptibility test be perform with eight commonly employ antibiotic against clinical isolate the effect of antibiotic in combination with wellcharacterized lytic phage t1245 be study to assess they antibacterial and antibiofilm efficacy ceftazidime colistin imipenem and meropenem significantly reduce bacterial density up to approximately 80 when combine with phage t1245 compare with control phage t1245 in combination with ceftazidime colistin and meropenem at subinhibitory concentration demonstrate significant reduction in biomass and bacterial viability of 3day establish biofilm compare with antibiotic alone in addition electron microscopy further confirm the disruption of biofilm structure and cell morphology upon treatment with phage t1245 and antibiotic include ceftazidime colistin and meropenem Combine treatment of phage t1245 with this antibiotic could be employ for the management of iA baumanniii infection and eradication of the bacterial biofilm	2022 Nov	Rosesathorn Soontarach, Ozioma Forstinus Nwabor, Supayang Piyawan Voravuthikunchai	Biofouling
36405598	phage derive lytic peptide a secret weapon against iAcinetobacter baumanniiiAn iin silicoi approach	iAcinetobacter baumanniii be a bacterial pathogen that be commonly associate with hospitalacquired illness antimicrobial drug resistance in iA baumanniii include several penicillin class first and secondgeneration cephalosporin cephamycin most aminoglycoside chloramphenicol and tetracycline the recent rise in multidrugresistant iA baumanniii strain have result in a increase in pneumoniae associate with ventilator urinary tract infection associate with the catheter and bloodstream infection all of which have increase complication in treatment cost of treatment and death small compound know as antimicrobial peptide amp be know to have damaging effect on pathogenic bacterium to determine they antimicrobial activity amp be create from protein acquire from various source and evaluate iin vitroi in the last phase of lytic cycle bacteriophage release hydrolytic enzyme call endolysin that cleave the host cell wall due to they superior potency and specificity compare to antibiotic lysin be use as antibacterial agent in the present study different type of endolysin from phage of iA baumanniii be select base on a extensive literature survey from the phalp database the sequence of the select lysin be retrieve in fasta format and antimicrobial peptide be find among they with the help of available bioinformatic tool the antibiofilm property antifungal property cellpenetrate property and cellular toxicity of the antimicrobial peptide be determine out of the fourteen antimicrobial peptide find from the eight select endolysin of iA baumanniii specific phage eight of they have antibiofilm property nine of they have antifungal property five of they have cellpenetrate property and all of they be nontoxic	2022	Abhishek Nandi, Ruchi Yadav, Aditi Singh	Front Med (Lausanne)
35810245	Assessment of physiological and electrochemical effect of a repurpose zinc dithiocarbamate complex on acinetobacter baumannii biofilm	acinetobacter baumannii be a infectious agent of global proportion and concern partly due to its proficiency in development of antibiotic resistance phenotype and biofilm formation dithiocarbamate dtc have be identify as possible alternative to the current antimicrobial we report here the evaluation of several dtcmetal complex against a baumannii planktonic cell and biofilm among the dtcmetal complex and dtc test ZnL1 nmethyl1 phenyldithiocarbamatoSS ZnII originally design as a antitumor agent be effective against biofilm form a baumannii a mic value of 125 µm comparable to that of gentamicin 5 µm be measure for planktonic cell in tryptic soy broth spectroscopy microscopy and biochemical analysis reveal cell membrane degradation and leakage after treatment with ZnL1 bioelectrochemical analysis show that ZnL1 reduce biofilm formation and decrease extracellular respiration of preform biofilm as corroborated by microscopic analysis due to the affinity of zn to cell and the metal chelate nature of L1 ligand we hypothesize ZnL1 could alter metalloprotein function in the membrane of a baumannii cell lead to alter redox balance result indicate that the DTCZn metal complex be a effective antimicrobial agent against early a baumannii biofilm under laboratory condition	2022 Jul	Qing Yang, Kayode Olaifa, Fartisincha P Andrew, Peter A Ajibade, Obinna M Ajunwa, Enrico Marsili	Sci Rep
36573013	antimicrobial resistance and biofilm formation capacity among acinetobacter baumannii strain isolate from patient with burn and ventilatorassociated pneumonia	acinetobacter baumannii be a pathogen responsible for nosocomial infection especially in patient with burn and ventilatorassociated pneumonia vap the aim of this study be to compare the biofilm formation capacity antimicrobial resistance pattern and molecular type base on pfge pulsedfield gel electrophoresis in a baumannii isolate from burn and vap patient	2023 Jan	Saeed Khoshnood, Nourkhoda Sadeghifard, Nahid Mahdian, Mohsen Heidary, Somayeh Mahdian, Maryam Mohammadi, Abbas Maleki, Mohammad Hossein Haddadi	J Clin Lab Anal
34825848	Association of capsular polysaccharide locus 2 with prognosis of iAcinetobacter baumanniii bacteraemia	iAcinetobacter baumanniii cause healthcareassociated infection worldwide capsular polysaccharide CPS be show a important virulence factor of iA baumanniii both iin vitroi and iin vivoi capsule locus 2 KL2 for CPS be the most common KL type and be associate with carbapenem resistance it be unclear whether KL2 be related to the clinical outcome of invasive iA baumanniii infection here we have follow patient with iA baumanniii bacteraemia prospectively between 2009 and 2014 onethird of the unduplicated blood isolate be randomly select each year for microbiological and clinical study the KL2 gene cluster be identify use polymerase chain reaction a total of 148 patient be enrol randomly Eighteen isolate 122 carry KL2 and 130 isolate 878 didnt compare with nonKL2 isolate KL2 isolate have significantly high resistance to imipenem sulbactam and tigecycline compare with the nonKL group in the KL2 group the hospital stay before development of bacteraemia be long ipi 0001 a high percentage have pneumonia ipi 0004 and the white blood cell count be low ipi 003 infection with KL2 iA baumanniii predict mortality adjust hazard ratio ahr 203 95 confidence interval CI 109378 ipi 003 independently of the Pitt bacteraemia score ahr 134 95 CI 123146 ipi 0001 and leucopenia ahr 216 95 CI 130357 ipi 0003 Thrombocytopenia contribute to the effect of KL2 on mortality in bacteraemia sobel test ipi 001 largescale study be warrant to confirm this finding and the underlying mechanism deserve further investigation	2022 Dec	Jia-Ling Yang, Chia-Jui Yang, Yu-Chung Chuang, Wang-Huei Sheng, Yee-Chun Chen, Shan-Chwen Chang	Emerg Microbes Infect
35817630	evaluation of sulbactam and colistinsulbactam efficacy against multiple resistant acinetobacter baumannii blood isolate	we aim to compare the result of the BD Phoenix tm m50 idast system and the gold standard broth microdilution method we also evaluate the potential of a new therapeutic combination colistinsulbactam for colistin resistance among acinetobacter baumanni strain	2022	Mehdi Meskini Heydarlou, Gül Durmaz, Bashar M S Ibrahi M	Indian J Med Microbiol
35773283	comparative genomics of acinetobacter baumannii and therapeutic bacteriophage from a patient undergo phage therapy	in 2016 a 68 yearold patient with a disseminate multidrugresistant acinetobacter baumannii infection be successfully treat use lytic bacteriophage here we report the genome of the nine phage use for treatment and three strain of a baumannii isolate prior to and during treatment the phage use in the initial treatment be related t4 like myophage Analysis of 19 a baumannii isolate collect before and during phage treatment show that resistance to the t4 like phage appear two day follow the start of treatment we generate complete genomic sequence for three a baumannii strain tp1 tp2 and tp3 collect before and during treatment support a clonal relationship furthermore we use strain tp1 to select for increase resistance to five of the phage in vitro and identify mutation that be also find in phageinsensitive isolate tp2 and tp3 which evolve in vivo during phage treatment this result support that in vitro investigation can produce result that be relevant to the in vivo environment	2022 Jun	Mei Liu, Adriana Hernandez-Morales, James Clark, Tram Le, Biswajit Biswas, Kimberly A Bishop-Lilly, Matthew Henry, Javier Quinones, Logan J Voegtly, Regina Z Cer, Theron Hamilton, Robert T Schooley, Scott Salka, Ry Young, Jason J Gill	Nat Commun
36402866	vaccination with a combination of planktonic and biofilm virulence factor confer protection against carbapenemresistant acinetobacter baumannii strain	acinetobacter baumannii be a multidrug resistant pathogen with the ability to switch between planktonic and biofilm phenotype although there be no vaccine against a baumannii infection many attempt have be make to develop vaccine use planktonic or biofilm antigen to cover the different phenotype of a baumannii during growth and attachment we combine planktonic upregulate antigen of iron receptor with biofilm upregulate antigen of pilus rod and evaluate immune response and protective efficacy of the combine vaccine use lethal and sublethal murine sepsis model the result show that the combine vaccine elicited high IgG antibody titer and confer protection against lethal dose of two Carbapenemresistant high adherent a baumannii strain complete bacterial clearance from all the affect tissue of the mouse challenge with a baumannii be a excellent achievement with we quadrivalent immunogen this result demonstrate both planktonic and biofilm antigen be important during antigen selection for vaccine design	2022 Nov	Fatemeh Ramezanalizadeh, Iraj Rasooli, Parviz Owlia, Shakiba Darvish Alipour Astaneh, Raziyeh Abdolhamidi	Sci Rep
35889132	sequencespecific Electrochemical genosensor for rapidforsey@ect detection of iblaisuboxa51 likesub gene in iAcinetobacter baumanniii	acinetobacter baumannii a baumannii be phenotypically indistinguishable from the acinetobacter calcoaceticus ca baumannii acb complex member use routine laboratory method early diagnosis play a important role in control a baumannii infection and this could be assist by the development of a rapid yet sensitive diagnostic test in this study we develop a enzymebase electrochemical genosensor for asymmetric pcr apcr amplicon detection of the blangak1 like gene in a baumannii a baumanniiblaOXA51 like gene pcr primer be design have the reverse primer modify at the 5 ′ end with fam a blangak1 like gene sequencespecific biotin label capture probe be design and immobilize use a synthetic oligomer famlabelled deposit on the work electrode of a streptavidinmodifie screenprinted carbon electrode spce the zot gene be use as a internal control with biotin and fam label as forward and reverse primer respectively the blangak1 like gene be amplify use asymmetric pcr apcr to generate singlestranded amplicon that be detect use the design spce the amperometric current response be detect with a peroxidaseconjugated antifluorescein antibody the assay be test use reference and clinical a baumannii strain and other nosocomial bacterium the analytical sensitivity of the assay at the genomic level and bacterial cell level be 05 pgmL 1443 ca and 103 CFUmL respectively the assay be 100 specific and sensitive for a baumannii base on accelerate stability performance the develop genosensor be stable for 16 year when store at 4 °C and up to 28 day at 25 °C the develop electrochemical genosensor be specific and sensitive and could be useful for rapid accurate diagnosis of a baumannii infection even in temperate region	2022 Jul	Swarnaletchumi Kanapathy, Godwin Attah Obande, Candy Chuah, Rafidah Hanim Shueb, Chan Yean Yean, Kirnpal Kaur Banga Singh	Microorganisms
36978490	the antimicrobial peptide octopromycin suppress biofilm formation and quorum sensing in iAcinetobacter baumanniii	iAcinetobacter baumanniii be a opportunistic bacterial pathogen that cause severe infection in immunocompromised individual iA baumanniii form biofilm and produce extracellular matrix which support bacterium to survive under harsh condition and be resistant to antibacterial treatment in the present study we investigate the biofilm and quorumsensing inhibitory effect of antimicrobial peptide octopromycin in iA baumanniii field emissionscang electron microscopy result clearly show significantly reduce biofilm mass and cause a collapse in biofilm architecture at the minimum inhibitory concentration 50 µgml and minimum bactericidal concentration 200 µgml of octopromycin antibioticresistant persister cell of iA baumanniii be successfully kill by octopromycin treatment and it inhibit violacein production in iChromobacterium violaceumi in a concentrationdependent manner octopromycin also inhibit alginate production surface movement swarm and swim and twitching motility of iA baumannniii confirm its antiquorumsensing activity multiple metabolic pathway twocomponent regulation system quorumsensing and antibiotic synthesisrelated pathway in iA baumanniii biofilm be strongly affect by octopromycin treatment the collective finding indicate that the antibacterial peptide octopromycin may control iA baumanniii biofilm through multitarget interaction octopromycin could be a desirable therapeutic option for the prevention and control of iA baumanniii infection	2023 Mar	Dinusha Chathurangi Rajapaksha, Shan Lakmal Edirisinghe, Chamilani Nikapitiya, Ilson Whang, Mahanama De Zoysa	Antibiotics (Basel)
35290154	Concurrent pigeon paramyxovirus1 and iAcinetobacter baumanniii infection in a fatal case of pneumonia	pigeon paramyxovirus type 1 ppmv1 a antigenic variant of avian paramyxovirus type 1 apmv1 mainly infect pigeon ppmv1 genotype VI be the dominant genotype infecting pigeon in China human infection of avian paramyxovirus be rarely report and usually develop mild symptom such as conjunctivitis we detect ppmv1 in the low respiratory sample from a fatal case with severe pneumonia this patient aged 64 year present cough fever and haemoptysis for 8 day and be admit to hospital on December 26 2020 he develop acute respiratory distress syndrome and sepsis in the follow day and die of multiple organ failure on January 7 2021 sputum and blood culture report multidrugresistant iAcinetobacter baumanniii ABA for sample collect on day 22 and 19 postillness respectively however clinical metagenomic sequencing further report ppmv1 besides ABA in the bronchoalveolar lavage fluid the ppmv1 genome show 9921 identity with a Chinese strain and belong to VI genotype by blast analysis multiple basic amino acid be observe at the cleavage site of F protein 113rkkrf117 which indicate high virulence of this ppmv1 strain to poultry the patient have close contact with pigeon before he illness and ppmv1 nucleic acid be detect from the pigeon feather ppmv antibody be also detect in the patient serum 20 day after illness in conclusion concurrent ppmv1 genotype vi21122 and ABA infection be identify in a fatal pneumonia case and crossspecy transmission of ppmv1 may occur between infect pigeon and the human be	2022 Dec	Xiaohui Zou, Lijun Suo, Yiming Wang, Hongyun Cao, Shengrui Mu, Chao Wu, Lizhen Yan, Xiaowei Qi, Jianwei Lu, Binghuai Lu, Yanyan Fan, Hui Li, Lixue Huang, Lili Ren, Bo Liu, Bin Cao	Emerg Microbes Infect
37017535	investigation of peptidoglycanassociated Lipoprotein of iAcinetobacter baumanniii and its interaction with Fibronectin to find its therapeutic potential	acinetobacter baumannii cause hospitalacquired infection and be responsible for high mortality and morbidity the interaction of this bacterium with the host be critical in bacterial pathogenesis and infection here we report the interaction of peptidoglycanassociated lipoprotein pal of a baumannii with host fibronectin FN to find its therapeutic potential the proteome of a baumannii be explore in the hostpathogen interaction database to filter out the pal of the bacterial outer membrane that interact with the host FN protein this interaction be confirm experimentally use purify recombinant pal and pure FN protein to investigate the pleiotropic role of pal protein different biochemical assay use wildtype pal and pal mutant be perform the result show that pal mediate bacterial pathogenesis adherence and invasion in host pulmonary epithelial cell and have a role in the biofilm formation bacterial motility and membrane integrity of bacterium all of the result suggest that pal interaction with FN play a vital role in hostcell interaction in addition the pal protein also interact with tolllike receptor 2 and marco receptor which suggest the role of pal protein in innate immune response we have also investigate the therapeutic potential of this protein for vaccine and therapeutic design use reverse vaccinology pal potential epitope be filter out that exhibit bind potential with host major histocompatibility complex class I mhci mhcii and B cell suggest that pal protein be a potential vaccine target the immune simulation show that pal protein could elevate innate and adaptive immune response with the generation of memory cell and would have subsequent potential to eliminate bacterial infection therefore the present study highlight the interaction ability of a novel hostpathogen interact partner palfn and uncover its therapeutic potential to combat infection cause by a baumannii	2023 May	Vandana Solanki, Monalisa Tiwari, Vishvanath Tiwari	Infect Immun
35537278	Phageantibiotic combination be a superior treatment against acinetobacter baumannii in a preclinical study	Clinical phage therapy be often deliver alongside antibiotic however the phenomenon of phageantibiotic synergy have be mostly study in vitro here we assess the in vivo bactericidal effect of a phageantibiotic combination on acinetobacter baumannii ab900 use phage øfg02 which bind to capsular polysaccharide and lead to antimicrobial resensitisation in vitro	2022 Jun	Fernando L Gordillo Altamirano, Xenia Kostoulias, Dinesh Subedi, Denis Korneev, Anton Y Peleg, Jeremy J Barr	EBioMedicine
36625664	development of nanoparticle adaptation Phenomena in acinetobacter baumannii Physiological Change and Defense response	the present work describe the evolution of a resistance phenotype to a multitarget antimicrobial agent namely silver nanoparticle nanosilver nag in the globally prevalent bacterial pathogen acinetobacter baumannii the gramnegative bacterium have recently be list as a critical priority pathogen require novel treatment option by the World Health Organization through prolong exposure to the important antimicrobial nanoparticle the bacterium develop mutation in gene that encode the protein subunit of organelle structure that be involve in celltosurface attachment as well as in a cell envelope capsular polysaccharide synthesisrelated gene this mutation be potentially correlate with stable physiological change in the biofilm growth behavior and with a evident protective effect against oxidative stress most likely as a feature of toxicity defense we further report a different adaptation response of a baumannii to the cationic form of silver Agsupsup the bacterium develop a tolerance phenotype to Agsupsup which be correlate with a indicative surge in respiratory activity and change in cell morphology of which this be report characteristic of tolerant bacterial population the finding regard adaptation phenomenon to nag highlight the risk of the longterm use of the nanoparticle on a priority pathogen the finding urge the implementation of strategy to overcome bacterial nag adaptation to good elucidate the toxicity mechanism of the nanoparticle and preserve the efficacy of the potent alternative antimicrobial agent in this era of antimicrobial resistance bimportanceb several recent study have report on the development of bacterial resistance to broadspectrum antimicrobial silver nanoparticle nanosilver nag nag be currently one of the most important alternative antimicrobial agent however no study have yet establish whether acinetobacter baumannii a globally prevalent nosocomial pathogen can develop resistance to the nanoparticle the study herein describe how a model strain of a baumannii with no inherent silver resistance determinant develop resistance to nag follow prolong exposure the stable physiological change be correlate with mutation detect in the bacterium genome this mutation render the bacterium capable of proliferating at a toxic nag concentration it be also find that a baumannii develop a slowertokill tolerance trait to Agsupsup which highlight the unique antimicrobial activity between the nanoparticulate and the ionic form of silver despite the prove efficacy of nag the observation of nag resistance in a baumannii emphasise the potential risk of the repeat overuse of this agent on a priority pathogen	2023 Feb	Oliver McNeilly, Riti Mann, Max Laurence Cummins, Steven P Djordjevic, Mehrad Hamidian, Cindy Gunawan	Microbiol Spectr
36375774	the evolution of carbapenem resistance determinant and major epidemiological lineage among carbapenemresistant acinetobacter baumannii isolate in Germany 20102019	the aim of this study be to investigate and compare the molecular epidemiology and carbapenem resistance determinant in clinical acinetobacter baumannii isolate collect during four multicentre surveillance study conduct by the PaulEhrlichSociety for infection therapy isolate be collect prospectively from hospital inpatient at 17 medical centre in Germany over four period of three to sixmonth start in October of each of 2010 2013 2016 and 2019 species identification be perform by malditof gyrB multiplex polymerase chain reaction pcr and detection of the intrinsic blasuboxa51 likesub gene minimum inhibitory concentration be determine by broth microdilution the prevalence of carbapenemaseencoding gene be investigate by oxamultiplex pcr and wholegenome sequencing molecular epidemiology be examine by reppcr and coregenome multilocus sequence type a total of 302 a baumannii isolate be collect resistance to imipenem andor meropenem be detect in 58 isolate 192 from 14 centre the proportion of carbapenemresistant isolate increase from 213 in 2010 to 333 in 2013 and then decrease to 138 in 2016 and 123 in 2019 fortysix of this isolate be associate with the international clonal lineage ic2 and five with ic1 the most prevalent carbapenemase gene detect be blasuboxa23 likesub n51 further carbapenemresistance determinant be blasubOXA40 likesub n1 blasuboxa58 likesub n3 and blasubndm1 sub n2 in one isolate isaba1 be detect upstream of blasuboxa51 likesub in conclusion ic2 be the most prevalent clonal lineage detect in this study interestingly in Germany carbapenem resistance seem to have decrease in a baumannii between 2013 and 2019	2022	Esther Wohlfarth, Michael Kresken, Paul G Higgins, Danuta Stefanik, Julia Wille, Dieter Hafner, Barbara Körber-Irrgang, Harald Seifert, Study Group “Antimicrobial Resistance” of the Paul-Ehrlich-Society for Infection Therapy	Int J Antimicrob Agents
35672689	evaluation of a direct phage DNA detectionbased taqman qpcr methodology for quantification of phage and its application in rapid ultrasensitive identification of acinetobacter baumannii	rapidforsey@ect phage enumerationquantitation and viable bacterium determination be critical for phage application and treatment of infectious patient cause by the pathogenic bacterium	2022 Jun	Jun Luo, Min Liu, Peng Wang, Qianyuan Li, Chunhua Luo, Hongping Wei, Yuanyuan Hu, Junping Yu	BMC Infect Dis
36040021	essential Fitness repertoire of Staphylococcus aureus during coinfection with acinetobacter baumannii iin Vivoi	Staphylococcus aureus represent a major human pathogen that be frequently involve in polymicrobial infection however the prevalence and role of coinfectious microbe on the pathogenesis and fitness essentiality of S aureus iin vivoi remain largely unknown in this study we firstly perform a retrospective surveillance of 760 clinical sample and reveal a notable predominance of coinfection with S aureus and acinetobacter baumannii the highdensity S aureus transposon mutant library couple to transposon insertion sequencing tnseq further identify a core set of gene enrich in metabolism of inorganic ion amino acid and carbohydrate which be essential for infection and tissue colonization of S aureus in the murine systemic infection model notably we reveal a differential requirement of fitness factor for S aureus in tissuespecific liver and kidney and infectiontypespecific manner mono and coinfection coinfection with a baumannii dramatically alter the fitness requirement of S aureus iin vivoi 49 of the monoinfection fitness gene in S aureus strain Newman be convert to nonessential and the functionality of atpbinding cassette ABC transporter be significantly elicited during coinfection furthermore the number of gene essential during coinfection 503 outnumber the gene essential during monoinfection 362 in addition the role of 3 infectiontypespecific gene in S aureus during monoinfection or coinfection with a baumannii be validate with competitive experiment iin vivoi we datum indicate a high incidence and clinical relevance of S aureus and a baumannii coinfection and provide novel insight into establish antimicrobial regimen to control coinfection bimportanceb polymicrobial infection be widespread in clinical setting which potentially correlate with increase infection severity and poor clinical outcome Staphylococcus aureus be a formidable human pathogen that cause a variety of disease in polymicrobial nature coinfection and interaction of S aureus have be describe with limited pathogen mainly include pseudomonas aeruginosa Candida albican and influenza a virus thus far the prevalence and role of coinfectious microbe on the pathogenesis and fitness essentiality of S aureus iin vivoi remain largely unknown understanding the polymicrobial composition and interaction from a community and genomewide perspective be thus crucial to shed light on S aureus pathogenesis strategy here we finding demonstrate for the first time that a high incidence rate and clinical relevance of coinfection be cause by S aureus and acinetobacter baumannii illustrate the importance of polymicrobial nature in investigate S aureus pathogenesis the infectiontypespecific gene likely serve as potential therapeutic target to control S aureus infection either in mono or coinfection situation provide novel insight into the development of antimicrobial regimen to control coinfection	2022 Oct	Gang Li, Wei Shen, Yali Gong, Ming Li, Xiaocai Rao, Qian Liu, Yanlan Yu, Jing Zhou, Keting Zhu, Mengmeng Yuan, Weilong Shang, Yi Yang, Shuguang Lu, Jing Wang, Yan Zhao	mSystems
36140032	minocycline and the spr741 adjuvant be a efficacious antibacterial combination for iAcinetobacter baumanniii infection	antibiotic resistance when it come to bacterial infection be not a problem that be go to disappear anytime soon with the lack of large investment in novel antibiotic research and the evergrowing increase of resistant isolate amongst the eskapee pathogen iEnterobacter cloacaei iStaphylococcus aureusi iKlebsiella pneumoniae iAcinetobacter baumanniii iPseudomonas aeruginosai iEnterococcusi sp and iEscherichia colii it be inevitable that more and more infection cause by extensively drugresistant XDR and pandrugresistant pdr strain will arise one strategy to counteract the grow threat be to use antibiotic adjuvant a drug class that on its own lack significant antibiotic activity but when mix with another antibiotic can potentiate increase kill of bacterium antibiotic adjuvant have various mechanism of action but polymyxin and polymyxinlike molecule can disrupt the gramnegative outer membrane and allow other drug good penetration into the bacterial periplasm and cytoplasm previously we show that spr741 have this adjuvant effect with regard to rifampin however rifampin be often not use clinically because of easily acquire resistance to find additional appropriate clinical partner for spr741 with respect to pulmonary and wound infection we investigate tetracycline and find a previously undocumented synergy with minocycline iin vitroi and iin vivoi in murine model of infection	2022 Sep	Yonas A Alamneh, Vlado Antonic, Brittany Garry, Michael J Pucci, Rania Abu-Taleb, Jonathan P Shearer, Samandra T Demons, Derese Getnet, Brett E Swierczewski, Troy Lister, Daniel V Zurawski	Antibiotics (Basel)
35948125	Comparison of pneumonia and nonpneumoniarelated acinetobacter baumannii complex bacteremia a singlecenter retrospective study	acinetobacter baumannii complex ABC be a group of increasingly prevalent opportunistic pathogen that cause a variety of lifethreatening nosocomial infection especially in the intensive care unit icu this study assess the difference between pneumonia and nonpneumoniarelated ABC bacteremia and possible independent risk factor for 30 day mortality	2023 May	Jun Xu, Yulu Xu, Xia Zheng	Am J Infect Control
36194009	the ddrr coregulator of the acinetobacter baumannii mutagenic DNA damage response potentiate umudab repression of errorprone polymerase	acinetobacter baumannii strain 17978 be a opportunistic pathogen with a unique DNA damage repair response that lack the LexA repressor but induce 150 gene after DNA damage it use the umud homolog umudab and the small protein ddrr unique to acinetobacter to repress multiple horizontally acquire iumudci errorprone polymerase gene through a unknown mechanism we use reverse transcriptionquantitative pcr and immunoblotting to elucidate umudab regulatory requirement and ddrr contribution to the corepression of this specialized regulon mutation in the putative umudab helixturnhelix hth domain could not repress the expression of the umudabddrr regulon a iddrRi insertion mutation in this hth mutant background produce even great derepression of the regulon suggest that ddrr exert a additional level of control over this mutagenic response this iddrRi hth mutant a baumannii cell overexpress umudab cleaving it after treatment with the dnadamaging agent mitomycin C this show that ddrr be not require for umudab selfcleavage and that umudab repression and selfcleavage action be independent a uncleavable iumuDAbi mutant with a atoy change at position 83 a83y could neither induce the umudabddrr regulon nor conduct SOS mutagenesis however a prophageencoded iumudrumby operon be still partially induce after DNA damage in this mutant surprisingly that prophage putative repressor be dispensable for prophageencoded iumudrumby induction imply another repressor involvement this study reveal that umudab behave like LexA require a nterminal hth motif for repression and cterminal selfcleavage for gene induction and subsequent SOS mutagenesis and ddrr cooperate with it to exert a additional level of repressive control on this pathogen mutagenic response to DNA damage bimportanceb acinetobacter baumannii be a nosocomial pathogen that acquire antibiotic resistance gene through conjugative transfer and carry out a robust mutagenic DNA damage response after exposure to condition typically encounter in health care setting such as antibiotic ultra-violet light and desiccation this species induce errorprone UmuDsub2subC polymerase this mutagenic capability increase a baumannii survival and virulence and be regulate by the umudabddrr corepressor system unique to the acinetobacter genus we study have reveal that the ddrr protein provide a additional layer of control in prevent mutagenic polymerase expression by enhancing umudab repression action understanding this repressor could lead to new drug target as multidrug resistance in hospitalacquired infection have decrease treatment option with limited new drug be develop	2022 Nov	Deborah Cook, Mollee D Flannigan, Belinda V Candra, Kaylee D Compton, Janelle M Hare	J Bacteriol
35706082	the spread of insertion sequence element and transposon in carbapenem resistant iAcinetobacter baumanniii in a Hospital setting in southwestern Iran	iAcinetobacter baumanniii be one of the most important hospital pathogenic bacterium that cause infectious disease the present study aim to determine the frequency of carbapenem resistance gene in association with transposable element and molecular type of carbapenemresistant iA baumanniii bacterium collect from patient in shiraz Iran	2022 Jun	Zahra Hashemizadeh, Gholamreza Hatam, Javad Fathi, Fatemeh Aminazadeh, Hossein Hosseini-Nave, Mahtab Hadadi, Nafiseh Hosseinzadeh Shakib, Sodeh Kholdi, Abdollah Bazargani	Infect Chemother
35899052	Zidebactam restore sulbactam susceptibility against carbapenemresistant iAcinetobacter baumanniii isolate	carbapenem be commonly use to treat infection cause by multidrugresistant MDR bacterium unfortunately carbapenem resistance be increasingly report in many gramnegative bacterium especially iAcinetobacter baumanniii diazabicyclooctane dbo βlactamase inhibitor such as avibactam AVI when combine with sulbactam successfully restore sulbactam susceptibility against certain carbapenemresistant iA baumanniii CRAB isolate in the present study we test zidebactam a novel dbo with a additional mechanism of action in combination with sulbactam against CRAB isolate include strain that exhibit resistance against sulbactamavibactam combination a panel of 43 geographically and genetically distinct CRAB isolate recover from different hospital and contain different mechanism of resistance be include in the present study we also test three reference strain ab0057 ab5075 and aye minimum inhibitory concentration mic for sulbactam range 012512 mgl and sulbactam plus 4 mgl zidebactam be perform use microdilution accord to clsi Standard a decrease ≥ 2 dilution in sulbactam mic be observe in 84 of the isolate when test in combination with zidebactam the sulbactamzidebactam combination be able to restore sulbactam susceptibility in 91 of the isolate include isolate that be resistant to sulbactamavibactam combination this datum encourage we to further explore sulbactamzidebactam in other experimental model especially against CRAB isolate resistant to other dbo	2022	Jose Cedano, Michelle Baez, Fernando Pasteran, Sabrina Daiana Montaña, Grace Ra, Venjaminne Fua, Alejandra Corso, Marcelo E Tolmasky, Robert A Bonomo, María Soledad Ramírez	Front Cell Infect Microbiol
36145435	faecal carriage of CarbapenemResistant iAcinetobacter baumanniii Comparison to Clinical isolate from the same period 20172019	increasing prevalence of a baumannii be find in the faecal sample of inpatient without infection cause by a baumannii 015 557806 the aim of the study be to determine whether there be a relationship between the clinical strain and the increase faecal occurrence characteristic of faecal and clinical isolate be compare between 2017 and 2019 and the direction of causality be assess by Granger causality test in the case of the antibiotic resistance faecal carriage of carbapenemresistant acinetobacter baumannii CRAb be grangercause by prevalence of CRAb in inpatient F 1584 p 0001 but inpatient prevalence be not grangercause by CRAb faecal carriage F 003 p 0855 Whole genome of 16 faecal isolate be sequence by illumina miseq cgmlst type be determine in faecal isolate the occurrence of carbapenem resistance be low than among the clinical isolate from the same period only blaoxa72 harbour st636 and st492 be detect and the blaoxa23 harbour ST2 and st49 strain previously dominant in clinical isolate be absent carriage of blaoxa72 be link to pmal1 like and pa1052 like plasmid in st636 and st492 isolate respectively both in clinical and faecal isolate the new st636 and st492 strain may colonise the gut microbiota of the patient which thus may play a role as a reservoir	2022 Sep	Bence Balázs, Zoltán Tóth, József Bálint Nagy, László Majoros, Ákos Tóth, Gábor Kardos	Pathogens
36431892	glycosphingolipid GSL from iSphingomonas paucimobilisi increase the efficacy of liposomebase nanovaccine against iAcinetobacter baumanniiiassociated Pneumonia in immunocompetent and immunocompromised mice	due to the high propensity of drug resistance in iAcinetobacter baumanniii the number of currently available therapeutic drug have become very limited thus it become incredibly important to prepare a effective vaccine formulation capable of eliciting a effective immune response against iA baumanniii in this study we prepare a liposomal vaccine formulation bear glycosphingolipid GSL from iSphingomonas paucimobilisi and load with the whole cell antigen wcAgsGSLsliposome of iA baumanniii the immunestimulatet potential and prophylactic efficacy of wcAgsGSLsliposome be compare with that of wcagsliposomes without GSL or free wcag in both immunocompetent and immunodeficient mouse the efficacy of vaccine formulation be determine by analyze antibody titer cytokine level and survival study in the immunize mouse the finding reveal that vaccination with wcAgsGSLsliposome stimulate a great secretion of antibody and cytokine high lymphocyte proliferation and increase expression of the costimulatory molecule antisera from wcagsGSLslosomesimmuned mouse remarkably reduce the biofilm formation by iA baumanniii most importantly wcagsGSLslosomesvaccinated mouse demonstrate a high defiance against the pathogen as compare to the immunization with wcagsliposomes without GSL or free wcag immunocompetent mouse immunize with wcAgsGSLsliposome show a 100 survival rate while that immunize with wcagsliposomes exhibit a 60 survival rate the protective effect of wcAgsGSLsliposome be also find to be high in immunocompromised mouse as the immunize mouse show a 50 survival rate which be great than the 20 survival rate of that immunize with wcagsliposomes the survival datum be also support by the finding of bacterial load and histological analysis that substantiated the great prophylactic potential of the wcAgsGSLsliposome this finding recommend that wcAgsGSLsliposome may be reckoned as a prospective vaccine to protect the person against iA baumanniii infection	2022 Nov	Masood Alam Khan, Khaled S Allemailem, Hamzah Maswadeh, Hina Younus	Molecules
36878462	molecular characterisation of colistin and carbapenemresistant clinical isolate of acinetobacter baumannii from Southeast Europe	to characterise 11 colistin and carbapenemresistant acinetobacter baumannii isolate recently emerge in hospital setting	2023 Mar	Ivana Goic-Barisic, Martina Seruga Music, Marina Drcelic, Semra Tuncbilek, Gulcin Akca, Sanja Jakovac, Marija Tonkić, Jasna Hrenovic	J Glob Antimicrob Resist
37124847	the molecular characterization of colistinresistant isolate of iAcinetobacter baumanniii from patient at intensive care unit	the objective of this study be to determine molecular characterization and genetic diversity of colistinresistant iA baumanniii clinical isolate in intensive Care unit hospitalize patient	2022 Jun	Safar Farajnia, Fariba Lotfi, Alireza Dehnad, Maryam Shojaie, Roya Raisi, Leila Rahbarnia, Ahad Bazmani, Behrooz Naghili, Samaneh Shiry	Iran J Microbiol
36308002	Clinical and genomic analysis of virulencerelated gene in bloodstream infection cause by iAcinetobacter baumanniii	iAcinetobacter baumanniii have emerge as a common cause of bloodstream infection which be associate with high mortality and long period of hospitalization to advance the medical care of we patient the study be design to identify microbial characteristic associate with poor clinical outcome a collection of 32 iA baumanniii bloodstream isolate with diverse genetic background as determine by multilocus sequence type be study this isolate be recover by unique patient 18 male 14 female age range 17 day to 87 year between 2011 and 2018 a sequential screen approach crossreferencing analysis use different endpoint be use to identify isolate with the good correlation between bacterial virulence and clinical prognosis isolate associate with more rapid iin vitroi growth rate short median survival time in preclinical infection model and hospital mortality be select as candidate for high virulence while that with opposite characteristic be select as control with low virulence Whole genome sequencing be undertake in the most promise clinical isolate we find five virulence gene betahemolysincytolysin Cpi1a Cpi1 spi1 like enhance entry protein fbpabc paa and 1 secretory system t6ss only present in a highly virulent isolate ab23 compare to a low virulence control isolate ab6 this genetic element could be associate with the poor prognosis of iA baumanniii bacteraemia and further investigation be warrant	2022 Dec	Bing Bai, Brianna M Eales, Wei Huang, Kimberly R Ledesma, Paul R Merlau, Guiqiu Li, Zhijian Yu, Vincent H Tam	Virulence
36054235	lipocalin2 be a essential component of the innate immune response to acinetobacter baumannii infection	acinetobacter baumannii be a opportunistic pathogen and a emerge global health threat within healthcare setting major presentation of a baumannii include bloodstream infection and ventilatorassociated pneumonia the increase prevalence of ventilate patient during the covid19 pandemic have lead to a rise in secondary bacterial pneumonia cause by multidrug resistant MDR a baumannii additionally due to its MDR status and the lack of antimicrobial drug in the development pipeline the World Health Organization have designate carbapenemresistant a baumannii to be its priority critical pathogen for the development of novel therapeutics to good inform the design of new treatment option a comprehensive understanding of how the host contain a baumannii infection be require here we investigate the innate immune response to a baumannii by assess the impact of infection on host gene expression use nanostring technology the transcriptional profile observe in the a baumannii infect host be characteristic of gramnegative bacteremia and reveal expression pattern consistent with the induction of nutritional immunity a process by which the host exploit the availability of essential nutrient metal to curtail bacterial proliferation the gene encoding for lipocalin2 lcn2 a siderophore sequestering protein be the most highly upregulate during a baumannii bacteremia of the target assess and correspond to robust lcn2 expression in tissue lcn2 mouse exhibit distinct organspecific gene expression change include increase transcription of gene involve in metal sequestration such as s100a8 and s100a9 suggest a potential compensatory mechanism to perturb metal homeostasis in vitro lcn2 inhibit the irondependent growth of a baumannii and induce ironregulated gene expression to elucidate the role of lcn2 in infection wt and lcn2 mouse be infect with a baumannii use both bacteremia and pneumonia model lcn2 be not require to control bacterial growth during bacteremia but be protective against mortality in contrast during pneumonia lcn2 mouse have increase bacterial burden in all organ evaluate suggest that lcn2 play a important role in inhibiting the survival and dissemination of a baumannii the control of a baumannii infection by lcn2 be likely multifactorial and we result suggest that impairment of iron acquisition by the pathogen be a contribute factor modulation of lcn2 expression or modify the structure of lcn2 to expand upon its ability to sequester siderophore may thus represent feasible avenue for therapeutic development against this pathogen	2022 Sep	Jessica R Sheldon, Lauren E Himmel, Dillon E Kunkle, Andrew J Monteith, K Nichole Maloney, Eric P Skaar	PLoS Pathog
35998891	biomimetic neutrophil nanotoxoid elicit potent immunity against iAcinetobacter baumanniii in multiple model of infection	iAcinetobacter baumanniii be a lead cause of antibioticresistant nosocomial infection with high mortality rate yet there be currently no clinically approve vaccine formulation during the onset of iA baumanniii infection neutrophil be the primary responder and play a major role in resist the pathogen here we design a biomimetic nanotoxoid for antivirulence vaccination by use neutrophil membranecoated nanoparticle to safely capture secreted iA baumanniii factor vaccination with the nanotoxoid formulation rapidly mobilize innate immune cell and promote pathogenspecific adaptive immunity in murine model of pneumonia septicemia and superficial wound infection immunization with the nanovaccine offer significant protection improve survival and reduce sign of acute inflammation Lower bacterial burden be observe in vaccinate animal regardless of the infection route altogether neutrophil nanotoxoid represent a effective platform for eliciting multivalent immunity to protect against multidrugresistant iA baumanniii in a wide range of disease condition	2022 Sep	Jiarong Zhou, Christian J Ventura, Yiyan Yu, Weiwei Gao, Ronnie H Fang, Liangfang Zhang	Nano Lett
35926057	acinetobacter baumannii complex national laboratorybased surveillance in South Africa 2017 to 2019	we aim to provide a analysis of a baumannii complex ABC isolate from blood culture in South Africa	2022	Olga Perovic, Adrian Duse, Vindana Chibabhai, Marianne Black, Mohamed Said, Elizabeth Prentice, Jeannette Wadula, Yesholata Mahabeer, K Swe Swe Han, Ruth Mogokotleng, Wilhelmina Strasheim, Michelle Lowe, Sabelle Jallow, Husna Ismail, for GERMS-SA	PLoS One
36519127	diversity of resistant determinant virulence factor and mobile genetic element in iAcinetobacter baumanniii from India a comprehensive in silico genome analysis	the frequency of infection associate with multidrug resistant iA baumanniii have risen substantially in India the use of nextgeneration sequencing NGS technique combine with comparative genomics have great potential for tracking monitoring and ultimately control the spread of this troublesome pathogen here we investigate the whole genome sequence of 47 ai baumanniii from India	2022	Shital N Kumkar, Ekta E Kamble, Nikeeta S Chavan, Dhiraj P Dhotre, Karishma R Pardesi	Front Cell Infect Microbiol
37151743	mutationbase fluoroquinolone resistance in carbapenemresistant iAcinetobacter baumanniii and iEscherichia colii isolate cause catheterrelated bloodstream infection	we study the presence of mutation in the chromosomal quinolone resistancedetermining region rrdr of the fluoroquinolone target igyrAi and iparCi gene and detect the carbapenem resistance cr encoding gene among iAcinetobacter baumanniii and iEscherichia colii isolate from catheterrelated bloodstream infection crbsis	2023	Mahmoud M Tawfick, Abeer K Adulall, Amani A El-Kholy, Arwa Ramadan El Manakhly	Int J Health Sci (Qassim)
36978447	phenotypic and genotypic investigation of CarbapenemResistant iAcinetobacter baumanniii in maharaj nakhon si thammarat Hospital Thailand	1 background iAcinetobacter baumanniii be well know as a causative agent of severe hospitalacquired infection especially in intensive care unit the present study characterise the genetic trait of biofilmforming carbapenemresistant iA baumanniii CRAB clinical isolate additionally this study determine the prevalence of biofilmproduce iA baumanniii isolate from a tertiary care hospital and investigate the association of biofilm with the distribution of biofilmrelated and antibiotic resistanceassociated genotype 2 method the 995 nonduplicate iA baumanniii isolate be identify and they susceptibility to different antibiotic be determine use the disk diffusion method use the modify microtiter plate assay the CRAB isolate be investigate for they biofilm formation ability hemolysin and protease activity be determine CRABs be subject to polymerase chain reaction pcr assay target iblaisubVIMsub iblaisubndmsub iblaisubimpsub iblaisuboxa23 likesub iblaisubOXA24 likesub iblaisuboxa51 likesub icsuiE and ipgaiB gene individual CRAB isolate be identify for they DNA fingerprint by repetitive element sequencebased reppcr 3 result among all iA baumanniii isolate 172 CRABs be identify the major antibiotic resistance gene among the CRAB isolate be iblaisuboxa51 likesub 100 ninetynine isolate 5756 be biofilm producer the most prevalent biofilm gene be ipgaiB 7965 follow by icsuiE 7674 evidence of virulence phenotype reveal that all CRAB exhibit proteolytic activity however only four isolate 233 be positive for the hemolyticproducing phenotype reppcr show that 172 CRAB isolate can be divide into 36DNA fingerprint pattern 4 conclusion the predominance of biofilmproduce CRAB isolate identify in this study be concern the characterisation of risk factor could aid in control the continual selection and spread of the iA baumanniii phenotype in hospital thereby improve patient care quality	2023 Mar	Sirijan Santajit, Phuangthip Bhoopong, Thida Kong-Ngoen, Witawat Tunyong, Dararat Horpet, Wanfudhla Paehoh-Ele, Tasneem Zahedeng, Pornpan Pumirat, Nitat Sookrung, Woranich Hinthong, Nitaya Indrawattana	Antibiotics (Basel)
35257970	genome sequence of a carbapenemaseencoding acinetobacter baumannii isolate of the sequence type 231 isolate from hospital wastewater in South Africa	the resistome virulome mobilome and phylogenetic relationship of the acinetobacter baumannii isolate fg121 depict the multilocus sequence type ST 231 isolate from hospital effluent water in South Africa be determine use wholegenome sequence analysis	2022 Jun	Emmanuel C Eze, Mohamed E El Zowalaty, Linda Falgenhauer, Manormoney Pillay	J Glob Antimicrob Resist
36104761	temporospatial variation in resistance determinant and clonality of acinetobacter baumannii and pseudomonas aeruginosa strain from Romanian hospital and wastewater	Romania be one of the European country report very high antimicrobial resistance amr rate and consumption of antimicrobial we aim to characterize the amr profile and clonality of 304 multidrug resistant MDR acinetobacter baumannii ab and pseudomonas aeruginosa pa strain isolate during two consecutive year 2018 and 2019 from hospital setting hospital collect sewage tank and the receive wastewater treatment plant wwtp locate in the main geographical region of Romania	2022 Sep	Irina Gheorghe-Barbu, Ilda Czobor Barbu, Laura Ioana Popa, Grațiela Grădișteanu Pîrcălăbioru, Marcela Popa, Luminița Măruțescu, Mihai Niță-Lazar, Alina Banciu, Cătălina Stoica, Ștefania Gheorghe, Irina Lucaciu, Oana Săndulescu, Simona Paraschiv, Marius Surleac, Daniela Talapan, Andrei Alexandru Muntean, Mădălina Preda, Mădălina-Maria Muntean, Cristiana Cerasella Dragomirescu, Mircea Ioan Popa, Dan Oțelea, Mariana Carmen Chifiriuc	Antimicrob Resist Infect Control
35670904	identification of antigenic property of acinetobacter baumannii protein as Novel Putative vaccine candidate use reverse vaccinology approach	multidrugresistant acinetobacter baumannii a baumannii infection be become more prevalent all over the world as a costeffective and preventative method vaccination seem to be require against this bacterium in the present study subtractive proteomics along with reverse vaccinology approach be use to predict suitable therapeutics against a baumannii use the vaxign online tool we study over 35 genome of a baumannii strain and choose outer membrane and secreted protein of a baumannii 16562 as possible vaccine candidate then investigation be perform on the immunogenicity antigenic characteristic physicochemical property bcell and MHC class I and MHC class ii molecule epitope density of protein after optimizing the codon of the protein the pcDNA31 expression construct be design and the immunogenicity allergenicity and physicochemical property of the vaccine construct be predict hcp and ompc protein be predict as extracellular and outer membrane protein respectively this protein interact with 10 other protein to form a network of protein interaction with virulence property immunoassays of hcp and ompc protein show antigenicity of 088 and 079 respectively this protein have 5 structural cell epitope point and 5 linear B epitope point they be also able to bind to different hla allele of mch class iclass ii as select immunogenic protein and design nonallergenic structure with solubility of 0650 and immunogenicity score of 091 the result of this in silico study indicate high specificity and the development of a significant humoral and cellular immune response it can be conclude that the hcp and ompc dual vaccine construct be one of the promise candidate against a baumannii the finding of this in silico study show excellent specificity and the emergence of a substantial humoral and cellular immune response this be a computerbased study that need to be test in vitro and in vivo to corroborate the conclusion of the vaccine design procedure	2022 Oct	Tohid Piri-Gharaghie, Abbas Doosti, Seyed Abbas Mirzaei	Appl Biochem Biotechnol
36951192	Natural antibody mediate protection against acinetobacter baumannii respiratory infection	acinetobacter baumannii cause a wide range of dangerous infection due to the emergence of pandrug resistant strain therefore there be a need for alternative therapeutics to treat this infection include that target the host immune response however immune response especially the humoral response against this pathogen be poorly understand	2023 Mar	Aminul Islam, Luis A Actis, Timothy J Wilson	J Infect Dis
35411393	in vitro activity of nitroxoline against carbapenemresistant acinetobacter baumannii isolate from the urinary tract	the old antimicrobial nitroxoline be currently repurpose for oral treatment of uncomplicated urinary tract infection utis	2022 Jun	Frieder Fuchs, Federico Becerra-Aparicio, Kyriaki Xanthopoulou, Harald Seifert, Paul G Higgins	J Antimicrob Chemother
37125467	navigating available treatment option for CarbapenemResistant acinetobacter baumanniicalcoaceticus complex infection	Carbapenemresistant acinetobacter baumanniicalcoaceticus complex CRAB be one of the toppriority pathogen for new antibiotic development unlike other antibioticresistant threat none of the available therapy have be show to consistently reduce mortality or improve patient outcome in clinical trial antibiotic combination therapy be routinely use in clinical practice however the prefer combination have not be define this narrative review focus on evidencebase solution for the treatment of invasive CRAB infection we dissect the promise and peril of traditional agent use in combination such as colistin sulbactam and the tetracycline and offer clinical pearl base on we interpretation of the available datum next we investigate the merit of newly develop βlactam agent like cefiderocol and sulbactamdurlobactam which have demonstrate contrasting result in recent randomize clinical trial the review conclude with the author perspective on the evolve treatment landscape for CRAB infection which be complicated by limited clinical datum imperfect treatment option and a need for future clinical trial we propose that effective treatment for CRAB infection require a personalize approach that incorporate host factor the site of infection pharmacokineticpharmacodynamic principle local molecular epidemiology of CRAB isolate and careful interpretation of antibiotic susceptibility testing result in most clinical scenario a doseoptimize sulbactambased regimen be recommend with the addition of at least one other in vitro active agent should sulbactamdurlobactam receive regulatory approval recommendation will need to be reevaluate with the most recent evidence	2023 May	Ryan K Shields, David L Paterson, Pranita D Tamma	Clin Infect Dis
36622150	protective capacity of monoclonal antibody against acinetobacter baumannii kill capsular polysaccharide	acinetobacter baumannii be a antibioticresistant opportunistic pathogen one of the main cause of hospital infection there be a urgent need for the development of therapy strategy which be not base on antibiotic hybridoma technology be use to obtain monoclonal antibody the antibody be characterize by enzyme immunoassay and fluorescence microscopy accord to they ability to opsonize a baumannii and to protect model animal from infection upon intraperitoneal and pulmonary injection monoclonal antibody mabs IgG against the kill capsular polysaccharide CPS of a baumannii be prepare use a glycoconjugate synthesized by squaricacid chemistry consisting of two CPS kill monomer unit and a carrier protein the mabs be highly specific stain the bacterial surface allow detection of a baumannii in infect lung tissue effectively opsonize the bacterium at nanogram concentration up to 15 ngmL for cps407 and demonstrate a high ability to protect a organism against bacterial infection upon intraperitoneal and lung injection in intraperitoneal infection of a mouse model with a baumannii kill the cps407 antibody protect at a dose of 25 μgmouse when bacterium be injected into the lung mab therapy prevent infection of the body and lead to a significant reduction of the bacterial load in infect tissue bimportanceb mabs detect a baumannii in infect lung tissue effectively opsonize bacterium and protect model animal from infection	2023 Feb	Anna Karatovskaya, Natalia Rudenko, Anna Zamyatina, Anton Zvonarev, Vladimir Oleinikov, Anna Shpirt, Andrei Perepelov, Yuriy Knirel, Fedor Brovko	Microbiol Spectr
36214673	a update to the database for iAcinetobacter baumanniii capsular polysaccharide locus type extend the extensive and diverse repertoire of gene find at and outside the k locus	several novel nonantibiotic therapeutics for the critical priority bacterial pathogen iAcinetobacter baumanniii rely on specificity to the cellsurface capsular polysaccharide CPS hence prediction of CPS type deduce from gene in whole genome sequence datum underpin the development and application of this therapy in this study we provide a comprehensive update to the iA baumanniii k locus reference sequence database for CPS type available in ikaptive v 201i to include 145 new KL provide a total of 237 KL reference sequence the database be also reconfigured for compatibility with the update ikaptive v 200i code that enable prediction of k type from special logic parameter define by detect combination of KL and additional gene outside the k locus validation of the database against 8994 publicly available iA baumanniii genome assembly from ncbi database identify the specific KL in 7345 of genome with perfect very high or high confidence poor sequence quality or the presence of insertion sequence be the main reason for low confidence level overall 17 KL be overrepresented in available genome with KL2 the most common follow by the related KL3 and KL22 substantial variation in gene content of the central portion of the k locus that usually include gene specific to the CPS type include 34 distinct group of gene for synthesis of various complex sugars and 400 gene for form linkage between sugars or add nonsugar substituent a repertoire of 681 gene type be find across the 237 KL with 884 find in 5 of KL	2022 Oct	Sarah M Cahill, Ruth M Hall, Johanna J Kenyon	Microb Genom
37138832	prevalent dominant iAcinetobacter baumanniii ST191195208 strain in bloodstream infection have high drug resistance and mortality	different sequence type of iAcinetobacter baumanniii ab have they own epidemiological characteristic drug resistance and toxicity	2023	Tianshui Niu, Lihua Guo, Xiaoyang Kong, Fei He, Chuhui Ru, Yonghong Xiao	Infect Drug Resist
35925415	the frequency of efflux pump gene expression in acinetobacter baumannii isolate from pulmonary secretion	acinetobacter baumannii be a important opportunistic pathogen and the cause of nosocomial infection worldwide in recent decade efflux pump be consider as the important cause of multidrug resistance of a baumannii the aim of this study be to determine the frequency of efflux pump gene and evaluate the antibiotic effect of tigecycline on the expression of adeB gene in isolate of multidrugresistant a baumannii 70 isolate of a baumannii be collect and confirm by biochemical and molecular test antibiotic resistance ciprofloxacin trimethoprimsulfamethoxazole and tigecycline be perform base on the minimum inhibitory concentration mic method then the effect of Carbonyl cyanide mchlorophenyl hydrazone inhibitor cccp on isolate be investigate and the frequency of adeB adeg adeJ and abeM gene be examine by pcr for isolate with reduce in mic titer also the antibiotic effect of tigecycline on adeB gene expression in a baumannii isolate be analyze by realtime pcr the antibiotic resistance for ciprofloxacin trimethoprimsulfamethoxazole and tigecycline be 971 958 and 372 respectively follow cccp inhibitor use the mic titer have a decrease in mic titer contain cccp inhibitor be 643 for ciprofloxacin 515 for trimethoprimsulfamethoxazole and 50 for tigecycline the frequency of gene associate with adeB adeg adeJ and abeM efflux pump be 100 928 86 and 985 respectively realtime pcr result show a correlation between the antibiotic effect of tigecycline on adeB gene expression the antibiotic resistance of the isolate be relatively high the isolate be resistant to ciprofloxacin and trimethoprimsulfamethoxazole antibiotic while more sensitive to tigecycline also efflux pump gene which be the antibiotic resistance factor of a baumannii be frequently high in the isolate but it seem that isolate use other effluxe pump than RND family to exit tigecycline	2022 Aug	Ebrahim Rafiei, Milad Shahini Shams Abadi, Behnam Zamanzad, Abolfazl Gholipour	AMB Express
36002081	eskape bacterium characterization reveal the presence of acinetobacter baumannii and pseudomonas aeruginosa outbreak in covid19vap patient	a decrease of detection of outbreak by multidrugresistant bacterium in critical area have be reduce due to covid19 pandemic therefore molecular epidemiological surveillance should be a primary tool to reveal association not evident by classical epidemiology the aim of this work be to demonstrate the presence of hide outbreak in the first wave of the covid19 pandemic and to associate they possible origin	2022 Aug	Miguel Ángel Loyola-Cruz, Emilio Mariano Durán-Manuel, Clemente Cruz-Cruz, Laura Margarita Márquez-Valdelamar, Juan Carlos Bravata-Alcántara, Iliana Alejandra Cortés-Ortíz, Mónica Alethia Cureño-Díaz, Gabriela Ibáñez-Cervantes, Verónica Fernández-Sánchez, Graciela Castro-Escarpulli, Juan Manuel Bello-López	Am J Infect Control
36173297	preferential selection of LowFrequency lipopolysaccharidemodified ColistinResistant mutant with a combination of antimicrobial in acinetobacter baumannii	colistin which target lipopolysaccharide LPS be use as a lastresort drug against severe infection cause by drugresistant acinetobacter baumannii however a baumannii possess two colistinresistance mechanism LPS modification cause by mutation in ipmrabi gene be often observe in clinical isolate of multidrugresistant gramnegative pathogen in addition to LPS modification a baumannii have a unique colistin resistance mechanism a complete loss of LPS due to mutation in the ilpxacdi gene which be involve in LPS biosynthesis this study aim to elucidate the detailed mechanism of the emergence of colistinresistant a baumannii use strain with the same genetic background various colistinresistant strain be generate experimentally use colistin alone and in combination with other antimicrobial such as meropenem and ciprofloxacin and the mutation spectrum be analyze iin vitroi selection of a baumannii in the presence of colistin lead to the emergence of strain harbor mutation in ilpxacdi gene result in LPSdeficient colistinresistant strain however combination of colistin with other antimicrobial lead to the selection of ipmrabi mutant strain result in strain with modify LPS lpsmodified strain further the LPSdeficient strain show decrease fitness and increase susceptibility to many antibiotic and disinfectant as LPSdeficient strain have a high biological cost than lpsmodified strain we finding suggest that ipmrabi mutant be more likely to be isolate in clinical setting we provide novel insight into the mechanism of resistance to colistin and provide substantial solution along with precaution for facilitate current research and treatment of colistinresistant a baumannii infection bimportanceb acinetobacter baumannii have develop resistance to various antimicrobial drug and its drugresistant strain cause nosocomial infection controlling this infection have become a global clinical challenge carbapenem antibiotic be the frontline treatment drug for infectious disease cause by a baumannii for patient with infection cause by carbapenemresistant a baumannii colistinbased therapy be often the only treatment option however a baumannii readily acquire resistance to colistin many patient infect with colistinresistant a baumannii undergo colistin treatment before isolation of the colistinresistant strain and it be hypothesize that colistin resistance predominantly emerge under selective pressure during colistin therapy although the concomitant use of colistin and carbapenem have be report to have a synergistic effect iin vitroi against carbapenemresistant a baumannii strain we observation strongly suggest the need for attention to the emergence of strain with a modify lipopolysaccharide during treatment	2022 Oct	Go Kamoshida, Noriteru Yamada, Tomoka Nakamura, Daiki Yamaguchi, Daichi Kai, Maho Yamashita, Chiaki Hayashi, Nana Kanda, Moe Sakaguchi, Hitoshi Morimoto, Teppei Sawada, Tomoko Okada, Yuki Kaya, Norihiko Takemoto, Kinnosuke Yahiro	Microbiol Spectr
37022167	Novel Clinical rngsbased Machine learning Model for rapidforsey@ect antimicrobial susceptibility test of acinetobacter baumannii	multidrugresistant MDR bacterium be important public health problem antibiotic susceptibility testing ast currently use timeconsumeng culturebase procedure which cause treatment delay and increase mortality we develop a machine learning model use acinetobacter baumannii as a example to explore a fast ast approach use metagenomic nextgeneration sequencing rngs datum the key genetic characteristic associate with antimicrobial resistance amr be select through a least absolute shrinkage and selection operator lasso regression model base on 1942 a baumannii genome the mngsast prediction model be accordingly establish validate and optimize use read simulation sequence of clinical isolate Clinical specimen be collect to evaluate the performance of the model retrospectively and prospectively we identify 20 31 24 and 3 amr signature of a baumannii for imipenem ceftazidime cefepime and ciprofloxacin respectively four mngsast model have a positive predictive value PPV great than 097 for 230 retrospective sample with negative predictive value npv of 100 imipenem 8667 ceftazidime 8667 cefepime and 9091 ciprofloxacin we method classify antibacterial phenotype with a accuracy of 9765 for imipenem 9657 for ceftazidime 9764 for cefepime and 9836 for ciprofloxacin the average report time of rngsbased ast be 191 h in contrast to the 633 h for culturebase ast thus yielding a significant reduction of 443 h mngsast prediction result coincide 100 with the phenotypic ast result when testing 50 prospective sample the rngsbased model could be use as a rapid genotypic ast approach to identify a baumannii and predict resistance and susceptibility to antibacterial and could be applicable to other pathogen and facilitate rational antimicrobial usage	2023 May	Xuejiao Hu, Yunhu Zhao, Peng Han, Suling Liu, Weijiang Liu, Cong Mai, Qianyun Deng, Jing Ren, Jiajie Luo, Fangyuan Chen, Xuefeng Jia, Jing Zhang, Guanhua Rao, Bing Gu	J Clin Microbiol
36519728	a image processingbased quantification of gram variability in acinetobacter baumannii	Gram staining differentiate bacterium as grampositive and gramnegative depend on they cell wall constituent and coloring cell in violet and pink respectively sometimes a subpopulation of the same bacterial species assume different color range from pink to violet for reason that be not completely understand yet we analyze conventional brightfield image and use a automated pipeline to count pink and violet cell the imageJbase processing algorithm quantify the gram variability in acinetobacter baumannii acicu in the stationary phase of growth with a percentage of 66 pink cell different bacterial strain and cell growth stage have be consider research hiGhlight Gram staining differentiate bacterium into grampositive violet and gramnegative pink Gram variability represent a inhomogeneous distribution of pink and violet cell within the same species we develop a imageJbase pipeline for the quantification of Gram variability in acinetobacter baumannii	2023 Mar	Sofia Canciello, Miranda Parisi, Massimiliano Lucidi, Paolo Visca, Gabriella Cincotti	Microsc Res Tech
35969073	genomic Analysis of a strain Collection containing Multidrug extensively drug pandrug and CarbapenemResistant modern Clinical isolate of acinetobacter baumannii	in this study we characterize a new collection that comprise multidrugresistant MDR extensively drugresistant XDR pandrugresistant pdr and carbapenemresistant modern clinical isolate of acinetobacter baumannii collect from hospital through national microbiological surveillance in Belgium bacterial isolate ini 43 be subject to wholegenome sequencing wgs combine illumina miseq and nanopore minion technology from which highquality genome chromosome and plasmid be ide novoi assemble antimicrobial susceptibility testing be perform along with genome analysis which identify intrinsic and acquire resistance determinant along with they genetic environment and vehicle furthermore the bacterial isolate be compare to the most prevalent a baumannii sequence type 2 ST2 pasteur scheme genome available from the bigsdb database of the 43 strain 40 carry determinant of resistance to carbapenem iblaisuboxa23 sub ini 29 be the most abundant acquire antimicrobial resistance gene with 39 isolate encoding at least two different type of oxa enzyme accord to the pasteur scheme the majority of the isolate be globally disseminate clone of ST2 ini 25 while less frequent sequence type include st636 ini 6 ST1 ini 4 st85 and ST78 ini 2 each and st604 st215 st158 and ST10 ini 1 each use the Oxford type scheme we identify 22 STs include two novel type st2454 and st2455 while the majority 2629 of iblaisuboxa23sub gene be chromosomally carry all iblaisuboxa72 sub gene be plasmid borne we result show the presence of highrisk clone of a baumannii within Belgian health care facility with frequent occurrence of gene encoding carbapenemase highlight the crucial need for constant surveillance	2022 Sep	Adam Valcek, Kristina Nesporova, Clémence Whiteway, Tim De Pooter, Wouter De Coster, Mojca Strazisar, Charles Van der Henst	Antimicrob Agents Chemother
35862760	acinetobacter baumannii genomic sequenceBased core genome multilocus sequence type use ridom seqsphere and antimicrobial susceptibility prediction in aresdb	wholegenome sequencing wgs be rapidly replace traditional type method for the investigation of infectious disease outbreak additionally wgs datum be be use to predict phenotypic antimicrobial susceptibility acinetobacter baumannii which be often multidrugresistant be a significant culprit in outbreak in health care setting a wellcharacterized collection of a baumannii be study use core genome multilocus sequence type cgmlst seventytwo isolate previously type by PCRelectrospray ionization mass spectrometry pcresim provide by the antimicrobial resistance Leadership Group arlg be analyze use a clinical microbiology laboratory develop workflow for cgmlst with genomic susceptibility prediction perform use the aresdb platform previously perform pcresim correlate with cgmlst use relatedness threshold of allelic difference of ≤9 and ≤ 200 allelic difference in 78 and 94 of isolate respectively Categorical agreement between genotypic and phenotypic antimicrobial susceptibility across a panel of 11 commonly use drug be 89 with minor major and very major error rate of 8 11 and 1 respectively	2022 Aug	Madiha Fida, Scott A Cunningham, Stephan Beisken, Andreas E Posch, Nicholas Chia, Patricio R Jeraldo, Matthew P Murphy, Nicole M Zinsmaster, Robin Patel, Antibacterial Resistance Leadership Group	J Clin Microbiol
36081797	Apolipoprotein E mimetic peptide cog1410 combat pandrugresistant iAcinetobacter baumanniii	the emergence of pandrugresistant bacterium break through the last line of defense and raise fear among people of incurable infection in the postantibiotic era the pharmaceutical field turn to seek nonconventional antiinfective agent antimicrobial peptide be consider a prospective solution to the crisis of antimicrobial resistance in this study we evaluate the antimicrobial efficiency of a apoe mimetic peptide cog1410 which have be confirm to exhibit strong neural protective activity and immunomodulatory function cog1410 show potent antimicrobial activity against pandrugresistant iAcinetobacter baumanniii even eliminate large inocula 10 sup8 sup CFUml within 30 minute lcsub999 sub in pbs and 50 pool human plasma be 2 μgml 14 μM and 8 μgml 56 μM respectively moreover cog1410 exhibit biofilm inhibition and eradication activity excellent stability in human plasma and a low propensity to induce resistance although cog1410 easily enter bacterial cytoplasm and bind to DNA nonspecifically the major mechanism of cog1410 kill be to disrupt the integrity of cell membrane and lead to leakage of cytoplasmic content without cause obvious pore on the cell surface or cell lysis additionally transcriptome analysis show that treatment with cog1410 enrich gene involve a series of oxidationreduction process dcfhda probe detect a increase ROS level in the presence of cog1410 indicate ROS be another hit of this AMP furthermore the action of cog1410 do not depend on the electronic interaction with the LPS layer in contrast to polymyxin B the strong synergistic interaction between cog1410 and polymyxin B dramatically reduce the work concentration of cog1410 expand the safety window of the application ic elegansi infection model show that combine therapy of cog1410 and polymyxin B be capable of significantly rescuing the infect nematode taken together we study demonstrate that cog1410 be a promise drug candidate in the battle against pandrugresistant iA baumanniii	2022	Bo Wang, Feng-Wan Zhang, Wei-Xiao Wang, Yan-Yan Zhao, Su-Yue Sun, Jin-Hong Yu, Michael P Vitek, George F Li, Rui Ma, Shiwei Wang, Zhiliang Hu, Wei Chen	Front Microbiol
36671278	multidrugresistant iAcinetobacter baumanniii infection in the United Kingdom versus Egypt trend and potential Natural product solution	iAcinetobacter baumanniii be a problematic pathogen of global concern it cause multiple type of infection especially among immunocompromised individual in intensive care unit one of the most serious concern related to this pathogen be its ability to become resistant to almost all the available antibiotic use in clinical practice moreover it have a great tendency to spread this resistance at a very high rate cross border and affect healthcare setting across multiple economic level in this review we trace back the report incidence in the PubMed and the web of Science database of iA baumanniii infection in both the United Kingdom and Egypt as two representative example for country of two different economic level high and lowmiddle income country additionally we compare the effort make by researcher from both country to find solution to the lack of available treatment by look into natural product reservoir a total of 113 study report infection incidence be include with most of they be conduct in Egypt especially the recent one on the one hand this pathogen be detect in the UK many year before it be report in Egypt on the other hand the contribution of Egyptian researcher to identify a solution use natural product be more notable than that of researcher in the UK tracing the prevalence of iA baumanniii infection over the year show that the infection be on the rise especially in Egypt versus the UK further concern be link to the spread of antibiotic resistance among the isolate collect from Egypt reach very alarming level Study conduct in the UK show early inclusion of highthroughput technology in the tracking and detection of iA baumanniii and its resistance than that conduct in Egypt possible explanation for this variation be analyze and discuss	2023 Jan	Wafaa H Elwakil, Soha S Rizk, Ali M El-Halawany, Mostafa E Rateb, Ahmed S Attia	Antibiotics (Basel)
36597783	advance in research on virulence factor of acinetobacter baumannii and they potential as novel therapeutic target	acinetobacter baumannii be a strictly aerobic nonmotile nonfermenting gramnegative bacillus it be a highly infectious and invasive pathogen with high mortality and morbidity rate among immunodeficient patient due to increase level of drug resistance and the inefficiency of exist antimicrobial treatment it be crucial to develop novel agent to control this pathogen several recent study have investigate virulence factor that be associate with the pathogenesis of a baumannii and could thus serve as novel therapeutic target the present review comprehensively summarize the current understanding of this virulence factor and they mechanism in a baumannii we also highlight factor that could be potential therapeutic target as well as list candidate virulence factor for future researcher and clinical practitioner	2023 Feb	Jian-Xia Zhou, Ding-Yun Feng, Xia Li, Jia-Xin Zhu, Wen-Bin Wu, Tian-Tuo Zhang	J Appl Microbiol
35820671	epidemiological characteristic of carbapenemresistant enterobacteriaceae and carbapenemresistant acinetobacter baumannii in a tertiary referral hospital in Korea	this study aim to identify the epidemiological characteristic of patient with carbapenemresistant enterobacteriaceae and acinetobacter baumannii CRE CRAB isolate in a tertiary referral hospital in Korea	2022 Jun	Sollan Kang, Ihn Sook Jeong	Osong Public Health Res Perspect
35726147	the change in epidemiology of imipenemresistant iAcinetobacter baumanniii Bacteremia in a pediatric intensive Care unit for 17 year	iAcinetobacter baumanniii infection cause high morbidity and mortality in intensive care unit icu patient however there be limited datum on the change of longterm epidemiology of imipenem resistance in iA baumanniii bacteremia among pediatric icu picu patient	2022 Jun	Dongsub Kim, Haejeong Lee, Joon-Sik Choi, Christina M Croney, Ki-Sup Park, Hyo Jung Park, Joongbum Cho, Sohee Son, Jin Yeong Kim, Soo-Han Choi, Hee Jae Huh, Kwan Soo Ko, Nam Yong Lee, Yae-Jean Kim	J Korean Med Sci
34592853	bioactivityguided isolation of compound from iSophora flavescensi with antibacterial activity against iAcinetobacter baumanniii	bioactivityguided fraction of a extract of iSophora flavescensi to identify antibacterial compound against iAcinetobacter baumanniii lead to the isolation of two new compound 2″iRi5 methoxy7hydroxy8lavandulylchromone 13 and 2iSiiβSisophobiflavonoid CE 19 and 18 know flavonoid 6aiRi11aiRimaackiain 1 2iSi8 prenylnaringenin 2 2iSiexiguaflavanone k 3 2isisophoraflavanone G 4 2iSileachianone a 5 2iSikushenol E 6 2iSileachianone G 7 ±kushenol F 8 2iSikurarinone 9 2iSikurarinol 10 2 sri3iri 374trihydroxy5methoxy8prenylflavanone 11 2isiisoxanthohumol 12 2isi2methoxykurarinone 14 2 iri3irikushenol I 15 calycosin 16 kuraridin 17 2iSikushenol a 18 and trifolirhizin 20 they structure be elucidate base on nmr ms and CD spectroscopic analysis among they b1 b b2 b b5 b and b15b exert modest antibacterial activity against iA baumanniii with micsub95 sub of 128256 μgmL for b2 b and 256512 μgmL for b1 b b5 b and b15 b	2022 Sep	Pin Li, Wern Chern Chai, Zhan-Yi Wang, Kai-Jun Tang, Jin-Yao Chen, Henrietta Venter, Susan J Semple, Lan Xiang	Nat Prod Res
36326019	serendipitous identification of phenylhydrazine derivative as potent inhibitor of carbapenemresistant iAcinetobacter baumanniii	bBackgroundb in the author previous study 423 methy l4oxo2thioxodioxothiazolidin5 ylidene methyl hydrazineyl benzonitrile be find to demonstrate potent antibacterial activity against iAcinetobacter baumanniii interestingly the aforementioned compound contain a 4 cyanophenylhydrazine motif bmaterial methodsb intrigued by this observation the author focus on prepare a library of 4 cyanophenylhydrazine derivative and study they detailed antibacterial potential bResultsb this study lead to the identification of a 4 cyanophenylhydrazine with potent inhibitory activity against carbapenemresistant iA baumanniii baa1605 with minimum inhibitory concentration mic of 025 μgml and high selectivity index of 640 the compound also demonstrate potent inhibition against multidrugresistant iA baumanniii isolate mic 0251 μgml bConclusionb the identify 4 cyanophenylhydrazine compound exhibit synergistic activity with amikacin tobramycin and polymyxin B against carbapenemresistant iA baumanniii baa1605	2022 Nov	Ramulu Parupalli, Ravikumar Akunuri, Grace Kaul, Abdul Akhir, Deepanshi Saxena, Shaik Mahammad Ghouse, Venkata Madhavi Yaddanapudi, Sidharth Chopra, Srinivas Nanduri	Future Med Chem
36190427	Clinical outcome of Eravacycline in patient treat predominately for CarbapenemResistant acinetobacter baumannii	fortysix patient be treat with eravacycline erv for acinetobacter baumannii infection where 695 of isolate be carbapenem resistant CRAB infection be primarily pulmonary 583 and most patient receive combination therapy 844 the median IQR erv duration be 69 day 51 to 111 thirtyday mortality be 239 in the cohort and 219 in CRAB patient one patient experience a ervpossible adverse event bimportanceb acinetobacter baumannii particularly when carbapenem resistant CRAB be one of the most challenging pathogen in the health care set this be complicated by the fact that there be no consensus guideline regard management of a baumannii infection however the recent infectious disease Society of America guideline for treatment of resistant gramnegative infection provide expert recommendation for CRAB management the panel suggest use minocycline among tetracycline derivative rather than eravacycline erv until sufficient clinical datum be available therefore we present the large multicenter realworld cohort in patient treat with erv for a baumannii where the majority of isolate be CRAB 695 we analysis demonstrate that patient treat with ervbased regimen achieve a 30 day mortality of 239 and have a low incidence of ervpossible adverse event 21 this study be important as it fill the gap in the literature regard the use of a novel tetracycline ie erv in the treatment of this challenging health care infection	2022 Oct	Sara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, Leonor M Rojas, Madeline A King, Benjamin M Pullinger, Athena L V Hobbs, Nicholson B Perkins, Michael P Veve, Jeannette Bouchard, Tristan Gore, Bruce Jones, James Truong, Justin Andrade, Glen Huang, Reese Cosimi, S Lena Kang-Birken, Kyle C Molina, Mark Biagi, Michael Pierce, Marco R Scipione, Jing J Zhao, Susan L Davis, Michael J Rybak	Microbiol Spectr
36512492	repurposed dihydroorotate dehydrogenase inhibitor with efficacy against drugresistant iAcinetobacter baumanniii	New antimicrobial be need for the treatment of extensively drugresistant iAcinetobacter baumanniii the de novo pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase dhodh be a validate drug target for malaria and human autoimmune disease we provide genetic evidence that iA baumanniii dhodh iabidhodh be essential for bacterial survival in rodent infection model we chemically validate the target by repurposing a unique library of 450 triazolopyrimidineimidazopyrimidine analog develop for we malaria dhodh program to identify 21 compound with submicromolar activity on iabidhodh the most potent dsm186 dhodh icsub50 sub 28 nm have a minimal inhibitory concentration of ≤ 1 µgml against geographically diverse iA baumanniii strain include meropenemresistant isolate a structurally related analog dsm161 with a long in vivo halflife confer significant protection in the neutropenic mouse thigh infection model encouragingly the development of resistance to this compound be not identify in vitro or in vivo lastly the Xray structure of iabidhodh bind to dsm186 be solve to 14 Å resolution this datum support the potential of iabidhodh as a drug target for the development of antimicrobial for the treatment of iA baumanniii and potentially other highrisk bacterial infection	2022 Dec	Thomas A Russo, Timothy C Umland, Xiaoyi Deng, Farah El Mazouni, Sreekanth Kokkonda, Ruth Olson, Ulrike Carlino-MacDonald, Janet Beanan, Cassandra L Alvarado, Diana R Tomchick, Alan Hutson, Hong Chen, Bruce Posner, Pradipsinh K Rathod, Susan A Charman, Margaret A Phillips	Proc Natl Acad Sci U S A
36778153	genomic relatedness and dissemination of iblai subndm5bab sub among iAcinetobacter baumanniii isolate from hospital environment and clinical specimen in Thailand	iAcinetobacter baumanniii iA baumanniii be a important cause of nosocomial infection especially in intensive care unit icus it have the propensity to tolerate various environment and multiple class of antibiotic we study aim to characterize the comparative genome of iA baumanniii from hospital environment and clinical isolate	2023	Thawatchai Kitti, Suphattra Manrueang, Udomluk Leungtongkam, Supat Khongfak, Rapee Thummeepak, Surat Wannalerdsakun, Thanyasiri Jindayok, Sutthirat Sitthisak	PeerJ
36537173	antiadhesion and antibiofilm activity of iLavandula maireii humbert essential oil against iAcinetobacter baumanniii isolate from hospital intensive care unit	this study aim to assess for the first time the antiadhesion and antibiofilm effect of iLavandula maireii humbert essential oil against multidrug resistant iAcinetobacter baumanniii scanning electron microscope be use for visualizing its antibiofilm activity and the effect of this oil on surface physicochemical parameter be examine as a possible antiadhesive target Chemical analysis of iLavandulaa maireii essential oil show a high content of carvacrol composition 7912 the oil test exhibit antibacterial efficacy with inhibition diameter of 33 to 3733 mm and minimum inhibitory and bactericidal concentration of 156 µl mlsup1sup the oil inhibit adhesion by 8366 detach 7330 of adherent cell and eliminate 6402 of the biofilm compare to the untreated control iLavandula maireii essential oil have prove its possible application as a preventive strategy by intervene in the initial adhesion of iAcinetobacter baumannii to polystyrenei	2022 Nov	Raja El Kheloui, Asma Laktib, Soufiane Elmegdar, Lahbib Fayzi, Chorouk Zanane, Fouad Msanda, Khalil Cherifi, Hassan Latrache, Rachida Mimouni, Fatima Hamadi	Biofouling
36752373	Comparison of the structure and activity of thioredoxin 2 and thioredoxin 1 from acinetobacter baumannii	thioredoxin trx be essential in a redoxcontrol system with many bacterium contain two trx Trx1 and trx2 due to a trx system critical function trx be target for novel antibiotic here a 120 Å highresolution structure of trx2 from acinetobacter baumannii abtrx2 a antibiotic resistant pathogenic superbug be elucidate by compare Trx1 and trx2 it be reveal that the two trx possess similar activity although trx2 contain a additional nterminal zincfinger domain and exhibit more flexible property in solution finally it be show that the trx2 zincfinger domain might be rotatable and that proper zinc coordination at the zincfinger domain be critical to abtrx2 activity this study enhance understanding of the trx system and will facilitate the design of novel antibiotic	2023 Mar	Ye Ji Chang, Ji Hye Sung, Chang Sup Lee, Jun Hyuck Lee, Hyun Ho Park	IUCrJ
36439128	a subtractive proteomics approach for the identification of immunodominant iAcinetobacter baumanniii vaccine candidate protein	iAcinetobacter baumanniii be one of the most lifethreatening multidrugresistant pathogen worldwide currently 5070 of clinical isolate of iA baumanniii be extensively drugresistant and available antibiotic option against iA baumanniii infection be limited there be still a need to discover specific ide factoi bacterial antigenic protein that could be effective vaccine candidate in human infection with the growth of research in recent year several candidate molecule have be identify for vaccine development so far no public health authority have approve vaccine against iA baumanniii	2022	Mustafa Burak Acar, Şerife Ayaz-Güner, Hüseyin Güner, Gökçen Dinç, Ayşegül Ulu Kılıç, Mehmet Doğanay, Servet Özcan	Front Immunol
36386651	iAcinetobacter baumanniii complexcaused bloodstream infection in icu during a 12 year period predicting fulminant sepsis by interpretable machine learning	iAcinetobacteri baumannii complexcaused bloodstream infection abcbsi be a potentially fatal infection in intensive care unit icus this study propose a interpretable machine learning ml model to predict abcbsi fulminant fatality	2022	Jun Xu, Xiaojun Chen, Xia Zheng	Front Microbiol
35987095	Structural insight into substrate bind of acinetobacter baumannii polyphosphateAMP phosphotransferase ppk2 a novel drug target	acinetobacter baumannii be a opportunistic pathogen know for high morbidity and mortality it cause lifethreatening infection such as ventilatorassociated pneumonia vap bacteremia meningitis wound and urinary tract infection UTI increase in carbapenem resistance exhibit by a baumannii have accentuate the need for novel target for effective treatment despite the pronounce relevance of ppk2 as a pathogenicity determinant in several pathogen it have not be explore as a drug target in a baumannii the present study be pilot to investigate the substrate bind by a baumannii ppk2 abppk2 a twodomain Class ii polyphosphate kinase 2 a homology model of abppk2 be develop and validate for molecular docking of atp and adp in the predict bind pocket further analysis of abppk2 reveal a set of common residue in the catalytic cleft interact with atp and adp which would be useful for the screen of inhibitor against a baumannii	2022 Oct	Lalit Kumar Gautam, Prince Sharma, Neena Capalash	Biochem Biophys Res Commun
36421279	contribution of rndtype efflux pump in reduced susceptibility to biocide in iAcinetobacter baumanniii	bacterial efflux pump be among the key mechanism of resistance against antibiotic and biocide we investigate whether differential expression level of the rndtype efflux pump adeabc and adeijk impact the susceptibility to commonly use biocide in multidrugresistant iAcinetobacter baumanniii susceptibility testing and timekill assay of define laboratory and clinical iA baumanniii strain with different level of efflux pump expression be perform after exposure to the biocide benzalkonium chloride chlorhexidine digluconate ethanol glucoprotamin octenidine dihydrochloride and triclosan while the impact of efflux pump expression on susceptibility to the biocide be limited noticeable difference be find in kill curve where adeabc expression correlate with great survival after exposure to benzalkonium chloride chlorhexidine digluconate glucoprotamin and octenidine dihydrochloride adeabc expression level do not impact kill kinetic with ethanol nor triclosan in conclusion this datum indicate that the overexpression of the rndtype efflux pump adeabc and adeijk contribute to the survival of iA baumanniii when expose to residual concentration of biocide	2022 Nov	Christina Meyer, Kai Lucaβen, Stefanie Gerson, Kyriaki Xanthopoulou, Thorsten Wille, Harald Seifert, Paul G Higgins	Antibiotics (Basel)
37214089	characterisation of pellicleforming ability in clinical carbapenemresistant iAcinetobacter baumanniii	iAcinetobacter baumanniii be report to have resistance towards carbapenem and the ability to form a airliquid biofilm pellicle which contribute to they virulence the gacsa twocomponent system have be previously show to play a role in pellicle formation therefore this study aim to detect the presence of igacai and igacSi gene in carbapenemresistant iAcinetobacter baumanniii CRAB isolate recover from patient in intensive care unit and to investigate they pellicle form ability	2023	Heng Kang Ng, Suat Moi Puah, Cindy Shuan Ju Teh, Nuryana Idris, Kek Heng Chua	PeerJ
35958553	CipA mediate complement resistance of iAcinetobacter baumanniii by formation of a factor idependent quadripartite assemblage	multidrugresistant iAcinetobacter baumanniii be know to be one of the lead pathogen that cause severe nosocomial infection to overcome eradication by the innate immune system during infection iA baumanniii develop a number of immune evasion strategy previously we identify CipA as a plasminogenbinding and complementinhibitory protein here we show that CipA inhibit all three complement activation pathway and interact with key complement component C3 C3 b c4 b c5 factor B factor D and in particular factor I CipA also target function of the c5 convertase as cleavage of c5 be impaired systematic screen of CipA variant identify two separate bind site for c3b and a factor Iinteracting domain locate at the cterminus structure prediction use alphafold2 and bind analysis employing CipA variant lack factor ibind capability confirm that the orientation of the cterminal domain be essential for the interaction with factor I hence we analysis point to a novel factor idependent mechanism of complement inactivation mediate by CipA of iA baumanniii recruitment of factor I by CipA initiate the assembly of a quadripartite complex follow bind of either factor H or c4bbinding protein to degrade c3b and C4b respectively loss of factor I bind in a CipAdeficient strain or a strain produce a CipA variant lack factor ibind capability correlate with a high susceptibility to human serum indicate that recruitment of factor I enable iA baumanniii to resist complementmediated kill	2022	Julia I Ries, Marie Heß, Noura Nouri, Thomas A Wichelhaus, Stephan Göttig, Franco H Falcone, Peter Kraiczy	Front Immunol
37022613	design of multiepitope peptide vaccine against acinetobacter baumannii through combine immunoinformatic and protein interactionbased approach	acinetobacter baumannii be one of the major pathogenic eskape bacterium which be responsible for about more than 722000 case in a year globally despite the alarming increase in multidrug resistance a safe and effective vaccine for acinetobacter infection be still not available hence in the current study a multiepitope vaccine construct be develop use linear B cell cytotoxic T cell and helper T cell epitope from the antigenic and wellconserved lipopolysaccharide assembly protein employing systematic immunoinformatic and structural vaccinology strategy the multipeptide vaccine be predict to be highly antigenic nonallergenic nontoxic and cover maximum population coverage worldwide further the vaccine construct be model along with adjuvant and peptide linker and validate to achieve a highquality threedimensional structure which be subsequently utilize for cytokine prediction disulfide engineering and docking analysis with tolllike receptor TLR4 ramachandran plot show 983 of the residue be locate in the most favorable and permit region thereby corroborate the feasibility of the model vaccine construct molecular dynamic simulation for a 100 n timeframe further confirm the stability of the bind vaccinereceptor complex finally in silico clone and codon adaptation be also perform with the pet28a plasmid vector to determine the efficiency of expression and translation of the vaccine immune simulation study demonstrate that the vaccine could trigger both B and T cell response and can elicit strong primary secondary and tertiary immune response the design multipeptide subunit vaccine would certainly expedite the experimental approach for the development of a vaccine against a baumannii infection	2023 Apr	Jyotirmayee Dey, Soumya Ranjan Mahapatra, Pawan K Singh, Samudyata C Prabhuswamimath, Namrata Misra, Mrutyunjay Suar	Immunol Res
35278346	Pharmacophore screen denovo design retrosynthetic analysis and combinatorial synthesis of a novel lead vtra11 against reca protein of acinetobacter baumannii	antibiotic and disinfectant resistance be acquire by activating recamediated DNA repair which maintain rosdependent DNA damage cause by the antimicrobial molecule to increase the efficacy of different antimicrobial a inhibitor can be develop against reca protein the present study aim to design a denovo inhibitor against reca protein of acinetobacter baumannii pharmacophorebased screen molecular mechanic molecular dynamic simulation MDS retrosynthetic analysis and combinatorial synthesis be use to design lead vtra11 against reca of a baumannii Pharmacophore model structurebase and ligandbase be create and a phase library of fdaapproved drug be prepare screening of the phase library against this pharmacophore model select thirteen lead molecule this filter lead be use for the denovo fragmentbase design which produce 253 combination this design molecule be further analyze for its interaction with active site of reca that select a hybrid vtra1 further retrosynthetic analysis and combinatorial synthesis produce 1000 analog of vtra1 by more than 100 modification this analog be use for XP docking bind free energy calculation and MDS analysis which finally select lead vtra11 against reca protein further mutation at the interact residue of reca with vtra11 alter the unfold rate of reca which suggest the bind of vtra11 to this residue may alter the stability of reca it be also find that vtra11 have reduce interaction of reca with LexA and ssDNA polydT show the lead efficacy in control the SOS response further it be also observe that vtra11 do not contain any predict human offtarget and no cytotoxicity to cell line as functional reca be involve in antimicrobial resistance denovo design lead vtra11 against reca may be further develop as a significant combination for therapeutic use against a baumannii	2022 Jun	Vishvanath Tiwari	Chem Biol Drug Des
35872312	structure of the K98 capsular polysaccharide from acinetobacter baumannii rev1184 contain a cyclic pyruvic acid acetal	the K98 capsular polysaccharide CPS from the acinetobacter baumannii clinical isolate rev1184 be study by sugar analysis and Smith degradation along with one and twodimensional sup1supH and sup13supC nmr spectroscopy and highresolution electrospray ionization mass spectrometry the CPS be find to consist of linear tetrasaccharide repeat kunit that include one residue each of dglcpnac dgalpnac 2acetamido2deoxydgalacturonic acid dgalpnaca and 2acetamido26 dideoxydglucose nacetylquinovosamine dQuipNAc with the galpnac residue decorate with a rconfigurated 46 pyruvic acid acetal group the CPS have a similar composition to that of a baumannii k4 but the topology of the tetrasaccharide kunit be different linear in K98 versus branch in k4 this be due to a difference in sequence for the wzy polymerase encode by the CPS biosynthesis gene cluster KL98 and kl4 with the wzy sub polymerase form a βdQuipNAc1 →3dgalpnac linkage between the K98 unit	2022 Oct	Anastasiya A Kasimova, Mikhail M Shneider, Mikhail V Edelstein, Alina A Dzhaparova, Alexander S Shashkov, Yuriy A Knirel, Johanna J Kenyon	Int J Biol Macromol
37150981	evaluation of activity of Zinc Oxide nanoparticle on human rotavirus and MultiDrug resistant acinetobacter baumannii	rotaviruse be the cause of acute gastroenteritis and severe diarrheal disease in child worldwide Children under the age of five be more susceptible to rotavirus infection due to such as the lack of effective drug and supportive therapy only the development of new antiviral agent against rotaviruse multidrugresistant acinetobacter baumannii be also one of the most challenging gramnegative bacterium to control and treat due to its antibiotic resistance particularly in intensive care unit	2023 May	Sara Minaeian, Pegah Khales, Seyed Morteza Hosseini-Hosseinabad, Mohammad Farahmand, Vahdat Poortahmasebi, Zahra Habib, Ahmad Tavakoli	Pharm Nanotechnol
35587639	high prevalence of st502 carrying a oxa24 Carbapenemase gene in carbapenemnonsusceptible iAcinetobacter baumanniicalcoaceticusi isolate in Romania	biBackgroundib iAcinetobacter baumanniii can cause difficulttotreat infection because it can acquire extensive antimicrobial resistance mechanism we aim to describe the antimicrobial resistance pattern and the genetic basis of carbapenemnonsusceptible iA baumanniii isolate in a University Hospital in Romania a country where multidrugresistant iA baumanniii be widespread bimethodsib we collect 104 consecutive meropenemnonsusceptible iA baumanniii isolate from 104 patient 36 female mean age SD of 63 16 year between May 2015 and August 2017 from a large tertiary center in Romania wholegenome sequencing of representative isolate from amplify fragment length polymorphism cluster be use to determine clonality and resistance pattern biresultsib all isolate be resistant to piperacillintazobactam ceftazidime and ciprofloxacin 885 to gentamicin and 904 to trimethoprimsulfamethoxazole in contrast 798 and 990 be susceptible to tobramycin and colistin respectively the only isolate resistant to colistin have a minimum inhibitory concentration mic of ≥ 16 mgL the iblasubOXA24subi gene be detect in 791 and iblasubOXA23subi in 209 of the isolate in one isolate iblasubOXA23subi be copresent with iblasubOXA24subi st502 Oxford scheme be the most prevalent sequence type and be exclusively associate with iblasubOXA24subi biconclusionsib st502 associate with iblasubOXA24subi be frequently observe in the region where carbapenemnonsusceptible iA baumanniii be find to be endemic in this isolate tobramycin and colistin might be the remain therapeutic option due to difference in gentamicin and tobramycin resistance in this isolate surveillance datum should not group gentamicin tobramycin and amikacin together as aminoglycoside	2022 Jun	Erlangga Yusuf, Manuela Tompa, Nikolaos Strepis, Corné H W Klaassen, Wil H F Goessens	Microb Drug Resist
36070164	myconanoparticle break antibiotic resistance in Staphylococcus aureus and acinetobacter baumannii	in this current study the extract of endophytic fungi aspergillus niger be utilize to synthesize the silver nanoparticle annp in silico screen be carry out by docking secondary metabolite of aspergillus niger with drugresistant protein such as penicillinbind protein pbp2a and clumping factor a of Staphylococcus aureus penicillinbind protein pbp3 and outer membrane protein of acinetobacter baumannii the molecular docking analysis reveal the interaction between secondary metabolite of aspergillus niger with virulence factor of the pathogenic bacterium annp be characterize by various physicochemical method to determine the size shape and stability antibacterial efficacy of synthesized nanoparticle annp be screen in clinical pathogen annp treatment significantly reduce the growth of MDR pathogen the result suggest that annp can be incorporate to produce antimicrobial agent to control drug resistant pathogenic bacterium	2023 Jan	S Janarthanan, S Ranjani, S Hemalatha	Appl Biochem Biotechnol
36238282	wholecell vaccine candidate induce a protective response against virulent iAcinetobacter baumanniii	iAcinetobacter baumanniii cause multisystem disease in both nosocomial setting and a predisposed general population the bacterium be not only desiccationresistant but also notoriously resistant to multiple antibiotic and drug of last resort include carbapenem colistin and sulbactam the World Health Organization have categorized carbapenemresistant iA baumanniii at the top of its critical pathogen list in a bid to direct urgent countermeasure development several earlystage vaccine have show a range of efficacy in healthy mouse but no vaccine candidate have advanced into clinical trial herein we report we finding that both a ionizing γradiationinactivated and a nonionizing ultraviolet cinactivated wholecell vaccine candidate protect neutropenic mouse from pulmonary challenge with virulent ab5075 a particularly pathogenic isolate in addition we demonstrate that a humoral response be sufficient for this protection iviai the passive immunization of neutropenic mouse	2022	Stephen J Dollery, Daniel V Zurawski, Ruth V Bushnell, John K Tobin, Taralyn J Wiggins, David A MacLeod, Naomi J P E R Tasker, Yonas A Alamneh, Rania Abu-Taleb, Christine M Czintos, Wanwen Su, Mariel G Escatte, Heather N Meeks, Michael J Daly, Gregory J Tobin	Front Immunol
37184390	alteration of iadeSi contribute to tigecycline resistance and collateral sensitivity to sulbactam in acinetobacter baumannii	the treatment of extensively drugresistant XDR a baumannii have emerge as a major problem tigecycline tgc and sulbactam sul be both effective antibiotic against XDR a baumannii here we investigate the inhost evolution and mechanism of collateral sensitivity cs phenomenon in development of tigecycline resistance accompany by a concomitant increase of sulbactam susceptibility a total of four XDR a baumannii strain be sequentially isolate from the same patient suffer from bacteremia coregenome multilocus sequence type separate all the strain into two cluster comparative analysis of isolate pair 1 reveal that multiplication of iblaisuboxa23sub within tni2006 I on the chromosome contribute to the change in the antimicrobial susceptibility phenotype of isolate pair 1 additionally we observe the emergence of cs to sulbactam in isolate pair 2 as demonstrate by a 8 fold increase in the tgc mic with a simultaneous 4 fold decrease in the sul mic compare to the parental strain ab3557 yzm0406 show partial deletion in the twocomponent system sensor iadeSi Reconstruction of the iadeSi mutant in ab3557 iin situi suggest that tgc resistance and cs to sul be mainly cause by the mutation of iadeSi overall we study report a novel cs combination of tgc and sul in a baumannii and further reveal a mechanism of cs attribute to the mutation of iadeSi this study provide a valuable foundation for develop effective regimen and sequential combination of tigecycline and sulbactam against XDR a baumannii bimportanceb collateral sensitivity cs have become a increasingly common evolutionary tradeoff during adaptive bacterial evolution here we report a novel combination of tigecycline tgc resistance and cs to sulbactam sul in a baumannii tgc and sul be both effective antibiotic against XDR a baumannii and it be essential to reveal the mechanism of cs between tgc and sul in we study the partial deletion of iadeSi a twocomponent system sensor be confirm to be the key factor contribute to this cs phenomenon this study provide a valuable foundation for develop effective regimen and sequential combination of tigecycline and sulbactam against XDR a baumannii	2023 May	Yunxing Yang, Xiaochen Liu, Danyan Zhou, Jintao He, Qiong Chen, Qingye Xu, Shenghai Wu, Weiying Zhang, Yue Yao, Ying Fu, Xiaoting Hua, Yunsong Yu, Xianjun Wang	Microbiol Spectr
37052493	infection of endothelial cell with acinetobacter baumannii reveal remodelling of mitochondrial protein complex	acinetobacter baumannii be a antibioticresistant gramnegative pathogen that cause a multitude of nosocomial infection however pathogenicity mechanism and the host cell response during infection remain unclear in this study we determine virulence trait of a baumannii clinical isolate belong to the most widely disseminate international clonal lineage international cluster 2 ic2 iin vitroi and iin vivoi complexome profiling of primary human endothelial cell with a baumannii reveal that mitochondria and in particular complex of the electron transport chain be important host cell target infection with highly virulent a baumannii remodelled assembly of mitochondrial protein complex and lead to metabolic adaptation this be characterize by reduce mitochondrial respiration and glycolysis in contrast to that observe in infection with lowpathogenicity a baumannii perturbation of oxidative phosphorylation destabilization of mitochondrial ribosome and interference with mitochondrial metabolic pathway be identify as important pathogenicity mechanism understanding the interaction of human host cell with the current global a baumannii clone be the basis to identify novel therapeutic target bimportanceb virulence trait of acinetobacter baumannii isolate of the worldwide most prevalent international clonal lineage ic2 remain largely unknown in we study multidrugresistant ic2 clinical isolate differ substantially in they virulence potential despite they close genetic relatedness we datum suggest that at least for some isolate mitochondria be important target organelle during infection of primary human endothelial cell complex of the respiratory chain be extensively remodelled after infection with a highly virulent a baumannii strain lead to metabolic adaptation characterize by severely reduce respiration and glycolysis perturbation of both mitochondrial morphology and mitoribosomes be identify as important pathogenicity mechanism we datum might help to further decipher the molecular mechanism of a baumannii and host mitochondrial interaction during infection	2023 Apr	Laura Leukert, Manuela Tietgen, Felix F Krause, Tilman G Schultze, Dominik C Fuhrmann, Charline Debruyne, Suzana P Salcedo, Alexander Visekruna, Llka Wittig, Stephan Göttig	Microbiol Spectr
36416541	overexpression of a DNA methyltransferase increase persister cell formation in acinetobacter baumannii	many mechanism have be propose to be involve in the formation of bacterial persister cell in this study we investigate the impact of idami encoding DNA methylation on persister cell formation in acinetobacter we construct plasmid overexpress idami encoding dnaadenine n6 methyltransferase and four gene as possibly involve in persistence and introduce they into three a baumannii strain for persister cell formation assay bacterium be expose to ciprofloxacin imipenem cefotaxime and rifampin and the transcription level of the gene be measure by qrtpcr in addition growth curve of strain be determine we find that all five gene be upregulate follow antibiotic exposure Dam overexpression increase persister cell formation rate and activate the four persister cellinvolved gene among the four persister cellinvolved gene only recc overexpression increase persister cell formation rate while irecCioverexpress strain show high growth rate idamioverexpress strain show decrease growth rate in this study we reveal that a DNA methyltransferase may regulate persister cell formation in a baumannii while recc seem to mediate epigenetic regulation of persister cell formation however Dam and recc may act at different persister cell formation state bimportanceb bacterial persister cell be not kill by high concentration of antibiotic despite its antibiotic susceptibility it have be know that they may cause antibiotic treatment failure and contribute to the evolution of antibiotic resistance although many mechanism have be suggest and verify for persister cell formation many remain to be uncover in this study we report that DNA methyltransferase lead to a increase in persister cell formation through transcriptional activation of several regulatory gene we result suggest that DNA methyltransferase could be target protein to prevent formation of persister cell	2022 Dec	Hyunkeun Kim, Jee Hong Kim, Hongbaek Cho, Kwan Soo Ko	Microbiol Spectr
37138308	molecular epidemiology of acinetobacter baumannii complex cause invasive infection in Korean child during 20012020	acinetobacter baumannii ab have emerge as one of the most problematic pathogen affect critically ill patient this study aim to investigate the longitudinal epidemiology of ab cause invasive disease in child	2023 May	Hyun Mi Kang, Ki Wook Yun, Eun Hwa Choi	Ann Clin Microbiol Antimicrob
36739749	aromatic hydrazide a potential solution for acinetobacter baumannii infection	the emergence of multidrugresistant bacterium and the poor efficacy of available antibiotic against this infection have lead to the urgent need for novel antibiotic acinetobacter baumannii be one of highpriority pathogen due to its ability to mount resistance to different class of antibiotic in a effort to provide novel agent in the fight against infection cause by a baumannii we synthesized a series of 46 aromatic hydrazide as potential treatment in this series 34 compound be find to be low to subμM inhibitor of a baumannii growth with mic value in the range of 8 μgmL to ≤0125 μgmL against a broad set of multidrugresistant clinical isolate this compound be not highly active against other bacterium we show that one of the most potent compound 3e be bacteriostatic and inhibitory to biofilm formation although it do not disrupt the preform biofilm additionally we find that this compound lack mammalian cytotoxicity the high antibacterial potency and the lack of mammalian cytotoxicity make this compound a promise lead series for development of a novel selective antiA baumannii antibiotic	2023 Mar	Keith D Green, Nishad Thamban Chandrika, Loan Y Vu, Allan H Pang, Oleg V Tsodikov, Sylvie Garneau-Tsodikova	Eur J Med Chem
36905472	Novel adjuvant nanovaccine induce immune response against acinetobacter baumannii	developing adjuvant vaccine to combat rise multidrugresistant MDR acinetobacter baumannii a baumannii infection be a promise and costeffective approach the aim of this analysis be to construct a pdnacpg c274 adjuvant nanovaccine and investigate its immunogenicity and protection in balbc mouse the cpg odn c274 adjuvant be chemically synthesized and clone into pcDNA31 and the clone be verify use pcr and bamhiecorv restriction enzyme digestion then utilize a complex coacervation approach pdnacpg c274 be encapsulated by chitosan cs nanoparticle nps tem and DLS be use to explore the property of the pdnacsnp complex TLR9 pathway activation be investigate in human hek293 and RAW 2647 mouse cell the vaccine immunogenicity and immuneprotective effectiveness be investigate in balbc mouse the pdnacpg c27lcsnp be small mean size 7921 ± 023 nm positively charge 3887 mv and appear to be spherical a continuous slow release pattern be achieve TLR9 activation be great in the mouse model with cpg odn c274 at concentration of 5 and 10 μgml with 56 and 55 respectively p 001 however in hek293 human cell by increase the concentration of cpg odn c274 from 1 to 50 μgml the activation rate of TLR9 also increase so that the high activation rate 81 be obtain at the concentration of 50 μgml p 0001 pdnacpg c27lcsnp immunize balbc mouse produce increase amount of totalIgG as well as IFN γ and il1b in serum sample compare to nonencapsulated pdnacpg c274 furthermore liver and lung injury as well as bacterial load in the liver lung and blood be reduce and balbc mouse immunize with pdnacpg c27lcsnp show potent protection 5075 against acute fatal Intraperitoneal a baumannii challenge pdnacpg c27lcsnp evoked totalIgG antibody th1 cellular immunity and the TLR9 pathway as well as protection against a acute fatal a baumannii challenge we finding suggest that this nanovaccine be a promise approach for avoid a baumannii infection when use as a powerful adjuvant	2023 Mar	Tohid Piri-Gharaghie, Abbas Doosti, Seyed Abbas Mirzaei	AMB Express
35283314	polymyxin dose tune the evolutionary dynamic of resistance in multidrugresistant acinetobacter baumannii	evolutionary principle have inform the design of strategy that slow or prevent antibiotic resistance however how antibiotic treatment regimen shape the evolutionary dynamic of resistance mutation remain a open question here we investigate vary concentration of the lastresort polymyxin on the evolution of resistance in acinetobacter baumannii	2022 Jul	Jinxin Zhao, Yan Zhu, Yu-Wei Lin, Heidi Yu, Hasini Wickremasinghe, Jiru Han, Tony Velkov, Michael J McDonald, Jian Li	Clin Microbiol Infect
36201141	in vitro and in vivo efficacy of cefiderocol plus tigecycline colistin or meropenem against carbapenemresistant acinetobacter baumannii	we investigate activity of cefiderocol combination therapy against carbapenemresistant acinetobacter baumannii CRAB a total of 123 clinical isolate of CRAB include 44 cefiderocolresistant isolate be test cefiderocol function synergistically with tigecycline in most cefiderocolsusceptible isolate 848 6779 but not with colistin or meropenem by checkerboard method cefiderocol function synergistically with tigecycline colistin and meropenem in 909 4044 477 2144 and 795 3544 cefiderocolresistant isolate respectively the timekill assay and the in vivo Galleria mellonella model confirm this observation in summary cefiderocol combine with tigecycline show synergistic effect against both cefiderocolsusceptible and resistant CRAB suggest a potentially valuable combination regimen	2022 Dec	Wentao Ni, Yifan Wang, Xinqian Ma, Yukun He, Jin Zhao, Jie Guan, Yanjun Li, Zhancheng Gao	Eur J Clin Microbiol Infect Dis
36395844	high diversity of the emerge pathogen acinetobacter baumannii and other acinetobacter spp in raw manure bioga plant digestate and rural and urban wastewater treatment plant with system specific antimicrobial resistance profile	Carbapenemresistant acinetobacter baumannii cause immense treatment problem in hospital there be still a knowledge gap on the abundance and stability of acquire resistance and the diversity of resistant acinetobacter in the environment the aim of the study be to investigate the diversity and antimicrobial resistance of acinetobacter spp release from livestock and human wastewater into the environment Raw and digest manure of small scale on farm bioga plant as well as untreated and treat wastewater and sewage sludge of rural and urban wastewater treatment plant wwtp be study comparatively a total of 132 acinetobacter isolate be phylogenetically identify 16S rRNA gene and rpoB sequence analysis and 14 different phylotype be detect fiftytwo isolate represent a baumannii which be cultured from raw and digest manure of different bioga plant and most stage of the rural wwtp no hospital wastewater receive and the two study urban wwtp receive veterinarian and human hospital wastewater multilocus sequence type pasteurmlst identify 23 novel and 12 know STs of a baumannii most novel STs 1823 be cultured from livestock sample and the rural wwtp a baumannii isolate from livestock and the rural wwtp be susceptible to carbapenem colistin ciprofloxacin ceftazidime and piperacillin in contrast a baumannii isolate from the two urban wwtp show clinical linkage with respect to mlst and be multidrug resistant MDR the presence of viable a baumannii in digest manure and sewage sludge confirm the survival of the strict aerobic bacterium during anoxic condition the study indicate the spread of diverse acinetobacter from anthropogenic source into the environment with a strong linkage of clinial associate MDR a baumannii strain to the inflow of hospital wastewater to wwtp a more frequent detection of acinetobacter in sewage sludge than effluent water indicate that particleattachment of acinetobacter must be consider by the risk assessment of this bacterium	2023 Feb	Dipen Pulami, Peter Kämpfer, Stefanie P Glaeser	Sci Total Environ
35981691	Risk factor for early mortality in patient with carbapenemresistant acinetobacter baumannii bacteraemia	although many death due to carbapenemresistant acinetobacter baumannii CRAB bacteraemia occur within a few day after the onset of bacteraemia risk factor for early mortality em have not be deeply investigate we aim to determine the risk factor for em and the difference between risk factor associate with em and late mortality LM in CRAB bacteraemia	2022 Dec	Chan Mi Lee, Chung-Jong Kim, Seong Eun Kim, Kyung-Hwa Park, Ji Yun Bae, Hee Jung Choi, Younghee Jung, Seung Soon Lee, Pyoeng Gyun Choe, Wan Beom Park, Eu Suk Kim, Je Eun Song, Yee Gyung Kwak, Sun Hee Lee, Shinwon Lee, Shinhye Cheon, Yeon Sook Kim, Yu Min Kang, Ji Hwan Bang, Sook-In Jung, Kyoung-Ho Song, Hong Bin Kim, Korea Infectious Diseases (KIND) Study Group	J Glob Antimicrob Resist
36401642	a novel pentavalent vaccine candidate completely protect against acinetobacter baumannii in a mouse model of peritonitis	acinetobacter baumannii be consider as one of the most virulent and infectious organism that have a increase ability to both evade host immune response and resist various class of antibiotic lead to lifethreatening infection multiple virulence factor have be implicate in the high prevalence rate of a baumannii in hospitalize and immunocompromised patient moreover improper use of antibiotic have lead to the emergence of extensive drugresistant strain that urgently require alternative strategy to control this superbug unfortunately the availability of a license vaccine against a baumannii infection be still challenge by the vast diversity among a baumannii strain here we report the development of a novel pentavalent vaccine candidate compose of two recombinant protein wza and yiad and a pool of capsular polysaccharide isolate from 3 clinical isolate we test this new vaccine in vivo in a mouse model of peritonitis against the standard strain atcc 19606 in addition to 3 clinical isolate of a baumannii Immunization with this vaccine completely protect the challenge mouse with 100 survival rate in the case of all the test bacterium further clinical study be urgently need to evaluate the efficacy and safety of this proprietary vaccine to protect patient from a baumannii lethal infection key point • recombinant protein pool wza and yiad immunization lead to a synergistic immune response • capsular polysaccharide pool induce up to 90 protection of test clinical isolate • the pentavalent pool show superiority with 100 survival of immunize mouse	2022 Dec	Yomna A Hagag, Heba Shehta Said, Hany I Kenawy, Ramadan Hassan	Appl Microbiol Biotechnol
35869778	Plasma and cerebrospinal fluid concentration of cefiderocol during successful treatment of carbapenemresistant acinetobacter baumannii meningitis	to date no realworld datum be available to describe cefiderocol use in carbapenemresistant acinetobacter baumannii CRAB meningitis furthermore cefiderocol pharmacokinetic PK datum to support CNS penetration in human subject be limited this gap pose a significant concern for clinician who be face with treat such infection when consider cefiderocol use	2022 Sep	Wesley D Kufel, Yasmeen Abouelhassan, Jeffrey M Steele, Ramiro L Gutierrez, Talha Perwez, George Bourdages, David P Nicolau	J Antimicrob Chemother
35872309	the K218 capsular polysaccharide produce by acinetobacter baumannii isolate 52249 include 57dinacetylpseudaminic acid link by a kpss3 glycosyltransferase	two acylated form of the high sugar 57diamino3579tetradeoxylglycerolmannonon2ulosonic acid call pseudaminic acid pse5ac7ac and pse5ac7rhb where R indicate r3hydroxybutanoyl have be find to occur in many capsular polysaccharide CPS type produce by isolate of a important human pathogen acinetobacter baumannii the presence of either a psaabcedf or psaabcghf gene module at the k locus KL for CPS biosynthesis determine the type of the variant produce here a a baumannii clinical isolate 52249 recover in 2015 in Moscow Russia be find to include a novel psaabcijf gene module in the kl218 sequence at the k locus the CPS from 52249 be extract and study by sugar analysis and partial acid hydrolysis along with one and twodimensional sup1supH and sup13supC nmr spectroscopy a branch tetrasaccharide repeat unit be identify which include a → 3αdgalp1→6αdglcpnac1→3βdgalpnac1 → main chain and pse5ac7ac attach as a side branch indicate that the psaabcijf gene module be associate with synthesis of this variant the K218 CPS be find to be structurally related to the k46 CPS of a baumannii and a comparison of the two structure enable the assignment of glycosyltransferase a kpss3 protein for the α2→6 linkage of the pse5ac7 ac residue to dgalp in K218 be identify	2022 Oct	Anastasiya A Kasimova, Aleksandra G Dudnik, Alexander S Shashkov, Mikhail M Shneider, Alex Christofferson, Andrey A Shelenkov, Yuliya V Mikhailova, Johanna J Kenyon, Yuriy A Knirel	Int J Biol Macromol
36648597	the tolpal system of acinetobacter baumannii be important for cell morphology antibiotic resistance and virulence	acinetobacter baumannii be a opportunistic human pathogen that have become a global threat to healthcare institution this gramnegative bacterium be one of the most successful human pathogen worldwide and responsible for hospitalacquired infection this be due to its outstanding potential to adapt to very different environment to persist in the human host and most important its ability to develop multidrug resistance we combine approach of genomic and phenotypic analysis lead to the identification of the envelope span tolpal system in a baumannii we find that the deletion of the tolQ tolr tolA tolB and pal gene affect cell morphology and increase antibiotic sensitivity such as the ∆tolpal mutant exhibit a significantly increase gentamicin and bacitracin sensitivity furthermore Galleria mellonella caterpillar kill assay reveal that the ∆tolpal mutant exhibit a decrease kill phenotype taken together we finding suggest that the tolpal system be important for cell morphology antibiotic resistance and virulence of a baumannii	2023 Jan	Josephine Joy Hubloher, Lisa Van der Sande, Christoph Schaudinn, Volker Müller, Beate Averhoff	Int Microbiol
36257427	transmission of antibiotic resistance gene through mobile genetic element in acinetobacter baumannii and genetransfer prevention	antibiotic resistance be a major global public health concern acinetobacter baumannii be a nosocomial pathogen that have emerge as a global threat because of its high level of resistance to many antibiotic particularly that consider as lastresort antibiotic such as carbapenem mobile genetic element mge play a important role in the dissemination and expression of antibiotic resistance gene ARGs include the mobilization of ARGs within and between species we conduct a indepth systematic investigation of the occurrence and dissemination of ARGs associate with mge in a baumannii we focus on a crosssectoral approach that integrate human animal and environment four strategy for the prevention of arg dissemination through mge have be discuss prevention of airborne transmission of ARGs use semipermeable membranecover thermophilic composting application of nanomaterial for the removal of emerge pollutant antibiotic and pathogen tertiary treatment technology for control ARGs and mge in wastewater treatment plant and the removal of ARGs by advanced oxidation technique this review contemplate and evaluate the major driver involve in the transmission of ARGs from the crosssectoral perspective and argtransfer prevention process	2023 Jan	Jeong Ho Jeon, Kyung-Min Jang, Jung Hun Lee, Lin-Woo Kang, Sang Hee Lee	Sci Total Environ
35908655	immunoinformaticsguided design of epitopebase subunit vaccine from pilus assembly protein of acinetobacter baumannii bacterium	acinetobacter baumannii a prominent pathogen responsible for chronic infection in the blood urinary tract and lung have a high mortality due to its virulence and limited preventive method the present study aim to characterize the pilus assembly protein of a baumannii to offer lead for epitopebase vaccine development filf be the putative pilus assembly protein that reportedly play a supreme character in the virulence of this wholist eskape bacterium implementing various bioinformatic tool lead to the recognition of many antigenic B and T cell epitope most promise B and tcell epitope be select base on they bind efficiency with commonly occur MHC allele finally we step down to fourteen protective antigenic peptide this epitope be also reveal to be nonallergenic and nontoxic as a result a vaccine chimera be create by link this epitope with appropriate linker and adjuvant such as βdefensin furthermore homology modeling and validation be carry out with the model structure be employ for molecular docking with the immunological receptor TLR4 find on lymphocyte cell as a result of the molecular dynamic simulation the interaction between human TLR4 and the multiepitope vaccine sequence be stable finally in silico clone and immune simulation be carry out to see the efficacy of the construct vaccine this be the first study target the pilus assembly protein from a baumannii to identify novel epitope that hold potential for further experimental design of multipeptide vaccine construct against the pathogen	2022 Sep	Soumya Ranjan Mahapatra, Jyotirmayee Dey, Aryan Jaiswal, Riya Roy, Namrata Misra, Mrutyunjay Suar	J Immunol Methods
37111234	Rifampicin enhanced carbapenem activity with improved antibacterial Effect and eradicate established iAcinetobacter baumanniii biofilm	biofilmmediated infection be critical to public health and a lead cause of resistance among pathogen amount to a prolong hospital stay and increase mortality rate in the intensive care unit in this study the antibacterial and antibiofilm activity of rifampicin or carbapenem monotherapy be compare with rifampicin and carbapenem combination therapy against rifampicinresistant and carbapenemresistant iAcinetobacter baumanniii isolate among 29 CRAB isolate 2429 83 be resistant to rifampicin with mic value between 2256 µgml checkerboard assay disclose that combination therapy at ficis between 18 and 14 improve the activity of carbapenem at subinhibitory concentration timekill kinetic indicate a 2 to 4log reduction at 12 mic rifampicin 14 mic carbapenem and 14 mic rifampicin 14 mic carbapenem against the isolate with the mic value range from 28 µgml the mtt assay reveal a dosedependent decrease of the cell viability of establish bacterial biofilm at 4 mic rifampicin 2 mic carbapenem with a percentage reduction of 4475 compare with monotherapy at 16 mic scanning electron microscopy further confirm bacterial cell membrane disruption suggest a synergism between carbapenem and rifampicin against a representative isolate the finding demonstrate that the combination of rifampicin with carbapenem could improve antibacterial activity and eradicate establish iAcinetobacter baumanniii biofilm	2023 Mar	Lois Chinwe Nwabor, Arnon Chukamnerd, Ozioma Forstinus Nwabor, Rattanaruji Pomwised, Supayang P Voravuthikunchai, Sarunyou Chusri	Pharmaceuticals (Basel)
36831915	Silver nanostarbased sers for the discrimination of clinically relevant iAcinetobacter baumanniii and iKlebsiella pneumoniae species and clone	the development of rapid reliable and lowcost method that enable discrimination among clinically relevant bacterium be crucial with emphasis on that list as who Global priority 1 critical pathogen such as carbapenemresistant iAcinetobacter baumanniii and carbapenemresistant or esblproducing iKlebsiella pneumoniae to address this problem we develop and validate a protocol of surfaceenhanced raman spectroscopy sers with silver nanostar for the discrimination of iA baumanniii and iK pneumoniae species and they globally disseminate and clinically relevant antibiotic resistant clone isolate be characterize by mixing bacterial colony with silver nanostar follow by deposition on filter paper for sers spectrum acquisition spectral datum be process with unsupervise and supervise multivariate datum analysis method include principal component analysis pca and partial leastsquare discriminant analysis PLSDA respectively we propose sers procedure use silver nanostar adsorbed to the bacterium follow by multivariate datum analysis enable differentiation between and within species this pilot study demonstrate the potential of sers for the rapid discrimination of clinically relevant iA baumanniii and iK pneumoniae species and clone display several advantage such as the ease of silver nanostar synthesis and the possible use of a handheld spectrometer which make this approach ideal for pointofcare application	2023 Jan	Miguel Peixoto de Almeida, Carla Rodrigues, Ângela Novais, Filipa Grosso, Nicolae Leopold, Luísa Peixe, Ricardo Franco, Eulália Pereira	Biosensors (Basel)
36361923	Complementary regulation of bfrr twocomponent and abair quorum sensing system to Express virulenceassociated gene in iAcinetobacter baumanniii	iAcinetobacter baumanniii express various virulence factor to adapt to hostile environment and infect susceptible host this study investigate the regulatory network of the bfrr twocomponent and abair quorum sensing qs system in the expression of virulenceassociated gene in iA baumanniii atcc 17978 the ΔibfmSi mutant exhibit a significant decrease in surface motility which presumably result from the low expression of ipilTi and iA1S0112iiA1S0119i gene cluster the ΔibfmRi mutant display a significant reduction in biofilm and pellicle formation due to the low expression of icsui operon the deletion of iabaRi do not affect the expression of ibfmRi or ibfmSi however the expression of iabaRi and iabaIi be upregulate in the ΔibfmRi mutant the ΔibfmRi mutant also produce more autoinducer than do the wildtype strain suggest that bfar negatively regulate the abair qs system the ΔibfmSi mutant exhibit no autoinducer production in the bioassay system the expression of the iA1S0112A1S0119i gene cluster be downregulated in the ΔiabaRi mutant whereas the expression of icsui operon be upregulate in this mutant with a high cell density in conclusion for the first time we demonstrate that the bfmrsabair qs system axis regulate the expression of virulenceassociated gene in iA baumanniii this study provide new insight into the complex network system involve in the regulation of virulenceassociated gene underlying the pathogenicity of iA baumanniii	2022 Oct	Hyo-Jeong Kim, Na-Yeong Kim, Seo-Yeon Ko, Seong-Yong Park, Man-Hwan Oh, Min-Sang Shin, Yoo-Chul Lee, Je-Chul Lee	Int J Mol Sci
36868326	peptidoglycanassociated lipoprotein contribute to the virulence of acinetobacter baumannii and serve as a vaccine candidate	the role of peptidoglycanassociated lipoprotein pal in a baumannii pathogenesis remain unclear here we illustrate its role by construct a pal deficient a baumannii mutant and its complementary strainTranscriptome analysis of the wt and pal mutant reveal a total of 596 differentially express gene gene ontology analysis reveal that pal deficiency cause the downregulation of gene related to material transport and metabolic process the pal mutant show a slow growth and be sensitive to detergent and serum kill compare to wt strain whereas the complemented pal mutant show rescue phenotype the pal mutant cause decrease mortality in mouse pneumonia infection compare to wt strain while the complemented pal mutant show increase mortality mice immunize with recombinant pal show 40 protection against a baumanniimediated pneumonia Collectively this datum indicate pal be a virulence factor of a baumannii and may serve as a potential target for preventive or therapeutic intervention	2023 Mar	Xi Zeng, Ning Wang, Chuanying Xiang, Qiang Liu, Daiyu Li, Yangyang Zhou, Xiaomin Zhang, Yu Xie, Weijun Zhang, Hong Yang, Ming Jiang, Xianchun Zong, Quanming Zou, Yun Shi	Genomics
35935213	corrigendum comparative respiratory tract microbiome between carbapenemresistant iAcinetobacter baumanniii colonization and ventilator associate pneumonia	this correct the article doi 103389 fmicb2022782210	2022	Tingting Xiao, Qian Guo, Yanzi Zhou, Ping Shen, Yuan Wang, Qiang Fang, Mo Li, Shuntian Zhang, Lihua Guo, Xiao Yu, Yulin Liao, Chunhui Wang, Xiaohui Chi, Xiaoyang Kong, Kai Zhou, Beiwen Zheng, Qixia Luo, Yunbo Chen, Huaiqiu Zhu, Yonghong Xiao	Front Microbiol
36920961	differential proteomic analysis and pathogenic effect of outer membrane vesicle derive from acinetobacter baumannii under normoxia and hypoxia	acinetobacter baumannii be a major causative agent of nosocomial infection and its outer membrane vesicle abomv have be show to be involve in pathogenicity by transport virulence factor and transfer information for communication between pathogen and host cell despite the fact that the infect site of a baumannii such as lung and skin soft tissue be hypoxic most study on AbOMV virulence have use abomv prepare under aerobic condition the present study aim to elucidate the protein profile and pathogenic impact of abomv release under hypoxic condition abomv be isolate from a baumannii under normoxic and hypoxic condition and they protein profile be compare the different effect of both normoxic and hypoxic abomv in cytokine response from mouse macrophage cytotoxicity to the human lung epithelial cell and bacterial invasion be then investigate we result show that a baumannii under hypoxia release large amount of omv with different protein profile although the cytotoxic effect of abomv from normoxia and hypoxia be comparable abomv from normoxia induce high tnfα production and invasion of Staphylococcus aureus and pseudomonas aeruginosa than that from hypoxia on the other hand abomv significantly enhance a baumannii invasion into lung epithelial cell in a dosedependent manner this result clearly demonstrate that abomv release from normoxic and hypoxic have different impact in pathogenesis this find provide new insight into the complex interaction between a baumannii coinfecting pathogen and host cell via omv in particular the different pathogenic effect of abomv under normoxic and hypoxic condition	2023	Sachio Suzuki, Phawinee Subsomwong, Kouji Narita, Noriaki Kawai, Takahito Ishiai, Wei Teng, Rojana Sukchawalit, Akio Nakane, Sadatomo Tasaka, Krisana Asano	PLoS One
36317921	pbp1a directly interact with the divisome complex to promote septal Peptidoglycan synthesis in acinetobacter baumannii	the class a penicillinbind protein apbp pbp1a and pbp1b be major peptidoglycan synthasis that synthesize more than half of the peptidoglycan per generation in Escherichia coli whereas apbp have distinct role in peptidoglycan biosynthesis during growth ie elongation and division they be semiredundant disruption of either be rescue by the other to maintain envelope homeostasis and promote proper growth acinetobacter baumannii be a nosocomial pathogen that have a high propensity to overcome antimicrobial treatment a baumannii contain both pbp1a and pbp1b encode by imrcAi and imrcBi respectively but only imrcAi deletion decrease fitness and contribute to colistin resistance through inactivation of lipooligosaccharide biosynthesis indicate that pbp1b be not functionally redundant with the pbp1a activity while previous study suggest a distinct role for pbp1a in division it be unknown whether its role in septal peptidoglycan biosynthesis be direct here we show that a baumannii pbp1a have a direct role in division through interaction with divisome component pbp1a localize to septal site during growth where it interact with the transpeptidase pbp3 a essential division component that regulate daughter cell formation pbp3 overexpression be sufficient to rescue the division defect in ΔimrcAi a baumannii however pbp1a overexpression be not sufficient to rescue the septal defect when pbp3 be inhibit suggest that they activity be not redundant overexpression of a major ddcarboxypeptidase pbp5 also restore the canonical a baumannii coccobacilli morphology in ΔimrcAi cell together this datum support a direct role for pbp1a in a baumannii division and highlight its role as a septal peptidoglycan synthase bimportanceb Peptidoglycan biosynthesis be a validate target of βlactam antibiotic and it be critical that we understand essential process in multidrugresistant pathogen such as acinetobacter baumannii while model system such as Escherichia coli have show that pbp1a be associate with side wall peptidoglycan synthesis we show herein that a baumannii pbp1a directly interact with the divisome component pbp3 to promote division suggest a unique role for the enzyme in this highly drugresistant nosocomial pathogen a baumannii demonstrate unanticipated resistance and tolerance to envelopetargeting antibiotic which may be drive by rewire peptidoglycan machinery and may underlie therapeutic failure during antibiotic treatment	2022 Dec	Katie N Kang, Joseph M Boll	J Bacteriol
36151303	Novel dform of hybrid peptide dap19 rapidly kill acinetobacter baumannii while tolerate proteolytic enzyme	antimicrobial peptide amp be be develop as potent alternative treatment to conventional antibiotic which be unlikely to induce bacterial resistance they can be design and modify to possess several druggable property we report herein a novel hybrid peptide of modify aurein a3 and cathelicidin p7 or a3p7 by a flipping technique it exhibit potent antibacterial activity against both gramnegative and positive pathogenic bacterium but have moderate hemolytic activity to reduce the sequence length and toxicity cterminal truncation be serially perform and eight truncate derivative ap12ap19 be obtain they have significantly less hemolytic activity while preserve antibacterial activity secondary structure of the candidate peptide in environment simulate bacterial membrane 30 mM SDS and 50 tfe determine by CD spectroscopy show αhelical structure consistent with predict in silico 3D structural model among the peptide ap19 demonstrate the good combination of broadspectrum antibacterial activity include toward acinetobacter baumannii and minimal hemolytic and cytotoxic activity a dform peptide dap19 in which all lenantiomer be substitute with the denantiomer maintain antibacterial activity in the presence of pepsin trypsin proteinase k and human plasma both isomer exhibit potent antibacterial activity against multidrug MDR and extensivelydrug resistant XDR clinical isolate of a baumannii comparable to the traditional antibiotic meropenem dap19 display rapid kill via membrane disruption and leakage of intracellular content additionally it show a low tendency to induce bacterial resistance we work suggest that dap19 could be further optimize and develop as a novel compound potentially for fight against MDR or XDR a baumannii	2022 Sep	Phanvimon Jariyarattanarach, Natthaporn Klubthawee, Mathira Wongchai, Sittiruk Roytrakul, Ratchaneewan Aunpad	Sci Rep
36271362	sulbactam combine with tigecycline improve outcome in patient with severe multidrugresistant acinetobacter baumannii pneumonia	the purpose of this study be to review the treatment plan of patient with multidrugresistant acinetobacter baumannii mdrab pneumonia and analyze the factor associate with patient death and the medication regimen	2022 Oct	Yanling Deng, Lin Chen, Mingrui Yue, Xiaobo Huang, Yang Yang, Hua Yu	BMC Infect Dis
35141834	spread of multidrugresistant acinetobacter baumannii isolate belong to ic1 and ic5 major clone in rondônia state	in Brazil carbapenemresistant a baumannii CRAB be a critical pathogen show high carbapenem resistance rate currently there be little epidemiological datum on a baumannii isolate in the Northern Brazilian region herein this study aim to characterize the resistance mechanism of CRAB isolate recover from hospitalize patient in the state of rondônia in 2019 most of CRAB be consider as extensively drugresistant and some of they show high mic for minocycline only polymyxin show a satisfactory activity all isolate carry blasuboxa23sub and be include in 14 distinct cluster with the predominance of clonal group a 29 the ic1 be the most frequent clonal group follow by ic5 and IC4 here we firstly report the epidemiological scenario of CRAB in the state of rondônia locate in the Brazilian Amazon region the high frequency of CRAB present XDR phenotype be of great concern due to limited therapeutical option especially in the actual pandemic scenario in which we observe a overcrowding of icu bed such result be essential to good characterize the epidemiology of CRAB in the entire Brazilian territory	2022 Jun	Tiago Barcelos Valiatti, Tatiane Silva Carvalho, Fernanda Fernandes Santos, Carolina Silva Nodari, Rodrigo Cayô, Juliana Thalita Paulino da Silva, Cicileia Correia da Silva, Jacqueline Andrade Ferreira, Lorena Brandhuber Moura, Levy Assis Dos Santos, Ana Cristina Gales	Braz J Microbiol
36341004	the significant role of Carbapenemsresistant iAcinetobacter baumanniii in mortality rate of patient with covid19	bBackgroundb infection cause by iAcinetobacter baumanniii especially carbapenemresistant cr strain pose important challenge in patient with covid19 infection therefore in the present study we investigate coinfection and antimicrobial resistance pattern as well as the role of iA baumanniii in the outcome of patient with covid19 bmaterial and methodsb between February 2019 and January 2021 141 patient with iA baumanniii infection be detect from seven different hospital a to G in Arak Iran and the antibacterial susceptibility pattern of this isolate be evaluate use disk diffusion and etest method fortyseven of this patient be coinfected with covid19 during the study the datum about the clinical course demographic datum and the role of iA baumanniii infection in the mortality rate of covid19 patient be collect bResultsb hospital a and B report the most patient with 53 38 and 47 33 respectively additionally most case 105 case 75 be report from surgical and general icus mechanical ventilator be detect as predisposing factor in 95 67 patient and infection be detect in 20 of patient on the 10th day after intubation all of the iA baumanniii isolate be resistant to different class of antibiotic such as carbapenem notably 33 47 patient be also positive for covid19 and 68 32 patient die due to the infection statistical analysis show a significant role of iA baumanniii coinfection in the mortality rate of covid19 patient pvalue 005 bConclusionb coinfection with iA baumanniii be one of the most important challenge in covid19 patient we result show that all isolate bacterium be cr and significantly increase mortality rate in covid19 patient	2023	Ali AliMohammadi, Nahid Chezani-Sharahi, Zahra Asgari Hezaveh, Elnaz Abbasi, Aref Shariati, Ehsanollah Ghaznavi-Rad	Vacunas
36986332	dissemination of Clinical iAcinetobacter baumanniii Isolate to Hospital environment during the covid19 Pandemic	the aim of this study be to find the source of iAcinetobacter baumanniii in the intensive care unit icu after a outbreak during the coronavirus disease 2019 covid19 pandemic as there be no iA baumanniii detect on usually screen susceptible surface the screen of the icu environment be do in April 2021 when eleven different sample be take one iA baumanniii isolate be recover from the air conditioner and be compare with four clinical iA baumanniii isolate obtain from patient hospitalize in January 2021 isolate be confirm by matrixassiste laser desorption ionizationtime of flight mass spectrometry malditof ms minimum inhibitory concentration mic be determine and the multilocus sequence type mlst be perform the molecular identification of iA baumanniii isolate as ST208 the presence of the same iblaisuboxa23sub carbapenemase gene and the same antibiotic susceptibility profile suggest that the isolate recover from the air conditioner be the same as the isolate recover from hospitalize patient the environmental isolate be recover three month late than the clinical isolate emphasize the ability of iA baumanniii to survive on dry abiotic surface the air conditioner in the clinical environment be a important but undoubtedly neglect source of iA baumanniii outbreak hence frequent disinfection of hospital air conditioner with appropriate disinfectant be mandatory to mitigate the circulation of iA baumanniii between patient and the hospital environment	2023 Mar	Emina Pustijanac, Jasna Hrenović, Mirna Vranić-Ladavac, Martina Močenić, Natalie Karčić, Lorena Lazarić Stefanović, Irena Hrstić, Jasenka Lončarić, Martina Šeruga Musić, Marina Drčelić, Dijana Majstorović, Ines Kovačić	Pathogens
37044198	physiologicallybased pharmacokinetic modeling to inform dose regimen and route of administration of rifampicin and colistin combination against acinetobacter baumannii	Carbapenemresistant acinetobacter baumannii CRAB be resistant to major antibiotic such as penicillin cephalosporin fluoroquinolone and aminoglycoside and have become a significant nosocomial pathogen the efficacy of rifampicin and colistin combination against CRAB could be dependent on the administration route and drug concentration at the site of infection	2023 Jun	Jiayuan Zhang, Chu Song, Mengyuan Wu, Jiali Yue, Shixing Zhu, Peijuan Zhu, Charles Oo, Jan-Frederik Schlender, Zhihua Lv, Yuanqi Zhu, Sherwin K B Sy, Mingming Yu	Eur J Pharm Sci
36551364	colistin monotherapy versus colistin plus Sitafloxacin for therapy of CarbapenemResistant iAcinetobacter baumanniii infection a Preliminary Study	the in vitro study of sitafloxacin against carbapenemresistant cr iAcinetobacter baumanniii demonstrate activity against most strain of cr iA baumanniii and the combination of colistin and sitafloxacin show a in vitro synergistic effect against cr iA baumanniii this study aim to compare efficacy and safety between colistin plus sitafloxacin with colistin alone for therapy for cr iA baumanniii infection this randomize control trial enrol 56 patient with cr iA baumanniii infection 28 group during 20182021 and the treatment duration be 714 day the study outcome be 28 day mortality clinical and microbiological response and adverse event there be no significant difference in 28 day mortality between group 321 combination versus 321 monotherapy ipi 1000 favorable clinical response at the end of treatment be comparable between group 815 combination versus 778 monotherapy ipi 0788 microbiological response at the end of treatment be also comparable between group 731 combination versus 741 monotherapy ipi 0934 acute kidney injury be find in 538 of the combination group and in 458 of the monotherapy group ipi 0571 in conclusion there be no significant difference in 28 day mortality between the colistin monotherapy and the colistin plus sitafloxacin group there be also no significant difference in adverse event between group	2022 Nov	Rujipas Sirijatuphat, Supawas Thawornkaew, Darat Ruangkriengsin, Visanu Thamlikitkul	Antibiotics (Basel)
37099644	unveiling mure ligase potential inhibitor for treat multidrug resistant iAcinetobacter baumanniii	iAcinetobacter baumanniii be a opportunistic pathogen with ability to cause serious infection such as bacteremia ventilator associate pneumonia and wound infection as strain of iA baumanniii be resistant to almost all clinically use antibiotic and with the emergence of carbapenem resistant phenotype warrant the search for novel antibiotic consider this herein a series of computer aid drug design approach be utilize to search novel chemical scaffold that bind strong to mure ligase enzyme of iA baumanniii which be involve peptidoglycan synthesis the work identify las22461675 las34000090 and las51177972 compound as promise bind molecule with mure enzyme have bind energy score of 105 kcalmol 93 kcalmol and 86 kcalmol respectively the compound be find to achieve dock inside the mure substrate bind pocket and establish close distance chemical interaction the interaction energy be dominate by van der waal and less contribution be see from hydrogen bond energy the dynamic simulation assay predict the complex stable with no major global and local change notice the dock stability be also validate by mmpbsa and mmgbsa bind free energy method the net mmgbsa bind free energy of las22461675 complex las34000090 complex and las51177972 complex be 2625 kcalmol 2723 kcalmol and 2964 kcalmol respectively similarly in case of mmpbsa the net energy value be in follow order las22461675 complex 2767 kcalmol las34000090 complex 2994 kcalmol and las51177972 complex 2732 kcalmol the amber entropy and waterswap method also confirm stable complex formation further molecular feature of the compound be determine that predict compound to have good druglike property and pharmacokinetic favorable the study conclude the compound to good candidate to be test by iin vivoi and iin vitroi experimental assaysCommunicated by ramaswamy H Sarma	2023 Apr	Ali Altharawi, Safar M Alqahatani, Mohammed M Alanazi, Muhammad Tahir Ul Qamar	J Biomol Struct Dyn
35595789	different clinical characteristic and impact of carbapenemresistance on outcome between acinetobacter baumannii and pseudomonas aeruginosa bacteraemia a prospective observational study	this study aim to evaluate the difference in clinical characteristic and impact of carbapenem resistance cr on outcome between acinetobacter baumannii ab and pseudomonas aeruginosa pa bacteraemia we prospectively identify all patient with ab and pa bacteraemia in 10 hospital over 1 year treatment failure be define as allcause 30 day mortality persistent bacteraemia or recurrent bacteraemia within 30 day we include 304 ab and 241 pa bacteraemia case cr be detect in 216 patient 71 with ab bacteraemia and 55 patient 23 with pa bacteraemia treatment failure be significantly high in CRAb than in CRPa 606 versus 345 p 0001 in ab severe sepsis or septic shock and high Pitt bacteraemia score be independent risk factor for treatment failure in the inappropriate empirical antibiotic group in pa hospitalacquired infection and high Pitt bacteraemia score be independent risk factor for treatment failure in both group cr be a independent risk factor in ab for treatment failure in both group but not in pa bacteraemia we demonstrate significant difference in clinical characteristic and impact of cr on clinical outcome between ab and pa bacteraemia suggest that different treatment approach may be need	2022 May	Chan Mi Lee, Young-Jun Kim, Sook-In Jung, Seong Eun Kim, Wan Beom Park, Pyoeng Gyun Choe, Eu Suk Kim, Chung-Jong Kim, Hee Jung Choi, Shinwon Lee, Sun Hee Lee, Younghee Jung, Ji Hwan Bang, Shinhye Cheon, Yee Gyung Kwak, Yu Min Kang, Kyung-Hwa Park, Kyoung-Ho Song, Hong Bin Kim, Korea INfectious Diseases (KIND) Study Group	Sci Rep
36383290	in vitro virulence activity of pseudomonas aeruginosa enhance by either acinetobacter baumannii or enterococcus faecium through the polymicrobial interaction	microbe within a infection impact neighbor pathogenicity this study aim to address in vitro virulence activity of pseudomonas aeruginosa under the binary interaction with acinetobacter baumannii or enterococcus faecium coisolated from two chronic wound infection the biofilm formation of pseudomonas be enhance 15 and 14 fold when it be simultaneously cultured with acinetobacter and enterococcus respectively pseudomonas motility be increase by 19 and 15 fold swim 36 and 19 fold swarm and 15 and 15 fold twitching in the dual culture with acinetobacter and enterococcus respectively the synergistic hemolysis activity of pseudomonas be observe with the heatkill acinetobacter and enterococcus cell the minimum inhibitory concentration of ciprofloxacin against pseudomonas be increase from μg mlsup1 sup 25 to 400 in the individual and mix culture respectively the pyocyanin production by pseudomonas in the single and mix culture with acinetobacter and enterococcus be μgmL 18 23 and 29 respectively the expression of lasI rhli and pqsR gene be upregulate by 10 19 and 163 fold and 49 10 and 93 fold when pseudomonas be incubate with acinetobacter and enterococcus respectively consider the entire community instead of a single pathogen may lead to a more effective therapeutic design for persistent infection cause by pseudomonas	2022 Nov	Ghazale Laliany, Saeid Amel Jamehdar, Ali Makhdoumi	Arch Microbiol
36658486	local characteristic of molecular epidemiolgy of acinetobacter baumannii in Jilin province northeast China	a baumannii be a opportunistic nosocomial pathogen which have severe antibiotic resistance however the epidemiology be less clearly understand in Jilin province and China thus 89 a baumannii isolate from a single hospital in Jilin province between 20132017 be perform by mlst in order to good understanding of the epidemiology of Jilin isolate Chinese strain originate from other domestic region and worldwide isolate in mlst database be analyze by silico phylogenetic tool together a total of 22 STs in Jilin be identify and 10 STs be find to be novel the top three predominant sequence type be st195 and 34 382 ST208 and 14 157 and st540 and 13 146 st369 be predict to be group founder and st195 st540 be subgroup founder of the majority STs in Jilin Province some newly discover singleton show close relationship with strain from other country which suggest that nationcross transmission be one of important origin of Jilin strain the majority of Jilin STs show clonality and close relationship with the majority from other region of China but occupation of individual STs in Jilin be different from that of other domestic region the aggregation trend and genetic relationship prove that predominant Jilin STs continue to mutate during transmission drug resistance facilitate transmission of Jilin abaumannii isolate because more than 94 of isolate be resistant to at least one carbapenem and the STs with strong resistance to carbapenem usually have more isolate in conclusion high diversity and different occupation of STs and occupation of novel STs prove that epidemiology of a baumannii in Jilin have special regional characteristic and drug resistance facilitate transmission of domestic strain and foreign strain	2023 Jan	Qingsong You, Xue Du, Nannan Hu, Yusi Zhang, Na Zhang, Fusheng Wang, Jinghua Li, Yanbo Sun, Fang Wang, Hongyan Shi	BMC Microbiol
36432857	Synergistic Effect of some methoxyflavone extract from rhizome of iKaempferia parviflorai Combine with gentamicin against CarbapenemResistant strain of iKlebsiella pneumoniae iPseudomonas aeruginosai and iAcinetobacter baumanniii	the present study aim to investigate the antibacterial activity of ethanolic iKaempferia parviflorai extract and the combine effect of the plant specific compound with gentamicin against clinical strain of carbapenemresistant iKlebsiella pneumoniae iPseudomonas aeruginosai and iAcinetobacter baumanniii the minimal inhibitory concentration mic of gentamicin and iKaempferia parviflorai extract against the test bacterial strain be determine by use broth microdilution the combine effect of iKaempferia parviflorai extract and gentamicin be investigate by use a checkerboard assay and express as a fractional inhibitory concentration index FICI crude ethanolic extract of iKaempferia parviflorai show the low median value of mic towards the test isolate ini 10 of this test bacterium at dose of 64 µgml compare to that of other iKaempferia extractsi among the isolate compound only three compound namely 357 trimethoxyflavone 35734 pentamethoxyflavone and 574trimethoxyflavone be identify by nmr structural analysis accord to they ficis the synergistic effect of gentamicin combine with 35734 pentamethoxyflavone be approximately 90 90 and 80 of test carbapenemresistant iKlebsiella pneumoniae crkp iPseudomonas aeruginosai CRPA and iAcinetobacter baumanniii CRAB respectively the present study conclude that 35734 pentamethoxyflavone extract from iKaempferia parviflorai potentiat the antibacterial action of gentamicin to combat bacterial resistance against the test bacterium	2022 Nov	Siriwoot Sookkhee, Choompone Sakonwasun, Pitchaya Mungkornasawakul, Phadungkiat Khamnoi, Nitwara Wikan, Wutigri Nimlamool	Plants (Basel)
36846201	Analysis of efflux Pump system and other drug resistance related gene mutation in tigecyclineresistant iAcinetobacter baumanniii	the isolation of tigecyclineresistant iAcinetobacter baumanniii in recent year have bring great difficulty to clinical prevention and treatment	2023	Wenzheng Zheng, Yubo Huang, Wenbin Wu, Jiaxin Zhu, Tiantuo Zhang	Comput Math Methods Med
36936223	Case report iAcinetobacter baumanniii septic arthritis in a immunocompetent infant	iAcinetobacter baumanniii be a gramnegative coccobacilli mainly cause nosocomial infection with poor prognosis especially in patient with prolong hospitalization or antibiotic administration iA baumanniii pneumonia be the most common clinical form and usually occur in critically ill patient in the intensive care unit however septic arthritis cause by iA baumanniii be rarely report in this report we describe a case of iA baumanniii septic arthritis combine with incomplete kawasaki disease in a infant the child chief complaint be a 2 week intermittent fever with poor response to antibiotic Initial physical examination reveal swollen lymph node in the neck pharynx congestion and the appearance of rash Combine with laboratory test the diagnosis of incomplete kawasaki disease be consider after administration of highdose intravenous immunoglobulin and corticosteroid the child fever improve and periungual desquamation appear simultaneously swelling of the right knee occur 5 day after the fever improve and imaging test of MRI and ultrasound suggest the existence of infection a diagnosis of septic arthritis be establish subsequently and arthroscopy be carry out iA baumanniii be finally identify by metagenomics nextgeneration sequencing of joint drain fluid for pathogenic microorganism treatment with meropenem be then start the patient eventually recover and be discharge from the hospital after 23 day of treatment with meropenem although iA baumanniii be not a common bacterium of septic arthritis this rare infection can still occur in infant early diagnosis pathogenic identification and target antibiotic treatment be important to reduce the occurrence of joint sequelae	2023	Yi Liao, Jiapeng Xiao, Feng Fang, Hua Zhou, Lingling Liu, Xinglou Liu	Front Med (Lausanne)
37149598	clonal relatedness of carbapenemresistant acinetobacter baumannii high prevalence of st136 suppassup in a burn center	Carbapenemresistant acinetobacter baumannii CRAB be a global health crisis this study aim to determine the clonal relatedness of antibioticresistant a baumannii isolate in hospitalize patient who suffer from burn wound infection	2023 May	Farzaneh Firoozeh, Mahnaz Nikibakhsh, Farzad Badmasti, Mohammad Zibaei, Vajihe Sadat Nikbin	Ann Clin Microbiol Antimicrob
36463365	acinetobacter baumannii reinforce the pathogenesis by promote il17 production in a mouse pneumonia model	interleukin17 il17 be involve in host defense against bacterial infection Little be know about the role of il17 in a baumanniiinfected pneumonia we objective be to investigate the role of il17 in pulmonary a baumannii infection in a mouse model we infect c57bl6 mouse intratracheally it with a baumannii to establish pneumonia model and find a baumannii infection elevate il17 expression in lung il17deficient il17 supsup mouse be resistant to pulmonary a baumannii infection show improve mouse survival reduce bacterium burden and alleviate lung inflammation further treatment of a baumanniiinfected il17supsup mouse with il17 exacerbate the severity of pneumonia this datum suggest a pathogenic role of il17 in pulmonary a baumannii infection further the infiltration and phagocytic function of neutrophil in bronchoalveolar lavage fluid be detect by flow cytometry the result show that il17supsup mouse have increase neutrophil infiltration and enhance phagocytosis in neutrophil at the early time of infection treatment of mouse with il17 suppress phagocytic function of neutrophil all datum suggest that il17 promote susceptibility of mouse to pulmonary a baumannii infection by suppressing neutrophil phagocytosis at early time of infection target il17 might be a potential therapeutic strategy in control the outcome of a baumannii pneumonia	2023 Feb	Yangyang Zhou, Chuanying Xiang, Ning Wang, Xiaomin Zhang, Yu Xie, Hong Yang, Gang Guo, Kaiyun Liu, Yan Li, Yun Shi	Med Microbiol Immunol
35861511	constitutive phenotypic modification of Lipid a in Clinical acinetobacter baumannii isolate	the degree of polymyxin B pmb resistance be measure in 40 clinical acinetobacter baumannii isolate obtain from health care facility all of the test isolate possess a multidrugresistant MDR phenotype against four class of antibiotic meropenem doxycycline gentamicin and erythromycin except for pmb the iblaisuboxa23sub gene be detect throughout the genetic analysis and experimental assay indicate that all of the MDR strain be carbapenemresistant a baumannii strain multilocus sequence typingbase genotyping reveal that nine select strain belong to the international clone ii lineage when matrixassiste laser desorption ionizationtime of flight mass spectrometry be perform intrinsic lipid a modification by phosphoethanolamine petn incorporation be noticeable only in the pmbresistant pmbsuprsup strain however the presence of hexa and pentaacylated lipid a due to the loss of the laurate csub12 sub acyl chain be note in all pmbsusceptible strain but not in the pmbsuprsup strain the reduction of negative surface charge in the pmbsuprsup strain be assess by zeta potential analysis fluorescence imaging use dansylPMB reveal that in the pmbsuprsup strain pmb be less likely to bind to the cell surface bimportanceb the widespread presence of MDR pathogen include a baumannii be cause serious hospitalacquired infection worldwide extensive surveillance of MDR clinical a baumannii isolate have be conduct but the underlying mechanism for they development of MDR phenotype be often neglect either lipid a modification or loss of lipopolysaccharide in gramnegative bacterium lead to pmbsuprsup phenotype the prevalence of intrinsic lipid a modification in pmbsuprsup clinical strain be attribute to high level of basal expression of ipmrCi and ieptA1i we finding suggest that new therapeutic strategy be warrant to combat MDR pathogen due to the emergence of many pmbsuprsup clinical strain	2022 Aug	Su-Hyun Kim, Sohyeon Yun, Woojun Park	Microbiol Spectr
36687622	colistin potentiation in multidrugresistant iAcinetobacter baumanniii by a noncytotoxic guanidine derivative of silver	a novel nanoformulation nf that sensitize iAcinetobacter baumanniii ab to otherwise ineffective colistin be describe in the present study infection due to multidrug resistant MDR ab represent a major therapeutic challenge especially in situation of preexisting colistin resistance colR subsequently boosting the effectiveness of colistin would be a good alternative tactic to treat ab infection rather than discovering a new class of antibiotic we have previously demonstrate a nf comprise selfassembled guanidinium and ionic silver nanoparticle adlag0 to have antibiofilm and bactericidal activity we report nf adlag0 for the very first time for the potentiation of colistin in gramnegative colistinresistant bacterium we result imply that a combination of clinically relevant concentration of colistin and adlag0 significantly decrease colistinresistant ab bacterial growth and viability which otherwise be elevate in the presence of only colistin in this study we have describe various combination of minimum inhibitory concentration mic of colistin miccol sup12 sup miccol and sup14sup miccol and that of adlag0 micadlag0 sup12 sup micadlag0 and sup14sup micadlag0 and test they against MDR ab culture the result in broth as well as in solid media signified that adlag0 be able to potentiate the antimicrobial activity of colistin at submic concentration furthermore the viability and metabolic activity of bacterial cell be also measure by ctc fluorescence assay and atp bioluminescence assay the result of this assay be in perfect concordance with the score of culture colony form unit and culture turbidity in addition quantitative realtime pcr qrtpcr be perform to unveil the expression of select gene dnagyra dnagyrb and dac this gene introduce negative supercoiling in the DNA and hence be important for basic cellular process this gene due to mutation modify the Lipid a of bacterium further resist the uptake of colistin therefore the expression of this gene be upregulate when ab be treat with only colistin substantiate that ab be resistant to colistin whereas the combination of miccol micadlag0 downregulated the expression of this gene imply that the develop formulation can potentiate the efficiency of colistin in conclusion adlag0 can potentiate the proficiency of colistin further enhancing colistinmediated death of ab by putatively disrupt the outer membrane om and facilitate bacterial death	2022	Deepak Kumar, Chaitali Singhal, Manisha Yadav, Pooja Joshi, Priyanka Patra, Subhash Tanwar, Amitava Das, Sumit Kumar Pramanik, Susmita Chaudhuri	Front Microbiol
37113664	a fresh phresponsive imipenemloaded nanocarrier against iAcinetobacter baumanniii with a synergetic effect	in recent year the treatment of iAcinetobacter baumanniii infection have become a press clinical challenge due to its increase incidence and its serious pathogenic risk the research and development of new antibacterial agent for iA baumanniii have attract the attention of the scientific community therefore we have construct a new phresponsive antibacterial nanodelivery system imigif8 for the antibacterial treatment of iA baumanniii due to its phsensitive characteristic the nanodelivery system offer a improve release of the load imipenem antibiotic at the acidic infection site base on the high loading capacity and positive charge of the modify ZIF8 nanoparticle they be excellent carrier and be suitable for imipenem loading the imigif8 nanosystem feature synergistic antibacterial effect combine ZIF8 and imipenem to eliminate iA baumanniii through different antibacterial mechanism when the load imipenem concentration reach 20 µgml imigif8 be highly effective against iA baumannii in vitroi imigif8 not only inhibit the biofilm formation of iA baumanniii but also have a potent kill effect furthermore in mouse with celiac disease the imigif8 nanosystem demonstrate excellent therapeutic efficacy against iA baumanniii at imipenem concentration of 10 mgkg and it can inhibit inflammatory reaction and local leukocyte infiltration due to its biocompatibility and biosafety this nanodelivery system be a promise therapeutic strategy in the clinical treatment of iA baumanniii infection provide a new direction for the treatment of antibacterial infection	2023	Shumin Gui, Xisheng Li, Mingming Feng, Hui Liu, Liwenhui Huang, Xinqing Niu	Front Bioeng Biotechnol
37059703	repurposing hostguest chemistry to sequester virulence and eradicate biofilm in multidrug resistant pseudomonas aeruginosa and acinetobacter baumannii	the limited diversity in target of available antibiotic therapy have put tremendous pressure on the treatment of bacterial pathogen where numerous resistance mechanism that counteract they function be become increasingly prevalent here we utilize a unconventional antivirulence screen of hostguest interact macrocycle and identify a watersoluble synthetic macrocycle pillar5arene that be nonbactericidalbacteriostatic and have a mechanism of action that involve bind to both homoserine lactone and lipopolysaccharide key virulence factor in gramnegative pathogen pillar5arene be active against top priority carbapenem and thirdfourthgeneration cephalosporinresistant pseudomonas aeruginosa and acinetobacter baumannii suppressing toxin and biofilm and increase the penetration and efficacy of standardofcare antibiotic in combine administration the bind of homoserine lactone and lipopolysaccharide also sequester they direct effect as toxin on eukaryotic membrane neutralizing key tool that promote bacterial colonization and impede immune defens both in vitro and in vivo pillar5arene evade both exist antibiotic resistance mechanism as well as the buildup of rapid toleranceresistance the versatility of macrocyclic hostguest chemistry provide ample strategy for tailor target of virulence in a wide range of gramnegative infectious disease	2023 Apr	Christopher Jonkergouw, Ngong Kodiah Beyeh, Ekaterina Osmekhina, Katarzyna Leskinen, S Maryamdokht Taimoory, Dmitrii Fedorov, Eduardo Anaya-Plaza, Mauri A Kostiainen, John F Trant, Robin H A Ras, Päivi Saavalainen, Markus B Linder	Nat Commun
36267170	iin vitroi evaluation of the antimicrobial activity of antiseptics against clinical iAcinetobacter baumanniii strain isolate from combat wound	healthcareassociated infection hcais be among the most prominent medical problem worldwide in the context of increase antibiotic resistance globally the use of antiseptics as the main active agent and potentiator of antibiotic for the treatment of purulentinflammatory complication of traumatic wound burn and surgical wound can be consider to tackle opportunistic infection and they prevention during war this study present a comparative investigation of the antimicrobial efficacy of antiseptics use for surgical antisepsis and antiseptic treatment of skin mucous membrane and wound against multidrugresistant clinical isolate of iAcinetobacter baumanniii as a wound pathogen of critical priority accord to the who it be find that strain of iA baumanniii which have natural and acquire resistance to antimicrobial drug remain susceptible to modern antiseptics antiseptic drug base on decamethoxine chlorhexidine octenidine polyhexanide and povidoneiodine 10 and 2 provide effective bactericidal activity against iA baumanniii within the work concentration of this drug Chlorhexidine and decamethoxine can inhibit biofilm formation by iA baumanniii cell in term of bactericidal property and biofilm formation inhibition chlorhexidine and decamethoxine be the most effective of all test antiseptics	2022	Tetyana Valeriyivna Denysko, Oleksandr Adamovych Nazarchuk, Oleksandr Gruzevskyi, Nataliia Ànatoliivna Bahniuk, Dmytro Valeriiovych Dmytriiev, Roman Mykolayovych Chornopyschuk, Vira Volodymyrivna Bebyk	Front Microbiol
36853012	therapeutic humanized monoclonal antibody exhibit Broad binding and protective efficacy against acinetobacter baumannii	acinetobacter baumannii be a extremely drugresistant pathogen necessitating the development of new therapy we seek to generate a cocktail of monoclonal antibody mabs that can target the full diversity of a baumannii isolate we have newly identify the antibody mab5 here we demonstrate that mab5 have broad bind against US ini 300 and international ini 250 isolate 7224 and 2876 respectively likely target oantigen capsular carbohydrate and exhibit protective efficacy iin vivoi	2023 Mar	Matthew Slarve, Zeferino Reyna, Elizabeth Burk, Juan Ruiz-Delgado, Rachel Li, Jun Yan, Brian Luna, Brad Spellberg	Antimicrob Agents Chemother
35181526	use engineer water nanostructure ewns for wound disinfection Case study of acinetobacter baumannii inactivation on skin and the inhibition of biofilm formation	engineer water nanostructure ewns be utilize to deliver a cocktail of nature derive antimicrobial to assess they efficacy as a solution to the problem of wound infection the wound related microorganism acinetobacter baumannii be inoculate on stainless steel and porcine skin and treat with ewns ewns be able to reduce a baumannii on stainless steel by 479 log in 15 minute and 2 log in 30 minute on porcine skin the ewns be able to reduce the strength of a baumannii biofilm on stainless steel by 8731 as measure with the xtt assay p 001 and 8627 in cellular count p 001 after two ewns intervention of 30 minute each total antimicrobial dose deliver to the surface be 142 ng SEM of biofilm after ewns treatment show reduce biomass this result indicate that the ewns technology have potential for application in field of wound disinfection and heal	2022 Jun	Nachiket Vaze, Philip Demokritou	Nanomedicine
36189355	biofilm formation be not a independent risk factor for mortality in patient with iAcinetobacter baumanniii bacteremia	in the past decade due to the high prevalence of the antibioticresistant isolate of iAcinetobacter baumanniii it have emerge as one of the most troublesome pathogen threaten the global healthcare system furthermore this pathogen have the ability to form biofilm which be another effective mechanism by which it survive in the presence of antibiotic however the clinical impact of biofilmforming iA baumanniii isolate on patient with bacteremia be largely unknown this retrospective study be conduct at five medical center in Taiwan over a 9year period a total of 252 and 459 patient with bacteremia cause by biofilm and nonbiofilmforming isolate of iA baumanniii respectively be enrol the clinical demographic antimicrobial susceptibility biofilmforming ability and patient clinical outcome be analyze the biofilmforming ability of the isolate be assess use a microtiter plate assay multivariate analysis reveal the high apache ii score shock status lack of appropriate antimicrobial therapy and carbapenem resistance of the infect strain be independent risk factor of 28 day mortality in the patient with iA baumanniii bacteremia however there be no significant difference between the 28day survival and nonsurvival group in term of the biofilm form ability compare to the patient infect with nonbiofilmforming isolate that infect with biofilmforming isolate have a low inhospital mortality rate patient with either congestive heart failure underlying hematological malignancy or chemotherapy recipient be more likely to become infect with the biofilmforming isolate multivariate analysis show congestive heart failure be a independent risk factor of infection with biofilmforming isolate while that with arterial line tend to be infect with nonbiofilmforming isolate there be no significant difference in the source of infection between the biofilmforming and nonbiofilmforming isolate group carbapenem susceptibility be also similar between this group in conclusion the patient infect with the biofilmforming isolate of the iA baumanniii exhibit different clinical feature than that infect with nonbiofilmforming isolate the biofilmforming ability of iA baumanniii may also influence the antibiotic susceptibility of its isolate however it be not a independent risk factor for a 28 day mortality in the patient with bacteremia	2022	Tsung-Ta Chiang, Tzu-Wen Huang, Jun-Ren Sun, Shu-Chen Kuo, Aristine Cheng, Chang-Pan Liu, Yuag-Meng Liu, Ya-Sung Yang, Te-Li Chen, Yi-Tzu Lee, Yung-Chih Wang	Front Cell Infect Microbiol
36604462	characterisation and sequencing of the novel phage abp95 which be effective against multigenoty of carbapenemresistant acinetobacter baumannii	acinetobacter baumannii have become one of the most challenging conditional pathogen in health facility it cause various infectious disease in human such as wound or urinary tract infection and pneumonia phage therapy have be use as a alternative strategy for antibioticresistant a baumannii infection and have be approve by several government previously we have report two potential phage therapy candidate abp1 and abp9 both of which be narrowhostrange phage in the present study we screen and isolate 22 a baumannii bacteriophage from hospital sewage water and determine that abp95 have a wide host range 29 58200 the biological and genomic characteristic and antiinfection potential of abp95 be also investigate abp95 belong to the myoviridae family with a gc content of 3785 and a genome size of 43176 bp its genome encode 77 putative gene none of which be virulence lysogeny or antibiotic resistance gene abp95 be find to accelerate wound heal in a diabetic mouse wound infection model by clear local infection of multidrugresistant a baumannii in conclusion the lytic phage abp95 which have a wide host range demonstrate potential as a candidate for phage therapy against multiple sequence type of carbapenemresistant a baumannii	2023 Jan	Li Huang, Siyi Huang, Lingli Jiang, Jingjie Tan, Xueping Yan, Chunmei Gou, Xinchong Chen, Lijuan Xiang, Dali Wang, Guangtao Huang, Yixin Zhang, Chengliang Deng	Sci Rep
37107101	quercetin Synergistic interaction with antibiotic against ColistinResistant iAcinetobacter baumanniii	infection cause by resistant strain of iAcinetobacter baumanniii be now a global problem that require the immediate development of new antimicrobial drug combination therapy be one of the strategy use to solve this problem base on this information the purpose of this study be to determine whether quercetin que in combination with three antibiotic be effective against colistinresistant iA baumanniii strain colrab the effect of the combination of que with colistin COL amikacin AMK and meropenem MEM be evaluate accord to the checkerboard synergy test the combination of que COL and que AMK show synergistic activity on colrab strain with FICI value in the range of 0187505 and 0187502825 respectively a 4 to 16 fold decrease in COL mic and a 16 to 64 fold decrease in AMK mic value be detect Synergistic activity be confirm by the timekill test and this combination be find to be bactericidal at the end of 24 h accord to spectrophotometric measurement the combination of que COL and que AMK induce membrane damage lead to the leakage of nucleic acid cell lysis and cell death be confirm with SEM observation the detect synergy offer a opportunity for the future development of treatment strategy for potential infection cause by colrab strain	2023 Apr	Elif Odabaş Köse, Özlem Koyuncu Özyurt, Süreyya Bilmen, Hakan Er, Cansu Kilit, Esra Aydemir	Antibiotics (Basel)
35980044	immune response to conjugate of fragment of the type kill capsular polysaccharide of acinetobacter baumannii with Carrier protein	the clonal bacterial species acinetobacter baumannii be a emerge multidrugresistant pathogen which cause highlethality infection cell of a baumannii be surround by the typespecific capsular polysaccharide CPS which provide resistance to the protective mechanism of the host and be consider a target for immunization the conjugate of three inert carrier protein and a baumannii type kill CPS fragment which contain various number of oligosaccharide repeat kunit be synthesized by periodate oxidation and squaric acid chemistry the conjugate be apply to immunize mouse and chemical synthesis by squaric acid be show to significantly improve the immunogenic property of glycoconjugate in balbc mouse IgG antibody be predominant among type kill CPS reactive antibody and they total content be several time high than that of IgM immune sera be characterize by they opsonization ability during practically the entire life of the experimental mouse the sera be crossreactive but the high specificity be observe against the antigen type kill CPS use for immunization the immunization of balbc and ICR1 mouse with a glycoconjugate without adjuvant lead to vary degree of stimulation of IL10 IL17A and tnfα production but not il4 production in the ICR1 mouse this be in contrast to the balbc mouse in which γIFN production be also activate the protective effectiveness of the glycoconjugate obtain by squaric acid chemistry be demonstrate by experiment that involve challenging immunize and nonimmunize animal with a lethal dose of a baumannii kill bimportanceb Immunization by glycoconjugate with a baumannii type kill CPS fragment induce a high level of antibody predominantly IgG in sera which react specifically with the CPS of a baumannii type kill as well as a long immunological memory the sera of immunize animal efficiently opsonize a baumannii type kill Immunization result in the balance production of proantiinflammatory lymphokine and protective antibody to ensure the survival of the mouse infect with a baumannii the level of specific antibody be sufficient to provide protective immunity against the challenge by a baumannii make this approach applicable in the development of vaccine preparation	2022 Oct	Natalia Rudenko, Anna Karatovskaya, Anna Zamyatina, Anna Shepelyakovskaya, Svetlana Semushina, Fedor Brovko, Anna Shpirt, Vladimir Torgov, Natalia Kolotyrkina, Alexandr Zinin, Anastasiya Kasimova, Andrei Perepelov, Mikhail Shneider, Yuriy Knirel	Microbiol Spectr
37093361	molecular docking antibiofilm antibacterial activity and therapeutic index of mcm11 peptide on acinetobacter baumannii strain	despite the huge effort of microbiologist infectious disease have yet remain one of the lead cause of death in human further highlight the research priority for control opportunistic pathogen many researcher have use antibacterial peptide to solve the problem of antibiotic resistance this research be thus conduct to investigate the antibacterial and antibiofilm activity of a novel modify cecropinmelittin 11 peptide with improve therapeutic property and low side effect after synthesis and purification of mcm11 nh2wrlfrrilrvlnh2 by solidphase synthesis and hplc method respectively the antibacterial and biofilm inhibitory activity be explore in vitro tmhmm be use to confirm the reaction of mcm11 on the plasma membrane of the prokaryotic cell the interaction between mcm11 on acinetobacter baumannii strain be investigate by molecular docking use ClusPro20 hemolysis and therapeutic index be also calculate to quantify the relative safety and adverse effect of mcm11 accord to the result mcm11 have a high inhibitory and lethal effect on a baumannii strain due to its cationic property and new specific sequence molecular docking reveal the release of a significant amount of energy when mcm11 bind to the surface of a baumannii in a appropriate site the finding indicate that mcm11 IC50 4 μgmL lysed 278 of rbc moreover 8 strain of acinetobacter baumannii show a favorable therapeutic index the mcm11 exhibit strong antibacterial and antibiofilm activity against a baumannii strain suggest its potential therapeutic role in infection cause by this strain similar to its impact on a baumannii mcm11 could be a suitable alternative to antibiotic in combat against antibioticresistant bacterium in the in vivo experiment	2023 Apr	Sajjad Eshtiaghi, Razieh Nazari, Mahdi Fasihi-Ramandi	Curr Microbiol
35420470	c6 hydroxymethylsubstited carbapenem ma1206 inhibit the Major iAcinetobacter baumanniii Carbapenemase oxa23 by impeding deacylation	acinetobacter baumannii have become a major nosocomial pathogen as it be often multidrugresistant which result in infection characterize by high mortality rate the bacterium achieve high level of resistance to βlactam antibiotic by produce βlactamase enzyme which destroy this valuable agent historically the carbapenem family of βlactam antibiotic have be the drug of choice for treat a baumannii infection however they effectiveness have be significantly diminish due to the pathogen production of carbapenemhydrolyzing class D βlactamase chdl thus new antibiotic and inhibitor of this enzyme be urgently need here we describe a new carbapenem antibiotic ma1206 in which the canonical c6 hydroxyethyl group have be replace with hydroxymethyl the antimicrobial susceptibility study present here demonstrate that this compound be more potent than meropenem and imipenem against a baumannii produce oxa23 the most prevalent chdl of this pathogen and also against strain produce the chdl oxa2440 and the class B metallo βlactamase vim2 we kinetic and mass spectrometry study reveal that this drug be a reversible inhibitor of oxa23 where inhibition take place through a branch pathway Xray crystallographic study molecular docking and molecular dynamic simulation of the oxa23ma1206 complex show that the c6 hydroxymethyl group form a hydrogen bond with the carboxylated catalytic lysine of oxa23 effectively prevent deacylation this result provide a promise strategy for design a new generation of CHDLresistant carbapenem to restore they efficacy against deadly a baumannii infection bimportanceb carbapenem antibiotic be the drug of choice for treatment of deadly infection cause by gramnegative bacterium however they efficacy be severely compromise by the wide spread of carbapenemhydrolyzing class D βlactamase chdl the importance of this research be the discovery that substitution of the canonical hydroxyethyl group of carbapenem by a hydroxymethyl significantly enhance stability against inactivation by the major chdl of acinetobacter baumannii oxa23 this result provide a novel strategy for design nextgeneration carbapenemasestable carbapenem to fight multidrugresistant infection cause by gramnegative pathogen	2022 Jun	Nichole K Stewart, Marta Toth, Maha A Alqurafi, Weirui Chai, Thu Q Nguyen, Pojun Quan, Mijoon Lee, John D Buynak, Clyde A Smith, Sergei B Vakulenko	mBio
35148917	infection control measure to stop the spread of sequence type 15 oxa23 produce acinetobacter baumannii in a Swedish burn Center	to describe the course of the outbreak and infection control measure to stop the spread of sequence type 15 oxa23 produce acinetobacter baumannii in the burn Center of uppsala University Hospital between November 2014 and the end of April 2015	2022 Dec	Marie Lindblad, Susanne Sütterlin, Eva Tano, Fredrik Huss, Birgitta Lytsy	Burns
35830449	Synergistic activity of colistin combine with other antimicrobial agent against colistinresistant acinetobacter baumannii clinical isolate	emerge resistance to colistin in acinetobacter baumannii clinical strain be concern because of the limited therapeutic choice for this important clinical pathogen we study the in vitro activity of different colistinbased antimicrobial agent combination against colistinresistant acinetobacter baumannii Fourteen clinical isolate of colistinresistant acinetobacter baumannii be obtain between 2015 and 2016 to identify colistinbased combination with synergistic activity multiple two antimicrobial combination base on 8 commercially available drug be evaluate by the checkerboard method the most effective colistinbased combination be vancomycin aztreonam ceftazidime and imipenem which show synergistic activity against all examine strain Colistinrifampin show synergy against four strain colistintigecycline and colistinamikacin mostly show indifferent result by use the checkerboard test we be able to find the most promise colistinbased combination that may provide more therapeutic option against colistinresistant acinetobacter baumannii	2022	Mashal M Almutairi	PLoS One
36726662	role of efflux pump in reduced susceptibility to tigecycline among Clinical isolate of iAcinetobacter baumanniii	iAcinetobacter baumanniii iA baumanniii be a very wellknown emerge pathogen and have become a major burden on healthcare system especially in intensive care unit icus tigecycline be the last resort drug for treatment of multidrugresistant iA baumanniii infection however nonsusceptibility to this drug be a rise problem resistance to tigecycline be mediate by resistancenodulationcell division RND efflux pump	2022	Ashoka Mahapatra, Amresh Pati, Kavita Gupta	Int J Appl Basic Med Res
35862390	adjuvant antimicrobial activity and resensitization efficacy of geraniol in combination with antibiotic on acinetobacter baumannii clinical isolate	adjuvant use of geraniol a plant essential oil component be know to increase the efficacy of antibiotic by act as a potent inhibitor of efflux mechanism in this study we assess the effect of a geraniolantibiotic combination in 21 acinetobacter baumannii clinical isolate consisting of high efflux he and low efflux LE activity group we determine the mic for geraniol and the four antibiotic and evaluate the adjuvant antimicrobial activity and resensitization efficacy of adjuvant geraniol Geraniolantibiotic combination significantly reduce the mic of all four antibiotic p 00001 and the fold change in mic decrease by 4 to 256 fold for tigecycline 16 to 4096 fold for ceftazidime 1 to 4096 fold for cefepime and 2 to 4096 fold for ciprofloxacin importantly geraniol show adjuvant antimicrobial activity and resensitization efficacy when use in combination with antibiotic in 21 a baumannii clinical isolate however there be no statistically significant difference between the he and LE group lo concentration 0125 and 00625 of geraniol show no cytotoxic or hemolytic activity we study show that geraniol act as a antibiotic adjuvant be a good candidate for in vivo study of combination therapy for the treatment of mdrxdr a baumannii infection	2022	Choon-Mee Kim, Young Jin Ko, Seul-Bi Lee, Sook Jin Jang	PLoS One
37033475	corrigendum detection and homology analysis of carbapenem resistant acinetobacter baumannii resistance gene	this correct the article doi 103389 fcimb2022987260	2023	Hua-Liang Huang, Yue-Yu Li, Hong-Bo Guo	Front Cell Infect Microbiol
36518018	high rate of extensively drugresistant iAcinetobacter baumanniii in a peruvian hospital 20132019	multidrugresistant MDR iAcinetobacter baumanniii have become a major concern of hospital care the objective of the study be to evaluate the evolution of antimicrobial resistance of iA baumanniii in a peruvian hospital from 2013 to 2019 a total of 993 iA baumanniii clinical isolate be recover antimicrobial resistance level be extremely high except for colistin among the remain antibacterial agent ampicillin plus sulbactam ams be the most active 714 of resistance with resistance level to the remain agent range from 759 to amikacin to 992 to ertapenem the presence of significant difference be observe in extensively drugresistant XDR iA baumanniii accord to sample origin no association be observe between MDR or XDR isolate and seasonality a impressive rate of XDR iA baumanniii isolate be find include a grow number of onlycolistinsusceptible isolate highlight the urgent need for new therapeutic alternative	2023 Apr	Rodrigo Samuel Barrientos-Yong, Bryan Andrei Hinojosa-Salas, Percy Genaro Salas-Ponce, Eddie Angles, Joaquim Ruiz, Maria J Pons	Trop Doct
35974429	Evolution and transmission of CefiderocolResistant acinetobacter baumannii during a Outbreak in the burn intensive Care unit	we report on 11 critically ill burn patient treat with cefiderocol for carbapenemresistant acinetobacter baumannii infection Clinical success be achieve in 36 and complicated by treatmentemergent resistance and interpatient transmission of cefiderocolresistant a baumannii resistant isolate harbor disrupt pirA and piuA gene that be not disrupt among susceptible isolate	2023 Feb	Steven M Smoke, Alison Brophy, Samuel Reveron, Alina Iovleva, Ellen G Kline, Michael Marano, Lincoln P Miller, Ryan K Shields	Clin Infect Dis
35595766	6bromo2 naphthol from silene armeria extract sensitize acinetobacter baumannii strain to polymyxin	the overuse of antibiotic have lead to the emergence of multidrugresistant bacterium which be resistant to various antibiotic combination therapy use natural compound with antibiotic have be find to have synergistic effect against several pathogen Synergistic natural compound can potentiate the effect of polymyxin for the treatment of acinetobacter baumannii infection out of 120 type of plant extract only silene armeria extract sae show a synergistic effect with polymyxin B pmb in we fractional inhibitory concentration and timekill analysis the survival rate of G mellonella infect with a baumannii atcc 17978 increase follow the synergistic treatment interestingly the addition of osmolyte such as trehalose canceled the synergistic effect of sae with pmb however the underlying mechanism remain unclear quadrupole timeofflight liquid chromatographymass spectrometry reveal 6 bromo2 naphthol 6b2n to be a major active compound that exhibit synergistic effect with pmb pretreatment with 6b2n make a baumannii cell more susceptible to pmb exposure in a time and concentrationdependent manner indicate that 6b2n exhibit consequential synergistic action with pmb moreover the exposure of 6B2 ntreated cell to pmb lead to high membrane leakage and permeability the present finding provide a promise approach for utilize plant extract as adjuvant to reduce the toxicity of pmb in a baumannii infection	2022 May	Mingyeong Kang, Wonjae Kim, Jaebok Lee, Hye Su Jung, Che Ok Jeon, Woojun Park	Sci Rep
35783393	genomic Characterization of mobile genetic element Associated with carbapenem resistance of iAcinetobacter baumanniii from India	with the excessive genome plasticity iAcinetobacter baumanniii can acquire and disseminate antimicrobial resistance amr gene often associate with mobile genetic element mge analyze the genetic environment of resistance gene often provide valuable information on the origin emergence evolution and spread of resistance thus we characterize the genomic feature of some clinical isolate of carbapenemresistant iA baumanniii CRAb to understand the role of diverse mge and they genetic context responsible for disseminate carbapenem resistance gene for this 17 clinical isolate of iA baumanniii obtain from multiple hospital in India between 2018 and 2019 be analyze amr determinant the genetic context of resistance gene and molecular epidemiology be study use wholegenome sequencing this study observe a increase prevalence of iblai subioxa23isub follow by dual carbapenemase iblai subioxa23isub and iblai subindmisub this study identify three novel Oxford mlst sequence type the majority of the isolate belong to the dominant clone ic2 follow by less prevalent clone such as ic7 and IC8 this study identify variation of abar4 and abgri belong to the ic2 lineage to the good of we knowledge this be the first study that provide comprehensive profiling of resistance island they related mge acquire amr gene and the distribution of clonal lineage of CRAb from India	2022	Saranya Vijayakumar, Jobin John Jacob, Karthick Vasudevan, Purva Mathur, Pallab Ray, Ayyanraj Neeravi, Ashtawarthani Baskaran, Agilandeeswari Kirubananthan, Shalini Anandan, Indranil Biswas, Kamini Walia, Balaji Veeraraghavan	Front Microbiol
35971084	transcriptomic analysis reveal the regulatory role of quorum sensing in the acinetobacter baumannii atcc 19606 via rnaseq	acinetobacter baumannii have emerge as the major opportunistic pathogen in healthcareassociated infection with highlevel antibiotic resistance and high mortality quorum sensing qs system be a celltocell bacterial communication mediate by the synthesis secretion and bind of autoinducer signal it be a global regulatory system to coordinate the behavior of individual bacterium in a population the present study focus on the qs system aim to investigate the regulatory role of qs in bacterial virulence and antibiotic resistance	2022 Aug	Li Xiong, Fanli Yi, Qiuju Yu, Xiyue Huang, Keping Ao, Yuanfang Wang, Yi Xie	BMC Microbiol
36005804	iin Vitroi activity of sulbactamdurlobactam against Global isolate of iAcinetobacter baumanniiiicalcoaceticusi complex collect from 2016 to 2021	sulbactamdurlobactam be a βlactam βlactamase inhibitor combination design to treat serious acinetobacter baumanniiicalcoaceticusi complex ABC infection include carbapenemnonsusceptible and multidrugresistant MDR isolate the current study characterize the iin vitroi activity of sulbactamdurlobactam against a collection of 5032 ABC clinical isolate collect in 33 country across the asiasouth Pacific region Europe Latin America the Middle East and North America from 2016 to 2021 the sulbactamdurlobactam micsub50sub and micsub90 sub be 1 and 2 μgmL respectively for all ABC isolate test the addition of durlobactam at a fix concentration of 4 μgmL to sulbactam decrease its micsub50 sub by 8 fold from 8 to 1 μgmL and its micsub90 sub by 32 fold from 64 to 2 μgmL for all ABC isolate the iin vitroi activity of sulbactamdurlobactam be maintain across individual ABC species year global region of collection specimen source and resistance phenotype include MDR and extensively drugresistant XDR isolate at 4 μgmL preliminary sulbactamdurlobactam susceptible mic breakpoint sulbactamdurlobactam inhibit 983 of all ABC isolate and 96 of sulbactam imipenem ciprofloxacin amikacin and minocyclinenonsusceptible isolate as well as colistinresistant MDR and XDR isolate most imipenemnonsusceptible ABC isolate 968 24882570 be carbapenemresistant a baumannii CRAB 969 24102488 of CRAB isolate be sulbactamdurlobactamsusceptible more than 80 of ABC isolate have sulbactamdurlobactam mic value that be ≥ 2 doublingdilution 4 fold low than sulbactam alone only 17 845032 of ABC isolate from 2016 to 2021 have sulbactamdurlobactam mic value of 4 μgmL of the 84 isolate 940 be a baumannii 48 be a pittii and 12 be a nosocomialis in summary sulbactamdurlobactam demonstrate potent antibacterial activity against a 2016 to 2021 collection of geographically diverse clinical isolate of ABC isolate include carbapenemnonsusceptible and MDR isolate	2022 Sep	James A Karlowsky, Meredith A Hackel, Sarah M McLeod, Alita A Miller	Antimicrob Agents Chemother
36195749	antibiotic resistance and carriage class I integron in clinical isolate of acinetobacter baumannii from Al muthanna Iraq	the goal of this work be to systematically characterize and detect class 1 2 and 3 integron with many antibiotic resistance a baumannii strain collect from a clinical environment in Iraq almuthanna hospital in this investigation 24 nonreplicated clinical strain of a baumannii be evaluate use Chrome agar as a selective medium and pcr of the rplB gene the clonal relatedness of the isolate to class 1 integron be evaluate use a pcr technique the prevalence of class 1 integron be detect by pcr in only 12 clone of a baumannii follow by HinfI digestion analysis show three identical band at 160 bp 1350 bp and 870 bp in addition pcr sequencing confirm the presence of gene cassette array consisting of aaca4cata8 aadA1 100 in class 1 integron the sequence analysis of the integron show 9787 identity with a baumannii isolate from Australia genbank accession number cp054302 among a baumannii isolate the blast analysis of this class I integron show that the presence of the intI1 aaca4cata8 aadA1 gene can considerably boost the acquisition of MDR phenotype in a baumannii isolate we conclude that antibiotic of many type be widely use the presence of integron in a baumannii be concern for public health in the clinical set it appear that the class 1 integron can be use as a predictive biomarker for the presence of MDR phenotype in this bacterium however the integron do not possess carbapenemase gene	2022 Dec	Yasir Adil Jabbar Alabdali	J Antibiot (Tokyo)
36045685	hybrid antigen express surface loop of BauA from iAcinetobacter baumanniii be capable of inducing protection against infection	iAcinetobacter baumanniii be a human bacterial pathogen of increase concern in clinical setting due to the emergence of antibiotic resistant strain and the lack of effective therapeutics researcher have be explore new treatment option such as novel drug candidate and vaccine to prevent severe infection and mortality bacterial surface antigen that be essential to iA baumanniii for acquire micronutrient eg iron zinc from nutrient restrict environment be be consider as target for vaccine or immunotherapy due to they crucial role for growth and pathogenesis in the human host BauA the outer membrane receptor for the siderophore acinetobactin be target for vaccine development in this study due to challenge in the commercial production of membrane protein for vaccine a novel hybrid antigen method develop by we group be use expose loop of BauA be select and display on a foreign scaffold to generate novel hybrid antigen design to elicit a immune response against the native BauA protein the potential epitope be incorporate into a scaffold derive from the clobe of iNeisseria meningitidisi transferrin bind protein B TbpB name the loopless clobe LCL hybrid protein display three select loop 5 7 and 8 individually or in combination be design and produce and evaluate in a iA baumanniii murine sepsis model as vaccine antigen Immunization with the recombinant BauA protein protect 100 of the mouse while immunization with hybrid antigen display individual loop achieve between 50 and 100 protection the LCL scaffold do not induce a protective immune response enable we to attribute the observe protection elicited by the hybrid antigen to the display loop notably the mouse immunize with the hybrid antigen display loop 7 be completely protect from infection taken together this result suggest that we hybrid antigen approach be a viable method for generate novel vaccine antigen that target membrane surface protein necessary for bacterial growth and pathogenesis and the loop 7 hybrid antigen can be a foundation for approach to combat iA baumanniii infection	2022	Somshukla Chaudhuri, Iraj Rasooli, Ramin Hatefi Oskouei, Mahdi Pishgahi, Abolfazl Jahangir, Vahid Farshchi Andisi, Anthony B Schryvers	Front Immunol
36909706	Computational exploration of molecular flexibility and interaction of meropenem analog with the active site of oxacillinase23 in iAcinetobacter baumanniii	bBackgroundb Carbapenemresistant iAcinetobacter baumanniii be a opportunistic pathogen responsible for nosocomial infection and be one of the big global threat accord to the World Health Organization who particularly cause substantial morbidity and mortality bObjectivesb this study aim at use computational approach to screen meropenem and its analog against oxa23 positive iAcinetobacter baumanniii analyze the correlation between kinetic and phenotypic characteristic bMethodsb a total of 5450 compound be screen use virtual screen workflow htus GlideSP and GlideXP to identify the good compound base on they bind energy and interaction against oxa23 and oxa27 as they have phenotypic datum available molecular dynamic simulation and density functional theory DFT study be perform from the outcome of molecular docking analysis bResultsb during simulation meropenem and its analog exhibit highlevel stable interaction with ser79 ser126 thr217 trp219 and arg259 of oxa23 meropenem display a covdock energy of about 35 and 19 kcal molsup1 sup against oxa23 and oxa27 respectively among the 5450 compound Pubchem10645796 pubchem25224737 and chembl14 record covdock energy between 60 and 90 kcal molsup1sup moreover the infrared ir spectrophotometric analysis reveal CO and CN atom show band at 1800 and 1125 cmsup1 sup respectively this observe datum be in congruence with the experimental observation bConclusionb the identify compound show good agreement with the spectrophotometric analysis use DFT method in the early study meropenem mic value be 32 μg mlsup1sup in oxa23 positive isolate a2265 compare to the mic of 1 μg mlsup1sup in Δiblai suboxa23sub a2265 Comparing the covdock energy and hydrogenbonding interaction the predict result be in good agreement with the experimental datum report early we result highlight the importance of oxa23 molecular docking study and they compliance with the phenotypic result it will help further in develop new antibiotic for treat severe infection associate with carbapenemresistant iA baumanniii	2023	Balajee Ramachandran, Saravanan Muthupandian, Jeyakanthan Jeyaraman, Bruno Silvester Lopes	Front Chem
36946729	development of modernize acinetobacter baumannii susceptibility test interpretive Criteria for recommend antimicrobial Agent use Pharmacometric approach	acinetobacter baumanniiAcinetobacter calcoaceticus complex refer to herein as a baumannii treatment guideline contain numerous old antimicrobial agent with susceptibility test interpretive criterion stic also know as susceptibility breakpoint set use only epidemiological datum we utilize a combination of iin vitroi surveillance datum preclinical murine thigh and lung infection model population pharmacokinetic simulation and pharmacokineticpharmacodynamic pkpd target attainment analysis to evaluate a baumannii stic for four commonly recommend antimicrobial from different class amikacin ceftazidime ciprofloxacin and minocycline antimicrobial iin vitroi surveillance datum be base on 1647 clinical a baumannii isolate obtain from 109 center in the United State and Europe among this isolate 5 be select for evaluation in murine infection model base on fitness and mic variability PK and doseranging study be conduct use neutropenic murine thigh and lung infection model the mic range for the 5 isolate evaluate be as follow amikacin 2 to 32 μgmL ceftazidime 4 to 16 μgmL ciprofloxacin 012 to 2 μgmL minocycline 025 to 4 μgmL all organism grow ≥ 15 logsub10 sub CFU in both model in untreated control Plasma and epithelial lining fluid elf pharmacokinetic for all drug be determine in mouse use liquid chromatographytandem mass spectrometry lcmsm method for each isolate 5 dose level of each drug be test individually in the thigh and lung infection model the inoculum rang from 79 to 84 and 68 to 77 logsub10 sub CFUmL for the lung and thigh model respectively pkpd target associate with net bacterial stasis and 1 and 2logsub10 sub CFU reduction from baseline be identify for each organisminfection model use hilltype model population pharmacokinetic model for each agent be identify from the literature use demographic variable for simulate patient with hospitalacquired or ventilatorassociated bacterial pneumonia or urinary tract infection include acute pyelonephritis who be administer maximal dose regimen of each agent estimate of protein bind and elf penetration ratio base on datum from the literature freedrug plasma and totaldrug concentrationtime profile be generate and pkpd index by mic be calculate percent probability of attain median and randomly assign pkpd target associate with the abovedescribed endpoint be determine recommend susceptible breakpoint for each agent be that represent the high mic at which the percent probability of achieve pkpd target associate with a 1logsub10 sub CFU reduction from baseline approach or be ≥90 the follow susceptible breakpoint for a baumannii be identify amikacin ≤ 8 μgmL for pneumonia ceftazidime ≤ 32 and ≤ 8 μgmL for pneumonia ciprofloxacin ≤ 1 μgmL and minocycline ≤05≤1 μgmL which correspond to the standard and high minocycline dose regimen of 200 mg per day and 200 mg every 12 h respectively implementation of appropriate stic will help clinician optimally use the abovedescribed agent and improve the likelihood of successful patient outcome	2023 Apr	A J Lepak, M Trang, J P Hammel, H S Sader, S M Bhavnani, B D VanScoy, J M Pogue, P G Ambrose, D R Andes, United States Committee on Antimicrobial Susceptibility Testing	Antimicrob Agents Chemother
36617220	development of a Bispecific antibody target Clinical isolate of acinetobacter baumannii	we previously report develop 2 anticapsular monoclonal antibody mab as a novel therapy for acinetobacter baumannii infection we seek to determine whether a bispecific mAb bsAb could improve avidity and efficacy while maximizing strain coverage in one molecule	2023 Apr	Travis B Nielsen, Jun Yan, Matthew Slarve, Rachel Li, Jason A Junge, Brian M Luna, Ian Wilkinson, Udaya Yerramalla, Brad Spellberg	J Infect Dis
33393388	evaluation of the significance of constant laser therapy 532 nm in various exposure Times on the heal process of wound infect by iAcinetobacter baumanniii	many considerable investigation focus on the stimulation of therapeutic manners of infect injury in mouse the exaggerate pathogen that induce wound be grampositive like staphylococcal and gramnegative for example iPseudomonas aeuroginosai and iAcinetobacter baumanniii iAcinetobacteri can generate a scale range of a infection that may be receive in a hospital or any wellness concern facility in order to know the significance of laser 532 nm with a constant irradiance at various exposure time on the heal process of wound infect by iAcinetobacter baumanniii this study be perform on the balbc mouse a elliptical fullthickness skin injury be make on the backside of 45 adult female balbc mouse injury be affect via iAcinetobacter baumanniii and be randomly assign into 3 group semiconductor diode continuous wave laser λ 532 nm with output power 40 mw be use the power density be 571 mwcmsup2sup while the fluency be 17 jcmsup2sup and 514 jcmsup2sup Fifteen mouse be classify accord to the time of irradiation the first group be infect and present as control without irradiation the second group be infect and irradiate for 5 minute the third group likewise be infect but irradiate for 15 minute all group be subdivided accord to the follow period 3 5 and 10 day after irradiation and the animal be kill after the treatment wound heal be make by measure the rate of wound closure and histopathological evaluation the study determine that 532 nm laser therapy have a obvious and positive influence on the heal of infect wound with fluence 514 jcmsup2sup	2022 Dec	Zahra Al-Timimi	Int J Low Extrem Wounds
36199598	correction Oxa376 and Oxa530 variant of βlactamase computational study uncover potential therapeutic target of iAcinetobacter baumanniii	this correct the article doi 101039d2ra02939a	2022 Sep	Sajal Kumar Halder, Maria Mulla Mim, Md Meharab Hassan Alif, Jannatul Fardous Shathi, Md Nuhu Alam, Aparna Shil, Mahbubul Kabir Himel	RSC Adv
36778331	replicative iAcinetobacter baumanniii strain interfere with phagosomal maturation by modulate the vacuolar pH	bacterial pneumonia be a common infection of the low respiratory tract that can afflict patient of all age multidrugresistant strain of iAcinetobacter baumanniii be increasingly responsible for cause nosocomial pneumonias thus pose a urgent threat alveolar macrophage play a critical role in overcome respiratory infection cause by this pathogen recently we and other have show that new clinical isolate of iA baumanniii but not the common lab strain atcc 19606 19606 can persist and replicate in macrophage within spacious vacuole that we call iA cinetobacteri C ontain V acuole ACV in this work we demonstrate that the modern iA baumanniii clinical isolate 398 but not the lab strain 19606 can infect alveolar macrophage and produce acs iin vivoi in a murine pneumonia model both strain initially interact with the alveolar macrophage endocytic pathway as indicate by eea1 and lamp1 marker however the fate of this strain diverge at a late stage while 19606 be eliminate in a autophagy pathway 398 replicate in acs and be not degrade we show that 398 revert the natural acidification of the phagosome by secreting large amount of ammonia a byproduct of amino acid catabolism we propose that this ability to survive within macrophage may be critical for the persistence of clinical iA baumanniii isolate in the lung during a respiratory infection	2023 Feb	Jesus S Distel, Gisela Di Venanzio, Joseph J Mackel, David A Rosen, Mario F Feldman	bioRxiv
36634346	Discovery and hittolead optimization of benzothiazole scaffoldbase DNA gyrase inhibitor with potent activity against iAcinetobacter baumanniii and iPseudomonas aeruginosai	we have develop compound with a promise activity against iAcinetobacter baumanniii and iPseudomonas aeruginosai which be both on the who priority list of antibioticresistant bacterium starting from DNA gyrase inhibitor b1 b we identify compound b27b feature a 10 fold improve aqueous solubility a 10 fold improve inhibition of topoisomerase iv from iA baumanniii and ip aeruginosai a 10 fold decrease inhibition of human topoisomerase iiα and no crossresistance to novobiocin cocrystal structure of b1b in complex with iEscherichia colii gyrb24 and iSib27b in complex with iA baumanniii gyrb23 and ip aeruginosai gyrb24 reveal they bind to the atpbinding pocket of the gyrb subunit in further optimization step solubility plasma free fraction and other adme property of b27b be improve by finetuning of lipophilicity in particular analog of b27b with retain antiGramnegative activity and improve plasma free fraction be identify the series be find to be nongenotoxic nonmutagenic devoid of mitochondrial toxicity and possess no ion channel liability	2023 Jan	Andrej Emanuel Cotman, Martina Durcik, Davide Benedetto Tiz, Federica Fulgheri, Daniela Secci, Maša Sterle, Štefan Možina, Žiga Skok, Nace Zidar, Anamarija Zega, Janez Ilaš, Lucija Peterlin Mašič, Tihomir Tomašič, Diarmaid Hughes, Douglas L Huseby, Sha Cao, Linnéa Garoff, Talía Berruga Fernández, Paraskevi Giachou, Lisa Crone, Ivailo Simoff, Richard Svensson, Bryndis Birnir, Sergiy V Korol, Zhe Jin, Francisca Vicente, Maria C Ramos, Mercedes de la Cruz, Björn Glinghammar, Lena Lenhammar, Sara R Henderson, Julia E A Mundy, Anthony Maxwell, Clare E M Stevenson, David M Lawson, Guido V Janssen, Geert Jan Sterk, Danijel Kikelj	J Med Chem
35841965	potentiate the activity of current antibiotic by naringin dihydrochalcone target the adeabc efflux pump of multidrugresistant acinetobacter baumannii	acinetobacter baumannii be a eskape pathogen responsible for severe nosocomial infection among all the mechanism contribute to multidrug resistance efflux pump have gain significant attention due to they widespread distribution among bacterial species and broad substrate specificity this study have investigate the diverse role of efflux pump present in carbapenemresistant a baumannii CRAB and screen a efflux pump inhibitor the result show the presence of adeabc adefgh adeijk and abem efflux pump in CRAB and experimental study use gene mutant demonstrate the significant role of adeabc in carbapenem resistance biofilm formation surface motility pathogenesis bacterial adherence and invasion to the host cell the structurebase ligand screen molecular mechanic molecular dynamic simulation and experimental validation use efflux pump mutant and antibiotic accumulation assay identify naringin dihydrochalcone ndc as the lead against adeb this lead be select as a capping agent for silver nanoparticle the ndccapped silver nanoparticle ndcagnps be characterize by UVspectroscopy Fouriertransform infrared spectroscopy ftir dynamic light scattering DLS and scan electron microscopy SEM the investigate molecular mechanism show that the ndcagnps possess multiple mechanism of action in addition to efflux inhibitory activity it also generate reactive oxygen and nitrogen species as well as cause change in the electrochemical gradient in CRAB the proton gradient be important for the function of adeabc hence alter the electrochemical gradient also disrupt its efflux activity moreover a baumannii do not develop any resistance against ndcagnps till several generation which be investigate the ndcagnps be also find to be effective against carbapenemresistant clinical isolate of a baumannii therefore the present study provide a insight into the efflux pump mediate carbapenem resistance and possible inhibitor ndcagnps to combat adeabc efflux pump mediate resistance	2022 Sep	Privita Verma, Monalisa Tiwari, Vishvanath Tiwari	Int J Biol Macromol
36858184	molecular docking and dynamic approach to screen the drug candidate against the Imipenemresistant CarO porin in acinetobacter baumannii	the multidrugresistant acinetobacter baumannii be a emerge nosocomial pathogen in the healthcare sector intrinsic resistance in a baumannii be a significant problem frame a perfect treatment regimen also this organism show more resistance towards the carbapenem antibiotic especially for imipenem and meropenem the development of carbapenemresistant acinetobacter baumannii be mainly due to the alteration or loss of the porin region in the outer membrane the most wellknown porin in acinetobacter baumannii be CarO carbapenemassociated outer membrane protein the CarO protein which function as a porin channel for carbapenem inflow may contribute to carbapenem resistance the current study identify a potent drug candidate with a good bind affinity to the carbapenemresistant outer membrane protein we investigate the specificity of carbapenem such as imipenem meropenem ertapenem biapenem doripenem and fluoroquinolone drug such as sitafloxacin against the imipenemresistant CarO protein be demonstrate use the computational approach molecular docking and dynamic simulation for 50 n as a result the high to low enzymeligand comple bind affinity exhibit a great bind affinity for ertapenem 776 kcal·molsup1sup and sitafloxacin 775 kcal·molsup1sup than biapenem doripenem meropenem and imipenem the molecular dynamic simulation and the mmpbsa analysis depict ertapenem 55431±25908 kjmol and sitafloxacin 47154 ± 11052 kjmol with good bind affinity and more stability against the imipenem resistant CarO protein when it compare to other antibiotic	2023 Apr	Mohanraj Gopikrishnan, C George Priya Doss	Microb Pathog
36174234	synergy of a virulent phage φ ab182 with antibiotic lead to successful elimination of biofilm form by MDR iAcinetobacter baumanniii	emergence of multiple drug resistant MDR strain of iAcinetobacter baumanniii and a withering drug discovery pipeline necessitate the search for effective alternative to replace or synergize with currently use antibiotic in this report we have describe the synergy assessment of a virulent iAcinetobacter baumanniii phage φ ab182 with a wide range of antibiotic myophage φ ab182 be isolate from sewage against MDR iA baumanniii and exhibit maximum stability at 25 °C and pH 7 it also have a short latent period of 9 minute with a large burst size of 287 the phylogenetic analysis of its major capsid protein gene indicate a 8415 similarity to the lytic iA baumanniii phage acj9 in the presence of antibiotic phage φ ab182 show the high synergy ipi 00001 with colistin follow by polymixin B ceftazidime and cefotaxime and this synergistic effect be further validate by time kill kinetic the combine action of phage φ ab182 with colistin polymixin B ceftazidime and cefotaxime be also synergistic for the eradication of biofilm form by iA baumanniii as measure by mbecsubcombinationsubmbecsubantibioticsub value 025 we thus propose bacteriophage φ ab182 as a potential antibacterial candidate in combination therapy the finding from this study strongly support the use of phage antibiotic synergy for the successful treatment of biofilm form MDR iA baumanniii infection	2022 Dec	Medhavi Vashisth, Shikha Yashveer, Anu Bala Jaglan, Nitin Virmani, Bidhan Chand Bera, Rajesh Kumar Vaid, Taruna Anand	Can J Microbiol
35475638	involvement of a phageencoded wzy protein in the Polymerization of k127 unit to form the capsular polysaccharide of acinetobacter baumannii Isolate 361454	a comprehensive understanding of capsular polysaccharide CPS diversity be critical to implementation of phage therapy to treat panresistant acinetobacter baumannii infection prediction from genome sequence can assist identification of the CPS type but can be complicated if gene outside the k locus CPS biosynthesis gene cluster be involve here the CPS produce by a baumannii clinical isolate 361454 carry a novel k locus kl127 be determine and compare to other CPSs kl127 differ from kl128 in only two of the glycosyltransferase igtri gene the k127 unit in 361454 CPS be the pentasaccharide βdglcipi1 →6d " GalipiNAc1 →6αdgalipi1→6βdglсipi1 →3βdgalipinac in which dglcipi at position 4 replace dGalipi in K128 and the glycosyltransferase encode by the different igtri gene form the surround linkage however although the kl127 and kl128 gene cluster encode nearly identical wzy polymerase the linkage between k unit that form the CPS chain be different ie βdGalipiNAc1 →3dgalipi in 361454 k127 and βidiGalipiNAc1 → 4dGalipi in kz1093 K128 the linkage between k127 unit in 361454 be the same as the kunit linkage in five know CPS structure and a gene encoding a wzy protein related to the wzy of the corresponding k loci be find encode in a prophage genome in the 361454 chromosome Closely related wzy protein be encode in unrelated phage in available kl127 carry genome however a clinical isolate kz1257 carry kl127 but not the prophage be find and k127 unit in the kz1257 CPS be βdGalipiNAc1 → 4dGalipi link confirm that wzysubkl127sub form this linkage and thus that the phageencoded wzysubph1sub form the βdGalipiNAc1 →3 would Galipi linkage in 361454 bimportanceb Bacteriophage therapy be a attractive innovative treatment for infection cause by extensively drug resistant acinetobacter baumannii for which there be few effective antibiotic treatment remain capsular polysaccharide CPS be a primary receptor for many lytic bacteriophage and thus knowledge of the chemical structure of CPS produce by the species will underpin the identification of suitable phage for therapeutic cocktail however recent research have show that some isolate carry additional gene outside of the CPS biosynthesis k locus which can modify the CPS structure this change can subsequently alter phage receptor site and may be a method utilize for natural phage resistance hence it be critical to understand the genetics that drive CPS synthesis and the extent to which gene outside of the k locus can affect the CPS structure	2022 Jun	Nikolay P Arbatsky, Anastasiya A Kasimova, Alexander S Shashkov, Mikhail M Shneider, Anastasiya V Popova, Dmitry A Shagin, Andrey A Shelenkov, Yuliya V Mikhailova, Yurii G Yanushevich, Ruth M Hall, Yuriy A Knirel, Johanna J Kenyon	Microbiol Spectr
36920795	the Impact of antimicrobial peptide on the iAcinetobacter baumanniii Inner membrane be modulate by Lipid polyunsaturation	the gramnegative pathogen iAcinetobacter baumanniii be a primary contributor to nosocomial multidrugresistant MDR infection to combat the rise of MDR infection novel feature of iA baumanniii need to be consider for the development of new treatment option one such feature be the preferential scavenging of exogenous lipid include hostderived polyunsaturated fatty acid pufa for membrane phospholipid synthesis this alteration in membrane composition impact both the lipid chemistry and the membrane biophysical property in this work we examine how antimicrobial peptide amp interact with the inner membrane of iA baumanniii in the presence and absence of polyunsaturated phospholipid use coarsegrained molecular dynamic simulation of complex iA baumanniii inner membrane model derive from lipidome of bacterium grow in the presence and absence of pufa we examine the impact of the adsorption of four prototypical amp CAMEL ll37 pexiganan and magainin2 on the membrane biophysical property we simulation reveal that the impact of AMP adsorption on the membrane biophysical property be dependent on both the membrane composition and the specific AMP involve both lipid headgroup charge and tail unsaturation play important role in drive the interaction that occur both within the membrane and between the membrane and amp the change to the membrane biophysical property also show a complex relationship with the amp physical property such as AMP charge chain length and chargetomass ratio Cumulatively this work highlight the importance of study amp use a complex membrane environment and provide insight into the mechanistic action of amp in polyunsaturated lipidrich bacterial membrane	2023 Apr	Hugo I MacDermott-Opeskin, Katie A Wilson, Megan L O'Mara	ACS Infect Dis
37034553	target shikimate kinase pathway of iAcinetobacter baumanniii a structurybase Computational approach to identify antibacterial compound	iAcinetobacter baumanniii iA baumanniii be a opportunistic bacterium that have develop multidrug resistance MDR to most of today antibiotic pose a significant risk to human health consider the fact that develop novel drug be a timeconsumeng and expensive procedure this research focus on utilize computational resource for repurposing antibacterial agent for iA baumanniii we target shikimate kinase a essential enzyme in iA baumanniii that play a significant role in the metabolic process the basis for generate new therapeutic compound be to inhibit the shikimate kinase and thereby target the shikimate pathway herein 1941 druglike compound be investigate in different iin silicoi technique for assess druglikeness property admet absorption distribution metabolism excretion and toxicity profiling bind affinity and conformation analysis utilize Autodockvina and swissdock chembl1237 chembl1237119 chembl2018096 and chembl39167178 be determine as potential drug candidate for suppressing shikimate kinase protein molecular dynamics simulation MDS result for root mean square deviation root mean square fluctuation hydrogen bond and gyration radius confirm the drug candidate molecular stability with the target protein accord to this study chembl1237 Lisinopril could be the most suitable candidate for iA baumanniii we investigation suggest that the inhibitor of shikimate kinase could represent promise treatment option for iA baumanniii however further iin vitroi and iin vivoi study be necessary to validate the therapeutic potential of the suggest drug candidate	2023	Aparna Shil, Most Afrin Akter, Arafin Sultana, Sajal Kumar Halder, Mahbubul Kabir Himel	J Trop Med
35862908	genome sequence of acinetobacter baumannii strain shouab01 isolated from Chinese giant salamander Andrias davidianus liver	this report describe the complete genome sequence of acinetobacter baumannii strain shouab01 which be isolate from the liver of a Chinese giant salamander Andrias davidianus shouab01 belong to sequence type 40 ST40 and its genome contain a circular chromosome size 3891862 bp and two circular plasmid size 8571 bp and 5870 bp	2022 Aug	Lu Yuan, Xiaoyan Zhang, Yufei Lyu, Yan Guo, Jie Chen, Dongshu Wang, Liping Wang, Hengliang Wang, Xiankai Liu	Microbiol Resour Announc
37196408	a sers bioassay base on vancomycinmodified PEIinterlayered nanocomposite and aptamerfunctionalized sers tag for synchronous detection of acinetobacter baumannii and Klebsiella pneumoniae	Klebsiella pneumoniae KP and acinetobacter baumannii ab be two important gramnegative bacterium that cause pneumonia and have be recently know to be associate with food the rapid detection of this pathogen in food be important to minimize they colonization of the gut and stop new threat of the disease from spread across the food chain herein a doubleedge sword aptasensor be develop for the synchronous detection of KP and ab in food and clinical sample a highly sensitive selective specific and synchronous detection of the target bacterium be achieve and the limit of detection LOD be 10 cellsmL with a liner range of 50 to 10 sup5 sup cellsmL the total assay time be 15 h this study do not only provide a new tool for the detection of the target bacterium but also serve as a promise tool for food safety and pneumonia diagnosis	2023 May	Clement Yaw Effah, Lihua Ding, Longlong Tan, Sitian He, Xiang Li, Huijie Yuan, Yi Li, Shaohua Liu, Tongwen Sun, Yongjun Wu	Food Chem
36345791	clean clothes or dirty clothes Outbreak investigation of carbapenemresistant iAcinetobacter baumanniii related to laundry contamination through multilocus sequence type mlst	to investigate the source in a outbreak of carbapenemresistant iAcinetobacter baumanniii CRA in a general hospital due to contamination of a laundry evaporative cool and the laundry environment use multilocus sequence type mlst	2022 Nov	Alfred Lok Hang Lee, Eddie Chi Ming Leung, Ben Wai Hong Wong, Leo Chun Hei Wong, Yoyo Lok Yiu Wong, Rosana Ka Yin Hung, Sindy Sin Yee Ho, Viola Chi Ying Chow	Infect Control Hosp Epidemiol
36796791	evaluation of loopmediate isothermal amplification assay for visual detection of acinetobacter baumannii directly from soil and water sample from mangalore	acinetobacter baumannii be a wellknown nosocomial pathogen that commonly inhabit soil and water and have be implicate in numerous hospitalacquired infection the exist method for detect a baumannii have several drawback such as be timeconsumeng expensive laborintensive and unable to distinguish between closely related acinetobacter species thus it be important to have a simple rapid sensitive and specific method for its detection in this study we develop a loopmediate isothermal amplification lamp assay use hydroxynaphthol blue dye to visualize a baumannii by target its pgaD gene the lamp assay be perform use a simple dry bath and be show to be specific and highly sensitive as it could detect up to 10 pgμl of a baumannii DNA further the optimize assay be use to detect a baumannii in soil and water sample by culturemedium enrichment out of 27 sample test 14 5185 sample be positive for a baumannii through lamp assay while only 5 1851 sample be find to be positive through conventional method thus the lamp assay have be find to be a simple rapid sensitive and specific method that can be use as a pointofcare diagnostic tool for detect a baumannii	2023 Mar	Srajana Nayak, Nia Do Carmo Lobo, Karanth Padyana Anupama, Ashwath Nayak, Sadanand Dangari Akshay, Biswajit Maiti	Lett Appl Microbiol
35973205	the ldTranspeptidase ldtsubabsub from iAcinetobacter baumanniii be poorly inhibited by carbapenem and have a unique Structural Architecture	ldtranspeptidase ldi be enzyme that catalyze reaction essential for biogenesis of the bacterial cell wall include formation of 33 crosslink peptidoglycan unlike the historically wellknown bacterial transpeptidase the penicillinbind protein pbp ldi be resistant to inhibition by the majority of βlactam antibiotic with the exception of carbapenem and penem allow bacterium to survive in the presence of this drug here we report characterization of ldtsubabsub from the clinically important pathogen iAcinetobacter baumanniii we show that iA baumanniii survive inactivation of ldtsubabsub alone or in combination with pbp1b or pbp2 while simultaneous inactivation of ldtsubabsub and pbp1a be lethal Minimal inhibitory concentration mic of all 13 βlactam antibiotic test decrease 2 to 8 fold for the ldtsubabsub deletion mutant while further decrease be see for both double mutant with the large synergistic effect observe for the ldtsubabsub pbp2 deletion mutant mass spectrometry experiment show that ldtsubabsub form complex in vitro only with carbapenem however the acylation rate of this antibiotic be very slow with the reaction take long than four hour to complete we Xray crystallographic study reveal that ldtsubabsub have a unique structural architecture and be the only know LDT to have two different peptidoglycanbind domain	2022 Sep	Marta Toth, Nichole K Stewart, Clyde A Smith, Mijoon Lee, Sergei B Vakulenko	ACS Infect Dis
36306681	Analysis of virulence protein in pathogenic acinetobacter baumannii to provide early warning of zoonotic risk	acinetobacter baumannii be a ubiquitous opportunistic pathogen usually with low virulence in recent year report of increase pathogenicity of a baumannii in livestock due to the migratory behaviour of wildlife have attract public health attention we previous study report that a a baumannii strain isolate from dead chick ccggd201101 show enhance pathogenicity but the mechanism for increase virulence be not understand here to screen potential virulence factor the proteome of the isolate strain ccggd201101 and the standard strain atcc19606 of a baumannii be compare and the possible virulenceenhancing mechanism be further analyse the 50 lethal dose ldsub50 sub value of ccggd201101 and standard strain atcc19606 in ICR mouse be determine to verify they bacterial toxicity 2d fluorescence difference gel electrophoresis 2ddige combine with matrixassiste laser desorptionionization time of flight mass spectrometry malditoftofm and quantitative realtime pcr rtqpcr be apply to screen and identify differentially express protein or gene that may be related to virulence enhancement bioinformatic analysis base on proteinprotein interaction ppi network be use to explore the function of potential virulence protein the pathogenicity of potential virulence factor be assess by phylogenetic analysis and a animal infection model the result show that the ldsub50sub of ccggd201101 for mouse be 1186 × 10 sup6 sup CFUmL and the virulence be increase by 1805 fold compare to atcc19606 fortyseven protein spot be significantly upregulate for the a baumannii ccggd201101 strain fold change ≥ 15 p 005 in total 14 upregulate protein be identify use proteomic analysis and the mRNA expression level of this protein be nearly identical with few exception accord to the ppi network and phylogenetic analysis the i78 family peptidase inhibitor 3oxoacylACP reductase fabg and glycine zipper be screen as be closely related to the pathogenicity of bacterium furthermore the i78 overexpression strain exhibit high lethality in mouse infection model which indicate that the i78 family peptidase inhibitor be a potential new virulence factor to enhance the pathogenicity of the a baumannii ccggd201101 strain the present study help we to good understand the mechanism of virulence enhancement and provide a scientific basis for establish a early warning system for enhance virulence of a baumannii from animal	2023 Jan	Deying Zou, Jiang Chang, Shiying Lu, Jianfeng Xu, Pan Hu, Kai Zhang, Xiaoli Sun, Wei Guo, Yansong Li, Zengshan Liu, Honglin Ren	Microbiol Res
35780348	molecular detection of mbl encoding gene in acinetobacter baumannii strain isolated from various sample at a tertiary Care Hospital in mymensingh	mbl produce acinetobacter baumannii be a major threat for therapeutic treatment of hospital acquire infection the aim of this study be to determine the prevalence of metallo βlactamase gene VIM imp SIM gene amongst isolate a baumannii this cross sectional study conduct in the department of microbiology mymensingh Medical College from March 2019 to February 2020 49 acinetobacter spp be isolate from different clinical sample include endotracheal aspirate wound swabpus urine and blood among 380 clinical sample 130 organism be isolate growth be 3421 out of 130 isolate strain 493769 be acinetobacter spp identify by standard bacteriological method and resistance to different antibiotic be assess with kirby bauer Disc diffusion method among 49 acinetobacter spp 397959 be acinetobacter baumannii which be identify by molecular method pcr direct oxa51 like gene multiplex pcr be do to determine mbl gene existence VIM imp SIM ceftriaxone 7948 show high resistance and colistin 1282 show low resistance all the strain be sensitive to tigecycline the distribution of mbl gene such as VIM 205128 imp 51282 and SIM 0 0 this study show that high level of antibiotic resistance and VIM be the most prevalent mbl gene among a baumannii highlight the need for indigenous antibiotic usage plan infection control measure to prevent the spread of this resistance gene	2022 Jul	H Ara, S K Paul, N Kobayashi, S A Nasreen, F Ahmed, S S Nila	Mymensingh Med J
35773688	evaluation the reactivity of a peptidebase monoclonal antibody derive from OmpA with drug resistant pulsotype of acinetobacter baumannii as a potential therapeutic approach	acinetobacter baumannii be a opportunistic and antibioticresistant pathogen that predominantly cause nosocomial infection there be urgent need for development nonantibioticbased treatment strategy we develop a novel monoclonal antibody mAb against a peptide of conserved outer membrane protein a OmpA and evaluate its reactivity with different pulsotype of a baumannii	2022 Jun	Omid Yeganeh, Mahdi Shabani, Parviz Pakzad, Nariman Mosaffa, Ali Hashemi	Ann Clin Microbiol Antimicrob
36442121	Metal retention and replacement in qued2 protect queuosinetRNA biosynthesis in metalstarved iAcinetobacter baumanniii	in response to bacterial infection the vertebrate host employ the metalsequestester protein calprotectin cp to withhold essential transition metal notably ZnII to inhibit bacterial growth previous study of the impact of cpimpose transitionmetal starvation in iA baumanniii identify two enzyme in the de novo biosynthesis pathway of queuosinetransfer ribonucleic acid QtRNA that become cellularly abundant one of which be qued2 a 6 carboxy 5678tetrahydropterin 6cphsub4sub synthase that catalyze the initial commit step of the pathway here we show that cp strongly disrupt q incorporation into tRNA as such we compare the iabiqued2 lowzinc paralog with a housekeeping obligatory ZnIIdependent enzyme qued the crystallographic structure of gniitound iabiqued2 reveal a distinct catalytic site coordination sphere and assembly state relative to qued and possess a dynamic loop immediately adjacent to the catalytic site that coordinate a second ZnII in the structure one of this loopcoordinating residue be a invariant Cys18 that protect qued2 from dissociation of the catalytic ZnII while maintain flux through the QtRNA biosynthesis pathway in cell we propose a metal retention model where Cys18 introduce coordinative plasticity into the catalytic site which slow metal release while also enhancing the metal promiscuity such that feii become a active cofactor this study reveal a complex multipronge evolutionary adaptation to cellular ZnII limitation in a key ZnII metalloenzyme in a important human pathogen	2022 Dec	Matthew R Jordan, Giovanni Gonzalez-Gutierrez, Jonathan C Trinidad, David P Giedroc	Proc Natl Acad Sci U S A
35975993	a Novel Triple combination to combat serious infection with CarbapenemResistant acinetobacter baumannii in a mouse Pneumonia Model	the ongoing crisis of antimicrobial resistance demand novel combination between antimicrobial and nonantimicrobial to manage infection cause by highly resistant pathogen this study aim to evaluate the effect of combine sodium ascorbate andor apotransferrin with imipenem form double and triple combination against 20 multiplecarbapenemaseproducing acinetobacter baumannii strain use the checkerboard test timekill assay and disc diffusion test the result of the checkerboard assay reveal that all double combination show indifference while only triple combination record a synergistic effect fractional inhibitory concentration index FICI 08 in 95 the test isolate moreover the mic of imipenem micsubimpsub be strongly reduce up to 128 fold reduction after treatment with the triple combination against highly resistant isolate and reach the susceptible range the timekill assay reveal that the triple combination lead to a 4logsub10 sub reduction in the CFU at 8 h compare with the initial bacterial count and no viable count be record at 10 h the mouse pneumonia model show restoration of lung function and structure with mild to moderate residual inflammation and moderately congested vessel observe 8 h follow administration of the triple rescue therapy additionally normal lung with normal patent alveole be detect 72 h follow treatment accordingly sodium ascorbate and apotransferrin be promise adjunct biological agent with the potential to restore the effectiveness of critically essential antibiotic like imipenem commonly use for the treatment of a baumannii infection bimportanceb combination therapy provide a perspective to threat multidrugresistant MDR strain the present study shed light on a novel and effective triple combination against carbapenemresistant a baumannii we iin vitroi result show that combine imipenem with apotransferrin and sodium ascorbate yield synergism in 95 of test isolate and this be associate with a mark reduction in imipenem mic shifting it below the breakpoint furthermore a bactericidal effect be record with no viable count detect at 10 h a iin vivoi murine model of pneumonia be induce to mimic human disease the triple combination therapy restore lung function and structure with mild to moderate residual inflammation and moderately congested vessel observe 8 h follow the initiation of therapy therefore we finding suggest novel insight about a promise new combination therapy against highly resistant carbapenemaseproducing a baumannii to restore the effectiveness of imipenem	2022 Oct	Lamiaa A Al-Madboly	Microbiol Spectr
36400832	Green synthesis of chitosan nanoparticle optimization characterization and antibacterial efficacy against multi drug resistant biofilmforming acinetobacter baumannii	chitosan nanoparticle CNPs be promise versatile cationic polymeric nanoparticle which have receive grow interest over last few decade the biocompatibility biodegradability environmental safety and nontoxicity of the chitosan nanoparticle make it prefer for a wide range of biological application include agriculture medical and pharmaceutical field in this study CNPs be biosynthesized by aqueous extract of eucalyptus globulus labill fresh leave as bioreductant boxbehnken design in 29 experimental run be use for optimization of different factor affect the production of CNPs the maximum yield of CNPs be 991 mgmL at pH of 45 chitosan concentration of 1 incubation time of 60 minute and temperature of 50 °C the crystallinity particle size and morphology of the biosynthesized CNPs be characterize the CNPs possess a positively charge surface of 311 mv the SEM image of the CNPs confirm the formation of spherical form with smooth surface the tem image show CNPs be spherical in shape and they size range be between 692 and 1010 nm Xray diffraction indicate the high degree of CNPs crystallinity ftir analysis reveal various functional group of organic compound include nh nhsub2sub CH CO CN OH CC coh and coc the thermogravimetric analysis result reveal that CNPs be thermally stable the antibacterial activity of CNPs be determine against pathogenic multidrugresistant bacterium acinetobacter baumannii the diameter of the inhibition zone be 12 16 and 30 mm use the concentration of 125 25 and 50 mgmL respectively when compare to previous study the biosynthesized CNPs produce use a aqueous extract of fresh eucalyptus globulus labill leave have the small particle size with a size range between 692 and 1010 nm consequently it be a promise candidate for a diverse range of medical application and pharmaceutical industry	2022 Nov	Noura El-Ahmady El-Naggar, Alaa M Shiha, Hoda Mahrous, A B Abeer Mohammed	Sci Rep
37067411	high genetic diversity of CarbapenemResistant acinetobacter baumannii isolate recovered in Nigerian hospital in 2016 to 2020	acinetobacter baumannii cause difficulttotreat infection mostly among immunocompromised patient clinically relevant a baumannii lineage and they carbapenem resistance mechanism be sparsely describe in Nigeria this study aim to characterize the diversity and genetic mechanism of carbapenem resistance among a baumannii strain isolate from hospital in southwestern Nigeria we sequence the genome of all a baumannii isolate submit to nigerias antimicrobial resistance surveillance reference laboratory between 2016 and 2020 on a illumina platform and perform iin silicoi genomic characterization selected strain be sequence use the Oxford nanopore technology to characterize the genetic context of carbapenem resistance gene the 86 a baumannii isolate be phylogenetically diverse and belong to 35 distinct Oxford sequence type supoxfsups 16 of which be novel and 28 Institut pasteur STs suppassupst thirtyeight 442 isolate belong to none of the know international clone ics over 50 of the isolate be phenotypically resistant to 10 of 12 test antimicrobial the majority ini 54 of the isolate be carbapenem resistant particularly the ic7 suppassupST25 100 and ic9 suppassupST85 917 strain iblaisuboxa23sub 349 and iblaisubndm1 sub 279 be the most common carbapenem resistance gene detect all iblaisuboxa23sub gene be carry on tni2006 I or tni2006 ilike transposon we finding suggest that a 10 kb tni125i composite transposon be the primary mean of iblaisubndm1 sub dissemination we finding highlight a increase in iblaisubndm1sub prevalence and the widespread transposonfacilitated dissemination of carbapenemase gene in diverse a baumannii lineage in southwestern Nigeria we make the case for improve surveillance of this pathogen in Nigeria and other understudy setting bimportanceb acinetobacter baumannii bacterium be increasingly clinically relevant due to they propensity to harbor gene conferring resistance to multiple antimicrobial as well as they ability to persist and disseminate in hospital environment and cause difficulttotreat nosocomial infection Little be know about the molecular epidemiology and antimicrobial resistance profile of this organism in Nigeria largely due to limited capacity for they isolation identification and antimicrobial susceptibility testing we study characterize the diversity and antimicrobial resistance profile of clinical a baumannii in southwestern Nigeria use wholegenome sequencing we also identify the key genetic element facilitate the dissemination of carbapenem resistance gene within this species this study provide key insight into the clinical burden and population dynamic of a baumannii in hospital in Nigeria and highlight the importance of routine wholegenome sequencingbased surveillance of this and other previously understudy pathogen in Nigeria and other similar setting	2023 Apr	Erkison Ewomazino Odih, Anderson O Oaikhena, Anthony Underwood, Yaovi Mahuton Gildas Hounmanou, Oyinlola O Oduyebo, Abayomi Fadeyi, Aaron O Aboderin, Veronica O Ogunleye, Silvia Argimón, Vitus Nnaemeka Akpunonu, Phillip O Oshun, Abiodun Egwuenu, Tochi J Okwor, Chikwe Ihekweazu, David M Aanensen, Anders Dalsgaard, Iruka N Okeke	mSphere
35789794	tigecycline suppress the virulence factor of multidrugresistant iAcinetobacter baumanniii allow human neutrophil to Act	to determine the ability of human neutrophil to kill multidrugresistant iAcinetobacter baumanniii mdrab in the presence of tigecycline tgc	2022	Yoshinori Sato, Nami Hatayama, Tsuneyuki Ubagai, Shigeru Tansho-Nagakawa, Yasuo Ono, Yusuke Yoshino	Infect Drug Resist
36189532	prevalence of virulence gene in acinetobacter baumannii isolated from Clinical sample in mymensingh Medical College Hospital Bangladesh	acinetobacter baumannii be a opportunistic bacterial pathogen that be the most important cause of hospitalacquired infection the objective of this study be to evaluate the predominance and determination of virulence encoding gene in a baumannii isolate during this crosssectional study period from February 2019 to March 2020 of 380 clinical sample include endotracheal aspirate 70 wound swab or pus 175 urine 70 and blood 65 analyse in inpatient admit to the hospital in different unit like icu surgery and burn unit of mymensingh Medical College Hospital out of 380 study sample 1303421 strain be yield growth among 130 isolate acinetobacter spp be 493769 totally 397959 be acinetobacter baumannii which be detect by molecular technique pcr further more the determination of virulence gene csgA and fimH detect by pcr among two study virulence gene csgA 3846 be the most prevalent virulent gene associate with disease severity and comorbidity of the patient in a baumannii infection	2022 Oct	H Ara, S K Paul, N Kobayashi, S A Nasreen, F Ahmed	Mymensingh Med J
36225352	Engineering of lysin by fusion of antimicrobial peptide cecropin a enhance its antibacterial property against multidrugresistant iAcinetobacter baumanniii	most clinical isolate of iAcinetobacter baumanniii a nosocomial pathogen be multidrugresistant MDR fueling the search for alternative therapy bacteriophagederived endolysin have potent antibacterial activity and be consider as alternative to antibiotic against iA baumanniii infection gramnegative bacterium possess outer lipid membrane that prevent direct contact between the endolysin and the cell wall we hypothesize that the fusion of antimicrobial peptide AMP with endolysin could help to reduce bacterial endolysin resistance and increase antimicrobial activity by membrane permeability action accordingly we fuse cecropin a a commonly use AMP with the nterminus of abendolysin which enhance the bactericidal activity of the chimeric endolysin the bactericidal activity of cecropin afuse abendolysin increase by at least 28 fold for various MDR iA baumanniii clinical isolate the iin vitroi bactericidal activity result also show high bacterial lysis by the chimeric endolysin than that by the parental lysin the engineer abendolysin eAbEndolysin show synergistic effect with the betalactam antibiotic cefotaxime ceftazidime and aztreonam and a additive effect with meropenem and imipenem eAbEndolysin have no cytotoxic effect on a549 cell line and rescue mouse 40 survival rate from systemic iA baumanniii infection together this finding suggest the potential of lysin therapy and may prompt its use as a alternative to antibiotic	2022	Md Maidul Islam, Dooyoung Kim, Kyeongmin Kim, Su-Jin Park, Samia Akter, Jeongah Kim, Seunghyeok Bang, Shukho Kim, Jungmin Kim, Je Chul Lee, Chang-Won Hong, Minsang Shin	Front Microbiol
36971237	Carbapenemresistant iAcinetobacter baumanniii load in patient and they environment the importance of detect carrier	the environment surround 30 of 31 carrier of carbapenemresistant iAcinetobacter baumanniii CRAB be contaminate by CRAB the environmental CRAB load be similar whether carrier be identify only by surveillance culture nonclinical carrier or also have positive clinical culture screening to detect and isolate nonclinical CRAB carrier may be important to prevent CRAB transmission	2023 Mar	Vered Schechner, Anat Or Lerner, Elizabeth Temkin, Yehuda Carmeli	Infect Control Hosp Epidemiol
35638734	invl a invasinlike adhesin be a type ii secretion system substrate required for acinetobacter baumannii uropathogenesis	acinetobacter baumannii be a opportunistic pathogen of grow concern as isolate be commonly multidrug resistant while a baumannii be most frequently associate with pulmonary infection a significant proportion of clinical isolate come from urinary source highlight its uropathogenic potential the type ii secretion system t2ss of commonly use model acinetobacter strain be important for virulence in various animal model but the potential role of the t2ss in urinary tract infection UTI remain unknown here we use a catheterassociated UTI CAUTI model to demonstrate that a modern urinary isolate upab1 require the t2ss for full virulence a proteomic screen to identify putative upab1 t2ss effector reveal a uncharacterize lipoprotein with structural similarity to the intimininvasin family which serve as type V secretion system t5ss adhesin require for the pathogenesis of several bacterium this protein designate invl lack the βbarrel domain associate with T5SSs but be confirm to require the t2ss for both surface localization and secretion this make invl the first identify t2ss effector belong to the intimininvasin family invl be confirm to be a adhesin as the protein bind to extracellular matrix component and mediate adhesion to urinary tract cell line iin vitroi additionally the iinvLi mutant be attenuate in the CAUTI model indicate a role in acinetobacter uropathogenesis finally bioinformatic analysis reveal that invl be present in nearly all clinical isolate belong to international clone 2 a lineage of significant clinical importance in all we conclude that the t2ss substrate invl be a adhesin require for a baumannii uropathogenesis bimportanceb while pathogenic acinetobacter can cause various infection we recently find that 20 of clinical isolate come from urinary source despite the clinical relevance of acinetobacter as a uropathogen few virulence factor involve in urinary tract colonization have be define here we identify a novel type ii secretion system effector invl which be require for full uropathogenesis by a modern urinary isolate although invl have predict structural similarity to the intimininvasin family of autotransporter adhesin invl be predict to be anchore to the membrane as a lipoprotein similar to other invasin homolog however we demonstrate that invl be a bona fide adhesin capable of bind extracellular matrix component and mediating adhesion to urinary tract cell line in all this work establish invl as a adhesin important for acinetobacteriis urinary tract virulence and represent the first report of a type ii secretion system effector belong to the intimininvasin family	2022 Jun	Clay D Jackson-Litteken, Gisela Di Venanzio, Nguyen-Hung Le, Nichollas E Scott, Bardya Djahanschiri, Jesus S Distel, Evan J Pardue, Ingo Ebersberger, Mario F Feldman	mBio
36622157	Blue Light sensing blsamediated modulation of meropenem resistance and biofilm formation in acinetobacter baumannii	the presence or absence of BlsA a protein with a blue lightsensing flavin domain in the genome of acinetobacter species have aroused curiosity about its role in the regulation of bacterial lifestyle under light genomic and transcriptomic analysis reveal the loss of BlsA in several multidrugresistant MDR a baumannii strain as well as the lightmediated induction of iblsAi along with a possible blsainteracting partner BipA they direct iin vivoi interaction be verify use a bacterial twohybrid system the result demonstrate that the cterminal region of BipA could bind to the cterminal residue of BlsA under blue light at 23 °C but not at 37 °C genetic manipulation of iblsAi and ibipAi reveal that the coexistence of BlsA and BipA be require to induce the lightdependent expression of iompAi in a baumannii atcc 17978 at 23 °C the same phenomenon occur in the blsadeficient MDR strain in we functional complementation assay however the underlying molecular mechanism remain poorly understand blsamodulated amount of OmpA the most abundant porin in the outer membrane affect the membrane integrity and permeability of small molecule Dark condition or the deletion of iompAi make the membrane more permeable to lipophilic ethidium bromide etbr but not to meropenem interestingly light illumination and low temperature condition make the cell more sensitive to meropenem however this bactericidal effect be not note in the iblsAi mutant or in the blsadeficient MDR strain lightmediated cell death and the reduction of biofilm formation at 23 °C be abolish in the iblsAi mutant strain suggest multifaceted role of BlsA in a baumannii strain bimportanceb Little be know about the functional role of BlsA and its interact partner in acinetobacter species intriguingly no BlsA homolog be find in several clinical isolate suggest that BlsA be not require inside the host because of the lack of blue light and the warm temperature condition as many chromophoreharboring protein interact with various partner to control lightdependent cellular behavior the maintenance of iblsAi in the genome of many acinetobacter species during they evolution may be beneficial when fluctuation occur in two important environmental factor light and temperature we study be the first to report the novel protein partner of BlsA namely BipA and its contribution to multiple phenotypic change include meropenem resistance and biofilm formation rapidforsey@ect physiological acclimation to change light or temperature condition may be possible in the presence of the lightsensing BlsA protein which may have more interact partner than expect	2023 Feb	Jihye Yang, Sohyeon Yun, Woojun Park	mSystems
36841724	Novel csucdna nanovaccine base on chitosan candidate vaccine against infection with acinetobacter baumannii	generating vaccine be a promise and effective method for stop the spread of acinetobacter baumannii a baumannii infection that be become more and more drugresistant MDR developing a DNA vaccine and testing its efficacy and protective effect in balbc mouse be the goal of this research	2023 Mar	Eskandar Hosseinnezhad-Lazarjani, Abbas Doosti, Ali Sharifzadeh	Vaccine
33685901	Semimechanistic pkpd modelling of fosfomycin and sulbactam combination against carbapenemresistant iAcinetobacter baumanniii	due to limited treatment option for carbapenemresistant iAcinetobacter baumanniii CRAB infection antibiotic combination be now consider potential treatment for CRAB this study aim to explore the utility of fosfomycinsulbactam combination fossul therapy against CRAB isolatessynergism of fossul against 50 clinical CRAB isolate be screen use the checkerboard method thereafter timekill study against two CRAB isolate be perform the timekill datum be describe use a semimechanistic pharmacokineticpharmacodynamic pkpd model Monte Carlo simulation be then perform to estimate the probability of stasis 1log kill and 2log kill after 24hour with combination therapy the fossul combination demonstrate a synergistic effect against 74 of isolate no antagonism be observe the micsub50sub and micsub90sub of fossul be decrease four to eightfold compare to the monotherapy micsub50sub and micsub90sub in the timekill study the combination display bactericidal activity against both isolate and synergistic activity against one isolate at the high clinically achievable concentration we pkpd model be able to describe the interaction between fosfomycin and sulbactam iin vitroi bacterial kill be mainly drive by sulbactam with fosfomycin augmentation fossul regimen that include sulbactam 4 gram every 8 hour demonstrate a probability of target attainment of 1logsub10 sub kill at 24 h of ∼6976 as compare to ∼ 1530 with monotherapy regimen at the high dose the reduction in the mic value and the achievement of a moderate PTA of a 2logsub10 sub reduction in bacterial burden demonstrate that fossul may potentially be effective against some CRAB infection	2023 May	S Mohd Sazlly Lim, A J Heffernan, J A Roberts, F B Sime	Antimicrob Agents Chemother
36413083	Characterization of a glycoside hydrolase endolysin from acinetobacter baumannii phage abtza1 with high antibacterial potency and novel structural feature	the classification of acinetobacter baumannii by who as priority 1 antibioticresistant pathogen underline the urgent need for novel antimicrobial agent towards this pathogen in this work screen of the a baumannii phage abtza1 genome allow the identification of a putative endolysin ablys1 ec32117 that belong to the glycoside hydrolase family 24 gh24 the sequence of ablys1 be clone express in E coli and purify the lytic activity and specificity of ablys1 be evaluate against a range of grampositive and gramnegative human pathogen ablys1 be find to display a high selectivity towards a baumannii kinetic analysis be carry out to characterize the dependence of its lytic activity on pH the enzyme show its maximal activity at pH value 78 the structure of ablys1 be determine by Xray crystallography to 182 Å resolution the overall structure reveal two helical domain a small antennalike nterminal domain and a large cterminal domain with six αhelice and a βhairpin both the antennalike and βhairpin region contain short sequence amseq1 and amseq2 with predict antimicrobial activity Engineering study reveal a key role of amseq1 and amseq2 on the enzyme lytic activity towards a baumannii cell but not towards purify peptidoglycan this suggest that both sequence affect the destabilization of the outer membrane thus provide access of the catalytic domain to the peptidoglycan in addition the deletion of amseq1 enhance the enzyme stability whereas the deletion of amseq2 diminish it the result suggest that ablys1 be a promise new enzybiotic with efficient lytic and antimicrobial activity	2023 Apr	Georgios E Premetis, Angeliki Stathi, Anastassios C Papageorgiou, Nikolaos E Labrou	FEBS J
36545493	characterize the role of phosphatidylglycerolphosphate phosphatase in iAcinetobacter baumanniii cell envelope biogenesis and antibiotic resistance	the dissemination of multidrug resistant iAcinetobacter baumanniii threaten global healthcare system and necessitate the development of novel therapeutic option the gramnegative bacterial cell envelope provide a first defensive barrier against antimicrobial assault essential component of this multilayered complex be the phospholipidrich membrane phosphatidylglycerol phosphate pgp phosphatase be responsible for a key step in the biosynthesis of a major phospholipid species phosphatidylglycerol pg but this enzyme have also be implicate in the biogenesis of other cell envelope component we bioinformatic analysis identify two putative pgp candidate in the iA baumanniii genome PgpA and PgpB Phospholipid analysis of isogenic ipgpai mutant in two distinct iA baumanniii strain reveal a shift in the desaturation level of phosphatidylethanolamine PE phospholipid species possibly due to the activation of the phospholipid desaturase desa we also investigate the impact of the inner membrane phosphatase on other cell envelope component which reveal a role of PgpB in the maintenance of the iA baumanniii peptidoglycan layer and consequently carbapenem resistance Collectively this work provide novel insight into the role of pgp phosphatase on the global lipidomic landscape of iA baumanniii and they interconnectivity with the biogenesis of other cell envelope component the nonessentiality of this candidate exemplify metabolic versatility of iA baumanniii which be believe to be key to its success as global pathogen	2023 Dec	Maoge Zang, Alice Ascari, Felise G Adams, Saleh Alquethamy, Bart A Eijkelkamp	Cell Surf
36301313	Quaternary Phosphonium compound unveiled as a potent Disinfectant against highly resistant iAcinetobacter baumanniii Clinical isolate	iAcinetobacter baumanniii be classify as a high threat pathogen urgently necessitating novel antimicrobial that evade resistance to combat its spread Quaternary ammonium compound qac have afford a valuable first line of defense against antimicrobial resistant pathogen as broadspectrum amphiphilic disinfectant molecule however a paucity of innovation in this space have drive the emergence of qac resistance through this work we seek to identify nextgeneration disinfectant molecule with efficacy against highly resistant iA baumanniii clinical isolate we select 12 bestinclass molecule from we previous investigation of quaternary ammonium and quaternary phosphonium compound qpc to test against a panel of 35 resistant iA baumanniii clinical isolate the result highlight the efficacy of we nextgeneration compound over lead commercial qac with we bestinclass qac 2pyr1111 and qpc p6p1010 display improve activity with a few exception furthermore we elucidate a correlation between colistin resistance and qac resistance wherein the only panresistant isolate of the panel also harbor colistin resistance exhibit resistance to all test qac notably p6p1010 maintain efficacy against this strain with a icsub90sub of 3 μM in addition p6p1010 display minimum biofilm eradication concentration as low as 32 μM against extensively drug resistant clinical isolate lastly examine the development of disinfectant resistance and crossresistance we generate QACresistant iA baumanniii mutant and observe the development of qac crossresistance in contrast neither disinfectant resistance nor crossresistance be observe in iA baumanniii under p6p1010 treatment taken together the result of this work illustrate the need for novel disinfectant compound to treat resistant pathogen such as iA baumanniii and underscore the promise of qpc such as p6p1010 as viable nextgeneration disinfectant molecule	2022 Nov	Marina E Michaud, Ryan A Allen, Kelly R Morrison-Lewis, Christian A Sanchez, Kevin P C Minbiole, Savannah J Post, William M Wuest	ACS Infect Dis
36377939	Structural basis of per1 mediated cefiderocol resistance and Synergistic inhibition of per1 by cefiderocol in combination with avibactam or Durlobactam in acinetobacter baumannii	cefiderocol be a novel siderophore cephalosporin that display activity against gramnegative bacterium to establish cefiderocol susceptibility level of acinetobacter baumannii strain from China we perform susceptibility testing and genomic analysis on 131 clinical isolate cefiderocol show high activity against the strain the production of per1 be the key mechanism of cefiderocol resistance iin silicoi study predict that avibactam and durlobactam could inhibit cefiderocol hydrolysis by per1 which be confirm by determine cefiderocol mic in combination with inhibitor	2022 Dec	Xiaochen Liu, Tailong Lei, Yunxing Yang, Linghong Zhang, Haiyang Liu, Sebastian Leptihn, Yunsong Yu, Xiaoting Hua	Antimicrob Agents Chemother
37210019	insight into the genetic context of sulfonamide resistance among early clinical isolate of acinetobacter baumannii	since the late 1930s resistance to sulfonamide have be accumulate across bacterial species include acinetobacter baumannii a opportunistic pathogen increasingly implicate the spread of antimicrobial resistance worldwide we study aim to explore event involve in the acquisition of sulfonamide resistance gene particularly sul2 among the early available isolate of a baumannii the study utilize the genomic datum of 19 strain of a baumannii isolate before 1985 the whole genome of 5 clinical isolate obtain from the Culture Collection University of göteborg CCUG Sweden be sequence use the illumina miseq system acquired resistance gene insertion sequence element and plasmid be detect use resfinder isfinder and plasmidseeker respectively while sequence type STs be assign use the pubmlst pasteur scheme blast be use to verify the occurrence of sul gene and to map they genetic surroundings the sul1 and sul2 gene be detect in 4 and 9 isolate respectively interestingly sul2 appear thirty year early than sul1 the sul2 gene be first locate in the genomic island gisul2 locate on a plasmid hereafter call nctc7364p with the emergence of international clone 1 the genetic context of sul2 evolve toward transposon tn6172 which be also plasmidmediated sulfonamide resistance in a baumannii be efficiently acquire and transfer vertically eg among the st52 and ST1 isolate as well as horizontally among nonrelate strain by mean of a few efficient transposon and plasmid timely acquisition of the sul gene have probably contribute to the survival skill of a baumannii under the high antimicrobial stress of hospital setting	2023 May	Anju Bala, Bernt Eric Uhlin, Nabil Karah	Infect Genet Evol
36948128	Structureactivity relationship of actively fhue transport rifabutin derivative with potent activity against acinetobacter baumannii	hospitalacquire infection be on the rise and represent both a clinical and financial burden with resistance emerge and a everdwindl armamentarium at hand infection cause by acinetobacter baumannii be particularly problematic since this bacterium have a high level of resistance and resilience to traditional and even lastresort antibiotic the antibiotic rifabutin be recently find to show potent in vitro and in vivo activity against extensively drug resistant a baumannii Building on this discovery we report on the synthesis and activity of rifabutin analog with a focus on nfunctionalization of the piperidine ring the antimicrobial testing uncover structure activity relationship sar for a baumannii that be not reflect in Staphylococcus aureus the cellular activity do not correlate with cellfree transcription inhibition but with bacterial intracellular compound accumulation mass spectrometrybased accumulation study confirm the involvement of the siderophore receptor fhue in active compound translocation at low concentration and they show a strong impact of the culture medium on the accumulation of rifabutin overall the study underline the structural feature require for strong accumulation of rifabutin in a baumannii and identify analog as or more potent than rifabutin against a baumannii	2023 Apr	M Maingot, M Bourotte, A C Vetter, B Schellhorn, K Antraygues, H Scherer, M Gitzinger, C Kemmer, G E Dale, O Defert, S Lociuro, M Brönstrup, N Willand, V Trebosc	Eur J Med Chem
37130458	structure of ydjh from acinetobacter baumannii reveal a active site of ydjh family sugar kinase	bacterial sugar kinase be a central enzyme for proper sugar degradation in bacterium essential for survival and growth therefore this enzyme family be a primary target for antibacterial drug development with ydjh most prefer to phosphorylate higherorder monosaccharide with a carboxylate terminus sugar kinase express diverse specificity and function make specificity determination of this family a prominent issue this study examine the ydjh crystal structure from acinetobacter baumannii abydjh which have a exceptionally high antibiotic resistance and be consider a superbug we structural and biochemical study reveal that abydjh have a widely open lid domain and be a solution dimer in addition the putative active site of abydjh be determine base on structural analysis sequence comparison and in silico docking finally we propose the active siteforming residue that determine various sugar specificity from abydjh this study contribute towards a deep understanding of the phosphorylation process and bacterial sugar metabolism of ydjh family to design the nextgeneration antibiotic for target a baumannii	2023 Apr	Gwan Hee Lee, Ju Hyeong Kim, Hyun Ji Ha, Hyun Ho Park	Biochem Biophys Res Commun
35837389	corrigendum the immune response against iAcinetobacter baumanniii a emerge pathogen in Nosocomial infection	this correct the article doi 103389 fimmu201700441	2022	María Guadalupe García-Patiño, Rodolfo García-Contreras, Paula Licona-Limón	Front Immunol
36895415	identification and prioritization of potential therapeutic molecule against LpxA from iAcinetobacter baumanniii a computational study	a baumannii be a ubiquitously find gramnegative multidrug resistant bacterial species from the eskape family of pathogen know to be the causative agent for hospitalacquired infection such as pneumonia meningitis endocarditis septicaemia and urinary tract infection iA baumanniii be implicate as a contributor to bloodstream infection in approximately 2 of all worldwide infection hence explore novel therapeutic agent against the bacterium be essential LpxA or udpiniacetylglucosamine acetyltransferase be a essential enzyme important in Lipid a biosynthesis which catalysis the reversible transfer of a acetyl group on the glucosamine 3oh of the UDPGlcNAc which be a crucial step in the biosynthesis of the protective lipopolysaccharide LPS layer of the bacterium which upon disruption can lead to the elimination of the bacterium which delineate LpxA as a appreciable drug target from iA baumanniii the present study perform high throughput virtual screen of LpxA against the enamineHTSClargemolecule library and perform toxicity and adme screen to identify the three promise lead molecule subject to molecular dynamic simulation Global and essential dynamic analysis of LpxA and its complex along with fel and mmpbsa base bind free energy delineate z367461724 and z219244584 as potential inhibitor against LpxA from iA baumanniii	2023	Rameez Jabeer Khan, Ekampreet Singh, Rajat Kumar Jha, Ankit Kumar, Saurabh Kumar Bhati, Mahrukh Parveez Zia, Monika Jain, Rashmi Prabha Singh, Jayaraman Muthukumaran, Amit Kumar Singh	Curr Res Struct Biol
36658487	antimicrobial activity of damino acid in combination with photosonoactivated hypericin nanoparticle against acinetobacter baumannii	the emergence of multidrugresistant acinetobacter baumannii strain be increase worldwide to overcome this lifethreatening infection the development of new treatment approach be critical for this purpose this study be conduct to determine the antimicrobial photosonodynamic therapy apsdt use hypericin nanoparticle hypnp in combination with DTryptophan DTrp against a baumannii	2023 Jan	Maryam Pourhajibagher, Nava Hosseini, Abbas Bahador	BMC Microbiol
36602381	the protective role of interleukin 17A in acinetobacter baumannii Pneumonia be Associated with Candida albican in the airway	Recent study have find that the coexistence of fungi and bacterium in the airway may increase the risk of infection contribute to the development of pneumonia and increase the severity of disease interleukin 17A IL17A play important role in host resistance to bacterial and fungal infection the objective of this study be to determine the effect of IL17A on acinetobacter baumanniiinfected rat with a previous Candida albican airway inoculation the incidence of a baumannii pneumonia be high in rat with C albican in the airway than in noninoculated rat and it decrease when amphotericin B be use to clear C albican which influence IL17A level IL17A have a protective effect in a baumannii pneumonia associate with C albican in the airway compare with a baumanniiinfected rat with C albican in the airway that do not receive IL17A recombinant IL17A ril17a supplementation decrease the incidence of a baumannii pneumonia 1015 versus 517 ip i0013 and the proportion of neutrophil in the lung 84 ± 35 versus 74 ± 43 ip i0033 reduce tissue destruction and inflammation and decrease level of myeloperoxidase mpo 1267 ± 015 versus 0233 ± 006 Ug ip i00004 reactive oxygen species ROS 132333 ± 7505 versus 64667 ± 10115 AU ip i00007 and lactate dehydrogenase LDH 2736 ± 005 versus 21816 ± 029 Ug ip i00313 iin vitroi experiment reveal that IL17A have no significant effect on the direct migration ability and bactericidal capability of neutrophil however IL17A restrain lysis cell death and increase apoptosis of neutrophil 29 ± 114 versus 7 ± 05 ip i00048 taken together we result suggest that C albican can depress IL17A level which when supplement may have a regulatory function that limit the accumulation of neutrophil in inflammatory area provide inflammatory response homeostasis	2023 Jan	Jiaxin Tang, Jiamin Li, Jinqing Pan, Xiaoyuan Shen, Xiangsheng Ye, Jiamin Zhou, Ni Wang, Liang Xie, Beth Burgwyn Fuchs, Michail S Lionakis, Eleftherios Mylonakis, Xiaojiang Tan	Infect Immun
37144752	interaction and simulation study suggest the possible molecular target of intrinsically disorder amyloidogenic antimicrobial peptide in iAcinetobacter baumanniii	iAcinetobacter baumanniii be one of the cause agent of nosocomial infection a wide range of antibiotic fail to work against this pathogen hence there be a urgent requirement to develop other therapeutics to solve this problem antimicrobial peptide amp be a diverse group of naturally occur peptide that have the ability to kill diverse group of microorganism the major challenge of use amp as therapeutics be they unstable nature and the fact that most of they molecular target be still unknown in this study we have select intrinsically disorder and amyloidogenic amp show activity against iA baumanniii that be bactenecin cath BF Citropin 11 dp7 nacath tachyplesin and wam1 to identify the probable target of this amp in iA baumanniii calculation of docking score bind energy dissociation constant and molecular dynamic analysis be perform with select seventeen possible molecular target the result show that the most probable molecular target of most of the intrinsically disorder amyloidogenic amp be udpnacetylenolpyruvoylglucosamine reductase murb follow by 3336 kDa outer membrane protein omp 3336 udpnacetylmuramoyllalanyldglutamate26diaminopimelate ligase mure and porin subfamily protein porinsubf further molecular dynamic analysis conclude that the target of antimicrobial peptide bactenecin be murb of iA baumanniii and identify other molecular target of select amp additionally the oligomerization capacity of the select amp be also investigate and it be show that the select amp form oligomeric state and interact with they molecular target in that state experimental validation use purify amp and molecular target need to be do to confirm the interactionCommunicated by ramaswamy H Sarma	2023 May	Sayani Sarkar, Aruna Kumari, Monalisa Tiwari, Vishvanath Tiwari	J Biomol Struct Dyn
36099298	deletion of a previously uncharacterize lipoprotein lirL confer resistance to a inhibitor of type ii signal peptidase in iAcinetobacter baumanniii	iAcinetobacter baumanniii be a clinically important predominantly health careassociated gramnegative bacterium with high rate of emerge resistance worldwide give the urgent need for novel antibacterial therapy against iA baumanniii we focus on inhibiting lipoprotein biosynthesis a pathway that be essential for envelope biogenesis in gramnegative bacterium the natural product globomycin which inhibit the essential type ii signal peptidase prolipoprotein signal peptidase LspA be ineffective against wildtype iA baumanniii clinical isolate due to its poor penetration through the outer membrane here we describe a globomycin analog g5132 that be more potent against wildtype and clinical iA baumanniii isolate mutation lead to g5132 resistance in iA baumanniii map to the signal peptide of a single hypothetical gene which we confirm encode a alaninerich lipoprotein and have rename ilirLi prolipoprotein signal peptidase inhibitor resistance lipoprotein LirL be a highly abundant lipoprotein primarily localize to the inner membrane deletion of ilirLi lead to g5132 resistance inefficient cell division increase sensitivity to serum and attenuate virulence signal peptide mutation that confer resistance to g5132 lead to the accumulation of diacylglycerylmodified LirL prolipoprotein in untreated cell without significant loss in cell viability suggest that this mutation overcome a block in lipoprotein biosynthetic flux by decrease LirL prolipoprotein substrate sensitivity to processing by LspA this study characterize a lipoprotein that play a critical role in resistance to LspA inhibitor and validate lipoprotein biosynthesis as a antibacterial target in iA baumanniii	2022 Sep	Ke-Jung Huang, Homer Pantua, Jingyu Diao, Elizabeth Skippington, Michael Volny, Wendy Sandoval, Varnesh Tiku, Yutian Peng, Meredith Sagolla, Donghong Yan, Jing Kang, Anand Kumar Katakam, Nairie Michaelian, Mike Reichelt, Man-Wah Tan, Cary D Austin, Min Xu, Emily Hanan, Sharookh B Kapadia	Proc Natl Acad Sci U S A
36951717	azolylpyrimidinediols as Novel Structural scaffold of dnagroove binder against intractable iAcinetobacter baumanniii	a unique class of antibacterial azolylpyrimidinediols apd and they analogue be develop some synthesized compound show excellent bacteriostatic potency especially triazolylpyrimidinediol triazolyl PD b7 ab exhibit good antiiAcinetobacter baumanniii potential with a low mic of 0002 mmolL triazolyl PD b7 ab with inconspicuous cytotoxicity and hemolytic activity could eradicate the establish biofilm show low resistance and exhibit favorable druglikeness Mechanistic exploration reveal that compound b7 ab without membranetargeting ability could decrease metabolic activity interact with DNA through groove bind action to block DNA replication rather than intercalate into and cleave DNA and thus inhibit bacterial growth further computation display that the low iEisubHOMOsub and large energy gap might help triazolyl PD b7 ab bind to biological target more easily moreover compound b7 ab give appreciable iin vivoi pharmacokinetic property and pharmacodynamics this finding of azolylpyrimidinediols as novel structural scaffold of dnagroove binder might imply a large promise for the treatment of iAcinetobacter baumanniii infection	2023 Apr	Yi-Min Tan, Ya Wang, Shuo Li, Shao-Lin Zhang, Cheng-He Zhou	J Med Chem
35869264	specific egg yolk antibody raise to biofilm associate protein bap be protective against murine pneumonia cause by acinetobacter baumannii	acinetobacter baumannii easily turn into pan drugresistant pdr with a high mortality rate no effective commercial antibiotic or approve vaccine be available against drugresistant strain of this pathogen Egg yolk immunoglobulin igy could be use as a simple and lowcost biotherapeutic against its infection this study evaluate the prophylactic potential of igy against a baumannii in a murine pneumonia model White leghorn hen be immunize with intramuscular injection of the recombinant biofilmassociated protein bap from a baumannii on day 0 21 42 and 63 the reactivity and antibiofilm activity of specific igy raise against the bap be evaluate by indirect elisa and a microtiter plate assay for biofilm formation the igy against bap be able to decrease the biofilm formation ability of a baumannii and protect the mouse against the challenge of a baumannii igy antibody raise here show a good antigenspecificity and protectivity which can be use in passive immunotherapy against a baumannii in conclusion the igy against biofilmassociated protein prove prophylactic in a murine pneumonia model	2022 Jul	Azam Ranjbar, Iraj Rasooli, Abolfazl Jahangiri, Fatemeh Ramezanalizadeh	Sci Rep
37133639	in vitro activity of omadacycline eravacycline cefiderocol apramycin and comparator antibiotic against acinetobacter baumannii cause bloodstream infection in Greece 20202021 a multicenter study	resistance of acinetobacter baumannii to multiple clinically important antimicrobial have increase to very high rate in Greece rendering most of they obsolete the aim of this study be to determine the molecular epidemiology and susceptibility of a baumannii isolate collect from different hospital across Greece singlepatient a baumannii strain isolate from blood culture and 271 from 19 hospital in a 6 month period November 2020 April 2021 be subject to minimum inhibitory concentration determination and molecular testing for carbapenemase 16S rRNA methyltransferase and mcr gene detection and epidemiological evaluation 989 of all isolate produce carbapenemase oxa23 the vast majority 918 of oxa23 producer harbor the armA and be assign mainly 943 to sequence group g1 corresponding to ic ii apramycin ebl1003 be the most active agent inhibiting 100 of the isolate at ≤ 16 mgL follow by cefiderocol which be active against at least 86 of they minocycline colistin and ampicillinsulbactam exhibit only sparse activity S 19 while eravacycline be 8 and 2 fold more active than minocycline and tigecycline respectively by comparison of they micsub50 subsub90 sub value oxa23arma produce a baumannii of international clone ii appear to be the prevail epidemiological type of this organism in Greece cefiderocol could provide a useful alternative for difficult to treat gramnegative infection while apramycin ebl1003 the structurally unique aminoglycoside currently in clinical development may represent a highly promise agent against multidrug resistant a baumanni infection due to its high susceptibility rate and low toxicity	2023 May	Irene Galani, Vassiliki Papoutsaki, Ilias Karaiskos, Nikolaos Moustakas, Lamprini Galani, Sofia Maraki, Viktoria Eirini Mavromanolaki, Olga Legga, Kimon Fountoulis, Evangelia D Platsouka, Panagiota Giannopoulou, Helen Papadogeorgaki, Maria Damala, Efrosini Chinou, Aggeliki Pasxali, Ioannis Deliolanis, Helen Vagiakou, Efthymia Petinaki, Anastasia Chli, Eleni Vagdatli, Polyzo Kazila, Vassiliki Papaioannou, Konstantina Kontopoulou, Atalia Noemi Ferke, Eleni Moraitou, Anastasia Antoniadou, Helen Giamarellou	Eur J Clin Microbiol Infect Dis
36358238	evaluation of FosfomycinSulbactam combination therapy against CarbapenemResistant iAcinetobacter baumanniii isolate in a hollowfibre infection Model	Static concentration in vitro study have demonstrate that fosfomycin or sulbactambased combination may be efficacious against carbapenemresistant iAcinetobacter baumanniii CRAB in the present study we aim to evaluate the bacterial kill and resistance suppression potential of fosfomycinsulbactam combination therapy against CRAB isolate in a dynamic infection model we simulate clinically relevant dose regimen of fosfomycin 8 gram every 8 h 1 h infusion and sulbactam 12 gram continuous infusion or 4 gram every 8 h 4 h infusion alone and in combination for 7 day in a hollowfibre infection model HFIM against three clinical isolate of CRAB the simulate pharmacokinetic profile in the HFIM be base on fosfomycin and sulbactam datum from critically ill patient fosfomycin monotherapy result in limited bacterial kill sulbactam monotherapy result in 3 to 4 logsub10 sub kill within the first 8 to 32 h follow by regrowth of up to 8 to 10 logsub10 sub CFUmL a combination of fosfomycin and continuous infusion of sulbactam lead to a 2 to 4 logsub10 sub reduction in bacterial burden within the first 24 h which be sustained throughout the duration of the experiment a combination of fosfomycin and extend infusion of sulbactam produce a 4 logsub10 sub reduction in colony count within 24 h this study demonstrate that fosfomycin in combination with sulbactam be a promise option for the treatment of MDR iA baumanniii further study be need to further assess the potential clinical utility of this combination	2022 Nov	Sazlyna Mohd Sazlly Lim, Aaron Heffernan, Saiyuri Naicker, Steven Wallis, Jason A Roberts, Fekade Bruck Sime	Antibiotics (Basel)
35653398	evolutionarily stable gene cluster shed light on the common grounds of pathogenicity in the acinetobacter calcoaceticusbaumannii complex	Nosocomial pathogen of the acinetobacter calcoaceticusbaumannii acb complex be a cautionary example for the worldwide spread of multi and pandrug resistant bacterium aiding the urgent demand for novel therapeutic target comparative genomics study between pathogen and they apathogenic relative shed light on the genetic basis of humanpathogen interaction yet exist study be limited in taxonomic scope sensing of the phylogenetic signal and resolution by largely analyze gene independent of they organization in functional gene cluster here we explore more than 3000 acinetobacter genome in a phylogenomic framework integrating orthologybased phylogenetic profiling and microsynteny conservation analysis we delineate gene cluster in the type strain a baumannii atcc 19606 whose evolutionary conservation indicate a functional integration of the subsumed gene this evolutionarily stable gene cluster esgc reveal metabolic pathway transcriptional regulator reside next to they target but also tie together subcluster with distinct function to form higherorder functional module we shortliste 150 esgc that either coemerge with the pathogenic acb clade or be preferentially find therein they provide a highresolution picture of genetic and functional change that coincide with the manifestation of the pathogenic phenotype in the acb clade Key innovation be the remodeling of the regulatoryeffector cascade connecting luxrluxision quorum sensing via a intermediate messenger to biofilm formation the extension of micronutrient scavenging system and the increase of metabolic flexibility by exploiting carbon source that be provide by the human host we could show experimentally that only member of the acb clade use kynurenine as a sole carbon and energy source a substance produce by human to finetune the antimicrobial innate immune response in summary this study provide a rich and unbiase set of novel testable hypothese on how pathogenic acinetobacter interact with and ultimately infect they human host it be a comprehensive resource for future research into novel therapeutic strategy	2022 Jun	Bardya Djahanschiri, Gisela Di Venanzio, Jesus S Distel, Jennifer Breisch, Marius Alfred Dieckmann, Alexander Goesmann, Beate Averhoff, Stephan Göttig, Gottfried Wilharm, Mario F Feldman, Ingo Ebersberger	PLoS Genet
36030268	human serum albumin hsa regulate the expression of histonelike nucleoid structure protein HNS in acinetobacter baumannii	accord to the center for Disease Control and prevention acinetobacter baumannii be list among the most threaten pathogen a baumannii be mainly a nosocomial pathogen with a distinctive ability to survive in multiple environment this characteristic together with this bacterium ability to acquire antibiotic resistance determinant make it a notorious pathogen the presence of human serum albumin hsa be associate with modification of expression level in numerous gene the presence of hsa in the culture medium be also correlate with a reduction in level of the global suppressor histonelike nucleoid structure protein HNS comparative transcriptome analysis of the wild type and isogenic Δhns strain cultured in lysogeny broth LB in the presence or absence of hsa reveal that the expression of a subset of eleven gene be modify in the Δhns cultured in LB and the wildtype strain in the presence of hsa point out this gene as candidate to be regulate by the presence of hsa through HNS six and five of this gene be up or downregulated respectively three of this gene have function in quorum sensing acdA kar and fadD one in quorum quenching aidA two in stress response katE ywrO three in metabolism phac yedL1 and yed L2 one in biofilm formation csuab and one in βoxidation of fatty acid fadA the regulation of this gene be assess by I transcriptional analysis and qpcr at the transcriptional level and ii by determine the phenotypic characteristic of each function the result of this study support the hypothesis that hsamediated reduction of HNS level may be one very important regulatory circuit utilize by a baumannii to adapt to select environment such as that where hsacontaining human fluid be abundant	2022 Aug	Jenny Escalante, Brent Nishimura, Marisel R Tuttobene, Tomás Subils, Camila Pimentel, Nardin Georgeos, Rodrigo Sieira, Robert A Bonomo, Marcelo E Tolmasky, Maria Soledad Ramirez	Sci Rep
35618774	immunosuppression broaden evolutionary pathway to drug resistance and treatment failure during acinetobacter baumannii pneumonia in mouse	acinetobacter baumannii be increasingly refractory to antibiotic treatment in healthcare setting as be true of most human pathogen the genetic path to antimicrobial resistance amr and the role that the immune system play in modulate amr during disease be poorly understand here we reproduce several route to fluoroquinolone resistance perform evolution experiment use sequential lung infection in mouse that be replete with or deplet of neutrophil provide two key insight into the evolution of drug resistance first neutropenic host act as reservoir for the accumulation of drug resistance during drug treatment selection for variant with alter drug sensitivity profile arise readily in the absence of neutrophil while immunocompetent animal restrict the appearance of this variant secondly antibiotic treatment failure in the immunocompromised host be show to occur without clinically define resistance a unexpected result that provide a model for how antibiotic failure occur clinically in the absence of amr the genetic mechanism underlying both this result be initiate by mutation activating the drug egress pump regulator adel which drive persistence in the presence of antibiotic therefore antibiotic persistence mutation present a twopronge risk during disease cause drug treatment failure in the immunocompromised host while simultaneously increase the emergence of highlevel amr	2022 Jun	Wenwen Huo, Lindsay M Busch, Juan Hernandez-Bird, Efrat Hamami, Christopher W Marshall, Edward Geisinger, Vaughn S Cooper, Tim van Opijnen, Jason W Rosch, Ralph R Isberg	Nat Microbiol
37158230	dksa be a conserved master regulator of stress response in acinetobacter baumannii	coordination of bacterial stress response mechanism be critical for longterm survival in harsh environment for successful host infection the general and specific stress response of wellstudy gramnegative pathogen like Escherichia coli be control by alternative sigma factor archetypically rpos the deadly hospital pathogen acinetobacter baumannii be notoriously resistant to environmental stress yet it lack rpos and the molecular mechanism drive this incredible stress tolerance remain poorly define here use functional genomics we identify the transcriptional regulator dksa as a master regulator for broad stress protection and virulence in a baumannii transcriptomics phenomics and in vivo animal study reveal that dksa control ribosomal protein expression metabolism mutation rate desiccation antibiotic resistance and host colonization in a nichespecific manner Phylogenetically dksa be highly conserved and welldistributed across Gammaproteobacteria with 966 contain dksa span 88 family this study lay the groundwork for understanding dksa as a major regulator of general stress response and virulence in this important pathogen	2023 May	Ram P Maharjan, Geraldine J Sullivan, Felise G Adams, Bhumika S Shah, Jane Hawkey, Natasha Delgado, Lucie Semenec, Hue Dinh, Liping Li, Francesca L Short, Julian Parkhill, Ian T Paulsen, Lars Barquist, Bart A Eijkelkamp, Amy K Cain	Nucleic Acids Res
36736497	development mechanism of resistant population postexposure to tigecycline in tigecyclineheteroresistant acinetobacter baumannii strain	tigecycline heteroresistance be highly prevalent in acinetobacter baumannii clinical isolate reduce the efficacy of tigecycline treatment this study investigate the population dynamic of a baumannii with tigecycline heteroresistance to determine the origin of resistance that occur over time after antibiotic exposure tigecycline heteroresistance be imitate by mixing tigecyclinesusceptible and resistant a baumannii isolate in a 110sup6 sup ratio and confirm use population analysis profiling growth curve and a invitro competition assay find no difference in bacterial fitness between tigecyclineresistant and susceptible population the green fluorescent protein gfp expression system and flow cytometry be use to monitor the population dynamic of the heteroresistant population while differentiating the resistant population from the susceptible population the mimick tigecycline heteroresistance be confirm to be reproducible and stable without tigecycline the gfpexpressing population ie the resistant population nearly go undetect because it only represent approximately 10sup6 sup of the entire population however when the mimick tigecyclineheteroresistant strain be treat with tigecycline most subpopulation express gfp be detect the survive a baumannii population upon exposure to tigecycline exhibit a high minimum inhibitory concentration for tigecycline equivalent to that of tigecyclineresistant isolate that be use to mimic heteroresistance this result indicate that the development of resistance in tigecyclineheteroresistant a baumannii strain result in decrease antibiotic efficacy may depend on the selection of a preexisting resistant subpopulation	2023 Apr	Jeongwoo Jo, Wonbeom Park, Dae-Hyuk Kweon, Kwan Soo Ko	Int J Antimicrob Agents
36417622	communityacquired acinetobacter baumannii pneumonia a rare case in Brazil	acinetobacter baumannii a common pathogen in nosocomial infection be a rare cause of communityacquired pneumonia this report highlight the difficulty in its early diagnosis and effective treatment as it be a multidrugresistant microorganism with rapid unfavorable progression to good understand its clinical outcome we search the literature for similar case but find no communityacquired case in Brazil	2022	Izadora Raduan Brigo, Leandro de Resende Yamamoto, Rodrigo Juliano Molina	Rev Soc Bras Med Trop
36830328	the RND efflux Pump gene expression in the biofilm formation of iAcinetobacter baumanniii	Multidrug resistant MDR iAcinetobacter baumanniii be a critical opportunistic pathogen in healthcareassociated infection hai this be attribute to several factor include its ability to develop biofilm that can enhance antimicrobial resistance amr in addition to create a environment for horizontal transfer of antibiotic resistance gene the role of the efflux pump in biofilm formation be important for study on alternative treatment for biofilm one of the significant efflux pump family be the RND efflux pump family which be common in Gram negative bacterium the aim be to study the role of the RND efflux pump in biofilm formation by iA baumanniii the biofilm formation potential of thirtyfour MDR iA baumanniii isolate be evaluate by crystal violet assay the effect of efflux pump inhibition and activation be study use the efflux pump inhibitor carbonyl cyanide 3chlorophenylhydrazone cccp and the RND efflux pump substrate levofloxacin at submic respectively the isolate be genotypically group by enterobacterial repetitive intergenic consensus eric type and the expression of iadeabci iadefghi and iadeibki efflux pump gene be measure by qpcr overall 882 3034 of isolate be biofilm producer the phenotype be variable include strong and weak producer efflux pump inhibition by cccp reduce the biofilm formation significantly ipi 005 in 176 634 of some isolate whereas submic of the substrate levofloxacin increase biofilm formation in 205 734 of other isolate overexpression of the three RND efflux pump gene be detect in five out of eleven select isolate for qpcr with remarkable overexpression in the iadeJi gene no correlation be detect between the biofilm phenotype pattern and the RND efflux pump gene expression in biofilm cell relative to planktonic cell in conclusion the role of the RND efflux pump adeabc adefgh and adeijk in biofilm formation do not appear to be pivotal and the expression differ accord to the genetic background of each strain thus this pump may not be a promise target for biofilm inhibition	2023 Feb	Ola A Abd El-Rahman, Fatma Rasslan, Safaa S Hassan, Hossam M Ashour, Reham Wasfi	Antibiotics (Basel)
35875928	charge effect of watersoluble porphyrin derivative as a prototype to fight infection cause by iAcinetobacter baumanniii by aPDT approach	in the last decadei acinetobacter baumanniii have emerge as a pathogen associate with infection in intensive care unit worldwide especially due to its ability to resist a extensive list of antibiotic in this context porphyrin have emerge as a important strategy in photodynamic therapy since they be a group of tetrapyrrolic compound with important photochemical and photobiological activity in this study the antimicrobial photodynamic activity of imesoitetra4inmethylipyridylporphyrin bhsub2subtmepy psupsupb and imesoitetra4sulfonatophenylporphyrin bhsub2subtppssup‒supb be evaluate against iA baumanniii by minimum inhibitory concentration mic antibiofilm activity and the interaction with antibiotic after exposure to whitelight LED irradiation the cationic derivative bhsub2subtmepy psupsupb be more potent mic 061 µm than bhsub2subtppssup‒supb with antibiofilm activity and increase the antimicrobial activity of ciprofloxacin and amikacin give this finding the tetracationic porphyrin can be assume as prototype to optimize and develop new agent by promote oxidative stress and inducing free radical production	2022 Jul	Carolina da Silva Canielles Caprara, Livia da Silva Freitas, Bernardo Almeida Iglesias, Lara Beatriz Ferreira, Daniela Fernandes Ramos	Biofouling
36034086	evaluation of plga nanoparticle contain outer membrane protein of iAcinetobacter baumanniii bacterium in stimulate the immune system in mouse	iAcinetobacter baumannii a baumanniii be know as a pathogen with antibiotic resistance cause respiratory infection plga have be approve for use in vaccine as well as drug delivery this study be perform to evaluate plga nanoparticle contain the outer membrane protein omp of iA baumanniii in stimulate the mice immune system and improve pneumonia	2022 Aug	Afshin Gholizadeh, Reza Shapoury, Parviz Pakzad, Mehdi Mahdavi, Hossein Danafar	Res Pharm Sci
36010006	in vitro activity of sulbactamdurlobactam against CarbapenemResistant iAcinetobacter baumanniii Clinical isolate a multicentre report from Italy	in the present study the in vitro activity of the sulbactamdurlobactam suldur combination be evaluate against 141 carbapenemresistant iA baumanniii CRiAbi clinical strain collect from six Italian laboratory over half 546 of this isolate be resistant to colistin the suldur combination be active against this CRiAbi isolate with micsub50sub and micsub90 sub value of 05 mgL and 4 mgL respectively only eleven isolate be resistant to suldur with mic value range from 8 to 128 mgL the suldur resistant iA baumanniii exhibit several antimicrobial resistance gene ARGs such as iblaisuboxa20sub iblaisubOXA58 sub iblaisuboxa66sub iblaisubADC25 sub iaac6Ib3i and iaac6 Ibcri and mutation in igyriA s81l and ipariC V104I d105e however in this isolate mutation Q488 k and y528h be find in pbp3 different determinant be also identify in this CRiAbi isolate include iadeabci iadefghi iadeibki iabesi iabaQi and iabaRi which encode multidrug efflux pump associate with resistance to multiple antibacterial agent this be the first report on the antimicrobial activity of suldur against carbapenemresistant iA baumanniii isolate select from multiple region in Italy	2022 Aug	Bernardetta Segatore, Alessandra Piccirilli, Sabrina Cherubini, Luigi Principe, Giovanni Alloggia, Maria Lina Mezzatesta, Mario Salmeri, Stefano Di Bella, Roberta Migliavacca, Aurora Piazza, Elisa Meroni, Paolo Fazii, Daniela Visaggio, Paolo Visca, Venere Cortazzo, Giulia De Angelis, Arianna Pompilio, Mariagrazia Perilli	Antibiotics (Basel)
37052656	revealing the singlechannel characteristic of oprd occab1 porin from hospital strain of acinetobacter baumannii	nowadays report of antimicrobial resistance amr against many antibiotic be increase because of they misapplication with this rise there be a serious decrease in the discovery and development of new type of antibiotic amid a increase in multidrug resistance unfermented acinetobacter baumannii from gramnegative bacterium which be one of the main cause of nosocomial infection and multidrug resistance have 4 main kind of antibiotic resistance mechanism inactivate antibiotic by enzyme reduce number of porin and change of they target or cellular function due to mutation and efflux pump in this study characterization of the possible mutation in oprd occab1 porin from hospital strain of a baumannii be investigate use single channel electrophysiology and compare with the standard oprd isolate from wild type atcc 19606 for this aim 5 a baumannii bacterium sample be obtain from patient infect with a baumannii after which oprd porin be isolate from this a baumannii strain oprd porin be then insert in a artificial lipid bilayer and the currentvoltage curve be obtain use electrical recording through a pair of agagcl electrode we observe that each porin have a characteristic conductance and single channel recording which then lead to difference in channel diameter finally the single channel datum have be compare with the gene sequence of each porin it be interesting to find out that each porin isolate have a unique porin diameter and decrease anion selectivity compare to the wild type	2023 Apr	Aliakbar Ebrahimi, Tuğçe Ergün, Özge Kaygusuz İzgördü, Cihan Darcan, Hüseyin Avci, Barçin Öztürk, Hatice Rahmet Güner, Hamed Ghorbanpoor, Fatma Doğan Güzel	Eur Biophys J
36475717	Penicillin binding protein 78 be a potential drug target in CarbapenemResistant acinetobacter baumannii	Limited therapeutic option dictate the need for new class of antimicrobial active against carbapenemresistant acinetobacter baumannii present datum confirm and extend penicillin bind protein 78 pbp 78 as a highvalue target in the cr a baumannii strain humc1 pbp 78 be essential for optimal growthsurvival of humc1 in iex vivoi human ascite and in a rat subcutaneous abscess model in a mouse pneumonia model the absence of pbp 78 decrease lethality 11 fold the loss of pbp 78 result in increase permeability sensitivity to complement and lysozymemediated bactericidal activity this change do not appear to be due to alteration in the cellular fatty acid composition or capsule production however a decrease in lipid a and a increase in coccoidal cell and cell aggregation be note the compromise of the stringent permeability barrier in the pbp 78 mutant be reflect by a increase susceptibility to several antimicrobial importantly expression of iampCi be not significantly affect by the loss of pbp 78 and serial passage of the mutant strain in human ascite over 7 day do not yield revertant possessing a wildtype phenotype in summary this datum and other feature support pbp 78 as a highvalue drug target for extensively drugresistant and cr a baumannii we result guide nextstage study the determination that the inactivation of pbp 78 result in a increase sensitivity to lysozyme enable the design of a highthroughput screen assay to identify small molecule compound that can specifically inhibit pbp 78 activity	2023 Jan	Thomas A Russo, Ulrike Carlino-MacDonald, Cassandra L Alvarado, Connor J Davies, Oscar Barnes, Grishma Trivedi, Parijat Mathur, Alan Hutson, Felise G Adams, Maoge Zang, Alice Ascari, Bart A Eijkelkamp	Antimicrob Agents Chemother
36482013	effect of biosynthesized selenium nanoparticle use nepeta extract against multidrugresistant pseudomonas aeruginosa and acinetobacter baumannii	the problem of drug resistance in bacterium have become one of the daily challenge of the clinical treatment of patient which inevitably force we to use agent other than common antibiotic among this we can take help from different property and application of nanoparticle nps in this work we evaluate the antibacterial activity of biosynthesized selenium nanoparticle senp against standard strain of multidrugresistant pseudomonas aeruginosa and acinetobacter baumannii the production of biosynthesized senp be prove by ultravioletvisible fourier transform infrared Xray diffractometer field emission scanning electron microscopy Dynamic light scattering and zeta potential method the cytotoxicity effect of senp be investigate by mtt assay disk diffusion agar DDA and minimum inhibitory concentration mic test be perform on the mention bacterium use different class of standard antibiotic and senp separately the impact of senp combine with the desire antibiotic for good treatment of this infection be evaluate by checkerboard assay to determine the synergism effect after the confirmation result base on the biosynthesis of senp both standard bacterial strain be susceptible to senp and have a zone of inhibition use the DDA test also the result of mic show that biosynthesized senp in low concentration than antibiotic cause no growth of bacterium on the other hand accord to the checkerboard assay senp have a synergistic effect with conventional antibiotic the antibacterial sensitivity test demonstrate the inhibition of bacterial growth in the presence of low concentration of senp than common antibiotic this property can be exert in future application to solve the drug resistance obstacle of microorganism in bacterial disease	2023 Feb	Shadi Zeraatkar, Maedeh Tahan, Hamid Sadeghian, Razieh Nazari, Mostafa Behmadi, Mahdi Hosseini Bafghi	J Basic Microbiol
36506188	lectinfortified Cationic copper sulfide nanoparticle Gain Dual target capability to treat CarbapenemResistant iAcinetobacter baumanniii infection	target drug delivery maximize the chance to combat infection cause by drugresistant pathogen herein lectinfortifie cationic copper sulfide cCuS nanoparticle be suggest for target adhesion to bacterial membrane and to enforce bacterial death jacalin a lectin from jackfruit seed be conjugated to fluorescein isothiocyanate FITC and its ability to recognize bacterial cell surface glycans be demonstrate jacalin form a noncovalent complex with cCuS which be investigate by fluorescence quenching measurement the datum reveal that jacalincCuS JcCuS have a good affinity with a association constant iKi subasub of 227 ± 028 × 10sup4sup msup1sup the resultant JcCuS complex display excellent antiinfective activity against carbapenemresistant iAcinetobacter baumanniii CRAB the minimum inhibitory concentration mic of cCuS be 625 μM which be 2 fold low than that of the broadspectrum antibiotic ciprofloxacin interestingly the mic of JcCuS be reduce to 1563 μM which be attribute to jacalin fortification the mechanistic study unveil that JcCuS affect the membrane integrity depolarize the inner membrane and produce excess reactive oxygen species to combat CRAB at a low concentration compare to cCuS iA baumanniii form a biofilm more readily which play a critical role in pathogenesis and resistance in clinical setting JcCuS 391 μM display strong antibiofilm activity without affect the metabolic viability of CRAB microscopy analysis confirm the inhibition of biofilm formation and disruption of the mature biofilm upon treatment with JcCuS furthermore JcCuS hinder pellicle formation and inhibit the biofilmassociated virulence factor of CRAB such as exopolysaccharide cell surface hydrophobicity swarm and twitching mobility the antiinfective potential of JcCuS be demonstrate by rescuing crabinfected zebrafish the reduction in pathogen proliferation in muscle tissue be observe in the treat group and the fish recover from the infection and be restore to normal life within 12 h the finding illustrate that lectin fortification offer a unique advantage in enhancing the therapeutic potential of antimicrobial against human pathogen of critical priority worldwide	2022 Dec	Dharshini Karnan Singaravelu, Dalal Nasser Binjawhar, Fuad Ameen, Anbazhagan Veerappan	ACS Omega
36073931	mechanism of isi26imediated amplification of the iaphA1i gene leading to tobramycin resistance in a acinetobacter baumannii Isolate	enhanced level of resistance to antibiotic arise from amplification of a antibiotic resistance gene that impact therapeutic option be increasingly observe amplification can also disclose novel phenotype lead to treatment failure however the mechanism be poorly understand here the route to amplification of the iaphA1i kanamycin and neomycin resistance gene during tobramycin treatment of a acinetobacter baumannii clinical isolate lead to tobramycin resistance and treatment failure be investigate in the tobramycinsusceptible parent isolate mrsn56 a single copy of iaphA1i be present in the pseudocompound transposon PTni6020 I bound by directly orient copy of isi26 I for two clinical resistant isolate new longread sequence datum be combine with available shortread datum to complete the genome Comparison to the complete genome of mrsn56 reveal that in both case isi26 I have generate a circular translocatable unit tu contain ptni6020i and additional adjacent DNA in one case this tu be reincorporated into the second product generate by the deletion that form the tu via the target conservative route and amplify about 7 time in the second case the tu be incorporate at a new location via the copyin route and amplify about 65 time experimental amplification iex vivoi by subjecting mrsn56 to tobramycin selection pressure yield different TUs which be incorporate at either the original location or a new location and amplify many time the outcome suggest that when ISi26i be involve amplification occur via roll circle replication of a newly form tu couple to the isi26 imediate tu formation or reincorporation step bimportanceb heteroresistance a significant issue that be know to impact antibiotic treatment outcome be cause by the presence of spontaneously arise cell with elevate level of resistance to therapeutically important antibiotic in a population of susceptible cell gene amplification be one welldocumented cause of heteroresistance but precisely how extensive amplification occur be not understand here we establish the case for the direct involvement of ISi26i activity in the amplification of the iaphA1i gene to disclose resistance to tobramycin the iaphA1i gene be usually find associate with isi26 I in gramnegative pathogen and be commonly find in extensively resistant acinetobacter baumannii strain isi26 I and related be cause adjacent deletion form a nonreplicating circular molecule know as a translocatable unit tu and amplification via a roll circle mechanism appear to be couple to either isi26 imediate tu formation or reincorporation related be find in grampositive pathogen may play a similar role	2022 Oct	Christopher J Harmer, Francois Lebreton, Jason Stam, Patrick T McGann, Ruth M Hall	Microbiol Spectr
36671325	use of highdose nebulized colistimethate in patient with ColistinOnly susceptible iAcinetobacter baumanniii vap Clinical Pharmacokinetic and microbiome feature	1 background Colistinonly susceptible cos iAcinetobacter baumanniii ab ventilatorassociated pneumonia vap represent a clinical challenge in the intensive Care unit icu due to the negligible lung diffusion of this molecule and the lowgrade evidence on efficacy of its nebulization 2 method we conduct a prospective observational study on 134 icu patient with cosab vap to describe the real life clinical use of highdose 5 MIU q8 aerosolized colistin use a vibrate mesh nebulizer Lung pharmacokinetic and microbiome feature be investigate 3 result patient be enrol during the covid19 pandemic with the icu present a sap ii of 42 3257 at vap diagnosis the median paosub2subfiosub2sub be 120 100164 403 be in septic shock and 246 have secondary bacteremia the twentyeight day mortality be 507 with 604 and 403 rate of clinical cure and microbiological eradication respectively we do not observe any drugrelate adverse event epithelial lining fluid colistin concentration be far above the CRAB minimalinhibitory concentration and the duration of nebulized therapy be a independent predictor of microbiological eradication 12 97514 versus 7 413 day or 95 CI 1069 10031138 ipi 0039 4 conclusion Highdose and prolong colistin nebulization use a vibrate mesh be a safe adjunctive therapeutic strategy for cosab vap its right place and efficacy in this set warrant investigation in interventional study	2023 Jan	Gennaro De Pascale, Gabriele Pintaudi, Lucia Lisi, Flavio De Maio, Salvatore Lucio Cutuli, Eloisa Sofia Tanzarella, Simone Carelli, Gianmarco Lombardi, Melania Cesarano, Veronica Gennenzi, Gabriella Maria Pia Ciotti, Domenico Luca Grieco, Brunella Posteraro, Maurizio Sanguinetti, Pierluigi Navarra, Massimo Antonelli	Antibiotics (Basel)
36787358	a conserved zincbinding site in iAcinetobacter baumanniii pbp2 require for elongasomedirected bacterial cell shape	iAcinetobacteri ibaumanniii be a gramnegative bacterial pathogen that cause challenging nosocomial infection βlactam target of penicillinbind protein pbymediated cell wall peptidoglycan pg formation be a wellestablished antimicrobial strategy exposure to carbapenem or zinc zndeprived growth condition lead to a rodtosphere morphological transition in iA baumanniii a effect resembling that cause by deficiency in the rodapbe2 pg synthesis complex require for cell wall elongation while it be recognize that carbapenem preferentially acylate pbp2 in iA baumanniii and therefore block the transpeptidase function of the rodapbe2 system the molecular detail underpin cell wall elongation inhibition upon zn starvation remain undefined here we report the Xray crystal structure of iA baumanniii pbp2 revealing a unexpected zn coordination site in the transpeptidase domain require for protein stability mutation in the znbind site of pbp2 cause a loss of bacterial rod shape and increase susceptibility to βlactam therefore provide a direct rationale for cell wall shape maintenance and zn homeostasis in iA baumanniii furthermore the Zncoordinaten residue be conserved in various " and γproteobacterial pbp2 ortholog consistent with a widespread znbind requirement for function that have be previously unknown due to the emergence of resistance to virtually all market antibiotic class alternative or complementary antimicrobial strategy need to be explore this finding offer a perspective for dual inhibition of Zndependent pg synthasis and metallo βlactamase by metal chelate agent consider the most soughtafter adjuvant to restore βlactam potency against gramnegative bacterium	2023 Feb	Carmina Micelli, Yunfei Dai, Nicole Raustad, Ralph R Isberg, Christopher G Dowson, Adrian J Lloyd, Edward Geisinger, Allister Crow, David I Roper	Proc Natl Acad Sci U S A
36177621	the ll37 antimicrobial peptide as a treatment for systematic infection of iAcinetobacter baumanniii in a mouse Model	the antimicrobial peptide amp play a critical role in the innate immunity of the host and be consider natural source illustrate a broadspectrum antimicrobial activity with high specificity and low cytotoxicity amp generally possess a net positive charge and have amphipathic structure thus amp can bind and interact with negatively charge bacterial cell membrane lead to destructive defect in biomembrane and end in cell death ll37 be the only human cathelicidinderived antimicrobial peptide that show a broad spectrum of antimicrobial activity	2023	Ehsan Zarei-Mehrvarz, Shohreh Fahimirad, Ehsanollah Ghaznavi-Rad, Shabnam Sadoogh Abbasian, Hamid Abtahi	Protein Pept Lett
37111736	Characterization of increase Extracellular vesiclemediated tigecycline resistance in iAcinetobacter baumanniii	Carbapenemresistant iAcinetobacter baumanniii CRAB be the most detrimental pathogen that cause hospitalacquired infection tigecycline tig be currently use as a potent antibiotic for treat CRAB infection however its overuse substantially induce the development of resistant isolate some molecular aspect of the resistance mechanism of ab to tig have be report but they be expect to be far more complicated and diverse than what have be characterize thus far in this study we identify bacterial extracellular vesicle evs which be nanosize lipidbilayered spherical structure as mediator of tig resistance use laboratorymade TIGresistant ab tigr ab we demonstrate that tigr ab produce more evs than control tigsusceptible ab TIGS ab transfer analysis of tigr abderive evs treat with proteinase or dnase to recipient TIGS ab show that tigr EV protein be major factor in tig resistance transfer additional transfer spectrum analysis demonstrate that evmediated tig resistance be selectively transfer to iEscherichia colii iSalmonella typhimuriumi and iproteus mirabilisi however this action be not observe in iKlebsiella pneumoniai and iStaphylococcus aureusi finally we show that evs be more likely to induce tig resistance than antibiotic we datum provide direct evidence that evs be potent cellderive component with a high selective occurrence of tig resistance in neighbor bacterial cell	2023 Apr	Hyejin Cho, Tesalonika Sondak, Kwang-Sun Kim	Pharmaceutics
34375286	structure base in silico screening revealed a potent acinetobacter baumannii Ftsz inhibitor from asinex antibacterial Library	the superbug acinetobacter baumannii be a increasingly prevalent pathogen of the intensive care unit where its treatment be challenging the identification of new drug target and the development of propitious therapeutics against this pathogen be of utmost importance a drug target cell division enzyme ftsr involve in a baumannii cytokinesis be a promise avenue for antibacterial therapy structure base virtual screen illustrate a leadlike molecule from asinex antibacterial library to have the good bind affinity for the ftsr active pocket Computational pharmacokinetic predict the compound to have the safe pharmacokinetic profile thus maximizing the chance of the molecule reach the market with enhance efficacy and less toxicity molecular dynamic simulation in a aqueous environment reveal the flexibility of protein loop region and upward extension follow by the backward movement of the inhibitor N ndimethylpyridazin3 amine ring on its axis the active pocket residue thr310 demonstrate to play significant role in inhibitor bind the bind free energy predict by mmgbsa and mmpbsa reflect system stability with a total value of 6215 kcalmol and 1060 kcalmol respectively the absolute bind free energy estimate by waterswap be 16 kcalmol that validate and affirm complex stability the inhibitor represent a promise scaffold as a lead optimization for the ftsr enzyme	2022	Afifa Navid, Sajjad Ahmad, Rida Sajjad, Saad Raza, Syed Sikander Azam	IEEE/ACM Trans Comput Biol Bioinform
37125465	sulbactamdurlobactam a step forward in treat CarbapenemResistant acinetobacter baumannii CRAB infection	antimicrobial resistance in gramnegative pathogen such as acinetobacter baumannii be a serious threat to human health sulbactamdurlobactam a unique βlactam and a βlactamase inhibitor combination be a novel agent target against carbapenemresistant a baumannii this supplement provide a summary of the development of suldur discuss its unique feature and role in treat infection cause by CRAB pathogen	2023 May	Richard R Watkins, Robert A Bonomo	Clin Infect Dis
37212653	contribution of irontransport system and " lactamase to cefiderocol resistance in Clinical isolate of acinetobacter baumannii endemic to New York City	the development of resistance to cefiderocol among multidrug resistant acinetobacter baumannii have be attribute to downregulation in iron transport system and a variety of βlactamase however the precise contribution of each in clinical isolate remain to be determine sixteen clinical isolate with vary degree of cefiderocol resistance be investigate susceptibility testing be perform with and without the presence of iron and avibactam expression of 10 iron transport system and iblaisubADCsub and iblaisuboxa51typesub be analyze by real time rtpcr the acquisition of a variety of βlactamase be also determine in 2 isolate the impact of silencing the iblaisubADCsub gene be achieve use a target specific group ii intron for most resistant isolate mics for cefiderocol be similar with or without the presence of iron and there be a overall decrease in expression of receptor include ipirAi and ipiuAi involve in ferric uptake however expression of the ferrous uptake system ifaoAi persist the addition of avibactam 4 μgmL lower most cefiderocol mic to 2 to 4 μgmL most isolate possess adc25 or adc33 cefiderocol resistance correlate with overexpression of iblaisubADCsub silencing of this βlactamase result in a ≥ 8 fold decrease in cefiderocol mic overexpression of specific iblaisubADCsub subtype in a background of generalize repression of ferric uptake system be consistent feature in clinical isolate of cefiderocolresistant iA baumanniii	2023 May	Habtamu Asrat, Jevon Samaroo-Campbell, Subhan Ata, John Quale	Antimicrob Agents Chemother
37065616	iAcinetobacter baumanniii adaptation to the host pH microenvironment be mediate by allelic variation in a single residue of BauA protein	iAcinetobacter baumanniii have be list as one of the most critical pathogen in nosocomial infection however the key gene and mechanism to adapt to the host microenvironment lack indepth understanding in this study a total of 76 isolate from 8 to 12 isolate per patient span 128 to 188 day be longitudinally collect from eight patient to investigate the withinhost evolution of iA baumanniii a total of 70 withinhost mutation be identify 80 of which be nonsynonymous indicate the important role of positive selection several evolutionary strategy of iA baumanniii to increase its potential to adapt to the host microenvironment be identify include hypermutation and recombination six gene be mutate in isolate from two or more patient include two TonBdependent receptor gene ibauAi and ibjab07104rs00665i in particular the siderophore receptor gene ibauAi be mutate in multiple isolate from four patient with three mlst type and all mutation be at amino acid 391 in ligandbinding site with 391T or 391A BauA be more strongly bind to siderophore which promote the ironabsorption activity of iA baumanniii at acidic or neutral pH respectively through the at mutation at site 391 of BauA iA baumanniii display two reversible phase to adapt to distinct pH microenvironment in conclusion we demonstrate the comprehensive withinhost evolutionary dynamic of iA baumanniii and discover a key mutation of BauA site 391 as a genetic switch to adapt to different pH value which may represent a model in the pathogen evolutionary adaption of the host microenvironment	2023 Apr	Tao Li, Deyan Luo, Nianzhi Ning, Xiong Liu, Fanghong Chen, Liangyan Zhang, Chunmei Bao, Zhan Li, Deyu Li, Hongjing Gu, Fen Qu, Xiaolan Yang, Yanyu Huang, Boan Li, Hui Wang	PNAS Nexus
37023677	dimeric 2 aminoimidazole be highly active adjuvant for grampositive selective antibiotic against acinetobacter baumannii	the center for Disease Control and prevention CDC report that hospital acquire infection have increase by 65 since 2019 one of the main contributor be the gramnegative bacterium acinetobacter baumannii previously we report aryl 2 aminoimidazole 2 ai adjuvant that potentiate macrolide antibiotic against a baumannii macrolide antibiotic be typically use to treat infection cause by grampositive bacterium but be ineffective against most gramnegative bacterium we describe a new class of dimeric 2ais that be highly active macrolide adjuvant with lead compound lower minimum inhibitory concentration mic to or below the grampositive breakpoint level against a baumannii the parent dimer lower the clarithromycin CLR mic against a baumannii 5075 from 32 μgmL to 1 μgmL at 75 μM 34 μgmL and a subsequent structure activity relationship sar study identify several compound with increase activity the lead compound lower the CLR mic to 2 μgmL at 15 μM 072 μgmL far exceeding the activity of both the parent dimer and the previous lead aryl 2ai furthermore this dimeric 2ais exhibit considerably reduce mammalian cell toxicity compare to aryl2 ai adjuvant with icsub50sub of the two lead compound against hepg2 cell of 200 μgmL give therapeutic index of 250	2023 May	Santiana A Marrujo, Veronica B Hubble, Jingdong Yang, Man Wang, Ansley M Nemeth, Samantha L Barlock, Dane Juarez, Richard D Smith, Roberta J Melander, Robert K Ernst, Mayland Chang, Christian Melander	Eur J Med Chem
35785672	immunoprotective characterization of egg yolk immunoglobulin raise to loop 3 of outer membrane protein 34 omp34 in a murine model against acinetobacter baumannii	acinetobacter baumannii be one of the most notorious nosocomial pathogen with high mortality rate recently egg yolk antibody igy have be consider as a promise biomolecule against pneumonia cause by this bacterium Loop 3 of outer membrane protein 34 omp34 be predict as a highly expose immunogenic peptide however its immunogenicity remain to be experimentally elucidate in the current study a construct compose of 5 copy of loop3 of omp34 label as omp34l3x5 be design this construct as well as the recombinant omp34 be express purify and injected into lay hen to raise specific antibody the specific igy be extract from hyperimmune egg yolk the omp34l3x5 and whole cell wcoo of a baumannii serve as antigen in indirect elisa to assess the purify igy reactivity this antibody be administer to neutropenic mouse 1 h before the challenge with 10 × ldsub50 sub of a clinical isolate of a baumannii the specific igy recognize recombinant omp34 p 00001 as well as wcoo of a baumannii p 005 the survival rate of mouse that receive anti omp34l3x5 or antiOmp34 igy be 8333 and 100 respectively all control mouse die within 24 h while mouse that receive nonspecific igy die within 72 h after 24 h bacterial load in the lung of mouse receive nonspecific igy antiOmp34L3X5 or antiOmp34 igy be 203 × 10 sup8 sup 22 × 10sup8 sup and 193 × 10sup8 sup cfuorgan respectively bacterial load in the spleen of mouse receive nonspecific igy antiOmp34L3X5 or antiOmp34 igy be 103 × 10sup8 sup 78 × 10sup7sup and 63 × 10sup7sup cfuorgan respectively bacterial load in lung and spleen of control mouse be 303 × 10sup9sup and 145 × 10 sup8 sup cfuorgan respectively	2022 Sep	Maryam Mesbahi Moghaddam, Iraj Rasooli, Mohammad Hossein Ghaini, Abolfazl Jahangiri, Fatemeh Ramezanalizadeh, Rasoul Ghasemkhah Tootkleh	Mol Immunol
36837545	prediction of Putative epitope peptide against barr Associated with TCS adaptation in iAcinetobacter baumanniii use a in silico approach	iBackground and objectivesi the barr protein be involve in the adaptation system of iA baumanniii and be associate with virulence factor responsible for systemic infection in hospitalize patient this study be conduct to characterize putative epitope peptide for the design of vaccine against barr protein use a immuneinformatic approach iMaterial and Methodsi fasta sequence of barr from five different strain of iA baumanniii be retrieve from the uniprot database and evaluate for they antigenicity allergenicity and vaccine property use bepipre Vaxijen algpred antigenpro and solpro they physiochemical property be assess use the expasy protparam server immunodominant bcell and tcell epitope peptide be predict use the iedb database and MHC cluster server with a final assessment of they interaction with tlr2 result a final selection of two peptide sequence 36 a and 22aa be make from the 38 antigenic peptide e1 be consider a soluble nonallergenic antigen and possess negative gravy value substantiate the hydrophilic nature of the protein further analysis on the tcell epitope class I immunogenicity and hla allele frequency yield tcell immunodominant peptide the proteinpeptide interaction of the tlr2 receptor show good similarity score in term of the high number of hydrogen bond compare to other proteinpeptide interaction iConclusionsi the two epitope predict from iBaeRi in the present investigation be promise vaccine candidate for target the TCS of iA baumanniii in systemic and nosocomial infection this study also demonstrate a alternative strategy to tackle and mitigating MDR strain of iA baumanniii and provide a useful reference for the design and construction of novel vaccine candidate against this bacterium	2023 Feb	A S Smiline Girija, Shoba Gunasekaran, Saman Habib, Mohammed Aljeldah, Basim R Al Shammari, Ahmad A Alshehri, Ameen S S Alwashmi, Safaa A Turkistani, Abdulsalam Alawfi, Amer Alshengeti, Mohammed Garout, Sara Alwarthan, Roua A Alsubki, Nouran M Moustafa, Ali A Rabaan	Medicina (Kaunas)
36704122	Stochastic activation of a family of tetr type transcriptional regulator control phenotypic heterogeneity in iAcinetobacter baumanniii	phenotypic heterogeneity be a important mechanism for regulate bacterial virulence where a single regulatory switch be typically activate to generate virulent and avirulent subpopulation the opportunistic pathogen iAcinetobacter baumanniii can transition at high frequency between virulent opaque viro and avirulent translucent subpopulation distinguished by cell that form opaque or translucent colony we demonstrate that expression of 11 tetrtype transcriptional regulator tttr can drive cell from the viro opaque subpopulation to cell that form translucent colony remarkably in a subpopulation of viro cell four of this tttr be stochastically activate in different combination to drive cell to the translucent state the result translucent subvariant exhibit unique phenotypic difference and the majority be avirulent due to they functional redundancy a quadruple mutant with all four of this tttr inactivate be require to observe a loss of switch from the viro state further we demonstrate a small RNA srvs act as a rheostat where the level of srvs expression influence both the viro to translucent switch frequency and which tttr be activate when viro cell switch in summary this work have reveal a new paradigm for phenotypic switch in bacterium where a unprecedented number of related transcriptional regulator be activate in different combination to control virulence and generate unique translucent subvariant with distinct phenotypic property	2022 Nov	María Pérez-Varela, Aimee R P Tierney, Emma Dawson, Anna R Hutcheson, Kyle A Tipton, Sarah E Anderson, Marina E Haldopoulos, Shaina Song, Brooke R Tomlinson, Lindsey N Shaw, David S Weiss, Minsu Kim, Philip N Rather	PNAS Nexus
36951563	the covid19 Pandemic sparked off a largescale Outbreak of CarbapenemResistant acinetobacter baumannii from the endemic strain at a Italian Hospital	acinetobacter baumannii be a nosocomial pathogen that pose a serious threat due to the rise of incidence of multidrugresistant MDR strain during the covid19 pandemic MDR a baumannii clone have cause several outbreak worldwide here we describe a detailed investigation of a MDR a baumannii outbreak that occur at policlinico San matteo Pavia Italy a total of 96 a baumannii strain isolate between January and July 2020 from 41 inpatient both sarscov2 positive and negative in different ward be characterize by phenotypic and genomic analysis combine illumina and nanopore sequencing antibiotic susceptibility testing reveal that all isolate be resistant to carbapenem and the sequence analysis attribute this to the carbapenemase gene iblaisuboxa23sub virulence factor screen unveil that all strain carry determinant for biofilm formation while plasmid analysis reveal the presence of two plasmid one of which be 100 kbp long and encode a phage sequence a core genomebase phylogeny be infer to integrate outbreak strain genome with background genome from public database and the local surveillance program all strain belong to the globally disseminate sequence type 2 ST2 clone and be mainly divide into two clade isolate from the outbreak cluster with surveillance isolate from 2019 suggest that the outbreak be cause by two strain that be already circulate in the hospital before the start of the pandemic the intensive spread of a baumannii in the hospital be enhance by the extreme emergency situation of the first covid19 pandemic wave that result in reduce attention to infection prevention and control practice bimportanceb the covid19 pandemic especially during the first wave pose a great challenge to the hospital management and generally promote nosocomial pathogen dissemination MDR a baumannii can easily spread and persist for a long time on surface cause outbreak in health care setting infection prevention and control practice epidemiological surveillance and microbiological screen be fundamental in order to control such outbreak here we sequence the genome of 96 isolate from a outbreak of MDR a baumannii strain use both short and longread technology in order to reconstruct the outbreak event in fine detail the sequence datum demonstrate that two endemic clone of MDR a baumannii be the source of this large hospital outbreak during the first covid19 pandemic wave confirm the effect of covid19 emergency disrupt the protection provide by the use of the standard prevention procedure	2023 Mar	Greta Petazzoni, Greta Bellinzona, Cristina Merla, Marta Corbella, Vincenzina Monzillo, Ørjan Samuelsen, Jukka Corander, Davide Sassera, Stefano Gaiarsa, Patrizia Cambieri	Microbiol Spectr
35403193	complete genome of the extensively antibioticresistant gc1 acinetobacter baumannii isolate mrsn 56 reveal a novel route to fluoroquinolone resistance	to examine the cause of antibiotic resistance in the extensively resistant global clone 1 gc1 acinetobacter baumannii isolate mrsn 56 recover at a US military treatment facility	2022 Jun	Christopher J Harmer, Francois Lebreton, Jason Stam, Patrick T McGann, Ruth M Hall	J Antimicrob Chemother
36905566	enhanced bacterial kill with a combination of sulbactamminocycline against dual carbapenemaseproducing acinetobacter baumannii	Carbapenemresistant acinetobacter baumannii CRAB be often difficult to treat consider the current circumstance there be a unquestionable need for new therapeutic option to treat CRAB infection in the present study the synergistic activity of sulbactambased combination be determine against genetically characterize CRAB isolate nonduplicate CRAB isolate and 150 recover from blood culture and endotracheal aspirate be include in this study the minimum inhibitory concentration mic of tetracycline minocycline tigecycline eravacycline and they comparator meropenem sulbactam cefoperazonesulbactam ceftazidimeavibactam and colistin be determine use the microbroth dilution method six isolate be test for the synergistic activity of various sulbactambased combination use timekill experiment tigecycline and minocycline show a wide spread of mic with most isolate in the range of 1 to 16 mgL the micsub90 sub of eravacycline 05 mgL be four dilution low than that of tigecycline 8 mgL minocycline with sulbactam be the most active dual combination against oxa23 like and 2 and NDM with oxa23 like producer and 1 which result in ≥ 2 logsub10 sub kill the combination of ceftazidimeavibactam with sulbactam show ≥ 3 logsub10 sub kill against all the three test oxa23 like produce CRAB isolate but show no activity against dual carbapenemase producer sulbactam with meropenem show ≥ 2 logsub10 sub kill against one oxa23 like produce CRAB isolate the finding suggest that sulbactambased combination may confer therapeutic benefit against CRAB infection	2023 May	Suriya Chandran, Yuvasri Manokaran, Saranya Vijayakumar, Baby Abirami Shankar, Yamuna Devi Bakthavatchalam, Hariharan Triplicane Dwarakanathan, Binesh Lal Yesudason, Balaji Veeraraghavan	Eur J Clin Microbiol Infect Dis
37082186	the novel twocomponent system amssr govern alternative metabolic pathway usage in iAcinetobacter baumanniii	in this study we identify a novel twocomponent system in iAcinetobacter baumanniii herein name amssr for regulator of alternative metabolic system only present in select gammaproteobacterial and betaproteobacterial species Bioinformatic analysis reveal that the histidine kinase amss contain 14 predict nterminal transmembrane domain and harbor a hybrid histidine kinase arrangement in its cterminus transcriptional analysis reveal the proton ionophore cccp selectively induce p isubamsssrsubi expression Disruption of iamssri result in decrease intracellular pH and increase depolarization of cytoplasmic membrane transcriptome profiling reveal a major reordering of metabolic circuit upon iamsri disruption with energy generation pathway typically use by bacterium grow in limited oxygen be favored interestingly we observe enhance growth rate for mutant strain in the presence of glucose which lead to overproduction of pyruvate to mitigate the toxic effect of carbon overflow we note acetate overproduction in iamssrinull strain result from a hyperactive ptaacka pathway additionally due to alter expression of key metabolic gene iamssri mutant favor a incomplete tca cycle rely heavily on a overactive glyoxylate shunt this metabolic reordering overproduce nadh which be not oxidize by the etc component of which be significantly downregulated upon iamssri disruption as a result the mutant almost exclusively rely on substrate phosphorylation for atp production and consequently display reduce oxygen consumption in the presence of glucose Collectively we datum suggest that disruption of iamssri affect the function of the aerobic respiratory chain impacting the energy status of the cell which in turn upregulate alternative metabolic and energy generation pathway	2023	Leila G Casella, Nathanial J Torres, Brooke R Tomlinson, Mark Shepherd, Lindsey N Shaw	Front Microbiol
37074187	collateral change in cell physiology Associated with adc7 " lactamase expression in acinetobacter baumannii	the adc ampc βlactamase be universally present in the acinetobacter baumannii chromosome suggest it may have a yettobeidentified cellular function use peptidoglycan composition analysis we show that overexpress the adc7 βlactamase in a baumannii drive change consistent with alter ldtranspeptidase activity base on this we test whether cell overexpress adc7 would exhibit new vulnerability as proof of principle a screen of transposon insertion reveal that a insertion in the distal 3 end of icanas encoding carbonic anhydrase result in a significant loss of viability when the iadc7i gene be overexpress a icanas deletion mutant exhibit a more pronounce loss of viability than the transposon insertion and this become amplify when cell overexpress adc7 interestingly overexpression of the oxa23 or tem1 βlactamase also lead to a pronounce loss of viability in cell with reduce carbonic anhydrase activity in addition we demonstrate that reduce canb activity lead to increase sensitivity to peptidoglycan synthesis inhibitor and to the carbonic anhydrase inhibitor ethoxzolamide furthermore this strain exhibit a synergistic interaction with the peptidoglycan inhibitor fosfomycin and ethoxzolamide we result highlight the impact of adc7 overexpression on cell physiology and reveal that the essential carbonic anhydrase canb may represent a novel target for antimicrobial agent that would exhibit increase potency against βlactamaseoverexpressing a baumannii bimportanceb acinetobacter baumannii have become resistant to all class of antibiotic with βlactam resistance responsible for the majority of treatment failure New class of antimicrobial be need to treat this highpriority pathogen this study have uncover a new genetic vulnerability in βlactamaseexpressing a baumannii where reduce carbonic anhydrase activity become lethal inhibitor of carbonic anhydrase could represent a new method for treat a baumannii infection	2023 Apr	Jennifer M Colquhoun, Marjan Farokhyfar, Alexander C Anderson, Christopher R Bethel, Robert A Bonomo, Anthony J Clarke, Philip N Rather	Microbiol Spectr
36695669	resveratrolloaded dipalmitoylphosphatidylcholine liposomal large Porous Microparticle inhalation for the treatment of bacterial Pneumonia caused by iAcinetobacter baumanniii	biBackgroundib iAcinetobacter baumanniiimediated bacterial pneumonia be a common disease that be harmful to human health dipalmitoylphosphatidylcholine dppc be the major lipid component of the pulmonary surfactant ps find in the alveolar space the ps help to keep surface tension low which allow for improve oxygen delivery resveratrol re be a phytoalexin find in plant that be release in response to injury or infection the therapeutic effect of re be limited due to its low solubility and bioavailability in this study we report pulmonary delivery of reload dppc liposomal large porous microparticle RDLPMs for treatment of iA baumanniiinduced pneumonia bimethodsib Novel RDLPMs be prepare by rotary evaporation and a freezedrying method in this study RDLPMs be evaluate by the particle size electric potential iin vitroi release and particle size distribution a rat model of iA baumanniiimediated pneumonia be establish and use for pharmacodynamic evaluation biresultsib the reload dppc liposome RDL consist of redppc 13 molmol and dppccholesterol 31 ww with a hydration time of 15 minute the RDL have a high encapsulation efficiency of 698 ± 16 a mean size of 1915 ± 45 nm and a high zeta potential of 124 ± 15 mv the RDLPMs be compose of mannitollarge porous microparticlesrdl 142 www and have a loading efficiency of 220 ± 024 the RDLPMs have a aerodynamic diameter 273 ± 065 μm a good fluidity 2830° ± 613° and demonstrate high lung deposition fine particle fraction 4333 surprisingly while penicillin show good microbial inhibition than the RDLPMs and re group iin vitroi the RDLPMs be more effective iin vivoi biConclusionib the RDLPMs show good powder property for pulmonary delivery the RDLPMs may inhibit the nuclear factor kappab pathway and downregulate the expression of cytokine downstream of tumor necrosis factorα and interleukin1 " as well as RDLPMs demonstrate some antibacterial property against iA baumanniii bacterium re when deliver in RDLPMs as a dry powder inhaler be a promise substitute for antibiotic in the treatment of iA baumanniii pneumonia	2023 Feb	Zicheng Yu, Tingting Wu, Xiaoyan Liu, Hongjun Chen, Chunxia Ren, Lifei Zhu	J Aerosol Med Pulm Drug Deliv
36626888	identification of a novel lysray family transcriptional regulator control acquisition of sulfur source in acinetobacter baumannii	lcysteine biosynthesis from inorganic sulfur represent a major mechanism by which reduce sulfur be incorporate into organic compound cysteine biosynthesis and regulation be well characterize in E coli however the regulation of sulfur metabolism in acinetobacter baumannii be only partly understand with the lysray type regulator gigc know to control some aspect of sulfur reduction in this study we have use transcriptomics and bioinformatic analysis to characterize a novel lysrtype transcriptional regulator encode by abuw1016 cbl in a highly multidrugresistant and virulent isolate of acinetobacter baumannii we have show that cbl be involve in control the expression of the gene require for uptake and reduction of various sulfur source in a baumannii we have identify the global regulon of cbl and propose a model of cysteine biosynthesis and its regulation by cbl and gigc in a baumannii	2023 Jan	Alaska Pokhrel, Hue Dinh, Liping Li, Karl A Hassan, Amy K Cain, Ian T Paulsen	Microb Physiol
37213517	mobile genetic element carry aminoglycoside resistance gene in iAcinetobacter baumanniii isolate belong to global clone 2	aminoglycoside be use to treat infection cause by carbapenemresistant iAcinetobacter baumanniii CRAB strain however resistance to aminoglycoside have increase remarkably in the last few year here we aim to determine the mobile genetic element mge associate with resistance to aminoglycoside in the global clone 2 gc2 iA baumanniii among the 315 iA baumanniii isolate 97 isolate be identify as gc2 and 52 of gc2 isolate 536 be resistant to all the aminoglycoside test the abgri3s carry iarmAi be detect in 88 gc2 isolate 907 and of they 17 isolate 193 carry a new variant of abgri3 abgri3subabi221 sub iapha6 I be locate in tniapha6 I of 30 isolate out of 55 iapha6iharboring isolate and 20 isolate be find to harbor tniapha6 I on a repaci6 plasmid tni6020i carry iapha1 bi be detect in 51 isolate 525 which be locate within abgri2 resistance island the praysupsup carry the iaadb gene be detect in 43 isolate 443 and no isolate be find to contain a class 1 integron harbor this gene the gc2 iA baumanniii isolate contain at least one mge carry the aminoglycoside resistance gene locate mostly either in the chromosome within abgris or on the plasmid thus it be likely that this mge play a role in the dissemination of aminoglycoside resistance gene in gc2 isolate from Iran	2023	Ghazal Naderi, Malihe Talebi, Roghayeh Gheybizadeh, Arash Seifi, Sedigheh Ghourchian, Mohammad Rahbar, Alireza Abdollahi, Abdolhossein Naseri, Parisa Eslami, Masoumeh Douraghi	Front Microbiol
37185538	evaluation of DNA extraction method for reliable quantification of iAcinetobacter baumanniii iKlebsiella pneumoniae and iPseudomonas aeruginosai	detection and quantification of DNA biomarker rely heavily on the yield and quality of DNA obtain by extraction from different matrice although a large number of study have compare the yield of different extraction method the repeatability and intermediate precision of this method have be largely overlook in the present study five extraction method be evaluate use digital pcr to determine they efficiency in extracting DNA from three different gramnegative bacterium in sputum sample the performance of two automated method GXT na and quickpick genomic DNA extraction kit use Arrow and kingfisher Duo automated system respectively two manual kitbase method qiaamp DNA mini kit dneasy ultraclean microbial kit and one manual nonkit method ctab be assess while GXT na extraction kit and the ctab method have the high DNA yield they do not meet the strict criterion for repeatability intermediate precision and measurement uncertainty for all three study bacterium however due to limited clinical sample a compromise be necessary and the GXT na extraction kit be find to be the method of choice the study also show that dpcr allow for accurate determination of extraction method repeatability which can help standardize molecular diagnostic approach additionally the determination of absolute copy number facilitate the calculation of measurement uncertainty which be find to be influence by the DNA extraction method use	2023 Apr	Alexandra Bogožalec Košir, Dane Lužnik, Viktorija Tomič, Mojca Milavec	Biosensors (Basel)
35522755	total synthesis of a all12icisilinked repeating unit from the iAcinetobacter baumanniii d78 capsular polysaccharide	Chemical synthetic effort have result in the preparation of the assign tetrasaccharide repeat subunit from the iAcinetobacter baumanniii kl4associated capsular polysaccharide a convergent synthetic strategy hinging on a 12 icisiselective 22 glycosylation to generate the fully protect tetrasaccharide be key to the success of this synthesis	2022 May	Dancan K Njeri, Justin R Ragains	Org Lett
36845495	removal of substrate inhibition of iAcinetobacter baumanniii xanthine oxidase by point mutation at gln201 enable efficient reduction of purine content in fish sauce	xanthine oxidase be a oxidase that have a molybdopterin structure with substrate inhibition here we show that a single point mutation q201 in the iAcinetobacter baumanniii xanthine oxidase abxod obtain mutant q201e iki subcatsub 79944 ssup1 sup no inhibition with high enzyme activity and decrease of substrate inhibition in 5 mmolL high substrate model and which cause two loop structure change at active center characterize by complete loss of substrate inhibition without reduction of enzymatic activity molecular docking result show that the change of flexible loop increase the affinity between substrate and enzyme and the formation of a ππ bond and two hydrogen bond make the substrate more stable in the active center ultimately q201e can still maintain good enzyme activity under high purine content a approximately 7 fold improvement over the wildtype indicate a broad application prospect in the manufacture of lowpurine food	2023 Mar	You Wen, Jiahui Xu, Donglei Pan, Chenghua Wang	Food Chem X
37171842	the evolutionary tale of eight novel plasmid in a colistinresistant environmental iAcinetobacter baumanniii isolate	iAcinetobacter baumanniii be a important opportunistic pathogen know for its high level of resistance to many antibiotic particularly that consider last resort such as colistin and carbapenem plasmid of this organism be increasingly associate with the spread of clinically important antibiotic resistance gene although iA baumanniii be a ubiquitous organism to date most of the focus have be on study strain recover from clinical sample ignore that isolate in the environment soil water food etc here we analyse the genetic structure of eight novel plasmid carry by a environmental colistinresistant iA baumanniii strain e072658 recover in a recycled fibre pulp in a paper mill in Finland it be show that e072658 carry a new variant of the imcr4i colistin resistance gene imcr47i in a novel tni3ifamily transposon call tni6926i carry by a novel plasmid p8e072658 e072658 be also resistant to sulphonamide compound consistent with this the isul2i sulphonamide resistance gene be find in a pidifi module e072658 also carry six additional plasmid with no antibiotic resistance gene but they contain several pidifi module share with plasmid carry by clinical strain detail analysis of the genetic structure of all eight plasmid carry by e072658 show a complex evolutionary history revealing genetic exchange event within the genus iAcinetobacteri beyond the clinical or environmental origin of the strain this work provide evidence that environmental strain might act as a source for some of the clinically significant antibiotic resistance gene	2023 May	Farzana T Prity, Liam A Tobin, Ram Maharajan, Ian T Paulsen, Amy K Cain, Mehrad Hamidian	Microb Genom
36711967	a novel strategy to characterize the pattern of βlactam antibioticinduce drug resistance in acinetobacter baumannii	Carbapenemresistant iAcinetobacter baumanniii CRAb be a urgent public health threat accord to the CDC this pathogen have few treatment option and cause severe nosocomial infection with 50 fatality rate although previous study have examine the proteome of CRAb there have be no focus analysis of dynamic change to βlactamase expression that may occur due to drug exposure here we present we initial proteomic study of variation in βlactamase expression that occur in CRAb with different βlactam antibiotic briefly drug resistance to ab atcc 19606 be induce by the administration of various class of βlactam antibiotic and the cellfree supernatant be isolate concentrate separate by sdspage digest with trypsin and identify by labelfree lcmsbased quantitative proteomics peptide be identify and evaluate use a 1789 sequence database of ab βlactamase from UniProt importantly we observe that different antibiotic even that of the same class iegi penicillin and amoxicillin induce nonequivalent response comprise various Class C and D serine βlactamase result in unique resistome this result open the door to a new approach of analyze and study the problem of multidrug resistance in bacterium that rely strongly on βlactamase expression	2023 Jan	Trae Hillyer, Bogdan M Benin, Chuanqi Sun, Noah Aguirre, Belinda Willard, Yuk Yin Sham, Woo Shik Shin	Res Sq
37089710	riparinb as a potential inhibitor of adeabc efflux system from iAcinetobacter baumanniii	iAcinetobacter baumanniii be a important opportunistic pathogen that cause serious healthrelated infection especially in intensive care unit the present study aim to investigate the antimicrobial activity of riparinb ripb alone and in association with norfloxacin against multidrugresistant clinical isolate of iA baumanniii for this the minimum inhibitory concentration be determine by the microdilution method for the evaluation of resistancemodulating activity mic value for antibiotic be determine in the presence or absence of subinhibitory concentration of ripb or chlorpromazine CPZ the adeabcaders efflux system gene from this isolate be detect by pcr docking study be also carry out to evaluate the interaction of riparinb and the adeabcaders efflux system the study be conduct from 2017 to 2019 the result show that ripb show weak intrinsic activity against the strain test on the other hand ripb be able to modulate norfloxacin response against iA baumanniii strain that express efflux pumpmediated resistance docking study provide projection of the interaction between ripb and etbr with the adeb protein suggest that ripb act by competitive inhibition with the drug result find by in vitro and in silico assay suggest that ripb in combination with norfloxacin have the potential to treat infection cause by multidrugresistant iA baumannii with efflux pump resistance	2023	Patrícia Virna Sales Leão, Ana Laura da Silva Ferreira, Felipe Araújo de Alcântara Oliveira, Avilnete Belém de Souza Mesquita, José de Sousa Lima-Net, Stanley Juan Chavéz Gutierrez, Carlos Emídio Sampaio Nogueira, Natália Cruz-Martins, Daniel Dias Rufino Arcanjo, Humberto Medeiros Barreto, Josie Haydée Lima Ferreira	Evid Based Complement Alternat Med
36289054	inhibitor Assessment against the LpxC enzyme of antibioticresistant acinetobacter baumannii use virtual screening dynamics simulation and in vitro assay	bacterial resistance be currently a significant global public health problem acinetobacter baumannii have be rank in the list of the World Health Organization as the most critical and priority pathogen for which new antibiotic be urgently need in this context computational method play a central role in the modern drug discovery process the purpose of the current study be to identify new potential therapeutic molecule to neutralize MDR a baumannii bacterium	2023 Feb	Manel Zoghlami, Maroua Oueslati, Zarrin Basharat, Najla Sadfi-Zouaoui, Abdelmonaem Messaoudi	Mol Inform
36651782	loss of a branch sugar in the acinetobacter baumannii K3 type capsular polysaccharide due to frameshift in the igtr6i glycosyltransferase gene lead to susceptibility to phage apk371	the type of capsular polysaccharide CPS on the cell surface of acinetobacter baumannii can determine the specificity of lytic bacteriophage under consideration for therapeutic use here we report the isolation of a phage on a extensively antibiotic resistant ST2 a baumannii isolate ab5001 that carry the KL3 CPS biosynthesis gene cluster predict a k3type CPS as the phage do not infect isolate carry KL3 or KL22 and know to produce K3 CPS the structure of the CPS isolate from a baumannii ab5001 be determine ab5001 produce a variant CPS form k3v1 that lack the βdGlсipiNAc side chain attach to the dGalipi residue in the K3 structure inspection of the KL3 sequence in the genome of ab5001 and other phagesusceptible isolate with a KL3 locus reveal singlebase deletion in igtr6i cause loss of the gtr6 glycosyltransferase that add the miss dGlсipiNAc side chain to the K3 CPS hence the presence of this sugar profoundly restrict the ability of the phage to digest the CPS the 41 kb linear doublestranded DNA dsDNA phage genome be identical to the genome of a phage isolate on a k37 produce isolate and thus be name apk371 apk371 also infect isolate carry kl116 consistent with this k3v1 resemble the k37 and K116 structure apk371 be a iFriunavirusi belong to the iAutographiviridaei family the phageencoded tail spike depolymerase dpoapl371 be not closely related to dpo encode by other sequence iFriunavirusesi include apk37 and apk116 bimportanceb lytic bacteriophage have potential for the treatment of otherwise untreatable extensively antibioticresistant bacterium for acinetobacter baumannii most phage exhibit specificity for the type of capsular polysaccharide CPS produce on the cell surface however resistance can arise via mutation in CPS gene that abolish this phage receptor here we show that singlebase deletion in a CPS gene result in alteration of the final structure rather than deletion of the capsule layer and hence affect the ability of a newly report podophage to infect strain produce the K3 CPS	2023 Feb	Olga Y Timoshina, Anastasiya A Kasimova, Mikhail M Shneider, Nikolay P Arbatsky, Alexander S Shashkov, Andrey A Shelenkov, Yuliya V Mikhailova, Anastasiya V Popova, Ruth M Hall, Yuriy A Knirel, Johanna J Kenyon	Microbiol Spectr
36830214	pulmonary Pharmacokinetic and Pharmacodynamic evaluation of ampicillinsulbactam regimen for Pneumonia caused by various bacterium include iAcinetobacter baumanniii	this study aim to assess the dose regimen of ampicillinsulbactam for pneumonia base on pulmonary pharmacokinetic pkpharmacodynamic PD target attainment use the literature datum we develop pulmonary PK model and estimate the probability of attain pkpd target in lung tissue against bacterium other than iA baumanniii the general treatment the pkpd target be set as both 50 time above the minimum inhibitory concentration T mic for ampicillin and 50 T 05 mic for sulbactam for the iA baumanniii treatment the pkpd target be set as 60 T mic for sulbactam the pulmonary pkpd breakpoint be define as the high minimum inhibitory concentration mic at which the target attainment probability in the lung tissue be ≥90 the lung tissueserum area under the drug concentrationtime curve from 0 to 3 h aucsub03hsub ratio for ampicillin and sulbactam be 0881 and 0368 respectively the ampicillinsulbactam aucsub03hsub ratio in the lung tissue be 389 for the general treatment the pulmonary pkpd breakpoint for ampicillinsulbactam at 3 gram four time daily in typical patient with creatinine clearance clsubcrsub of 60 mlmin be 2 μgmL which cover the micsub90ssub the mic that inhibit the growth of 90 of the strain of most grampositive and gramnegative bacterium for the iA baumanniii treatment the pulmonary pkpd breakpoint for ampicillinsulbactam at 9 gram 4h infusion three time daily 27 gday in patient with a clsubcrsub of 60 mlmin be 4 μgmL which cover the micsub90sub of iA baumanniii a pkpd evaluation for pneumonia should be perform in the lung tissue the target site rather than in the blood because sulbactam concentration be low in lung tissue this finding should facilitate the selection of ampicillinsulbactam regimen for pneumonia cause by various bacterium include iA baumanniii	2023 Feb	Tetsushu Onita, Kazuro Ikawa, Noriyuki Ishihara, Hiroki Tamaki, Takahisa Yano, Kohji Naora, Norifumi Morikawa	Antibiotics (Basel)
37150474	metaviromics analysis of marine biofilm reveal a glycoside hydrolase endolysin with high specificity towards acinetobacter baumannii	multidrugresistant MDR bacterium be a grow threat to the public health among they the gramnegative acinetobacter baumannii be consider today as the most dangerous MDR pathogen phagederived endolysin be peptidoglycan pg hydrolytic enzyme that can function as effective tool in the fight against MDR bacterium in the present work the viral diversity of a marine environmental sample biofilm form near a industrial zone be mined for the identification of a putative endolysin ablys2 that belong to the glycoside hydrolase family 24 gh24 ec 32117 the coding sequence of ablys2 be clone and express in E coli the lytic activity and specificity of the recombinant enzyme be evaluate against suspension of a range of grampositive and gramnegative human pathogen use turbidity assay ablys2 display enhance selectivity towards a baumannii cell compare to other bacterium kinetic analysis be carry out to characterize the dependence of its lytic activity on pH and show that the enzyme exhibit its maximal activity at pH 55 thermostability analysis show that ablys2 display melting temperature tsubmsub 471 °C florescence microscopy and cell viability assay establish that ablys2 be active towards live culture of a baumannii cell with a inhibitory concentration icsub50 sub 341 ± 009 μM molecular modeling allow the prediction of important amino acid residue involve in catalysis the result of the present study suggest that ablys2 provide efficient lytic and antimicrobial activity towards a baumannii cell and therefore be a promise new antimicrobial against this pathogen	2023 May	Georgios E Premetis, Nikolaos D Georgakis, Angeliki Stathi, Nikolaos E Labrou	Biochim Biophys Acta Proteins Proteom
36685419	Assessment of potassium ion channel during electric signalling in biofilm formation of iAcinetobacter baumanniii for find antibiofilm molecule	iAcinetobacter baumanniii be a opportunistic eskape pathogen which cause nosocomial infection and can produce biofilm that act as resistant determinant the role of quorum sensing chemical signal in biofilm establishment have already be study extensively but the existence of electrochemical signal during biofilm formation by iA baumanniii have not yet be investigate the current study evaluate the presence of electrical signal type of ion channel involve and they role in biofilm formation use spectroscopic and microbiological method the finding suggest that the potassium ion channel have a significant role in the electrical signal during the biofilm formation by iA baumanniii further iinsilicoi screen molecular mechanic and molecular dynamic simulation study identify a potential lead ginc12496555 specific inhibitor which target the potassium ion channel protein of iA baumanniii mutational analysis of the interact residue show alteration in the unfold rate of this protein after the select mutation which show its role in the stability of this protein it be also observe that identify lead have high antibiofilm activity no human offtarget and noncytotoxicity to cell line thus identify lead against the potassium channel of iA baumanniii may be use as a effective therapeutic for the treatment of iA baumanniii infection after further experimental validation	2023 Jan	Monalisa Tiwari, Shruti Panwar, Vishvanath Tiwari	Heliyon
36840561	complete genome sequence of acinetobacter baumannii strain kbn10p04593 a Clinical Isolate from South Korea	acinetobacter baumannii be a opportunistic nosocomial pathogen that be responsible for various lifethreating infection in immunocompromised host we present the complete 393mb genome sequence of a baumannii kbn10p04593 generate by combine pacbio and illumina technology	2023 Mar	Md Maidul Islam, Jeongah Kim, Kyeongmin Kim, Je Chul Lee, Minsang Shin	Microbiol Resour Announc
36646070	do colonization with mrsa esbl produce enterobacteriaceae andor acinetobacter baumannii increase the risk for postoperative surgical site infection	evaluation of the role of indicator pathogen in equine surgical site infection SSI and other infectionpromoting factor	2023 Mar	Heidrun Gehlen, Katja-Sophia Klein, Roswitha Merle, Antina Lübke-Becker, Sabita D Stoeckle	Vet Med Sci
36880170	exploitation of a novel adjuvant for polymyxin B against multidrugresistant acinetobacter baumannii	although polymyxin have be use as a lastresort antibiotic against resistant bacterium its use be restrict due to nephrotoxicity and neurotoxicity while the present antibiotic resistance issue compel clinician to reconsider polymyxin use in severe illness case polymyxinresistant microorganism exert a effect	2023 Apr	Seon-Yeong Kim, Hwi Won Seo, Min-Seon Park, Chul Min Park, Jinho Seo, Jaerang Rho, Subeen Myung, Kwan Soo Ko, Jun-Seob Kim, Choong-Min Ryu	J Antimicrob Chemother
36408560	successful treatment with tigecycline of severe pandrugresistant acinetobacter baumannii pneumonia complicated with a diaphragmatic hernia a case report	acinetobacter baumannii a baumannii be one of the most common pathogen that cause hospitalacquired infection in recent year drugresistant a baumannii have become prevalent worldwide and pandrugresistant a baumannii be increasingly be observe however treat pandrugresistant a baumannii be very difficult	2023 Jan	Xinglou Liu, Hua Zhou, Sainan Shu, Ge Li, Feng Fang	Ann Palliat Med
36704103	corrigendum diversity of resistant determinant virulence factor and mobile genetic element in iAcinetobacter baumanniii from India a comprehensive in silico genome analysis	this correct the article doi 103389 fcimb2022997897	2022	Shital N Kumkar, Ekta E Kamble, Nikeeta S Chavan, Dhiraj P Dhotre, Karishma R Pardesi	Front Cell Infect Microbiol
35794134	overcoming addition of phosphoethanolamine to lipid a mediate colistin resistance in acinetobacter baumannii clinical isolate with colistinsulbactam combination therapy	overcoming colistinresistant acinetobacter baumannii corab have become a major concern due to the lack of effective antibiotic this study aim to explore the prevalence of corab clinical isolate in Thailand they mechanism of resistance and test the efficacy of colistin plus sulbactam against corab isolate the colistin resistance rate among carbapenemresistant a baumannii be 1514 the mcr gene or its variant be not detect in corab isolate by pcr screen the lipid a mass spectra of corab isolate show the additional mhsupsup ion peak at mz 2034 that correlate to the phosphoethanolamine petn addition to lipid a N 2730 the important amino acid substitution be find at position s14p a138t A227V in PmrB that be associate with overexpression of the petn transferase PmrC and contribute the petn addition the lipopolysacccharide production gene lpxacd be not related to lipid a mass spectra a colistin plus sulbactam combination exhibit the synergy rate at 867 against corab isolate compare to sulbactam 8589 resistance or colistin 1514 resistance alone the excellent synergistic activity of colistin plus sulbactam combination have the potential for the treatment of corab infection	2022 Jul	Sukrit Srisakul, Dhammika Leshan Wannigama, Paul G Higgins, Cameron Hurst, Shuichi Abe, Parichart Hongsing, Thammakorn Saethang, Sirirat Luk-In, Tingting Liao, Naris Kueakulpattana, Aye Mya Sithu Shein, Lin Gan, Rosalyn Kupwiwat, Chanikan Tanasatitchai, Pattama Wapeesittipan, Phatthranit Phattharapornjaroen, Vishnu Nayak Badavath, Asada Leelahavanichkul, Tanittha Chatsuwan	Sci Rep
35925988	correction rescued chlorhexidine activity by resveratrol against carbapenemresistant acinetobacter baumannii via downregulation of adeb efflux pump	this correct the article doi 101371 journalpone0243082	2022	Uthaibhorn Singkham-In, Paul G Higgins, Dhammika Leshan Wannigama, Parichart Hongsing, Tanittha Chatsuwan	PLoS One
36905104	evaluation of combination therapy with colistin in a experimental mouse pneumonia model induce by carbapenemresistant acinetobacter baumannii strain	the treatment option be limited in acinetobacter baumannii infection in this study the effectiveness of colistin monotherapy and combination of colistin with different antibiotic be investigate in a experimental pneumonia model induce by carbapenemresistant a baumannii strain mice in the study be divide into five group as control no treatment colistin monotherapy colistin sulbactam colistin imipenem and colistin tigecycline combination the modify experimental surgical pneumonia model of esposito and pennington be apply to all group the presence of bacterium in blood and lung sample be investigate result be compare in blood culture while there be no difference between the control and colistin group there be a statistical difference between the control and the combination group p 0029 when the group be compare in term of lung tissue culture positivity there be a statistical difference between the control group and all treatment group colistin colistin sulbactam colistin imipenem and colistin tigecycline p 0026 p 0001 p 0001 and p 0002 respectively the number of microorganism that grow in the lung tissue be find to be statistically significantly low in all treatment group in comparison with the control group p 0001 both monotherapy and combination therapy of colistin be find to be effective in the treatment of carbapenemresistant a baumannii pneumonia but the superiority of combination therapy over colistin monotherapy have not be demonstrate	2023 Mar	Onur Unal, Onur Kaya, Tuba Ozturk, Emel Sesli Cetin, Ibak Gonen, Esra Nurlu Temel, Fusun Zeynep Akcam	Fundam Clin Pharmacol
36468875	antimicrobial susceptibility test performed in RPMI 1640 reveal Azithromycin efficacy against CarbapenemResistant acinetobacter baumannii and predict iin Vivoi outcome in Galleria mellonella	antimicrobial susceptibility testing ast in RPMI 1640 a more physiologically relevant culture medium reveal that a substantial proportion of carbapenemresistant acinetobacter baumannii isolate be susceptible to azithromycin a macrolide antibiotic not currently consider effective against a baumannii experiment use Galleria mellonella validate this iin vitroi datum we find that RPMI 1640s predictive accuracy for iin vivoi outcome be superior to that of muellerhinton ii broth also support the use of more physiologically relevant ast culturing condition	2023 Jan	Sarah Miller, Kristine Goy, Rosemary She, Brad Spellberg, Brian Luna	Antimicrob Agents Chemother
36446189	complete chemical structure of the K135 capsular polysaccharide produce by acinetobacter baumannii res546 that contain 57diNacetyl8 epipseudaminic acid	a structurally diverse capsular polysaccharide CPS in the outer cell envelope play a important role in the virulence of the important bacterial pathogen acinetobacter baumannii more than 75 different CPS structure have be determine for the species to date and many CPSs include isomer of a high sugar namely 57 diamino3579tetradeoxynon2ulosonic acid recently a novel isomer have the dglycerolmanno configuration 57diNacetyl8 epipseudaminic acid 8epse5ac7 ac have be identify in the CPS from a baumannii clinical isolate res546 carbohydr Res 513 2022 108531 here the complete chemical structure of this CPS designate K135 be elucidate the CPS be find to have a branch tetrasaccharide k unit and to include the high sugar as part of a 8ePse5Ac7Ac2 → 6 αgal disaccharide branch from a → 3αdglcpnac1 → 3 " dglcpnac1 → main chain assignment of glycosyltransferase encode by the CPS biosynthesis gene cluster in the res546 genome enable the first sugar of the k unit and hence the topology of the K135 CPS to be determine	2023 Jan	Alexander S Shashkov, Anastasiya A Kasimova, Nikolay P Arbatsky, Sof'ya N Senchenkova, Andrei V Perepelov, Andrei S Dmitrenok, Alexander O Chizhov, Yuriy A Knirel, Mikhail M Shneider, Anastasia V Popova, Johanna J Kenyon	Carbohydr Res
35663863	identification of promoter Region marker Associated with altered expression of resistancenodulationdivision antibiotic efflux pump in iAcinetobacter baumanniii	genetic alteration lead to the constitutive upregulation of specific efflux pump contribute to antibacterial resistance in multidrug resistant bacterium the identification of such resistance marker remain one of the most challenging task of genomelevel resistance predictor in this study 487 nonredundant genetic event be identify in upstream zone of three operon coding for resistancenodulationdivision RND efflux pump of 4130 iAcinetobacter baumanniii isolate this event include insertion sequence small indel and single nucleotide polymorphism in some case alteration explicitly modify the expression motif describe for this operon such as the promoter box operator and ShineDalgarno sequence in addition change in DNA curvature and mRNA secondary structure which be structural element that regulate expression be also calculate accord to they influence on RND upregulation the catalog of upstream modification be associate with experimentally verify presume and probably irrelevant degree of certainty for experimental verification DNA of upstream sequence independently carry select marker three for each RND operon be fuse to a luciferase reporter plasmid system five out of the nine select marker test show significant increase in expression with respect to the wildtype sequence control in particular a 25 fold expression increase be observe with the isiabai1 insertion sequence upstream the iadeabci pump next overexpression of each of the three multispecific RND pump be link to they respective antibacterial substrate by a deep iA baumanniii literature screen consequently a datum flow framework be then develop to link genomic upregulatory RND determinant to potential antibiotic resistance assignment of potential increase in minimal inhibitory concentration at the experimentally verify level be permit for 42 isolate to 78 unrelated antibacterial agent include tigecycline which be overlook by conventional resistome predictor thus we protocol may represent a timesaving filter step prior to laborious confirmation experiment for effluxdriven resistance altogether a computationalexperimental pipeline contain all component require for identify the upstream regulatory resistome be propose this schema may provide the foundational stone for the elaboration of tool approaching antibiotic efflux that complement routine resistome predictor for prevent antimicrobial therapy failure against difficulttothreat bacterium	2022	Mireia López-Siles, Michael J McConnell, Antonio J Martín-Galiano	Front Microbiol
36630484	catheterization of mouse trigger resurgent urinary tract infection seed by a bladder reservoir of iAcinetobacter baumanniii	the antibioticresistant bacterium iAcinetobacter baumanniii be a lead cause of hospitalassociated infection despite surveillance and infection control effort new iA baumanniii strain be regularly isolate from health care facility worldwide in a mouse model of urinary tract infection we find that mouse infect with iA baumanniii display high bacterial burden in urine for several week two month after the resolution of iA baumanniii infection inserting a catheter into the bladder of mouse with resolve infection lead to the resurgence of a samestrain urinary tract infection in 53 of the mouse within 24 hour we identify intracellular iA baumanniii bacterium in the bladder epithelial cell of mouse with resolve infection which we propose could act as a host reservoir that be activate upon insertion of a catheter lead to a resurgent secondary infection	2023 Jan	Jennie E Hazen, Gisela Di Venanzio, Scott J Hultgren, Mario F Feldman	Sci Transl Med
37018343	use of the waxworm Galleria mellonella larvae as a infection model to study acinetobacter baumannii	Galleria mellonella larvae have be increasingly use in research include microbial infection study they act as suitable preliminary infection model to study hostpathogen interaction due to they advantage such as the ability to survive at 37 °C mimick human body temperature they immune system share similarity with mammalian immune system and they short life cycle allow largescale study here we present a protocol for simple rear and maintenance of G mellonella without require special instrument and specialized training this allow the continuous supply of healthy G mellonella for research purpose besides this protocol also provide detailed procedure on the I G mellonella infection assay kill assay and bacterial burden assay for virulence study and ii bacterial cell harvesting from infect larvae and RNA extraction for bacterial gene expression study during infection we protocol could not only be use in the study of a baumannii virulence but can also be modify accord to different bacterial strain	2023	Kah Ern Ten, Nazmul Hasan Muzahid, Sadequr Rahman, Hock Siew Tan	PLoS One
35060164	Intraventricular colistin sulphate as a last resort therapy in a patient with multidrugresistant acinetobacter baumannii induce postneurosurgical ventriculitis	Limited therapeutic option exist for multidrugresistantextensively drugresistant acinetobacter baumannii mdrxdrab meningitisventriculitis a combination of intravenous and intraventricular ivtintrathecal it polymyxin achieve good therapeutic outcome for case of healthcareassociated mdrxdrab meningitisventriculitis colistin be commercially available as colistin sulphate and its sulphomethylated derivative however the effect and safety of colistin sulphate in the treatment of mdrxdrab meningitisventriculitis have not be report we report on a 66 yearold male patient who develop postneurosurgical ventriculitis cause by mdrab ivt concomitant intravenous colistin sulphate be use as a lastresort antimicrobial therapy the patient ventriculitis be dramatically improve and the concentration of CSF colistin be high than the mic breakpoint throughout the treatment meanwhile no nephrotoxicity or neurotoxicity be observe during the treatment	2022 Jul	Xu-Ben Yu, Yue-Yue Huang, Xiao-Shan Zhang, Yu-Zhen Wang, Da-Wei Shi, Chun-Hong Zhang, Jie Chen, Xiao-Rong Wang, Guan-Yang Lin	Br J Clin Pharmacol
37156803	antibacterial activity of vbabampht2 phage hydrophobic amino acid fusion endolysin combine with colistin against acinetobacter baumannii	phage lytic enzyme be promise antimicrobial agent in this study a endolysin derive from vbabampht2 vPhT2 be identify this endolysin represent the conserved lysozyme domain recombinant endolysin lysAB vT2 and hydrophobic fusion endolysin lysABvT2fusion be express and purify both endolysin show lytic activity against bacterial crude cell wall of gramnegative bacterium the mic of lysABvT2fusion be 2 mgml corresponding to 100 µm while the mic of lysabvt2 be more than 10 mgml 400 µm combination of lysABvT2fusion with colistin polymyxin B or copper be synergistic against a baumannii FICI value as 025 antibacterial activity of lysABvT2fusion plus colistin at the fractional inhibitory concentration fic reveal that it can inhibit Escherichia coli Klebsiella pneumoniae and various strain of extremely drugresistant a baumannii xdrab and phage resistant a baumannii the lysAB vT2fusion still retain its antibacterial activity after incubate the enzyme at 4 20 40 and 60 °C for 30 minute the lysABvT2fusion could inhibit the mature biofilm and incubation of lysABvT2fusion with t24 human cell infect with a baumannii lead to a partial reduction of LDH release from t24 cell in summary we study highlight the antimicrobial ability of engineer lysabvt2 fusion endolysin which can be apply for the control of a baumannii infection	2023 May	Sutthirat Sitthisak, Suphattra Manrueang, Supat Khongfak, Udomluk Leungtongkam, Rapee Thummeepak, Aunchalee Thanwisai, Nathan Burton, Gurneet K Dhanoa, Panagiotis Tsapras, Antonia P Sagona	Sci Rep
37140387	identification of a Outbreak cluster of extensively antibioticresistant gc1 acinetobacter baumannii isolate in US military treatment facility	a outbreak involve a extensively antibioticresistant acinetobacter baumannii strain in three military treatment facility be identify fiftynine isolate recover from 30 patient over a 4 year period be find among a large collection of isolate use core genome multilocus sequence type mlst they differ by only 0 to 18 single nucleotide polymorphism snp and carry the same resistance determinant except that the iapha6 I gene be miss in 25 isolate they represent a novel sublineage of gc1 lineage 1 that likely originate in Afghanistan bimportanceb a baumannii be recognize as one of the most important nosocomial pathogen and carbapenemresistant strain pose a particularly difficult treatment challenge Outbreak link to this pathogen be report worldwide particularly during period of societal upheaval such as natural disaster and conflict understanding how this organism enter and establish itself within the hospital environment be key to interrupt transmission but few genomic study have examine this transmission over a prolong period though historical this report provide a indepth analysis of nosocomial transmission of this organism across continent and within and between different hospital	2023 May	Ting L Luo, Christopher J Harmer, Francois Lebreton, Jason Stam, Jason W Bennett, Ruth M Hall, Patrick T Mc Gann	Microbiol Spectr
36598351	the structure of a tautomerase superfamily member link to the type VI secretion system of acinetobacter baumannii	bacterium exploit specialized secretion system to assist in competition for resource in collaboration and in communication here a protocol for the recombinant production purification and crystallization of a protein link to the acinetobacter baumannii type VI secretion system be provide a highresolution structure of this trimeric protein be report revealing the characteristic dual βα " subunit fold typical of long subunit member of the tautomerase superfamily the protein do not appear to be toxic to bacterium or yeast under the condition test the possible biological role of this protein be discuss	2023 Jan	Genady Pankov, Gabriela Mol Avelar, Grant Buchanan, Sarah J Coulthurst, William N Hunter	Acta Crystallogr F Struct Biol Commun
36420820	clearing a eskape pathogen in a Model Organism a Polypyridyl RutheniumII complex theranostic that treat a resistant acinetobacter baumannii infection in Galleria mellonella	in previous study we have describe the therapeutic action of luminescent dinuclear rutheniumII complex base on the tetrapyridylphenazine tpphz bridge ligand on pathogenic strain of Escherichia coli and enterococcus faecalis herein the antimicrobial activity of the complex against pernicious gramnegative eskape pathogenic strain of acinetobacter baumannii ab12 ab16 ab184 and ab210 and pseudomonas aeruginosa pa2017 PA 007 imp and PA 004 crcn be report estimate minimum inhibitory concentration and minimum bactericidal concentration for the complex reveal the complex show potent activity against all a baumannii strain in both glucose define minimal media and standard nutrient rich muellerhintonid although the activity be low in p aureginosa a moderately high potency be observe and retain in carbapenemresistant strain optical microscopy show that the compound be rapidly internalized by a baumannii as previous report have reveal the complex exhibit no toxicity in Galleria Mellonella up to concentration of 80 mgkg the ability to clear pathogenic infection within this model be explore the pathogenic concentration to the larvae for each bacterium be determine to be ≥10sup5 sup for ab184 and ≥10sup3sup CFUmL for pa2017 it be find a single dose of the compound totally clear a pathogenic a baumannii infection from all treat G mellonella within 96 h uniquely in this condition thanks to the imaging property of the complex the clearance of the bacterium within the hemolymph of G mellonella could be directly visualized through both optical and transmission electron microscopy	2023 Feb	Kirsty Smitten, Hannah M Southam, Simon Fairbanks, Arthur Graf, Adrien Chauvet, Jim A Thomas	Chemistry
35603837	genomic surveillance uncover ongoing transmission of carbapenemresistant iAcinetobacter baumanniii CRAB and identify actionable route of transmission in a endemic set	in we center previous infection prevention and control ipc resource be concentrate on multidrugresistant organism other than CRAB because the rate of CRAB be stable with no evidence of outbreak trigger by a increase in the baseline rate of CRAB isolate in clinical culture we investigate horizontal transmission of CRAB to guide target ipc action	2023 Mar	Sean Wei Xiang Ong, Pooja Rao, Wei Xin Khong, Victor Yi Fa Ong, Prakki Sai Rama Sridatta, Natascha May Thevasagayam, Benjamin Choon Heng Ho, Brenda Sze Peng Ang, Partha Pratim De, Oon Tek Ng, Kalisvar Marimuthu	Infect Control Hosp Epidemiol
36831178	the Iron Content of human serum albumin modulate the susceptibility of iAcinetobacter baumanniii to cefiderocol	the mortality rate of patient infect with iAcinetobacter baumanniii who be treat with cefiderocol CFDC be not as favorable as that receive the good available treatment for pulmonary and bloodstream infection previous study show that the presence of human serum albumin hsa or hsacontaining fluid such as human serum hs or human pleural fluid hpf in the growth medium be correlate with a decrease in the expression of gene associate with highaffinity siderophoremediated iron uptake system this observation may explain the complexity of the observe clinical performance of CFDC in pulmonary and bloodstream infection because ferric siderophore transporter enhance the penetration of CFDC into the bacterial cell the removal of hsa from hs or hpf result in a reduction in the minimal inhibitory concentration mic of CFDC Concomitant with this result a enhancement in the expression of TonBdependent transporter know to play a crucial role in transport iron be observe in addition to inducing modification in ironuptake gene expression the removal of hsa also decrease the expression of βlactamase gene taken together this observation suggest that environmental hsa have a role in the expression level of select iA baumanniii gene furthermore the removal of iron from hsa have the same effect as the removal of hsa upon the expression of gene associate with iron uptake system also suggest that at least one of the mechanism by which hsa regulate the expression of certain gene be through act as a iron source	2023 Feb	Jenny Escalante, Brent Nishimura, Marisel R Tuttobene, Tomás Subils, Vyanka Mezcord, Luis A Actis, Marcelo E Tolmasky, Robert A Bonomo, María Soledad Ramirez	Biomedicines
36978405	antimicrobial therapy duration for bloodstream infection caused by iPseudomonas aeruginosai or iAcinetobacter baumanniicalcoaceticus complexi a retrospective cohort Study	ideal therapy duration for iPseudomonas aeruginosai or iAcinetobacter baumanniicalcoaceticus complexi ABC bloodstream infection BSI be not define especially in the context of carbapenem resistance in this study we compare short ≤ 7 day and longterm 7 day antimicrobial therapy duration for this infection	2023 Mar	Rodrigo Douglas Rodrigues, Rebeca Carvalho Lacerda Garcia, Gabriel Almeida Bittencourt, Vicente Bouchet Waichel, Ester Carvalho Lacerda Garcia, Maria Helena Rigatto	Antibiotics (Basel)
36971982	Novel antimicrobial peptide saap mutant as a good adjuvant to sulbactambased treatment against Clinical strain of XDR acinetobacter baumannii	the production of extend spectrum βlactamase esbl in extensively drugresistant XDR strain of acinetobacter baumannii have create havoc amongst clinician make the treatment procedure challenging Carbapenemresistant strain have display total ineffectiveness towards new combination of βlactam βlactamase inhibitor βlβli in tertiary healthcare setting therefore the present study be aim to design potential βlactamase antimicrobial peptide AMP inhibitor against esbl produce by the strain we have construct a AMP mutant library with high antimicrobial efficacy range 15 to 27 than they parent peptide the mutant be thoroughly screen base on different physicochemical and immunogenic property revealing three peptide namely saap148 hfiap1 myticalinC6 and they mutant with safe pharmacokinetic profile molecular docking highlight saap148m15 display maximum inhibitory potential with low bind energy against NDM1 11487 kcalmol follow by oxa23 10325 kcalmol and oxa58 9253 kcalmol the intermolecular interaction profile display saap148m15 exhibiting hydrogen bond and van der waal hydrophobic interaction with the crucial residue of metallo βlactamase ipr001279 and penicillinbind transpeptidase ipr001460 domain coarsegrained clustering and molecular dynamic simulation MDS further validate the stable backbone profile and minimal residuelevel fluctuation of the proteinpeptide complex that be maintain throughout the simulation timeframe the present study hypothesised that the combination of sulbactam βL with saap148m15 βLI hold immense potential in inhibiting the esbl alongside restoration of sulbactam activity the current in silico finding upon further experimental validation can pave path towards design of successful therapeutic strategy against XDR strain of a baumannii	2023 Mar	Aniket Naha, Sudha Ramaiah	Probiotics Antimicrob Proteins
33593839	target superoxide dismutase confer enhance reactive oxygen species mediate eradication of polymyxin B induce iAcinetobacter baumanniii persister	bacterial persister represent noninheritable drug tolerant population that be link to recalcitrance of infection in healthcare setting the rise of antibiotic resistance and depletion of new antibiotic in drug discovery pipeline have make the task of persister eradication more daunting in the present study we report that treatment of iAcinetobacter baumanniii with the last resort antibiotic polymyxin B display continuous variation in tolerance among different clinical isolate mechanistically polymyxin B persister exhibit disruption of proton motive force lead delocalisation of cell division protein to attain a growth arrest phenotype tolerance study on mutant strain reveal that superoxide dismutase isodBi activity be a major contributor in tolerance of iA baumanniii to polymyxin B use a dual fluorescence base persister detection system screen of various antibiotic be perform to eradicate polymyxin B induce persister of iA baumanniii Rifampicin exhibit eradication of polymyxin B tolerant population by log reduction of 6 in magnitude against different clinical isolate of iA baumanniii we establish that enhance generation of ROS by rifampicin lead to clearance of this polymyxin B persister it be further demonstrate as a proof of concept that rifampicin potentiate the kill of polymyxin B persister in murine wound infection model we find that the effect be link to significant down regulation of isodBi by rifampicin which contribute to high generation of ROS in polymyxin B tolerant cell in view of this result we propose that the combination of polymyxin B and rifampicin be a effective antipersister strategy in clear polymyxin B induce iA baumanniii persister	2023 May	Vineet Dubey, Rinki Gupta, Ranjana Pathania	Antimicrob Agents Chemother
36775993	in vivo efficacy resistance prevention of cefiderocol in combination with ceftazidimeavibactam ampicillinsulbactam or meropenem use humansimulated regimen versus acinetobacter baumannii	evaluate the in vivo efficacy and resistance prevention of cefiderocol in combination with ceftazidimeavibactam ampicillinsulbactam and meropenem use humansimulated regimen hsr in the murine infection model	2023 Apr	Christian M Gill, Debora Santini, Miki Takemura, Christopher Longshaw, Yoshinori Yamano, Roger Echols, David P Nicolau	J Antimicrob Chemother
35483311	the role of quorum sensing biofilm formation and iron acquisition as key virulence mechanism in acinetobacter baumannii and the corresponding antivirulence strategy	acinetobacter baumannii be a nosocomial pathogen responsible for several serious infection include pneumonia sepsis and meningitis the propensity of this bacterium to rapidly acquire antibiotic resistance lead to the emergence and spread of multidrugresistant a baumannii strain as a result antibiotic be become less effective in treat infection cause by this pathogen in recent year increase effort have focus on develop therapeutic compound that could reduce the ability of a baumannii to establish infection by inhibiting the virulence factor and pathogenesis of this pathogen without interfere with the bacterial viability this alternative therapeutic option may impose mild selective pressure reduce the likelihood of antivirulence resistance development to develop novel antivirulence therapy a indepth understanding of the bacterial virulence mechanism be crucial to identify potential drug target this review summarise the late discovery about the virulence of a baumannii focus on quorum sensing biofilm formation and iron acquisition along with the corresponding antivirulence strategy this article also elaborate on the practical challenge involve in develop antivirulence drug therapeutic agent that target bacterial virulence factor may play a crucial role in control infection in the human host combining antivirulence agent with exist antibiotic could enhance the therapeutic potential of this antibiotic against a baumannii although antivirulence therapy have be envision as a attractive alternative to overcome antimicrobial resistance additional research on the possibility of develop resistance against antivirulence drug be encourage to evaluate the sustainability of this strategy moreover future study on the efficacy of antivirulence therapy against a diverse panel of clinical isolate and in polymicrobial a baumannii infection be require to provide more valuable information about its clinical application	2022 Jul	Soffi Kei Kei Law, Hock Siew Tan	Microbiol Res
34387183	decreaseng incidence of iAcinetobacter baumanniii pneumonia and trend in antibiotic consumption a singlecenter retrospective observational study	to describe the epidemiology of iAcinetobacter baumannniii ab pneumonia at we center include the antibiotic exposure pattern of individual ab pneumonia case and to investigate whether hospitalwide antibiotic consumption trend be associate with trend in ab pneumonia incidence	2022 Sep	Andrew T Peters, Chiagozie I Pickens, Michael J Postelnick, Teresa R Zembower, Chao Qi, Richard G Wunderink	Infect Control Hosp Epidemiol
37184409	identification of a specific biomarker of acinetobacter baumannii Global clone 1 by Machine learning and pcr related to metabolic Fitness of eskape pathogen	since the emergence of highrisk clone worldwide constant investigation have be undertake to comprehend the molecular basis that lead to they prevalent dissemination in nosocomial setting over time so far the complex and multifactorial genetic trait of this type of epidemic clone have allow only the identification of biomarker with low specificity a machine learning algorithm be able to recognize unequivocally a biomarker for early and accurate detection of acinetobacter baumannii global clone 1 gc1 one of the most disseminate highrisk clone a support vector machine model identify the U1 sequence with a length of 367 nucleotide that match a fragment of the imoacbi gene which encode the molybdenum cofactor biosynthesis C and B protein U1 differentiate specifically between a baumannii gc1 and nonGC1 strain become a suitable biomarker capable of be translate into clinical setting as a molecular type method for early diagnosis base on pcr as show here since the metabolic pathway of Mo enzyme have be recognize as putative therapeutic target for eskape enterococcus faecium Staphylococcus aureus Klebsiella pneumoniae acinetobacter baumannii pseudomonas aeruginosa and enterobacter species pathogen we finding highlight that machine learning can also be useful in knowledge gap of highrisk clone and provide noteworthy support to the literature to identify relevant nosocomial biomarker for other multidrugresistant highrisk clone bimportanceb a baumannii gc1 be a important highrisk clone that rapidly develop extreme drug resistance in the nosocomial niche furthermore several strain have be identify worldwide in environmental sample exacerbate the risk of human interaction early diagnosis be mandatory to limit its dissemination and to outline appropriate antibiotic stewardship schedule a region with a length of 367 bp U1 within the imoacbi gene that be not subject to lateral genetic transfer or to antibiotic pressure be successfully find by a support vector machine model that predict a baumannii gc1 strain at the same time research on the group of Mo enzyme propose this metabolic pathway related to the superbug metabolism as a potential future drug target site for eskape pathogen due to its central role in bacterial fitness during infection this finding confirm that machine learning use for the identification of biomarker of highrisk lineage can also serve to identify putative novel therapeutic target site	2023 May	Verónica Elizabeth Álvarez, María Paula Quiroga, Daniela Centrón	mSystems
37110495	molecular epidemiological investigation and management of Outbreak caused by CarbapenemResistant iAcinetobacter baumanniii in a neonatal intensive Care unit	the present study describe a epidemiological investigation into a carbapenemresistant iAcinetobacter baumanniii CRAB outbreak which have occur in a neonatal intensive care unit NICU and the subsequent strengthen of infection control intervention upon the onset of the outbreak exist infection control intervention be review and a set of containment measure be institute all CRAB isolate be characterize in term of antimicrobial susceptibility testing and they genetic relatedness the investigation process identify gap within the nicus exist infection control measure which have likely result in the outbreak CRAB be isolate from nine preterm infant five colonize and four infect all five colonize patient be discharge well however three out of four of the infect infant die Outbreak investigation and genomic subtyping of environmental swab reveal that mini syringe driver share between patient and a sink in the milk preparation room have serve as CRAB reservoir with possible transmission via the hand of healthcare worker implementation of immediate action such as reinforcement of hand hygiene practice intensified environmental clean geographical cohorting review of milk handle practice and sink management protocol have result in no further CRAB isolation the CRAB outbreak in the NICU underline the importance of consistent compliance with infectioncontrol intervention integration of epidemiological and microbiological datum together with comprehensive preventive measure successfully bring the outbreak to a halt	2023 Apr	Jia Jie Woon, Azanna Ahmad Kamar, Cindy Shuan Ju Teh, Nuryana Idris, Rosliza Zhazali, Suzana Saaibon, Harvinderjit Kaur Basauhra Singh, Jasreena Kaur Gill Charanjeet Singh, Adeeba Kamarulzaman, Sasheela Ponnampalavanar	Microorganisms
36735546	protein therapeutic target candidate against iAcinetobacter baumanniii a pathogen of concern to Planetary Health a networkbased integrative omic drug Discovery approach	iAcinetobacter baumanniii a opportunistic gramnegative pathogen responsible for several nosocomial infection have develop resistance to various antibiotic protein involve in the twocomponent system TCS virulence and antibiotic resistance ar help this pathogen in regulate antibiotic susceptibility and virulence mechanism the present study report a networkbase integrative omic approach to drug discovery to identify key regulatory protein as therapeutic candidate against iA baumanniii we collect datum on the TCS virulence and ar protein from various database p2cs VFDB ardb and paidbak which be subject to network hostpathogen and gene expression datum analysis Network analysis identify 43 hub and 10 protein be find to be interact with human protein associate with vital pathway of the 53 43 10 pathogen protein 46 have no ortholog in the human host twelve protein namely rpfc wzc ompr envz bfms pilg histidine kinase ABC 3 transport family protein outer membrane porin oprd family Csud pgm and LpxA be differentially express in the resistant strain we propose this protein as key regulator that warrant evaluation as therapeutic target candidate in the future furthermore structure prediction of ABC 3 transport family protein be perform as a case study the finding from this study be poise to facilitate and inform drug discovery and development against iA baumanniii	2023 Feb	Aishwarya Swain, Archana Pan	OMICS
36483204	the combination effect of meropenemsulbactampolymyxinB on the pharmacodynamic parameter for mutant selection window against carbapenemresistant iAcinetobacter baumanniii	the objective of this study be to evaluate whether combination of sulbactam meropenem and polymyxinB could reduce or close the gap of mutant selection window msw of individual antibiotic against iAcinetobacter baumanniii harbor oxa23 mic of three antimicrobial use alone and in combination meropenempolymyxinB or meropenempolymyxinBsulbactam be obtain in 11 clinical isolate and mutant prevention concentration be determine in 4 of the 11 isolate all isolate be resistant to meropenem or polymyxinB combining meropenem and polymyxinB with or without sulbactam result in synergistic bactericidal activity Pharmacokinetic PK simulation of drug concentration in the blood and epithelial lining fluid couple with pharmacodynamic PD evaluation reveal that the fraction of time over the 24h in term of free drug concentration within the msw ifitsubmswsub and above the mpc ifiTsubMPCsub be optimize by combination therapy the resultant clinical regimen of meropenem polymyxinB and sulbactam evaluate in the pkpd analysis be 2 gram q8h 25 mgkg loading dose follow by 15 mgkg q12h and 3 gram q8h respectively in patient with normal renal function subsequent corresponding equivalent exposure regimen would depend on the extent of renal failure the overall result indicate that combination antibiotic consisting of sulbactammeropenempolymyxinB can confer potential efficacy against iA baumanniii harbor oxa23 and reduce the opportunity for bacterium to develop further resistance this study provide a framework for pharmacodynamic evaluation of drugresistant mutant suppression in a antimicrobial coadministration set the result thereby lay the groundwork for additional study and future clinical confirmation be warrant	2022	Jiayuan Zhang, Shuo Diao, Yanfei Liu, Hongxiang Wang, Yuwei Liu, Shixing Zhu, Kun Feng, Xiaoqian Tang, Charles Oo, Peijuan Zhu, Zhihua Lv, Mingming Yu, Sherwin K B Sy, Yuanqi Zhu	Front Microbiol
36121221	assess the role of coldshock protein C a Novel regulator of acinetobacter baumannii biofilm formation and virulence	acinetobacter baumannii be a formidable opportunistic pathogen that be notoriously difficult to eradicate from hospital setting this resilience be often attribute to a proclivity for biofilm formation which facilitate a high tolerance toward external stress desiccation and antimicrobial despite this little be know regard the mechanism orchestrating a baumannii biofilm formation here we perform RNA sequencing rnaseq on biofilm and planktonic population for the multidrugresistant isolate ab5075 and identify 438 gene with alter expression to assess the potential role of gene upregulate within biofilm we test the biofilmforming capacity of they respective mutant from a a baumannii transposon library in so do we uncover 24 gene whose disruption lead to reduce biofilm formation one such element cold shock protein C icspCi have a highly mucoid colony phenotype enhance tolerance to polysaccharide degradation alter antibiotic tolerance and diminish adherence to abiotic surface rnaseq of the icspCi mutant reveal 201 gene with alter expression include the downregulation of pile and fimbria gene and the upregulation of multidrug efflux pump use transcriptional arrest assay it appear that cspc mediate its effect at least in part through RNA chaperone activity influence the halflife of several important transcript finally we show that cspc be require for survival during challenge by the human immune system and be key for a baumannii dissemination andor colonization during systemic infection Collectively we work identify a cadre of new biofilmassociated gene within a baumannii and provide unique insight into the global regulatory network of this emerge human pathogen	2022 Oct	Brooke R Tomlinson, Grant A Denham, Nathanial J Torres, Robert S Brzozowski, Jessie L Allen, Jessica K Jackson, Prahathees J Eswara, Lindsey N Shaw	Infect Immun
35831359	genomic analysis uncover laccasecod gene and biosynthetic gene cluster encoding antimicrobial compound in laccaseproducing acinetobacter baumannii	laccase be multicopper oxidase family enzyme that can oxidize various substrate in this study we isolate laccaseproducing acinetobacter spp from the environment and one isolate of laccaseproducing acinetobacter baumannii designate ni65 be identify the ni65 strain exhibit constitutive production of extracellular laccase in a crude extract use 26 dimethoxyphenol as a substrate when supplement with 2 mM cusosub4sub wholegenome sequencing of the ni65 strain reveal a genome size of 36 mb with 3471 proteincod sequence the phylogenetic analysis show high similarity to the genome of a baumannii ncimb8209 three laccase protein PcoA and copa that belong to bacterial copa superfamily and lacab that belong to the ibacterial bilirubin oxidase superfamily be identify this protein be encode by three laccasecod gene pcoA copA and lacab the lacab gene show a sequence similar to that of polyphenol oxidase ppo gene cluster encoding the catabolized compound involve in the utilization of plant substance and secondary metabolite biosynthesis gene cluster encoding antimicrobial compound be identify this be the first report of wholegenome sequencing of laccaseproducing a baumannii and the datum from this study help to elucidate the genome of a baumannii to facilitate its application in synthetic biology for enzyme production	2022 Jul	Renuka Pooalai, Supat Khongfak, Udomluk Leungtongkam, Rapee Thummeepak, Duangkamol Kunthalert, Sutthirat Sitthisak	Sci Rep
37120145	the clinical feature and genomic epidemiology of carbapenemresistant acinetobacter baumannii infection at a tertiary hospital in Vietnam	to characterise the clinical feature of acinetobacter baumannii infection and investigate the phylogenetic structure and transmission dynamic of a baumannii in Vietnam	2023 Apr	Duong Thi Hong Diep, Huynh Minh Tuan, Kha My Ngoc, Chau Vinh, Tran Thi Ngoc Dung, Voong Vinh Phat, Quynh Nguyen, Dong Thi Hoai Tam, Lam Vinh Nien, Bui Thi Hanh Duyen, Cao Thi Phung, Nguyen Hoang Bac, Tran Diep Tuan, Guy Thwaites, Maia A Rabaa, Duy Thanh Pham	J Glob Antimicrob Resist
36604484	bfrr encode a regulatory system involve in light signal transduction modulate motility and desiccation tolerance in the human pathogen acinetobacter baumannii	we have previously show that acinetobacter baumannii as well as other relevant clinical bacterial pathogen such as Staphylococcus aureus and pseudomonas aeruginosa perceive and respond to light at 37 °C the normal temperature in mammal host in this work we present evidence indicate that the twocomponent system bfrr transduce a light signal in a baumannii at this temperature show selective involvement of the bfar and bfms component depend on the specific cellular process in fact both bfar and bfms participate in modulation of motility by light while only bfar be involve in light regulation of desiccation tolerance in this microorganism neither bfar nor bfms contain a photoreceptor domain and then most likely the system be sensing light indirectly intriguingly this system inhibit blsA expression at 37 °C suggest antagonistic function of both signal system furthermore we present evidence indicate that the phosphorylatable form of bfar repress motility overall we provide experimental evidence on a new biological function of this multifaceted system that broaden we understanding of a baumanniis physiology and response to light	2023 Jan	Bárbara Perez Mora, Rocío Giordano, Valentín Permingeat, Malena Calderone, Natalia Arana, Gabriela Müller, Ramiro E Rodríguez, Renatas Krasauskas, María Alejandra Mussi	Sci Rep
35511209	efficacy of Eravacycline iVersusi good previously available therapy for adult with Pneumonia due to difficulttotreat resistant DTR iAcinetobacter baumanniii	multidrugresistant iAcinetobacter baumanniii remain challenging to treat although eravacycline have iin vitroi activity against this pathogen there be no study evaluate outcome	2022 Dec	Courtney J Scott, Elizabeth Zhu, Rebecca A Jayakumar, Guogen Shan, Velliyur Viswesh	Ann Pharmacother
35339024	a extensive computational study to identify potential inhibitor of acylhomoserinelactone synthase from acinetobacter baumannii strain aye	a member of the eskape family of pathogen a baumannii be a opportunistic gramnegative multidrugresistant bacterium a baumannii be a ubiquitous coccobacillus involve in various hospitalrelated infection such as wound infection pneumonia urinary tract infection septicaemia endocarditis and ventilator assist pneumonia and account for approximately 12 of all nosocomial bloodstream infection hence it become imperative to identify potential therapeutic agent against the dreadful pathogen the quorumsensing pathway become a attractive drug target due to its role in biofilm regulation and formation which provide the bacterium insulation from the harsh environment a crucial protein in biofilm formation and regulation be acylhomoserinelactone synthase ahls responsible for produce signal molecule that trigger the signalling pathway for biofilm formation and regulation the current study model the threedimensional structure of ahls in a baumannii strain aye follow by highthroughput virtual screen of the enamineAC smallmolecule database to identify lead molecule against its acylatedACP acyl Carrier protein substratebind site base on the estimate bind affinity estimate inhibition constant adme analysis and interaction pattern of the screen molecule three lead candidate q815888654 z2416029019 z3766992625 be identify along with a control molecule j8c8 this molecule be then subject to molecular dynamic simulation where the physiological effect of ligand bind on the protein be virtually predict and analyse the mmpbsa base bind free energy calculation show favourable result for q815888654 2277 ± 294 kcalmol z2416029019 3368 ± 263 kcalmol z3766992625 2144 ± 340 kcalmol the study employ global and essential dynamic analysis mmpbsa base bind free energy free energy landscape and dynamic crosscorrelation matrix to suggest q815888654 z2416029019 and z3766992625 as potential inhibitor against the acylatedACP substratebind site in ahls from a baumannii	2022 Jul	Rajat Kumar Jha, Rameez Jabeer Khan, Ekampreet Singh, Ankit Kumar, Monika Jain, Jayaraman Muthukumaran, Amit Kumar Singh	J Mol Graph Model
36566558	aptamerbased dnAcatalyzed amplification strategy for sensitive fluorescence resonance energy transfer detection of acinetobacter baumannii	acinetobacter baumannii a baumannii be a common pathogen that cause hospitalacquired infection and be resistant to a wide variety of antibiotic consequently the rapid and highly sensitive detection of a baumannii be require during the early stage of infection therefore we develop a dnAcatalyzed amplification mechanism base on aptamer combine with a novel fluorescence resonance energy transfer fret method base on graphene oxide go for the detection of a baumannii in the presence of a baumannii a aptamer bind to a baumannii release the template strand which trigger a entropydriven catalysis edc reaction one edc product be then use as the catalyst for catalytic hairpin assembly CHA on a go nanosheet finally the go release a huge amount of famlabeled DNA duplice which could be detect with fret this strategy circumvent the extraction of nucleic acid and be easy to execute with a detection time of ≤ 15 h the detection of a baumannii with this method range from 5 cfumL to 1 × 10 sup5 sup cfumL with a detection limit of 11 cfumL the method be sufficiently sensitive and specific to detect a baumannii rapidly in cerebrospinal fluid in summary we strategy provide a new option for the early detection and pointofcare testing poct of a baumannii infection allow they early and more precise treatment	2023 Apr	Jingling Xie, Hui Jiang, Yuanqing Zhao, Min Zhong, Xinrui Jin, Zixin Zhu, Baolin Li, Jinglan Guo, Limei Zhang, Jinbo Liu	Talanta
36406595	use of Taguchi design for optimization of dieseloil biodegradation use consortium of iPseudomonas stutzerii icellulosimicrobium cellulansi iAcinetobacter baumanniii and iPseudomonas balearicai isolate from tarball in terengganu Beach Malaysia	a consortium of bacterium capable of decomposing oily hydrocarbons be isolate from tarballs on the beach of terengganu Malaysia and classify as iPseudomonas stutzerii icellulosimicrobium cellulansi iAcinetobacter baumanniii and iPseudomonas balearicai the Taguchi design be use to optimize the biodegradation of diesel use this bacterium as a consortium the high biodegradation of dieseloil in the experimental test be 936 and the individual nalkane decompose 876976 over 30 day optimal setting be inoculum size of 25 millileter 1248 odsub600 nmsub 12 vie the initial dieseloil in a minimal salt medium of pH 70 300 glsup1sup NaCl and 20 glsup1sup nhsub4subnosub3sub concentration incubate at 42 °C temperature and 150 rpm agitation speed parameter significantly improve dieseloil removal by consortium as show by the model determination coefficient rsup2 sup 9089 ipi 0001 with a synergistic effect of agitation speed significantly contribute 8103 Taguchi design determine the optimal setting for the parameter under study which significantly improve dieseloil removal by consortium this can be use to design a novel bioremediation strategy that can achieve optimal decontamination of oil pollution in a short time	2022 Dec	Bruno Martins Nkem, Normala Halimoon, Fatimah Md Yusoff, Wan Lutfi Wan Johari	J Environ Health Sci Eng
36043158	the pharmacokineticspharmacodynamics and Neurotoxicity of tigecycline Intraventricular injection for the treatment of extensively DrugResistant iAcinetobacter baumanniii intracranial infection	this study aim to provide feasible suggestion for intraventricular injection of tigecycline to treat intractable iAcinetobacter baumanniii intracranial infection by study its pharmacokineticspharmacodynamics and neurotoxicity	2022	Qi Huang, Xingwen Zhang, Aijun Jia, Qi Huang, Yu Jiang, Liangyi Xie	Infect Drug Resist
36036636	evaluation report of the colistin broth disk elution method with iAcinetobacter baumanniii isolate from a lowresource setting	the rapid emergence of drug resistance in acinetobacter baumannii have put forward the use of colistin as a lastresort treatment for infection with a baumannii empirical colistin use without prior susceptibility testing have be one of the factor that have be promote drug resistance in lowresource setting in this regard while the advocate broth microdilution bmd method for colistin susceptibility testing be often consider cumbersome the preferable colistin broth disk elution cbde method have not yet be approve for a baumannii to prevent the underreporting of colistin susceptibility we test the cbde method for a baumannii and compare the result with that of bmd a total of 125 a baumannii include 100 susceptible and 25 resistant isolate be test via the cbde method and compare with the standard bmd method the essential agreement categorical agreement sensitivity and specificity for cbde be 976 ini 122 984 ini 123 100 and 9840 respectively the percentage of major error find be 16 ini 2 and no very major error be find cbde in a baumannii could be consider in lowresource setting bimportanceb the relatively cumbersome broth microdilution bmd method for routine colistin susceptibility testing have not be adopt especially in lowresource setting often lead to the underreporting of colistin susceptibility and the promotion of the empirical use of colistin in this regard the muchpreferred colistin broth disk elution cbde method have not yet be approve for a baumannii we evaluate colistin susceptibility via the cbde method compare the result with that of the bmd method in 125 a baumannii isolate with various profile and infer that the cbde method use 50 μl inoculum could be helpful at least in resourcelimited setup versus not report susceptibility testing for colistin	2022 Oct	Swati Sharma, Tuhina Banerjee, Rahul Garg, Padma Das	Microbiol Spectr
35889996	comment on mitteregger et al a variant carbapenem Inactivation method CIM for iAcinetobacter baumanniii Group with shortened timetoresult rCIMA ipathogensi 2022 i11i 482	we have read the article publish by mitteregger et al	2022 Jul	Andrei-Alexandru Muntean, Madalina-Maria Muntean, Saoussen Oueslati, Remy Bonnin, Thierry Naas, Mircea Ioan Popa	Pathogens
36817105	galaxy asist a webbase platform for mapping and assessment of global standard of antimicrobial susceptibility a case study in iAcinetobacter baumanniii genome	antimicrobial susceptibility testing ast be use to determine the susceptibility of a organism to antibiotic the determination of susceptibility be base on mic breakpoint and be provide by eucast and clsi likewise phenotypic classification criterion develop by cdcecdc be use for the classification of pathogen into susceptible multidrugresistant extremely drugresistant or totally drugresistant category wholegenome sequencing wgsbased diagnosis be now supplement exist goldstandard microbiology method for rapid and more precise ast and therefore eucast recommend quality criterion to assess wholegenome sequence for report the same in this study this three global standard mic breakpoint phenotypic classification and genome quality be apply to the large publicly available datum for acinetobacter baumannii ab the most critical priority pathogen identify by who	2022	Tina Sharma, Rakesh Kumar, Jasmeer Singh Kalra, Shreya Singh, Gurpreet Singh Bhalla, Anshu Bhardwaj	Front Microbiol
36338049	Effect of amikacin polymyxinB and sulbactam combination on the pharmacodynamic index of mutant selection against multidrug resistant iAcinetobacter baumanniii	amikacin and polymyxin as monotherapy be ineffective against multidrugresistant iAcinetobacter baumanniii at the clinical dose when polymyxin aminoglycoside and sulbactam be coadministered the combination exhibit iin vitroi synergistic activity the minimum inhibitory concentration mic and mutant prevention concentration mpc be determine in 11 and 5 clinical resistant isolate of iA baumanniii harbor oxa23 respectively in order to derive the fraction of time over the 24h wherein the free drug concentration be within the mutant selection window ifitsubmswsub and the fraction of time that the free drug concentration be above the mpc ifiTsubMPCsub from simulate pharmacokinetic profile the combination of this three antibiotic can confer susceptibility in multidrug resistant iA baumanniii and reduce the opportunity for bacterium to develop further resistance Clinical intravenous dose regimen of amikacin polymyxinB and sulbactam be predict to optimize ifitsubmswsub and ifiTsubMPCsub from drug exposure in the blood mean ifiTsubMPCsub be ≥ 60 and ≥ 80 for amikacin and polymyxinB whereas mean ifitsubmswsub be reduce to 30 and 15 respectively in the triple antibiotic combination due to the low free drug concentration of amikacin and polymyxinB simulate in the epithelial lining fluid the two predict pharmacodynamic parameter in the lung after intravenous administration be not optimal even in the combination therapy set	2022	Shixing Zhu, Chu Song, Jiayuan Zhang, Shuo Diao, Tobias M Heinrichs, Frederico S Martins, Zhihua Lv, Yuanqi Zhu, Mingming Yu, Sherwin K B Sy	Front Microbiol
36188613	emergence of high colistin resistance in carbapenem resistant iAcinetobacter baumanniii in Pakistan and its potential management through immunomodulatory effect of a extract from iSaussurea lappai	carbapenem resistant iAcinetobacter baumanniii have emerge as one of the most difficult to treat nosocomial bacterial infection in recent year it be one of the major cause of secondary infection in covid19 patient in develop country the polycationic polypeptide antibiotic colistin be use as a last resort drug to treat carbapenem resistant iA baumanniii infection therefore resistance to colistin be consider as a serious medical threat the purpose of this study be to assess the current status of colistin resistance in Pakistan a country where carbapenem resistant iA bumanniii infection be endemic to understand the impact of colistin resistance on virulence in mouse and to assess alternative strategy to treat such infection out of 150 isolate collect from five hospital in Pakistan during 201920 84 be carbapenem resistant and 73 be additionally resistant to colistin there be two isolate resistant to all test antibiotic and 83 of colistin resistant isolate be susceptible to only tetracycline family drug doxycycline and minocycline doxycycline exhibit a synergetic bactericidal effect with colistin even in colistin resistant isolate exposure of iA baumanniii 17978 to sub inhibitory concentration of colistin identify novel point mutation associate with colistin resistance colistin tolerance acquire independent of mutation in ilpxA lpxB lpxCi ilpxdi and ipmrabi supress the proinflammatory immune response in epithelial cell and the virulence in a mouse infection model moreover the oral administration of water extract of iSaussuria lappai although not show antimicrobial activity against iA baumannii in vitroi lower the number of colonizing bacterium in liver spleen and lung of the mouse model and also lower the level of neutrophil and interleukin 8 in mouse we finding suggest that the be lappai extract exhibit a immunomodulatory effect with potential to reduce and cure systemic infection by both opaque and translucent colony variant of iA baumanniii	2022	Umaira Ahsan, Fizza Mushtaq, Sidrah Saleem, Abdul Malik, Hira Sarfaraz, Muhammad Shahzad, Bernt Eric Uhlin, Irfan Ahmad	Front Pharmacol
35749272	Engineering phage tail fiber protein as a widespectrum probe for iAcinetobacter baumanniii strain with a Recognition rate of 100	as a multidrugresistant pathogen iAcinetobacter baumanniii have long be identify as one of the most common nosocomial bacterium highperformance recognition probe for widespectrum detection of iA baumanniii be highly desire to achieve efficient diagnosis and timely treatment of infectious disease induce by this pathogen a engineering tail fiber protein etfp name as gp50 encode by lytic phage abp9 be express in iEscherichia colii and identify as a bind protein for iA baumanniii accord to the result of genome sequencing of a iA baumanniii wild strain and phageresistant strain the bind receptor of etfp gp50 be infer to be a lipopolysaccharide distribute on the bacterial surface the engineering protein do not show lytic activity to iA baumanniii which facilitate the development of reliable diagnosis kit and biosensor with high flexibility and low falsenegative rate the result of specificity study show that etfp gp50 be a speciesspecific bind protein with a recognition rate of 100 for all test 77 iA baumanniii strain while that of the natural phage abp9 be only 273 with the engineering protein a fluorescence method be develop to detect iA baumanniii with a detection range of 20 × 10 sup2 sup to 20 × 10 sup8 sup cfu mlsup1sup the method have be use for the quantification of iA baumanniii in a diverse sample matrix with acceptable reliability the work demonstrate the application potential of etfp gp50 as a ideal recognition probe for rapid screen of iA baumanniii strain in a complicated sample matrix	2022 Jul	Ying Chen, Honglin Yang, Shuai Luo, Lin Wang, Shuguang Lu, Zhifeng Fu	Anal Chem
37149411	mortality and ventilator dependence in critically ill patient with ventilatorassociated pneumonia cause by carbapenemresistant acinetobacter baumannii	Carbapenemresistant acinetobacter baumannii CRAB be a key pathogen associate with ventilatorassociated pneumonia vap Research on treatment outcome especially ventilator dependence in patient with vap cause by CRAB remain limited	2023 Apr	Hsiao-Hui Kao, Chung-Kan Peng, Chau-Chyun Sheu, Yu-Chao Lin, Ming-Cheng Chan, Sheng-Huei Wang, Chia-Min Chen, Yi-Cheng Shen, Zhe-Rong Zheng, Yi-Tsung Lin, Han-Shui Hsu, Jia-Yih Feng, Kuang-Yao Yang, T-CARE (Taiwan Critical Care and Infection) Group	J Microbiol Immunol Infect
36361685	rhamnetin a Natural flavonoid ameliorate organ damage in a mouse Model of CarbapenemResistant iAcinetobacter baumanniiinduced sepsis	in sepsis the persistence of uncontrolled inflammatory response of infect host cell eventually lead to severe lung and organ failure and ultimately death Carbapenemresistant iAcinetobacter baumanniii CRAB causative bacterium of sepsis and lung failure in acute case belong to a group of critical pathogen that cannot be eradicated use the currently available antibiotic this underline the necessity of develop new mode of therapeutics that can control sepsis at the initial stage in this study we investigate the antiinflammatory activity in vitro and in vivo and the antiseptic effect of rhamnetin a naturally occur flavonoid we find that among its isoform the potency of rhamnetin be less explore but rhamnetin possess superior antiinflammatory activity with least cytotoxicity rhamnetin show significant antiinflammatory effect in lipopolysaccharide CRAB and iEscherichia colii iE coliistimulated mouse macrophage by inhibiting the release of interleukin6 and nitric oxide in a mouse model of sepsis infect with clinically isolate CRAB or iE colii rhamnetin significantly reduce the bacterial burden in the organ in addition normalized proinflammatory cytokine level in lung lysate and histological analysis of lung tissue indicate alleviation of lung damage this study imply that a potent natural product such as rhamnetin could be a future therapeutic for treat carbapenemresistant gramnegative sepsis	2022 Oct	Hyeju Lee, Manigandan Krishnan, Minju Kim, Young Kyung Yoon, Yangmee Kim	Int J Mol Sci
36307731	in vitro analysis of synergistic combination of polymyxin B with 12 other antibiotic against MDR acinetobacter baumannii isolate from a Chinese tertiary hospital	in clinical practice polymyxin be suggest to be use in combination with other antibiotic for improve they antibacterial efficacy and prevent the emergency of antibioticresistant strain however even though synergistic combination of polymyxin B with many antibiotic have be confirm in various study with different bacterial species and analyze method which antibiotic be the good option for combination therapy of polymyxin B against MDR a baumannii remain uncertain in this study we systematically analyze the synergistic combination of polymyxin B with 12 other antibiotic against MDR a baumannii isolate from a Chinese tertiary hospital use the checkerboard assay the result suggest that for polymyxin bbase combination therapy against MDR a baumannii as characterize in this hospital cefperazonesulbactam may be the good partner since it have the high synergistic rate and the good synergistic effect with polymyxin B minocycline imipenem meropenem ceftazidime cefepime amikacin and sulfamethoxazole also have some synergistic effect with polymyxin B but piperacillintazobactam ciprofloxacin levofloxacin and tobramycin show no synergism none of this 12 antibiotic have a antagonistic effect when combine with polymyxin B	2023 Jan	Hui Liu, Dan Hu, Dongxin Wang, Han Wu, Yunjun Pan, Xin Chen, Lin Qi, Lian Li, Rongxin Liang	J Antibiot (Tokyo)
36006253	multicenter Study of the Risk factor and outcome of bloodstream infection caused by carbapenemnonsusceptible iAcinetobacter baumanniii in Indonesia	the prevalence of bacteremia cause by carbapenemnonsusceptible iAcinetobacter baumanniii cnsab continue to increase and it be associate with a high mortality rate early recognition of infection and mortality determinant risk factor be necessary for adequate antibiotic administration we aim to determine the risk factor and outcome of cnsab bacteremia in Indonesia a multicenter casecontrol study be conduct in three referral hospital in Indonesia data be collect retrospectively from January 2019 to December 2021 case be define as patient with bacteremia where cnsab be isolate from the blood while the control be patient with bacteremia cause by carbapenemsusceptible iA baumanniii csab Risk factor for bacteremia and mortality associate with cnsab bacteremia be determine use univariate analysis chisquared and student ititest or mannwhitney test and multivariate logistic regression analysis a total of 144 bacteremia patient be include of whom 72 patient be for each case and control group the final model of multivariate regression analysis reveal that bacteremia source from the low respiratory tract adjust odd ratio aor 324 95 CI 158663 ipi 0001 and the use of central venous catheter aor 256 95 CI 127518 ipi 0009 be independent risk factor for cnsab bacteremia charlson comorbidity index ≥ 4 aor 2856 95 CI 30626590 ipi 0003 and Pitt Bacteremia score ≥ 4 aor 644 95 CI 1173538 ipi 0032 be independent risk factor for mortality due to cnsab bacteremia only high Pitt Bacteremia score be a independent risk factor for mortality of csab bacteremia in conclusion we identify the risk factor for cnsabassociated bacteremia and the risk factor for death which be relevant for empiric therapy and infection control prevention as well as prognosis evaluation of patient with bloodstream infection	2022 Jul	Dewi Anggraini, Dewi Santosaningsih, Pepy Dwi Endraswari, Novira Jasmin, Fajri Marindra Siregar, Usman Hadi, Kuntaman Kuntaman	Trop Med Infect Dis
35352448	mushroomshaped structure form in acinetobacter baumannii biofilm grow in a roller bioreactor be associate with quorum sensingdependent Csupilus assembly	there be currently a need to develop simple biofilm model that facilitate investigation of the architecturebiology of mature bacterial biofilm in a consistentstandardized manner give they environmental and clinical importance and the need for new antibiofilm intervention this study introduce a novel biofilm culture system term the roll biofilm bioreactor RBB this easily operate system allow adherent microbial cell to be repeatedly expose to airsolidliquid interface optimizing biofilm growth the RBB be exploit to investigate biofilm formation in acinetobacter baumannii high level of a baumannii biofilm biomass reproducibly accumulate in the RBB and importantly undergo a maturation step to form large mushroomshaped structure that have not be observe in other model base on image analysis of biofilm development and genetic manipulation we show how nacylhomoserine lactonedependent quorum sensing qs impact on biofilm differentiation composition and antibiotic tolerance we result indicate that extracellular DNA eDNA be a key matrix component in mature acinetobacter biofilm as the mushroomlike structure consist of dense cellular mass encase in a eDNA mesh moreover this study reveal the contribution of qs to a baumannii biofilm differentiation through Csu pilus assembly regulation understanding the mechanism of structural development of mature biofilm help to identify new biofilm eradication and removal strategy	2022 Sep	Manuel Romero, Celia Mayer, Stephan Heeb, Krittanont Wattanavaekin, Miguel Cámara, Ana Otero, Paul Williams	Environ Microbiol
36936715	epidemiology and mortality outcome of carbapenem and colistinresistant iKlebsiella pneumoniae Escherichia coli acinetobacter baumanniii and iPseudomonas aeruginosai bloodstream infection	bloodstream infection cause by carbapenemresistant gramnegative bacterium represent a major therapeutic challenge to clinician worldwide this study examine the epidemiology of carbapenem and colistin resistance in iKlebsiella pneumoniae Escherichia coli pseudomonas aeruginosai and iAcinetobacter baumanniii blood isolate in a academic institution in oman	2023 Jun	A Balkhair, K Al Saadi, B Al Adawi	IJID Reg
36621329	enhanced antibiofilm activity of the minocyclineandgalliumnitrate use niosome wrapping against acinetobacter baumannii in c57bl6 mouse pneumonia model	acinetobacter baumannii be a worldwide health issue in term of its high antibiotic resistance and ability to form biofilm nanoparticle nps with high biocompatibility high penetrating ability and low medication dose can successfully treat the antibioticresistant infection in this research the antibiofilm activity of niosome contain minocycline and gallium nitrate gan against a baumannii biofilm be determine in order to improve they antibiofilm property minocycline and gan be encapsulated in niosome as biocompatible drug carrier the niosome size zeta potential shape stability drug entrapment efficacy drug release pattern and antibacterial activity be assess several clinical sample be isolate from the lung of patient hospitalize at loghman hospital Tehran Iran the biofilm formation of most lethal clinical isolate of a baumannii be analyze the pneumonia model be generate by intranasally administer a baumannii suspension to anesthetize mouse whose immune system be compromise twice by cyclophosphamide Lung infection of the mouse with a baumannii be confirm use pcr after treatment the lung be excise under sterile condition and stain with hematoxylin and eosin he to determine histological symptom inflammation and intercellular secretion the niosome contain minocycline and gan have a average size of 230 nm and a zeta potential of 40 mv respectively the percentage of drug entrapment and delay drug release be both high in niosomal formulation niosome contain minocycline and gan disperse 1 3 and 5 day old biofilm the mouse give the combination of two compound require less time to be treat than the animal give the single medication minocycline the minocycline ganloaded niosome could be consider as promise candidate to treat the infection cause by a baumannii biofilm	2023 Feb	Farnaz Shamkani, Seyed Mahmoud Barzi, Farzad Badmasti, Mohsen Chiani, Esmat Mirabzadeh, Mahdi Zafari, Morvarid Shafiei	Int Immunopharmacol
35412620	genomic analysis of ctxm115 and oxa2372 coproducing acinetobacter baumannii and they potential to spread resistance gene by natural transformation	to characterize acinetobacter baumannii strain coproducing the esbl ctxm115 and carbapenemhydrolysing class D βlactamase chdl and to assess the potential diffusion of they resistance gene by horizontal transfer	2022 May	Jean-Baptiste Vuillemenot, Maxime Bour, Racha Beyrouthy, Richard Bonnet, Maria-Halima Laaberki, Xavier Charpentier, Raymond Ruimy, Patrick Plésiat, Anaïs Potron	J Antimicrob Chemother
36086811	Zinc oxide nanoparticle impact the expression of the gene involve in toxinantitoxin system in multidrugresistant acinetobacter baumannii	the aim of this study be to investigate the effect of zinc oxide nanoparticle mnonp on the expression of gene involve in toxinantitoxin of system in multidrugresistant MDR acinetobacter baumannii seventy clinical isolate of a baumannii be collect from variuo clinical sample antimicrobial susceptibility test be determine by disk diffusion type ii of systemrelated gene include GNAT xrelike hipA hipB hicA hicB be screen use polymerase chain reaction pcr mnonp prepare and characterize by field emission scan electron microscopy and Xray diffraction mic of mnonp of a baumannii isolate be perform use the microdilution method the expression of type ii of systemsrelated gene be assess with and without exposure to mnonp use realtime pcr the high rate of resistance and sensitivity be observe against cefepime 7714 and ampicillinsulbactam 4285 respectively all a baumannii isolate be consider as MDR in this study three of loci be identify for a baumannii include gnatxrelike hicah and hipahipbise and they prevalence be 100 42 and 271 respectively there be no significant relationship between the prevalence of this system and the origin of a baumannii we datum show significant correlation between the presence of hicah system and resistance to ceftazidime meropenem imipenem and cefepime p 005 and the presence of hipahipbise system and resistance to ceftazidime meropenem imipenem and cefepime p 005 in presence of mnonp the expression of all study gene decrease GNAT and hicB show the high and low expression change by 24 fold p 0001 and 13 fold p 005 respectively this study demonstrate the promise potential of nanoparticle to impact the expression of the gene involve in of system so the application of mnonp may be helpful to design targetbase strategy towards mdr pathogen for empower clinical application by microbiologist and nanotechnologist	2022 Sep	Shahla Shahbazi, Ali Shivaee, Marzieh Nasiri, Maryam Mirshekar, Samira Sabzi, Omid K Sariani	J Basic Microbiol
35721097	antibiotic treatment of iAcinetobacter baumanniii superinfection in patient with sarscov2 infection admitt to intensive Care unit a Observational retrospective Study	in covid19 patient on mechanical ventilation vap from iAcinetobacter baumanniii remain a crucial risk factor for death antibiotic resistance represent a important problem in treat this infection this study aim to describe the evolution of the superinfection from iPDR acinetobacter baumanniii in patient with acute respiratory failure from sarscov2 infection admit to icu and compare the impact of two different antibiotic strategy on microbiological negativization	2022	Erika Casarotta, Elisa Bottari, Sara Vannicola, Rachele Giorgetti, Roberta Domizi, Andrea Carsetti, Elisa Damiani, Claudia Scorcella, Vincenzo Gabbanelli, Simona Pantanetti, Benedetto Marini, Abele Donati, Erica Adrario	Front Med (Lausanne)
35669527	dissemination and genetic relatedness of multidrugresistant and extensively DrugResistant iAcinetobacter baumanniii isolate from a burn Hospital in Iraq	iAcinetobacter baumanniii be a aggressive opportunistic bacterial pathogen that cause severe nosocomial infection especially among burn patient a increase number of hospitalsacquired infection have be report all over the world however little attention have be pay to the relatedness between iA baumanniii isolate from different hospital environment and patient in this study 27 isolate be collect from the burn and plastic surgery Hospital of Al sulaymaniyah City Iraq from January through December 2019 11 from patient and 16 from the ward environment identify to species level as iA baumanniii use vitek 2 system and molecular detection of i16 rrnai gene and then confirm by target the iblai suboxa51 sub gene moreover the isolate be characterize by mean of automated antimicrobial susceptibility assay antimicrobialresistant pattern a phenotypic method use a combine disk test and molecular method for the detection of class a and C iβilactamase gene and finally the genetic relatedness be classify antimicrobial susceptibility testing show that 63 1727 of the retrieve iA baumanniii isolate be extensively drugresistant to 89 antimicrobial class furthermore 37 1027 of the isolate be classify as multidrugresistant 8 isolate exhibit similar resistant pattern and the other two isolate show 2 different pattern while resistance be great in isolate from patient than from the ward environment Combine disk test show that two isolate contain extendedspectrum iβilactamase all isolate carry iblai subtem1sub and two copy of the iblai subctx1 sub gene be indicate in one isolate while iblai subshvsub be absent in all isolate twentyfour isolate carry the iblai subampcsub gene among they 3 isolate harbor the insertion sequence ISiAba1i upstream to the gene use enterobacterial repetitive intergenic consensus pcr the isolate be cluster into 6 distinct type among they two cluster each of four strain be classify to contain isolate from both patient and environment the cluster of similar genotype be find in inpatient as well as the environment of different ward during time period suggest transmission within the hospital identification of possible infection source and control the transmission of this aggressive resistance strain should be strictly conduct	2022	Aras A K Shali, Paywast J Jalal, Sehand K Arif	Can J Infect Dis Med Microbiol
33856245	iVibrio vulnificusisided necrotizing fasciitis complicated by multidrugresistant iAcinetobacter baumanniii infection efficacy of Chemical necrectomy use 40 benzoic acid	necrotizing fasciitis be a lifethreatening skin and soft tissue infection associate with high morbidity and mortality in adult patient this infection can present as either type 1 infection cause by a mix microflora iStreptococcii iEnterobacteriacaei iBacteroidesi sp and ipeptostreptococcusi sp most commonly develop in patient after surgery or in diabetic patient or as type 2 the latter type be monomicrobial and usually cause by group a iStreptococcii rarely this type can be also cause by other pathogen such as iVibrio vulnificusi iv vulnificusi be a small mobile gramnegative rod capable of cause 3 type of infection in humansgastroenteritis primary infection of the vascular bed and wound infection if infecting a wound iv vulnificusi can cause a lifethreatening conditionnecrotizing fasciitis we present a rare case of necrotizing fasciitis develop after a insect bite follow by exposure to the seawater rapidforsey@ect propagation of the infectious complication in the region of the right low limb lead to a serious consideration of the necessity of amputation due to the clearly demarcate necrose and secondary skin and soft tissue infection cause by a multiresistant strain of iAcinetobacter baumanniii we however resort to the use of selective chemical necrectomy use 40 benzoic acida unique application in this kind of condition the chemical necrectomy be successful relatively gentle and thanks to its selectivity vital part of the limb remain preserve and could have be subsequently salvaged at minimum blood loss moreover the antimicrobial effect of benzoic acid lead to rapid decolonization of the necrosis and wound bed preparation which allow we to perform defect closure use splitthickness skin graft the patient subsequently heal without further complication and return to normal life	2023 Mar	Bretislav Lipový, Radomir Mager, Filip Raška, Marketa Hanslianová, Josef Blažek, Hana Křemečková, Ivan Suchánek, Martin Hladík	Int J Low Extrem Wounds
37152898	identification of fungusgrow termiteassociated halogenatedPKS maduralactomycin a as a potential inhibitor of murf protein of multidrugresistant iAcinetobacter baumanniii	multidrugresistant iAcinetobacter baumanniii infection have become a major public health concern globally inhibition of its essential murf protein have be propose as a potential target for broadspectrum drug this study aim to evaluate the potential of a novel ecological niche of 374 fungusgrow termite associate Natural product nps the molecular docking and computational pharmacokinetic screen four compound ie termstrin B fridamycin a Maduralactomycin a and natalenamide C as potential compound that have high bind affinity and favourable proteinligand interaction the compound Maduralactomycin a induce more stability base on its low average rmsd value 231 Å and low standard deviation 035 support by the consistent flexibility and βfactor during the protein timedependent motion while hydrogen bond analysis indicate that termstrin B have form the strong intraprotein interaction solvent accessibility be in good agreement with Maduralactomycin a compactness Maduralactomycin a have the strong bind energy among all the compound 34848 kcalmol follow by termstrin B 32119 kcalmol since this finding suggest Maduralactomycin a and termstrin B as promise candidate for inhibition of murf protein the favourable bind energy of Maduralactomycin a make it a more important compound to warrant further investigation however experimental validation use animal model and clinical trial be recommend before reach any final conclusion	2023	Muhammad Shoaib, Iram Shehzadi, Muhammad Umair Asif, Yulong Shen, Jinfeng Ni	Front Mol Biosci
37152405	Assessment of effective antimicrobial regimen and mortalityrelated Risk factor for bloodstream infection caused by CarbapenemResistant iAcinetobacter baumanniii	this study aim to determine the clinical feature risk factor and effective antimicrobial therapy for Carbapenemresistant iAcinetobacter baumanniii CRAB bloodstream infection BSI	2023	Shumin Gu, Jianqiu Xiong, Suqin Peng, Longhua Hu, Hongying Zhu, Yanping Xiao, Hong Luo, Yaping Hang, Yanhui Chen, Xueyao Fang, Xingwei Cao, Youling Fang, Fuxing Li, Junqi Zhu, Qiaoshi Zhong	Infect Drug Resist
36825087	virulence potential of multidrugresistant iAcinetobacter baumanniii isolate from covid19 patient on mechanical ventilation the first report from Serbia	since the who declare the covid19 pandemic in March 2020 the disease have spread rapidly lead to overload of the health system and many of the patient infect with sarscov2 need to be admit to the intensive care unit icu around 10 of patient with the severe manifestation of covid19 need noninvasive or invasive mechanical ventilation which represent a risk factor for iAcinetobacter baumanniii superinfection the 64 iA baumanniii isolate be recover from covid19 patient admit to icu at General Hospital Dr Laza k Lazarević Šabac Serbia during the period from December 2020 to February 2021 all patient require mechanical ventilation and mortality rate be 100 the goal of this study be to evaluate antibiotic resistance profile and virulence potential of iA baumanniii isolate recover from patient with severe form of covid19 who have a need for mechanical ventilation all test iA baumanniii isolate ini 64 be sensitive to colistin while resistant to meropenem imipenem gentamicin tobramycin and levofloxacin accord to the broth microdilution method and MDR phenotype be confirm in all test isolate representative of international clone 2 ic2 classify by multiplex pcr for clonal lineage identification iblai subampcsub iblai suboxa51sub and iblai suboxa23sub gene be present as well as ISiAba1i insertion sequence upstream of iblai suboxa23sub clonal distribution of one dominant strain be find but individual strain show phenotypic difference in the level of antibiotic resistance biofilm formation and bind to mucin and motility accord to pfge four isolate be sequence and antibiotic resistance gene as well as virulence factor gene be analyze in this genome the result of this study represent the first report on virulence potential of MDR iA baumanniii from hospital in Serbia	2023	Katarina Novović, Snežana Kuzmanović Nedeljković, Mirjana Poledica, Gordana Nikolić, Bojana Grujić, Branko Jovčić, Milan Kojić, Brankica Filipić	Front Microbiol
36514799	resistance to cefiderocol involved expression of per1 " lactamase and Downregulation of Iron transporter system in CarbapenemResistant iAcinetobacter baumanniii	cefiderocol CFDC be a promise antimicrobial agent against multidrug resistant gramnegative bacterium however CFDC resistance have emerge in carbapenemresistant iAcinetobacter baumanniii CRAB but the underlying mechanism remain unclear	2022	Yukun He, Yifan Wang, Xinqian Ma, Lili Zhao, Jie Guan, Jin Zhao, Wenyi Yu, Yanjun Li, Wentao Ni, Zhancheng Gao	Infect Drug Resist
36058511	draft genome sequence of extensively drug resistant and pandrug resistant acinetobacter baumannii strain isolate from hospital wastewater in South Africa	acinetobacter baumannii be a significant opportunistic pathogen cause nosocomial infection infection cause by a baumannii be often difficult to treat because this bacterium be often multidrugresistant and show high environmental adaptability here we report on the analysis of three a baumannii strain isolate from hospital effluent in South Africa	2022 Dec	Emmanuel C Eze, Linda Falgenhauer, Mohamed E El Zowalaty	J Glob Antimicrob Resist
36047802	a ipyrfiBased efficient genetic manipulation platform in acinetobacter baumannii to explore the vital DNA component of adaptive immunity for if CRISPRCas	acinetobacter baumannii be a important pathogenic bacterium with multidrug resistance which cause infection with high mortality rate indepth genetic analysis of a baumannii virulence and drugresistant gene be highly desirable in this study we utilize the conserved ipyrfiflanking fragment to rapidly generate uracil auxotrophy host with ipyrFi delete in model and clinical a baumannii strain and then introduce the ipyrFi gene as the selectable and counterselectable marker to establish a series of gene manipulation vector for gene deletion with the suicide ipyrfibased plasmid the secondcrossover colony screen with the ipyrFi5 fluoroorotic acid 5FOA system be obtain more quickly and efficiently than that screen with the isacBisucrose system by use the replicative plasmid the recognize protospaceradjacent motif pam bias for type if crispr be experimentally reveal in a baumannii aye interestingly interference recognize only the pamcc sequence whereas adaptation priming tolerate 4 pam sequence furthermore we also perform a rapid and extensive modification of the if CRISPRCas element and reveal that the role of doublenucleotide sequence mutant at the end of the repeat could be critical during both crispr interference and priming we also find strong bias for a and demonstrate that adaptation could tolerate certain sequence and size variation of the leader in a baumannii in conclusion this ipyrfibased genetic manipulation system be readily applicable and efficient for explore the genetic characteristic of a baumannii bimportanceb in this study we develop the widely applicable and efficient ipyrfibased selection and counterselection system in a baumannii for gene manipulation in most case this ipyrfi5foa genetic manipulation system be very effective and enable we to obtain markerfree mutant in a very short period of time utilizeng this system and the separate mechanism of interference andor prime adaptation we experiment reveal some recognition mechanism difference for the key DNA element of pam leader and repeat in the priming adaptation process of the if CRISPRCas system of a baumannii which provide some new and original insight for the study of the molecular mechanism of this process and lay a foundation for further study	2022 Oct	Shuqi Wu, Run Xu, Mengjiao Su, Can Gao, Yang Liu, Yujia Chen, Guangxin Luan, Xu Jia, Rui Wang	Microbiol Spectr
35610601	epidemiology and outcome associate with carbapenemresistant acinetobacter baumannii and carbapenemresistant pseudomonas aeruginosa a retrospective cohort study	Carbapenemresistant acinetobacter baumannii CRAB and carbapenemresistant pseudomonas aeruginosa CRPA be a grow threat the objective of this study be to describe CRAB and CRPA epidemiology and identify factor associate with mortality and length of stay los postculture	2022 May	Amanda Vivo, Margaret A Fitzpatrick, Katie J Suda, Makoto M Jones, Eli N Perencevich, Michael A Rubin, Swetha Ramanathan, Geneva M Wilson, Martin E Evans, Charlesnika T Evans	BMC Infect Dis
35855908	insight into mobile genetic element and the role of conjugative plasmid in transfer aminoglycoside resistance in extensively drugresistant iAcinetobacter baumanniii ab329	iAcinetobacter baumanniii be a major cause of nosocomial infection and the incidence of extensively drugresistant iA baumanniii xdrab infection have dramatically increase worldwide in this study we aim to explore the complete genome sequence of xdrab 329 st116698 oxfordPasteur which be a outbreak clone from a hospital in Thailand wholegenome sequencing wgs be perform use shortread illumina and longread pacbio sequencing and a conjugation assay of its plasmid be perform the complete genome sequence of iA baumanniii ab329 reveal a circular chromosome 3948038 bp in length with 39 gc content antibiotic resistance gene ARGs include betalactam resistance iblai suboxa51 sub iblai subadc25 sub iblai suboxa23sub iblai subtem1 Dsub aminoglycoside resistance iaph3iIa iaphi3 " ib iaphi6 id iarmiA tetracycline resistance itetiB itet R macrolide resistance imphiE imsriE and efflux pump be find mobile genetic element mge analysis of iA baumanniii ab329 reveal two plasmid pab329a and pab329 b three prophage 19 genomic island GIs and 33 insertion sequence ISs pab329a be a small circular plasmid of 8731 bp and pab329b be a megaplasmid of 82120 bp iaphi3via be detect in pab329 b and a major facilitator superfamily MFS transporter be detect in the prophage acinetobacter baumanniii resistance island 4 abar4 harbor tetracycline and aminoglycoside resistance be detect in the genome of iA baumanniii ab329 pab329 b which belong to reptype GR6 plasmid lineage ln1 be a conjugative plasmid with the ability to transfer a aminoglycoside resistance gene to sodium azideresistant iA baumanniii this study provide insight into the feature of the mge of xdrabii which be the main reservoir and source of dissemination of ARGs	2022	Supat Khongfak, Rapee Thummeepak, Udomluk Leungtongkam, Kannipa Tasanapak, Aunchalee Thanwisai, Sutthirat Sitthisak	PeerJ
35736241	bactericidal synergism between phage yc06 and antibiotic a combination Strategy to target multidrugresistant acinetobacter baumannii iin Vitroi and iin Vivoi	Phageantibiotic combination pac therapy be a potential new alternative to treat infection cause by pathogenic bacterium particularly that cause by antibioticresistant bacterium in the present study phage yc06 against highly multidrugresistant acinetobacter baumannii 4015 be isolate identify and characterize compare with antibiotic alone the timekill experiment iin vitroi show that yc06 and antibiotic mixture that include the chloramphenicol imipenem and cefotaxime combination could produce phageantibiotic synergy pas which reduce the ultimate effective concentration of antibiotic no phageresistant bacterium have be isolate during the whole timekill experiment iin vitroi of note pas be dose dependent require a moderate phage dose to achieve maximum pas effect in addition pas could effectively inhibit biofilm formation and remove mature biofilm iin vitroi furthermore pas between the combination of yc06 and antibiotic mixture iin vivoi be validate use a zebrafish infection model overall the result of this study demonstrate that pac could be a viable strategy to treat infection cause by highlevel multidrugresistant acinetobacter baumannii or other drugresistant bacterium through switch to other type of phage and antibiotic mixture bimportanceb the treatment of multidrugresistant bacterial infection be a urgent clinical problem the combination of bacteriophage and antibiotic could produce synergistic bactericidal effect which could reduce the emergence of antibiotic resistance and antibiotic consumption in antibioticsensitive bacterium restore efficacy to antibiotic in antibioticresistant bacterium and prevent the occurrence of phageresistant bacterium Phageantibiotic combination pac might be a potential new alternative for clinical treatment of multidrugresistant bacterial infection	2022 Aug	Jun Luo, Libo Xie, Min Liu, Qianyuan Li, Peng Wang, Chunhua Luo	Microbiol Spectr
36534485	reservoir of CarbapenemResistant iAcinetobacter baumanniii in the Hospital environment and Colonization pressure a surveillanceBased Study in Indian intensive Care unit	the endemicity of iAcinetobacter baumanniii in intensive care unit icus be a serious concern we study the reservoir of iA baumanniii in the icu and they effect on colonization pressure and transmission a prospective surveillance 6 month be conduct screening culture rectal and axillary swab be collect within 48 hour admission and in 120 hour Surveillance culture from patient surroundings health care worker hcw and hospital sewage be collect iA baumanniii be identify by phenotypic and genotypic method carbapenem resistance and insertion sequence element be detect type be do by repetitive extragenic palindromicpolymerase chain reaction and multilocus sequence type Colonization pressure be calculate and compare with environment colonizer of the 87 patient 2183 19 be colonize with iA baumanniii 7368 1419 be import and 2631 519 acquire carrier axilla be the commonest site from the environment 15 bed rail 3333 515 and suction tube 2666 415 be the common site hcw show 75 340 carriage carbapenem resistance with iblaisuboxa51sub iblaisuboxa23sub and ISiAba1i be 9189 3437 strong correlation between colonization pressure and environmental colonizer be see irisup2 sup 0719 ipi 0032 carbapenem and polymyxin B be ipi ≤ 005 significant exposure sequence type 623 be the predominant cluster with isolate from carrier hcw and environment Colonization pressure of carbapenemresistant iA baumanniii depend on they presence in the hospital hand of hcw be a important vehicle for transmission infection control measure should consider reduce the environmental reservoir	2022 Dec	Swati Sharma, Arghya Das, Rahul Garg, Sangita Pramanik, Pooja Marndi, Ravindra Singh, Tuhina Banerjee, Ghanshyam Yadav, Ashok Kumar	Microb Drug Resist
36534183	investigation of the synergistic effect of glycolipid biosurfactant produce by shewanella alga with some antibiotic against planktonic and biofilm form of mrsa and antibiotic resistant acinetobacter baumannii	to tackle antibiotic resistance and the appearance of multidrugresistant MDR strain one current approach be the combine use of biosurfactant with antibiotic to increase they efficacy the antimicrobial ability of biosurfactant produce by shewanella alga strain b12 be examine use the agar well diffusion method versus some resistant gramnegative and grampositive bacterium the minimum Inhibitory Concentration mic of glycolipidbiosurfact of b12 gbb12 be perform by the broth dilution technique the inhibition of biofilm formation disruption of biofilm and reduce the population of viable cell in biofilm be evaluate by the microtiter plate method finally scanning electron microscopy SEM analysis be use to confirm the disruption of the cell membrane by gbb12 in all experiment when gbb12 be add to antibiotic except amikacin the antimicrobial activity be increase the synergistic effect of gbb12 and antibiotic ciprofloxacin and gentamycin against methicillinresistant Staphylococcus aureus mrsa and acinetobacter baumannii be confirm by the fractional Inhibitory Concentration index FICI gbb12 gentamycin mixture almost completely inhibit the formation of a baumannii biofilm reach 998 inhibition also the rate of mrsa biofilm inhibition treat with gbb12 ciprofloxacin mixture be find to be 994 biosurfactantantibiotic mixture could be adequate replacement for traditional antibiotic in the near future this study show the potential of gbb12 as antimicrobial and antibiofilm agent	2022 Dec	Nazanin Amirinejad, Poorandokht Shahriary, Mehdi Hassanshahian	World J Microbiol Biotechnol
36139979	in vitro and in Vivo antimicrobial activity of the Novel peptide omn6 against multidrugresistant iAcinetobacter baumanniii	the rapid worldwide spread of antimicrobial resistance highlight the significant need for the development of innovative treatment to fight multidrugresistant bacterium this study describe the potent antimicrobial activity of the novel peptide omn6 against a wide array of drugresistant iAcinetobacter baumanniii clinical isolate omn6 prevent the growth of all test isolate regardless of any preexisting resistance mechanism moreover in vitro serialpassagergag study demonstrate that no resistance develop against omn6 importantly omn6 be highly efficacious in treat animal model of lung and blood infection cause by multidrugresistant iA baumanniii taken together this result point to omn6 as a novel antimicrobial agent with the potential to treat lifethreatening infection cause by multidrugresistant iA baumanniii avoid resistance	2022 Sep	Janna Michaeli, Shira Mandel, Shelly Maximov, Jonathan Zazoun, Paola Savoia, Nimmi Kothari, Thomas Valmont, Livia Ferrari, Leonard R Duncan, Stephen Hawser, Moshe Cohen-Kutner, Niv Bachnoff	Antibiotics (Basel)
35985003	multilocus sequence type of CarbapenemResistant iAcinetobacter baumanniii isolate harboring iblaisuboxa23sub and iblaisubimpsub in cattle from punjab Pakistan	iAcinetobacter baumanniii be a notorious bacterial pathogen that can cause a array of nosocomial infection in clinical setting however the datum from the veterinary setting be limited and especially in Pakistan no such study be conduct so far to investigate the prevalence antimicrobial resistance and distribution of specific sequence type of iA baumanniii in cattle a total of 1960 sample be collect from cattle over 18 month from punjab Pakistan the isolate obtain be identify use the api2une system and confirm through pcr the isolate iA baumanniii isolate be further screen for antimicrobial susceptibility and the presence of resistance gene multilocus sequence type be carry out to characterize the carbapenemresistant iA baumanniii CRAB isolate result reveal a overall prevalence of iA baumanniii at 331 651960 with a high prevalence of 738 54731 in dairy cattle compare to beef cattle at 441 11249 among 65 iA baumanniii isolate 277 1865 be CRAB all CRAB isolate harbor class D βlactamase gene iblaisuboxa23sub and iblaisuboxa51 sub whereas 944 1718 CRAB isolate carry class B βlactamase gene iblaisubimpsub and only one isolate have iblaisubndm1 sub gene the commonly find sequence type for CRAB isolate be ST2 and st642 corresponding to 10 and 05 isolate respectively the presence of CRAB in cattle indicate a alarming situation that necessitate a urgent and efficient surveillance system to limit the transmission of CRAB among the cattle population and its possible transmission to human and the environment	2022 Oct	Minhas Alam, Muhammad Hidayat Rasool, Iahtasham Khan, Mohsin Khurshid, Bilal Aslam	Microb Drug Resist
35736874	alert germ infection chest Xray and ct finding in hospitalized patient affect by multidrugresistant iAcinetobacter baumanniii Pneumonia	acinetobacter baumannii ab be a opportunistic gramnegative pathogen intrinsically resistant to many antimicrobial the aim of this retrospective study be to describe the imaging feature on chest Xray CXR and compute tomography ct scan in hospitalize patient with multidrugresistant MDR ab pneumonia CXR and ct finding be grade on a threepoint scale 1 represent normal attenuation 2 represent groundglass attenuation and 3 represent consolidation for each lung zone with a total of six lung zone in each patient the extent of disease be grade use a fivepoint scale 0 no involvement 1 involve 25 of the zone 2 25−50 3 50−75 and 4 involve 75 of the zone point from all zone be add for a final total cumulative score range from 0 to 72 among 94 patient who test positive for MDR ab and underwent CXR male 529 female 471 mean age 642 year range 1−90 year 68 patient underwent both CXR and chest ct examination the percentage of patient with a positive ct score be significantly high than that obtain on CXR 6765 3594 pvalue 000258 ct score 2188 ± 1577 be significantly pvalue 00014 high than CXR score 1506 ± 1829 CXR and ct reveal prevalent bilateral abnormal finding mainly locate in the inferior and middle zone of the lung they primarily consist of peripheral groundglass opacity and consolidation which predominate on CXR and ct respectively	2022 Jun	Raffaella Capasso, Antonio Pinto, Nicola Serra, Umberto Atripaldi, Adele Corcione, Giorgio Bocchini, Salvatore Guarino, Roberta Lieto, Gaetano Rea, Giacomo Sica, Tullio Valente	Tomography
37192494	tigecyclinecontaining regimen and multi DrugResistant iAcinetobacter baumanniii a systematic review and metaanalysis	biIntroductionib the use of tigecycline tg for the treatment of iAcinetobacter baumanniii be controversial in this systematic review and metaanalysis we aim to good explore the safety and efficacy of tg for the treatment of multi drugresistant MDR acinetobacter bimethodsib we search PubMedMEDLINE scopus cochrane Central and web of Science to identify study report the clinical and microbiological efficacy and safety of regimen contain tg in patient with drug susceptibility testing dsTconfirmed MDR iA baumanniii publish until December 30 2022 Observational study be include if they report clinical and microbiological efficacy of tgbased regimen the newcastleptawa scale nos and Joana Briggs Institute JBI critical appraisal tool be use to assess the quality of include study biresultsib there be 30 observational study of which 19 study be cohort and 11 study be single group study pooled clinical response and failure rate in the tgcontaining regimen group be 581 95 confidence interval CI 492666 and 402 95 CI 311500 respectively the pool microbiological response rate be 321 95 CI 198475 and the pool allcause mortality rate be 411 95 CI 341484 pooled clinical response and failure rate in the colistinbased regimen group be 527 427625 and 431 331538 respectively the pool microbiological response rate be 429 162745 and the pool allcause mortality rate be 343 261435 biconclusionsib accord to we result the efficacy of the tgbased regimen be the same as other antibiotic however we study show a high mortality rate and a low rate of microbiological eradication for tg compare with colistinbased regimen therefore we study do not recommend it for the treatment of MDR iA baumanniii however this be a prevalence metaanalysis of observational study and for good conclusion experimental study be require	2023 May	Fatemeh Sodeifian, Moein Zangiabadian, Erfan Arabpour, Naghmeh Kian, Fartous Yazarlou, Mehdi Goudarzi, Rosella Centis, Zahra Sadat Seghatoleslami, Mahdis Chahar Kameh, Bardia Danaei, Hossein Goudarzi, Mohammad Javad Nasiri, Giovanni Sotgiu, Giovanni Battista Migliori	Microb Drug Resist
37063277	effect of traditional Chinese medicine monomer interfere with quorumsensing on virulence factor of extensively drugresistant iAcinetobacter baumanniii	the antimicrobial resistance of iAcinetobacter baumanniii iA baumanniii clinical isolate have emerge as a great threat to public health quorum sensing qs be one of the resistance mechanism for drugresistant iA baumanniii interfering with qs be a promise strategy to combat infection cause by drugresistant bacterium this study explore the qs inhibition ability of thirtyfour traditional Chinese medicine monomer tcmm and assess the effect of qs inhibitor qsis on the virulence factor of twelve extensively drugresistant iA baumanniii xdrab strain nine traditional Chinese medicine monomer such as caffeic acid cinnamic acid and myricetin be find to be able to inhibit the bacterial qs then at 18 of the minimal inhibitory concentration we find that this qsis inhibit extensively drugresistant iA baumanniii adhesion and biofilm formation and downregulated the expression level of virulenceassociated gene iabaI abaR csuE pgaai and ibapi in conclusion nine traditional Chinese medicine monomer have qs inhibitory activity and may downregulate qs gene to interfere with the qs system which could inhibit the expression of extensively drugresistant iA baumanniii virulence factor this result suggest that traditional Chinese medicine monomer could develop as novel antivirulence compound to control extensively drugresistant iA baumanniii infection	2023	Li Zeng, Fei Lin, Baodong Ling	Front Pharmacol
36992253	use a aluminum hydroxidechitosan Matrix increase the vaccine potential and immune response of mice against multidrugresistant iAcinetobacter baumanniii	iAcinetobacter baumanniii be a gramnegative immobile aerobic nosocomial opportunistic coccobacillus that cause pneumonia septicemia and urinary tract infection in immunosuppressed patient there be no commercially available alternative antimicrobial and multidrug resistance be a urgent concern that require emergency measure and new therapeutic strategy this study evaluate a multidrugresistant iA baumanniii wholecell vaccine inactivate and adsorbed on a aluminum hydroxidechitosan mAhC matrix in a iA baumanniii sepsis model in immunosuppressed mouse by cyclophosphamide cy cytreated mouse be divide into immunize nonimmunize and adjuvantinoculated group three vaccine dose be give at 0d 14D and 28d follow by a lethal dose of 40 × 10 sup8 sup CFUmL of iA baumanniii immunized cytreated mouse underwent a significant humoral response with the high IgG level and a high survival rate 85 this differ from the nonimmunize cytreated mouse none of whom survive ipi 0001 and from the adjuvant group with 45 survival ipi 005 histological datum reveal the evident expansion of white spleen pulp from immunize cytreated mouse whereas in nonimmunize and adjuvant cytreated mouse there be more significant organ tissue damage we result confirm the proofofconcept of the immune response and vaccine protection in a sepsis model in cytreated mouse contribute to the advancement of new alternative for protection against iA baumanniii infection	2023 Mar	Túllio T Deusdará, Mellanie K C Félix, Helio de S Brito, Edson W S Cangussu, Wellington de S Moura, Benedito Albuquerque, Marcos G Silva, Gil R Dos Santos, Paula B de Morais, Elizangela F da Silva, Yury O Chaves, Luis Andre M Mariúba, Paulo A Nogueira, Spartaco Astolfi-Filho, Enedina N Assunção, Sabrina Epiphanio, Claudio R F Marinho, Igor V Brandi, Kelvinson F Viana, Eugenio E Oliveira, Alex Sander R Cangussu	Vaccines (Basel)
36833021	the Impact of multidrugresistant iAcinetobacter baumanniii infection in critically Ill patient with or without covid19 infection	this be a singlecenter retrospective cohort study aim to evaluate the clinical outcome of multidrug resistance in iAcinetobacter baumanniii infection mdrab in intensive care unit icu patient with or without a covid19 infection and risk factor for blood stream infection a total of 170 patient with mdrab be enrol in the study of this 118 70 patient be admit to the icu due to a covid19 infection Comparing the covid19 and noncovid19 group the use of mechanical ventilation 9831 versus 7692 ipi 0000 the presence of septic shock 9661 versus 8269 ipi 0002 and the use of steroid 9915 versus 7115 ipi 0000 and tocilizumab therapy 3305 versus 0 ipi 0000 be more prevalent and statistically more significant in patient with covid19 infection the average length of the icu stay 212 versus 2833 ipi 00042 be significantly low in patient with covid19 infection Survival rate be 2119 for the covid19 group and 2885 for noncovid19 group with a ipivalue 00361 covid19 status be associate with significantly high hazard of death hr 179 CI 95 102315 ipi 0043 High sofab 1507 versus 1207 ipi 00032 and the placement of a intravascular device 9706 versus 8971 ipi 0046 be significantly associate with the development of a bloodstream infection we study have show that critically ill patient with a mdrab infection who be admit due to a covid19 infection have a high hazard for death compare to noncovid19 infect patient	2023 Feb	Thamer A Alenazi, Maryam S Bin Shaman, Durria M Suliman, Turkiah A Alanazi, Shoroq M Altawalbeh, Hanan Alshareef, Doha I Lahreche, Sayer Al-Azzam, Mohammad Araydah, Reema Karasneh, Faycal Rebahi, Marwah H Alharbi, Mamoon A Aldeyab	Healthcare (Basel)
36599842	the prevalence presentation and outcome of colistin susceptibleonly acinetobacter baumanniiassociated pneumonia in intensive care unit a multicenter observational study	hospitalacquire pneumonia hap and ventilatorassociated pneumonia vap cause by carbapenemresistant acinetobacter baumannii CRAB be both associate with significant morbidity and mortality in daily clinical practice as well as in a critical care set it be unclear whether colistin susceptibleonly acinetobacter baumannii cso ab be a unique phenotype separate from or a subset of crabassociated pneumonia the aim of this study be to investigate the prevalence of cso ab pneumonia and compare the presentation and outcome between cso ab and crabassociated pneumonia in critically ill patient this multicenter retrospective cohort study initially recruit 955 patient with crgnb pneumonia after exclusion 575 patient leave who be icuadmitt and have CRAB nosocomial pneumonia remain among they 79 patient have cso ab pneumonia classify as the cso ab group the other 496 patient be classify as the CRAB group we compare demographic characteristic disease severity and treatment outcome between the two group the prevalence of cso ab among all case of CRAB pneumonia be 1374 79575 the cso ab and CRAB group have similar demographic characteristic and disease severity at initial presentation the inhospital mortality rate be 456 and 464 for cso ab and CRAB group respectively p 0991 the cso ab group have significantly good clinical outcome at day 7 658 versus 524 p 0036 but long length of icu stay 27 day versus 19 day p 0043 compare to the CRAB group however other treatment outcome include clinical outcome at day 14 and 28 mortality microbiological eradication ventilator weaning and newly onset dialysis be similar in conclusion cso ab account for 1374 of all case of CRAB pneumonia and the clinical presentation and treatment outcome of cso ab and CRAB pneumonia be similar	2023 Jan	Sheng-Huei Wang, Kuang-Yao Yang, Chau-Chyun Sheu, Yu-Chao Lin, Ming-Cheng Chan, Jia-Yih Feng, Chia-Min Chen, Chih-Yu Chen, Zhe-Rong Zheng, Yu-Ching Chou, Chung-Kan Peng	Sci Rep
36105785	investigation of effect of the colistin loading dosage on the clinical microbiological and Laboratory result in iAcinetobacter baumanniii ventilator Associated Pneumonia Pneumonia	adult patient administer colistin with and without LD for MDR iAcinetobacter baumanniii VAPpneumonia in intensive care unit icus in a tertiary teaching hospital between 1 January 2018 and 31 December 2019 be include in this retrospective cohort study the primary endpoint be a assessment of clinical and microbiological success between treatment group secondary endpoint include 14 and 30 day mortality and development of nephrotoxicity	2022	Ayşegül Seremet Keski N, Derya Seyman, Kübra Demir Önder, Filiz Kizilateş, Olgun Keski N	Int J Clin Pract
35910596	replacement of the dominant st191 clone by st369 among CarbapenemResistant iAcinetobacter baumanniii bloodstream isolate at a tertiary Care Hospital in South Korea	the clonal dissemination of carbapenemresistant iAcinetobacter baumanniii CRAB bacteremia be a serious clinical problem worldwide however the factor related to the emergence and replacement of predominant CRAB clone in nosocomial setting be unclear by multilocus sequence type mlst we evaluate the genetic relatedness of CRAB bloodstream isolate at a tertiary care hospital over a 35 year period and investigate the clinical and microbiologic characteristic of the predominant sequence type STs one hundred and seventynine CRAB bloodstream isolate be collect from June 2016 to December 2019 and they mlst accord to Oxford scheme and clinical datum be obtain the predominant STs be assess for iin vitroi growth competitive growth and virulence in a mouse model of intraperitoneal infection two dominant clonesST369 ini 98 and st191 ini 48 belong to international clone 2 ic2 be recover from patient admit to intensive care unit icus or ward st191 predominate 61 2743 from June 2016 to July 2017 whereas st369 72 98136 which be first isolate from a patient admit to the emergency room replace st191 15 21136 after August 2017 in a multivariate analysis leukopenia or 362 95 CI 104126 ipi 004 and st191 or 369 or 532 95 CI 1252265 ipi 002 be independent risk factor for 7day mortality compare with nonST369 st369 be associate with a short time to bacteremia from icu admission 7 versus 11 day ipi 001 pneumonia as a origin of bacteremia 67 versus 52 ipi 004 leukopenia 28 versus 11 ipi 001 and a low 7day survival rate 41 versus 70 ipi 001 iin vitroi ST 369 isolate have significantly high growth rate and enhance competitive growth compare to st191 finally st369 have great virulence and a high mortality rate than other STs in a mouse infection model we report almostcomplete replacement of the predominant st191 clone by st369 within a 8 month period at we hospital st369 have a high incidence density rate of CRAB bacteremia a short time to bacteremia after icu admission and a high early mortality rate which may be in part explain by its fast competitive growth rate and high virulence than st191	2022	Seong Eun Kim, Su-Mi Choi, Yohan Yu, Sung Un Shin, Tae Hoon Oh, Seung-Ji Kang, Kyung-Hwa Park, Jong Hee Shin, Uh Jin Kim, Sook In Jung	Front Microbiol
35844614	iAcinetobacter baumanniii Outer membrane protein a induce pulmonary epithelial barrier dysfunction and bacterial translocation through the tlr2iqgap1 axis	pulmonary epithelial barrier dysfunction be a critical pathophysiological process in pneumonia and associate invasive infection such as that cause by iAcinetobacter baumanniii however the mechanism underlying iA baumanniiinduced pulmonary epithelial barrier dysfunction and bacterial translocation remain unclear in this study lung of mouse and a549 human epithelial cell monolayer be challenge with the iA baumanniii wildtype strain and a outer membrane protein a iompAi deletion strain in addition epithelial cell in culture be treat with purify OmpA protein or transfect with a eukaryotic expression vector encoding iompAi pcmviompaya bacterial translocation across cell monolayer and intrapulmonary burden be measure barrier function be evaluate iin vivoi and iin vitroi cell migration ability be determine the specific inhibitor c29 and jsh23 be use to suppress the activity of tolllike receptor 2 tlr2 and of nfκb respectively iqgtPaseactivating protein 1 iqgap1 small interfere RNA be use to knock down endogenous iqgap1 expression in this work we show that OmpA from iA baumanniii increase the production of proinflammatory cytokine remodel the cytoskeleton and internalized intercellular adheren junction ajs this change eventually induce pulmonary epithelial barrier dysfunction to promote bacterial translocation iqgap1 target small interfere RNA and chemical inhibition of tlr2 or nfκb prevent high permeability of the pulmonary epithelial barrier tlr2ntly signal be involve in ompainduced inflammation iqgap1 mediate ompainduced open of the pulmonary epithelial barrier iviai cytoskeleton dynamic remodeling and cellular redistribution of the major aj protein ecadherin this observation indicate that iA baumanniii use OmpA to overcome epithelial defence and cross the pulmonary epithelial barrier	2022	Wang Zhang, Hua Zhou, Yan Jiang, Jintao He, Yue Yao, Jianfeng Wang, Xiaochen Liu, Sebastian Leptihn, Xiaoting Hua, Yunsong Yu	Front Immunol
36069988	Pharmacokinetic study of highdose oral rifampicin in critically Ill patient with multidrugresistant acinetobacter baumannii infection	although rifampicin RIF be use as a synergistic agent for multidrugresistant acinetobacter baumannii mdrab infection the optimal pharmacokinetic PK index of this medication have not be study in the intensive care unit icu setting this study aim to evaluate the PK of high dose oral RIF follow fasting versus feed condition in term of achieve the therapeutic goal in critically ill patient with mdrab infection	2022 Dec	Hossein Karballaei-Mirzahosseini, Romina Kaveh-Ahangaran, Bita Shahrami, Mohammad Reza Rouini, Atabak Najafi, Arezoo Ahmadi, Sima Sadrai, Amirmahdi Mojtahedzadeh, Farhad Najmeddin, Mojtaba Mojtahedzadeh	Daru
35834022	investigating biofilm formation and antibiofilm activity use Real time cell Analysis method in carbapenem resistant acinetobacter baumannii strain	acinetobacter baumannii be a significant nosocomial pathogen with its biofilm form capacity play a important role in its pathogenicity the fast and reliable detection of the biofilm formation and measurement of antibiofilm activity of various molecule be critical for combating a baumannii infection in this study we aim to detect biofilm formation by real time cell analysis rtca method in clinical a baumannii isolate and to investigate antibiofilm activity of tigecycline tgc nacetylcysteine nac and acetylsalicylic acid asa the effect of the test drug on expression of biofilmrelated gene bap and csuE in clinical a baumannii strain be also analyze by real time quantitative reverse transcription polymerase chain reaction rtqpcr biofilm form capacity for strong and weak biofilm producer a baumannii strain be detect within 10 h by rtca method p 005 we also observe that subminimum inhibitory concentration of nac tgc and asa tgc combination could significantly reduce biofilm formation and expression of biofilmrelated gene in a baumanii strain no statistically significant activity of the test drug be detect against mature biofilm of the bacterial strain with the rtca method this result suggest that reproducible result on biofilm production capacity of a baumannii strain and antibiofilm activity of various compound can be obtain in a short time use rtca method therefore rtca method seem to be a beneficial technique for biofilm detection and can help in combating a baumannii infection by give health provider the opportunity of implement antibiofilm treatment strategy in a timely manner	2022 Jul	Aybala Temel, Bayrı Erac	Curr Microbiol
35795185	predictor of occurrence and 30 Day mortality for coinfection of CarbapenemResistant iKlebsiella pneumoniae and CarbapenemResistant iAcinetobacter baumanniii	the phenomenon of coinfection with multiple carbapenemresistant bacterium be grow which pose a great challenge for infection control and treatment this study aim to analyze predictor of occurrence and 30 day mortality for carbapenemresistant iKlebsiella pneumoniae and carbapenemresistant iAcinetobacter baumanniii coinfection	2022	Dongmei Lv, Yan Zuo, Yuerong Wang, Zhongxin Wang, Yuanhong Xu	Front Cell Infect Microbiol
36889382	complete genome sequence of the multidrugresistant clinical isolate acinetobacter baumannii kbn10p05679 insight into antimicrobial resistance genotype and potential virulence trait	acinetobacter baumannii a nosocomial pathogen exhibit multidrug resistance and be a major concern worldwide we therefore aim to evaluate the genomic feature of the clinical strain a baumannii kbn10p05679 to elucidate its antibiotic resistance mechanism and virulence factor	2023 Mar	Md Maidul Islam, Jeongah Kim, Kyeongmin Kim, Dooyoung Kim, Samia Akter, Seunghyeok Bang, Shukho Kim, Jungmin Kim, Je Chul Lee, Minsang Shin	J Glob Antimicrob Resist
36830307	emergence and Evolution of oxa23 produce st46subpassubst462suboxfsubkl28ocl1 CarbapenemResistant iAcinetobacter baumanniii mediated by a Novel isiaba1ibased tni7534i transposon	Carbapenemresistant iAcinetobacter baumanniii CRAB isolate of global clone 1 gc1 and global clone 2 gc2 have be widely report nevertheless nonGC1 and nonGC2 CRAB strain have be study less in particular no report concern sequence type 46 st46subpassub CRAB strain have be describe thus far in this work the genomic feature and possible evolution mechanism of st46subpassub oxa23 produce CRAB isolate from clinical specimen be report for the first time antimicrobial susceptibility testing of three st46subpassub strain reveal identical resistance profile resistance to imipenem meropenem ciprofloxacin and the combination of cefoperazonesulbactam at a 21 ratio they be find to belong to st46subpassub and st462suboxfsub with capsular polysaccharide 28 KL28 and lipooligosaccharide 1 ocl1 respectively wholegenome sequencing wgs reveal that all contain one copy of chromosomal iblaisuboxa23sub which be locate in a novel isiaba1ibased tni7534i composite transposon in particular another copy of the tni7534i composite transposon be identify in a hgz103 type plasmid with 9 bp target site duplication TSD acaacatgc in the iA baumanniii zhou strain as the strain originate from two neighbor intensive care unit icus st46subpassub oxa23 produce CRAB strain may have evolve via transposition event or a pidifi module base on the genbank database st46subpassub strain be collect from various source however most be collect in Hangzhou China from 2014 to 2021 pangenome analysis reveal 3276 core gene 0 softcore gene 768 shell gene and 443 cloud gene share among all st46subpassub strain in conclusion the emergence of st46subpassub CRAB strain might present a new threat to healthcare setting therefore effective surveillance be require to prevent further dissemination	2023 Feb	Haiyang Liu, Xiaochen Liu, Jintao He, Linghong Zhang, Feng Zhao, Zhihui Zhou, Xiaoting Hua, Yunsong Yu	Antibiotics (Basel)
36814503	Risk factor of clonally related multi and extensively DrugResistant iAcinetobacter baumanniii in severely Ill covid19 patient	the secondary infection of multi and extensively drugresistant iAcinetobacter baumanniii in severely ill covid19 individual be usually associate with extend hospitalisation and a high mortality rate the current study aim to assess the exact incidence rate of iA baumanniii coinfection in severely ill covid19 patient admit to intensive care unit icus to identify the possible mechanism of iA baumanniii transfer to covid19 patient and to find out they resistance rate against different antibiotic	2023	Meqdad Saleh Ahmed, Zirak Faqe Ahmed Abdulrahman, Zanan Mohammed Ameen Taha	Can J Infect Dis Med Microbiol
36677463	CarbapenemResistant iAcinetobacter baumanniii biofilmassociated gene BiofilmEradication potential of disinfectant and biofilminhibitory Effect of selenium nanoparticle	this study aim to investigate the biofilmproduction ability of carbapenemresistant acinetobacter baumannii CRAB the biofilmeradication potential of 70 ethanol and 05 sodium hypochlorite the effect of selenium nanoparticle senp against planktonic and biofilmembedded CRAB and the relationship between biofilm production and bacterial genotype a total of 111 CRAB isolate be test for antimicrobial susceptibility biofilm formation presence of the gene encoding carbapenemase and biofilmassociated virulence factor the antibiofilm effect of disinfectant and senp against CRAB isolate be also test the vast majority of the test isolate be biofilm producer 919 the bap ompA and csuE gene be find in 57 70 and 76 of the CRAB isolate with the csuE be significantly more common among biofilm producer 786 compare to nonbiofilmproducing CRAB 25 the test disinfectant show a good antibiofilm effect on moderate and strong biofilm producer than on weak producer p 001 the senp show a inhibitory effect against all test planktonic mic range 000015 to 125 mgmL and biofilmembedded CRAB with a minimum biofilm inhibitory concentration of less than 015 mgmL for 90 of biofilm producer in conclusion senp might be use as promise therapeutic and medical device coating agent thus serve as a alternative approach for the prevention of biofilmrelated infection	2023 Jan	Aleksandra Smitran, Bojana Lukovic, LJiljana Bozic, Dijana Jelic, Milos Jovicevic, Jovana Kabic, Dusan Kekic, Jovana Ranin, Natasa Opavski, Ina Gajic	Microorganisms
36649500	Clinical epidemiology treatment and prognostic factor of hospitalacquire Pneumonia caused by the extensively DrugResistant acinetobacter baumannii	extensively drugresistant acinetobacter baumannii xdrab can acquire drug resistance gene which be rapidly clone and transmit lead to worldwide spread and pose significant treatment challenge this study aim to clarify effective treatment method during xdrab infection and factor affect patient prognosis	2023 Jan	Changquan Fang, Limin Xu, Yujun Li, Shuquan Wei, Zhuxiang Zhao, Ziwen Zhao	Clin Lab
36439789	microbiological characteristic and risk factor on prognosis associate with iAcinetobacter baumanniii bacteremia in general hospital a singlecenter retrospective study	iAcinetobacter baumanniii be one of the most important pathogenic bacterium cause nosocomial infection and have a high mortality rate Assessment of the microbiological characteristic and risk factor on prognosis associate with iAbaumanniii be essential in this study we aim to investigate the clinical characteristic and prognostic risk factor of patient with iAbaumanniii bacteremia	2022	Zhiyong Wei, Shuai Zhou, Ying Zhang, Lin Zheng, Lina Zhao, Yan Cui, Keliang Xie	Front Microbiol
36009955	iAcinetobacter baumanniii infectionrelated mortality in hospitalized patient Risk factor and potential target for Clinical and antimicrobial stewardship intervention	due to resistance and scarcity of treatment option nosocomial acinetobacter baumannii infection be associate with significant fatality rate we investigate the factor contribute to infectionrelated death to develop tailor stewardship intervention that could reduce this high mortality rate we review the medical record of adult inpatient with a baumannii infection over two year patient demographic and clinical datum be collect and statistically analyze the study include 321 patient with positive a baumannii microbiological culture with respiratory infection accounting for 586 soft tissue 293 bacteremia 86 urine 21 and other 14 the study population 's median IQR age be 626 389−949 year and hospital stay be 20 95−40 day statistical analysis reveal that various risk factor contribute significantly to high inhospital allcause mortality 44 as well as 14day and 28day mortality rate death increase by a factor of 104 with every additional year of age p 0000 admission to the critical care unit p 0000 or 286 and patient admit with a infectious diagnosis have nearly three time the mortality rate as that admit with other diagnosis p 0000 or 312 male gender p 0001 or 214 any comorbid condition p 0000 or 529 prolong hospitalization 7 day p 0023 or 198 and hospital acquisition of infection p 0027 or 168 be among the most significant predictor of mortality all variable be investigate for they impact on allcause 14day and 28day mortality rate improving multidisciplinary infection control practice regular disinfection of patient care equipment and optimal intubation practice that avoid unnecessary intubation be necessary intervention to reduce infectionrelated mortality rate good antibiotic selection and deescalation short hospital stay whenever possible prompt medical stabilization of comorbid condition and few unnecessary admission to critical care unit will all lead to improve outcome	2022 Aug	Diaa Alrahmany, Ahmed F Omar, Aisha Alreesi, Gehan Harb, Islam M Ghazi	Antibiotics (Basel)
35644906	fourier transform infrared spectroscopy as a new tool for surveillance in local stewardship antimicrobial program a retrospective study in a nosocomial acinetobacter baumannii outbreak	the aim of we study be to determine the discriminatory power of the fourier transform infrared spectroscopy ftir use multilocus sequence type mlst and pulsedfield gel electrophoresis pfge as molecular type reference the study include seventeen isolate oxa23 and oxa58 produce acinetobacter baumannii previously recover from clinical specimen during the period May 2010 April 2011 molecular type be perform by pfge and mlst the specimen be analyze in quadruplicate use the ir biotyper bruker GmbH Bremen Germany for each isolate the average of the spectra be use for the analysis of the datum Comparing ftir datum with mlst the result obtain by ir biotyper be very consistent with that from mlst since the software be able to differentiate the three ST assign to the strain Comparing ftir datum with pfge most result could be confirm as ir biotyper clearly differentiated ST80 SLV oxa58 produce a baumannii pulsotype 3 from the rest of strain of oxa58 produce a baumannii pulsotype 1 and 2 all the oxa23 produce a baumannii isolate pulsotype 4 group together by ftir ftir prove to be a effective tool to investigate local epidemiology and can achieve the same typeability and discriminatory power as genomebase method	2022 Sep	Inmaculada Guerrero-Lozano, Fátima Galán-Sánchez, Manuel Rodríguez-Iglesias	Braz J Microbiol
37104206	therapeutic prospection of Animal venomsderived antimicrobial peptide against infection by multidrugresistant iAcinetobacter baumanniii a systematic review of preclinical Study	infection cause by multidrugresistant iAcinetobacter baumanniii mdrab have become a public health emergency due to the small therapeutic arsenal available to treat this infection health agency have highlight the importance of develop new antimicrobial against mdrab in this context antimicrobial peptide amp stand out and animal venom be a rich source of this compound here we aim to summarize the current knowledge on the use of animal venomderive amp in the treatment of mdrab infection in vivo a systematic review be perform accord to the preferr report items for systematic review and metaAnalys guideline the eight study include in this review identify the antibacterial activity of eleven different amp against mdrab most of the study amp originate from arthropod venom in addition all amp be positively charge and rich in lysine residue in vivo assay show that the use of this compound reduce mdrabinduced lethality and bacterial load in invasive bacteremia and pneumonia and superficial wound infection model moreover animal venomderive amp have pleiotropic effect such as prohealing antiinflammatory and antioxidant activity that help treat infection Animal venomderive amp be a potential source of prototype molecule for the development of new therapeutic agent against mdrab	2023 Apr	William Gustavo Lima, Maria Elena de Lima	Toxins (Basel)
36801627	Impact of septic episode cause by acinetobacter baumannii Klebsiella pneumoniae and pseudomonas aeruginosa in a tertiary hospital clinical and economic consideration in year 20182020	to evaluate incidence therapy and antibiotic resistance trend in septic episode cause by three multidrug resistant bacterium in a tertiary hospital by also estimating they economic impact	2023 Apr	Jacopo Garlasco, Iva Beqiraj, Cesare Bolla, Elisabeth Maria Irene Marino, Cristian Zanelli, Corrado Gualco, Andrea Rocchetti, Maria Michela Gianino	J Infect Public Health
36526063	pyrogallol downregulate the expression of virulenceassociated protein in acinetobacter baumannii and show antiinfection activity by improve nonspecific immune response in zebrafish model	acinetobacter baumannii a virulent uropathogen with widespread antibiotic resistance have arisen as a critical scientific challenge necessitating the development of innovative therapeutic agent this be the first study reveal the proteomic change in a baumannii upon pyrogallol treatment for understanding the mechanism use nanolcmsmsbased quantitative proteomics and qpcr analysis the obtain result find that pyrogallol treatment dramatically downregulated the expression level of several key protein such as groel DnaK ClpB sodb kate bap csuab PgaA pgac bfar OmpA and seca in a baumannii which be involve in chaperonemiated oxidative stress response antioxidant defence system biofilm formation virulence enzyme production bacterial adhesion capsule formation and antibiotic resistance accordingly the pyrogallol dramatically enhance the lifespan of a baumanniiinfected zebrafish by inhibiting bacterial colonization demonstrate the antiinfective potential of pyrogallol against a baumannii further the histopathological result also demonstrate the disease protection efficacy of pyrogallol against the pathognomonic sign of a baumannii infection in addition the pyrogallol treatment effectively improve the immune parameter such as serum myeloperoxidase activity leukocyte respiratory burst activity and serum lysozyme activity in zebrafish against a baumannii infection base on the result the present study strongly propose pyrogallol as a promise therapeutic agent for treat a baumannii infection	2023 Jan	Gurusamy Abirami, Rajaiah Alexpandi, Sadasivan Sudhin, Ravindran Durgadevi, Prithiviraj Swasthikka Roshni, Ponnuchamy Kumar, Arumugam Veera Ravi	Int J Biol Macromol
36343485	eugenol and geraniol impede Csupilus assembly and evade multidrugresistant acinetobacter baumannii biofilm invitro and insilico evidence	acinetobacter baumannii form robust biofilm which aid protection against antimicrobial and account for adaptation in hospital setting biofilm formation by a baumannii have worsen the scenario of drug resistance therefore new strategy be require to tackle biofilmforming multidrugresistant a baumannii the present study investigate compound with antimicrobial and antibiofilm property against a baumannii different antimicrobial be select from available report initially comparative antimicrobial activity against a baumannii isolate be assess most potent antimicrobial compound be further analyze for timekill kinetic biofilm inhibition and exopolysaccharide eps reduction in they presence and absence the antibiofilm potential be also confirm with SEM analysis the relative gene expression of the csuE gene and molecular docking be carry out to investigate the molecular mechanism of mature biofilm disruption the result demonstrate eugenol and geraniol as the most potent inhibitor with mic of 608 mM and 324 mM respectively with the potential to significantly inhibit growth and eps production complete inhibition of a baumannii mature biofilm be observe with a maximum of 6089 mM and 1296 mM concentration of eugenol and geraniol respectively the SEM analysis and low expression of the csuE gene show the effectiveness of potent antibiofilm agent Insilico docking show efficient bind of eugenol and geraniol with the csuE protein of archaic pilus the finding of molecular docking concordant the assumption that this molecule may prevent the assembly of mature pilus which result in abolish biofilm in conclusion the antibiofilm virtue of eugenol and geraniol be elucidate to be use in the future to control the persistence of biofilmforming drugresistant a baumannii	2022 Dec	Monika Choudhary, Rahul Shrivastava, Jitendraa Vashistt	Biochem Biophys Res Commun
35529054	Assessment of sustained efficacy and resistance emergence under humansimulated exposure of cefiderocol against iAcinetobacter baumanniii use iin vitroi chemostat and iin vivoi murine infection model	this study evaluate the sustained kill and potential for resistance development of iAcinetobacter baumanniii expose to humansimulated exposure of cefiderocol over 72 h in iin vitroi and iin vivoi infection model	2022 Jun	Christian M Gill, Kamilia Abdelraouf, Merime Oota, Rio Nakamura, Miho Kuroiwa, Yoshino Ishioka, Miki Takemura, Yoshinori Yamano, David P Nicolau	JAC Antimicrob Resist
37154184	a systematic review and metaanalysis for risk factor profile in patient with resistant acinetobacter baumannii infection relative to control patient	acinetobacter baumannii be a major cause of nosocomial infection and high mortality rate evaluation of risk factor for such resistant infection may aid surveillance and diagnostic initiative as well as can be crucial in early and appropriate antibiotic therapy	2023 Mar	Prity Rani Deshwal, Raisa Fathima, Muskan Aggarwal, Nalla Surender Reddy, Pramil Tiwari	Int J Risk Saf Med
37072328	57diamino3579tetradeoxynon2ulosonic acid in the capsular polysaccharide of acinetobacter baumannii	the polysaccharide capsule surround bacterial cell play a important role in pathogenesis of infection cause by the opportunistic pathogen acinetobacter baumannii by provide protection from external factor the structure of the capsular polysaccharide CPS produce by a baumannii isolate and the corresponding CPS biosynthesis gene cluster be highly diverse although many of they be related many type of a baumannii CPSs contain isomer of 57diamino3579tetradeoxynon2ulosonic acid DTNA three of this isomer namely acinetaminic acid lglycerolaltro isomer 8 epiacinetaminic acid dglycerolaltro isomer and 8 epipseudaminic acid dglycerolmanno isomer have not be find so far in naturally occur carbohydrate from other species in a baumannii CPSs dtna carry nacyl substituent at position 5 and 7 in some CPSs both nacetyl and N3hydroxybutanoyl group be present remarkably pseudaminic acid carry the risomer and legionaminic acid carry the sisomer of the 3hydroxybutanoyl group the review address the structure and genetics of biosynthesis of a baumannii CPSs contain diNacyl derivative of DTNA	2023 Feb	Yuriy A Knirel, Anastasia A Kasimova, Nikolay P Arbatsky, Mikhail M Shneider, Anastasia V Popova, Fedor A Brovko, Aleksander S Shashkov, Sofia N Senchenkova, Andrei V Perepelov, Anna M Shpirt	Biochemistry (Mosc)
36986580	drug combination of ciprofloxacin and polymyxin B for the treatment of multidrugresistant iAcinetobacter baumanniii infection a drug pair limit the development of resistance	Polymyxin be consider as lastresort antibiotic to treat infection cause by iAcinetobacter baumanniii however there be increase report of resistance in iA baumanniii to polymyxin in this study inhalable combinational dry powder consisting of ciprofloxacin CIP and polymyxin B pmb be prepare by spraydrying the obtain powder be characterize with respect to the particle property solid state in vitro dissolution and in vitro aerosol performance the antibacterial effect of the combination dry powder against multidrugresistant iA baumanniii be assess in a timekill study mutant from the timekill study be further investigate by population analysis profiling minimum inhibitory concentration testing and genomic comparison inhalable dry powder consisting of CIP pmb and they combination show a fine particle fraction above 30 a index of robust aerosol performance of inhaled dry powder formulation in the literature the combination of CIP and pmb exhibit a synergistic antibacterial effect against iA baumanniii and suppress the development of CIP and pmb resistance genome analysis reveal only a few genetic difference of 36 snp between mutant and the progenitor isolate this study suggest that inhalable spraydry powder compose of the combination of CIP and pmb be promise for the treatment of respiratory infection cause by iA baumanniii and this combination can enhance the kill efficiency and suppress the development of drug resistance	2023 Feb	Junwei Wang, Marc Stegger, Arshnee Moodley, Mingshi Yang	Pharmaceutics
36860160	incidence mortality and risk factor associate with carbapenemresistant acinetobacter baumannii bacteremia within 30 day after liver transplantation	Carbapenemresistant acinetobacter baumannii bacteremia crabb be a fatal infectious complication of liver transplantation LT this study investigate the incidence effect and risk factor associate with crabb during the early postLT period among 1051 eligible LT recipient 29 patient experience crabb within 30 day of LT with a cumulative incidence of 27 in the patient with crabb and 29 and match control and 145 by nestedcase control design the cumulative incidence of death on day 5 10 and 30 from the index date be 586 655 and 655 and 21 28 and 42 respectively p 001 Pretransplant meld or 111 95 confidence interval CI 104119 p 002 severe encephalopathy or 462 95 CI 1241861 p 025 donor body mass index or 57 95 CI 4175 p 001 and reoperation or 640 95 CI 1193682 p 032 be independent risk factor for 30 day crabb crabb show extremely high mortality within 30 day after LT especially within 5 day after its occurrence therefore assessment of risk factor and early detection of CRAB follow by proper treatment be necessary to control crabb after LT	2023 May	Eun-Ki Min, Seung Hyuk Yim, Mun Chae Choi, Jae Geun Lee, Dong Jin Joo, Myoung Soo Kim, Deok-Gie Kim	Clin Transplant
36651366	Antiinflammatory effect of nab and NaPc in iAcinetobacter baumanniiistimulated thp1 cell iviai tlr2nf κbrosnlrp3 pathway	this study evaluate the antiinflammation effect of the three main shortchain fatty acid scca on iAcinetobacter baumanniiinduced thp1 cell the three main scca could inhibit iA baumanniiistimulated thp1 cell nfκb pathway activity and the expression of nlrp3 inflammasome and gsdmd and increase autophagy the three main scca especially the sodium butyrate nab have the effect of downregulation of ROS and itlr2i expression in thp1 cell nab and sodium propionate NaPc but not sodium acetate NaAc dramatically suppress iil1 βi and iIFNγi expression the result indicate that nab and NaPc could significantly inhibit the inflammation of thp1 cell induce by iA baumanniii and the inhibitory effect be in the order of nab NaPc NaAC nab and NaPc may inhibit inflammation through tlr2nf κbrosnlrp3 signal pathway	2022 Dec	Chen Shu, Zhang Yan-Yan, Zhang Hai, Ding Long-Kun, Xi Yue, Yan Man, Sun Chang, Wu Liang, Hu Hao	Acta Pharm
36240659	in silico and in vitro insight into the prediction and analysis of natural photosensitive compound target acinetobacter baumannii biofilmassociated protein	the spread of acinetobacter baumannii strain have become a global concern due to its extensive antibiotic resistance and biofilm formation to overcome it new antimicrobial strategy have be need among they antimicrobial photodynamic therapy aPDT be a efficient approach against various microorganism this study be focus on the use of curcumin cur and quercetin qct as natural photosensitive compound to improve the activity of aPDT against a baumannii biofilmassociated protein bap	2022 Dec	Maryam Pourhajibagher, Farzaneh Bazarjani, Abbas Bahador	Photodiagnosis Photodyn Ther
36014428	iin silicoi evaluation of bioactive compound of iArtemisia pallensi target the efflux protein of multidrugresistant iAcinetobacter baumanniii lac4 strain	iAcinetobacter baumanniii iA baumanniii be one of the major representative aetiology of recalcitrant nosocomial infection genotypic and phenotypic alteration in iA baumanniii have result in a significant surge in multidrug resistance MDR of all the factor responsible for the development of antimicrobial resistance amr efflux protein pump play a paramount role in pursuit of a safe alternative for the prevention and control of iA baumanniii infection bioactive compound from the aerial part of the medicinal plant iArtemisia pallensi be study gcms analysis of the ethanol extract of iA pallensi detect five major compound lilac alcohol a spathulenol lilac alcohol C nhexadecanoic acid and vulgarin in silico examination be perform use the schrödinger suite homology modelling be perform to predict the structure of the efflux protein of iA baumanniiiLAC4 strain MDR abep the identify bioactive compound be analyse for they bind efficiency with MDR abep high bind efficiency be observe with vulgarin with a glide score of 4775 kcalmol and stereoisomer of lilac alcohol a 3706 kcalmol and lilac alcohol C 3706 kcalmol we molecular dynamic simulation study unveil the stability of the ligandefflux protein complex Vulgarin and lilac alcohol a possess strong and stable bind efficiency with MDR abep furthermore validation of the absorption distribution metabolism excretion and toxicity admet property of the ligand strongly suggest that this compound could serve as a lead molecule in the development of a alternate drug from iA pallensi	2022 Aug	Suvaiyarasan Suvaithenamudhan, Sivapunniyam Ananth, Vanitha Mariappan, Victor Violet Dhayabaran, Subbiah Parthasarathy, Pitchaipillai Sankar Ganesh, Esaki Muthu Shankar	Molecules
35884165	the Impact of antimicrobial stewardship and infection Control intervention on iAcinetobacter baumanniii resistance rates in the icu of a tertiary Care Center in Lebanon	antimicrobial resistance be a serious threat to global health cause increase mortality and morbidity especially among critically ill patient this toll be expect to rise follow the covid19 pandemic Carbapenemresistant iAcinetobacter baumanniii CRAb be among the gramnegative pathogen lead antimicrobial resistance globally it be list as a critical priority pathogen by the who and be implicate in hospitalacquired infection and outbreak particularly in critically ill patient Recent report from Lebanon describe increase rate of infection with CRAb hence the need to develop concerted intervention to control its spread we set to describe the impact of combine antimicrobial stewardship and infection control measure on resistance rate and colonization pressure of CRAb in the intensive care unit of a tertiary care center in Lebanon before the covid19 pandemic the antimicrobial stewardship program introduce a carbapenemspar initiative in April 2019 during the same period infection control intervention involve focus screen monitoring and tracking of CRAb as well as compliance with specific measure from January 2018 to January 2020 we report a statistically significant decrease in carbapenem consumption and a decrease in resistance rate of isolate iA baumanniii the colonization pressure of CRAb also decrease significantly reach record low level at the end of the intervention period the result indicate that a multidisciplinary approach and combine intervention between the stewardship and infection control team can lead to a sustained reduction in resistance rate and CRAb spread in icus	2022 Jul	Nesrine A Rizk, Nada Zahreddine, Nisrine Haddad, Rihab Ahmadieh, Audra Hannun, Souad Bou Harb, Sara F Haddad, Rony M Zeenny, Souha S Kanj	Antibiotics (Basel)
36717837	Glycyrrhetinic acid protect against multidrugresistant acinetobacter baumanniiinduced lung epithelial cell injury by regulate inflammation and oxidative stress	Glycyrrhetinic acid ga be a bioeffective component of licorice the ga be a monomer and the ingredient be a oleananetype pentacyclic triterpene that have be use as a remedy for year due to the abuse of antibiotic people pay attention to the emergence of multidrugresistant acinetobacter baumannii mdrab as a conditional pathogen mdrab cause severe infection endangering human life we previous study find ga play a important role in yinhua Pinggan a Chinese medicine however whether ga could protect lung epithelium from mdrabinduced cell injury be elusive herein we investigate the effect of ga on mmrabinfected a549 cell the result show ga have slightly antibacterial activity to mdrab in the ga high concentration but no impact on drug resistance gene Notwithstand ga could reverse mdrabinduced cell apoptosis hamper adhesion and invasion of mdrab to cell and inhibit proinflammatory cytokine expression of il1 " IL6 and tnf besides mdrabinduced reactive oxygen species prooxidative protein malonaldehyde and myeloperoxidase of cell be decrease by ga while antioxidative protein be recover show antioxidative capacity of ga might play a critical role the expression of tolllike receptor tlrs 1 2 4 5 6 and 9 be increase by mdrab infection while ga reverse the tendency interestingly ga inhibit mdrab induce myeloiddifferentiationfactor88 expression myd88 one downstream confactor of tlrs but no affection on interferon regulatory factor 3 IRF3 the other one indicate ga inhibit mdrab induce cell injury by impact tlrmyv88 pathway to attenuate inflammation altogether we result demonstrate that ga protect against mdrabinduced cell injury through its antioxidative and antiinflammatory property which deserve further study in the future	2023 Jan	Piaoyi Guo, Liang Jin, Huifen Zhou, Yida Bao, Jiehong Yang, Jing Chen, Yu He, Daojun Yu, Haitong Wan	BMC Pharmacol Toxicol
35890012	reply to muntean et al comment on mitteregger et al a variant carbapenem Inactivation method CIM for iAcinetobacter baumanniii Group with shortened timetoresult rCIMA ipathogensi 2022 i11i 482	we appreciate the interest in we publication and agree that a different acronym for the method would have be good	2022 Jul	Dieter Mitteregger, Julian Wessely, Ivan Barišić, Branka Bedenić, Dieter Kosak, Michael Kundi	Pathogens
35708005	isolation of a lytic bacteriophage against extensively drugresistant acinetobacter baumannii infection and its dramatic effect in rat model of burn infection	acinetobacter baumannii be a opportunistic nosocomial pathogen belong to the moraxellaceae family the emergence of multidrug resistant strain of this pathogen cause many problem for hospital and patient the aim of the current study be to isolate identify and morphologically physiologically and in vivo analyze a new lytic bacteriophage target extensively drugresistant XDR a baumannii	2022 Jul	Ehsanollah Ghaznavi-Rad, Majid Komijani, Alireza Moradabadi, Marzieh Rezaei, Nima Shaykh-Baygloo	J Clin Lab Anal
35683622	colistin monotherapy versus colistin plus meropenem combination therapy for the treatment of multidrugresistant iAcinetobacter baumanniii infection a metaanalysis	1 introduction colistin combination therapy with other antibiotic be a way to enhance colistin activity the purpose of this metaanalysis be to compare the efficacy and safety of treatment with colistin monotherapy versus colistin plus meropenem combination therapy in patient with drugresistant iAcinetobacter baumanniii infection 2 method all study be include if they report one or more of the follow outcome clinical improvement complete microbiological response 14day mortality hospital mortality or nephrotoxicity 3 result three randomize control trial and seven retrospective study be include in the metaanalysis colistin monotherapy have similar rate of clinical improvement 14day mortality hospital mortality and nephrotoxicity as colistin plus meropenem combination therapy regard complete microbiological response the colistin plus meropenem combination be good than colistin monotherapy 4 discussion previous metaanaly demonstrate heterogeneity in study quality and a lack of evidence support the use of colistinbased combination therapy we metaanalysis clearly show that colistin combine with meropenem be not superior to colistin monotherapy for the treatment of iAcinetobacter baumanniii infection 5 conclusion the efficacy and safety of treatment with colistin monotherapy and that of colistin plus meropenem combination therapy in patient with drugresistant iAcinetobacter baumanniii infection be comparable the majority of the evidence be obtain from nonrandomized study and highquality randomize control trial be need to confirm the role of colistin plus meropenem combination therapy in the treatment of multidrugresistant iAcinetobacter baumanniii infection	2022 Jun	Chienhsiu Huang, Ihung Chen, Tiju Tang	J Clin Med
35285526	observation of clinical efficacy of the cefoperazonesulbactam antiinfective regimen in the treatment of multidrugresistant acinetobacter baumannii lung infection	sulbactam and sulbactamcontaining βlactam antibiotic be often use in the treatment of acinetobacter baumannii we aim to further examine the clinical efficacy of a cefoperazonesulbactam antiinfective regimen in multidrugresistant a baumannii mdrab lung infection	2022 Jul	Qinxue Wang, Min Huang, Suming Zhou	J Clin Pharm Ther
37217796	in vitro activity of ceftazidimeavibactam imipenemrelebactam and meropenemvaborbactam alone or in combination with polymyxin B against carbapenem resistant acinetobacter baumannii	Nosocomial infection cause by CarbapenemResistant acinetobacter baumannii CRA baumannii have become a challenge in clinical practice acting as the last resort antibacterial agent for the treatment of CRA baumannii infection polymyxin have high risk of nephrotoxicity and poor clinical efficacy ceftazidimeavibactam imipenemrelebactam and meropenemvaborbactam be three βlactam βlactamase inhibitor combination complex that newly approve by the food and drug Administration for the treatment of carbapenemresistant gramnegative bacterial infection in this study we analyze the in vitro activity of that novel antibacterial agent alone or in combination with polymyxin B against the CRA baumannii obtain from a Chinese tertiary hospital we result suggest that that novel antibacterial agent should not be use alone for the treatment of CRA baumannii infection as they cannot prevent the regrowth of bacterium at the clinical achievable blood concentration imipenemrelebactam and meropenemvaborbactam should not be use as the substitute of imipenem and meropenem for polymyxin B base combination therapy against CRA baumannii since they have no edge over imipenem and meropenem on antibacterial activity when in combination with polymyxin B ceftazidimeavibactam may be more suitable than ceftazidime for polymyxin B base combination therapy against CRA baumannii as it have a high synergistic rate with polymyxin B and the antibacterial activity of ceftazidimeavibactam be much high than that of ceftazidime when test in combination with polymyxin B ceftazidimeavibactam may also be the good choice than imipenem and meropenem for polymyxin B base combination therapy against CRA baumannii as it have a high synergistic rate with polymyxin B	2023 May	Rongxin Liang, Dongxing Wang, Mingjin Hu, Yuxia Gu, Meijun Wang, Dan Hu, Mingan Zhu, Meng Wang	J Antibiot (Tokyo)
36762540	molecular tracking of carbapenemresistant iAcinetobacter baumanniii clinical isolate a multicentre study over a 4 year period across eastern China	bintroductionb Colonization by carbapenemresistant iAcinetobacter baumanniii CRAB cause therapeutic and economic problem for critically ill patient bgap statementb the analysis of CRAB in China be limited to certain regionsbAimsb to investigate the antibiotic susceptibility molecular characterization and clonal relationship among CRAB isolate from multiple hospital of eastern ChinabMethodologyb isolate from 29 tertiary hospital from September 2015 to September 2018 be recover all strain be analyse use antimicrobial susceptibility testing to detect they tolerance pcr be also use to detect multiple βlactamase gene after multilocus sequence type mlst of seven housekeeping gene eburst be use to assess clonal complex and explore evolutionary relationshipsbResultsb all isolate show resistance to carbapenem while remain susceptible to colistin and tigecycline all isolate be detect with iblai suboxa51 sub gene by pcr and 801 harbour the iblai suboxa23 sub gene the prevalence of blasuboxa23sub gene be remarkably increase from 507 in 2015 to 905 in 2018 other gene such as iblai suboxa24sub iblai subogaka sub iblai subimp24sub iblai subVIM2sub iblai subshvsub iblai subampcsub and iblai subtemsub be also obtain while iblai subkpcsub iblai subndm1 sub iblai subimp4sub and iblai subSIM1 sub be not find in this strain mlst show all isolate could be divide into 26 know sequence type STs and ten novel STs and 472 isolate belong to st195 and ST208 eburst reveal clonal complex 92 as the major clonal complex 984 which include 885 2326 of know STs and 80 810 of unknown STs phylogenetic analysis also find that almost all CRAB isolate could cluster into one lineage suggest a epidemic of this CRAB lineage this indicate severe nosocomial infection of CRAB in multiple hospital of eastern ChinabConclusionb a outbreak of st195 and ST208 crabresistant clone with iblai suboxa23 sub gene might be happen in multiple hospital in eastern China	2023 Feb	Yayun Zhao, Yunzhu Zhu, Hui Zhang, Lingyan Zhang, Jiabin Li, Ying Ye	J Med Microbiol
36314248	ag ncs as a potent antibiofilm agent against pathogenic iPseudomonas aeruginosai and iAcinetobacter baumanniii and drugresistant iBacillus subtilisi by affect chemotaxis and flagellar assembly pathway gene	biofilm infection be highly resistant to commercial antibiotic therefore develop a potent agent against such drugresistant bacterial infection be highly desirable here we synthesized positively charge silver nanocluster ag ncs with a diameter of 2 nm which be find to be very effective antibacterial and antibiofilm agent against tetracyclineresistant iBacillus subtilisi and most importantly multidrugresistant pathogenic strain of iPseudomonas aeruginosai and iAcinetobacter baumanniii ag ncs be able to both prevent and eradicate the biofilm formation very effectively the antibiofilm activity can be significantly increase with αamylase andor dnase which degrade the structural component of biofilm the antibiofilm activity of antibiotic get considerably lower due to poor penetration and the acidic microenvironment of biofilm however the potency of antibiotic get significantly increase when apply with ag ncs finally RNA seqbased analysis have demonstrate that the biofilm degradation be likely due to the regulation of bacterial chemotaxis and flagellar assembly pathway gene by ag ncs	2022 Nov	Anirudh Singh, Komal Rani, Vibha Tandon, Amaresh Kumar Sahoo, Sintu Kumar Samanta	Biomater Sci
35156902	high throughput virtual screen and molecular dynamic simulation analysis of phytomolecule against bfar of iAcinetobacter baumanniii antivirulent drug development campaign	iAcinetobacter baumanniii be a notorious multidrug resistant bacterium responsible for several hospital acquire infection assist by its capacity to develop biofilm iA baumanniii bfar RstA a response regulator from the bfrr twocomponent signal transduction system be the major controller of iA baumanniii biofilm development and formation as a result bfar represent a novel target for antibiofilm treatment against iA baumanniii the discovery of the highresolution crystal structure of bfar provide a good chance for computational screen of its probable inhibitor therefore in this study we aim to search new less toxic and natural bfar inhibitor from 8450 phytomolecule available in the Indian medicinal plant phytochemistry and therapeutic imppat database by analyze molecular docking against bfar pdb id 6br7 out of this 8450 phytomolecule 6742 molecule be successfully dock with bfar with the docking score range 6305 kcalmol to 5120 kcalmol structure basedmolecular docking sbmd and admet absorption distribution metabolism excretion toxicity profile examination reveal that norepinephrine australine calystegine B3 77 adiepialexine and alphamethylnoradrenaline phytocompound strongly bind to the active site residue of bfar furthermore molecular dynamic simulation MDS study for 100 n and the bind free energy mmgbsa analysis elucidate the bind mechanism of calystegine B3 77 adiepialexine and alphamethylnoradrenaline to bfar in summary this phytocompound seem to have the promise molecule against bfar and thus necessitate further verification by both iin vitroi and iin vivoi experiment highlight bfar play a key role in biofilm development and exopolysaccharide eps synthesis in iA baumanniiiComputational approach to search for promise bfar inhibitor from impaat database the lead phytomolecule such as calystegine B3 77 adiepialexine and alphamethylnoradrenaline display significant bind with bfar active site the outcome of bfar bind phytomolecule have broaden the scope of hit molecule validationcommunicated by ramaswamy H Sarma	2023 Apr	Kiran Bharat Lokhande, Sarika Vishnu Pawar, Smriti Madkaiker, Neelu Nawani, Swamy K Venkateswara, Payel Ghosh	J Biomol Struct Dyn
36683677	susceptibility profile of iblai suboxa23sub and metallo βlactamase coharbouring isolate of carbapenem resistant iAcinetobacter baumanniii CRAB against standard drug and combination	the rapid emergence of carbapenem resistant iAcinetobacter baumanniii CRAB have result in a alarming situation worldwide realizing the dearth of literature on susceptibility of CRAB in genetic context in the develop region this study be perform to determine the susceptibility profile against standard drugscombination and the association of iinvitroi drug synergy with the prevalent molecular determinant	2022	Swati Sharma, Tuhina Banerjee, Ghanshyam Yadav, Ashok Kumar	Front Cell Infect Microbiol
36293559	Effect of subminimum Inhibitory concentration of imipenem and colistin on expression of BiofilmSpecific antibiotic resistance and virulence gene in iAcinetobacter baumanniii sequence type 1894	antibiotic at suboptimal dose promote biofilm formation and the development of antibiotic resistance the underlying molecular mechanism however be not investigate here we report the effect of subminimum inhibitory concentration submic of imipenem and colistin on gene associate with biofilm formation and biofilmspecific antibiotic resistance in a multidrugtolerant clinical strain of iAcinetobacter baumanniii sequence type ST 1894 comparative transcriptome analysis be perform in untreated biofilm and biofilm treat with submic dose of imipenem and colistin RNA sequencing datum show that 78 and 285 gene be differentially express in imipenem and colistintreated biofilm cell respectively among the differentially express gene deg 48 and 197 gene be upregulate exclusively in imipenem and colistintreated biofilm cell respectively the upregulate gene include that encoding matrix synthesis ipgabi multidrug efflux pump novel00738 fimbrial protein and homoserine lactone synthase AbaI upregulation of biofilmassociated gene might enhance biofilm formation when treat with submic of antibiotic the downregulated gene include that encoding DNA gyrase novel00171 30S ribosomal protein s20 novel00584 and ribosome release factor rrf be downregulated when the biofilm cell be treat with imipenem and colistin Downregulation of this gene affect protein synthesis which in turn slow down cell metabolism and make biofilm cell more tolerant to antibiotic in this investigation we also find that 5 of 138 small RNAs srna be differentially express in biofilm regardless of antibiotic treatment or not of this srna00203 show the high expression level in biofilm srna regulate gene expression and be associate with biofilm formation which may in turn affect the expression of biofilmspecific antibiotic resistance in summary when biofilm cell be expose to submic dose of colistin and imipenem coordinate gene response result in increase biofilm production multidrug efflux pump expression and the slowdown of metabolism which lead to drug tolerance in biofilm target antibioticinduce or repress biofilmspecific gene represent a new strategy for the development of innovative and effective treatment for biofilmassociated infection cause by iA baumanniii	2022 Oct	Abebe Mekuria Shenkutie, Jiaying Zhang, Mianzhi Yao, Daniel Asrat, Franklin W N Chow, Polly H M Leung	Int J Mol Sci
37120729	meropenem in combination with baicalein exhibit synergism against extensively drug resistant and pandrugresistant acinetobacter baumannii clinical isolate in vitro	several study have demonstrate that the effectiveness of carbapenem against drugresistant acinetobacter baumannii infection have be decrease combination therapy with two or more drug be currently under investigation to overcome the emerge resistance against carbapenem in this study we test the possible synergistic interaction of a potent antibacterial flavonoid baicalein with meropenem to illustrate this duo antibacterial and antibiofilm effect on 15 extensively drug resistant or pandrugresistant xdrpdr a baumannii clinical isolate in vitro isolate include in the study be identify with malditof ms and antibiotic resistance pattern be study accord to eucast protocol carbapenem resistance be confirm with the modify Hodge test and resistance gene be also analyze with genotypical method then checkerboard and timekill assay be perform to analyze antibacterial synergism additionally a biofilm inhibition assay be perform for screen the antibiofilm activity to provide structural and mechanistic insight into baicalein action proteinligand docking and interaction profiling calculation be conduct we study shed light on the remarkable potential of the baicaleinmeropenem combination since either synergistic or additive antibacterial activity be observe against every xdrpdr a baumannii strain in question furthermore the baicaleinmeropenem combination display significantly good antibiofilm activity in contrast to standalone use in silico study predict that this positive effect arise from inhibition by baicalein of a baumannii betalactamase andor penicillinbind protein overall we finding highlight the prospective potential benefit of baicalein in combination with meropenem for the treatment of carbapenemresistant a baumannii infection	2023 Jan	Mümtaz Güran, Kadir Çakıral, Kerem Teralı, Tülay Kandemir, Gizem Şanlıtürk, Melda Meral Öcal, Toğrul Nagiyev, Fatih Köksal	Pathog Dis
36516915	geographic pattern of acinetobacter baumannii and carbapenem resistance in the asiapacific Region result from the antimicrobial test Leadership and Surveillance atlas program 20122019	this study aim to investigate the geographic distribution of carbapenemresistant acinetobacter baumannii CRAB isolate in the asiapacific region	2023 Feb	Yu-Lin Lee, Wen-Chien Ko, Po-Ren Hsueh	Int J Infect Dis
36504816	formic acid a organic acid food preservative induce viablebutnonculturable state and trigger new antimicrobial resistance trait in iAcinetobacter baumanniii and iKlebsiella pneumoniae	numerous human pathogen especially gramnegative bacterium be able to enter the viablebutnonculturable vbnc state when they be expose to environmental stressor and pose the risk of be resuscitate and cause infection after the removal of the trigger widely use food preservative like weak organic acid be potential vbnc inducer in food processing and packaging facility but have only be report for foodborne pathogen in the present study it be demonstrate for the first time that one such agent formic acid FA can induce a vbnc state at food processing storage and distribution temperature 4 25 and 37sup°supc with a varied time of treatment day 410 in pathogenic gramnegative bacterium iAcinetobacter baumanniii and iKlebsiella pneumoniae the use of hospitalassociated pathogen be critical base on the early report that demonstrate the presence of this bacterium in hospital kitchen and commonly consume food vbnc induction be validate by multiple parameter eg nonculturability metabolic activity as energy production respiratory marker and membrane integrity furthermore it be demonstrate that the removal of FA be able to resuscitate vbnc with a increase expression of multiple virulence and antimicrobial resistance amr gene in both ipathogensi since food additivespreservatives be significantly use in most food manufacturing facility supply to hospital contamination of this package food with pathogenic bacterium and the consequence of exposure to food additive emerge as pertinent issue for infection control and control of antimicrobial resistance in the hospital set	2022	Manisha Yadav, Samridhi Dhyani, Pooja Joshi, Sakshi Awasthi, Subhash Tanwar, Vishal Gupta, Deepak K Rathore, Susmita Chaudhuri	Front Microbiol
36500701	the antiMultidugrugresistant iAcinetobacter baumanniii Study on 13diamino7Hpyrrolo32 fquinazoline compound	as a major public health problem the prevalence of iAcinetobacter baumanniii iA baumanniii infection in hospital due to the pathogen multipleantibiotic resistance have attract extensive attention we previously report a series of 13 diamino7 hpyrrolo32 fquinazoline pqz compound which be design by target iEscherichia colii dihydrofolate reductase iecidhfr and exhibit potent antibacterial activity in the current study base on we molecularmodeling study it be propose that pqz compound may function as potent iA baumanniii dhfr iabiDHFRinhitor as well which inspire we to consider they antiiA baumanniii ability we further find that three pqz compound oyyf1 172 and 175 show significant antibacterial activity against iA baumanniii include multidrugresistant MDR strain which be significantly strong than the typical dhfrinhibitor trimethoprim TMP and superior to or comparable to the other test antibacterial agent belong to βlactam aminoglycoside and quinolone the significant synergistic effect between the representative compound oyyf1 and the dihydropteroate synthase dhpsinhibitor sulfamethoxazole SMZ be observe in both the microdilutioncheckerboard assay and timekilling assay which indicate that use SMZ in combination with pqz compound could help to reduce the require dosage and forestall resistance we study show that pqz be a promise scaffold for the further development of folatemetabolism inhibitor against MDR iA baumanniii	2022 Dec	Han Wu, Hongtong Chen, Jungan Zhang, Xinxin Hu, Chunyang Xie, Weiting Cao, Ziqi Zhao, Zengshuo Xiao, Yixin Ren, Luyao Dong, Peiyi Sun, Xuefu You, Xinyi Yang, Wei Hong, Hao Wang	Molecules
35625347	Combine pkpd index May be a more appropriate pkpd index for cefoperazonesulbactam against iAcinetobacter baumanniii in patient with hospitalacquire Pneumonia	cefoperazonesulbactam cpzsul be a βlactam and βlactamase inhibitor combination therapy for the treatment of respiratory tract infection use datum from a prospective multiplecenter openlabel clinical trial in 54 patient with hospitalacquired pneumonia or ventilatorassociated pneumonia cause by multidrugresistant acinetobacter baumannii ab we show that a combine pkpd index T miccpzt micsul be a more appropriate pkpd index against ab compare to the pkpd index T mic for a single drug for a 2 h infusion the pkpd cutoff of cpzsul 2 g1 gram q8h for clinical and microbiological efficacy be 42 and 105 mgL respectively the corresponding cumulative fraction of response be 465 and 253 respectively result base on the combine pkpd index be quite similar to that base on the joint probability of target attainment the two drug have interaction from the viewpoint of pkpd when the dose of one drug be too high the pkpd cutoff be often determine by another drug in which the dose be maintain in most case sulbactam exert the main effect against infection by ab in the complex cpzsul which be similar to the literature report when the mic of CPZ be 8 16 or 32 mgL a cpzsul 2 g1 gram q8h 2 g2 gram q8h or 2 g2 gram q6h infusion be all 3 h be recommend respectively a clinical efficacy and safety study to confirm simulation result be warrant	2022 May	Yingjie Zhou, Jing Zhang, Yuancheng Chen, Jufang Wu, Beining Guo, Xiaojie Wu, Yingyuan Zhang, Minggui Wang, Ru Ya, Hao Huang	Antibiotics (Basel)
36980344	the prevalence of virulence factor gene among carbapenemnonsusceptible iAcinetobacter baumanniii Clinical strain and they usefulness as potential molecular biomarker of infection	healthcareassociated infection cause by multidrugresistant iAcinetobacter baumanniii strain be a serious global threat therefore it be important to expand the knowledge on the mechanism of pathogenicity of this particular bacterium the aim of this study be to assess the distribution of select virulence factor gene ibapi isura1i iomp3336i ibauAi ibauSi and ipldi among carbapenemnonsusceptible clinical iA baumanniii isolate and to evaluate they potential usefulness as genetic marker for rapid diagnostics of iA baumanniii infection moreover we aim to compare the virulence gene prevalence with the occurrence of carbapenemase gene a total of 100 carbapenemnonsusceptible iA baumanniii clinical isolate be include in the study the presence of virulence factor and iblaisubOXAsub gene be evaluate by realtime pcr the occurrence of virulence factor gene be as follow 1000 for the ibapi and isura1i gene 990 for the ibasd and ipldi gene the ibauAi and iomp3336i gene be absent among the study strain the predominant gene ibapi and isura1i be involve in biofilm formation and they presence among all clinical strain can be apply as a genetic marker to recognize iA baumanniii infection high frequency of the ibasd geneinvolved in siderophore biosynthesis and the gene encoding phospholipase D ipldiwere also note among iblaisuboxasubpositive strain show they potential role in a pathogenicity of iblaisuboxasubpositive iA baumanniii clinical strain	2023 Mar	Dagmara Depka, Tomasz Bogiel, Mateusz Rzepka, Eugenia Gospodarek-Komkowska	Diagnostics (Basel)
36154439	genomic Analysis of CarbapenemResistant acinetobacter baumannii strain recovered from Chilean hospital reveal lineage specific to South America and multiple route for Acquisition of antibiotic resistance gene	Carbapenemresistant acinetobacter baumannii CRiAbi be a public health threat accounting for a significant number of hospitalacquired infection despite the importance of this pathogen there be scarce literature on a baumannii molecular epidemiology and evolutionary pathway relevant to resistance emergence in South American strain we analyze the genomic context of 34 CRiAbi isolate recover from clinical sample between 2010 and 2013 from two hospital in Santiago Chile use wholegenome sequencing several Institut pasteur scheme sequence type STs be identify among the 34 genome study here include ST1 st15 ST79 st162 and st109 no ST2 the most widespread sequence type strain be detect Chilean isolate be phylogenetically closely related form lineage specific to South America eg ST1 ST79 and st15 the genomic context of the resistance gene be diverse while gene be present in a plasmid in st15 strain all gene be chromosomal in ST79 strain different variant of a small rep3 plasmid play a central role in the acquisition of the ioxa58i carbapenem and iaacC2i aminoglycoside resistance gene in ST1 st15 and ST79 strain the iaacC2i gene along with iblaisubTEMsub be find in a novel transposon name tni6925i here variant of tni7 be also find to play a important role in the acquisition of the iaadA1i and idfra1i gene this work draw a detailed picture of the genetic context of antibiotic resistance gene in a set of carbapenemresistant a baumannii strain recover from two Chilean hospital and reveal a complex evolutionary picture of antibiotic resistance gene acquisition event via multiple route involve several mobile genetic element bimportanceb treat infection cause by carbapenemresistant a baumannii CRiAbi have become a global challenge give that CRiAbi strain be also often resistant to a wide range of antibiotic Analysis of wholegenome sequence datum be now a standard approach for study the genomic context of antibiotic resistance gene however genome sequence datum from South American country be scarce here phylogenetic and genomic analysis of 34 CRiAbi strain recover from 2010 to 2013 from two Chilean hospital reveal a complex picture lead to the generation of resistant lineage specific to South America from this isolate we characterize several mobile genetic element some of which be describe for the first time the genome sequence and analysis present here further we understanding of the mechanism lead to multipledrug resistance extensive drug resistance and pandrug resistance phenotype in South America therefore this be a significant contribution to elucidating the global molecular epidemiology of CRiAbi	2022 Oct	Barbara P Brito, Jonathan Koong, Aniela Wozniak, Andres Opazo-Capurro, Joyce To, Patricia Garcia, Mehrad Hamidian	Microbiol Spectr
35098390	resistance trait and molecular characterization of multidrugresistant acinetobacter baumannii isolate from a intensive care unit of a tertiary hospital in guangdong southern China	this study aim to characterize antimicrobial resistance amr of all the nonduplicated acinetobacter baumannii strain isolate from a intensive care unit in a tertiary hospital during the period of January 1 to December 31 2015	2022 Aug	Zhuo-Ran Chen, Hui-Wu Guo, Jun Liu, Qing Pan, Mao-Zhang Fu, Ying-Kun Qiu, Nai-Kei Wong, Yuan-Chun Huang	Int Microbiol
34933656	multicenter surveillance of iin vitroi activity of cefepimezidebactam cefepimeenmetazobactam omadacycline eravacycline and comparator antibiotic against ienterobacterales pseudomonas aeruginosai and iAcinetobacter baumanniii complex cause bloodstream infection in Taiwan 2020	to determine the iin vitroi activity of novel and comparator antibiotic against gramnegative bacterium GNB in Taiwan	2022 Jun	Shio-Shin Jean, Wen-Chien Ko, Min-Chi Lu, Wen-Sen Lee, Po-Ren Hsueh, SMART Program	Expert Rev Anti Infect Ther
37043383	development of a immunochromatographic lateral flow assay to rapidly detect oxa23 oxa40 oxa58 and ndmmediated carbapenem resistance determinant in iAcinetobacter baumanniii	bintroductionb iAcinetobacter baumanniii infection can be extremely challenging to treat owing to the worldwide prevalence of multidrugresistant isolate especially against carbapenem Colonization with carbapenemresistant iA baumanniii CRAb require rapid action from a infection control perspective because the organism be know for its propensity for epidemic spreadbb bHypothesisGap statementb there be a unmet medical need to rapidly identify CRAb to enable appropriate antimicrobial treatment and to prevent transmissionbb bAimb we aim be to expand the oxadetection ability of the rapid immunochromatographic test ICT oxa23 iKiSeT Coris BioConcept to include oxa40 and oxa58 like carbapenemase which together confer carbapenem resistance to more than 94 of CRAb isolate worldwidebb bMethodologyb we use hybridoma technology to generate mab against oxa40 and oxa58 and select they for productivity and specificity against recombinant and endogenous oxa40 and oxa58 combination of the result mab be analyse in ICT format for they ability to detect recombinant roxa40subhis6sub or roxa58subhis6sub respectively subsequently select antibody pair be implement into singleOXA40 or singleoxa58 prototype and the final oxa234058 NDM ICT and be evaluate on clinical iAcinetobacteri spp isolate with welldefined carbapenem resistance mechanismsbb bResultsb five antiOXA40 and antiOXA58 mab be select competition elisa with combination of this antibody reveal that the antiOXA40 antibody bind to one of two bind cluster on oxa40 while antiOXA58 antibody bind to one of four bind cluster on oxa58 direct bind to the corresponding antigen in a ICT format have leave only three antibody against roxa40subhis6sub and roxa58subhis6sub respectively for the subsequent sandwich ICT selection procedure which reveal that the antiOXA40 5 and antiOXA58 a8 mab in combination with the crossreactive mAb c8 perform good they be implement into singleOXA40 and singleoxa58 ICT prototype and evaluate this single ICT prototype demonstrate 100 specificity and sensitivity base on this result a oxa234058ndmmict be develop complemented with oxa23 and NDMspecific detection a evaluation with select carbapenemresistant iAcinetobacteri spp isolate ini34 show 100 specificitybb bConclusionb with this easytouse detection assay one can save 1248 h in diagnostics which help to treat patient early with appropriate antibiotic and allow immediate intervention to control transmission of crabbb	2023 Apr	Sonja Mertins, Paul G Higgins, Caroline Thunissen, Henri Magein, Quentin Gilleman, Pascal Mertens, María González Rodríguez, Liza Marie Maus, Harald Seifert, Martin Krönke, Alexander Klimka	J Med Microbiol
36641839	a twoyear retrospective study of multidrugresistant acinetobacter baumannii respiratory infection in critically Ill patient Clinical and microbiological finding	acinetobacter baumannii infection be a serious public health problem because it be highly resistant to antimicrobial therapy and cause a high fatality rate in critically ill patient the aim of the study be to examine the demographic microbiological finding clinical presentation and outcome of multidrugresistant acinetobacter baumannii respiratory infection in adult icu intubate patient during covid19 pandemic	2023 Mar	Taghreed A Hafiz, Shahad S Alghamdi, Murad A Mubaraki, Shymaa S M Alghamdi, Abdulwahab Alothaybi, Esraa Aldawood, Fawziah Alotaibi	J Infect Public Health
36339188	detection of multidrugresistant iAcinetobacter baumanniii by metagenomic nextgeneration sequencing in central nervous system infection after neurosurgery a case report	Central nervous system CNS infection be one of the most serious complication after neurosurgery traditional clinical method be difficult to diagnose the pathogen of intracranial infection due to recent advance in genomic approach especially sequencing technology metagenomic nextgeneration sequencing rngs have be apply in many research and clinical setting	2022	Ying Tian, Han Xia, Linlin Zhang, Jian-Xin Zhou	Front Public Health
35745838	effectiveness and Nephrotoxicity of loading Dose colistinmeropenem versus loading Dose colistinimipenem in the treatment of CarbapenemResistant iAcinetobacter baumanniii infection	Carbapenemresistant acinetobacter baumannii CRAB be become more widely recognize as a serious cause of nosocomial infection and colistin have be reintroduce in recent year for the treatment of CRAB infection combination of colistin and meropenem or imipenem have be find to be effective against CRAB isolate whereas clinical investigation have not definitively demonstrate the theoretical benefit of colistin combine therapy in patient with CRAB infection the objective of this study be to compare the primary outcome 30 day survival rate and secondary outcome clinical response microbiological response and nephrotoxicity between patient who receive loading dose LD colistin−meropenem and LD colistin−imipenem for the treatment of CRAB infection a retrospective cohort analysis be perform at Chiang mai University Hospital in patient with CRAB infection who receive LD colistin−meropenem or LD colistin−imipenem between 2011 and 2017 and 379 patient fulfil the requirement for the inclusion criterion the result of this study show that patient who receive LD colistin−imipenem have a low 30 day survival rate adjust hr 057 95 CI 037−090 p 0015 and a low clinical response ahr 056 95 CI 035−090 p 0017 compare with that who receive LD colistin−meropenem the microbiological response in patient with LD colistin−imipenem be 052 time ahr low than that in that who receive colistin−meropenem 95 CI 034−081 p 0004 however there be no significant difference in nephrotoxicity ahr 103 95 CI 067−157 p 0897 between the two combination regimen in conclusion when compare the combination of LD colistin with imipenem or meropenem the combination of LD colistin and meropenem provide a good survival rate for treat CRAB thus we suggest that combination of LD colistin and meropenem should be consider when treat CRAB infection	2022 Jun	Wasan Katip, Peninnah Oberdorfer, Nongyao Kasatpibal	Pharmaceutics
35704614	coexistence of blandm1 blangak1 blaoxa23 and armA in conjunction with novel mutation detect in RND efflux pump regulator in tigecycline resistant clinical isolate of acinetobacter baumannii	this study have investigate a total of 51 acinetobacter baumannii isolate for the prevalence of resistant determinant in tigecycline susceptible and nonsusceptible clinical isolate of a baumannii antimicrobial susceptibility testing reveal 74 of isolate be tigecycline resistant mutation in rndefflux pump regulatory gene and the expression of efflux pump gene be measure in tigecycline resistant isolate there be a strong corelation between the blandm1 and armA wherein majority of the isolate that be positive for blandm1 have also harbor armA compare with tsab tigecycline susceptible a baumannii tnab tigecycline nonsusceptible a baumannii isolate show increase distribution of blandm1 p 0048 blaimp1 p 00001 and blangak1 p 00029 carbapenemase gene the variant of rndefflux pump regulatory gene due to aminoacid mutation in ade f12 k84e wilr n268h and q299r and adeL g21r and Q262r be identify in tigecycline resistant isolate as well as isaba1 mediate disruption of aden be observe cause overexpression of adeIJK efflux pump additionally mutation in aders be also associate with increase expression of adeabc efflux pump besides tnab isolate show significantly p 00001 high ability of biofilm formation as compare to tsab isolate the tigecycline resistance due to mutation in contemporary a baumannii isolate have a high ability to form biofilm may pose therapeutic difficulty	2022 Jul	Ajit Ramesh Sawant, Sudhakar Pagal, Ashutosh Kumar Amar, Lipsa Panda, Sheela Devi C, P Shashikala, Reba Kanungo, K Prashanth	Pathog Dis
35368079	a carbapenemresistant acinetobacter baumannii outbreak associate with a polymyxin shortage during the COVID pandemic a in vitro and biofilm analysis of synergy between meropenem gentamicin and sulbactam	during the covid19 pandemic the burden of nosocomial infection cause by MDR pathogen have cause a shortage of polymyxin thus we evaluate the in vitro synergism and antibiofilm activity of antimicrobial combination and propose a test kit for synergism against carbapenemresistant acinetobacter baumannii CRAB	2022 May	Viviane Chaiben, Carolina Hikari Yamada, João Paulo Telles, Ana Paula de Andrade, Lavinia Nery Villa Stangler Arend, Victoria Stadler Tasca Ribeiro, Leticia Ramos Dantas, Paula Hansen Suss, Felipe Francisco Tuon	J Antimicrob Chemother
37201122	genomic determinant of Pathogenicity and antimicrobial resistance of Nosocomial iAcinetobacter baumanniii Clinical isolate of hospitalized patient 20192021 from a sentinel Hospital in Hangzhou China	iAcinetobacter baumanniii iA baumanniii or ab be one of the most opportunistic nosocomial pathogen threaten public healthcare across country iA baumanniii have become a primary grow concern due to its exceptional ability to acquire antimicrobial resistance amr to multiple antimicrobial agent which be increasingly report and more prevalent every year therefore there be a urgent need to evaluate the amr knowledge of iA baumanniii for effective clinical treatment of nosocomial infection this study aim to investigate the clinical distribution amr phenotype and genotype and genomic characteristic of iA baumanniii isolate recover from hospitalize patient of different clinical department of a sentinel hospital to improve clinical practice	2023	Chenxing Wei, Jian Chen, Tanveer Muhammad Anwar, Lingling Huang, Wenjie Yang, Xueyan Dong, Qiong Chen, Min Yue, Daojun Yu	Infect Drug Resist
36908383	successful treatment of pandrug resistant iAcinetobacter baumanniii nosocomial meningitisventriculitis by combine intravenous and intrathecal colistintigecycline administration a case series	this study aim to evaluate the efficacy of combine intraventricular and intravenous coadministration of colistin and tigecycline in the management of pandrug resistant iAcinetobacter baumanniii meningitisventriculitis	2022	Andreas Theofanopoulos, Dionysia Fermeli, Dionysios Vekios, Aristeidis Bizos, Markos Marangos, Constantine Constantoyannis, Vasileios Panagiotopoulos, Stelios F Assimakopoulos	Infez Med
36474037	improving nhsub3sub and hsub2sub removal efficiency with pilotscale biotrickling filter by coimmobiling Kosakonia oryzae fb23 and acinetobacter baumannii l54	in this study two nhsub4subsupsupn and ssup2 sup removal strain namely Kosakonia oryzae fb23 and acinetobacter baumannii l54 be isolate from the pack material in a longrunning biotrickling filter BTF the removal capacity of combine fb23 and l54 fb23 l54 toward 100 mg lsup1sup of nhsub4subsupsupn and 200 mg lsup1sup of ssup2sup reach 9731 ± 162 and 9857 ± 112 under the optimal condition 320 °C and initial pH 70 which be high than that of single strain then fb23 and l54 liquid inoculum be prepare and they concentration respectively reach 156 × 10 sup9 sup CFU mlsup1sup and 105 × 10 sup9 sup CFU mlsup1 sup by add different resuspension solution and protective agent after 12 week storage at 25 °C finally pilotscale BTF test show that nhsub3sub and hsub2sub in the real exhaust gas from a pharmaceutical factory be effectively remove with removal rate 87 and maximum elimination capacity be reach 136 gram nhsub3sub msup3sup hsup1sup and 176 gram hsub2sub msup3sup hsup1 sup at 18 °C34 °C and pH 4070 in the BTF load with bamboo charcoal pack material coimmobilized with fb23 and l54 after coimmobilization of fb23 and l54 in the bamboo charcoal pack material the new microbial diversity composition contain the dominant genera of acinetobacter Mycobacterium Kosakonia and Sulfobacillus be form and the diversity of entire bacterial community be decrease compare to the control this result indicate that fb23 and l54 have potential to be develop into liquid readytouse inoculum for effectively remove nhsub3sub and hsub2sub from exhaust gas in BTF	2023 Mar	Qiuyan Zhu, Pengyu Wu, Budong Chen, Qijun Wu, Feifei Cao, Hao Wang, Yuxia Mei, Yunxiang Liang, Xiaowen Sun, Zhenmin Chen	Environ Sci Pollut Res Int
36288018	molecular epidemiology of Clinical CarbapenemResistant iAcinetobacter baumanniicalcoaceticusi complex isolate in tertiary Care hospital in Java and Sulawesi Island Indonesia	Carbapenemresistant iAcinetobacter baumannii a baumanniicalcoaceticusi complex CRAbcc be a important pathogen cause nosocomial infection worldwide however molecular epidemiology of the iA baumanniicalcoaceticusi complex in Indonesian hospital be scarce this study aim to determine the clonal relatedness of CRAbcc in two tertiary care hospital in malang and manado in Indonesia the CRAbcc isolate from routine clinical culture in two tertiary care hospital in malang and manado be identify use the vitek2sup®sup system biomérieux lyon France multilocus variablenumber tandemrepeat analysis MLVA type multilocus sequence type mlst clonal complex CC and phylogenetic tree analysis be conduct for a subset of isolate seventythree CRAbcc isolate be collect the CRAbcc isolate be frequently find among lowerrespiratorytract specimen we detect the MLVA type mt 1 MT3 and MT4 crabcc isolate belong to the sequence type ST 642 and CC1 be the predominant clone in this study in conclusion we identify the clonal relatedness of iA baumanniicalcoaceticusi complex isolate in two tertiary care hospital in malang and manado in Indonesia further study be require to investigate the clinical importance and distribution of st642 in Indonesian hospital for develop prevention and control measure	2022 Sep	Heriyannis Homenta, Julyadharma Julyadharma, Hani Susianti, Noorhamdani Noorhamdani, Dewi Santosaningsih	Trop Med Infect Dis
36190276	antimicrobial and AntiInflammatory activity of maf1 derived antimicrobial peptide mt6 and its denantiomer DMt6 against acinetobacter baumannii by target cell membrane and lipopolysaccharide interaction	antibiotic resistance in acinetobacter baumannii be on the rise around the world highlight the urgent need for novel antimicrobial drug antimicrobial peptide amp contribute to effective protection against infection by pathogen make they the most promise option for nextgeneration antibiotic here we report two design cationic antimicrobialderived peptide mt6 and its dextroisomer DMt6 belong to the analog of maf1 which be isolate from the instar larvae of housefly both mt6 and DMt6 have a broadspectrum antimicrobial activity that be accompany by strong antibacterial activity especially against iA baumanniii planktonic bacterium and biofilm additionally the effect of DMt6 against iA baumanniii be stable in a variety of physiological setting include enzyme salt ion and hydrogen ion environment importantly DMt6 clean the bacterium on Caenorhabditis elegan without cause apparent toxicity and exhibit good activity iin vivoi both mt6 and DMt6 demonstrate synergistic or additive capability with traditional antibiotic against iA baumanniii demonstrate they characteristic as potential complement to combination therapy scanning electron microscopy SEM and laser scan confocal microscope lscm experiment reveal that two analog display rapid bact ericidal activity by destroy cell membrane integrity furthermore in lipopolysaccharide lpsstimulated macrophage cell this amp drastically decrease il1 " and TNFa gene expression and protein secretion imply antiinflammatory characteristic this trait be likely due to its dual function of directly bind LPS and inhibiting the lPsactivated mitogenactivated protein kinase mapk signal pathway in macrophage we finding suggest that DMt6 could be further develop as a novel antimicrobialantiinflammatory agent and use in the treatment of a baumannii infection bimportanceb around 700000 people worldwide die each year from antibioticresistant pathogen acinetobacter baumannii in clinical specimen increase year by year and it be develop a strong resistance to clinical drug which be result in iA baumanniii become the main opportunistic pathogen antimicrobial peptide show great potential as new antibacterial drug that can replace traditional antibiotic in we study mt6 and DMt6 two new antimicrobial peptide be design base on a natural peptide that we first discover in the hemlymphocyte of housefly larvae both mt6 and DMt6 show broadspectrum antimicrobial activity especially against iA baumanniii by damaging membrane integrity moreover DMt6 show good immunoregulatory activity against LPS induce inflammation through its lesneutralizining and suppression on mapk signal this study suggest that DMt6 be a promise candidate drug as a derive peptide against a baumannii	2022 Oct	Delong Kong, Xuan Hua, Rui Zhou, Jie Cui, Tao Wang, Fanyun Kong, Hongjuan You, Xiangye Liu, Joseph Adu-Amankwaah, Guo Guo, Kuiyang Zheng, Jianwei Wu, Renxian Tang	Microbiol Spectr
36994014	rapidforsey@ect spread and high mortality due to communityacquired pneumonia cause by iAcinetobacter baumanniii capab in a covid19 intensive care unit	iAcinetobacter baumanniii be a rare but dangerous gramnegative bacterium cause nosocomial infection especially in intensive care unit the increase use of antibiotic in the treatment of bacterial infection lead to drug resistance delay or failure in treatment the patient be a 48 yearold man with coronavirus disease covid19 be treat in the intensive care unit after contract iAcinetobacter baumanniii the patient condition deteriorate and he develop severe pulmonary problem due to the unknown presence of iAcinetobacter baumanniii in the patient this bacterium transmit to six other patient in the ward which result in they death in this report we describe the cause and risk factor of the disease and the result of laboratory test and therapeutic process	2022 Dec	Navid Shafigh, Fatemeh Roodneshin, Elnaz Shafigh, Mahtab Poor Zamany Nejat Kermany, Shadi Ziaie, James Miller, Mohammad Gharehbeglou, Niyoosha Masoumzadeh, Morteza Hasheminik, Jamshid Ordoni Avval	J Family Med Prim Care
37088438	efficacy of cefiderocol versus colistincontaining regimen for treatment of bacteremic ventilatorassociated pneumonia cause by carbapenemresistant acinetobacter baumannii in covid19 patient	ventilatorassociated pneumonia vap cause by carbapenemresistant acinetobacter baumannii CRAB in patient hospitalize in intensive care unit icu be a important and challenging complication include in covid19 patient consider the poor lung penetration of most antibiotic include intravenous colistin due to the poor pkpd at the infection site the choice of the good antibiotic regimen be still be debate	2023 Apr	Alessandro Russo, Andrea Bruni, Sara Gullì, Cristian Borrazzo, Angela Quirino, Rosaria Lionello, Francesca Serapide, Eugenio Garofalo, Riccardo Serraino, Francesco Romeo, Nadia Marascio, Giovanni Matera, Federico Longhini, Enrico Maria Trecarichi, Carlo Torti	Int J Antimicrob Agents
36080431	wholegenome Analysis of iAcinetobacter baumanniii strain ab43 containing a type IFb CRISPRCas system insight into the relationship with drug resistance	the CRISPRCas system be a bacterial and archaea adaptive immune system and be a newly recognize mechanism for control antibiotic resistance gene transfer iAcinetobacter baumanniii iA baumanniii be a important organism responsible for a variety of nosocomial infection iA baumanniii infection have become problematic worldwide because of the resistance of iA baumanniii to multiple antibiotic thus it be clinically significant to explore the relationship between the CRISPRCas system and drug resistance in iA baumanniii this study aim to analyze the genomic characteristic of the iA baumanniii strain ab3 contain the type IFb CRISPRCas system which be isolate from a tertiary care hospital in China and to investigate the relationship between the CRISPRCas system and antibiotic resistance in this strain the wholegenome sequencing wgs of the ab43 strain be perform use illumina and pacbio sequencing the complete genome of ab43 consist of a 3854806 bp chromosome and a 104309 bp plasmid the specific characteristic of the CRISPRCas system in ab43 be describe as follow 1 the strain ab43 carry a complete type IFb CRISPRCas system 2 homology analysis confirm that the icasi gene in ab43 share high sequence similarity with the same subtype icasi gene 3 a total of 28 of 105 iA baumanniii ab43 crispr spacer match gene in the bacteriophage genome database and the plasmid database imply that the CRISPRCas system in ab43 provide immunity against invasive bacteriophage and plasmid 4 none of the crispr spacer in iA baumanniii ab43 be match with antimicrobial resistance gene in the ncbi database in addition we analyze the presence of antibiotic resistance gene and insertion sequence in the ab43 strain and find that the number of antibiotic resistance gene be not low than in the no CRISPRCas system strain this study support the idea that the CRISPRCas system may inhibit drugresistance gene expression via endogenous gene regulation except to the publish mechanism that the CRISPRCas system efficiently limit the acquisition of antibiotic resistance gene that make bacterium sensitive to antibiotic	2022 Sep	Tingting Guo, Jie Yang, Xiaoli Sun, Yuhang Wang, Liying Yang, Guimei Kong, Hongmei Jiao, Guangyu Bao, Guocai Li	Molecules
35730377	epidemiological and genetic characteristic of clinical carbapenemresistant iAcinetobacter baumanniii strain collect countrywide from hospital intensive care unit icus in China	iAcinetobacter baumanniii be one of the key gramnegative pathogen that can cause serious nosocomial infection in China a large proportion of clinical iA baumanniii strain be multidrug resistant among which strain resistant to carbapenem be particularly worrisome as infection cause by such strain may limit the choice of exist antibiotic we conduct a nationwide and genomebase surveillance on the prevalence and antibiotic susceptibility profile of carbapenemresistant iA baumanniii CRAB strain collect from intensive care unit icus in hospital in different province and investigate the route of transmission and mechanism of resistance by wholegenome sequencing and phylogenetic analysis we find that CRAB strain be prevalent in 714 5577 of the icus survey clonal spread of CRAB be find in 376 2977 of icus and a total of 22 different clone be identify most clone be transmissible within one icu but up to six clone could be detect in at least three hospital in addition carbapenemhydrolysing class D βlactamase chdl be find to be mainly responsible for carbapenemresistance in iA baumanniii and the ST2 globalclone be the predominant type of CRAB in China importantly we find that CRAB isolate currently exhibit a extremely low rate of resistance to colistin 04 and tigecycline 25 but a high rate of resistance to ceftazidimeavibactam 702 finding in this work shall facilitate development of appropriate antimicrobial regimen for treatment of CRAB infection further surveillance and research on the evolutionary and epidemiological feature of clinical CRAB strain be necessary	2022 Dec	Congcong Liu, Kaichao Chen, Yuchen Wu, Ling Huang, Yinfei Fang, Jiayue Lu, Yu Zeng, Miaomiao Xie, Edward Wai Chi Chan, Sheng Chen, Rong Zhang	Emerg Microbes Infect
35735748	differential binding of carbapenem with the adeabc efflux Pump and modulation of the expression of adeb linked to Novel mutation within twocomponent system ader in CarbapenemResistant acinetobacter baumannii	resistancenodulationdivisiontype efflux system adeabc play a important role in carbapenem resistance among acinetobacter baumannii however a knowledge gap be observe regard the role of its regulator ader in carbapenemresistant a baumannii CRAB this study effectively combine microbiological analysis with a iinsilicoi structural approach to understand the contribution of ader among CRAB ini 38 additionally molecular docking be perform for the first time to study the interaction of fdaapproved carbapenem and pump inhibitor paβn with the open and close structure of adeb at the three bind site periplasmic proximal distal it be observe that open conformation of adeb facilitate the bind of carbapenem and paβn at entrance and proximal site compare to the close conformation paβn be find to block carbapenem interact residue in adeb establish its role as a competitive inhibitor of adeb substrate overexpression of adeabc be detect by qrtpcr among 29 of CRABs and several mutation within ades gly186val ser188phe glu121ly val255ile and ader val120ile ala136val be detect by sequencing the sequence and structurebase study of ader be perform to analyze the probable effect of this mutation on regulation of the twocomponent system TCS especially utilize its threedimensional structure ades mutation inhibit the transfer of a phosphate group to ader prevent the bind of ader to the intercistronic region lead to overexpression of adeabc the elucidation of the role of mutation in ader improve we understanding of tcsbased regulation identification of the key residue of adeb interact with carbapenem and paβn may help in future design of novel inhibitor bimportanceb adeabc be a important efflux pump in a baumannii that play a role in resistance toward different antibiotic include the last resort antibiotic carbapenem this pump be regulate by a twocomponent system ader to understand the bind of carbapenem with adeabc and pump inhibition by paβn we analyze for the first time the possible atomic level interaction of carbapenem and paβn with adeb in the current study aderSassociated novel mutation in clinical a baumannii be report for the first time and a sequencestructure base iinsilicoi approach be use to interpret they role in adeabc overexpression lead to carbapenem resistance none of the previous study have undertake both this aspect simultaneously this study analyze the open and close conformation of adeb they bind with carbapenem and key residue involve in it this help in visualizing the plausible atomic level cause of pump inhibition drive the discovery of novel inhibitor	2022 Aug	Subhasree Roy, Vivek Junghare, Shanta Dutta, Saugata Hazra, Sulagna Basu	mSystems
37102650	acinetobacter baumannii outer membrane protein a induce autophagy in bone marrowderive dendritic cell involve the pi3kmtor pathway	Outer membrane protein a OmpA be the major virulence factor of acinetobacter baumannii and play a wide role in the pathogenesis and antimicrobial resistance of a baumannii Dendritic cell dc be the most effective antigenpresent cell and play a crucial role in regulate the immune response to multiple antigen and immune sentry we aim to study the role and molecular mechanism of ompainduced mouse bone marrowderive dendritic cell bmdc autophagy in the immune response of a baumannii	2023 Apr	Hongyi Tan, Liyan Cao	Immun Inflamm Dis
36935582	nomogram for predict 90 day mortality in patient with iAcinetobacter baumanniiicaused hospitalacquired and ventilatorassociated pneumonia in the respiratory intensive care unit	we build a prediction model of mortality risk in patient the with iAcinetobacter baumanniii abcaused hospitalacquired hap and ventilatorassociated pneumonia vap	2023 Mar	Yongjian Pei, Yongkang Huang, Xue Pan, Zhen Yao, Chen Chen, Anyuan Zhong, Yufei Xing, Bin Qian, Shi Minhua, Tong Zhou	J Int Med Res
35740181	identifying target for antibiotic use for the management of CarbapenemResistant iAcinetobacter baumanniii CRAb in hospital a multicentre nonlinear timesery Study	solution be need to inform antimicrobial stewardship ams regard balancing the access to effective antimicrobial with the need to control antimicrobial resistance theoretical and mathematical model suggest a nonlinear relationship between antibiotic use and resistance indicate the existence of threshold of antibiotic use beyond which resistance would be trigger it be anticipate that threshold may vary across population depend on host environment and organism factor further research be need to evaluate threshold in antibiotic use for a specific pathogen across different setting the objective of this study be to identify threshold of population antibiotic use associate with the incidence of carbapenemresistant iAcinetobacter baumanniii CRAb across six hospital site in oman the study be a ecological multicentre evaluation that involve collect historical antibiotic use and CRAb incidence over the period from January 2015 to December 2019 by use nonlinear timesery analysis we identify different threshold in the use of thirdgeneration cephalosporin piperacillintazobactam aminoglycoside and fluoroquinolone across participate hospital the identification of different threshold emphasise the need for tailor analysis base on modelling datum from each hospital the determine threshold can be use to set target for each hospital ams provide a balance between access to this antibiotic versus control CRAb incidence	2022 Jun	Zainab Said Al-Hashimy, Barbara R Conway, Mubarak Al-Yaqoobi, Faryal Khamis, Ghalib Zahran Al Mawali, Aisha Mahad Al Maashani, Yaqoob Said Al Hadhrami, Said Salim Al Alawi, Mohammed Said Al Mamari, William J Lattyak, Elizabeth A Lattyak, Motasem Aldiab, Ian Gould, José-María López-Lozano, Mamoon A Aldeyab	Antibiotics (Basel)
37180447	evaluating the efficiency of a nomogram base on the datum of neurosurgical intensive care unit patient to predict pulmonary infection of multidrugresistant iAcinetobacter baumanniii	pulmonary infection cause by multidrugresistant iAcinetobacter baumanniii mdrab be a common and serious complication after brain injury there be no definitive method for its prediction and it be usually accompany by a poor prognosis this study aim to construct and evaluate a nomogram base on patient datum from the neurosurgical intensive care unit nsicu to predict the probability of mdrab pulmonary infection	2023	Di Wu, Zhuang Sha, Yibing Fan, Jiangyuan Yuan, Weiwei Jiang, Mingqi Liu, Meng Nie, Chenrui Wu, Tao Liu, Yupeng Chen, Jiancheng Feng, Shiying Dong, Jin Li, Jian Sun, Chongjie Pang, Rongcai Jiang	Front Cell Infect Microbiol
35843396	the k89 capsular polysaccharide produce by acinetobacter baumannii luh5552 consist of a pentameric repeatunit that include a 3acetamido36 dideoxydgalactose residue	acinetobacter baumannii isolate luh5552 carry the kl89 capsule biosynthesis gene cluster capsular polysaccharide CPS isolate from luh5552 be analyze by sugar analysis Smith degradation and one and twodimensional sup1supH and sup13supC nmr spectroscopy the k89 CPS structure have not be see before in a baumannii CPS structure resolve to date and include a 3acetamido36dideoxydgalactose dfucp3nac residue which be rare amongst a baumannii CPS the k89 CPS have a → 3αdgalpnac1 →3βdGlcpNAc1 → main chain with a βdglcp1→2βdfucp3nac1 →6d glcp side branch that be α1 →4 link to dgalpnac the role of the wzy polymerase and the four glycosyltransferase encode by the kl89 gene cluster in the biosynthesis of the k89 CPS be assign two glycosyltransferase gtr121 and gtr122 link the dfucp3nac to its neighbor sugars	2022 Sep	Nikolay P Arbatsky, Alexander S Shashkov, Mikhail M Shneider, Anastasiya V Popova, Anastasiya A Kasimova, Konstantin A Miroshnikov, Yuriy A Knirel, Ruth M Hall, Johanna J Kenyon	Int J Biol Macromol
36839558	efficacy of fosfomycincontaining regimen for treatment of Bacteremia due to PanDrug resistant iAcinetobacter baumanniii in critically Ill patient a Case Series Study	iAcinetobacter baumanniii ab have evolve over the last decade as a major problem in carbapenemresistant gramnegative nosocomial infection associate with high mortality rate especially in the intensive care unit icu Recent report highlight the increase prevalence of resistance to colistin a last resort therapeutic option for carbapenemresistant ab we retrospectively evaluate the characteristic treatment regimen and outcome of twenty patient with pandrug resistant pdr ab primary bacteremia hospitalize in the icu of the University General Hospital of patras during a twoyear period October 2020 September 2022 the 28day mortality reach 50 between survivor and nonsurvivor no difference be find regard age gender and charlson comorbidity index CCI however nonsurvivor have high apache ii score and high prevalence of septic shock and covid19 infection a significantly high percentage in the survivor group receive fosfomycin as part of the combination regimen inclusion of fosfomycin in the combination therapeutic regimen be associate with significantly good survival as compare to nonfosfomycincontaining regimen in view of the increase prevalence of pdrab infection in icus its associate high rate of mortality and the lack of effective treatment option the observe survival benefit with fosfomycin inclusion in the therapeutic regimen merit further validation in large prospective study	2023 Feb	Stelios F Assimakopoulos, Vassilis Karamouzos, Gerasimos Eleftheriotis, Maria Lagadinou, Christina Bartzavali, Fevronia Kolonitsiou, Fotini Paliogianni, Fotini Fligou, Markos Marangos	Pathogens
34864936	infectious disease Society of America guidance on the treatment of ampc " lactamaseproducing enterobacterale CarbapenemResistant acinetobacter baumannii and Stenotrophomonas maltophilia infection	the infectious disease Society of America idsa be commit to provide uptodate guidance on the treatment of antimicrobialresistant infection a previous guidance document focus on infection cause by extendedspectrum βlactamaseproducing enterobacterale esble carbapenemresistant enterobacterale CRE and pseudomonas aeruginosa with difficulttotreat resistance DTRP aeruginosa here guidance be provide for treat ampc βlactamaseproducing enterobacterale ampce carbapenemresistant acinetobacter baumannii CRAB and Stenotrophomonas maltophilia infection a panel of 6 infectious disease specialist with expertise in manage antimicrobialresistant infection formulate question about the treatment of ampce CRAB and S maltophilia infection answer be present as suggest approach and corresponding rationale in contrast to guidance in the previous document publish datum on the optimal treatment of ampce CRAB and S maltophilia infection be limited as such guidance in this document be provide as suggest approach base on clinical experience expert opinion and a review of the available literature because of difference in the epidemiology of resistance and availability of specific antiinfective internationally this document focus on the treatment of infection in the United State preferr and alternative treatment suggestion be provide assume the causative organism have be identify and antibiotic susceptibility result be know approach to empiric treatment duration of therapy and other management consideration be also discuss briefly suggestion apply for both adult and pediatric population the field of antimicrobial resistance be highly dynamic Consultation with a infectious disease specialist be recommend for the treatment of antimicrobialresistant infection this document be current as of 17 September 2021 and will be update annually the most current version of this document include date of publication be available at wwwidsocietyorgpracticeguidelineamrguidance20	2022 Jul	Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, Amy J Mathers, David van Duin, Cornelius J Clancy	Clin Infect Dis
37052117	sulbactamdurlobactam a novel βlactam βlactamase inhibitor combination target carbapenemresistant acinetobacter baumannii infection	Carbapenemresistant acinetobacter baumannii CRAB be a difficulttotreat nosocomial pathogen responsible for significant morbidity and mortality sulbactamdurlobactam suldur formerly etx2514sul be a novel βlactam βlactamase inhibitor design specifically for the treatment of CRAB infection the United State food and drug Administration FDA fasttrack approval of suldur for the treatment of CRAB infection be currently pend after completion of the phase iii attack trial which compare suldur to colistin both in combination with imipenemcilastatin IMI for patient with crabassociated hospitalacquired bacterial pneumonia ventilatorassociated pneumonia and bacteremia the result of this trial demonstrate that suldur be noninferior to colistin for CRAB while also possessing a much more favorable safety profile suldur be welltolerated with the most common side effect be headache nausea and injectionsite phlebitis with the current landscape of limited effective treatment option for CRAB infection suldur represent a promise therapeutic option for the treatment of this severe infection this review will discuss the pharmacology spectrum of activity pharmacokineticspharmacodynamics in vitro and clinical study safety dose administration as well as the potential role in therapy for suldur	2023 Apr	Amer El-Ghali, Ashlan J Kunz Coyne, Kaylee Caniff, Callan Bleick, Michael J Rybak	Pharmacotherapy
36339332	development and evaluation of a rapid and sensitive multienzyme isothermal rapid amplification with a lateral flow dipstick assay for detection of iAcinetobacter baumanniii in spiked blood specimen	this study aim to establish the multienzyme isothermal rapid amplification with a lateral flow dipstick miralfd assay and evaluate its performance in detection of iA baumanniii in spiked blood specimen	2022	Wei-Wei Hu, Jian-Wei He, Shu-Liang Guo, Jin Li	Front Cell Infect Microbiol
36225744	Pharmacokinetic Analysis and in vitro synergy evaluation of cefiderocol sulbactam and tigecycline in a extensively DrugResistant iAcinetobacter baumanniii Pneumonia patient receiving continuous venovenous hemodiafiltration	antimicrobial treatment for extensively drugresistant iAcinetobacter baumanniii xdrab infection have prove lackluster while dose challenge in patient receive continuous renal replacement therapy continue we describe a patient receive cefiderocol ampicillinsulbactam and tigecycline for xdrab while undergo continuous venovenous hemodiafiltration the clinical course cefiderocol and sulbactam pharmacokinetic and synergy assessment be describe	2022 Oct	Emir Kobic, Yasmeen Abouelhassan, Kumara Singaravelu, David P Nicolau	Open Forum Infect Dis
36403713	Immunization with recombinant dcaplike protein and abompa reveal protection against sepsis infection of multidrug resistant acinetobacter baumannii st2suppassup in a c57bl6 mouse model	the prevalence of infection associate with multidrug resistant MDR acinetobacter baumannii be increase worldwide therefore the introduction of effective vaccine against this bacterium seem necessary	2023 Jan	Sepideh Fereshteh, Soheila Ajdary, Amin Sepehr, Negin Bolourchi, Seyed Mahmoud Barzi, Fatemeh Haririzadeh Jouriani, Farhad Riazi-Rad, Fereshteh Shahcheraghi, Farzad Badmasti	Microb Pathog
37192727	pharmacokineticspharmacodynamics of cefiderocol administer by continuous infusion in a case series of critically ill patient with carbapenemresistant acinetobacter baumannii infection undergo continuous venovenous haemodiafiltration cvvhdf	to assess the pharmacokineticspharmacodynamics pkpd of cefiderocol administer by continuous infusion CI in a case series of critically ill patient with carbapenemresistant acinetobacter baumannii CRAB infection undergo continuous venovenous haemodiafiltration cvvhdf	2023 May	Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, Paolo Gaibani, Antonio Siniscalchi, Pierluigi Viale, Federico Pea	Int J Antimicrob Agents
37125469	the pharmacokineticspharmacodynamic relationship of Durlobactam in combination with sulbactam in in vitro and in Vivo infection Model system versus acinetobacter baumanniicalcoaceticus complex	sulbactamdurlobactam be a βlactam βlactamase inhibitor combination currently in development for the treatment of infection cause by acinetobacter include multidrugresistant MDR isolate although sulbactam be a βlactamase inhibitor of a subset of ambler class a enzyme it also demonstrate intrinsic antibacterial activity against a limited number of bacterial species include acinetobacter and have be use effectively in the treatment of susceptible acinetobacterassociated infection increasing prevalence of βlactamasemediated resistance however have erode the effectiveness of sulbactam in the treatment of this pathogen Durlobactam be a rationally design βlactamase inhibitor within the diazabicyclooctane dbo class the compound demonstrate a broad spectrum of inhibition of serine βlactamase activity with particularly potent activity against class D enzyme a attribute which differentiate it from other dbo inhibitor when combine with sulbactam durlobactam effectively restore the susceptibility of resistant isolate through βlactamase inhibition the present review describe the pharmacokineticpharmacodynamic pkpd relationship associate with the activity of sulbactam and durlobactam establish in nonclinical infection model with MDR acinetobacter baumannii isolate this information aid in the determination of pkpd target for efficacy which can be use to forecast efficacious dose regimen of the combination in human	2023 May	John P O'Donnell, Sujata M Bhavnani	Clin Infect Dis
36822004	a new acridinebased photosensitizer with ultralow light requirement efficiently inactivate carbapenemresistant acinetobacter baumannii and methicillinresistant Staphylococcus aureus and degrade they antibiotic resistance gene	the spread of antibiotic resistant pathogen and antibiotic resistance gene ARGs in the environment pose a serious threat to public health however exist method be difficult to effectively remove antibiotic resistant pathogen and ARGs from the environment in this study we synthesized a new acridinebased photosensitizer 27dibromo9mesityl10 methylacridinium perchlorate ym3 by the heavy atom effect which could photodynamically inactivate antibiotic resistant pathogen and reduce ARGs by generate singlet oxygen sup1suposub2sub in a aqueous environment the sup1suposub2sub yield of ym3 be 49 time that of its modify precursor ym3 could reduce the culturable number and even the viable count of methicillinresistant Staphylococcus aureus and carbapenemresistant acinetobacter baumannii to 0 inactivation rate 9999999 after 2 and 8 h of lowintensity blue light 15 wmsup2 sup irradiation respectively after 20 h of light exposure the copy number of ARGs in both bacterium be reduce by 580 and 448 log respectively which might indicate that ARGs have be degrade in addition ym3 still have a efficient bactericidal effect after five inactivation cycle this characteristic of ultralow light intensity requirement and efficient bactericidal ability make ym3 have good application prospect for disinfection in indoor and sunlight environment	2023 Mar	Xiaojie Xu, Min Yang, Yunhan Jiang, Ningyao Tao, Yulong Fu, Jiahui Fan, Xin Xu, Huixiang Shi, Zhan Lu, Chaofeng Shen	Environ Int
36944292	carboxymuconolactone decarboxylase be a prospective molecular target for multidrug resistant acinetobacter baumanniicomputational modeling molecular docking and dynamic simulation study	multidrugresistant acinetobacter baumannii mdrab a priorityI pathogen declare by the World Health Organization become a potential healthcare concern worldwide with a high mortality rate thus the identification of putative molecular target and potential lead molecule be a important concern in healthcare the present study aim to screen a prospective molecular target and effectual binder for the drug discovery of mdrab by computational virtual screen approach base on the functional role γcarboxymuconolactone decarboxylase CMD be prioritize as the target and its threedimensional 3D structure be computationally model base on the availability of the 3D structure twentyfive herbal molecule be select by database search and they druglikeliness pharmacokinetic and toxicity feature be predict the effectual bind of the select molecule towards CMD be predict by molecular docking the stability of the bestdock complex be predict by molecular dynamic md simulation for 100 n and bind energy calculation be carry out by molecular mechanic generalize bear and surface area solvation mmgbsa method out of twentyfive molecule screen hirsutine a indole alkaloid of Uncaria rhynchophylla and thymoquinone a phytochemical of nigella sativa be qualified for drug likeliness pharmacokinetic and toxicity feature and demonstrate significant effectual bind to CMD when compare with the bind of cocrystallized inhibitor and CMD control the dock complex of hirsutine and thymoquinone and CMD be stabilize by the bind energy of 8 30 and 8 46 kcalmol respectively this molecule be qualified in term of ideal drug likeliness adme and toxicity property md simulation study show that the ligandprotein complex be stable throughout the simulation the bind free energy of the complex by mmgbsa be estimate to be 4208157745 kcalmol and 3658618242 kcalmol for hirsutine and thymoquinone respectively when compare with the calculate bind free energy of the control 2875032666 kcalmol this study conclude that hirsutine and thymoquinone can act as potential lead molecule against CMD and the present hypothesis can be scaled up to develop potential inhibitor against mdrab	2023 May	Shraddha Rana, Sinosh Skariyachan, Akshay Uttarkar, Vidya Niranjan	Comput Biol Med
36060733	iin silicoi analysis reveal the coexistence of CRISPRCas type if1 and type IF2 system and its association with restrict phage invasion in iAcinetobacter baumanniii	iAcinetobacter baumanniii a opportunistic pathogen rapidly acquire antibiotic resistance thus compelling researcher to develop alternative treatment at utmost priority phagebase therapy be of appreciable benefit however CRISPRCas system be a major constraint in this approach hence for effective implementation and a promise future of phagebase therapy a multifaceted understanding of the CRISPRCas system be necessary	2022	Gulshan Yadav, Ruchi Singh	Front Microbiol
35920876	in vitro activity of eravacycline and cefoperazone sulbactam against extensivelydrug resistant and pandrug resistant acinetobacter baumannii isolate from a tertiary hospital in Greece	we evaluate the in vitro activity of eravacycline and cefoperazonesulbactam against 42 XDR and 58 pdr acinetobacter baumannii isolate from blood and bronchoalveolar infection the minimum and maximum mic for eravacycline be 0125 and 4 mgL respectively the mic50 be 2 mgL and the mic90 be 3 mgL the minimum and maximum mic for cefoperazonesulbactam be 24 and 256 mgL respectively the mic50 and mic90 be both 256 mgL this novel agent be not adequate for the treatment of a baumannii infection in we hospital and we recommend that mi crobiology laboratory perform they own evaluation before include they in clinical practice	2022 Jul	Georgios Meletis, Efthymia Protonotariou, Ioanna Gkeka, Angeliki Kassomenaki, Paraskevi Mantzana, Areti Tychala, Nikoletta Vlachodimou, Anastasia Kourti, Lemonia Skoura	New Microbiol
35453048	Combine in silico approach and whole genome sequencing acinetobacter baumannii ST218 isolate harbor adc73 βlactamase which have a similar cloop with adc56 and adc68 βlactamase	multidrugresistant acinetobacter baumannii be a noteworthy nosocomialpathogen and this pathogenborne infection be difficult to treat it be significant to make strain type with wgs and to add new genome datum to the literature therefore in we study we aim to strain type of the a baumannii a24 isolate from Turkey and reveal information about adc73 βlactamase	2022 Jul	Melike Gülbüz, Ayşegül Saral Sariyer	J Mol Graph Model
35755062	polymyxin BTigecycline combination versus polymyxin B or tigecycline Alone for the treatment of hospitalacquire Pneumonia caused by CarbapenemResistant iEnterobacteriaceaei or CarbapenemResistant iAcinetobacter baumanniii	it be not clear whether polymyxin Btigecycline pmbtgc combination be good than pmb or tgc alone in the treatment of hospitalacquired pneumonia hap cause by carbapenemresistant organism CRO	2022	Kang Chang, Haibo Wang, Jianping Zhao, Xianghong Yang, Bo Wu, Wenkui Sun, Man Huang, Zhenshun Cheng, Hong Chen, Yuanlin Song, Ping Chen, Xiangqi Chen, Xin Gan, Wanli Ma, Lihua Xing, Yimin Wang, Xiaoying Gu, Xiaohui Zou, Bin Cao	Front Med (Lausanne)
36139948	the molecular detection of Class B and Class D carbapenemase in Clinical strain of iAcinetobacter calcoaceticusbaumanniii complex the high burden of antibiotic resistance and the CoExistence of Carbapenemase gene	the emergence of carbapenemresistant iAcinetobacter calcoaceticusiibaumanniii complex cracb in clinical environment be a significant global concern this critical pathogen have show resistance to a broad spectrum of antibacterial drug include carbapenem mostly due to the acquisition of various βlactamase gene Clinical sample and 1985 be collect aseptically from multiple source and grow on blood and macconkey agar isolate and antimicrobial susceptibility be confirm with the vitek2 system the modify Hodge test confirm the cracb phenotype and specific pcr primer be use for the molecular identification of iblaisubOXAsub and iblaisubndmsub gene of the 1985 sample 1250 629 be culturepositive and 200 439 be cracb isolate of this isolate 354 be recover from pus sample and 235 from tracheal secretion obtain from patient in intensive care unit 493 and medical ward 202 a antibiogram indicate that 100 of the cracb isolate be resistant to βlactam antibiotic and βlactam inhibitor 865 to ciprofloxacin and 835 to amikacin while the most effective antibiotic be tigecycline and colistin the cracb isolate display resistance to eight different aware class of antibiotic all isolate exhibit the iblaisuboxa51 sub gene while iblaisuboxa23sub be present in 945 iblaisubVIMsub in 37 and iblaisubndmsub in 14 of the isolate the iblaisuboxa51 sub iblaisuboxa23sub and iblaisuboxa24sub gene coexisted in 13 65 isolate cracb isolate with coexisting iblaisuboxa23sub iblaisuboxa24sub iblaisubndmsub iblaisuboxa51sub and iblaisubVIMsub gene be highly prevalent in clinical sample from Pakistan cracb strain be highly critical pathogen and present resistance to virtually all antibacterial drug except tigecycline and colistin	2022 Aug	Hasan Ejaz, Muhammad Usman Qamar, Kashaf Junaid, Sonia Younas, Zeeshan Taj, Syed Nasir Abbas Bukhari, Abualgasim E Abdalla, Khalid O A Abosalif, Naveed Ahmad, Zikria Saleem, Eman H M Salem	Antibiotics (Basel)
35631436	bacterial Community and genomic Analysis of CarbapenemResistant iAcinetobacter baumanniii isolate from the environment of a Health Care facility in the western Region of Saudi Arabia	the escalating transmission of hospitalacquired infection especially that due to antimicrobialresistant bacterium be a major health challenge worldwide in this study a culturomic analysis of bacterial community in a tertiary care hospital in the western region of Saudi Arabia be perform use environmental sample the genome sequencing of four iAcinetobacter baumanniii be perform on isolate recover from a intensive care unit icu environment and clinical sample a total of 361 bacterial isolate from surface and air sample be identify by malditof technique or 16S rRNA gene sequencing the isolate be classify into 70 distinct species include eskape pathogen resistance in grampositive isolate be mainly find to be against benzylpenicillin azithromycin ampicillin and trimethoprimsulfamethoxazole carbapenem and multidrugresistant isolate of iA baumanniii and iKlebsiella pneumoniai be find on the icu surface genome sequencing reveal that the carbapenemresistant iA baumanniii isolate from icu environment be link with that of clinical origin the isolate ab133henv be classify as a novel sequence type st2528 base on a new allele of oxfgdhb286 three betalactamantibioticresistance gene iblaisubADC25 sub iblaisuboxa23sub and iblaisuboxa66 sub be find in most of the analyze genome Collectively the result of this study highlight the spread of antimicrobialresistant nosocomial pathogen in a health care facility in Saudi Arabia	2022 May	Muhammad Yasir, Abdullah Mohammad Subahi, Hani A Shukri, Fehmida Bibi, Sayed Sartaj Sohrab, Maha Alawi, Anees A Sindi, Asif A Jiman-Fatani, Esam I Azhar	Pharmaceuticals (Basel)
37107006	Sulfonamidoboronic acid as CrossClass inhibitor of a expandedspectrum Class C Cephalosporinase adc33 and a Class D Carbapenemase oxa2440 Strategic compound Design to combat resistance in iAcinetobacter baumanniii	iAcinetobacter baumanniii be a gramnegative organism list as a urgent threat pathogen by the World Health Organization who Carbapenemresistant iA baumanniii CRAB especially present therapeutic challenge due to complex mechanism of resistance to iβilactam one of the most important mechanism be the production of iβilactamase enzyme capable of hydrolyze iβilactam antibiotic coexpression of multiple class of iβilactamase be present in CRAB therefore the design and synthesis of crossclass inhibitor be a important strategy to preserve the efficacy of currently available antibiotic to identify new nonclassical iβilactamase inhibitor we previously identify a sulfonamidomethaneboronic acid bcr167b active against iacinetobacteriderived class C iβilactamase adc7 the compound demonstrate affinity for adc7 with a ikisubisub 160 nm and prove to be able to decrease mic value of ceftazidime and cefotaxime in different bacterial strain herein we describe the activity of bcr167b against other iβilactamase in iA baumanniii the cefepimehydrolysing class C extendedspectrum iβilactamase esac adc33 and the carbapenemhydrolyzing oxa2440 class D this investigation demonstrate bcr167b as a valuable crossclass C and D inhibitor and the paper describe we attempt to further improve its activity five chiral analogue of bcr167b be rationally design and synthesized the structure of oxa2440 and adc33 in complex with bcr167 b and select chiral analogue be obtain the structure activity relationship sar be highlight offer insight into the main determinant for crossclass CD inhibitor and impetus for novel drug design	2023 Mar	Maria Luisa Introvigne, Trevor J Beardsley, Micah C Fernando, David A Leonard, Bradley J Wallar, Susan D Rudin, Magdalena A Taracila, Philip N Rather, Jennifer M Colquhoun, Shaina Song, Francesco Fini, Kristine M Hujer, Andrea M Hujer, Fabio Prati, Rachel A Powers, Robert A Bonomo, Emilia Caselli	Antibiotics (Basel)
36206776	genomic characterisation of multidrugresistant Escherichia coli Klebsiella pneumoniae and acinetobacter baumannii in two intensive care unit in hanoi viet nam a prospective observational cohort study	viet nam have high rate of antimicrobial resistance amr but little capacity for genomic surveillance this study use whole genome sequencing to examine the prevalence and transmission of three key amr pathogen in two intensive care unit icus in hanoi viet nam	2022 Nov	Leah W Roberts, Le Thi Hoi, Fahad A Khokhar, Nguyen Thi Hoa, Tran Van Giang, Cuong Bui, Tran Hai Ninh, Dao Xuan Co, Nguyen Gia Binh, Hoang Bao Long, Dang Thi Huong, James E Bryan, Archie Herrick, Theresa Feltwell, Behzad Nadjm, H Rogier van Doorn, Julian Parkhill, Nguyen Vu Trung, Nguyen Van Kinh, Zamin Iqbal, M Estée Török	Lancet Microbe
36846794	Dynamic state of plasmid genomic architecture result from dercdmediated sitespecific recombination in iAcinetobacter baumanniii rep3 superfamily resistance plasmid carry iblasubOXA58subi and tniapha6 iresistance module	the acquisition of iblai suboxasub gene encoding different carbapenemhydrolyzing classD βlactamase chdl represent a main determinant of carbapenem resistance in the nosocomial pathogen iAcinetobacter baumanniii the iblasubOXA58subi gene in particular be generally embed in similar resistance module rm carry by plasmid unique to the iAcinetobacteri genus lack selftransferability the ample variation in the immediate genomic context in which iblasubOXA58subi contain RMs be insert among this plasmid and the almost invariable presence at they border of nonidentical 28 bp sequence potentially recognize by the host xerc and xerd tyrosine recombinase pxercd like site suggest a involvement of this site in the lateral mobilization of the gene structure they encircle however whether and how this pxercd site participate in this process be only beginning to be understand here we use a series of experimental approach to analyze the contribution of pxercdmediated sitespecific recombination to the generation of structural diversity between resistance plasmid carry pxercdbounded iblai suboxa58sub and tniapha6 icontaining rm harbor by two phylogenetically and epidemiologicallyclosely related iA baumanniii strain of we collection ab242 and ab825 during adaptation to the hospital environment we analysis disclose the existence of different ibona fidei pair of recombinationallyactive pxercd site in this plasmid some mediating reversible intramolecular inversion and other reversible plasmid fusionsresolution all of the identify recombinationallyactive pair share identical ggtgta sequence at the cr spacer separate the xerc and xerdbinding region the fusion of two ab825 plasmid mediate by a pair of recombinationallyactive pxercd site display sequence difference at the cr spacer could be infer on the basis of sequence comparison analysis but no evidence of reversibility could be obtain in this case the reversible plasmid genome rearrangement mediate by recombinationallyactive pair of pxercd site report here probably represent a ancient mechanism of generate structural diversity in the iAcinetobacteri plasmid pool this recursive process could facilitate a rapid adaptation of a eventual bacterial host to change environment and have certainly contribute to the evolution of iAcinetobacteri plasmid and the capture and dissemination of iblai subogaka sub gene among iAcinetobacteri and noniAcinetobacteri population coresiding in the hospital niche	2023	Lucía Giacone, M Marcela Cameranesi, Rocío I Sanchez, Adriana S Limansky, Jorgelina Morán-Barrio, Alejandro M Viale	Front Microbiol
36846731	the effectiveness of colistinlevofloxacin compare to colistinmeropenem in the treatment of ventilatorassociated pneumonia vap cause by carbapenemresistant iAcinetobacter baumanniii a randomize control clinical trial	the treatment of ventilatorassociated pneumonia vap cause by carbapenemresistant iAcinetobacter baumanniii CRAB be still a great challenge this study evaluate the effectiveness of the colistinlevofloxacin regimen compare to the usual colistinmeropenem regimen in the treatment of patient with vap cause by CRAB	2023 Feb	Mahnaz Momenzadeh, Rasool Soltani, Fatemeh Shafiee, Atousa Hakamifard, Morteza Pourahmad, Saeed Abbasi	Res Pharm Sci
36296249	computerbased identification of potential druggable target in multidrugresistant iAcinetobacter baumanniii a Combine in silico in vitro and in Vivo Study	the remarkable rise in antimicrobial resistance be alarming for iAcinetobacter baumanniii which necessitate effective strategy for the discovery of promise antiacinetobacter agent we use a subtractive proteomics approach to identify unique protein drug target shortlisted target pass through subtractive channel include essentiality nonhomology to the human proteome druggability subcellular localization prediction and conservation sixtyeight drug target be shortliste among this glutamine synthetase dihydrodipicolinate reductase udpnacetylglucosamine acyltransferase aspartate 1decarboxylase and bifunctional udpnacetylglucosamine diphosphorylaseglucosamine1 phosphate nacetyltransferase be evaluate in vitro by determine the minimum inhibitory concentration mic of candidate ligand citric acid dipicolinic acid dtartaric acid malonic acid and 2Nmorpholinoethanesulfonic acid mes respectively which rang from 325 to 1500 μgmL except for mes 25 mgmL the candidate ligand citric acid dtartaric acid and malonic acid show good bind energy score to they target upon apply molecular docking in addition to a significant reduction in iA baumanniii microbial load in the wound infection mouse model this ligand also exhibit good tolerability to human skin fibroblast the significant increase in the mic of malonic acid in βalanine and pantothenatesupplemented media confirm its selective inhibition to aspartate 1decarboxylase in conclusion three out of sixtyeight potential iA baumanniii drug target be effectively inhibit in vitro and in vivo by promise ligand	2022 Oct	Omar H Badie, Ahmed F Basyony, Reham Samir	Microorganisms
36608719	geographic pattern of carbapenemresistant multidrugresistant and difficulttotreat acinetobacter baumannii in the asiapacific region result from the antimicrobial test Leadership and Surveillance atlas program 2020	this study evaluate the invitro activity of multiple class of antibiotic include novel βlactam combination agent tigecycline and colistin against carbapenemresistant CRAB multidrugresistant mdrab and difficulttotreat dtrab acinetobacter baumannii minimum inhibitory concentration mic be determine use the broth microdilution method susceptibility profile and the distribution of select antimicrobial among country be illustrate and examine base on the breakpoint of the Clinical and Laboratory Standard Institute European Committee on antimicrobial susceptibility test and the US food and drug Administration in total 847 a baumannii isolate be evaluate and 692 isolate be characterize as CRAB mdrab or dtrab the prevalence of drugresistant a baumannii be 700 in South Korea India and China while the resistance rate of tigecycline be 55 the mic of meropenem and meropenemvaborbactam for drugresistant a baumannii be equal both micsub50sub and micsub90 sub be 32 mgL range 02532 mgL the overall resistance rate remain high for multiple class of antibiotic include penicillin cephalosporin carbapenem quinolone and aminoglycoside 840 960 980 880 and 870 respectively but not colistin or tigecycline 11 and 43 respectively China show the low susceptibility to tigecycline for drugresistant a baumannii isolate compare with other country in conclusion the resistance rate of drugresistant a baumannii remain high against multiple class of antimicrobial colistin be the most potent agent follow by tigecycline the geographic pattern of tigecyclineresistant a baumannii varied among country therefore continuous surveillance of a baumannii resistance profile in different region be require	2023 Feb	Chih-Hao Chen, Pin-Han Wu, Min-Chi Lu, Mao-Wang Ho, Po-Ren Hsueh	Int J Antimicrob Agents
36498604	comment on huang et al colistin monotherapy versus colistin plus meropenem combination therapy for the treatment of multidrugresistant iAcinetobacter baumanniii infection a metaanalysis ij Clin Medi 2022 i11i 3239	in the recently publish metaanalysis title colistin monotherapy versus colistin plus meropenem combination therapy for the treatment of multidrugresistant iAcinetobacter baumanniii infection a metaanalysis huang et al compare the efficacy and safety of treatment with colistin monotherapy versus colistin plus meropenem combination therapy in patient with drugresistant iAcinetobacter baumanniii infection	2022 Nov	Vered Daitch, Mical Paul, Leonard Leibovici	J Clin Med
36985347	healthcareassociated bloodstream infection due to multidrugresistant iAcinetobacter baumanniii in covid19 intensive Care unit a singlecenter retrospective Study	healthcareassociated infection be a emerge cause of morbidity and mortality in covid19 intensive care unit icus worldwide especially that cause by multidrugresistant MDR pathogen the objective of this study be to assess the incidence of bloodstream infection BSIs among critically ill covid19 patient and to analyze the characteristic of healthcareassociated BSIs due to MDR iAcinetobacter baumanniii in a covid19 icu a singlecenter retrospective study be conduct at a tertiary hospital during a 5 month period the detection of carbapenemase gene be perform by pcr and genetic relatedness by pulsedfield gel electrophoresis pfge and multilocussequence type a total of 193 episode be register in 176 covid19 icu patient with a incidence of 251000 patientday at risk iA baumanniii be the most common etiological agent 403 with a resistance to carbapenem of 100 the iblaisuboxa23sub gene be detect in ST2 isolate while the iblaisuboxa24sub be st636 specific pfge reveal a homogeneous genetic background of the isolate the clonal spread of oxa23 positive iA baumanniii be responsible for the high prevalence of MDR iA baumanniii BSIs in we covid19 icu further surveillance of resistance trend and mechanism be need along with change in behavior to improve the implementation of infection control and the rational use of antibiotic	2023 Mar	Karolina Dobrović, Tea Škrobo, Katarina Selec, Marko Jelić, Rok Čivljak, Jasminka Peršec, Sanja Sakan, Nikolina Bušić, Antonija Mihelčić, Sonja Hleb, Arjana Tambić Andrašević	Microorganisms
36978298	epidemiological characteristic and antimicrobial resistance change of CarbapenemResistant iKlebsiella pneumoniae and iAcinetobacter baumanniii under the covid19 Outbreak a interrupted time Series Analysis in a large Teaching Hospital	to investigate the epidemiological characteristic and resistance change of carbapenemresistant organism CRO under the covid19 outbreak to provide evidence for precise prevention and control measure against hospitalacquired infection during the pandemic	2023 Feb	Xinyi Yang, Xu Liu, Weibin Li, Lin Shi, Yingchao Zeng, Haohai Xia, Qixian Huang, Jia Li, Xiaojie Li, Bo Hu, Lianping Yang	Antibiotics (Basel)
34521591	in vitro activity of cefiderocol cefepimeenmetazobactam cefepimezidebactam eravacycline omadacycline and other comparative agent against carbapenemnonsusceptible pseudomonas aeruginosa and acinetobacter baumannii isolate associate from bloodstream infection in Taiwan between 20182020	this study aim to investigate the in vitro susceptibility of carbapenemnonsusceptible pseudomonas aeruginosa CNSPA and acinetobacter baumannii cnsab isolate to cefiderocol novel βlactamase inhibitor BLI combination new tetracycline analogue and other comparative antibiotic	2022 Oct	Po-Yu Liu, Wen-Chien Ko, Wen-Sen Lee, Po-Liang Lu, Yen-Hsu Chen, Shu-Hsing Cheng, Min-Chi Lu, Chi-Ying Lin, Ting-Shu Wu, Muh-Yong Yen, Lih-Shinn Wang, Chang-Pan Liu, Pei-Lan Shao, Yu-Lin Lee, Zhi-Yuan Shi, Yao-Shen Chen, Fu-Der Wang, Shu-Hui Tseng, Chao-Nan Lin, Yu-Hui Chen, Wang-Huei Sheng, Chun-Ming Lee, Hung-Jen Tang, Po-Ren Hsueh	J Microbiol Immunol Infect
37148452	antibacterial property and efficacy of ll37 fragment gf17d3 and Scolopendin a2 peptide against resistant Clinical strain of Staphylococcus aureus pseudomonas aeruginosa and acinetobacter baumannii in vitro and in Vivo Model Study	pseudomonas aeruginosa Staphylococcus aureus and acinetobacter baumannii have emerge as major clinical threat owing to the increase prevalence of ventilatorassociated pneumonia cause by multidrugresistant or extensively drugresistant strain the present study aim to assess the antibacterial effect and efficacy of ll37 fragment gf17d3 and synthetic Scolopendin a2 peptide against resistant clinical strain in vitro and in vivo model p aeruginosa S aureus and a baumannii be isolate from clinical infection they antibiotic resistance and minimum inhibitory concentration be assess ll37 fragment gf17d3 peptide be select from available database Scolopendin a2 peptide 6th amino acid proline be substitute with lysine and peptide and mic be determine the biofilm inhibitory activity be quantify at sub mic concentration synergetic effect of Scolopendin a2 and imipenem be assess by checkerboard after mouse nasal infection with p aeruginosa peptide LD50 be determine isolate harbor complete resistance toward the majority of antibiotic and mic value rang between 1 and 512 µgml the majority of isolate exhibit strong biofilm activity synthetic peptide show low mic value than antibiotic agent and the low mic value be obtain for synthetic peptide in combination with antibiotic the synergism effect of Scolopendin a2 with imipenem be also determine Scolopendin a2 be find to have antibacterial efficacy against p aeruginosa S aureus and a baumannii with mic 64 µgml 8 µgml and 16 µgml respectively and ll37 show antibacterial efficacy against p aeruginosa S aureus and a baumannii with mic 128 µgml 32 µgml and 32 µgml respectively both amp decrease biofilm by ≥ 96 at 1 × mic the biofilm inhibitory activity be measure at sub mic concentration of the peptide and the result demonstrate that Scolopendin a2 exhibit antibiofilm activity at 14 × mic and 12 × mic concentration be 479 to 638 although ll37 among 14 × mic and 12 × mic concentration be 213 to 496 against three pathogen the combination of Scolopendin a2 and antibiotic demonstrate synergistic activityresistant strain with fic value ≤ 05 for three pathogen while ll37 and antibiotic show synergistic activity fic value ≤ 05 for only p aeruginosa infection model Scolopendin a2 with imipenem 2 × mic be efficacious in vivo with a 100 survival rate follow treatment at 2 × mic after 120 h the mRNA expression of biofilmrelated gene be decrease for both peptide synthesis Scolopendin a2 decrease the expression of biofilm formation gene compare to the control group synthetic Scolopendin a2 exhibit antimicrobial activity without cause toxicity on the human epithelial cell line base on we finding it seem that synthetic Scolopendin a2 be a appropriate antimicrobial source that could be a promise option in combination with antibiotic for a topical medication and in the prevention of acute and chronic infection cause by multidrugresistant bacterium nevertheless additional experiment be require to assess another potential of this novel AMP	2023 May	Nastaran Farzi, Mana Oloomi, Golnaz Bahramali, Seyed Davar Siadat, Saeid Bouzari	Probiotics Antimicrob Proteins
36830183	intravenous polymyxin B as adjunctive therapy to highdose tigecycline for the treatment of Nosocomial Pneumonia due to CarbapenemResistant iAcinetobacter baumanniii and iKlebsiella pneumoniae a propensity scorematched cohort Study	although the combination of polymyxin and tigecycline be widely use in treat carbapenemresistant bacterial infection the benefit of this combination be still uncertain to assess whether add polymyxin B to the highdose tigecycline regimen would result in good clinical outcome than the highdose tigecycline therapy in patient with pneumonia cause by carbapenemresistant iKlebsiella pneumoniae and iAcinetobacter baumanniii we conduct a propensity scorematch cohort study in a single center between July 2019 and December 2021 of the 162 eligible patient 102 be include in the 11 match cohort the overall 14day mortality in the match cohort be 245 compare with highdose tigecycline the combination therapy be not associate with good clinical outcome and show similar 14day mortality or 072 95 CI 027183 ipi 0486 clinical cure or 109 95 CI 048254 ipi 0823 microbiological cure or 096 95 CI 039253 ipi 0928 and rate of nephrotoxicity or 085 95 CI 036199 ipi 0712 Subgroup analysis also do not demonstrate any statistical difference base on this result it be reasonable to recommend against add polymyxin B to the highdose tigecycline regimen in treat pneumonia cause by carbapenemresistant iK pneumoniae and iA baumanniii	2023 Jan	Lei Zha, Xue Zhang, Yusheng Cheng, Qiancheng Xu, Lingxi Liu, Simin Chen, Zhiwei Lu, Jun Guo, Boris Tefsen	Antibiotics (Basel)
36113767	extensively drugresistant acinetobacter baumannii coproducing vim2 and oxa23 in intensive care unit result of a oneday point prevalence in a Tunisian hospital	the main objective of this study be to identify carbapenem resistance mechanism among clinical commensal and environmental carbapenemresistant acinetobacter baumannii CRAB strain isolate in 5 Tunisian intensive care unit icus	2022 Nov	Sana Ferjani, Lamia Kanzari, Elaa Maamar, Zaineb Hamzaoui, Amel Rehaiem, Asma Ferjani, Ilhem Boutiba-Ben Boubaker	Infect Dis Now
36009980	a randomized control Trial of colistin Combine with sulbactam 9 gram per Day versus 12 gram per Day in the treatment of extensively DrugResistant iAcinetobacter baumanniii Pneumonia a Interim Analysis	extensively drugresistant iA baumanniii xdrab pneumonia have a high mortality rate in hospitalize patient one of the recommend treatment be colistin combine with sulbactam however the optimal dosage of sulbactam be unclear in a openlabel superiority randomize control trial patient diagnose with xdrab pneumonia be randomly assign 11 to receive colistin in combination with sulbactam at either 9 gday or 12 gday the primary outcome be the 28day mortality rate in the intentiontotreat population a total of 88 patient receive colistin in combination with sulbactam at a dosage of either 12 gday and 45 or 9 gday and 43 trend toward a low mortality rate be observe in the 12 gday group at 7 day 111 versus 233 14 day 333 versus 419 and 28 day 467 versus 581 the microbiological cure rate at day 7 be significantly high in the 12 gday group 905 versus 581 ipi 002 factor associate with mortality at 28 day be asthma cirrhosis apacheii score ≥ 28 and a dosage of sulbactam of 9 gday for mortality at any timepoint treatment with colistin combine with sulbactam at 12 gday be not superior to the combination treatment with sulbactam at 9 gday however due to be a interim analysis this trial be underpower to detect mortality difference	2022 Aug	Chutchawan Ungthammakhun, Vasin Vasikasin, Dhitiwat Changpradub	Antibiotics (Basel)
36979049	genomic comparative Analysis of two MultiDrug resistance MDR iAcinetobacter baumanniii Clinical strain assign to International clonal lineage ii recovered prearrange and postcovid19 Pandemic	after the emergence of covid19 numerous case of iA baumanniiiSARSCoV2 coinfection be report whether the coinfecting iA baumanniii strain have distinctive characteristic remain unknown	2023 Feb	German Matias Traglia, Fernando Pasteran, Jenny Escalante, Brent Nishimura, Marisel R Tuttobene, Tomás Subils, Maria Rosa Nuñez, María Gabriela Rivollier, Alejandra Corso, Marcelo E Tolmasky, Maria Soledad Ramirez	Biology (Basel)
36556126	reply to daitch et al comment on huang et al colistin monotherapy versus colistin plus meropenem combination therapy for the treatment of multidrugresistant iAcinetobacter baumanniii infection a metaanalysis ij Clin Medi 2022 i11i 3239	this be a author reply to the letter to the editor entitle colistin monotherapy versus colistin plus meropenem combination therapy for the treatment of multidrugresistant iAcinetobacter baumanniii infection a metaanalysis by daitch V et al	2022 Dec	Chienhsiu Huang, Ihung Chen, Tiju Tang	J Clin Med
37182534	efficacy and safety of sulbactamdurlobactam versus colistin for the treatment of patient with serious infection cause by acinetobacter baumanniicalcoaceticus complex a multicentre randomise activecontrolled phase 3 noninferiority clinical trial attack	a urgent need exist for antibiotic to treat infection cause by carbapenemresistant acinetobacter baumanniicalcoaceticus complex ABC sulbactamdurlobactam be a βlactam βlactamase inhibitor combination with activity against acinetobacter include multidrugresistant strain in a phase 3 pathogenspecific randomise control trial we compare the efficacy and safety of sulbactamdurlobactam versus colistin both in combination with imipenemcilastatin as background therapy in patient with serious infection cause by carbapenemresistant ABC	2023 May	Keith S Kaye, Andrew F Shorr, Richard G Wunderink, Bin Du, Gabrielle E Poirier, Khurram Rana, Alita Miller, Drew Lewis, John O'Donnell, Lan Chen, Harald Reinhart, Subasree Srinivasan, Robin Isaacs, David Altarac	Lancet Infect Dis
36483408	a 12 year epidemiological study of iAcinetobacter baumanniii from blood culture isolate in a single tertiarycare hospital use polymerase chain reaction pcrbased open read frame type	iAcinetobacter baumanniii be a causative agent of healthcareassociated infection and the introduction and spread of iA baumanniii that have acquire drug resistance within a hospital be serious healthcare problem we investigate the transition of epidemic clone and the occurrence of outbreak by molecular epidemiological analysis to understand the longterm behavior of iA baumanniii within a single facility	2022	Yuji Fujikura, Takaaki Hamamoto, Atsushi Yuki, Ayumi Sampei, Nozomi Ichie, Kazuho Takamizawa, Sakika Nomura, Yusuke Serizawa, Tomohiro Ohno, Hironori Tsujimoto	Antimicrob Steward Healthc Epidemiol
37154773	evaluation of matrixassisted laser desorption IonizationTime of Flight mass spectrometry for molecular type of acinetobacter baumannii in Comparison with orthogonal method	Colonization and subsequent health careassociated infection HCAI with acinetobacter baumannii be a concern for vulnerable patient group within the hospital set Outbreak involve multidrugresistant strain be associate with increase patient morbidity and mortality and poorer overall outcome reliable molecular type method can help to trace transmission route and manage outbreak in addition to method deploy by reference laboratory matrixassiste laser desorption ionizationtime of flight mass spectrometry malditof ms may assist by make initial inhouse judgment on strain relatedness however limited study on method reproducibility exist for this application we apply malditof ms type to a baumannii isolate associate with a nosocomial outbreak and evaluate different method for datum analysis in addition we compare malditof ms with wholegenome sequencing wgs and fourier transform infrared spectroscopy ftir as orthogonal method to further explore they resolution for bacterial strain type a related subgroup of isolate consistently cluster separately from the main outbreak group by all investigate method this find combine with epidemiological datum from the outbreak indicate that this method identify a separate transmission event unrelated to the main outbreak however the malditof ms upstream approach introduce measurement variability impacting method reproducibility and limiting its reliability as a standalone type method availability of inhouse type method with wellcharacterized source of measurement uncertainty could assist with rapid and dependable confirmation or denial of suspect transmission event this work highlight some of the step to be improve before such tool can be fully integrate into routine diagnostic service workflow for strain type bimportanceb manage the transmission of antimicrobial resistance necessitate reliable method for tracking outbreak we compare the performance of malditof ms with orthogonal approach for strain type include wgs and ftir for acinetobacter baumannii isolate correlate with a health careassociated infection HCAI event Combine with epidemiological datum all method investigate identify a group of isolate that be temporally and spatially link to the outbreak yet potentially attribute to a separate transmission event this may have implication for guide infection control strategy during a outbreak however the technical reproducibility of malditof ms need to be improve for it to be employ as a standalone type method as different stage of the experimental workflow introduce bias influence interpretation of biomarker peak datum availability of inhouse method for strain type of bacterium could improve infection control practice follow increase report of outbreak of antimicrobialresistant organism during the covid19 pandemic related to sessional usage of personal protective equipment ppe	2023 May	Eloise J Busby, Ronan M Doyle, Clara Leboreiro Babe, Kathryn A Harris, Damien Mack, Gema Méndez-Cervantes, Denise M O'Sullivan, Vicky Pang, Zahra Sadouki, Priya Solanki, Jim F Huggett, Timothy D McHugh, Emmanuel Q Wey	Microbiol Spectr
36507894	erratum a 12 year epidemiological study of iAcinetobacter baumanniii from blood culture isolate in a single tertiarycare hospital use polymerase chain reaction pcrbased open read frame type erratum	this correct the article doi 101017ash2022279	2022	Yuji Fujikura, Takaaki Hamamoto, Atsushi Yuki, Ayumi Sampei, Nozomi Ichie, Kazuho Takamizawa, Sakika Nomura, Yusuke Serizawa, Tomohiro Ohno, Hironori Tsujimoto	Antimicrob Steward Healthc Epidemiol
37110408	cefiderocolbased versus colistinbased regimen for severe CarbapenemResistant iAcinetobacter baumanniii infection a propensity scoreWeighted retrospective cohort Study during the first two year of the covid19 Pandemic	a large increase in multidrugresistant iAcinetobacter baumanniii especially carbapenemresistant strain occur during the first two year of the covid19 pandemic pose important challenge in its treatment cefiderocol appear to be a good option for the treatment of Carbapenemresistant iAcinetobacter baumanniii CRAb but to date the guideline and evidence available be conflict	2023 Apr	Maria Mazzitelli, Dario Gregori, Lolita Sasset, Marco Trevenzoli, Vincenzo Scaglione, Sara Lo Menzo, Serena Marinello, Daniele Mengato, Francesca Venturini, Ivo Tiberio, Paolo Navalesi, Annamaria Cattelan	Microorganisms
36752319	Structural and functional characterization of 1deoxydxylulose5 phosphate synthase DXS from iAcinetobacter baumanniii identification of promise lead molecule from virtual screen molecular docking and molecular dynamic simulation	the advent of multi drug resistance and extensivedrug resistance among various pathogen have cause a rise in nosocomial infection which in turn have lead to rise hospitalacquired infectionrelated mortality rate amongst they carbapenemresistant iAcinetobacter baumanniii be one of the most notorious bacterial species categorized as a priority 1 critical pathogen by the who therefore the discovery and development of novel antibiotic as well as the identification of potential inhibitor have become the need of the hour in this study we have employ computational method to explore and identify molecule capable of inhibiting enzyme essential in the methylerythritol 4 phosphate MEP biosynthetic pathway the high throughput virtual screen of small molecule enamine Advanced Collection ac library against the highly conserved substratebind site of the DXS target protein provide we with a total of 1000 molecule the top four potential candidate molecule namely z3353989070 z3353989049 z2295848528 and z1685501455 alongside fluoropyruvate control a know inhibitor of DXS be choose for a molecular dynamic simulation study the molecular dynamic simulation trajectory suggest high structural and thermodynamical stability and strong bind affinity of all the dxsligand complex moreover the mmpbsabased bind free energy calculation also exhibit strong interaction of the select ligand molecule with DXS in conclusion we have find that all four molecule display good result and strong bind affinity than the control in the end base on all the abovementioned criterion we have propose z3353989049 to be the promise lead candidate against DXS from iA baumanniiiCommunicated by ramaswamy H Sarma	2023 Feb	Mahrukh Parveez Zia, Ekampreet Singh, Monika Jain, Jayaraman Muthukumaran, Amit Kumar Singh	J Biomol Struct Dyn
36976013	genomic Characterization of CarbapenemResistant acinetobacter baumannii CRAB in mechanically ventilated covid19 patient and Impact of infection Control measure on reduce CRAB circulation during the second Wave of the sarscov2 Pandemic in Milan Italy	covid19 have significantly affect hospital infection prevention and control ipc practice especially in intensive care unit icus this frequently cause dissemination of multidrugresistant organism MDROs include carbapenemresistant acinetobacter baumannii CRAB here we report the management of a CRAB outbreak in a large icu covid19 hub Hospital in Italy together with retrospective genotypic analysis by wholegenome sequencing wgs bacterial strain obtain from severe covid19 mechanically ventilate patient diagnose with CRAB infection or colonization between October 2020 and May 2021 be analyze by wgs to assess antimicrobial resistance and virulence gene along with mobile genetic element phylogenetic analysis in combination with epidemiological datum be use to identify putative transmission chain CRAB infection and colonization be diagnose in 1440 35 and 2640 65 case respectively with isolation within 48 h from admission in 7 case 175 all CRAB strain belong to pasteur sequence type 2 ST2 and 5 different Oxford STs and present iblaisuboxa23sub genecarrying tni2006 I transposon phylogenetic analysis reveal the existence of four transmission chain inside and among icus circulate mainly between November and January 2021 a tailor ipc strategy be compose of a 5 point bundle include icu module temporary conversion to crabicus and dynamic reopening with limited impact on icu admission rate after its implementation no CRAB transmission chain be detect we study underly the potentiality of integrating classical epidemiological study with genomic investigation to identify transmission route during outbreak which could represent a valuable tool to ensure ipc strategy and prevent the spread of MDROs bimportanceb infection prevention and control ipc practice be of paramount importance for prevent the spread of multidrugresistant organism MDROs in hospital especially in the intensive care unit icu wholegenome sequencing wgs be see as a promise tool for ipc but its employment be currently still limited covid19 pandemic have pose dramatic challenge in ipc practice cause worldwide several outbreak of MDROs include carbapenemresistant acinetobacter baumannii CRAB we present the management of a CRAB outbreak in a large icu covid19 hub hospital in Italy use a tailor ipc strategy that allow we to contain CRAB transmission while prevent icu closure during a critical pandemic period the analysis of clinical and epidemiological datum couple with retrospective genotypic analysis by wgs identify different putative transmission chain and confirm the effectiveness of the ipc strategy implement this could be a promise approach for future ipc strategy	2023 Mar	Davide Mangioni, Valeria Fox, Liliane Chatenoud, Matteo Bolis, Nicola Bottino, Lisa Cariani, Flaminia Gentiloni Silverj, Caterina Matinato, Gianpaola Monti, Antonio Muscatello, Antonio Teri, Leonardo Terranova, Alessandra Piatti, Andrea Gori, Giacomo Grasselli, Nino Stocchetti, Claudia Alteri, Alessandra Bandera	Microbiol Spectr
